data_2kg0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kg0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 121.048 0.452 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -136.27 165.48 25.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.678 1.191 . . . . 0.0 108.451 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.62 1.34 37.7 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.961 -0.355 . . . . 0.0 112.447 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -61.56 144.54 54.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 117.66 0.73 . . . . 0.0 110.808 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 159' ' ' PHE . 10.7 p -151.77 176.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 124.116 0.966 . . . . 0.0 108.521 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 22.4 ttt180 -136.63 147.47 46.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.06 148.28 44.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -152.46 160.27 43.27 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.66 3.65 71.02 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 120' ' ' PHE . 83.5 mt -55.55 140.57 65.83 Favored Pre-proline 0 N--CA 1.453 -0.316 0 C-N-CA 123.321 0.648 . . . . 0.0 110.596 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 24.5 Cg_exo -58.85 16.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 125.172 3.915 . . . . 0.0 116.081 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.474 ' H ' ' C ' ' A' ' 118' ' ' LEU . 22.0 m-85 57.03 9.41 0.63 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.554 1.141 . . . . 0.0 112.847 -171.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.05 -3.16 1.51 Allowed Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.793 -0.567 . . . . 0.0 112.304 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 28.2 t -63.62 153.18 36.74 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 125' ' ' GLU . 5.7 t -150.47 -169.19 3.32 Favored 'General case' 0 CA--C 1.526 0.05 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.445 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -51.71 -33.69 35.48 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.139 0.427 . . . . 0.0 111.81 -178.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.462 ' H ' HG22 ' A' ' 123' ' ' THR . 40.4 tt0 -76.78 -22.67 53.4 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.447 0.699 . . . . 0.0 112.018 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.482 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 47.2 mm-40 -94.73 -33.87 12.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.431 -0.793 . . . . 0.0 109.33 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.412 HG13 ' SG ' ' A' ' 122' ' ' CYS . 54.0 mt -64.32 -34.57 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.33 -34.02 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.661 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -72.34 -26.6 61.99 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.898 172.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 19.3 t80 -72.09 -23.06 61.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.655 0.264 . . . . 0.0 110.549 175.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -118.14 32.87 5.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.397 1.079 . . . . 0.0 109.042 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.0 t -68.26 -11.67 59.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.122 0.569 . . . . 0.0 112.342 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.56 15.24 63.58 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.7 mt -144.14 -162.33 1.45 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.36 1.864 . . . . 0.0 107.196 -173.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -147.94 162.32 39.54 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.981 -0.449 . . . . 0.0 110.069 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.39 148.03 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 158' ' ' GLN . 21.0 m -73.83 153.71 89.12 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 118.588 0.631 . . . . 0.0 110.254 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.89 139.36 25.39 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 124.109 3.206 . . . . 0.0 112.477 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.5 t30 40.59 37.56 0.49 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.369 1.068 . . . . 0.0 111.988 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.86 27.73 13.62 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-O 118.72 -1.045 . . . . 0.0 112.057 -173.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.7 mt -133.37 145.3 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 119.375 1.588 . . . . 0.0 109.36 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.4 m -137.8 144.76 41.7 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.772 0.829 . . . . 0.0 109.158 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 87.2 mt -136.96 93.72 13.27 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 123.454 0.702 . . . . 0.0 110.029 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.5 150.84 32.91 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.221 2.614 . . . . 0.0 110.764 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -141.57 166.69 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.096 0 CA-C-O 121.437 0.637 . . . . 0.0 111.43 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.43 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 64.7 m-20 -92.3 176.99 2.3 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.721 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.43 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 35.3 Cg_exo -58.75 -19.18 44.98 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.962 2.441 . . . . 0.0 111.83 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -82.82 -7.56 59.65 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.526 0.73 . . . . 0.0 110.657 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.93 13.44 81.24 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.307 0.48 . . . . 0.0 112.323 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -105.61 149.07 26.64 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.5 pt -68.86 149.76 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.456 0.646 . . . . 0.0 111.493 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 45.4 p -74.91 -7.34 53.26 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.222 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.65 -0.75 36.61 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -140.37 170.72 15.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.066 0.546 . . . . 0.0 110.409 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -157.22 -178.69 7.55 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.269 0.628 . . . . 0.0 111.079 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -143.98 148.85 35.87 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.435 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 76.2 t -146.84 165.34 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 137' ' ' VAL . 40.8 tt0 -128.52 105.99 8.67 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 167.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.599 ' CE2' HG11 ' A' ' 113' ' ' VAL . 35.1 m-85 -74.69 173.01 11.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.389 170.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.19 90.7 0.9 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.192 0.52 . . . . 0.0 109.796 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.9 t 63.15 170.24 0.15 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.591 1.157 . . . . 0.0 112.415 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -22.06 65.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.5 0.72 . . . . 0.0 111.598 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.71 -43.48 75.92 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.907 -0.495 . . . . 0.0 111.032 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -39.15 84.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.511 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.19 -37.23 71.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.129 -0.357 . . . . 0.0 110.867 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -71.78 -28.86 63.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.896 -0.138 . . . . 0.0 110.902 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -72.98 -39.18 66.33 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.656 0.265 . . . . 0.0 110.549 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.53 -17.88 63.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.106 0.562 . . . . 0.0 112.195 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.33 -13.01 61.61 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.462 0.574 . . . . 0.0 111.366 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.05 -11.74 81.47 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.465 ' HB2' HG12 ' A' ' 183' ' ' VAL . 69.9 mmtt -88.54 0.55 56.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.296 1.438 . . . . 0.0 111.705 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -54.54 133.18 46.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.443 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 90.6 mttt 59.51 5.59 0.67 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.617 1.567 . . . . 0.0 114.075 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -76.95 170.41 16.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -112.59 158.31 20.12 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -169.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.1 tt -102.9 -9.52 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.574 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 154.43 -29.08 0.7 Allowed Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.935 -0.37 . . . . 0.0 112.611 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -157.51 0.96 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.411 0.605 . . . . 0.0 111.382 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -145.64 153.46 41.05 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.21 1.004 . . . . 0.0 108.508 -173.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -97.01 152.95 18.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.989 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 38.7 mm -127.47 162.2 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -128.71 160.37 32.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 171' ' ' LYS . 26.5 m -137.0 39.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 123.103 0.561 . . . . 0.0 111.674 -162.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 3.4 m-30 -52.71 152.87 3.5 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.922 0.489 . . . . 0.0 109.816 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -80.06 170.16 16.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.633 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 10.0 t -158.01 179.97 8.69 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.479 0.312 . . . . 0.0 110.821 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -148.18 170.53 17.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.284 1.433 . . . . 0.0 108.291 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -53.92 -31.81 51.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.74 -2.77 2.69 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -122.14 2.16 9.8 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.861 0.864 . . . . 0.0 111.013 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.56 11.55 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-O 120.968 0.413 . . . . 0.0 111.14 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -68.95 13.03 0.11 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 29.3 m -67.24 -1.98 5.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.393 0.677 . . . . 0.0 111.456 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.247 -1.358 . . . . 0.0 110.968 178.272 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.2 p30 . . . . . 0 N--CA 1.444 -0.727 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -128.07 7.13 6.01 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.07 -8.74 25.15 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -64.12 142.18 58.5 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.479 0.657 . . . . 0.0 111.608 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.616 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.4 p -152.92 177.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.435 1.094 . . . . 0.0 108.686 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.408 ' H ' HG21 ' A' ' 113' ' ' VAL . 65.0 ttt180 -135.65 153.66 51.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.951 0.9 . . . . 0.0 109.1 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -126.5 135.62 51.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -150.69 50.68 0.87 Allowed 'General case' 0 C--O 1.226 -0.166 0 CA-C-O 121.282 0.563 . . . . 0.0 112.443 -172.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -160.03 15.94 0.21 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.7 153.46 90.82 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -168.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 24.5 Cg_exo -59.44 143.63 99.65 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.754 2.303 . . . . 0.0 107.951 163.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -69.71 6.73 1.05 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.74 10.66 5.46 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 48.8 t -66.29 157.82 30.64 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.285 1.034 . . . . 0.0 111.404 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 125' ' ' GLU . 3.7 t -152.16 -174.8 5.0 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.248 0.619 . . . . 0.0 109.825 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.561 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -51.77 -34.01 37.7 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 123.378 0.671 . . . . 0.0 112.471 -176.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.447 ' H ' HG23 ' A' ' 123' ' ' THR . 40.2 tt0 -72.39 -25.96 61.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.016 0.527 . . . . 0.0 112.166 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -93.1 -30.7 15.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.76 -40.74 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.35 -34.51 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 O-C-N 122.159 -0.338 . . . . 0.0 111.193 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -74.34 -28.71 61.27 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.162 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 28.9 t80 -67.15 -21.21 65.82 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -115.41 37.15 3.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.341 1.056 . . . . 0.0 108.385 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.2 t -69.48 154.84 41.41 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 167.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.27 5.1 85.11 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.0 mt -141.78 -172.2 3.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.668 1.987 . . . . 0.0 106.01 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -147.79 162.6 38.89 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.634 -0.666 . . . . 0.0 110.845 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.7 mt -141.32 147.9 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 158' ' ' GLN . 19.4 m -72.64 154.47 91.42 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 118.459 0.572 . . . . 0.0 110.305 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -48.63 138.61 24.99 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.055 3.17 . . . . 0.0 112.179 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 t30 41.53 36.4 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.471 1.109 . . . . 0.0 112.014 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.25 28.64 10.31 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.793 -1.004 . . . . 0.0 111.739 -173.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.5 mt -136.56 145.75 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 119.061 1.431 . . . . 0.0 109.351 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.0 m -139.5 149.46 43.98 Favored 'General case' 0 N--CA 1.458 -0.048 0 C-N-CA 123.509 0.724 . . . . 0.0 109.827 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 11.9 mt -144.48 93.26 5.85 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 124.075 0.95 . . . . 0.0 109.649 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -55.72 159.61 11.12 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.813 3.009 . . . . 0.0 111.307 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.2 m -141.21 166.02 18.54 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 CA-C-O 121.216 0.531 . . . . 0.0 111.543 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 66.9 m-20 -90.05 176.48 3.01 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.831 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.421 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -58.85 -19.25 46.12 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.089 2.526 . . . . 0.0 111.736 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -82.81 -9.01 59.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.563 0.745 . . . . 0.0 110.745 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.35 11.16 80.98 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 123.384 0.516 . . . . 0.0 112.272 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -102.81 148.75 25.24 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.2 pt -68.17 151.23 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.912 0.863 . . . . 0.0 112.263 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.7 p -79.11 5.87 10.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.481 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.7 15.35 80.73 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -140.83 164.74 29.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.49 178.19 10.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.249 0.547 . . . . 0.0 110.465 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -144.71 145.18 31.59 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 67.9 t -143.79 162.98 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.414 ' O ' HG21 ' A' ' 137' ' ' VAL . 49.3 tt0 -129.17 101.83 6.19 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 169.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.616 ' CE2' HG11 ' A' ' 113' ' ' VAL . 43.6 m-85 -71.55 171.17 11.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.328 171.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.47 93.53 1.19 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 61.8 169.8 0.11 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.688 1.195 . . . . 0.0 111.343 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -61.99 -26.75 68.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.762 -0.586 . . . . 0.0 110.9 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.16 -42.48 90.84 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.243 -0.286 . . . . 0.0 111.119 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -38.79 69.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.53 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.91 -40.54 80.59 Favored 'General case' 0 N--CA 1.457 -0.101 0 O-C-N 122.013 -0.43 . . . . 0.0 110.898 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -67.83 -31.05 70.63 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.719 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -71.56 -39.46 70.63 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.632 0.253 . . . . 0.0 111.011 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.98 -15.39 62.21 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.96 -9.33 51.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.685 0.675 . . . . 0.0 111.524 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.14 -11.96 85.07 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.485 ' HB2' HG13 ' A' ' 183' ' ' VAL . 69.5 mmtt -85.74 2.81 43.97 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.243 1.417 . . . . 0.0 111.588 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -56.28 136.9 53.05 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.972 -0.455 . . . . 0.0 110.314 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 33.0 mttp 50.99 11.39 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.179 1.792 . . . . 0.0 114.242 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.02 179.36 5.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.259 1.024 . . . . 0.0 109.085 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -126.46 163.27 23.7 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -170.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mt -113.0 -13.13 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.277 1.031 . . . . 0.0 111.849 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.41 -27.1 1.37 Allowed Glycine 0 CA--C 1.528 0.901 0 O-C-N 121.922 -0.486 . . . . 0.0 113.975 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -153.05 11.49 0.47 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.843 0.822 . . . . 0.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.11 -173.57 3.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.445 1.098 . . . . 0.0 108.384 -172.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -137.06 144.14 43.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 19.0 mm -116.79 162.62 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -167.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -129.64 154.08 47.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 171' ' ' LYS . 34.5 m -131.24 33.66 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 C-N-CA 123.839 0.855 . . . . 0.0 111.011 -166.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -53.55 154.61 3.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -81.93 170.57 15.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.362 -0.837 . . . . 0.0 111.826 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.8 t -158.88 -173.7 4.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.521 0.328 . . . . 0.0 111.533 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 51.3 m -147.81 168.04 23.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.964 1.306 . . . . 0.0 109.174 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -56.91 -30.75 64.22 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.724 0.409 . . . . 0.0 110.897 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.84 -6.53 6.01 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -117.25 1.91 12.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.589 0.755 . . . . 0.0 111.312 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.61 15.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.269 0.557 . . . . 0.0 110.928 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -69.26 11.53 0.22 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.421 0.688 . . . . 0.0 112.811 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 65.8 p -69.29 -1.52 8.35 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.412 0.685 . . . . 0.0 111.243 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.746 -1.121 . . . . 0.0 110.959 177.949 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.4 p30 . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 120.452 0.168 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -125.15 4.26 7.87 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.5 -9.76 53.17 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -62.5 141.36 58.45 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.568 0.699 . . . . 0.0 110.596 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.629 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.5 p -150.6 172.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -137.34 152.83 50.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp -136.92 148.2 46.86 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -173.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -158.3 154.93 27.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.689 0.281 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.08 -7.08 60.22 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.59 HD11 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -63.82 157.99 64.07 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.881 0.341 . . . . 0.0 111.777 -176.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 21.8 Cg_exo -57.82 152.13 51.88 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.348 2.699 . . . . 0.0 112.522 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -67.89 -5.53 17.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.93 -0.89 31.91 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.436 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 41.8 t -68.2 153.01 44.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.344 0.657 . . . . 0.0 109.407 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.545 HG21 ' H ' ' A' ' 125' ' ' GLU . 8.7 t -154.31 -174.63 5.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 174.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.4 ptpp? -56.48 -20.69 21.34 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.545 ' H ' HG21 ' A' ' 123' ' ' THR . 42.2 mt-10 -82.18 -21.86 36.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.911 0.484 . . . . 0.0 111.218 177.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.411 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 60.2 mm-40 -90.74 -33.65 15.67 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.2 mt -61.4 -36.39 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.79 -33.63 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.002 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -75.66 -26.91 58.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.993 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -67.94 -27.57 66.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.413 ' CE1' ' HG3' ' A' ' 171' ' ' LYS . 42.9 m-85 -108.79 34.71 3.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.3 t -67.15 152.0 46.54 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.94 4.24 90.35 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -172.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.2 mt -139.49 -171.56 3.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.165 1.786 . . . . 0.0 106.543 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -146.95 162.54 38.52 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.858 -0.526 . . . . 0.0 110.691 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 mt -141.82 148.74 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.9 m -74.46 154.6 87.81 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 118.476 0.58 . . . . 0.0 110.422 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.15 140.01 26.05 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.073 3.182 . . . . 0.0 112.229 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.6 t30 41.77 34.9 0.45 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.36 1.064 . . . . 0.0 111.929 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.32 30.17 8.04 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-O 118.941 -0.922 . . . . 0.0 111.801 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.8 mt -138.35 146.94 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 118.902 1.351 . . . . 0.0 109.922 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.6 m -140.76 146.88 38.29 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 123.86 0.864 . . . . 0.0 109.643 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.4 mt -142.35 92.84 7.29 Favored Pre-proline 0 CA--C 1.528 0.104 0 C-N-CA 124.268 1.027 . . . . 0.0 109.395 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.99 156.4 15.84 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.584 2.856 . . . . 0.0 111.539 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.4 m -142.43 167.06 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-O 121.367 0.603 . . . . 0.0 110.914 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 61.7 m-20 -91.03 176.52 2.81 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.707 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.418 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 38.5 Cg_exo -58.07 -20.01 43.7 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.823 2.349 . . . . 0.0 111.712 176.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -80.66 -8.81 59.75 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.165 0.986 . . . . 0.0 111.219 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.53 2.52 90.54 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -174.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -79.14 134.66 36.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.007 1.323 . . . . 0.0 108.886 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.5 pt -68.52 146.52 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.579 0.704 . . . . 0.0 110.163 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.4 p -76.4 0.85 18.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.24 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 85.95 7.44 80.82 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -141.43 168.55 19.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.356 0.578 . . . . 0.0 110.347 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.1 179.43 9.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.308 0.575 . . . . 0.0 111.078 -173.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -143.56 146.21 33.14 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.463 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.2 t -146.38 164.72 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.419 ' O ' HG22 ' A' ' 137' ' ' VAL . 53.1 tt0 -129.51 102.58 6.45 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 169.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.629 ' CE2' HG11 ' A' ' 113' ' ' VAL . 37.9 m-85 -73.07 171.57 12.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.379 171.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 92.45 0.91 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.8 t 61.88 167.2 0.11 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.787 1.235 . . . . 0.0 111.488 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -14.2 61.99 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.904 -0.498 . . . . 0.0 111.091 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.404 ' HG2' ' HZ2' ' A' ' 167' ' ' LYS . 35.5 tt0 -68.61 -41.81 79.03 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 122.05 -0.406 . . . . 0.0 110.546 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.86 -39.67 72.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.51 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.44 -38.76 74.95 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.198 -0.314 . . . . 0.0 110.804 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -68.87 -29.82 68.2 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.764 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.404 ' HZ2' ' HG2' ' A' ' 163' ' ' GLU . 38.3 mttp -73.24 -38.15 66.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.622 0.248 . . . . 0.0 110.759 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.01 -16.81 63.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.75 -9.68 57.85 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.408 0.549 . . . . 0.0 111.548 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.19 -12.77 81.62 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.413 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 68.9 mmtt -82.74 -2.37 54.12 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 125.599 1.56 . . . . 0.0 111.973 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -52.69 133.11 36.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.651 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 56.37 9.69 0.56 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.202 1.801 . . . . 0.0 114.4 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.06 173.04 9.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.068 0.947 . . . . 0.0 108.82 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -125.4 160.27 29.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.796 -0.565 . . . . 0.0 112.169 -172.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.1 tt -113.04 -1.93 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.2 -36.92 0.65 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 121.731 -0.606 . . . . 0.0 113.685 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -155.62 6.87 0.23 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.533 0.666 . . . . 0.0 110.74 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.76 135.36 24.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -86.1 157.9 19.93 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.727 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 27.6 mm -125.05 160.85 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -127.5 156.24 42.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.407 HG12 ' HB2' ' A' ' 171' ' ' LYS . 33.1 m -131.71 130.71 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -137.19 153.91 50.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -76.42 164.09 26.33 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.692 0.678 . . . . 0.0 110.006 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -159.4 -175.35 5.16 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.45 0.167 . . . . 0.0 111.373 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.4 t -148.85 171.84 15.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.947 0.899 . . . . 0.0 110.011 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -60.24 -28.61 68.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.269 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.63 -0.94 2.31 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.8 0.84 . . . . 0.0 112.571 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.59 2.37 7.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.542 0.737 . . . . 0.0 111.601 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 193' ' ' SER . 9.4 p -144.72 10.53 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 122.131 -0.356 . . . . 0.0 111.866 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -69.75 15.6 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 191' ' ' VAL . 34.2 m -68.61 -0.48 5.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.593 0.757 . . . . 0.0 111.087 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.237 -1.363 . . . . 0.0 111.244 178.105 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -129.39 5.16 5.19 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.72 -10.16 52.58 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -63.11 141.18 58.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.563 0.696 . . . . 0.0 110.471 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.623 HG13 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -150.92 175.94 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.932 -177.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -135.4 154.16 51.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 109.28 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.9 tp -139.3 150.28 45.23 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -156.72 157.78 35.73 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.13 -5.13 71.62 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.615 ' H ' HD12 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.93 155.95 90.59 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 116.94 0.37 . . . . 0.0 111.529 -176.437 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 31.3 Cg_exo -54.65 151.25 32.32 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.125 3.217 . . . . 0.0 112.183 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.88 -8.74 16.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.05 0.387 . . . . 0.0 111.688 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.57 -0.1 30.79 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.457 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 44.6 t -64.25 153.77 37.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.292 0.637 . . . . 0.0 109.293 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.566 HG21 ' H ' ' A' ' 125' ' ' GLU . 10.4 t -154.87 -176.17 5.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.441 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 0.9 OUTLIER -57.29 -21.75 36.88 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.566 ' H ' HG21 ' A' ' 123' ' ' THR . 39.4 tt0 -78.74 -25.23 44.5 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.19 0.596 . . . . 0.0 110.744 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -87.9 -37.08 16.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.31 -35.06 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.0 p -79.69 -32.45 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.712 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -75.32 -28.05 59.5 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.961 172.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -66.05 -26.42 67.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -111.77 32.58 5.34 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.838 0.855 . . . . 0.0 109.017 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.0 t -64.31 148.89 49.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.59 3.71 86.12 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -172.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 17.9 mt -138.53 -170.55 2.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.744 1.617 . . . . 0.0 106.715 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -146.78 162.2 39.05 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.87 -0.519 . . . . 0.0 110.374 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.3 mt -142.04 148.44 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.6 m -73.29 154.49 90.19 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 118.595 0.634 . . . . 0.0 110.369 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.1 138.74 27.74 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 124.074 3.183 . . . . 0.0 112.155 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.1 t30 41.65 35.81 0.52 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.313 1.045 . . . . 0.0 112.047 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.04 29.96 8.13 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 119.04 -0.867 . . . . 0.0 111.895 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.9 mt -138.24 145.54 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.775 1.288 . . . . 0.0 109.658 -176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 86.3 m -139.59 150.2 44.74 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 123.822 0.849 . . . . 0.0 109.621 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 92.6 mt -139.81 90.77 10.8 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.829 0.852 . . . . 0.0 110.093 -174.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.47 153.87 21.56 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.468 2.779 . . . . 0.0 111.813 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.5 m -142.57 169.09 13.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 121.382 0.61 . . . . 0.0 111.207 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 59.5 m-20 -96.12 177.46 1.73 Allowed Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.105 0.962 . . . . 0.0 108.781 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.418 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 40.5 Cg_exo -58.04 -20.55 45.99 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.952 2.435 . . . . 0.0 111.625 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.26 -10.7 59.61 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.184 0.994 . . . . 0.0 110.956 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.22 4.39 86.5 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -83.43 136.31 34.36 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.068 1.347 . . . . 0.0 108.806 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.1 pt -66.98 148.01 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 121.79 0.805 . . . . 0.0 110.754 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.6 p -75.26 -0.69 20.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.16 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 88.28 5.94 75.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -138.53 169.78 17.17 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.279 0.54 . . . . 0.0 110.207 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.81 179.13 9.39 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.212 0.605 . . . . 0.0 110.798 -174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -143.65 145.55 32.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 60.2 t -145.81 164.59 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.418 ' O ' HG22 ' A' ' 137' ' ' VAL . 52.6 tt0 -129.19 102.22 6.36 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.623 ' CE2' HG13 ' A' ' 113' ' ' VAL . 44.6 m-85 -72.74 171.2 13.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.263 172.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.86 92.73 0.71 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t 61.67 168.67 0.11 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.758 1.223 . . . . 0.0 111.505 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -14.66 62.68 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.95 -0.469 . . . . 0.0 111.24 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.07 -42.4 76.27 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 122.052 -0.405 . . . . 0.0 110.679 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -38.89 73.24 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.523 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.48 -39.04 75.55 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.279 -0.263 . . . . 0.0 110.717 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -69.02 -29.05 67.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.892 -0.14 . . . . 0.0 110.956 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -73.52 -38.19 65.38 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.095 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.8 -21.65 66.04 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 97.0 mt -70.35 -7.71 44.88 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 122.847 0.459 . . . . 0.0 111.733 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.04 -15.47 81.37 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -76.07 -55.02 5.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.257 1.023 . . . . 0.0 110.856 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.418 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 0.7 OUTLIER 23.86 -101.79 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.863 1.265 . . . . 0.0 113.052 -165.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -71.18 19.55 0.05 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -174.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.28 178.74 0.18 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.003 0.921 . . . . 0.0 111.099 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -128.58 161.18 30.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.343 0.657 . . . . 0.0 110.746 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.0 tt -117.94 -0.08 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.42 -36.17 0.64 Allowed Glycine 0 CA--C 1.529 0.953 0 O-C-N 122.046 -0.409 . . . . 0.0 113.422 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -156.72 5.74 0.16 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.314 0.557 . . . . 0.0 110.489 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -146.51 156.17 43.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.514 1.126 . . . . 0.0 108.485 -170.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -104.07 153.81 20.44 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.373 0.606 . . . . 0.0 110.113 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 30.1 mm -120.12 172.14 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -172.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.409 ' HA ' ' HD1' ' A' ' 172' ' ' HIS . 21.8 mt-10 -139.54 155.94 47.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.418 ' CG2' ' HA ' ' A' ' 172' ' ' HIS . 22.2 m -130.71 137.5 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -148.18 160.49 42.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -80.18 165.32 22.54 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.677 0.671 . . . . 0.0 110.778 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.7 t -158.74 -174.41 4.76 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.144 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.6 t -147.98 171.85 15.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.162 0.985 . . . . 0.0 109.796 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -59.36 -31.39 69.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.652 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.78 -6.02 7.15 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.678 0.791 . . . . 0.0 112.537 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -118.45 3.01 11.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.598 0.759 . . . . 0.0 111.168 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' A' ' 193' ' ' SER . 8.5 p -145.26 9.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 122.272 -0.267 . . . . 0.0 111.613 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -69.26 13.5 0.12 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 191' ' ' VAL . 24.7 m -67.14 -1.16 3.97 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.509 0.723 . . . . 0.0 111.205 176.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.287 177.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.027 0.442 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -121.7 7.65 9.98 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.64 -9.77 41.26 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -61.27 138.63 58.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.731 0.776 . . . . 0.0 110.823 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.581 HG12 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -150.27 174.97 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.235 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 58.4 ttt180 -136.58 155.38 50.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.3 tp -138.28 147.4 43.59 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -173.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -154.72 162.48 41.1 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.83 1.45 58.65 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.6 mt -56.97 150.04 41.3 Favored Pre-proline 0 N--CA 1.453 -0.292 0 C-N-CA 123.23 0.612 . . . . 0.0 111.982 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.27 26.16 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 1 C-N-CA 125.346 4.031 . . . . 0.0 113.522 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.582 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 15.4 m-30 53.47 13.85 0.5 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.903 1.281 . . . . 0.0 114.162 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.02 -13.99 0.58 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.994 0.815 . . . . 0.0 112.724 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.4 m -67.35 153.5 43.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.448 0.624 . . . . 0.0 110.389 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 t -147.23 -160.8 1.21 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.93 0.892 . . . . 0.0 108.733 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.487 ' HE3' ' CD1' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -50.34 -31.26 14.07 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -84.07 -19.64 33.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -96.27 -31.54 12.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.756 -0.59 . . . . 0.0 109.816 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.4 mt -62.98 -36.31 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 172.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.7 p -79.32 -32.2 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.921 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -74.15 -30.66 62.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.248 172.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.89 -22.06 65.98 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 118.267 0.485 . . . . 0.0 110.111 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -115.84 31.44 6.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.516 1.126 . . . . 0.0 109.214 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.6 t -63.06 139.58 58.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.87 1.75 90.63 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.8 mt -138.82 78.37 1.67 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.153 1.381 . . . . 0.0 107.673 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -50.07 160.01 0.38 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.858 0.863 . . . . 0.0 113.293 -174.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.1 mt -136.41 153.18 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.93 155.36 32.61 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 122.597 0.359 . . . . 0.0 110.592 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.99 -31.0 7.8 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.84 3.693 . . . . 0.0 114.084 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -160.12 105.57 1.54 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.04 20.93 1.11 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-O 118.686 -1.063 . . . . 0.0 112.756 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.2 mt -117.48 147.26 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 119.257 1.529 . . . . 0.0 110.271 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.4 m -142.11 144.87 33.72 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.958 0.903 . . . . 0.0 109.49 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.487 ' CD1' ' HE3' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -139.65 97.81 8.12 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 123.793 0.837 . . . . 0.0 110.047 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.18 154.9 31.68 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.871 3.047 . . . . 0.0 110.998 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.32 168.83 13.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-O 121.408 0.623 . . . . 0.0 111.503 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.424 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 62.9 m-20 -95.13 176.64 2.17 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.549 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.424 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -58.08 -19.6 41.81 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.976 2.451 . . . . 0.0 111.913 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.23 -8.14 59.7 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.166 0.986 . . . . 0.0 111.117 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.08 2.76 89.19 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.582 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 80.0 tttt -81.08 134.2 35.62 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.922 1.289 . . . . 0.0 108.304 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.1 148.93 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.505 0.669 . . . . 0.0 109.753 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 53.4 p -72.4 1.46 7.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.989 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 95.75 0.95 62.05 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -140.96 169.71 17.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.913 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.65 -177.89 6.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -144.66 146.46 32.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.492 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 84.4 t -146.16 163.2 10.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -130.87 94.6 3.64 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.274 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.581 ' CE2' HG12 ' A' ' 113' ' ' VAL . 53.3 m-85 -65.69 170.66 4.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.89 93.37 0.76 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.4 t 62.36 168.28 0.12 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.774 1.23 . . . . 0.0 111.392 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -62.12 -27.55 69.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.713 -0.617 . . . . 0.0 110.901 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.42 -41.28 93.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.198 -0.314 . . . . 0.0 111.016 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -37.88 71.69 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -59.1 -38.48 79.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.83 -0.544 . . . . 0.0 110.648 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -68.87 -31.31 70.16 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.45 0.3 . . . . 0.0 110.572 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -71.0 -40.06 72.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.574 0.226 . . . . 0.0 110.59 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.47 -15.08 62.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.62 -11.84 55.4 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.829 0.741 . . . . 0.0 111.934 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.0 -10.65 84.11 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.409 ' HB2' HG12 ' A' ' 183' ' ' VAL . 65.5 mmtt -88.02 -3.38 58.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.214 1.406 . . . . 0.0 112.893 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.457 ' CD2' ' HZ3' ' A' ' 173' ' ' LYS . 6.4 t60 -43.29 -21.47 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.457 ' HZ3' ' CD2' ' A' ' 172' ' ' HIS . 60.0 mttp -139.58 18.56 2.53 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.522 1.055 . . . . 0.0 111.798 176.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -76.29 -175.65 3.29 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 122.97 0.508 . . . . 0.0 110.323 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -134.57 163.42 29.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.09 -13.44 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.544 0.738 . . . . 0.0 111.971 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.95 -31.68 0.5 Allowed Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.74 -0.6 . . . . 0.0 113.986 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -152.56 2.96 0.34 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.649 0.725 . . . . 0.0 110.909 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -144.69 155.11 43.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.362 1.065 . . . . 0.0 108.164 -174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -106.78 151.22 25.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.272 0.558 . . . . 0.0 110.037 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.8 mm -121.19 159.93 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -171.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -133.44 145.92 50.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 171' ' ' LYS . 18.0 m -115.98 136.84 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 9.1 m-85 -137.24 154.27 50.19 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -76.05 163.0 27.57 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.068 0.849 . . . . 0.0 110.544 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.3 t -158.89 -175.43 5.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.8 m -148.66 170.94 17.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.05 1.34 . . . . 0.0 109.269 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -57.87 -31.77 67.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.877 0.471 . . . . 0.0 111.394 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.37 -5.18 9.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -115.71 2.26 13.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.728 0.811 . . . . 0.0 111.005 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 193' ' ' SER . 8.7 p -142.35 9.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 111.18 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -70.22 16.34 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.374 0.67 . . . . 0.0 112.797 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 191' ' ' VAL . 30.0 m -68.45 -0.51 5.06 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.6 0.76 . . . . 0.0 111.23 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.373 178.379 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.8 p30 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -122.47 8.58 9.6 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.14 -8.75 49.63 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -61.77 141.36 57.94 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.553 0.692 . . . . 0.0 110.612 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.616 HG13 ' CE2' ' A' ' 159' ' ' PHE . 7.2 p -151.05 175.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -137.01 154.04 50.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.7 tp -133.08 148.32 52.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -152.89 160.66 43.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.82 3.93 70.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.33 150.01 45.32 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 117.118 0.459 . . . . 0.0 111.97 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.11 25.25 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 125.143 3.895 . . . . 0.0 113.66 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.62 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 22.6 m-30 52.35 13.48 0.3 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.071 1.348 . . . . 0.0 114.192 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.29 -8.86 1.11 Allowed Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.861 0.755 . . . . 0.0 112.458 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 7.0 t -59.62 149.62 29.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.218 1.007 . . . . 0.0 110.953 174.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 2.4 t -141.16 -167.86 2.49 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.465 0.706 . . . . 0.0 109.298 172.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.552 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.8 mptt -51.18 -29.2 13.22 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.436 0.562 . . . . 0.0 112.356 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -81.22 -19.91 42.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.446 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 5.7 mp0 -92.98 -33.91 13.95 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.773 -0.58 . . . . 0.0 109.439 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.42 -34.9 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.4 p -84.1 -32.45 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.007 -173.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -72.91 -27.57 61.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -70.77 -25.94 63.12 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.739 0.304 . . . . 0.0 110.429 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -113.71 32.77 5.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.459 1.104 . . . . 0.0 109.016 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.0 t -67.3 -17.01 64.6 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.965 0.506 . . . . 0.0 111.983 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.36 15.41 60.04 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.8 mt -143.73 -163.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.207 1.803 . . . . 0.0 107.403 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -146.94 162.61 38.36 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.3 mt -142.16 150.86 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.2 155.23 86.24 Favored Pre-proline 0 C--O 1.232 0.135 0 O-C-N 122.032 -0.417 . . . . 0.0 110.471 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.09 136.81 29.81 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 124.006 3.137 . . . . 0.0 112.245 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.6 t30 40.05 38.92 0.55 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.448 1.099 . . . . 0.0 112.07 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.67 28.19 13.25 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-O 118.859 -0.967 . . . . 0.0 111.876 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.96 147.15 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 118.99 1.395 . . . . 0.0 109.548 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 88.6 m -138.47 148.38 44.29 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.073 0.949 . . . . 0.0 108.991 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 6.3 mt -145.74 99.04 4.43 Favored Pre-proline 0 N--CA 1.453 -0.315 0 C-N-CA 123.091 0.557 . . . . 0.0 110.225 -174.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.7 157.59 18.94 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.499 2.8 . . . . 0.0 110.334 171.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.3 m -145.68 163.73 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-O 121.427 0.632 . . . . 0.0 111.324 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.401 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 57.8 m-20 -89.69 175.5 3.82 Favored Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.579 174.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.5 Cg_exo -57.95 -20.46 44.88 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.734 2.289 . . . . 0.0 111.385 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -79.48 -9.96 59.71 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.102 0.961 . . . . 0.0 111.252 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.56 0.7 90.06 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -173.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.62 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 85.3 tttt -72.28 131.79 43.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.914 1.286 . . . . 0.0 108.891 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.518 ' C ' ' H ' ' A' ' 153' ' ' GLY . 8.4 pt -71.88 10.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -169.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p 67.49 -15.71 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.532 1.133 . . . . 0.0 112.197 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 101.33 6.44 50.94 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.338 0.971 . . . . 0.0 112.814 175.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -142.68 168.82 18.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.058 0.929 . . . . 0.0 111.936 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.11 -178.82 7.59 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.671 0.788 . . . . 0.0 110.59 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -143.59 146.24 33.14 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -177.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.45 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.3 t -146.42 165.01 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -174.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -129.46 96.15 4.2 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.68 0.753 . . . . 0.0 109.009 170.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.616 ' CE2' HG13 ' A' ' 113' ' ' VAL . 36.3 m-85 -68.6 172.07 6.74 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.23 93.45 1.09 Allowed 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t 61.27 168.73 0.1 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.683 1.193 . . . . 0.0 111.455 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -61.73 -27.3 68.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.76 -0.587 . . . . 0.0 110.65 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.32 -36.21 79.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.05 -0.406 . . . . 0.0 111.515 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 159' ' ' PHE . 0.8 OUTLIER -74.76 -40.0 61.47 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.14 -37.89 72.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 122.296 -0.252 . . . . 0.0 110.614 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -68.74 -32.12 71.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.601 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -71.3 -38.56 71.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.581 0.229 . . . . 0.0 110.795 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.52 -18.46 63.84 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.821 0.448 . . . . 0.0 112.033 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.418 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 93.9 mt -65.95 -14.37 61.45 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.641 0.655 . . . . 0.0 111.836 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.86 -10.26 80.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.425 ' HB2' HG13 ' A' ' 183' ' ' VAL . 63.6 mmtt -90.58 -1.97 57.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.814 1.246 . . . . 0.0 112.606 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -43.93 -19.92 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.42 17.02 2.39 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.364 0.984 . . . . 0.0 111.833 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -75.65 -173.78 2.3 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-O 120.997 0.427 . . . . 0.0 110.119 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -134.43 166.21 23.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -170.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.6 -19.83 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 124.633 1.173 . . . . 0.0 109.989 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 179' ' ' ARG . . . 137.02 135.48 3.39 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 45.32 2.47 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.791 2.036 . . . . 0.0 115.215 -173.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 177' ' ' GLY . 52.3 ttm-85 -151.46 166.8 29.98 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.188 0.595 . . . . 0.0 110.143 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -120.78 155.09 34.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.4 mm -123.44 162.57 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -170.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -134.37 150.6 50.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 171' ' ' LYS . 19.7 m -119.77 135.6 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -134.84 153.48 52.02 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -76.49 162.95 27.39 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.674 -0.641 . . . . 0.0 110.629 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.5 t -158.86 -175.93 5.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.3 m -148.18 168.95 21.13 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.249 1.419 . . . . 0.0 109.192 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -57.44 -31.91 66.37 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.734 0.414 . . . . 0.0 111.173 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.87 -16.74 59.89 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -102.35 0.44 34.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.405 0.682 . . . . 0.0 111.47 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.1 p -143.35 14.33 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.002 0.43 . . . . 0.0 111.027 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -69.45 13.45 0.13 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.4 m -68.01 -0.68 4.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.592 0.757 . . . . 0.0 111.199 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.094 178.541 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 110.865 -0.05 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -136.89 2.63 2.63 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.57 -10.23 75.2 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 122.08 -0.388 . . . . 0.0 112.66 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -65.44 150.34 48.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.593 0.711 . . . . 0.0 110.323 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.59 HG13 ' CE2' ' A' ' 159' ' ' PHE . 7.0 p -153.11 175.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.676 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -132.32 153.75 50.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.378 1.071 . . . . 0.0 108.673 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.1 tp -137.4 146.52 44.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -152.6 169.41 22.74 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.85 8.59 86.53 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 120' ' ' PHE . 89.5 mt -57.18 142.65 74.72 Favored Pre-proline 0 N--CA 1.451 -0.412 0 C-N-CA 122.858 0.463 . . . . 0.0 111.9 -174.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.99 27.45 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 125.235 3.956 . . . . 0.0 113.609 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 118' ' ' LEU . 83.3 m-85 54.79 8.13 0.2 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.03 1.332 . . . . 0.0 114.536 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -136.81 -5.13 1.98 Allowed Glycine 0 CA--C 1.528 0.87 0 CA-C-N 118.786 0.721 . . . . 0.0 112.169 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 44.4 t -61.62 153.04 29.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.69 0.796 . . . . 0.0 111.147 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 t -156.16 -163.35 1.45 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -46.17 -39.26 9.39 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.428 0.691 . . . . 0.0 112.679 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -83.72 -15.3 49.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.5 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 65.5 mm-40 -98.81 -31.47 11.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.401 HG13 ' SG ' ' A' ' 122' ' ' CYS . 32.5 mt -64.37 -37.68 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 172.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.4 -33.16 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.528 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -74.14 -25.89 60.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.137 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 181' ' ' ILE . 53.8 t80 -71.78 -20.35 61.88 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.872 0.305 . . . . 0.0 110.667 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -120.94 33.59 5.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.481 1.112 . . . . 0.0 108.455 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -64.0 -17.63 63.5 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.16 0.584 . . . . 0.0 112.439 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.27 15.28 58.74 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.4 mt -144.04 -162.53 1.49 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.486 1.514 . . . . 0.0 108.457 -172.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -145.97 163.04 36.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.9 mt -142.25 150.32 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.3 m -74.55 155.99 87.15 Favored Pre-proline 0 CA--C 1.53 0.177 0 O-C-N 121.995 -0.441 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.83 133.48 22.43 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 124.196 3.264 . . . . 0.0 112.464 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.2 t30 38.62 39.34 0.32 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.582 1.153 . . . . 0.0 112.16 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.5 35.36 3.97 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-O 119.044 -0.864 . . . . 0.0 111.246 -174.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -137.84 146.68 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 118.74 1.27 . . . . 0.0 109.42 -176.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.3 m -138.23 144.23 40.5 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 123.574 0.749 . . . . 0.0 109.166 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.5 mt -137.78 87.28 17.19 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 123.71 0.804 . . . . 0.0 109.396 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.67 158.85 18.67 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.095 2.53 . . . . 0.0 110.855 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 150' ' ' LYS . 31.3 m -141.42 160.34 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 121.552 0.691 . . . . 0.0 112.24 174.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 148' ' ' GLU . 22.0 m-20 -83.54 174.12 6.43 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.826 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 33.7 Cg_exo -59.9 -2.65 1.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.274 3.316 . . . . 0.0 113.045 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 146' ' ' ASP . 30.8 tt0 -117.15 1.38 12.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.799 0.839 . . . . 0.0 110.759 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.06 2.83 88.06 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 22.3 mtpt -69.54 161.31 29.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.487 ' C ' ' H ' ' A' ' 153' ' ' GLY . 4.8 pt -95.95 13.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -167.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 p 62.71 -3.37 0.31 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.916 0.886 . . . . 0.0 112.358 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 77.27 6.02 85.95 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.779 1.181 . . . . 0.0 113.014 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -142.41 168.41 19.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.238 1.019 . . . . 0.0 111.72 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.27 -177.98 6.99 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.059 0.944 . . . . 0.0 110.453 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -145.56 148.11 32.81 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.451 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 61.7 t -146.11 165.0 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -129.74 95.85 4.08 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.74 0.781 . . . . 0.0 108.982 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.59 ' CE2' HG13 ' A' ' 113' ' ' VAL . 46.1 m-85 -69.03 170.9 9.02 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.763 174.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.29 94.05 0.9 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.7 t 62.66 168.44 0.13 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.538 1.135 . . . . 0.0 111.621 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -61.86 -26.05 67.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.61 -36.55 84.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.035 0.379 . . . . 0.0 111.704 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.64 -39.97 64.11 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.484 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.05 -34.76 70.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.293 -0.254 . . . . 0.0 110.631 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -69.16 -32.15 71.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.336 0.255 . . . . 0.0 110.516 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -72.53 -38.05 68.15 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.766 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.01 -19.56 64.47 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.113 0.565 . . . . 0.0 112.341 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 95.2 mt -67.65 -8.46 34.96 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.584 0.629 . . . . 0.0 111.284 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.66 8.09 66.88 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -118.76 3.7 11.62 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 123.852 0.861 . . . . 0.0 111.289 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.444 ' CD2' ' HZ2' ' A' ' 173' ' ' LYS . 5.3 t60 -42.2 -24.48 0.05 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.444 ' HZ2' ' CD2' ' A' ' 172' ' ' HIS . 61.1 mttp -137.5 18.32 2.91 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.355 0.98 . . . . 0.0 110.897 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -81.57 174.12 11.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.711 1.604 . . . . 0.0 108.792 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -120.35 158.46 27.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.2 tt -98.09 -12.51 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.499 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.87 -26.66 1.77 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.248 0.451 . . . . 0.0 112.209 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -155.4 5.83 0.22 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.148 0.579 . . . . 0.0 110.789 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -145.75 160.57 41.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.556 1.142 . . . . 0.0 108.197 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -107.93 145.27 34.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 130' ' ' PHE . 31.3 mm -122.02 160.62 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -129.98 144.86 51.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 169' ' ' LEU . 11.0 m -119.3 143.21 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -150.41 156.01 40.67 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -73.71 156.77 37.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.983 0.42 . . . . 0.0 110.696 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.7 t -157.68 -177.06 6.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.118 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.6 t -152.08 174.8 13.25 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.14 0.976 . . . . 0.0 109.558 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.6 tp60 -59.03 -31.7 69.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.726 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.09 -3.8 6.19 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -118.79 2.95 11.65 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.664 0.786 . . . . 0.0 111.308 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 193' ' ' SER . 7.8 p -144.5 10.51 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.913 0.387 . . . . 0.0 111.204 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -68.2 14.12 0.07 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 191' ' ' VAL . 25.0 m -68.69 -0.58 5.44 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.433 0.693 . . . . 0.0 111.239 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.079 178.371 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.6 p30 . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -118.15 7.45 12.15 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.03 -8.91 42.68 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.93 139.96 58.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.423 0.63 . . . . 0.0 110.705 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.621 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.4 p -149.51 175.81 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.205 1.002 . . . . 0.0 108.764 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -137.49 144.42 42.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.06 0.544 . . . . 0.0 109.743 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.02 152.25 36.76 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.457 ' HE ' ' HB3' ' A' ' 154' ' ' GLU . 19.3 tpp85 -157.6 152.1 25.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.27 2.45 90.59 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 171.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.59 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -68.25 158.49 84.27 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 37.7 Cg_exo -52.21 153.66 12.44 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.026 2.484 . . . . 0.0 114.311 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -68.25 -1.55 6.42 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.944 0.497 . . . . 0.0 111.802 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.77 2.96 10.97 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.446 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 52.5 t -66.3 153.51 42.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.025 0.93 . . . . 0.0 109.605 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.561 HG21 ' H ' ' A' ' 125' ' ' GLU . 10.0 t -154.97 -175.24 5.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 2.4 ptpp? -56.45 -22.06 29.57 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.561 ' H ' HG21 ' A' ' 123' ' ' THR . 40.8 tt0 -77.72 -25.07 49.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.242 0.617 . . . . 0.0 110.899 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.408 ' HB2' ' HG ' ' A' ' 122' ' ' CYS . 60.3 mm-40 -89.05 -35.52 16.3 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.6 -34.35 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.58 -34.07 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.658 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -73.17 -25.72 60.9 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.921 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -72.04 -25.97 62.01 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.64 0.257 . . . . 0.0 110.336 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -111.29 30.5 6.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.531 1.132 . . . . 0.0 109.022 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.6 t -65.74 -14.68 61.78 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.753 0.421 . . . . 0.0 111.865 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.17 15.26 63.32 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.4 mt -143.26 -162.8 1.51 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.249 1.819 . . . . 0.0 107.35 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -147.15 162.29 39.16 Favored 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.2 mt -142.38 152.09 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.9 m -77.65 153.86 81.09 Favored Pre-proline 0 CA--C 1.528 0.105 0 CA-C-N 118.153 0.433 . . . . 0.0 110.683 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.37 140.7 34.11 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.097 3.198 . . . . 0.0 112.094 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 42.02 36.39 0.67 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.201 1.0 . . . . 0.0 111.929 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -99.76 29.28 12.37 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 118.898 -0.945 . . . . 0.0 111.943 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 77.6 mt -137.72 146.07 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.847 1.324 . . . . 0.0 110.2 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.1 m -142.17 147.55 36.8 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.009 0.924 . . . . 0.0 109.728 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.4 mt -140.78 96.48 7.48 Favored Pre-proline 0 CA--C 1.527 0.094 0 C-N-CA 124.243 1.017 . . . . 0.0 109.849 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.74 154.88 8.73 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.713 2.942 . . . . 0.0 112.019 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.77 165.13 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-O 121.244 0.545 . . . . 0.0 110.467 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.432 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 67.7 m-20 -86.13 176.4 3.62 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.929 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.432 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -59.1 -17.77 40.17 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.102 2.535 . . . . 0.0 111.85 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -86.89 -4.69 59.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.594 0.758 . . . . 0.0 110.789 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.46 11.15 83.58 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 123.477 0.56 . . . . 0.0 112.534 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -102.22 149.81 23.93 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 117.455 0.628 . . . . 0.0 109.55 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.6 pt -69.22 151.87 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.729 0.776 . . . . 0.0 112.606 -170.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.3 p -86.98 -7.14 58.45 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.144 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.74 6.36 57.25 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-O 119.768 -0.462 . . . . 0.0 112.781 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.457 ' HB3' ' HE ' ' A' ' 116' ' ' ARG . 23.0 pt-20 -140.02 168.45 19.79 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.433 0.617 . . . . 0.0 110.546 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.21 178.51 10.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.069 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -141.57 143.95 33.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.453 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 69.6 t -144.56 162.61 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -174.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -128.51 97.62 4.77 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.863 0.84 . . . . 0.0 109.02 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.621 ' CE2' HG11 ' A' ' 113' ' ' VAL . 38.5 m-85 -69.07 171.57 8.03 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.433 173.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.29 92.57 0.79 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t 61.33 170.42 0.11 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.757 1.223 . . . . 0.0 111.423 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -62.63 -27.18 69.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.818 -0.551 . . . . 0.0 110.696 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.48 -41.56 85.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.153 -0.342 . . . . 0.0 111.133 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.51 -39.55 67.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.497 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.66 -38.26 74.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.002 -0.436 . . . . 0.0 110.93 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -69.27 -30.05 68.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.755 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -72.58 -38.93 67.74 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 120.46 0.172 . . . . 0.0 111.082 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.411 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.39 -19.39 64.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.766 0.427 . . . . 0.0 112.127 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.4 mt -69.19 -11.65 60.98 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.842 -0.536 . . . . 0.0 111.345 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.87 -13.24 80.84 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.422 ' HB2' HG12 ' A' ' 183' ' ' VAL . 70.3 mmtt -83.41 -1.04 52.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.299 1.439 . . . . 0.0 111.924 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.462 ' CD2' ' HZ2' ' A' ' 173' ' ' LYS . 6.1 t60 -54.81 134.81 48.1 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.248 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.462 ' HZ2' ' CD2' ' A' ' 172' ' ' HIS . 47.6 mttp 56.85 6.33 0.3 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.993 1.717 . . . . 0.0 114.567 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.13 172.49 11.63 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.051 0.94 . . . . 0.0 109.325 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -123.05 158.85 29.68 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.949 -0.47 . . . . 0.0 112.197 -170.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.6 tt -112.75 -2.24 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.08 -32.43 0.66 Allowed Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.931 -0.481 . . . . 0.0 113.936 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -156.45 4.21 0.16 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.85 0.825 . . . . 0.0 111.163 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -147.74 159.68 43.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.252 1.021 . . . . 0.0 108.477 -170.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -109.02 130.16 55.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.411 0.624 . . . . 0.0 109.968 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.55 166.53 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -130.65 154.14 48.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 171' ' ' LYS . 24.4 m -135.79 125.2 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -133.47 163.69 28.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.418 ' HG2' ' H ' ' A' ' 186' ' ' SER . 8.5 tttm -88.64 169.11 11.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.456 1.025 . . . . 0.0 111.598 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.418 ' H ' ' HG2' ' A' ' 185' ' ' LYS . 8.6 t -158.32 -177.22 6.38 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.084 0.554 . . . . 0.0 111.156 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.1 m -149.35 168.77 22.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.144 1.378 . . . . 0.0 108.69 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -56.43 -32.54 64.98 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.45 0.3 . . . . 0.0 111.641 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.54 -2.43 6.57 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -117.0 3.02 12.77 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.964 0.906 . . . . 0.0 110.8 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 193' ' ' SER . 7.6 p -143.27 11.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 121.221 0.534 . . . . 0.0 110.825 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -68.06 13.77 0.08 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.85 0.86 . . . . 0.0 113.068 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 191' ' ' VAL . 24.4 m -68.28 -1.24 5.86 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.57 0.748 . . . . 0.0 111.254 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.125 178.564 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.1 p30 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.359 0.123 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.83 2.54 6.67 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.09 -10.19 51.21 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.395 174.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -64.04 143.61 57.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.428 0.632 . . . . 0.0 110.372 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.645 HG13 ' CE2' ' A' ' 159' ' ' PHE . 9.9 p -150.81 178.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.911 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.427 ' H ' HG21 ' A' ' 113' ' ' VAL . 5.8 mtm180 -133.28 165.07 25.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.318 0.647 . . . . 0.0 111.087 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.8 tp -147.23 145.16 29.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -154.82 171.2 20.0 Favored 'General case' 0 CA--C 1.527 0.084 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.72 10.45 86.23 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 120' ' ' PHE . 95.2 mt -55.15 149.65 24.5 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 123.289 0.636 . . . . 0.0 111.494 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.06 27.38 0.21 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.798 2.332 . . . . 0.0 113.454 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.49 ' H ' ' C ' ' A' ' 118' ' ' LEU . 62.6 m-85 51.04 12.96 0.13 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.926 1.691 . . . . 0.0 113.603 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.19 -8.14 1.21 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 22.5 t -61.84 154.07 27.0 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.779 0.831 . . . . 0.0 109.847 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.516 HG21 ' H ' ' A' ' 125' ' ' GLU . 10.0 t -147.69 -174.86 4.66 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.8 ptpp? -55.33 -20.12 10.7 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.516 ' H ' HG21 ' A' ' 123' ' ' THR . 42.2 mt-10 -83.6 -22.38 32.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.018 0.527 . . . . 0.0 111.342 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.496 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 64.3 mm-40 -92.43 -30.49 15.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.49 -36.44 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.07 -32.11 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.685 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -73.15 -27.62 61.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.065 172.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 24.1 t80 -71.67 -24.34 61.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 110.504 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -115.49 32.14 6.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.442 1.097 . . . . 0.0 108.727 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 t -67.92 -16.97 64.31 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.936 0.495 . . . . 0.0 112.075 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.66 15.66 59.9 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.0 mt -143.47 -164.83 1.95 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.229 1.812 . . . . 0.0 107.307 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -148.06 161.23 41.81 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.839 -0.538 . . . . 0.0 110.038 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.9 mt -140.43 150.83 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 158' ' ' GLN . 18.5 m -77.56 154.09 81.36 Favored Pre-proline 0 CA--C 1.528 0.128 0 CA-C-N 118.407 0.549 . . . . 0.0 110.354 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.1 141.31 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.925 3.083 . . . . 0.0 111.949 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 43.13 35.18 0.76 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.906 0.882 . . . . 0.0 111.777 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.99 28.82 13.48 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-O 119.245 -0.753 . . . . 0.0 111.968 -173.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.8 mt -138.24 144.78 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 118.817 1.308 . . . . 0.0 109.731 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.7 m -140.35 145.74 37.54 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.592 0.757 . . . . 0.0 109.234 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.0 mt -141.76 94.21 7.38 Favored Pre-proline 0 N--CA 1.455 -0.208 0 C-N-CA 124.154 0.982 . . . . 0.0 109.061 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.06 152.89 22.65 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.334 2.689 . . . . 0.0 110.624 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.47 166.02 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 CA-C-O 121.328 0.585 . . . . 0.0 111.072 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.426 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 58.9 m-20 -91.56 177.07 2.36 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.861 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.426 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 32.6 Cg_exo -59.07 -19.43 48.74 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.942 2.428 . . . . 0.0 111.762 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -81.95 -7.46 59.61 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.768 0.827 . . . . 0.0 110.672 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.33 12.31 83.26 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.675 0.655 . . . . 0.0 112.151 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -102.0 149.97 23.7 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.8 pt -68.24 148.28 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.465 0.65 . . . . 0.0 111.577 -171.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.2 p -76.6 -4.03 40.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.705 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.7 4.31 54.68 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 123.048 0.356 . . . . 0.0 112.46 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -145.15 171.16 14.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.247 0.524 . . . . 0.0 110.092 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.21 179.12 9.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.3 0.572 . . . . 0.0 110.5 -175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -144.4 143.79 31.09 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.455 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 90.4 t -145.99 164.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -174.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.425 ' O ' HG21 ' A' ' 137' ' ' VAL . 52.2 tt0 -129.82 102.77 6.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.645 ' CE2' HG13 ' A' ' 113' ' ' VAL . 34.0 m-85 -73.83 172.2 11.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.322 171.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.17 91.58 0.72 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.084 0.469 . . . . 0.0 109.815 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 61.61 168.53 0.11 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.666 1.186 . . . . 0.0 111.476 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -16.43 63.91 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.885 -0.51 . . . . 0.0 111.055 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -66.01 -42.96 89.0 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.973 -0.454 . . . . 0.0 110.342 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.73 -39.69 73.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.458 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.31 -38.32 73.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.244 -0.285 . . . . 0.0 110.856 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -69.26 -29.98 68.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.728 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -72.52 -38.35 68.11 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.513 0.197 . . . . 0.0 110.814 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.412 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.91 -19.58 65.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.731 0.412 . . . . 0.0 111.935 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.55 -12.06 59.49 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.464 0.574 . . . . 0.0 111.336 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.98 -11.96 78.96 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.45 ' HB2' HG13 ' A' ' 183' ' ' VAL . 69.5 mmtt -87.39 1.63 52.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.263 1.425 . . . . 0.0 111.614 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.433 ' NE2' ' HE3' ' A' ' 173' ' ' LYS . 65.3 t60 -54.32 134.26 45.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.433 ' HE3' ' NE2' ' A' ' 172' ' ' HIS . 90.9 mttt 53.5 14.01 0.53 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.545 1.538 . . . . 0.0 113.967 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.02 163.04 20.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.886 0.766 . . . . 0.0 109.607 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -101.31 159.09 15.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.6 tt -114.99 -7.29 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 160.28 -37.79 0.45 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-O 119.916 -0.38 . . . . 0.0 112.971 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -155.57 11.86 0.32 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.35 0.575 . . . . 0.0 110.761 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -136.0 -179.82 5.89 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.283 1.033 . . . . 0.0 109.141 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -126.15 141.54 51.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.7 mm -112.82 160.87 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -129.89 94.46 3.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -170.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 171' ' ' LYS . 13.9 m -74.24 140.44 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.149 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -146.26 161.43 40.29 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -79.55 161.72 25.8 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.833 0.742 . . . . 0.0 109.965 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -157.2 -174.2 4.8 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.53 -0.106 . . . . 0.0 111.13 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.7 t -147.4 172.07 14.5 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.808 0.843 . . . . 0.0 110.155 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -59.99 -31.55 70.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.746 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.42 -1.27 7.98 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -114.36 0.34 14.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.792 0.837 . . . . 0.0 110.547 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.92 14.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 120.956 0.408 . . . . 0.0 110.785 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -67.08 9.8 0.18 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 31.3 m -68.7 -0.7 5.6 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.443 0.697 . . . . 0.0 111.292 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.785 -1.103 . . . . 0.0 111.151 178.347 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.0 p30 . . . . . 0 N--CA 1.446 -0.657 0 CA-C-O 120.853 0.359 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.62 7.82 10.04 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.34 -9.28 30.88 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -61.86 138.22 58.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.362 0.601 . . . . 0.0 110.669 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.609 HG12 ' CE2' ' A' ' 159' ' ' PHE . 8.5 p -150.25 175.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.044 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -132.35 151.16 51.97 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.608 0.763 . . . . 0.0 110.695 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -123.34 148.71 45.73 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 124.281 1.032 . . . . 0.0 108.39 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -153.18 161.08 42.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.81 0.53 85.18 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.8 mt -53.34 134.93 51.84 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 124.07 0.948 . . . . 0.0 111.238 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -60.31 142.98 99.44 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 107.262 -1.861 . . . . 0.0 107.262 170.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.43 ' CD2' ' HE2' ' A' ' 150' ' ' LYS . 17.5 m-85 -66.9 -2.11 4.82 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.92 -174.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.02 -0.9 27.0 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 47.4 t -63.69 142.77 58.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.031 0.932 . . . . 0.0 109.829 176.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.4 t -148.82 -160.9 1.24 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -45.21 -41.03 7.91 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.539 0.736 . . . . 0.0 112.953 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.76 -23.06 49.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 9.9 mp0 -86.3 -39.56 16.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.0 mt -64.45 -36.32 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 p -80.64 -34.13 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.08 -170.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -81.2 -20.64 40.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.869 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -71.89 -22.75 61.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 171.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -115.48 35.96 4.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.501 1.12 . . . . 0.0 109.139 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.8 t -62.64 142.53 58.01 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.17 5.11 75.39 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 39.0 mt -140.44 72.13 1.39 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.13 1.372 . . . . 0.0 107.97 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -49.55 159.3 0.36 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.036 0.934 . . . . 0.0 113.473 -174.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.4 mt -135.33 146.91 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.6 m -71.41 155.61 92.56 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 118.506 0.594 . . . . 0.0 110.236 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.89 135.23 23.25 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 124.094 3.196 . . . . 0.0 112.301 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.4 t30 40.21 38.16 0.49 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.423 1.089 . . . . 0.0 111.996 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.02 33.83 4.69 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.7 mt -140.29 143.92 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 118.522 1.161 . . . . 0.0 108.842 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.0 m -136.91 147.95 46.73 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.439 0.695 . . . . 0.0 109.299 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 88.2 mt -139.75 93.42 9.6 Favored Pre-proline 0 C--O 1.234 0.249 0 C-N-CA 123.278 0.631 . . . . 0.0 110.485 -173.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.04 154.81 26.01 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.931 2.421 . . . . 0.0 110.325 171.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.1 m -146.58 164.64 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 CA-C-O 121.429 0.633 . . . . 0.0 111.588 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.4 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 59.0 m-20 -90.99 176.04 3.17 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.469 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.8 Cg_exo -58.09 -20.67 47.06 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.842 2.361 . . . . 0.0 111.563 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.63 -10.4 59.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.35 1.06 . . . . 0.0 111.214 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.96 1.58 90.65 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.43 ' HE2' ' CD2' ' A' ' 120' ' ' PHE . 52.2 tttm -73.58 130.59 40.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.888 1.275 . . . . 0.0 109.152 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.535 ' C ' ' H ' ' A' ' 153' ' ' GLY . 9.0 pt -70.31 9.93 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -168.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 66.63 -15.88 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.97 0.908 . . . . 0.0 112.417 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 100.41 3.19 55.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.547 1.07 . . . . 0.0 113.063 175.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -139.71 170.41 15.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.263 1.032 . . . . 0.0 111.425 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -160.99 -178.05 6.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.943 0.497 . . . . 0.0 110.561 -174.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -142.52 145.06 33.25 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 89.6 t -145.09 164.3 12.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.409 ' O ' HG22 ' A' ' 137' ' ' VAL . 53.2 tt0 -131.16 101.33 5.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.609 ' CE2' HG12 ' A' ' 113' ' ' VAL . 47.5 m-85 -71.61 171.64 11.09 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.341 171.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 93.05 0.95 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.14 0.495 . . . . 0.0 109.98 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t 62.09 169.43 0.12 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.498 1.119 . . . . 0.0 111.02 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.74 -21.03 66.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.771 -0.58 . . . . 0.0 111.174 -175.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.73 -42.94 99.91 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.917 -0.489 . . . . 0.0 110.302 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.77 -38.69 76.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.4 -40.53 82.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.026 -0.421 . . . . 0.0 110.701 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -68.03 -30.91 70.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.566 0.346 . . . . 0.0 110.668 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -71.6 -39.78 70.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 110.511 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.35 -13.33 61.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.4 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 92.4 mt -67.23 -14.09 62.58 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 118.97 0.805 . . . . 0.0 111.954 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.61 -11.9 77.41 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -85.43 -4.94 59.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.17 1.388 . . . . 0.0 113.049 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.417 ' HB2' HG21 ' A' ' 183' ' ' VAL . 13.0 t60 -42.51 -23.54 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -140.55 17.57 2.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.205 0.911 . . . . 0.0 112.005 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -74.6 -174.82 2.21 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.086 0.469 . . . . 0.0 110.11 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.14 159.11 37.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.771 -171.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.1 tt -110.59 -6.36 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 150.53 -29.14 1.06 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.985 -0.341 . . . . 0.0 113.164 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -156.43 4.17 0.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.485 0.642 . . . . 0.0 110.834 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -149.84 157.95 43.69 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.406 1.083 . . . . 0.0 108.49 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -104.83 150.88 24.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.8 mm -123.68 161.93 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -172.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -132.25 157.36 44.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' ' 172' ' ' HIS . 17.8 m -129.91 135.62 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -132.82 158.85 41.44 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -75.16 160.94 29.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.947 0.794 . . . . 0.0 109.629 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t -154.05 -174.1 4.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.724 0.297 . . . . 0.0 111.575 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.5 m -146.11 166.89 24.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.176 0.99 . . . . 0.0 109.977 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -60.09 -32.11 70.65 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.407 0.283 . . . . 0.0 110.564 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -63.54 -17.28 62.63 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -100.0 -0.94 38.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.308 0.643 . . . . 0.0 111.4 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 193' ' ' SER . 9.8 p -143.6 12.07 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.941 0.401 . . . . 0.0 111.523 -174.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -68.17 12.56 0.11 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 191' ' ' VAL . 30.0 m -68.95 -1.15 6.68 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.357 0.663 . . . . 0.0 111.127 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.236 -1.364 . . . . 0.0 111.147 178.419 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 p30 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -136.25 7.19 3.11 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 107.53 -8.55 37.56 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -62.6 143.73 56.96 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.508 0.67 . . . . 0.0 110.934 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.614 HG12 ' CE2' ' A' ' 159' ' ' PHE . 7.4 p -152.2 173.79 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -136.69 152.97 50.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -135.06 150.81 50.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 122.279 0.232 . . . . 0.0 110.566 -172.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -153.63 147.71 25.65 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.895 0.478 . . . . 0.0 109.908 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.74 -0.97 59.59 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.547 HD11 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -64.38 156.95 74.47 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-N 117.255 0.528 . . . . 0.0 111.508 -176.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 121' ' ' GLY . 27.9 Cg_exo -56.06 147.48 64.05 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.678 2.919 . . . . 0.0 111.762 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -70.41 17.54 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 119' ' ' PRO . . . -137.72 5.42 3.42 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.446 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 36.5 t -66.78 152.52 45.37 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.599 1.159 . . . . 0.0 110.552 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 125' ' ' GLU . 5.4 t -155.09 -168.39 2.86 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.549 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -51.87 -32.6 32.89 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.42 ' H ' HG22 ' A' ' 123' ' ' THR . 42.6 tt0 -73.13 -25.23 60.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.517 0.727 . . . . 0.0 112.049 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -92.51 -33.23 14.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.718 -0.614 . . . . 0.0 109.516 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.15 -34.26 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.02 -38.34 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.877 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -77.06 -21.39 54.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.073 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -71.0 -26.07 62.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 170.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.4 ' HA ' ' HE3' ' A' ' 171' ' ' LYS . 37.3 m-85 -108.15 39.4 1.97 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.6 t -68.65 157.21 36.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.4 5.87 78.78 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -173.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.0 mt -142.52 -172.42 3.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.291 1.837 . . . . 0.0 106.583 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -147.24 164.15 34.11 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.847 -0.533 . . . . 0.0 110.392 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 mt -142.08 148.23 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 158' ' ' GLN . 21.4 m -73.6 154.45 89.58 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 118.598 0.635 . . . . 0.0 110.134 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.62 138.5 25.03 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.016 3.144 . . . . 0.0 112.213 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.9 t30 40.71 37.93 0.56 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.304 1.041 . . . . 0.0 111.917 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.31 29.36 9.64 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.978 -0.901 . . . . 0.0 111.83 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.7 mt -135.36 147.09 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 119.056 1.428 . . . . 0.0 109.368 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.1 m -138.53 151.14 47.08 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.35 0.66 . . . . 0.0 109.712 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.1 mt -144.55 100.7 4.73 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -55.58 155.22 22.11 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.121 2.547 . . . . 0.0 110.13 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 150' ' ' LYS . 27.2 m -140.78 159.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 121.752 0.787 . . . . 0.0 112.429 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 148' ' ' GLU . 17.0 m-20 -86.57 175.04 4.76 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.623 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.418 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 35.5 Cg_exo -59.74 1.79 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.509 3.473 . . . . 0.0 113.402 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 146' ' ' ASP . 30.0 tt0 -123.36 3.37 9.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.947 0.899 . . . . 0.0 110.832 -175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.28 5.96 89.65 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 39.5 mtpt -66.99 167.2 12.19 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 153' ' ' GLY . 1.0 OUTLIER -116.85 10.76 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -167.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 p 63.14 -7.14 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 77.94 12.2 84.65 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.914 0.768 . . . . 0.0 113.354 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -143.06 164.33 30.4 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.229 1.014 . . . . 0.0 110.923 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -153.93 -178.47 7.09 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.038 0.535 . . . . 0.0 111.33 -172.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -145.43 150.32 36.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.469 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 64.4 t -148.12 165.65 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.246 0.546 . . . . 0.0 110.003 -174.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 137' ' ' VAL . 47.6 tt0 -130.13 105.97 8.3 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 168.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.614 ' CE2' HG12 ' A' ' 113' ' ' VAL . 35.7 m-85 -76.23 173.15 11.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.644 171.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.83 91.84 1.19 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t 62.82 166.99 0.12 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.727 1.211 . . . . 0.0 111.819 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -15.66 62.38 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.995 -0.441 . . . . 0.0 111.247 -175.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.94 -41.91 73.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.925 -0.484 . . . . 0.0 110.676 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 159' ' ' PHE . 0.6 OUTLIER -68.86 -39.28 79.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.504 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.21 -36.29 70.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.102 -0.374 . . . . 0.0 111.107 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -73.22 -29.07 62.54 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -73.5 -38.34 65.39 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.76 -16.3 62.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.153 0.581 . . . . 0.0 112.16 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.35 -12.35 60.96 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.626 0.648 . . . . 0.0 111.333 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.56 -12.3 80.36 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.432 ' HB2' HG11 ' A' ' 183' ' ' VAL . 66.9 mmtt -84.15 -2.98 57.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.252 1.421 . . . . 0.0 111.978 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -52.11 128.96 26.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.945 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.9 mttt 61.61 9.24 2.67 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.632 1.573 . . . . 0.0 114.138 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -74.43 173.66 9.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.433 1.093 . . . . 0.0 109.053 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -125.95 154.47 42.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -170.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.2 mt -86.47 -18.43 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.164 0.986 . . . . 0.0 110.809 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 143.21 -18.23 2.31 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.837 -0.424 . . . . 0.0 113.056 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -151.34 -3.66 0.3 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.59 0.695 . . . . 0.0 111.231 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -148.06 154.85 40.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -105.51 156.91 17.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.342 0.591 . . . . 0.0 110.04 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 33.0 mm -127.11 163.74 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -170.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -128.55 156.34 43.47 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 171' ' ' LYS . 33.5 m -129.93 129.56 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -135.72 146.11 47.37 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -73.04 160.63 31.76 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.763 0.71 . . . . 0.0 110.333 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -159.28 -177.26 6.32 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.1 m -146.11 169.73 18.12 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.787 1.235 . . . . 0.0 109.332 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -56.64 -31.49 64.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.741 0.416 . . . . 0.0 111.136 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.76 2.95 1.63 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -124.26 1.38 8.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.521 0.729 . . . . 0.0 110.838 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 193' ' ' SER . 8.2 p -142.68 10.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.728 0.299 . . . . 0.0 111.486 -176.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -69.83 15.42 0.08 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 191' ' ' VAL . 20.6 t -69.54 -1.44 8.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.122 0.569 . . . . 0.0 110.846 176.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 117.83 -1.081 . . . . 0.0 111.061 177.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.219 0.533 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -129.9 167.08 18.73 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.701 1.2 . . . . 0.0 108.394 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.54 -5.44 29.89 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 120.045 -0.308 . . . . 0.0 112.352 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -61.56 140.39 58.12 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.745 0.783 . . . . 0.0 111.196 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.526 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.5 p -149.98 175.97 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.504 1.122 . . . . 0.0 108.157 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 79.3 ttt180 -135.92 146.36 47.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.74 0.416 . . . . 0.0 110.266 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.91 150.74 42.52 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 125.06 1.344 . . . . 0.0 108.372 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -158.96 147.57 18.32 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 110.313 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.85 -3.65 57.39 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -65.07 155.76 82.97 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 117.257 0.529 . . . . 0.0 110.756 -178.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 32.4 Cg_exo -53.37 147.65 36.21 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.612 2.875 . . . . 0.0 112.147 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -66.32 2.27 1.29 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -125.39 6.9 8.04 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.427 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 40.7 t -67.85 155.1 40.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.839 0.855 . . . . 0.0 110.68 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.414 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 4.7 t -154.57 -172.38 4.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.265 0.626 . . . . 0.0 109.523 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.3 OUTLIER -50.72 -30.98 15.25 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 123.21 0.604 . . . . 0.0 112.626 -176.444 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.31 -23.46 51.02 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -92.59 -30.37 15.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.4 mt -66.99 -41.02 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.8 p -73.51 -33.88 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.488 -176.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -73.04 -28.38 62.3 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.212 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 12.1 t80 -69.82 -19.56 63.47 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -118.95 33.39 5.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.374 1.47 . . . . 0.0 109.438 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.2 t -69.22 -4.07 16.23 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.807 -0.558 . . . . 0.0 112.289 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -106.25 20.08 36.01 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.429 ' HB3' HD12 ' A' ' 164' ' ' LEU . 55.2 mt -141.23 -167.02 2.3 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.842 2.457 . . . . 0.0 104.83 -173.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.28 -21.35 0.69 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.554 HG23 ' H ' ' A' ' 137' ' ' VAL . 1.5 mt 52.06 178.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.204 1.002 . . . . 0.0 112.681 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.554 ' H ' HG23 ' A' ' 136' ' ' ILE . 25.1 m -116.44 155.63 48.33 Favored Pre-proline 0 CA--C 1.529 0.138 0 O-C-N 121.338 -0.851 . . . . 0.0 109.69 169.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.0 137.77 22.3 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.197 3.265 . . . . 0.0 112.569 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.1 t30 41.45 36.14 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.273 1.029 . . . . 0.0 111.766 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.64 27.75 13.2 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-O 118.792 -1.005 . . . . 0.0 112.021 -172.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.2 mt -135.23 145.58 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.088 1.444 . . . . 0.0 109.502 -177.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.8 m -138.12 149.75 46.21 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.755 0.822 . . . . 0.0 109.79 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.5 mt -145.11 94.19 5.35 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 124.023 0.929 . . . . 0.0 109.404 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -55.88 159.18 12.32 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.76 2.973 . . . . 0.0 111.638 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.5 167.45 16.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 121.409 0.624 . . . . 0.0 111.285 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 63.9 m-20 -91.89 176.53 2.67 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.421 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 37.2 Cg_exo -58.35 -19.79 44.88 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.822 2.348 . . . . 0.0 111.67 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -81.37 -9.03 59.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.129 0.972 . . . . 0.0 111.213 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.54 2.45 90.62 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -81.57 133.14 35.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.865 1.266 . . . . 0.0 108.416 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.9 pt -66.33 148.29 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 110.122 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.8 p -75.54 2.82 10.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.198 -174.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.39 6.3 89.35 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -139.25 164.06 30.81 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.087 0.555 . . . . 0.0 109.697 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.81 -178.65 7.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.339 0.59 . . . . 0.0 110.925 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -144.92 147.72 33.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.484 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.5 t -144.88 166.6 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -129.26 106.42 8.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 167.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 59.6 m-85 -74.87 171.05 14.72 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.465 170.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.34 88.65 0.46 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.1 0.476 . . . . 0.0 110.055 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.7 t 64.35 170.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.651 1.18 . . . . 0.0 111.583 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -17.53 63.47 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.769 0.428 . . . . 0.0 111.59 -174.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.24 -45.41 66.56 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.914 -0.492 . . . . 0.0 110.531 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -70.83 -31.68 68.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.97 92.78 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.674 -0.641 . . . . 0.0 111.069 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -68.78 -29.06 67.36 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.884 -0.143 . . . . 0.0 110.784 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -70.95 -37.63 72.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.417 -0.177 . . . . 0.0 110.578 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.511 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.16 -20.5 65.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.38 -12.23 60.8 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.087 -0.383 . . . . 0.0 111.421 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.81 -12.56 80.89 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 130' ' ' PHE . 71.7 mmtt -83.96 -0.08 50.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.102 1.361 . . . . 0.0 111.638 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -53.64 127.18 24.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.83 0.348 . . . . 0.0 110.228 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.8 mttp 54.2 20.29 2.53 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.785 1.634 . . . . 0.0 114.034 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -82.78 -13.71 55.78 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 47.5 mtt180 73.49 171.32 0.3 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.011 1.324 . . . . 0.0 114.509 171.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.98 -12.45 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 154.09 -29.96 0.72 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-N 118.476 0.58 . . . . 0.0 113.993 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -151.79 -0.36 0.33 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.956 0.878 . . . . 0.0 111.162 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -147.8 150.37 34.09 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -174.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 175' ' ' ARG . 22.6 p90 -93.49 152.32 19.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.165 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 30.1 mm -122.54 159.24 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.453 ' HB3' ' CE1' ' A' ' 184' ' ' PHE . 5.4 mm-40 -125.17 155.28 40.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.497 -175.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 171' ' ' LYS . 34.4 m -138.09 131.58 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 182' ' ' GLU . 7.3 m-85 -142.18 156.06 45.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -75.91 160.78 29.56 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.679 0.672 . . . . 0.0 110.25 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.0 t -155.54 -174.62 5.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.8 t -147.98 173.19 13.14 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.5 1.12 . . . . 0.0 109.88 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -60.36 -31.71 70.58 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.75 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.14 -0.72 2.63 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -121.55 1.95 10.11 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.548 0.739 . . . . 0.0 111.339 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 193' ' ' SER . 8.3 p -144.16 11.13 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 120.899 0.38 . . . . 0.0 111.287 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -69.09 14.89 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 191' ' ' VAL . 30.6 m -67.49 -3.17 7.82 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.292 0.637 . . . . 0.0 111.307 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.184 178.244 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 52.3 p30 . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.79 9.42 1.33 Allowed 'General case' 0 C--N 1.34 0.153 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.21 -5.99 50.02 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 112.172 -0.371 . . . . 0.0 112.172 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -63.49 144.47 56.96 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.645 0.736 . . . . 0.0 110.681 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.5 p -154.0 174.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.642 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -135.62 154.79 51.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.97 0.908 . . . . 0.0 108.66 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -138.65 148.85 44.54 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.405 ' CG ' ' H ' ' A' ' 117' ' ' GLY . 23.8 ttp180 -156.38 174.6 15.17 Favored 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.405 ' H ' ' CG ' ' A' ' 116' ' ' ARG . . . 86.05 5.15 83.65 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.45 HD22 ' HG ' ' A' ' 122' ' ' CYS . 95.0 mt -59.92 150.47 68.99 Favored Pre-proline 0 N--CA 1.452 -0.339 0 C-N-CA 123.594 0.757 . . . . 0.0 112.101 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.3 23.99 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 125.142 3.894 . . . . 0.0 113.965 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 54.77 5.68 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.23 1.412 . . . . 0.0 114.43 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.69 -6.28 3.35 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.956 0.798 . . . . 0.0 111.802 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 10.0 t -61.77 150.53 36.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.038 0.935 . . . . 0.0 110.938 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.8 t -143.37 -166.66 2.37 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.477 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 mptt -51.35 -28.69 13.07 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.344 0.52 . . . . 0.0 111.995 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -78.52 -23.91 46.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.527 0.731 . . . . 0.0 112.331 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.489 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 7.0 mp0 -92.88 -33.7 14.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.411 HG13 ' SG ' ' A' ' 122' ' ' CYS . 42.5 mt -61.88 -33.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.0 p -83.32 -30.61 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.003 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -73.32 -29.87 62.98 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.907 171.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -68.65 -25.84 65.03 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.205 -0.309 . . . . 0.0 110.671 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -115.8 33.31 5.56 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.666 1.186 . . . . 0.0 109.214 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.1 t -64.35 -13.93 53.35 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.963 0.505 . . . . 0.0 112.252 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.01 13.15 67.68 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.423 ' HB3' HD12 ' A' ' 164' ' ' LEU . 69.4 mt -137.5 -162.22 1.27 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.011 1.724 . . . . 0.0 107.482 -173.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.57 -18.04 0.7 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.629 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER 46.33 -166.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.847 0.859 . . . . 0.0 112.971 -176.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.629 ' H ' HG22 ' A' ' 136' ' ' ILE . 17.0 m -129.21 156.02 78.99 Favored Pre-proline 0 C--N 1.338 0.108 0 C-N-CA 123.852 0.861 . . . . 0.0 109.786 173.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.78 135.59 28.21 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.173 3.249 . . . . 0.0 112.301 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 55.1 t30 40.31 37.36 0.42 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.624 1.17 . . . . 0.0 112.33 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -96.52 28.08 14.81 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 118.934 -0.926 . . . . 0.0 111.75 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.1 mt -132.96 147.01 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 118.968 1.384 . . . . 0.0 109.314 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.8 m -138.11 147.41 43.94 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 123.807 0.843 . . . . 0.0 109.542 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 91.9 mt -139.5 94.38 9.46 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.527 0.731 . . . . 0.0 110.336 -173.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.82 151.62 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.022 2.481 . . . . 0.0 110.695 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.94 166.32 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.331 0.586 . . . . 0.0 111.266 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.423 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 64.4 m-20 -90.82 176.96 2.53 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.684 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 36.9 Cg_exo -58.76 -18.72 42.68 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.981 2.454 . . . . 0.0 111.755 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -81.32 -10.86 59.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.865 0.866 . . . . 0.0 110.683 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.7 14.43 75.72 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -106.54 148.42 28.25 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.5 pt -67.64 149.5 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.421 0.629 . . . . 0.0 111.671 -170.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.5 p -76.42 -7.8 55.82 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.007 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.61 -3.5 32.46 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -139.26 169.89 16.95 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.34 0.57 . . . . 0.0 111.265 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.41 -178.92 7.48 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 111.335 -173.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -144.14 148.11 34.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 59.9 t -145.76 164.83 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -127.75 99.21 5.46 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 169.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.586 ' CE2' HG11 ' A' ' 113' ' ' VAL . 48.5 m-85 -70.15 172.45 8.02 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.121 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.1 87.56 0.4 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.871 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.5 t 62.6 172.62 0.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.546 1.138 . . . . 0.0 111.383 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -31.11 70.71 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.906 -0.496 . . . . 0.0 111.007 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -59.4 -41.64 89.9 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.331 -0.231 . . . . 0.0 111.06 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -72.78 -38.93 67.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.487 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -62.8 -34.94 78.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.984 -0.448 . . . . 0.0 110.408 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.31 -27.26 66.14 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.53 0.332 . . . . 0.0 110.299 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -77.27 -38.07 51.65 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.339 0.114 . . . . 0.0 111.181 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.409 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -59.53 -24.41 63.65 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.55 -9.14 47.44 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 122.95 0.5 . . . . 0.0 111.493 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.58 -16.84 78.68 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -76.14 -55.52 5.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.116 0.966 . . . . 0.0 110.678 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.413 ' HA ' HG23 ' A' ' 183' ' ' VAL . 0.6 OUTLIER 23.77 -98.65 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.861 1.264 . . . . 0.0 112.941 -165.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -72.8 20.17 0.08 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -174.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -62.77 -178.22 0.19 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.108 0.963 . . . . 0.0 111.269 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -133.74 168.49 18.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.194 0.598 . . . . 0.0 112.37 -173.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mt -116.47 -13.55 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.521 0.729 . . . . 0.0 112.009 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.44 -31.34 0.53 Allowed Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.52 0.6 . . . . 0.0 114.024 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -152.25 3.06 0.36 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.791 0.796 . . . . 0.0 110.995 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -144.03 156.89 44.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -105.83 148.37 27.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.474 0.654 . . . . 0.0 109.499 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.94 174.92 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -172.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -138.63 154.66 48.67 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.413 HG23 ' HA ' ' A' ' 172' ' ' HIS . 17.0 m -129.92 134.94 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -142.44 151.72 42.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -74.09 154.13 39.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.877 0.37 . . . . 0.0 110.553 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.6 t -157.37 179.41 9.28 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.849 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.9 m -150.76 170.74 18.51 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.137 0.975 . . . . 0.0 108.69 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -54.34 -30.84 52.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.682 0.393 . . . . 0.0 111.328 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.54 0.54 2.18 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.308 0.643 . . . . 0.0 112.701 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -121.25 0.06 10.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.138 0.975 . . . . 0.0 110.932 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.11 14.44 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 121.035 0.445 . . . . 0.0 111.11 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -69.33 10.58 0.31 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 59.1 p -69.23 -0.9 6.73 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.352 0.661 . . . . 0.0 111.201 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 117.185 -1.388 . . . . 0.0 110.896 177.59 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.453 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 5.4 t-20 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -132.88 0.69 3.53 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.03 -9.61 25.08 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.477 -0.392 . . . . 0.0 112.523 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -65.48 147.91 52.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.519 0.676 . . . . 0.0 111.094 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.573 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.6 p -155.49 178.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.207 1.003 . . . . 0.0 108.737 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.4 ' H ' HG21 ' A' ' 113' ' ' VAL . 7.4 mtm180 -134.43 162.81 31.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.938 0.495 . . . . 0.0 111.495 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tp -145.97 142.79 29.01 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.405 ' C ' ' H ' ' A' ' 118' ' ' LEU . 40.7 ttm180 -151.49 -18.54 0.2 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 181' ' ' ILE . . . -78.94 12.9 21.63 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.264 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 116' ' ' ARG . 97.6 mt -59.6 153.7 49.66 Favored Pre-proline 0 N--CA 1.449 -0.516 0 C-N-CA 124.494 1.118 . . . . 0.0 113.267 -172.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.56 147.64 15.77 Favored 'Trans proline' 0 N--CA 1.442 -1.51 0 C-N-CA 123.793 2.995 . . . . 0.0 106.169 162.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.593 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 23.7 m-85 -70.69 10.57 0.48 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -172.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.38 1.18 12.74 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 118.446 0.567 . . . . 0.0 111.88 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.413 ' HG ' ' HB3' ' A' ' 126' ' ' GLU . 48.6 t -65.89 156.44 33.39 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.261 0.625 . . . . 0.0 111.591 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.46 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 2.6 t -152.93 -173.54 4.61 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.577 0.751 . . . . 0.0 109.506 173.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.568 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.2 mptt -50.16 -36.19 29.22 Favored 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.58 -17.66 59.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.413 ' HB3' ' HG ' ' A' ' 122' ' ' CYS . 9.5 tp10 -101.74 -26.68 13.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.9 mt -66.85 -39.91 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.45 -34.77 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.368 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -71.08 -28.75 64.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.498 173.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 21.6 t80 -69.48 -23.16 63.6 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.025 0.375 . . . . 0.0 110.275 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -115.2 32.73 5.86 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.743 1.217 . . . . 0.0 109.244 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 t -68.8 -8.04 39.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.07 0.548 . . . . 0.0 111.994 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.92 15.72 60.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.415 ' HB3' HD12 ' A' ' 164' ' ' LEU . 52.5 mt -138.89 -159.75 0.99 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.002 2.121 . . . . 0.0 105.816 -174.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.52 -28.14 0.54 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 2.5 mt 57.38 162.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.968 0.907 . . . . 0.0 112.352 -175.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 158' ' ' GLN . 2.4 m -74.4 161.34 78.54 Favored Pre-proline 0 C--O 1.231 0.09 0 O-C-N 121.0 -1.063 . . . . 0.0 108.643 169.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -46.07 -30.12 7.06 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.024 3.15 . . . . 0.0 112.738 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -162.33 134.26 5.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 171.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -173.92 17.87 0.05 OUTLIER Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.774 -1.014 . . . . 0.0 113.578 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.1 mt -108.4 147.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 119.517 1.659 . . . . 0.0 109.982 -173.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.5 m -140.66 150.78 43.96 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 123.68 0.792 . . . . 0.0 108.918 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.0 mt -146.76 97.43 4.25 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.062 0.545 . . . . 0.0 110.141 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.34 160.76 10.41 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.611 2.874 . . . . 0.0 111.047 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 151' ' ' ILE . 31.4 m -146.08 165.04 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 CA-C-O 121.295 0.569 . . . . 0.0 111.282 173.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -90.85 175.6 3.52 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 124.167 0.987 . . . . 0.0 108.524 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.07 -20.21 44.62 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.831 2.354 . . . . 0.0 111.352 174.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -79.39 -10.09 59.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.086 0.955 . . . . 0.0 111.253 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.01 0.54 90.37 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -173.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.593 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 87.1 tttt -73.85 134.73 43.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.831 1.253 . . . . 0.0 108.575 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 153' ' ' GLY . 9.3 pt -71.6 10.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -169.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 65.12 -17.2 0.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.859 1.264 . . . . 0.0 112.175 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 105.4 -3.49 40.11 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.04 1.305 . . . . 0.0 112.506 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -132.6 169.59 16.41 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 118.772 1.286 . . . . 0.0 111.505 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.41 -178.37 7.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.12 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -143.39 145.41 32.63 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -175.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.493 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 41.5 t -145.35 160.91 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.404 ' O ' HG22 ' A' ' 137' ' ' VAL . 49.6 tt0 -126.51 119.45 27.19 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 166.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.573 ' CE2' HG11 ' A' ' 113' ' ' VAL . 48.5 m-85 -88.71 174.73 7.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.462 170.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.12 88.42 0.42 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.581 0.753 . . . . 0.0 109.876 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.69 168.06 0.13 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.514 1.126 . . . . 0.0 111.184 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.453 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 1.5 tm0? -64.5 -23.91 67.43 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.846 -0.533 . . . . 0.0 111.214 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.83 -41.13 99.21 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.116 -0.365 . . . . 0.0 110.725 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -70.87 -37.75 73.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.451 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -61.85 -33.86 74.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.066 -0.396 . . . . 0.0 110.803 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -72.43 -27.16 62.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -74.09 -38.12 63.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.544 0.212 . . . . 0.0 110.512 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -61.48 -21.52 64.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.753 0.421 . . . . 0.0 112.086 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.2 mt -68.27 -13.45 62.26 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.965 -0.459 . . . . 0.0 111.161 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.5 -11.99 82.47 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.434 ' HB2' HG12 ' A' ' 183' ' ' VAL . 68.3 mmtt -85.37 -1.67 57.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.478 1.111 . . . . 0.0 112.179 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -51.93 129.08 26.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.748 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 62.72 11.09 4.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.404 1.482 . . . . 0.0 114.335 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -71.39 -171.44 0.62 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.035 0.834 . . . . 0.0 109.361 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -134.36 164.49 27.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -171.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.8 mt -115.53 -11.48 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.764 0.826 . . . . 0.0 111.932 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 151.35 -25.96 0.98 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 121.891 -0.506 . . . . 0.0 113.938 175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -153.59 2.14 0.26 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 117.736 0.768 . . . . 0.0 111.083 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -147.0 160.15 42.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.91 0.884 . . . . 0.0 108.672 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -107.13 145.22 32.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.458 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 21.9 mm -113.17 162.41 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -171.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -130.34 150.91 51.36 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 171' ' ' LYS . 32.6 m -128.11 134.3 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -175.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -136.61 163.56 30.27 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -82.59 158.59 23.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.879 -0.513 . . . . 0.0 109.959 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.6 t -158.99 -177.33 6.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.469 -0.145 . . . . 0.0 111.325 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.2 t -148.31 178.18 8.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.651 0.78 . . . . 0.0 110.301 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -60.48 -31.95 70.96 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.188 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -65.76 -7.16 14.29 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -112.02 1.38 16.35 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.506 0.723 . . . . 0.0 111.055 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 193' ' ' SER . 9.4 p -144.2 11.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 120.911 0.386 . . . . 0.0 111.555 -176.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -69.18 14.16 0.09 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 191' ' ' VAL . 24.1 m -69.19 -0.4 5.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.574 0.75 . . . . 0.0 111.184 176.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.859 -1.067 . . . . 0.0 111.155 178.254 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 p30 . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 120.835 0.35 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -127.81 3.9 6.03 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 162' ' ' GLN . . . 111.12 -8.83 29.16 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -64.08 142.77 58.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.643 0.735 . . . . 0.0 111.154 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.553 HG13 ' CE2' ' A' ' 159' ' ' PHE . 9.2 p -153.13 175.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.997 1.319 . . . . 0.0 108.037 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -138.97 145.95 40.35 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.09 152.82 35.81 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 123.867 0.867 . . . . 0.0 109.098 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.424 ' HD2' ' CE2' ' A' ' 184' ' ' PHE . 5.8 mtt180 -153.3 166.49 32.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.47 1.56 88.79 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.6 146.95 42.52 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 117.294 0.547 . . . . 0.0 110.78 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 9.7 Cg_exo -63.63 150.17 89.14 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.026 1.818 . . . . 0.0 108.577 167.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -70.32 5.3 1.79 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -125.94 5.51 7.87 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.448 ' HG ' ' CG ' ' A' ' 126' ' ' GLU . 46.2 t -70.33 157.51 37.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.896 0.479 . . . . 0.0 110.858 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.4 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 4.6 t -154.93 -171.63 3.9 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.262 0.625 . . . . 0.0 109.527 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.4 OUTLIER -51.22 -30.88 18.75 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -80.04 -17.84 51.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.448 ' CG ' ' HG ' ' A' ' 122' ' ' CYS . 28.7 tt0 -107.0 -20.24 13.38 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.8 mt -71.27 -39.92 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 167.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -71.17 -38.73 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.217 -177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -74.66 -22.77 58.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.519 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -69.35 -26.6 64.77 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 170.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.487 ' HA ' ' HE3' ' A' ' 171' ' ' LYS . 36.4 m-85 -106.82 32.32 4.65 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.677 0.791 . . . . 0.0 109.629 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.4 t -61.11 146.15 48.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 169.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.58 2.49 76.05 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.412 ' HB3' HD12 ' A' ' 164' ' ' LEU . 23.2 mt -134.58 -172.16 2.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -141.59 -17.73 0.78 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -171.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.616 HG23 ' H ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER 45.84 -165.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.88 0.872 . . . . 0.0 113.272 -176.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.616 ' H ' HG23 ' A' ' 136' ' ' ILE . 17.4 m -129.9 156.08 79.56 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 124.068 0.947 . . . . 0.0 109.769 173.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.14 136.54 30.23 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.045 3.163 . . . . 0.0 112.252 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.5 t30 40.1 38.33 0.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.556 1.142 . . . . 0.0 112.206 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.04 28.66 13.56 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 118.877 -0.957 . . . . 0.0 111.86 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.8 mt -134.31 147.67 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 119.048 1.424 . . . . 0.0 109.538 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.5 m -139.6 149.93 44.4 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.586 0.754 . . . . 0.0 109.788 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.1 mt -145.52 95.42 4.98 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 123.896 0.878 . . . . 0.0 109.309 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.11 160.96 7.33 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.799 2.999 . . . . 0.0 111.635 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.4 m -141.71 164.71 18.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 121.283 0.564 . . . . 0.0 111.249 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.416 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 67.2 m-20 -86.93 176.12 3.79 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.975 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 34.2 Cg_exo -59.08 -20.23 52.88 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.038 2.492 . . . . 0.0 111.61 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -82.43 -9.85 59.28 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.561 0.744 . . . . 0.0 110.575 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.84 8.48 79.48 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.312 0.482 . . . . 0.0 112.246 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -97.11 147.62 23.86 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 117.616 0.708 . . . . 0.0 109.147 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.0 pt -69.53 152.9 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.719 0.771 . . . . 0.0 112.022 -172.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.7 p -82.74 0.61 42.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.037 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.9 8.3 86.86 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.026 -0.429 . . . . 0.0 112.026 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -138.62 160.38 39.76 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.31 -179.5 7.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.149 0.499 . . . . 0.0 110.909 -172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -145.46 148.58 33.42 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -174.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 60.0 t -145.12 163.9 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -128.28 95.61 4.21 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.553 ' CE2' HG13 ' A' ' 113' ' ' VAL . 52.8 m-85 -67.99 171.71 6.45 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.139 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.56 89.71 0.37 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.644 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.7 167.75 0.13 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.481 1.113 . . . . 0.0 111.007 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 36.8 tp60 -65.96 -20.07 66.08 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.707 -0.62 . . . . 0.0 111.211 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.07 -41.78 94.78 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.998 -0.438 . . . . 0.0 110.593 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -69.72 -36.3 75.76 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.502 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -61.75 -36.23 80.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.036 -0.415 . . . . 0.0 110.845 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.78 -27.26 63.78 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -74.11 -38.0 63.96 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.608 0.242 . . . . 0.0 110.685 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.95 -19.94 64.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.164 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.9 -8.85 52.1 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.041 -0.412 . . . . 0.0 111.419 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.25 -18.21 80.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 131' ' ' PHE . 70.1 mmtt -70.19 -61.21 1.86 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.567 1.147 . . . . 0.0 109.582 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.449 ' HD1' ' HA ' ' A' ' 182' ' ' GLU . 0.9 OUTLIER 25.34 -108.59 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.418 1.087 . . . . 0.0 112.715 -165.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -66.61 10.74 0.11 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -65.57 171.64 3.96 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.554 1.542 . . . . 0.0 109.925 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -123.86 165.25 17.69 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -168.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mt -105.64 -13.28 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.637 0.775 . . . . 0.0 111.963 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.1 -24.28 1.42 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.794 -0.448 . . . . 0.0 113.53 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -152.63 0.98 0.3 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.683 0.741 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -148.27 153.95 39.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.966 0.906 . . . . 0.0 108.73 -172.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -101.02 150.6 22.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.7 mm -117.92 171.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.449 ' HA ' ' HD1' ' A' ' 172' ' ' HIS . 18.2 mt-10 -139.45 160.13 40.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 24.7 m -132.95 127.3 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . 0.424 ' CE2' ' HD2' ' A' ' 116' ' ' ARG . 3.1 m-30 -128.07 154.55 45.57 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -75.48 163.25 27.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.796 -0.565 . . . . 0.0 110.592 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.7 t -159.06 -175.61 5.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.6 m -149.57 169.02 21.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.292 1.437 . . . . 0.0 109.138 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -57.7 -32.33 67.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.675 0.39 . . . . 0.0 111.38 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -66.94 -1.34 3.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -117.92 1.64 12.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.858 0.863 . . . . 0.0 110.911 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 193' ' ' SER . 7.6 p -143.56 12.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-O 121.036 0.446 . . . . 0.0 110.956 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -68.71 13.45 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 191' ' ' VAL . 30.7 m -67.28 -2.31 5.8 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.346 0.658 . . . . 0.0 111.364 177.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.198 -1.382 . . . . 0.0 111.056 178.479 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -131.78 6.51 4.34 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.33 -9.68 42.33 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -65.1 144.91 56.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.641 0.734 . . . . 0.0 111.048 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.561 HG12 ' CE2' ' A' ' 159' ' ' PHE . 11.1 p -152.9 174.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.137 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 59.1 ttt180 -136.35 145.33 45.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.043 0.537 . . . . 0.0 109.61 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.3 143.15 48.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -154.35 143.42 21.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.45 -1.11 46.29 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.499 ' HA ' ' CD1' ' A' ' 181' ' ' ILE . 0.0 OUTLIER -67.95 157.45 86.78 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 117.468 0.634 . . . . 0.0 111.055 -176.228 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -54.58 144.85 61.76 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.176 2.584 . . . . 0.0 111.36 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -71.0 12.27 0.31 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.67 5.82 5.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 51.2 t -69.16 158.44 34.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.387 1.075 . . . . 0.0 110.644 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 125' ' ' GLU . 6.5 t -153.73 -178.98 7.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.442 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 4.0 ptpp? -53.34 -25.36 14.81 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.5 ' H ' HG22 ' A' ' 123' ' ' THR . 41.5 mt-10 -78.34 -22.94 47.27 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.939 0.336 . . . . 0.0 111.611 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -92.69 -30.34 15.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.81 -45.6 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.69 -33.77 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.59 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -72.86 -31.36 64.68 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.494 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -67.34 -16.65 64.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.293 0.497 . . . . 0.0 110.203 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -120.08 30.46 6.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.499 1.119 . . . . 0.0 109.515 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.6 t -63.44 138.15 58.41 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.35 2.43 90.27 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.2 mt -138.07 76.22 1.56 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.198 1.399 . . . . 0.0 107.784 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -49.85 158.11 0.53 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.19 0.996 . . . . 0.0 113.472 -174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.68 147.59 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.1 m -70.66 155.25 93.67 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 118.521 0.601 . . . . 0.0 110.354 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -48.8 138.0 26.69 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.92 3.08 . . . . 0.0 111.739 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.8 t30 41.79 37.22 0.73 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.043 0.937 . . . . 0.0 111.802 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.61 31.85 6.8 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -173.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -139.51 145.97 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.238 1.019 . . . . 0.0 109.077 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.6 m -140.35 151.28 44.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.53 100.0 4.1 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.72 149.55 18.98 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.082 2.521 . . . . 0.0 110.934 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 24.5 m -145.25 160.84 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.434 0.635 . . . . 0.0 110.719 172.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -87.38 176.42 3.47 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -57.67 -18.25 32.38 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.825 2.35 . . . . 0.0 111.944 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.01 -8.54 58.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.425 1.09 . . . . 0.0 111.431 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.04 2.07 88.43 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -68.81 123.91 22.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.715 1.606 . . . . 0.0 109.824 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.439 ' C ' ' H ' ' A' ' 153' ' ' GLY . 8.0 pt -78.28 3.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -165.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p 66.27 -16.76 0.12 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 94.68 9.64 58.54 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.947 0.784 . . . . 0.0 113.794 174.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -143.09 163.51 32.64 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.31 1.055 . . . . 0.0 110.676 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.93 -177.06 6.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.278 0.631 . . . . 0.0 111.089 -173.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -147.17 150.47 34.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.481 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 87.6 t -147.14 165.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -175.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.411 ' O ' HG22 ' A' ' 137' ' ' VAL . 54.5 tt0 -133.44 98.54 4.25 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.004 0.921 . . . . 0.0 108.898 170.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.561 ' CE2' HG12 ' A' ' 113' ' ' VAL . 58.2 m-85 -69.82 170.54 10.86 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -67.82 92.52 0.36 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.15 0.5 . . . . 0.0 110.196 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.2 t 62.42 169.65 0.13 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.717 1.207 . . . . 0.0 111.095 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -12.31 56.3 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.033 -0.417 . . . . 0.0 111.489 -175.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.438 ' CD ' ' HZ1' ' A' ' 167' ' ' LYS . 3.2 tm-20 -74.48 -44.23 52.45 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.492 0.317 . . . . 0.0 110.384 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.07 -36.72 77.93 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.476 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.32 -38.97 78.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.087 -0.383 . . . . 0.0 110.701 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.35 -31.64 71.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.449 0.3 . . . . 0.0 110.623 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.438 ' HZ1' ' CD ' ' A' ' 163' ' ' GLU . 29.6 mttp -69.92 -39.06 76.37 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.434 174.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.73 -13.83 62.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.533 0.333 . . . . 0.0 111.727 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.447 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 93.9 mt -68.21 -12.26 60.68 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.737 -0.602 . . . . 0.0 111.042 175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.3 13.08 8.23 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.463 ' HB2' HG12 ' A' ' 183' ' ' VAL . 62.5 mmtt -118.87 -0.0 11.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.882 1.673 . . . . 0.0 112.353 -178.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -46.63 -20.95 0.15 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -142.83 15.65 1.94 Allowed 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.536 -0.728 . . . . 0.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -81.82 178.68 8.18 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.819 1.248 . . . . 0.0 109.616 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -129.85 154.26 47.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.02 -16.49 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.143 0.977 . . . . 0.0 111.198 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 153.66 -24.96 0.74 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.746 -0.474 . . . . 0.0 113.399 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -152.54 0.92 0.3 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.794 0.797 . . . . 0.0 111.257 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -148.39 152.78 37.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.938 0.895 . . . . 0.0 108.651 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -103.31 154.83 18.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.39 0.614 . . . . 0.0 110.529 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 26.0 mm -126.22 160.17 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.637 -171.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -129.86 151.97 49.85 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 171' ' ' LYS . 35.8 m -125.77 49.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.028 0.931 . . . . 0.0 113.372 -167.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . 0.432 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 3.5 m-30 -52.1 151.73 3.6 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.789 -0.569 . . . . 0.0 110.226 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -76.28 163.77 26.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.958 -0.464 . . . . 0.0 110.149 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.2 t -159.64 -177.15 6.18 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.2 m -145.24 171.46 14.53 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.753 1.221 . . . . 0.0 109.37 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -57.79 -32.13 67.24 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.764 0.426 . . . . 0.0 111.527 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.33 -4.83 8.79 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -116.63 2.27 12.96 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.751 0.821 . . . . 0.0 110.926 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 193' ' ' SER . 8.4 p -142.83 10.7 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 120.992 0.425 . . . . 0.0 111.172 -177.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -68.99 13.7 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 191' ' ' VAL . 23.2 m -68.22 -1.9 7.06 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.253 176.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.807 -1.092 . . . . 0.0 111.147 178.153 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -134.78 5.81 3.4 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.67 -9.58 32.43 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -63.23 143.11 58.08 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.551 0.691 . . . . 0.0 111.078 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.598 HG13 ' CE2' ' A' ' 159' ' ' PHE . 10.5 p -152.34 174.55 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.372 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 51.3 ttt180 -138.94 147.2 41.95 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.021 0.528 . . . . 0.0 109.976 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -120.98 151.17 40.05 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.457 1.103 . . . . 0.0 109.205 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -157.65 164.83 36.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.14 1.8 88.33 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 120' ' ' PHE . 45.3 mt -53.68 143.53 38.49 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.137 0.575 . . . . 0.0 110.32 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.415 ' CG ' ' SG ' ' A' ' 122' ' ' CYS . 72.8 Cg_endo -72.87 27.96 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 124.785 3.657 . . . . 0.0 113.933 -174.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' A' ' 118' ' ' LEU . 16.9 m-85 52.34 18.82 0.98 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.162 0.985 . . . . 0.0 113.275 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -148.09 -13.97 0.13 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.797 -0.565 . . . . 0.0 113.003 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 119' ' ' PRO . 6.8 m -62.95 158.89 18.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.585 0.692 . . . . 0.0 110.698 174.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 t -148.77 -165.03 2.17 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 2.5 mptt -49.91 -34.7 21.21 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.541 0.61 . . . . 0.0 112.049 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.36 -16.58 58.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -101.45 -29.38 12.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.3 mt -65.33 -34.01 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.2 -34.81 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.005 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -71.13 -27.09 63.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.174 -0.611 . . . . 0.0 111.043 172.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 8.8 t80 -70.19 -26.08 63.73 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 174.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -111.82 30.55 6.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.301 1.04 . . . . 0.0 109.545 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -67.57 -14.86 63.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.923 0.489 . . . . 0.0 111.83 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -94.42 16.62 60.69 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 36.6 mt -143.98 -162.05 1.39 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.349 1.859 . . . . 0.0 107.157 -173.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -146.79 165.29 30.13 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.1 mt -142.73 154.49 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.13 156.45 38.55 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.95 -31.06 7.77 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 124.509 3.473 . . . . 0.0 113.813 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -161.41 110.42 1.56 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -149.04 6.51 0.83 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.63 -1.095 . . . . 0.0 113.24 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 78.5 mt -97.68 147.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 119.471 1.636 . . . . 0.0 109.507 -174.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 92.0 m -139.82 147.21 40.41 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.7 mt -143.69 97.24 5.48 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 123.293 0.637 . . . . 0.0 109.408 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.72 159.35 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.404 2.736 . . . . 0.0 110.267 173.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.58 159.68 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-O 121.356 0.598 . . . . 0.0 110.963 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.41 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 54.7 m-20 -84.16 175.75 4.38 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.842 176.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.41 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 36.4 Cg_exo -58.5 -19.11 42.69 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.891 2.394 . . . . 0.0 111.522 175.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -82.64 -10.26 59.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.807 0.843 . . . . 0.0 110.872 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.17 10.81 73.96 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.341 0.496 . . . . 0.0 112.444 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -98.74 150.39 21.86 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 117.436 0.618 . . . . 0.0 109.908 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.476 ' C ' ' H ' ' A' ' 153' ' ' GLY . 6.1 pt -73.77 8.1 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 -160.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 67.06 -21.59 0.11 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.133 0.973 . . . . 0.0 113.533 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 105.21 6.84 38.77 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.862 0.744 . . . . 0.0 113.479 175.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -142.72 168.1 20.52 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.249 1.024 . . . . 0.0 110.787 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -157.74 -179.46 8.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.241 0.543 . . . . 0.0 111.26 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.93 151.74 39.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 40.5 t -147.37 166.06 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -128.99 97.42 4.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 168.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.598 ' CE2' HG13 ' A' ' 113' ' ' VAL . 38.5 m-85 -67.86 172.82 4.98 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.197 0.522 . . . . 0.0 109.916 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.79 90.9 0.61 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t 62.3 167.18 0.11 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.933 1.293 . . . . 0.0 111.738 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -15.69 63.07 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.888 -0.508 . . . . 0.0 111.053 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.421 ' HG2' ' HZ1' ' A' ' 167' ' ' LYS . 35.3 tt0 -67.48 -41.92 83.79 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.876 -0.515 . . . . 0.0 110.443 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 159' ' ' PHE . 1.1 tm? -71.17 -39.26 71.97 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -56.66 -35.78 68.79 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.267 -0.271 . . . . 0.0 111.039 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -71.91 -30.29 65.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.565 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.421 ' HZ1' ' HG2' ' A' ' 163' ' ' GLU . 40.3 mttp -72.34 -37.28 68.9 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.644 0.259 . . . . 0.0 110.487 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.428 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.93 -18.76 64.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.937 0.495 . . . . 0.0 112.09 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.98 -14.64 63.12 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.698 -0.626 . . . . 0.0 111.036 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.58 -12.78 80.44 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 130' ' ' PHE . 71.3 mmtt -83.64 -2.64 56.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.736 1.214 . . . . 0.0 111.692 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -52.55 122.68 9.37 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 77.7 mttt 60.98 17.04 7.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.326 1.45 . . . . 0.0 113.822 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -79.87 -18.41 50.78 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.36 1.064 . . . . 0.0 113.287 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 79.23 174.41 0.15 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.24 1.416 . . . . 0.0 114.573 170.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.77 -15.2 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.24 0.616 . . . . 0.0 112.611 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.24 -29.3 0.64 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 118.556 0.616 . . . . 0.0 114.191 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -151.51 -1.48 0.33 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.885 0.843 . . . . 0.0 111.066 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -145.78 151.59 38.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -97.19 151.2 20.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.027 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 37.5 mm -123.62 157.5 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -172.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -127.82 158.92 36.4 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 171' ' ' LYS . 35.5 m -133.84 130.5 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . 0.424 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 9.0 m-85 -136.98 150.38 48.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -75.84 158.43 32.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.337 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.9 t -156.71 -175.83 5.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.3 m -145.57 169.48 18.32 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.625 1.17 . . . . 0.0 109.744 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -57.16 -32.24 66.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.847 0.459 . . . . 0.0 111.116 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.24 -2.03 3.92 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -121.0 1.93 10.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.88 0.872 . . . . 0.0 111.051 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 193' ' ' SER . 7.1 p -143.89 11.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.885 0.374 . . . . 0.0 111.318 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -67.72 12.3 0.11 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 191' ' ' VAL . 30.2 m -69.69 0.38 5.63 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.387 0.675 . . . . 0.0 111.28 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.275 -1.345 . . . . 0.0 111.149 178.091 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -142.07 4.17 1.63 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.45 -5.9 33.59 Favored Glycine 0 N--CA 1.45 -0.375 0 O-C-N 122.245 -0.284 . . . . 0.0 112.581 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -63.03 148.36 47.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.766 0.793 . . . . 0.0 111.286 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.574 HG13 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -155.11 174.77 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.428 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -137.17 152.21 49.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tp -133.81 150.98 51.43 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -154.07 169.98 22.23 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.83 4.96 88.63 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.556 HD22 ' HG ' ' A' ' 122' ' ' CYS . 2.6 mp -58.5 149.05 62.96 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 117.035 0.418 . . . . 0.0 111.609 -175.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 15.3 Cg_exo -62.04 146.97 95.99 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.255 1.97 . . . . 0.0 108.715 167.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -71.35 2.99 4.08 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.24 5.74 12.08 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.556 ' HG ' HD22 ' A' ' 118' ' ' LEU . 49.0 t -66.86 154.43 40.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.249 1.02 . . . . 0.0 111.134 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.2 t -156.05 -166.44 2.19 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.03 -53.14 28.86 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.714 0.688 . . . . 0.0 109.518 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.496 ' HA ' ' CG2' ' A' ' 128' ' ' VAL . 32.6 tt0 -53.36 -21.25 5.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.333 1.453 . . . . 0.0 113.843 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 75.6 mm-40 -97.91 -19.67 17.94 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.004 -1.06 . . . . 0.0 110.635 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.2 mt -86.08 -26.18 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.496 ' CG2' ' HA ' ' A' ' 125' ' ' GLU . 29.0 m -78.88 -33.7 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.04 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -72.66 -32.08 65.56 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.454 0.57 . . . . 0.0 110.698 172.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 16.6 t80 -70.44 -24.39 62.88 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.395 -0.19 . . . . 0.0 111.379 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -120.56 29.25 7.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.855 0.862 . . . . 0.0 109.706 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 t -63.18 -11.54 21.52 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.036 0.534 . . . . 0.0 111.967 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.49 13.95 65.76 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.41 ' HB3' HD12 ' A' ' 164' ' ' LEU . 76.4 mt -137.76 -159.4 0.95 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.641 1.976 . . . . 0.0 106.627 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -141.76 -21.52 0.73 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -175.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.596 HG21 ' H ' ' A' ' 137' ' ' VAL . 1.7 mt 51.6 -176.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.683 0.793 . . . . 0.0 112.606 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.596 ' H ' HG21 ' A' ' 136' ' ' ILE . 20.6 m -120.51 154.83 56.95 Favored Pre-proline 0 C--N 1.339 0.145 0 O-C-N 121.501 -0.749 . . . . 0.0 109.174 167.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.84 134.71 17.67 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.154 3.236 . . . . 0.0 112.746 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.2 t30 41.01 36.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.601 1.161 . . . . 0.0 112.557 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -81.87 -4.61 90.26 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.301 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.91 151.15 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.989 0.894 . . . . 0.0 110.732 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.8 m -143.2 144.33 32.13 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.756 0.822 . . . . 0.0 109.346 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.5 mt -139.54 94.98 9.16 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 124.065 0.946 . . . . 0.0 108.615 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.95 158.6 16.8 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.447 2.765 . . . . 0.0 110.691 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 150' ' ' LYS . 28.5 m -141.5 160.42 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.593 0.711 . . . . 0.0 112.187 174.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -85.55 174.04 6.2 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.467 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.03 -9.67 6.57 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.679 2.92 . . . . 0.0 112.539 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -104.3 -1.48 26.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.599 0.759 . . . . 0.0 111.27 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.66 4.38 90.12 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 79.0 mttt -66.86 162.56 21.41 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 153' ' ' GLY . 4.4 pt -109.6 11.27 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -166.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 p 63.33 -5.85 0.22 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 69.96 12.22 67.8 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.205 0.907 . . . . 0.0 113.252 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -141.27 164.79 29.3 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.044 0.922 . . . . 0.0 110.574 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.69 -178.04 7.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.55 0.74 . . . . 0.0 110.539 -172.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -145.45 154.66 42.48 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 5.4 t -147.38 169.16 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.407 ' O ' HG23 ' A' ' 137' ' ' VAL . 51.1 tt0 -126.96 115.95 20.03 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.959 -1.496 . . . . 0.0 106.959 164.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.574 ' CE2' HG13 ' A' ' 113' ' ' VAL . 51.7 m-85 -85.26 173.53 10.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.302 172.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.09 88.48 0.6 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.13 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.1 t 64.62 168.33 0.17 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.488 1.115 . . . . 0.0 111.511 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -19.58 63.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.866 0.466 . . . . 0.0 111.752 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.21 -42.57 65.62 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.038 -0.414 . . . . 0.0 111.244 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -68.1 -36.06 79.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.42 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -60.73 -35.06 75.42 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.282 -0.261 . . . . 0.0 110.785 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -71.41 -28.14 63.79 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -74.55 -37.98 62.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.693 0.282 . . . . 0.0 110.602 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.432 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -61.54 -23.49 65.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.932 176.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 99.1 mt -69.26 -12.1 61.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.349 0.522 . . . . 0.0 111.411 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.85 -10.66 83.65 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 130' ' ' PHE . 67.3 mmtt -89.02 2.02 54.65 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.822 1.249 . . . . 0.0 112.231 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -52.53 132.64 35.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.974 176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 59.38 12.04 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.48 1.512 . . . . 0.0 114.345 -176.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -72.89 -169.93 0.65 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.018 0.826 . . . . 0.0 109.53 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.76 168.0 19.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.24 -13.62 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.438 0.695 . . . . 0.0 111.583 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 152.23 -26.05 0.88 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.394 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -154.49 2.78 0.22 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.66 0.73 . . . . 0.0 111.174 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -148.17 157.51 43.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.062 0.945 . . . . 0.0 108.686 -171.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -101.99 146.29 28.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.0 162.12 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -125.59 153.11 44.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.826 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.444 HG13 ' HB2' ' A' ' 171' ' ' LYS . 23.2 m -136.79 132.56 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -177.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -146.16 154.04 41.34 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -77.53 154.67 32.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.694 0.283 . . . . 0.0 110.724 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.9 t -158.37 -178.64 7.43 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.538 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 66.3 m -148.05 170.3 18.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.695 1.198 . . . . 0.0 108.952 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -56.37 -29.58 61.61 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.761 0.424 . . . . 0.0 111.246 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -66.58 -1.03 3.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.477 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -123.16 2.3 9.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.679 0.792 . . . . 0.0 111.167 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' A' ' 193' ' ' SER . 7.3 p -145.07 9.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -69.19 15.14 0.07 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 191' ' ' VAL . 25.2 m -69.06 -0.07 5.3 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.691 0.797 . . . . 0.0 111.113 176.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.211 -1.376 . . . . 0.0 111.227 178.017 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 25.8 p30 . . . . . 0 N--CA 1.445 -0.691 0 CA-C-O 120.506 0.193 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -126.62 4.29 6.79 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.74 -13.49 13.15 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -61.88 139.18 58.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.485 0.659 . . . . 0.0 111.06 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.604 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.9 p -150.91 177.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.725 -177.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -133.26 161.51 34.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.202 0.601 . . . . 0.0 110.67 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -141.61 148.46 39.27 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.629 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -153.6 161.45 42.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.12 4.72 89.67 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.528 HD22 ' HG ' ' A' ' 122' ' ' CYS . 2.9 mp -59.0 153.22 46.01 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 117.324 0.562 . . . . 0.0 111.487 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -62.26 146.27 95.91 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.387 2.058 . . . . 0.0 108.163 166.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -73.92 10.63 1.1 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.53 3.47 7.63 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.528 ' HG ' HD22 ' A' ' 118' ' ' LEU . 32.5 t -66.6 151.22 47.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.731 1.212 . . . . 0.0 110.981 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.43 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 3.0 t -146.94 -168.29 3.0 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.568 0.747 . . . . 0.0 109.142 172.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.584 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 mptt -51.69 -29.31 17.7 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -76.02 -24.23 55.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.114 0.566 . . . . 0.0 111.93 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.468 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 5.7 mp0 -90.84 -35.34 14.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.478 -0.764 . . . . 0.0 110.0 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.51 -32.54 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.73 -31.84 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.003 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -71.74 -27.64 63.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.755 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -69.78 -27.03 64.58 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -114.3 32.68 5.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.412 1.085 . . . . 0.0 109.53 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.8 t -64.5 -13.62 53.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.959 0.504 . . . . 0.0 112.164 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.31 13.67 67.05 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.412 ' HB3' HD12 ' A' ' 164' ' ' LEU . 74.5 mt -136.72 -161.47 1.17 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.241 1.817 . . . . 0.0 107.24 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.17 -18.22 0.73 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 117.295 2.331 . . . . 0.0 117.295 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.623 HG21 ' H ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER 46.12 -166.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.819 0.848 . . . . 0.0 112.772 -176.242 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.623 ' H ' HG21 ' A' ' 136' ' ' ILE . 16.4 m -129.98 156.17 79.51 Favored Pre-proline 0 CA--C 1.528 0.106 0 C-N-CA 123.898 0.879 . . . . 0.0 109.852 172.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.96 137.15 22.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.027 3.151 . . . . 0.0 112.178 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 39.52 36.58 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.755 1.222 . . . . 0.0 112.952 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.15 5.33 75.23 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 119.13 -0.817 . . . . 0.0 112.507 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.6 mt -113.28 147.77 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 118.84 1.32 . . . . 0.0 109.476 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.0 m -139.56 150.7 45.37 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.505 0.722 . . . . 0.0 109.249 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 6.1 mt -144.48 97.14 5.13 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.513 0.725 . . . . 0.0 109.52 -175.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 163.81 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 124.11 3.207 . . . . 0.0 112.056 174.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 18.1 m -145.06 160.76 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 110.321 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.406 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 60.9 m-20 -84.64 175.54 4.54 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 32.5 Cg_exo -58.67 -20.22 49.63 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.74 2.294 . . . . 0.0 111.045 174.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.25 -12.88 60.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.108 0.963 . . . . 0.0 110.768 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.77 8.27 76.78 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.459 0.552 . . . . 0.0 112.268 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -95.48 148.96 21.93 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 117.433 0.617 . . . . 0.0 109.785 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 153' ' ' GLY . 6.1 pt -77.24 7.35 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 -160.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 67.96 -22.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 175.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 94.42 15.59 46.56 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.339 -0.701 . . . . 0.0 113.233 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.77 168.06 20.69 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.286 1.043 . . . . 0.0 110.466 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.99 -179.56 8.33 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.395 0.617 . . . . 0.0 111.154 -173.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -144.06 147.98 34.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.461 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 48.4 t -145.83 165.26 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -127.92 100.71 6.02 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 168.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.604 ' CE2' HG11 ' A' ' 113' ' ' VAL . 47.5 m-85 -70.29 172.05 8.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.971 174.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.41 88.93 0.33 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.564 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.89 168.31 0.13 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.623 1.169 . . . . 0.0 111.026 -174.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -16.95 64.31 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.741 -0.599 . . . . 0.0 111.266 -176.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . 0.435 ' HG2' ' HZ2' ' A' ' 167' ' ' LYS . 35.2 tt0 -69.09 -39.9 78.74 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.86 -0.525 . . . . 0.0 110.685 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 134' ' ' LEU . 0.9 OUTLIER -72.13 -35.21 69.06 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.455 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -60.72 -36.57 79.17 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.076 -0.39 . . . . 0.0 110.625 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.02 -28.54 65.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.435 ' HZ2' ' HG2' ' A' ' 163' ' ' GLU . 40.5 mttp -72.88 -37.1 67.43 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 121.285 -0.166 . . . . 0.0 110.946 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.39 65.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.98 -11.34 60.65 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.613 0.365 . . . . 0.0 111.707 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.78 -16.85 80.15 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -76.27 -56.59 4.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.106 0.962 . . . . 0.0 110.791 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.2 t60 23.76 -99.87 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.881 1.272 . . . . 0.0 112.63 -164.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -70.74 17.39 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -61.28 179.37 0.21 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.616 0.767 . . . . 0.0 111.237 172.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -132.33 164.22 26.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.17 0.588 . . . . 0.0 112.104 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.2 mt -108.79 -12.82 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.32 0.648 . . . . 0.0 112.258 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.82 -24.92 1.31 Allowed Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.866 -0.521 . . . . 0.0 113.962 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -151.56 2.09 0.39 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 117.624 0.712 . . . . 0.0 110.731 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -149.79 157.46 43.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.284 1.034 . . . . 0.0 108.395 -171.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -107.37 153.25 23.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.343 0.592 . . . . 0.0 109.563 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.0 mm -119.01 171.92 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -172.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -139.92 158.31 44.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.07 133.9 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -134.68 158.29 44.47 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -79.26 163.79 24.66 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.849 0.749 . . . . 0.0 109.701 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.4 t -156.82 -173.26 4.38 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.236 -0.29 . . . . 0.0 111.768 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.2 m -147.04 167.63 23.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.626 1.171 . . . . 0.0 109.713 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -59.91 -30.68 69.19 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.55 -1.42 2.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.971 0.908 . . . . 0.0 112.455 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -122.99 2.23 9.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.12 0.968 . . . . 0.0 111.201 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.428 ' C ' ' H ' ' A' ' 193' ' ' SER . 7.6 p -143.98 11.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-O 120.936 0.398 . . . . 0.0 111.207 -176.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -67.16 11.67 0.1 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 191' ' ' VAL . 20.7 t -69.34 -1.99 9.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.524 0.73 . . . . 0.0 110.818 176.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.246 -1.359 . . . . 0.0 111.257 177.953 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.419 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 5.9 t-20 . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -126.59 9.71 7.13 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.85 -9.7 40.45 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -62.49 138.79 58.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.47 0.653 . . . . 0.0 110.218 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.9 p -148.6 175.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.862 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -131.56 160.94 33.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.663 0.785 . . . . 0.0 110.045 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.2 tp -144.54 140.83 29.06 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -156.67 172.87 17.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.04 8.01 84.57 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 72.0 mt -56.72 150.58 35.92 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.91 0.884 . . . . 0.0 111.819 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.83 20.34 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 124.844 3.696 . . . . 0.0 113.428 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 55.21 11.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.631 1.172 . . . . 0.0 114.131 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.22 -7.63 1.94 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 21.8 t -66.33 151.46 47.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.271 1.029 . . . . 0.0 110.342 175.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.453 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 6.4 t -143.27 -173.46 3.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 170.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.452 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.9 ptpp? -54.71 -17.39 3.37 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.447 ' H ' HG22 ' A' ' 123' ' ' THR . 42.1 mt-10 -83.69 -26.12 30.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.949 0.5 . . . . 0.0 111.341 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.461 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 4.8 mp0 -87.59 -32.55 19.27 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.68 -35.62 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 p -82.27 -34.08 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.164 -173.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -79.67 -20.82 45.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.47 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -73.72 -26.08 60.52 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 170.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -111.14 36.85 3.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.175 1.39 . . . . 0.0 109.024 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.3 t -68.11 -11.27 58.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 112.412 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.09 20.96 46.71 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.428 ' HB3' HD13 ' A' ' 164' ' ' LEU . 43.4 mt -141.27 -173.06 3.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.475 2.31 . . . . 0.0 105.043 -172.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -138.64 -18.12 1.09 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -174.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.605 HG23 ' H ' ' A' ' 137' ' ' VAL . 1.3 mt 50.83 -177.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.208 1.003 . . . . 0.0 112.454 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.605 ' H ' HG23 ' A' ' 136' ' ' ILE . 18.9 m -121.45 155.88 58.71 Favored Pre-proline 0 CA--C 1.528 0.119 0 O-C-N 121.361 -0.837 . . . . 0.0 109.869 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.68 138.1 25.84 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.907 3.072 . . . . 0.0 111.881 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 43.26 35.51 0.87 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.849 0.859 . . . . 0.0 111.538 -177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -99.07 28.71 14.01 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 119.256 -0.747 . . . . 0.0 111.737 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.4 mt -138.49 146.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 118.505 1.152 . . . . 0.0 109.513 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 96.8 m -143.9 151.55 39.97 Favored 'General case' 0 C--N 1.335 -0.051 0 C-N-CA 123.623 0.769 . . . . 0.0 109.268 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.453 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 1.4 mt -145.48 101.15 4.36 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -52.18 149.51 21.76 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.384 2.723 . . . . 0.0 111.32 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -145.01 165.74 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.361 0.6 . . . . 0.0 110.75 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.409 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 65.9 m-20 -86.59 176.27 3.7 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.409 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 37.8 Cg_exo -57.9 -17.82 32.13 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.982 2.455 . . . . 0.0 112.088 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -86.28 -8.82 57.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.324 1.05 . . . . 0.0 111.458 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.71 1.7 88.96 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -76.66 131.33 38.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.451 1.5 . . . . 0.0 109.092 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.9 pt -70.89 147.34 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.394 0.616 . . . . 0.0 110.319 -174.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.2 p -80.77 -9.7 59.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.165 -174.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 111.72 -6.48 27.81 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.734 -0.481 . . . . 0.0 112.798 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -139.29 166.49 24.41 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 117.78 0.79 . . . . 0.0 110.452 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -150.33 -176.81 5.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.039 0.536 . . . . 0.0 111.058 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -144.67 147.64 33.3 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -174.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 85.7 t -147.7 164.18 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -129.67 104.87 7.68 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 113' ' ' VAL . 59.0 m-85 -74.31 169.52 17.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.12 91.74 0.37 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.9 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 16.4 t 63.76 171.31 0.17 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.201 1.0 . . . . 0.0 111.135 -175.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 0.6 OUTLIER -61.7 -30.04 70.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.109 -0.369 . . . . 0.0 110.604 -176.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -63.01 -36.69 84.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -76.6 -33.51 58.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.421 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -64.76 -34.7 78.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.682 -0.636 . . . . 0.0 110.839 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -69.97 -29.76 66.95 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -71.81 -37.45 70.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.454 0.169 . . . . 0.0 110.859 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.41 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -60.83 -22.67 64.43 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 122.649 0.38 . . . . 0.0 112.018 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 97.6 mt -68.46 -11.65 60.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 122.213 -0.304 . . . . 0.0 111.397 177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.27 -19.44 79.64 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.15 -63.14 1.14 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.044 0.938 . . . . 0.0 109.458 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.438 ' HD1' ' HA ' ' A' ' 182' ' ' GLU . 1.2 t60 25.11 -107.5 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.45 1.1 . . . . 0.0 112.521 -166.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -68.07 12.77 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.08 171.19 11.36 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.497 1.519 . . . . 0.0 109.635 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 96.8 mtt180 -116.92 155.98 28.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -169.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.49 -14.31 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.476 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.32 -27.23 0.61 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.643 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -154.47 -1.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.607 0.703 . . . . 0.0 111.583 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -145.84 150.63 36.52 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.949 0.899 . . . . 0.0 108.727 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 175' ' ' ARG . 25.6 p90 -91.43 159.58 15.89 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.865 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 36.2 mm -125.27 174.38 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.438 ' HA ' ' HD1' ' A' ' 172' ' ' HIS . 14.4 mt-10 -138.96 142.17 38.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.2 m -114.61 139.29 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -137.42 159.4 42.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -77.72 163.62 25.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.83 0.741 . . . . 0.0 109.59 175.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t -156.13 -173.18 4.39 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.563 0.22 . . . . 0.0 111.561 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.4 m -147.29 168.99 20.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.351 1.06 . . . . 0.0 109.64 -176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -58.94 -30.35 67.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.638 0.375 . . . . 0.0 110.885 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -67.28 -2.33 5.83 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.368 0.667 . . . . 0.0 112.673 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -116.78 0.49 12.55 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.447 0.699 . . . . 0.0 110.496 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.414 ' C ' ' H ' ' A' ' 193' ' ' SER . 9.9 p -144.59 8.52 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -70.39 16.2 0.08 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 191' ' ' VAL . 35.1 m -68.87 0.02 4.93 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.471 0.708 . . . . 0.0 111.073 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.372 177.896 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 58.5 t30 . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.6 m -144.81 8.04 1.26 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.845 0.458 . . . . 0.0 112.079 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.08 168.4 25.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.156 0.435 . . . . 0.0 111.006 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -150.9 4.83 0.48 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.614 0.366 . . . . 0.0 111.755 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.6 p -149.88 7.91 0.65 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.785 0.434 . . . . 0.0 111.845 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.9 157.1 40.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.036 0.446 . . . . 0.0 110.759 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -161.43 29.84 0.13 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.826 0.85 . . . . 0.0 109.856 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -136.27 165.48 25.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.678 1.191 . . . . 0.0 108.451 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.62 1.34 37.7 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.961 -0.355 . . . . 0.0 112.447 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -61.56 144.54 54.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 117.66 0.73 . . . . 0.0 110.808 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.599 HG11 ' CE2' ' A' ' 159' ' ' PHE . 10.7 p -151.77 176.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 124.116 0.966 . . . . 0.0 108.521 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 22.4 ttt180 -136.63 147.47 46.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.06 148.28 44.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -152.46 160.27 43.27 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.66 3.65 71.02 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 120' ' ' PHE . 83.5 mt -55.55 140.57 65.83 Favored Pre-proline 0 N--CA 1.453 -0.316 0 C-N-CA 123.321 0.648 . . . . 0.0 110.596 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 24.5 Cg_exo -58.85 16.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 125.172 3.915 . . . . 0.0 116.081 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.474 ' H ' ' C ' ' A' ' 118' ' ' LEU . 22.0 m-85 57.03 9.41 0.63 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.554 1.141 . . . . 0.0 112.847 -171.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.05 -3.16 1.51 Allowed Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.793 -0.567 . . . . 0.0 112.304 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 28.2 t -63.62 153.18 36.74 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 125' ' ' GLU . 5.7 t -150.47 -169.19 3.32 Favored 'General case' 0 CA--C 1.526 0.05 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.445 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -51.71 -33.69 35.48 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.139 0.427 . . . . 0.0 111.81 -178.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.462 ' H ' HG22 ' A' ' 123' ' ' THR . 40.4 tt0 -76.78 -22.67 53.4 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.447 0.699 . . . . 0.0 112.018 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.482 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 47.2 mm-40 -94.73 -33.87 12.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.431 -0.793 . . . . 0.0 109.33 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.412 HG13 ' SG ' ' A' ' 122' ' ' CYS . 54.0 mt -64.32 -34.57 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.33 -34.02 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.661 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -72.34 -26.6 61.99 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.898 172.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 19.3 t80 -72.09 -23.06 61.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.655 0.264 . . . . 0.0 110.549 175.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -118.14 32.87 5.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.397 1.079 . . . . 0.0 109.042 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.0 t -68.26 -11.67 59.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.122 0.569 . . . . 0.0 112.342 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.56 15.24 63.58 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.7 mt -144.14 -162.33 1.45 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.36 1.864 . . . . 0.0 107.196 -173.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -147.94 162.32 39.54 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.981 -0.449 . . . . 0.0 110.069 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.39 148.03 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 158' ' ' GLN . 21.0 m -73.83 153.71 89.12 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 118.588 0.631 . . . . 0.0 110.254 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.89 139.36 25.39 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 124.109 3.206 . . . . 0.0 112.477 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.5 t30 40.59 37.56 0.49 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.369 1.068 . . . . 0.0 111.988 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.86 27.73 13.62 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-O 118.72 -1.045 . . . . 0.0 112.057 -173.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.7 mt -133.37 145.3 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 119.375 1.588 . . . . 0.0 109.36 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.4 m -137.8 144.76 41.7 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.772 0.829 . . . . 0.0 109.158 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 87.2 mt -136.96 93.72 13.27 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 123.454 0.702 . . . . 0.0 110.029 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.5 150.84 32.91 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.221 2.614 . . . . 0.0 110.764 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -141.57 166.69 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.096 0 CA-C-O 121.437 0.637 . . . . 0.0 111.43 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.43 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 64.7 m-20 -92.3 176.99 2.3 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.721 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.43 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 35.3 Cg_exo -58.75 -19.18 44.98 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.962 2.441 . . . . 0.0 111.83 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -82.82 -7.56 59.65 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.526 0.73 . . . . 0.0 110.657 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.93 13.44 81.24 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.307 0.48 . . . . 0.0 112.323 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -105.61 149.07 26.64 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.5 pt -68.86 149.76 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.456 0.646 . . . . 0.0 111.493 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 45.4 p -74.91 -7.34 53.26 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.222 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.65 -0.75 36.61 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -140.37 170.72 15.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.066 0.546 . . . . 0.0 110.409 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -157.22 -178.69 7.55 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.269 0.628 . . . . 0.0 111.079 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -143.98 148.85 35.87 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.435 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 76.2 t -146.84 165.34 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.427 ' O ' HG23 ' A' ' 137' ' ' VAL . 40.8 tt0 -128.52 105.99 8.67 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 167.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.599 ' CE2' HG11 ' A' ' 113' ' ' VAL . 35.1 m-85 -74.69 173.01 11.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.389 170.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.19 90.7 0.9 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.192 0.52 . . . . 0.0 109.796 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.9 t 63.15 170.24 0.15 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.591 1.157 . . . . 0.0 112.415 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -22.06 65.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.5 0.72 . . . . 0.0 111.598 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.71 -43.48 75.92 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.907 -0.495 . . . . 0.0 111.032 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -39.15 84.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.511 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.19 -37.23 71.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.129 -0.357 . . . . 0.0 110.867 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -71.78 -28.86 63.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.896 -0.138 . . . . 0.0 110.902 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -72.98 -39.18 66.33 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.656 0.265 . . . . 0.0 110.549 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.53 -17.88 63.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.106 0.562 . . . . 0.0 112.195 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.33 -13.01 61.61 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.462 0.574 . . . . 0.0 111.366 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.05 -11.74 81.47 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.465 ' HB2' HG12 ' A' ' 183' ' ' VAL . 69.9 mmtt -88.54 0.55 56.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.296 1.438 . . . . 0.0 111.705 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -54.54 133.18 46.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.443 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.446 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 90.6 mttt 59.51 5.59 0.67 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.617 1.567 . . . . 0.0 114.075 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -76.95 170.41 16.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -112.59 158.31 20.12 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -169.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.1 tt -102.9 -9.52 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.574 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 154.43 -29.08 0.7 Allowed Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.935 -0.37 . . . . 0.0 112.611 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -157.51 0.96 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.411 0.605 . . . . 0.0 111.382 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -145.64 153.46 41.05 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.21 1.004 . . . . 0.0 108.508 -173.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -97.01 152.95 18.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.989 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 38.7 mm -127.47 162.2 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -128.71 160.37 32.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 171' ' ' LYS . 26.5 m -137.0 39.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 123.103 0.561 . . . . 0.0 111.674 -162.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.661 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 3.4 m-30 -52.71 152.87 3.5 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.922 0.489 . . . . 0.0 109.816 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -80.06 170.16 16.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.633 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 10.0 t -158.01 179.97 8.69 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.479 0.312 . . . . 0.0 110.821 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -148.18 170.53 17.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.284 1.433 . . . . 0.0 108.291 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -53.92 -31.81 51.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.74 -2.77 2.69 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -122.14 2.16 9.8 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.861 0.864 . . . . 0.0 111.013 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.56 11.55 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-O 120.968 0.413 . . . . 0.0 111.14 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -68.95 13.03 0.11 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 29.3 m -67.24 -1.98 5.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.393 0.677 . . . . 0.0 111.456 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.247 -1.358 . . . . 0.0 110.968 178.272 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.412 1 O4'-C1'-N19 114.164 5.964 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.439 ' C4 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.954 0 O4'-C1'-N19 111.759 3.559 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.471 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.407 -3.792 0 C3'-C2'-C1' 104.759 3.621 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.471 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.829 1 O4'-C1'-N19 115.594 7.394 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.446 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.952 1 C5'-C4'-C3' 109.362 -4.092 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.661 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.634 0 O4'-C1'-C2' 102.677 -2.659 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -146.42 14.08 1.24 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.017 0.527 . . . . 0.0 111.463 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.45 179.29 7.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.726 0.81 . . . . 0.0 109.62 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -149.01 157.11 43.17 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.697 0.284 . . . . 0.0 110.723 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.6 m -145.87 19.87 1.45 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.788 0.835 . . . . 0.0 110.629 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.36 33.98 0.09 Allowed 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.033 0.933 . . . . 0.0 112.136 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -146.85 28.8 1.02 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -170.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -128.07 7.13 6.01 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.07 -8.74 25.15 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -64.12 142.18 58.5 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.479 0.657 . . . . 0.0 111.608 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.616 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.4 p -152.92 177.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.435 1.094 . . . . 0.0 108.686 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.408 ' H ' HG21 ' A' ' 113' ' ' VAL . 65.0 ttt180 -135.65 153.66 51.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.951 0.9 . . . . 0.0 109.1 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -126.5 135.62 51.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -150.69 50.68 0.87 Allowed 'General case' 0 C--O 1.226 -0.166 0 CA-C-O 121.282 0.563 . . . . 0.0 112.443 -172.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -160.03 15.94 0.21 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.7 153.46 90.82 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -168.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 24.5 Cg_exo -59.44 143.63 99.65 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.754 2.303 . . . . 0.0 107.951 163.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -69.71 6.73 1.05 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.74 10.66 5.46 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 48.8 t -66.29 157.82 30.64 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.285 1.034 . . . . 0.0 111.404 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 125' ' ' GLU . 3.7 t -152.16 -174.8 5.0 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.248 0.619 . . . . 0.0 109.825 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.561 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -51.77 -34.01 37.7 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 123.378 0.671 . . . . 0.0 112.471 -176.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.447 ' H ' HG23 ' A' ' 123' ' ' THR . 40.2 tt0 -72.39 -25.96 61.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.016 0.527 . . . . 0.0 112.166 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -93.1 -30.7 15.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.76 -40.74 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.35 -34.51 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 O-C-N 122.159 -0.338 . . . . 0.0 111.193 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -74.34 -28.71 61.27 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.162 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 28.9 t80 -67.15 -21.21 65.82 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -115.41 37.15 3.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.341 1.056 . . . . 0.0 108.385 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.2 t -69.48 154.84 41.41 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 167.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.27 5.1 85.11 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 24.0 mt -141.78 -172.2 3.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.668 1.987 . . . . 0.0 106.01 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -147.79 162.6 38.89 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.634 -0.666 . . . . 0.0 110.845 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.7 mt -141.32 147.9 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 158' ' ' GLN . 19.4 m -72.64 154.47 91.42 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 118.459 0.572 . . . . 0.0 110.305 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -48.63 138.61 24.99 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.055 3.17 . . . . 0.0 112.179 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 t30 41.53 36.4 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.471 1.109 . . . . 0.0 112.014 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.25 28.64 10.31 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.793 -1.004 . . . . 0.0 111.739 -173.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.5 mt -136.56 145.75 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 119.061 1.431 . . . . 0.0 109.351 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.0 m -139.5 149.46 43.98 Favored 'General case' 0 N--CA 1.458 -0.048 0 C-N-CA 123.509 0.724 . . . . 0.0 109.827 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 11.9 mt -144.48 93.26 5.85 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 124.075 0.95 . . . . 0.0 109.649 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -55.72 159.61 11.12 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.813 3.009 . . . . 0.0 111.307 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.2 m -141.21 166.02 18.54 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 CA-C-O 121.216 0.531 . . . . 0.0 111.543 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 66.9 m-20 -90.05 176.48 3.01 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.831 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.421 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -58.85 -19.25 46.12 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.089 2.526 . . . . 0.0 111.736 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -82.81 -9.01 59.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.563 0.745 . . . . 0.0 110.745 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.35 11.16 80.98 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 123.384 0.516 . . . . 0.0 112.272 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -102.81 148.75 25.24 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.2 pt -68.17 151.23 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.912 0.863 . . . . 0.0 112.263 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.7 p -79.11 5.87 10.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.481 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.7 15.35 80.73 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -140.83 164.74 29.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.49 178.19 10.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.249 0.547 . . . . 0.0 110.465 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -144.71 145.18 31.59 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 67.9 t -143.79 162.98 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.414 ' O ' HG21 ' A' ' 137' ' ' VAL . 49.3 tt0 -129.17 101.83 6.19 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 169.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.616 ' CE2' HG11 ' A' ' 113' ' ' VAL . 43.6 m-85 -71.55 171.17 11.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.328 171.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.47 93.53 1.19 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 61.8 169.8 0.11 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.688 1.195 . . . . 0.0 111.343 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -61.99 -26.75 68.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.762 -0.586 . . . . 0.0 110.9 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.16 -42.48 90.84 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.243 -0.286 . . . . 0.0 111.119 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -38.79 69.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.53 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.91 -40.54 80.59 Favored 'General case' 0 N--CA 1.457 -0.101 0 O-C-N 122.013 -0.43 . . . . 0.0 110.898 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -67.83 -31.05 70.63 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.719 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -71.56 -39.46 70.63 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.632 0.253 . . . . 0.0 111.011 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.98 -15.39 62.21 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.96 -9.33 51.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.685 0.675 . . . . 0.0 111.524 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.14 -11.96 85.07 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.485 ' HB2' HG13 ' A' ' 183' ' ' VAL . 69.5 mmtt -85.74 2.81 43.97 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.243 1.417 . . . . 0.0 111.588 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -56.28 136.9 53.05 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.972 -0.455 . . . . 0.0 110.314 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.445 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 33.0 mttp 50.99 11.39 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.179 1.792 . . . . 0.0 114.242 -175.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.02 179.36 5.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.259 1.024 . . . . 0.0 109.085 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -126.46 163.27 23.7 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -170.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mt -113.0 -13.13 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.277 1.031 . . . . 0.0 111.849 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.41 -27.1 1.37 Allowed Glycine 0 CA--C 1.528 0.901 0 O-C-N 121.922 -0.486 . . . . 0.0 113.975 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -153.05 11.49 0.47 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.843 0.822 . . . . 0.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.11 -173.57 3.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.445 1.098 . . . . 0.0 108.384 -172.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.578 ' HH ' ' N6 ' ' B' ' 5' ' ' ' A' . 5.3 p90 -137.06 144.14 43.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 168.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 19.0 mm -116.79 162.62 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -167.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -129.64 154.08 47.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 171' ' ' LYS . 34.5 m -131.24 33.66 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 C-N-CA 123.839 0.855 . . . . 0.0 111.011 -166.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.67 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 10.6 m-30 -53.55 154.61 3.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -81.93 170.57 15.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.362 -0.837 . . . . 0.0 111.826 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.8 t -158.88 -173.7 4.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.521 0.328 . . . . 0.0 111.533 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 51.3 m -147.81 168.04 23.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.964 1.306 . . . . 0.0 109.174 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -56.91 -30.75 64.22 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.724 0.409 . . . . 0.0 110.897 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.84 -6.53 6.01 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -117.25 1.91 12.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.589 0.755 . . . . 0.0 111.312 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.61 15.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.269 0.557 . . . . 0.0 110.928 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -69.26 11.53 0.22 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.421 0.688 . . . . 0.0 112.811 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 65.8 p -69.29 -1.52 8.35 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.412 0.685 . . . . 0.0 111.243 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.746 -1.121 . . . . 0.0 110.959 177.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.422 ' C4 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.949 0 C5'-C4'-C3' 110.18 -3.547 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.471 1 C1'-O4'-C4' 105.045 -5.062 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.444 " H4'" " C5'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.149 0 O4'-C1'-N19 111.487 3.287 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.571 HO2' " C1'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.556 1 O4'-C1'-N19 113.975 5.775 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.606 " H1'" ' C6 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.412 -3.457 2 C1'-O4'-C4' 105.672 -4.365 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.67 " H1'" ' CZ ' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 O4'-C1'-N19 111.358 3.158 . 0.0 OUTLIER '7D dist 6g' 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.8 p30 . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 110.646 -0.131 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.4 p -144.4 19.5 1.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.971 0.508 . . . . 0.0 111.441 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -142.11 4.73 1.65 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -147.5 3.61 0.76 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.074 0.55 . . . . 0.0 110.694 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 t -156.25 -173.45 4.51 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.107 0.963 . . . . 0.0 108.92 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.61 161.55 37.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.01 0.524 . . . . 0.0 110.678 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -155.29 31.22 0.39 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.677 0.391 . . . . 0.0 111.046 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -125.15 4.26 7.87 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.5 -9.76 53.17 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -62.5 141.36 58.45 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.568 0.699 . . . . 0.0 110.596 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.629 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.5 p -150.6 172.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -137.34 152.83 50.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp -136.92 148.2 46.86 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -173.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -158.3 154.93 27.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.689 0.281 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.08 -7.08 60.22 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.59 HD11 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -63.82 157.99 64.07 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.881 0.341 . . . . 0.0 111.777 -176.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 21.8 Cg_exo -57.82 152.13 51.88 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.348 2.699 . . . . 0.0 112.522 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.406 ' CD2' ' C8 ' ' B' ' 1' ' ' ' A' . 82.7 m-85 -67.89 -5.53 17.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.93 -0.89 31.91 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.436 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 41.8 t -68.2 153.01 44.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.344 0.657 . . . . 0.0 109.407 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.545 HG21 ' H ' ' A' ' 125' ' ' GLU . 8.7 t -154.31 -174.63 5.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 174.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.4 ptpp? -56.48 -20.69 21.34 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.545 ' H ' HG21 ' A' ' 123' ' ' THR . 42.2 mt-10 -82.18 -21.86 36.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.911 0.484 . . . . 0.0 111.218 177.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.411 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 60.2 mm-40 -90.74 -33.65 15.67 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.2 mt -61.4 -36.39 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.79 -33.63 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.002 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -75.66 -26.91 58.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.993 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -67.94 -27.57 66.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.413 ' CE1' ' HG3' ' A' ' 171' ' ' LYS . 42.9 m-85 -108.79 34.71 3.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.3 t -67.15 152.0 46.54 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.94 4.24 90.35 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -172.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.2 mt -139.49 -171.56 3.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.165 1.786 . . . . 0.0 106.543 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -146.95 162.54 38.52 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.858 -0.526 . . . . 0.0 110.691 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 mt -141.82 148.74 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.9 m -74.46 154.6 87.81 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 118.476 0.58 . . . . 0.0 110.422 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.15 140.01 26.05 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.073 3.182 . . . . 0.0 112.229 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.6 t30 41.77 34.9 0.45 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.36 1.064 . . . . 0.0 111.929 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.32 30.17 8.04 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-O 118.941 -0.922 . . . . 0.0 111.801 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.8 mt -138.35 146.94 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 118.902 1.351 . . . . 0.0 109.922 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.6 m -140.76 146.88 38.29 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 123.86 0.864 . . . . 0.0 109.643 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.4 mt -142.35 92.84 7.29 Favored Pre-proline 0 CA--C 1.528 0.104 0 C-N-CA 124.268 1.027 . . . . 0.0 109.395 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.99 156.4 15.84 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.584 2.856 . . . . 0.0 111.539 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.4 m -142.43 167.06 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-O 121.367 0.603 . . . . 0.0 110.914 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 61.7 m-20 -91.03 176.52 2.81 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.707 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.418 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 38.5 Cg_exo -58.07 -20.01 43.7 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.823 2.349 . . . . 0.0 111.712 176.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -80.66 -8.81 59.75 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.165 0.986 . . . . 0.0 111.219 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.53 2.52 90.54 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -174.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.449 ' HE3' ' N3 ' ' B' ' 1' ' ' ' A' . 82.5 tttt -79.14 134.66 36.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.007 1.323 . . . . 0.0 108.886 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.5 pt -68.52 146.52 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.579 0.704 . . . . 0.0 110.163 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.4 p -76.4 0.85 18.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.24 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 85.95 7.44 80.82 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -141.43 168.55 19.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.356 0.578 . . . . 0.0 110.347 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.1 179.43 9.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.308 0.575 . . . . 0.0 111.078 -173.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -143.56 146.21 33.14 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.463 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.2 t -146.38 164.72 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.419 ' O ' HG22 ' A' ' 137' ' ' VAL . 53.1 tt0 -129.51 102.58 6.45 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 169.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.629 ' CE2' HG11 ' A' ' 113' ' ' VAL . 37.9 m-85 -73.07 171.57 12.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.379 171.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 92.45 0.91 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.8 t 61.88 167.2 0.11 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.787 1.235 . . . . 0.0 111.488 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -14.2 61.99 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.904 -0.498 . . . . 0.0 111.091 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.404 ' HG2' ' HZ2' ' A' ' 167' ' ' LYS . 35.5 tt0 -68.61 -41.81 79.03 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 122.05 -0.406 . . . . 0.0 110.546 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.86 -39.67 72.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.51 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.44 -38.76 74.95 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.198 -0.314 . . . . 0.0 110.804 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -68.87 -29.82 68.2 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.764 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.404 ' HZ2' ' HG2' ' A' ' 163' ' ' GLU . 38.3 mttp -73.24 -38.15 66.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.622 0.248 . . . . 0.0 110.759 175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.01 -16.81 63.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.75 -9.68 57.85 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.408 0.549 . . . . 0.0 111.548 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.19 -12.77 81.62 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.413 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 68.9 mmtt -82.74 -2.37 54.12 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 125.599 1.56 . . . . 0.0 111.973 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.413 ' CE1' HO2' ' B' ' 6' ' ' ' U' . 14.4 t60 -52.69 133.11 36.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.651 176.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.498 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 44.5 mttp 56.37 9.69 0.56 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.202 1.801 . . . . 0.0 114.4 -176.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.06 173.04 9.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.068 0.947 . . . . 0.0 108.82 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -125.4 160.27 29.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.796 -0.565 . . . . 0.0 112.169 -172.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.1 tt -113.04 -1.93 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.2 -36.92 0.65 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 121.731 -0.606 . . . . 0.0 113.685 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -155.62 6.87 0.23 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.533 0.666 . . . . 0.0 110.74 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.76 135.36 24.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -86.1 157.9 19.93 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.727 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 27.6 mm -125.05 160.85 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -127.5 156.24 42.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.407 HG12 ' HB2' ' A' ' 171' ' ' LYS . 33.1 m -131.71 130.71 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.569 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 5.7 m-85 -137.19 153.91 50.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -175.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -76.42 164.09 26.33 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.692 0.678 . . . . 0.0 110.006 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -159.4 -175.35 5.16 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.45 0.167 . . . . 0.0 111.373 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.4 t -148.85 171.84 15.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.947 0.899 . . . . 0.0 110.011 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -60.24 -28.61 68.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.269 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.63 -0.94 2.31 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.8 0.84 . . . . 0.0 112.571 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.59 2.37 7.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.542 0.737 . . . . 0.0 111.601 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 193' ' ' SER . 9.4 p -144.72 10.53 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 122.131 -0.356 . . . . 0.0 111.866 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -69.75 15.6 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 191' ' ' VAL . 34.2 m -68.61 -0.48 5.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.593 0.757 . . . . 0.0 111.087 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.237 -1.363 . . . . 0.0 111.244 178.105 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.449 ' N3 ' ' HE3' ' A' ' 150' ' ' LYS . . . . . . . . 0 O4'--C4' 1.407 -3.838 2 C1'-O4'-C4' 100.322 -10.309 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.718 1 C5'-C4'-C3' 109.005 -4.33 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.496 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.408 -3.74 1 P-O3'-C3' 125.381 4.734 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.496 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.869 2 O4'-C1'-N19 117.68 9.48 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.63 " H1'" ' C6 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.828 0 C4'-C3'-C2' 99.217 -3.483 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.63 ' C6 ' " H1'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.45 0 P-O3'-C3' 122.998 2.748 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 120.548 0.213 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -152.73 -0.5 0.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.734 0.413 . . . . 0.0 111.807 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.01 14.65 0.72 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.266 0.626 . . . . 0.0 110.282 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -139.67 6.61 2.27 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.948 0.899 . . . . 0.0 111.117 -174.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.9 m -71.12 -2.48 15.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.577 0.751 . . . . 0.0 112.372 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -154.61 163.63 39.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.886 0.374 . . . . 0.0 111.316 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -159.56 35.13 0.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.51 0.724 . . . . 0.0 110.399 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -129.39 5.16 5.19 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.72 -10.16 52.58 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -63.11 141.18 58.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.563 0.696 . . . . 0.0 110.471 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.623 HG13 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -150.92 175.94 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.932 -177.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -135.4 154.16 51.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 109.28 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.9 tp -139.3 150.28 45.23 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -156.72 157.78 35.73 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.13 -5.13 71.62 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.615 ' H ' HD12 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.93 155.95 90.59 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 116.94 0.37 . . . . 0.0 111.529 -176.437 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 31.3 Cg_exo -54.65 151.25 32.32 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.125 3.217 . . . . 0.0 112.183 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.454 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 22.9 m-85 -64.88 -8.74 16.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.05 0.387 . . . . 0.0 111.688 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.57 -0.1 30.79 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.457 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 44.6 t -64.25 153.77 37.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.292 0.637 . . . . 0.0 109.293 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.566 HG21 ' H ' ' A' ' 125' ' ' GLU . 10.4 t -154.87 -176.17 5.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.441 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 0.9 OUTLIER -57.29 -21.75 36.88 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.566 ' H ' HG21 ' A' ' 123' ' ' THR . 39.4 tt0 -78.74 -25.23 44.5 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.19 0.596 . . . . 0.0 110.744 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -87.9 -37.08 16.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.31 -35.06 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.0 p -79.69 -32.45 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.712 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -75.32 -28.05 59.5 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.961 172.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -66.05 -26.42 67.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -111.77 32.58 5.34 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.838 0.855 . . . . 0.0 109.017 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.0 t -64.31 148.89 49.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.59 3.71 86.12 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -172.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 17.9 mt -138.53 -170.55 2.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.744 1.617 . . . . 0.0 106.715 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -146.78 162.2 39.05 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.87 -0.519 . . . . 0.0 110.374 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.3 mt -142.04 148.44 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.6 m -73.29 154.49 90.19 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 118.595 0.634 . . . . 0.0 110.369 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.1 138.74 27.74 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 124.074 3.183 . . . . 0.0 112.155 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.1 t30 41.65 35.81 0.52 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.313 1.045 . . . . 0.0 112.047 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.04 29.96 8.13 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 119.04 -0.867 . . . . 0.0 111.895 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.9 mt -138.24 145.54 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.775 1.288 . . . . 0.0 109.658 -176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 86.3 m -139.59 150.2 44.74 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 123.822 0.849 . . . . 0.0 109.621 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 92.6 mt -139.81 90.77 10.8 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.829 0.852 . . . . 0.0 110.093 -174.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.47 153.87 21.56 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.468 2.779 . . . . 0.0 111.813 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.5 m -142.57 169.09 13.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 121.382 0.61 . . . . 0.0 111.207 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 59.5 m-20 -96.12 177.46 1.73 Allowed Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.105 0.962 . . . . 0.0 108.781 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.418 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 40.5 Cg_exo -58.04 -20.55 45.99 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.952 2.435 . . . . 0.0 111.625 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.26 -10.7 59.61 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.184 0.994 . . . . 0.0 110.956 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.22 4.39 86.5 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.463 ' HE3' ' N3 ' ' B' ' 1' ' ' ' A' . 55.0 tttm -83.43 136.31 34.36 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.068 1.347 . . . . 0.0 108.806 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.1 pt -66.98 148.01 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 121.79 0.805 . . . . 0.0 110.754 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.6 p -75.26 -0.69 20.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.16 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 88.28 5.94 75.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -138.53 169.78 17.17 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.279 0.54 . . . . 0.0 110.207 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.81 179.13 9.39 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.212 0.605 . . . . 0.0 110.798 -174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -143.65 145.55 32.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 60.2 t -145.81 164.59 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.418 ' O ' HG22 ' A' ' 137' ' ' VAL . 52.6 tt0 -129.19 102.22 6.36 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.623 ' CE2' HG13 ' A' ' 113' ' ' VAL . 44.6 m-85 -72.74 171.2 13.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.263 172.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.86 92.73 0.71 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t 61.67 168.67 0.11 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.758 1.223 . . . . 0.0 111.505 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -14.66 62.68 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.95 -0.469 . . . . 0.0 111.24 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.07 -42.4 76.27 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 122.052 -0.405 . . . . 0.0 110.679 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.84 -38.89 73.24 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.523 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.48 -39.04 75.55 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.279 -0.263 . . . . 0.0 110.717 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -69.02 -29.05 67.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.892 -0.14 . . . . 0.0 110.956 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -73.52 -38.19 65.38 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.095 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.8 -21.65 66.04 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 97.0 mt -70.35 -7.71 44.88 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 122.847 0.459 . . . . 0.0 111.733 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.04 -15.47 81.37 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -76.07 -55.02 5.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.257 1.023 . . . . 0.0 110.856 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.418 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 0.7 OUTLIER 23.86 -101.79 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.863 1.265 . . . . 0.0 113.052 -165.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.459 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 56.0 mttp -71.18 19.55 0.05 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -174.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.28 178.74 0.18 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.003 0.921 . . . . 0.0 111.099 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -128.58 161.18 30.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.343 0.657 . . . . 0.0 110.746 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.0 tt -117.94 -0.08 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.42 -36.17 0.64 Allowed Glycine 0 CA--C 1.529 0.953 0 O-C-N 122.046 -0.409 . . . . 0.0 113.422 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -156.72 5.74 0.16 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.314 0.557 . . . . 0.0 110.489 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -146.51 156.17 43.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.514 1.126 . . . . 0.0 108.485 -170.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -104.07 153.81 20.44 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.373 0.606 . . . . 0.0 110.113 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 30.1 mm -120.12 172.14 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -172.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.409 ' HA ' ' HD1' ' A' ' 172' ' ' HIS . 21.8 mt-10 -139.54 155.94 47.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.418 ' CG2' ' HA ' ' A' ' 172' ' ' HIS . 22.2 m -130.71 137.5 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.468 ' CE1' ' C2 ' ' B' ' 6' ' ' ' U' . 33.0 m-85 -148.18 160.49 42.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -80.18 165.32 22.54 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.677 0.671 . . . . 0.0 110.778 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.7 t -158.74 -174.41 4.76 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.144 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.6 t -147.98 171.85 15.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.162 0.985 . . . . 0.0 109.796 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -59.36 -31.39 69.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.652 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.78 -6.02 7.15 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.678 0.791 . . . . 0.0 112.537 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -118.45 3.01 11.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.598 0.759 . . . . 0.0 111.168 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' A' ' 193' ' ' SER . 8.5 p -145.26 9.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 122.272 -0.267 . . . . 0.0 111.613 -175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -69.26 13.5 0.12 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 191' ' ' VAL . 24.7 m -67.14 -1.16 3.97 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.509 0.723 . . . . 0.0 111.205 176.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.287 177.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.534 ' C8 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.052 0 C3'-C2'-C1' 104.638 3.486 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.454 ' C5 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 P--O5' 1.617 2.387 1 C5'-C4'-C3' 108.691 -4.539 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.433 ' OP1' " H1'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.123 1 P-O3'-C3' 124.925 4.354 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.012 1 O4'-C1'-N19 114.712 6.512 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.625 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.02 1 C5'-C4'-C3' 107.946 -5.036 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.625 ' C5 ' " H1'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.658 0 C3'-C2'-C1' 98.779 -3.024 . 0.0 OUTLIER '7D dist 4a' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.8 t30 . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -152.52 169.31 22.95 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.04 0.536 . . . . 0.0 110.136 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.39 175.77 13.16 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.012 0.525 . . . . 0.0 110.737 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 55.21 16.39 1.63 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.48 1.112 . . . . 0.0 113.401 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.3 p -153.67 166.89 31.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 122.04 -0.412 . . . . 0.0 110.68 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 47.0 25.65 0.51 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.188 1.395 . . . . 0.0 114.754 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -150.27 29.89 0.7 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.027 0.442 . . . . 0.0 111.758 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -121.7 7.65 9.98 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.64 -9.77 41.26 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -61.27 138.63 58.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.731 0.776 . . . . 0.0 110.823 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.581 HG12 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -150.27 174.97 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.235 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 58.4 ttt180 -136.58 155.38 50.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.3 tp -138.28 147.4 43.59 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -173.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -154.72 162.48 41.1 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.83 1.45 58.65 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.6 mt -56.97 150.04 41.3 Favored Pre-proline 0 N--CA 1.453 -0.292 0 C-N-CA 123.23 0.612 . . . . 0.0 111.982 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.27 26.16 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 1 C-N-CA 125.346 4.031 . . . . 0.0 113.522 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.582 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 15.4 m-30 53.47 13.85 0.5 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.903 1.281 . . . . 0.0 114.162 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.02 -13.99 0.58 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.994 0.815 . . . . 0.0 112.724 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.4 m -67.35 153.5 43.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.448 0.624 . . . . 0.0 110.389 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 t -147.23 -160.8 1.21 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.93 0.892 . . . . 0.0 108.733 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.487 ' HE3' ' CD1' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -50.34 -31.26 14.07 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -84.07 -19.64 33.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -96.27 -31.54 12.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.756 -0.59 . . . . 0.0 109.816 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.4 mt -62.98 -36.31 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 172.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.7 p -79.32 -32.2 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.921 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -74.15 -30.66 62.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.248 172.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.89 -22.06 65.98 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 118.267 0.485 . . . . 0.0 110.111 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -115.84 31.44 6.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.516 1.126 . . . . 0.0 109.214 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.6 t -63.06 139.58 58.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.87 1.75 90.63 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.8 mt -138.82 78.37 1.67 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.153 1.381 . . . . 0.0 107.673 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -50.07 160.01 0.38 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.858 0.863 . . . . 0.0 113.293 -174.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.1 mt -136.41 153.18 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.93 155.36 32.61 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 122.597 0.359 . . . . 0.0 110.592 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.99 -31.0 7.8 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.84 3.693 . . . . 0.0 114.084 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -160.12 105.57 1.54 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.04 20.93 1.11 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-O 118.686 -1.063 . . . . 0.0 112.756 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.2 mt -117.48 147.26 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 119.257 1.529 . . . . 0.0 110.271 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.4 m -142.11 144.87 33.72 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.958 0.903 . . . . 0.0 109.49 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.487 ' CD1' ' HE3' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -139.65 97.81 8.12 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 123.793 0.837 . . . . 0.0 110.047 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.18 154.9 31.68 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.871 3.047 . . . . 0.0 110.998 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.32 168.83 13.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-O 121.408 0.623 . . . . 0.0 111.503 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.424 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 62.9 m-20 -95.13 176.64 2.17 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.549 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.424 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -58.08 -19.6 41.81 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.976 2.451 . . . . 0.0 111.913 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.23 -8.14 59.7 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.166 0.986 . . . . 0.0 111.117 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.08 2.76 89.19 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.582 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 80.0 tttt -81.08 134.2 35.62 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.922 1.289 . . . . 0.0 108.304 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.1 148.93 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.505 0.669 . . . . 0.0 109.753 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 53.4 p -72.4 1.46 7.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.989 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 95.75 0.95 62.05 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -140.96 169.71 17.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.913 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.65 -177.89 6.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -144.66 146.46 32.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.492 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 84.4 t -146.16 163.2 10.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -130.87 94.6 3.64 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.274 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.581 ' CE2' HG12 ' A' ' 113' ' ' VAL . 53.3 m-85 -65.69 170.66 4.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.89 93.37 0.76 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.4 t 62.36 168.28 0.12 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.774 1.23 . . . . 0.0 111.392 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -62.12 -27.55 69.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.713 -0.617 . . . . 0.0 110.901 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.42 -41.28 93.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.198 -0.314 . . . . 0.0 111.016 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -37.88 71.69 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -59.1 -38.48 79.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.83 -0.544 . . . . 0.0 110.648 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -68.87 -31.31 70.16 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.45 0.3 . . . . 0.0 110.572 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -71.0 -40.06 72.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.574 0.226 . . . . 0.0 110.59 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.47 -15.08 62.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.62 -11.84 55.4 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.829 0.741 . . . . 0.0 111.934 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.0 -10.65 84.11 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.409 ' HB2' HG12 ' A' ' 183' ' ' VAL . 65.5 mmtt -88.02 -3.38 58.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.214 1.406 . . . . 0.0 112.893 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.457 ' CD2' ' HZ3' ' A' ' 173' ' ' LYS . 6.4 t60 -43.29 -21.47 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.457 ' HZ3' ' CD2' ' A' ' 172' ' ' HIS . 60.0 mttp -139.58 18.56 2.53 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.522 1.055 . . . . 0.0 111.798 176.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -76.29 -175.65 3.29 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 122.97 0.508 . . . . 0.0 110.323 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -134.57 163.42 29.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.09 -13.44 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.544 0.738 . . . . 0.0 111.971 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.95 -31.68 0.5 Allowed Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.74 -0.6 . . . . 0.0 113.986 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -152.56 2.96 0.34 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.649 0.725 . . . . 0.0 110.909 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -144.69 155.11 43.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.362 1.065 . . . . 0.0 108.164 -174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -106.78 151.22 25.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.272 0.558 . . . . 0.0 110.037 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.8 mm -121.19 159.93 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -171.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -133.44 145.92 50.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 171' ' ' LYS . 18.0 m -115.98 136.84 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.696 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 9.1 m-85 -137.24 154.27 50.19 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -76.05 163.0 27.57 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.068 0.849 . . . . 0.0 110.544 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.3 t -158.89 -175.43 5.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.8 m -148.66 170.94 17.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.05 1.34 . . . . 0.0 109.269 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -57.87 -31.77 67.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.877 0.471 . . . . 0.0 111.394 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.37 -5.18 9.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -115.71 2.26 13.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.728 0.811 . . . . 0.0 111.005 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 193' ' ' SER . 8.7 p -142.35 9.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 111.18 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -70.22 16.34 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.374 0.67 . . . . 0.0 112.797 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 191' ' ' VAL . 30.0 m -68.45 -0.51 5.06 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.6 0.76 . . . . 0.0 111.23 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.373 178.379 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.189 2 O4'-C1'-N19 113.809 5.609 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.455 " H1'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.6 2 C5'-C4'-C3' 106.478 -6.014 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.455 ' OP1' " H1'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.071 2 P-O3'-C3' 125.389 4.741 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.494 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.414 -3.214 1 O4'-C1'-N19 114.94 6.74 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.404 ' C2 ' ' HE3' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.763 1 C5'-C4'-C3' 109.324 -4.118 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.696 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.492 0 C5'-C4'-C3' 111.241 -2.839 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 m -143.38 8.55 1.59 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.879 0.472 . . . . 0.0 111.45 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.12 172.43 17.56 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.315 0.646 . . . . 0.0 109.96 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -146.49 -3.02 0.64 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.733 0.413 . . . . 0.0 111.536 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.7 p -155.98 169.8 23.62 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.017 0.527 . . . . 0.0 110.383 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 41.55 46.1 2.99 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.74 1.216 . . . . 0.0 114.047 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -145.28 26.76 1.3 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -122.47 8.58 9.6 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.14 -8.75 49.63 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -61.77 141.36 57.94 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.553 0.692 . . . . 0.0 110.612 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.616 HG13 ' CE2' ' A' ' 159' ' ' PHE . 7.2 p -151.05 175.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -137.01 154.04 50.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.7 tp -133.08 148.32 52.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.413 ' HD2' ' C6 ' ' B' ' 4' ' ' ' G' . 20.3 tpp85 -152.89 160.66 43.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.82 3.93 70.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 95.8 mt -57.33 150.01 45.32 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 117.118 0.459 . . . . 0.0 111.97 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.11 25.25 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 125.143 3.895 . . . . 0.0 113.66 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.62 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 22.6 m-30 52.35 13.48 0.3 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.071 1.348 . . . . 0.0 114.192 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.29 -8.86 1.11 Allowed Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.861 0.755 . . . . 0.0 112.458 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 7.0 t -59.62 149.62 29.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.218 1.007 . . . . 0.0 110.953 174.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 2.4 t -141.16 -167.86 2.49 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.465 0.706 . . . . 0.0 109.298 172.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.552 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.8 mptt -51.18 -29.2 13.22 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.436 0.562 . . . . 0.0 112.356 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -81.22 -19.91 42.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.446 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 5.7 mp0 -92.98 -33.91 13.95 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.773 -0.58 . . . . 0.0 109.439 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.42 -34.9 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.4 p -84.1 -32.45 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.007 -173.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -72.91 -27.57 61.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -70.77 -25.94 63.12 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.739 0.304 . . . . 0.0 110.429 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -113.71 32.77 5.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.459 1.104 . . . . 0.0 109.016 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.0 t -67.3 -17.01 64.6 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.965 0.506 . . . . 0.0 111.983 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.36 15.41 60.04 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.8 mt -143.73 -163.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.207 1.803 . . . . 0.0 107.403 -173.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -146.94 162.61 38.36 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.3 mt -142.16 150.86 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.2 155.23 86.24 Favored Pre-proline 0 C--O 1.232 0.135 0 O-C-N 122.032 -0.417 . . . . 0.0 110.471 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.09 136.81 29.81 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 124.006 3.137 . . . . 0.0 112.245 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.6 t30 40.05 38.92 0.55 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.448 1.099 . . . . 0.0 112.07 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.67 28.19 13.25 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-O 118.859 -0.967 . . . . 0.0 111.876 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.96 147.15 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 118.99 1.395 . . . . 0.0 109.548 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 88.6 m -138.47 148.38 44.29 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.073 0.949 . . . . 0.0 108.991 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 6.3 mt -145.74 99.04 4.43 Favored Pre-proline 0 N--CA 1.453 -0.315 0 C-N-CA 123.091 0.557 . . . . 0.0 110.225 -174.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.7 157.59 18.94 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.499 2.8 . . . . 0.0 110.334 171.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.3 m -145.68 163.73 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-O 121.427 0.632 . . . . 0.0 111.324 173.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.401 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 57.8 m-20 -89.69 175.5 3.82 Favored Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.579 174.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.5 Cg_exo -57.95 -20.46 44.88 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.734 2.289 . . . . 0.0 111.385 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -79.48 -9.96 59.71 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.102 0.961 . . . . 0.0 111.252 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.56 0.7 90.06 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -173.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.62 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 85.3 tttt -72.28 131.79 43.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.914 1.286 . . . . 0.0 108.891 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.518 ' C ' ' H ' ' A' ' 153' ' ' GLY . 8.4 pt -71.88 10.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -169.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p 67.49 -15.71 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.532 1.133 . . . . 0.0 112.197 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 101.33 6.44 50.94 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.338 0.971 . . . . 0.0 112.814 175.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -142.68 168.82 18.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.058 0.929 . . . . 0.0 111.936 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.11 -178.82 7.59 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.671 0.788 . . . . 0.0 110.59 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -143.59 146.24 33.14 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -177.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.45 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.3 t -146.42 165.01 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -174.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -129.46 96.15 4.2 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.68 0.753 . . . . 0.0 109.009 170.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.616 ' CE2' HG13 ' A' ' 113' ' ' VAL . 36.3 m-85 -68.6 172.07 6.74 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.23 93.45 1.09 Allowed 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t 61.27 168.73 0.1 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.683 1.193 . . . . 0.0 111.455 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -61.73 -27.3 68.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.76 -0.587 . . . . 0.0 110.65 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.32 -36.21 79.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.05 -0.406 . . . . 0.0 111.515 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 159' ' ' PHE . 0.8 OUTLIER -74.76 -40.0 61.47 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.14 -37.89 72.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 122.296 -0.252 . . . . 0.0 110.614 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -68.74 -32.12 71.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.601 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -71.3 -38.56 71.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.581 0.229 . . . . 0.0 110.795 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.52 -18.46 63.84 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.821 0.448 . . . . 0.0 112.033 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.418 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 93.9 mt -65.95 -14.37 61.45 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.641 0.655 . . . . 0.0 111.836 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.86 -10.26 80.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.425 ' HB2' HG13 ' A' ' 183' ' ' VAL . 63.6 mmtt -90.58 -1.97 57.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.814 1.246 . . . . 0.0 112.606 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.429 ' CE1' ' H2 ' ' B' ' 5' ' ' ' A' . 14.5 t60 -43.93 -19.92 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.42 17.02 2.39 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.364 0.984 . . . . 0.0 111.833 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -75.65 -173.78 2.3 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-O 120.997 0.427 . . . . 0.0 110.119 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -134.43 166.21 23.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -170.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.6 -19.83 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 124.633 1.173 . . . . 0.0 109.989 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 179' ' ' ARG . . . 137.02 135.48 3.39 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 45.32 2.47 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.791 2.036 . . . . 0.0 115.215 -173.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 177' ' ' GLY . 52.3 ttm-85 -151.46 166.8 29.98 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.188 0.595 . . . . 0.0 110.143 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -120.78 155.09 34.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.4 mm -123.44 162.57 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -170.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -134.37 150.6 50.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 171' ' ' LYS . 19.7 m -119.77 135.6 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.687 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 11.8 m-30 -134.84 153.48 52.02 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -76.49 162.95 27.39 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.674 -0.641 . . . . 0.0 110.629 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.5 t -158.86 -175.93 5.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.3 m -148.18 168.95 21.13 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.249 1.419 . . . . 0.0 109.192 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -57.44 -31.91 66.37 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.734 0.414 . . . . 0.0 111.173 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.87 -16.74 59.89 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -102.35 0.44 34.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.405 0.682 . . . . 0.0 111.47 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.1 p -143.35 14.33 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.002 0.43 . . . . 0.0 111.027 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -69.45 13.45 0.13 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.4 m -68.01 -0.68 4.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.592 0.757 . . . . 0.0 111.199 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.094 178.541 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.291 2 O4'-C1'-N19 114.166 5.966 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.453 ' C4 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.655 1 C5'-C4'-C3' 107.301 -5.466 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.481 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.405 -3.998 0 C3'-C2'-C1' 104.471 3.301 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.487 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.831 2 O4'-C1'-N19 116.235 8.035 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.429 ' H2 ' ' CE1' ' A' ' 172' ' ' HIS . . . . . . . . 0 O4'--C4' 1.418 -2.926 1 C5'-C4'-C3' 109.477 -4.015 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.687 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.523 0 C5'-C4'-C3' 110.885 -3.077 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.6 t -146.82 15.95 1.23 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.927 0.491 . . . . 0.0 111.035 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.2 4.45 1.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -145.32 -6.89 0.63 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.899 0.318 . . . . 0.0 111.467 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.7 t -156.03 157.14 35.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.868 0.467 . . . . 0.0 109.835 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -163.65 -179.41 6.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.658 0.783 . . . . 0.0 109.902 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.05 26.5 0.26 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.982 0.513 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -136.89 2.63 2.63 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.57 -10.23 75.2 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 122.08 -0.388 . . . . 0.0 112.66 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -65.44 150.34 48.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.593 0.711 . . . . 0.0 110.323 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.59 HG13 ' CE2' ' A' ' 159' ' ' PHE . 7.0 p -153.11 175.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.676 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -132.32 153.75 50.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.378 1.071 . . . . 0.0 108.673 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.1 tp -137.4 146.52 44.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -152.6 169.41 22.74 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.85 8.59 86.53 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 120' ' ' PHE . 89.5 mt -57.18 142.65 74.72 Favored Pre-proline 0 N--CA 1.451 -0.412 0 C-N-CA 122.858 0.463 . . . . 0.0 111.9 -174.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.99 27.45 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 125.235 3.956 . . . . 0.0 113.609 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.452 ' CE2' H5'' ' B' ' 1' ' ' ' A' . 83.3 m-85 54.79 8.13 0.2 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.03 1.332 . . . . 0.0 114.536 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -136.81 -5.13 1.98 Allowed Glycine 0 CA--C 1.528 0.87 0 CA-C-N 118.786 0.721 . . . . 0.0 112.169 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 44.4 t -61.62 153.04 29.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.69 0.796 . . . . 0.0 111.147 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 t -156.16 -163.35 1.45 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -46.17 -39.26 9.39 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.428 0.691 . . . . 0.0 112.679 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -83.72 -15.3 49.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.5 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 65.5 mm-40 -98.81 -31.47 11.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.401 HG13 ' SG ' ' A' ' 122' ' ' CYS . 32.5 mt -64.37 -37.68 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 172.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.4 -33.16 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.528 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -74.14 -25.89 60.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.137 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 181' ' ' ILE . 53.8 t80 -71.78 -20.35 61.88 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.872 0.305 . . . . 0.0 110.667 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -120.94 33.59 5.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.481 1.112 . . . . 0.0 108.455 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -64.0 -17.63 63.5 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.16 0.584 . . . . 0.0 112.439 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.27 15.28 58.74 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 56.4 mt -144.04 -162.53 1.49 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.486 1.514 . . . . 0.0 108.457 -172.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -145.97 163.04 36.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.9 mt -142.25 150.32 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.3 m -74.55 155.99 87.15 Favored Pre-proline 0 CA--C 1.53 0.177 0 O-C-N 121.995 -0.441 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.83 133.48 22.43 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 124.196 3.264 . . . . 0.0 112.464 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.2 t30 38.62 39.34 0.32 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.582 1.153 . . . . 0.0 112.16 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.5 35.36 3.97 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-O 119.044 -0.864 . . . . 0.0 111.246 -174.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -137.84 146.68 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 118.74 1.27 . . . . 0.0 109.42 -176.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.3 m -138.23 144.23 40.5 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 123.574 0.749 . . . . 0.0 109.166 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.5 mt -137.78 87.28 17.19 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 123.71 0.804 . . . . 0.0 109.396 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.67 158.85 18.67 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.095 2.53 . . . . 0.0 110.855 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 150' ' ' LYS . 31.3 m -141.42 160.34 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 121.552 0.691 . . . . 0.0 112.24 174.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 148' ' ' GLU . 22.0 m-20 -83.54 174.12 6.43 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.826 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 33.7 Cg_exo -59.9 -2.65 1.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.274 3.316 . . . . 0.0 113.045 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 146' ' ' ASP . 30.8 tt0 -117.15 1.38 12.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.799 0.839 . . . . 0.0 110.759 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.06 2.83 88.06 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 22.3 mtpt -69.54 161.31 29.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.487 ' C ' ' H ' ' A' ' 153' ' ' GLY . 4.8 pt -95.95 13.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -167.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 p 62.71 -3.37 0.31 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.916 0.886 . . . . 0.0 112.358 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 77.27 6.02 85.95 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.779 1.181 . . . . 0.0 113.014 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -142.41 168.41 19.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.238 1.019 . . . . 0.0 111.72 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.27 -177.98 6.99 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.059 0.944 . . . . 0.0 110.453 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -145.56 148.11 32.81 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.451 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 61.7 t -146.11 165.0 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -129.74 95.85 4.08 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.74 0.781 . . . . 0.0 108.982 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.59 ' CE2' HG13 ' A' ' 113' ' ' VAL . 46.1 m-85 -69.03 170.9 9.02 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.763 174.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.29 94.05 0.9 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.7 t 62.66 168.44 0.13 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.538 1.135 . . . . 0.0 111.621 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -61.86 -26.05 67.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.61 -36.55 84.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.035 0.379 . . . . 0.0 111.704 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.64 -39.97 64.11 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.484 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.05 -34.76 70.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.293 -0.254 . . . . 0.0 110.631 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -69.16 -32.15 71.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.336 0.255 . . . . 0.0 110.516 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -72.53 -38.05 68.15 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.766 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.01 -19.56 64.47 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.113 0.565 . . . . 0.0 112.341 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.422 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 95.2 mt -67.65 -8.46 34.96 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.584 0.629 . . . . 0.0 111.284 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.66 8.09 66.88 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -118.76 3.7 11.62 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 123.852 0.861 . . . . 0.0 111.289 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.444 ' CD2' ' HZ2' ' A' ' 173' ' ' LYS . 5.3 t60 -42.2 -24.48 0.05 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.444 ' HZ2' ' CD2' ' A' ' 172' ' ' HIS . 61.1 mttp -137.5 18.32 2.91 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.355 0.98 . . . . 0.0 110.897 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -81.57 174.12 11.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.711 1.604 . . . . 0.0 108.792 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -120.35 158.46 27.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.2 tt -98.09 -12.51 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.499 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.87 -26.66 1.77 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.248 0.451 . . . . 0.0 112.209 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -155.4 5.83 0.22 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.148 0.579 . . . . 0.0 110.789 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -145.75 160.57 41.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.556 1.142 . . . . 0.0 108.197 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.409 ' CZ ' ' C2 ' ' B' ' 3' ' ' ' G' . 19.7 p90 -107.93 145.27 34.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 130' ' ' PHE . 31.3 mm -122.02 160.62 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -129.98 144.86 51.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 169' ' ' LEU . 11.0 m -119.3 143.21 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.428 ' CE1' ' C2 ' ' B' ' 6' ' ' ' U' . 47.5 m-85 -150.41 156.01 40.67 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -73.71 156.77 37.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.983 0.42 . . . . 0.0 110.696 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.7 t -157.68 -177.06 6.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.118 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.6 t -152.08 174.8 13.25 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.14 0.976 . . . . 0.0 109.558 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.6 tp60 -59.03 -31.7 69.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.726 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.09 -3.8 6.19 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -118.79 2.95 11.65 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.664 0.786 . . . . 0.0 111.308 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 193' ' ' SER . 7.8 p -144.5 10.51 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.913 0.387 . . . . 0.0 111.204 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -68.2 14.12 0.07 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 191' ' ' VAL . 25.0 m -68.69 -0.58 5.44 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.433 0.693 . . . . 0.0 111.239 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.079 178.371 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.452 H5'' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.413 -3.309 0 C5'-C4'-C3' 110.353 -3.432 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 C5'-C4'-C3' 110.179 -3.548 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.522 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.411 -3.534 1 P-O3'-C3' 125.3 4.667 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.522 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.9 1 O4'-C1'-N19 115.041 6.841 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.565 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.84 1 C5'-C4'-C3' 108.304 -4.798 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.565 ' C5 ' " H1'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.541 0 O4'-C1'-C2' 103.075 -2.375 . 0.0 OUTLIER '7D dist 4a' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.5 t30 . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.4 p -150.54 12.84 0.72 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.225 0.61 . . . . 0.0 111.517 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.42 -179.3 6.85 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.87 0.468 . . . . 0.0 110.734 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 52.48 26.99 4.59 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.709 0.804 . . . . 0.0 112.409 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.1 p -140.93 18.83 2.3 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.693 0.797 . . . . 0.0 110.98 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.2 52.98 1.82 Allowed 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.888 0.875 . . . . 0.0 110.041 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -147.73 34.78 0.85 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.447 -171.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -118.15 7.45 12.15 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.03 -8.91 42.68 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.93 139.96 58.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.423 0.63 . . . . 0.0 110.705 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.621 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.4 p -149.51 175.81 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.205 1.002 . . . . 0.0 108.764 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -137.49 144.42 42.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.06 0.544 . . . . 0.0 109.743 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.02 152.25 36.76 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.457 ' HE ' ' HB3' ' A' ' 154' ' ' GLU . 19.3 tpp85 -157.6 152.1 25.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.27 2.45 90.59 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 171.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.59 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -68.25 158.49 84.27 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 37.7 Cg_exo -52.21 153.66 12.44 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.026 2.484 . . . . 0.0 114.311 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.59 ' CE1' ' C5 ' ' B' ' 2' ' ' ' G' . 55.0 m-85 -68.25 -1.55 6.42 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.944 0.497 . . . . 0.0 111.802 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.77 2.96 10.97 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.446 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 52.5 t -66.3 153.51 42.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.025 0.93 . . . . 0.0 109.605 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.561 HG21 ' H ' ' A' ' 125' ' ' GLU . 10.0 t -154.97 -175.24 5.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 2.4 ptpp? -56.45 -22.06 29.57 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.561 ' H ' HG21 ' A' ' 123' ' ' THR . 40.8 tt0 -77.72 -25.07 49.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.242 0.617 . . . . 0.0 110.899 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.408 ' HB2' ' HG ' ' A' ' 122' ' ' CYS . 60.3 mm-40 -89.05 -35.52 16.3 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.6 -34.35 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.58 -34.07 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.658 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -73.17 -25.72 60.9 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.921 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -72.04 -25.97 62.01 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.64 0.257 . . . . 0.0 110.336 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -111.29 30.5 6.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.531 1.132 . . . . 0.0 109.022 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.6 t -65.74 -14.68 61.78 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.753 0.421 . . . . 0.0 111.865 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.17 15.26 63.32 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 33.4 mt -143.26 -162.8 1.51 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.249 1.819 . . . . 0.0 107.35 -173.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -147.15 162.29 39.16 Favored 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.2 mt -142.38 152.09 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.9 m -77.65 153.86 81.09 Favored Pre-proline 0 CA--C 1.528 0.105 0 CA-C-N 118.153 0.433 . . . . 0.0 110.683 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.37 140.7 34.11 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.097 3.198 . . . . 0.0 112.094 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 42.02 36.39 0.67 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.201 1.0 . . . . 0.0 111.929 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -99.76 29.28 12.37 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 118.898 -0.945 . . . . 0.0 111.943 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 77.6 mt -137.72 146.07 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.847 1.324 . . . . 0.0 110.2 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.1 m -142.17 147.55 36.8 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.009 0.924 . . . . 0.0 109.728 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.4 mt -140.78 96.48 7.48 Favored Pre-proline 0 CA--C 1.527 0.094 0 C-N-CA 124.243 1.017 . . . . 0.0 109.849 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.74 154.88 8.73 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.713 2.942 . . . . 0.0 112.019 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.77 165.13 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-O 121.244 0.545 . . . . 0.0 110.467 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.432 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 67.7 m-20 -86.13 176.4 3.62 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.929 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.432 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -59.1 -17.77 40.17 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.102 2.535 . . . . 0.0 111.85 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -86.89 -4.69 59.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.594 0.758 . . . . 0.0 110.789 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.46 11.15 83.58 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 123.477 0.56 . . . . 0.0 112.534 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -102.22 149.81 23.93 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 117.455 0.628 . . . . 0.0 109.55 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.6 pt -69.22 151.87 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.729 0.776 . . . . 0.0 112.606 -170.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.3 p -86.98 -7.14 58.45 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.144 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.74 6.36 57.25 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-O 119.768 -0.462 . . . . 0.0 112.781 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.457 ' HB3' ' HE ' ' A' ' 116' ' ' ARG . 23.0 pt-20 -140.02 168.45 19.79 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.433 0.617 . . . . 0.0 110.546 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.21 178.51 10.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.069 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -141.57 143.95 33.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.453 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 69.6 t -144.56 162.61 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -174.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -128.51 97.62 4.77 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.863 0.84 . . . . 0.0 109.02 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.621 ' CE2' HG11 ' A' ' 113' ' ' VAL . 38.5 m-85 -69.07 171.57 8.03 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.433 173.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.29 92.57 0.79 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t 61.33 170.42 0.11 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.757 1.223 . . . . 0.0 111.423 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -62.63 -27.18 69.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.818 -0.551 . . . . 0.0 110.696 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.48 -41.56 85.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.153 -0.342 . . . . 0.0 111.133 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.51 -39.55 67.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.497 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.66 -38.26 74.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.002 -0.436 . . . . 0.0 110.93 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -69.27 -30.05 68.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.755 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -72.58 -38.93 67.74 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 120.46 0.172 . . . . 0.0 111.082 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.411 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.39 -19.39 64.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.766 0.427 . . . . 0.0 112.127 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.4 mt -69.19 -11.65 60.98 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.842 -0.536 . . . . 0.0 111.345 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.87 -13.24 80.84 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.422 ' HB2' HG12 ' A' ' 183' ' ' VAL . 70.3 mmtt -83.41 -1.04 52.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.299 1.439 . . . . 0.0 111.924 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.462 ' CD2' ' HZ2' ' A' ' 173' ' ' LYS . 6.1 t60 -54.81 134.81 48.1 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.248 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.553 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 47.6 mttp 56.85 6.33 0.3 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.993 1.717 . . . . 0.0 114.567 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.13 172.49 11.63 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.051 0.94 . . . . 0.0 109.325 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -123.05 158.85 29.68 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.949 -0.47 . . . . 0.0 112.197 -170.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.6 tt -112.75 -2.24 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.08 -32.43 0.66 Allowed Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.931 -0.481 . . . . 0.0 113.936 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -156.45 4.21 0.16 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.85 0.825 . . . . 0.0 111.163 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -147.74 159.68 43.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.252 1.021 . . . . 0.0 108.477 -170.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -109.02 130.16 55.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.411 0.624 . . . . 0.0 109.968 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.0 mm -94.55 166.53 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -130.65 154.14 48.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 171' ' ' LYS . 24.4 m -135.79 125.2 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.643 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 8.2 m-30 -133.47 163.69 28.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.418 ' HG2' ' H ' ' A' ' 186' ' ' SER . 8.5 tttm -88.64 169.11 11.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.456 1.025 . . . . 0.0 111.598 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.418 ' H ' ' HG2' ' A' ' 185' ' ' LYS . 8.6 t -158.32 -177.22 6.38 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.084 0.554 . . . . 0.0 111.156 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.1 m -149.35 168.77 22.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.144 1.378 . . . . 0.0 108.69 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -56.43 -32.54 64.98 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.45 0.3 . . . . 0.0 111.641 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.54 -2.43 6.57 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -117.0 3.02 12.77 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.964 0.906 . . . . 0.0 110.8 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 193' ' ' SER . 7.6 p -143.27 11.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 121.221 0.534 . . . . 0.0 110.825 -177.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -68.06 13.77 0.08 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.85 0.86 . . . . 0.0 113.068 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 191' ' ' VAL . 24.4 m -68.28 -1.24 5.86 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.57 0.748 . . . . 0.0 111.254 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.125 178.564 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.942 2 O4'-C1'-N19 114.567 6.367 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.59 ' C5 ' ' CE1' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.748 1 C5'-C4'-C3' 106.12 -6.254 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.623 2.972 2 P-O3'-C3' 124.651 4.126 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.425 ' C6 ' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 O4'--C4' 1.418 -2.885 2 O4'-C1'-N19 117.131 8.931 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.553 ' C2 ' ' HE3' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.075 1 C5'-C4'-C3' 109.407 -4.062 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.643 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.502 0 P-O3'-C3' 123.604 3.253 . 0.013 4d . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.921 -0.029 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.5 m 48.44 28.55 1.73 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.147 0.979 . . . . 0.0 112.933 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.33 17.7 1.53 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.453 0.701 . . . . 0.0 110.417 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -148.97 179.31 7.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.951 0.9 . . . . 0.0 109.125 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.5 m -135.52 172.85 12.42 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.771 0.428 . . . . 0.0 110.893 -177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -150.23 169.37 21.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.749 0.419 . . . . 0.0 111.082 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -152.78 30.55 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.203 0.601 . . . . 0.0 110.963 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.83 2.54 6.67 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.09 -10.19 51.21 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.395 174.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -64.04 143.61 57.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.428 0.632 . . . . 0.0 110.372 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.645 HG13 ' CE2' ' A' ' 159' ' ' PHE . 9.9 p -150.81 178.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.911 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.427 ' H ' HG21 ' A' ' 113' ' ' VAL . 5.8 mtm180 -133.28 165.07 25.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.318 0.647 . . . . 0.0 111.087 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.8 tp -147.23 145.16 29.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -154.82 171.2 20.0 Favored 'General case' 0 CA--C 1.527 0.084 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.72 10.45 86.23 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 120' ' ' PHE . 95.2 mt -55.15 149.65 24.5 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 123.289 0.636 . . . . 0.0 111.494 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.06 27.38 0.21 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.798 2.332 . . . . 0.0 113.454 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.549 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 62.6 m-85 51.04 12.96 0.13 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.926 1.691 . . . . 0.0 113.603 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.19 -8.14 1.21 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 22.5 t -61.84 154.07 27.0 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.779 0.831 . . . . 0.0 109.847 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.516 HG21 ' H ' ' A' ' 125' ' ' GLU . 10.0 t -147.69 -174.86 4.66 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.8 ptpp? -55.33 -20.12 10.7 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.516 ' H ' HG21 ' A' ' 123' ' ' THR . 42.2 mt-10 -83.6 -22.38 32.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.018 0.527 . . . . 0.0 111.342 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.496 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 64.3 mm-40 -92.43 -30.49 15.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.49 -36.44 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.07 -32.11 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.685 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -73.15 -27.62 61.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.065 172.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 24.1 t80 -71.67 -24.34 61.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 110.504 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -115.49 32.14 6.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.442 1.097 . . . . 0.0 108.727 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 t -67.92 -16.97 64.31 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.936 0.495 . . . . 0.0 112.075 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.66 15.66 59.9 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.0 mt -143.47 -164.83 1.95 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.229 1.812 . . . . 0.0 107.307 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -148.06 161.23 41.81 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.839 -0.538 . . . . 0.0 110.038 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.9 mt -140.43 150.83 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 158' ' ' GLN . 18.5 m -77.56 154.09 81.36 Favored Pre-proline 0 CA--C 1.528 0.128 0 CA-C-N 118.407 0.549 . . . . 0.0 110.354 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.1 141.31 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.925 3.083 . . . . 0.0 111.949 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 43.13 35.18 0.76 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.906 0.882 . . . . 0.0 111.777 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.99 28.82 13.48 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-O 119.245 -0.753 . . . . 0.0 111.968 -173.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.8 mt -138.24 144.78 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 118.817 1.308 . . . . 0.0 109.731 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.7 m -140.35 145.74 37.54 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.592 0.757 . . . . 0.0 109.234 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.0 mt -141.76 94.21 7.38 Favored Pre-proline 0 N--CA 1.455 -0.208 0 C-N-CA 124.154 0.982 . . . . 0.0 109.061 -176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.06 152.89 22.65 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.334 2.689 . . . . 0.0 110.624 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.47 166.02 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 CA-C-O 121.328 0.585 . . . . 0.0 111.072 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.426 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 58.9 m-20 -91.56 177.07 2.36 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.861 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.426 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 32.6 Cg_exo -59.07 -19.43 48.74 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.942 2.428 . . . . 0.0 111.762 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -81.95 -7.46 59.61 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.768 0.827 . . . . 0.0 110.672 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.33 12.31 83.26 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.675 0.655 . . . . 0.0 112.151 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -102.0 149.97 23.7 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.8 pt -68.24 148.28 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.465 0.65 . . . . 0.0 111.577 -171.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.2 p -76.6 -4.03 40.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.705 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.7 4.31 54.68 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 123.048 0.356 . . . . 0.0 112.46 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -145.15 171.16 14.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.247 0.524 . . . . 0.0 110.092 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.21 179.12 9.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.3 0.572 . . . . 0.0 110.5 -175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -144.4 143.79 31.09 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.455 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 90.4 t -145.99 164.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -174.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.425 ' O ' HG21 ' A' ' 137' ' ' VAL . 52.2 tt0 -129.82 102.77 6.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.645 ' CE2' HG13 ' A' ' 113' ' ' VAL . 34.0 m-85 -73.83 172.2 11.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.322 171.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.17 91.58 0.72 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.084 0.469 . . . . 0.0 109.815 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 61.61 168.53 0.11 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.666 1.186 . . . . 0.0 111.476 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -16.43 63.91 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.885 -0.51 . . . . 0.0 111.055 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -66.01 -42.96 89.0 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.973 -0.454 . . . . 0.0 110.342 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.73 -39.69 73.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.458 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.31 -38.32 73.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.244 -0.285 . . . . 0.0 110.856 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -69.26 -29.98 68.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.728 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -72.52 -38.35 68.11 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.513 0.197 . . . . 0.0 110.814 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.412 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.91 -19.58 65.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.731 0.412 . . . . 0.0 111.935 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.55 -12.06 59.49 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.464 0.574 . . . . 0.0 111.336 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.98 -11.96 78.96 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.45 ' HB2' HG13 ' A' ' 183' ' ' VAL . 69.5 mmtt -87.39 1.63 52.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.263 1.425 . . . . 0.0 111.614 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.433 ' NE2' ' HE3' ' A' ' 173' ' ' LYS . 65.3 t60 -54.32 134.26 45.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.504 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 90.9 mttt 53.5 14.01 0.53 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.545 1.538 . . . . 0.0 113.967 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.02 163.04 20.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.886 0.766 . . . . 0.0 109.607 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -101.31 159.09 15.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.6 tt -114.99 -7.29 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 160.28 -37.79 0.45 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-O 119.916 -0.38 . . . . 0.0 112.971 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -155.57 11.86 0.32 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.35 0.575 . . . . 0.0 110.761 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -136.0 -179.82 5.89 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.283 1.033 . . . . 0.0 109.141 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -126.15 141.54 51.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.7 mm -112.82 160.87 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.459 ' CG ' ' H22' ' B' ' 3' ' ' ' G' . 22.7 mm-40 -129.89 94.46 3.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -170.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 171' ' ' LYS . 13.9 m -74.24 140.44 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.149 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.602 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 18.3 m-85 -146.26 161.43 40.29 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -79.55 161.72 25.8 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.833 0.742 . . . . 0.0 109.965 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -157.2 -174.2 4.8 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.53 -0.106 . . . . 0.0 111.13 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.7 t -147.4 172.07 14.5 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.808 0.843 . . . . 0.0 110.155 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -59.99 -31.55 70.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.746 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.42 -1.27 7.98 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -114.36 0.34 14.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.792 0.837 . . . . 0.0 110.547 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.92 14.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 120.956 0.408 . . . . 0.0 110.785 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -67.08 9.8 0.18 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 31.3 m -68.7 -0.7 5.6 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.443 0.697 . . . . 0.0 111.292 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.785 -1.103 . . . . 0.0 111.151 178.347 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.142 2 O4'-C1'-N19 114.381 6.181 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.549 ' C5 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.92 1 C5'-C4'-C3' 107.031 -5.646 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.459 ' H22' ' CG ' ' A' ' 182' ' ' GLU . . . . . . . . 0 O4'--C4' 1.411 -3.532 2 P-O3'-C3' 124.863 4.302 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.948 1 O4'-C1'-N19 115.167 6.967 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.56 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.176 1 C5'-C4'-C3' 108.606 -4.596 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.602 " H1'" ' CZ ' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.522 0 P-O3'-C3' 122.814 2.595 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.5 p -147.62 9.23 0.91 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.777 0.431 . . . . 0.0 111.568 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -147.14 8.51 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.144 0.577 . . . . 0.0 111.204 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -146.09 162.88 36.94 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.686 0.794 . . . . 0.0 109.41 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.5 p 49.31 18.03 0.24 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.801 1.241 . . . . 0.0 113.441 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.18 40.95 2.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.149 0.98 . . . . 0.0 110.179 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -146.98 35.08 0.91 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.47 -172.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.62 7.82 10.04 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.34 -9.28 30.88 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -61.86 138.22 58.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.362 0.601 . . . . 0.0 110.669 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.609 HG12 ' CE2' ' A' ' 159' ' ' PHE . 8.5 p -150.25 175.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.044 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -132.35 151.16 51.97 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.608 0.763 . . . . 0.0 110.695 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -123.34 148.71 45.73 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 124.281 1.032 . . . . 0.0 108.39 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -153.18 161.08 42.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.81 0.53 85.18 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.8 mt -53.34 134.93 51.84 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 124.07 0.948 . . . . 0.0 111.238 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -60.31 142.98 99.44 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 107.262 -1.861 . . . . 0.0 107.262 170.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.454 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 17.5 m-85 -66.9 -2.11 4.82 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.92 -174.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.02 -0.9 27.0 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 47.4 t -63.69 142.77 58.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.031 0.932 . . . . 0.0 109.829 176.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.4 t -148.82 -160.9 1.24 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -45.21 -41.03 7.91 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.539 0.736 . . . . 0.0 112.953 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.76 -23.06 49.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 9.9 mp0 -86.3 -39.56 16.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.0 mt -64.45 -36.32 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 p -80.64 -34.13 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.08 -170.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -81.2 -20.64 40.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.869 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -71.89 -22.75 61.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 171.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -115.48 35.96 4.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.501 1.12 . . . . 0.0 109.139 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.8 t -62.64 142.53 58.01 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.17 5.11 75.39 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 39.0 mt -140.44 72.13 1.39 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.13 1.372 . . . . 0.0 107.97 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -49.55 159.3 0.36 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.036 0.934 . . . . 0.0 113.473 -174.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.4 mt -135.33 146.91 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.6 m -71.41 155.61 92.56 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 118.506 0.594 . . . . 0.0 110.236 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.89 135.23 23.25 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 124.094 3.196 . . . . 0.0 112.301 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.4 t30 40.21 38.16 0.49 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.423 1.089 . . . . 0.0 111.996 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.02 33.83 4.69 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.7 mt -140.29 143.92 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 118.522 1.161 . . . . 0.0 108.842 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.0 m -136.91 147.95 46.73 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.439 0.695 . . . . 0.0 109.299 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 88.2 mt -139.75 93.42 9.6 Favored Pre-proline 0 C--O 1.234 0.249 0 C-N-CA 123.278 0.631 . . . . 0.0 110.485 -173.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.04 154.81 26.01 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.931 2.421 . . . . 0.0 110.325 171.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.1 m -146.58 164.64 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 CA-C-O 121.429 0.633 . . . . 0.0 111.588 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.4 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 59.0 m-20 -90.99 176.04 3.17 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.469 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.8 Cg_exo -58.09 -20.67 47.06 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.842 2.361 . . . . 0.0 111.563 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.63 -10.4 59.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.35 1.06 . . . . 0.0 111.214 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.96 1.58 90.65 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.43 ' HE2' ' CD2' ' A' ' 120' ' ' PHE . 52.2 tttm -73.58 130.59 40.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.888 1.275 . . . . 0.0 109.152 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.535 ' C ' ' H ' ' A' ' 153' ' ' GLY . 9.0 pt -70.31 9.93 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -168.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 66.63 -15.88 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.97 0.908 . . . . 0.0 112.417 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 100.41 3.19 55.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.547 1.07 . . . . 0.0 113.063 175.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -139.71 170.41 15.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.263 1.032 . . . . 0.0 111.425 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -160.99 -178.05 6.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.943 0.497 . . . . 0.0 110.561 -174.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -142.52 145.06 33.25 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 89.6 t -145.09 164.3 12.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.409 ' O ' HG22 ' A' ' 137' ' ' VAL . 53.2 tt0 -131.16 101.33 5.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.609 ' CE2' HG12 ' A' ' 113' ' ' VAL . 47.5 m-85 -71.61 171.64 11.09 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.341 171.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 93.05 0.95 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.14 0.495 . . . . 0.0 109.98 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t 62.09 169.43 0.12 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.498 1.119 . . . . 0.0 111.02 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.74 -21.03 66.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.771 -0.58 . . . . 0.0 111.174 -175.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.73 -42.94 99.91 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.917 -0.489 . . . . 0.0 110.302 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.77 -38.69 76.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.4 -40.53 82.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.026 -0.421 . . . . 0.0 110.701 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -68.03 -30.91 70.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.566 0.346 . . . . 0.0 110.668 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -71.6 -39.78 70.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 110.511 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.35 -13.33 61.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.4 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 92.4 mt -67.23 -14.09 62.58 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 118.97 0.805 . . . . 0.0 111.954 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.61 -11.9 77.41 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -85.43 -4.94 59.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.17 1.388 . . . . 0.0 113.049 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.549 ' CE1' HO2' ' B' ' 6' ' ' ' U' . 13.0 t60 -42.51 -23.54 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.415 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 98.5 mttt -140.55 17.57 2.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.205 0.911 . . . . 0.0 112.005 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -74.6 -174.82 2.21 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.086 0.469 . . . . 0.0 110.11 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.14 159.11 37.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.771 -171.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.1 tt -110.59 -6.36 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 150.53 -29.14 1.06 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.985 -0.341 . . . . 0.0 113.164 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -156.43 4.17 0.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.485 0.642 . . . . 0.0 110.834 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -149.84 157.95 43.69 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.406 1.083 . . . . 0.0 108.49 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -104.83 150.88 24.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.8 mm -123.68 161.93 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -172.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -132.25 157.36 44.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.417 HG21 ' HB2' ' A' ' 172' ' ' HIS . 17.8 m -129.91 135.62 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.558 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 5.4 m-85 -132.82 158.85 41.44 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -75.16 160.94 29.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.947 0.794 . . . . 0.0 109.629 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t -154.05 -174.1 4.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.724 0.297 . . . . 0.0 111.575 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.5 m -146.11 166.89 24.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.176 0.99 . . . . 0.0 109.977 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -60.09 -32.11 70.65 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.407 0.283 . . . . 0.0 110.564 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -63.54 -17.28 62.63 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -100.0 -0.94 38.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.308 0.643 . . . . 0.0 111.4 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 193' ' ' SER . 9.8 p -143.6 12.07 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.941 0.401 . . . . 0.0 111.523 -174.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -68.17 12.56 0.11 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 191' ' ' VAL . 30.0 m -68.95 -1.15 6.68 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.357 0.663 . . . . 0.0 111.127 176.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.236 -1.364 . . . . 0.0 111.147 178.419 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.58 ' C8 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.413 -3.338 0 C5'-C4'-C3' 111.872 -2.418 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.462 H5'' " H5'" ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.769 1 O4'-C1'-N19 113.022 4.822 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.52 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.408 -3.739 0 C3'-C2'-C1' 104.807 3.675 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.52 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.777 2 O4'-C1'-N19 116.747 8.547 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.435 ' H2 ' ' CE1' ' A' ' 172' ' ' HIS . . . . . . . . 0 O4'--C4' 1.419 -2.861 0 C5'-C4'-C3' 109.811 -3.793 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.558 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.424 -2.454 0 C5'-C4'-C3' 109.624 -3.917 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 120.412 0.148 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.3 p -150.66 2.97 0.47 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.558 0.343 . . . . 0.0 111.922 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.17 9.84 0.67 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.776 0.43 . . . . 0.0 111.312 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -154.45 160.34 41.56 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.025 0.53 . . . . 0.0 110.539 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.0 m -152.9 159.49 42.99 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.449 0.7 . . . . 0.0 109.953 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.84 122.71 22.04 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.716 0.406 . . . . 0.0 109.96 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -164.12 23.91 0.07 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -136.25 7.19 3.11 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 107.53 -8.55 37.56 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -62.6 143.73 56.96 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.508 0.67 . . . . 0.0 110.934 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.614 HG12 ' CE2' ' A' ' 159' ' ' PHE . 7.4 p -152.2 173.79 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -136.69 152.97 50.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -135.06 150.81 50.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 122.279 0.232 . . . . 0.0 110.566 -172.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 -153.63 147.71 25.65 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.895 0.478 . . . . 0.0 109.908 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.74 -0.97 59.59 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.547 HD11 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -64.38 156.95 74.47 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-N 117.255 0.528 . . . . 0.0 111.508 -176.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 121' ' ' GLY . 27.9 Cg_exo -56.06 147.48 64.05 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.678 2.919 . . . . 0.0 111.762 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.578 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 23.9 m-85 -70.41 17.54 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 119' ' ' PRO . . . -137.72 5.42 3.42 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.446 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 36.5 t -66.78 152.52 45.37 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.599 1.159 . . . . 0.0 110.552 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 125' ' ' GLU . 5.4 t -155.09 -168.39 2.86 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.549 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -51.87 -32.6 32.89 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.42 ' H ' HG22 ' A' ' 123' ' ' THR . 42.6 tt0 -73.13 -25.23 60.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.517 0.727 . . . . 0.0 112.049 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -92.51 -33.23 14.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.718 -0.614 . . . . 0.0 109.516 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.15 -34.26 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.02 -38.34 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.877 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -77.06 -21.39 54.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.073 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -71.0 -26.07 62.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 170.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.4 ' HA ' ' HE3' ' A' ' 171' ' ' LYS . 37.3 m-85 -108.15 39.4 1.97 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.6 t -68.65 157.21 36.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.4 5.87 78.78 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -173.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.0 mt -142.52 -172.42 3.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.291 1.837 . . . . 0.0 106.583 -177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -147.24 164.15 34.11 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.847 -0.533 . . . . 0.0 110.392 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 mt -142.08 148.23 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 158' ' ' GLN . 21.4 m -73.6 154.45 89.58 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 118.598 0.635 . . . . 0.0 110.134 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.62 138.5 25.03 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.016 3.144 . . . . 0.0 112.213 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.9 t30 40.71 37.93 0.56 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.304 1.041 . . . . 0.0 111.917 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.31 29.36 9.64 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.978 -0.901 . . . . 0.0 111.83 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.7 mt -135.36 147.09 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 119.056 1.428 . . . . 0.0 109.368 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.1 m -138.53 151.14 47.08 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.35 0.66 . . . . 0.0 109.712 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.1 mt -144.55 100.7 4.73 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -55.58 155.22 22.11 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.121 2.547 . . . . 0.0 110.13 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 150' ' ' LYS . 27.2 m -140.78 159.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 121.752 0.787 . . . . 0.0 112.429 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 148' ' ' GLU . 17.0 m-20 -86.57 175.04 4.76 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.623 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.418 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 35.5 Cg_exo -59.74 1.79 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.509 3.473 . . . . 0.0 113.402 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 146' ' ' ASP . 30.0 tt0 -123.36 3.37 9.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.947 0.899 . . . . 0.0 110.832 -175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.28 5.96 89.65 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 39.5 mtpt -66.99 167.2 12.19 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 153' ' ' GLY . 1.0 OUTLIER -116.85 10.76 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -167.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 p 63.14 -7.14 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 77.94 12.2 84.65 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.914 0.768 . . . . 0.0 113.354 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -143.06 164.33 30.4 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.229 1.014 . . . . 0.0 110.923 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -153.93 -178.47 7.09 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.038 0.535 . . . . 0.0 111.33 -172.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -145.43 150.32 36.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.469 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 64.4 t -148.12 165.65 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.246 0.546 . . . . 0.0 110.003 -174.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 137' ' ' VAL . 47.6 tt0 -130.13 105.97 8.3 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 168.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.614 ' CE2' HG12 ' A' ' 113' ' ' VAL . 35.7 m-85 -76.23 173.15 11.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.644 171.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.83 91.84 1.19 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t 62.82 166.99 0.12 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.727 1.211 . . . . 0.0 111.819 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -15.66 62.38 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.995 -0.441 . . . . 0.0 111.247 -175.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.94 -41.91 73.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.925 -0.484 . . . . 0.0 110.676 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 159' ' ' PHE . 0.6 OUTLIER -68.86 -39.28 79.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.504 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.21 -36.29 70.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.102 -0.374 . . . . 0.0 111.107 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -73.22 -29.07 62.54 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -73.5 -38.34 65.39 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.76 -16.3 62.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.153 0.581 . . . . 0.0 112.16 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.35 -12.35 60.96 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.626 0.648 . . . . 0.0 111.333 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.56 -12.3 80.36 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.432 ' HB2' HG11 ' A' ' 183' ' ' VAL . 66.9 mmtt -84.15 -2.98 57.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.252 1.421 . . . . 0.0 111.978 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -52.11 128.96 26.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.945 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.9 mttt 61.61 9.24 2.67 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.632 1.573 . . . . 0.0 114.138 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -74.43 173.66 9.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.433 1.093 . . . . 0.0 109.053 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -125.95 154.47 42.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -170.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.2 mt -86.47 -18.43 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.164 0.986 . . . . 0.0 110.809 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 143.21 -18.23 2.31 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.837 -0.424 . . . . 0.0 113.056 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -151.34 -3.66 0.3 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.59 0.695 . . . . 0.0 111.231 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -148.06 154.85 40.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -105.51 156.91 17.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.342 0.591 . . . . 0.0 110.04 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 33.0 mm -127.11 163.74 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -170.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -128.55 156.34 43.47 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 171' ' ' LYS . 33.5 m -129.93 129.56 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.692 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 6.6 m-30 -135.72 146.11 47.37 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -175.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -73.04 160.63 31.76 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.763 0.71 . . . . 0.0 110.333 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -159.28 -177.26 6.32 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.1 m -146.11 169.73 18.12 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.787 1.235 . . . . 0.0 109.332 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -56.64 -31.49 64.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.741 0.416 . . . . 0.0 111.136 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.76 2.95 1.63 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -124.26 1.38 8.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.521 0.729 . . . . 0.0 110.838 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 193' ' ' SER . 8.2 p -142.68 10.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.728 0.299 . . . . 0.0 111.486 -176.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -69.83 15.42 0.08 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 191' ' ' VAL . 20.6 t -69.54 -1.44 8.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.122 0.569 . . . . 0.0 110.846 176.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 117.83 -1.081 . . . . 0.0 111.061 177.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.309 0 C4'-C3'-C2' 99.584 -3.116 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.578 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.601 0 O4'-C1'-N19 112.199 3.999 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.42 ' P ' " H3'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.928 0 C3'-C2'-C1' 104.935 3.816 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.446 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.845 2 O4'-C1'-N19 117.562 9.362 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.06 1 C5'-C4'-C3' 109.108 -4.261 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.692 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-C2' 102.523 -2.769 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 110.659 -0.126 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.1 m -145.68 164.17 32.59 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 122.917 0.487 . . . . 0.0 110.319 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.39 21.33 0.84 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.135 0.574 . . . . 0.0 110.891 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -134.38 16.22 3.73 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.053 0.541 . . . . 0.0 111.346 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t -144.71 -11.1 0.59 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.524 0.33 . . . . 0.0 111.539 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.31 155.3 24.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.859 0.463 . . . . 0.0 110.555 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -157.23 35.79 0.28 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.936 0.895 . . . . 0.0 109.709 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -129.9 167.08 18.73 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.701 1.2 . . . . 0.0 108.394 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.54 -5.44 29.89 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 120.045 -0.308 . . . . 0.0 112.352 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -61.56 140.39 58.12 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.745 0.783 . . . . 0.0 111.196 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.526 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.5 p -149.98 175.97 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.504 1.122 . . . . 0.0 108.157 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 79.3 ttt180 -135.92 146.36 47.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.74 0.416 . . . . 0.0 110.266 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.91 150.74 42.52 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 125.06 1.344 . . . . 0.0 108.372 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -158.96 147.57 18.32 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 110.313 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.85 -3.65 57.39 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -65.07 155.76 82.97 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 117.257 0.529 . . . . 0.0 110.756 -178.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 32.4 Cg_exo -53.37 147.65 36.21 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.612 2.875 . . . . 0.0 112.147 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.676 ' CE2' " H1'" ' B' ' 1' ' ' ' A' . 26.4 m-85 -66.32 2.27 1.29 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -125.39 6.9 8.04 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.427 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 40.7 t -67.85 155.1 40.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.839 0.855 . . . . 0.0 110.68 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.414 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 4.7 t -154.57 -172.38 4.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.265 0.626 . . . . 0.0 109.523 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.3 OUTLIER -50.72 -30.98 15.25 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 123.21 0.604 . . . . 0.0 112.626 -176.444 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.31 -23.46 51.02 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -92.59 -30.37 15.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.4 mt -66.99 -41.02 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.8 p -73.51 -33.88 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.488 -176.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -73.04 -28.38 62.3 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.212 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 12.1 t80 -69.82 -19.56 63.47 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -118.95 33.39 5.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.374 1.47 . . . . 0.0 109.438 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.2 t -69.22 -4.07 16.23 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.807 -0.558 . . . . 0.0 112.289 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -106.25 20.08 36.01 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.429 ' HB3' HD12 ' A' ' 164' ' ' LEU . 55.2 mt -141.23 -167.02 2.3 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.842 2.457 . . . . 0.0 104.83 -173.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.28 -21.35 0.69 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.554 HG23 ' H ' ' A' ' 137' ' ' VAL . 1.5 mt 52.06 178.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.204 1.002 . . . . 0.0 112.681 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.554 ' H ' HG23 ' A' ' 136' ' ' ILE . 25.1 m -116.44 155.63 48.33 Favored Pre-proline 0 CA--C 1.529 0.138 0 O-C-N 121.338 -0.851 . . . . 0.0 109.69 169.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.0 137.77 22.3 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.197 3.265 . . . . 0.0 112.569 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.1 t30 41.45 36.14 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.273 1.029 . . . . 0.0 111.766 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.64 27.75 13.2 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-O 118.792 -1.005 . . . . 0.0 112.021 -172.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.2 mt -135.23 145.58 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.088 1.444 . . . . 0.0 109.502 -177.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.8 m -138.12 149.75 46.21 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.755 0.822 . . . . 0.0 109.79 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.5 mt -145.11 94.19 5.35 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 124.023 0.929 . . . . 0.0 109.404 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -55.88 159.18 12.32 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.76 2.973 . . . . 0.0 111.638 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.5 167.45 16.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 121.409 0.624 . . . . 0.0 111.285 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 63.9 m-20 -91.89 176.53 2.67 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.421 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 37.2 Cg_exo -58.35 -19.79 44.88 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.822 2.348 . . . . 0.0 111.67 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -81.37 -9.03 59.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.129 0.972 . . . . 0.0 111.213 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.54 2.45 90.62 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.471 ' HE3' ' N3 ' ' B' ' 1' ' ' ' A' . 76.2 tttt -81.57 133.14 35.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.865 1.266 . . . . 0.0 108.416 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.9 pt -66.33 148.29 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 110.122 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.8 p -75.54 2.82 10.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.198 -174.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.39 6.3 89.35 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -139.25 164.06 30.81 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.087 0.555 . . . . 0.0 109.697 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.81 -178.65 7.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.339 0.59 . . . . 0.0 110.925 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -144.92 147.72 33.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.484 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.5 t -144.88 166.6 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -129.26 106.42 8.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 167.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 59.6 m-85 -74.87 171.05 14.72 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.465 170.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.34 88.65 0.46 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.1 0.476 . . . . 0.0 110.055 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.7 t 64.35 170.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.651 1.18 . . . . 0.0 111.583 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -17.53 63.47 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.769 0.428 . . . . 0.0 111.59 -174.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.24 -45.41 66.56 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.914 -0.492 . . . . 0.0 110.531 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -70.83 -31.68 68.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.97 92.78 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.674 -0.641 . . . . 0.0 111.069 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -68.78 -29.06 67.36 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.884 -0.143 . . . . 0.0 110.784 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -70.95 -37.63 72.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.417 -0.177 . . . . 0.0 110.578 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.511 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.16 -20.5 65.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.38 -12.23 60.8 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.087 -0.383 . . . . 0.0 111.421 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.81 -12.56 80.89 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 130' ' ' PHE . 71.7 mmtt -83.96 -0.08 50.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.102 1.361 . . . . 0.0 111.638 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -53.64 127.18 24.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.83 0.348 . . . . 0.0 110.228 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.629 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 26.8 mttp 54.2 20.29 2.53 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.785 1.634 . . . . 0.0 114.034 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -82.78 -13.71 55.78 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 47.5 mtt180 73.49 171.32 0.3 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.011 1.324 . . . . 0.0 114.509 171.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.98 -12.45 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 154.09 -29.96 0.72 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-N 118.476 0.58 . . . . 0.0 113.993 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -151.79 -0.36 0.33 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.956 0.878 . . . . 0.0 111.162 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -147.8 150.37 34.09 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -174.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 175' ' ' ARG . 22.6 p90 -93.49 152.32 19.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.165 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 30.1 mm -122.54 159.24 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.453 ' HB3' ' CE1' ' A' ' 184' ' ' PHE . 5.4 mm-40 -125.17 155.28 40.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.497 -175.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 171' ' ' LYS . 34.4 m -138.09 131.58 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.592 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 7.3 m-85 -142.18 156.06 45.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -75.91 160.78 29.56 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.679 0.672 . . . . 0.0 110.25 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.0 t -155.54 -174.62 5.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.8 t -147.98 173.19 13.14 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.5 1.12 . . . . 0.0 109.88 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -60.36 -31.71 70.58 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.75 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.14 -0.72 2.63 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -121.55 1.95 10.11 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.548 0.739 . . . . 0.0 111.339 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 193' ' ' SER . 8.3 p -144.16 11.13 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 120.899 0.38 . . . . 0.0 111.287 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -69.09 14.89 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 191' ' ' VAL . 30.6 m -67.49 -3.17 7.82 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.292 0.637 . . . . 0.0 111.307 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.184 178.244 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.676 " H1'" ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.146 1 C5'-C4'-C3' 108.548 -4.635 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.429 " H1'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.421 -2.692 2 O4'-C1'-N19 113.906 5.706 OUTLIER-EPSILON 0.107 1t . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.451 ' C8 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.102 1 P-O3'-C3' 124.631 4.109 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.734 1 O4'-C1'-N19 115.875 7.675 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.629 ' C2 ' ' HE3' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.897 0 C5'-C4'-C3' 109.831 -3.779 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.592 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.636 0 C5'-C4'-C3' 110.077 -3.616 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 106' ' ' ASP . 89.2 p -162.0 -172.35 3.22 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.733 0.413 . . . . 0.0 110.753 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.08 15.36 0.05 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.854 0.861 . . . . 0.0 111.939 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 104' ' ' SER . 33.4 t70 -128.56 13.58 6.49 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.889 0.876 . . . . 0.0 110.187 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.3 p -132.66 3.25 3.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.526 0.73 . . . . 0.0 110.709 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.459 ' HB3' ' HE3' ' A' ' 185' ' ' LYS . . . -159.25 164.6 34.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.077 1.351 . . . . 0.0 108.187 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -156.91 13.29 0.26 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.79 9.42 1.33 Allowed 'General case' 0 C--N 1.34 0.153 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.21 -5.99 50.02 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 112.172 -0.371 . . . . 0.0 112.172 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -63.49 144.47 56.96 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.645 0.736 . . . . 0.0 110.681 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.5 p -154.0 174.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.642 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -135.62 154.79 51.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.97 0.908 . . . . 0.0 108.66 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -138.65 148.85 44.54 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.405 ' CG ' ' H ' ' A' ' 117' ' ' GLY . 23.8 ttp180 -156.38 174.6 15.17 Favored 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.405 ' H ' ' CG ' ' A' ' 116' ' ' ARG . . . 86.05 5.15 83.65 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.45 HD22 ' HG ' ' A' ' 122' ' ' CYS . 95.0 mt -59.92 150.47 68.99 Favored Pre-proline 0 N--CA 1.452 -0.339 0 C-N-CA 123.594 0.757 . . . . 0.0 112.101 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.3 23.99 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 125.142 3.894 . . . . 0.0 113.965 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.515 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 22.0 m-30 54.77 5.68 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.23 1.412 . . . . 0.0 114.43 -177.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.69 -6.28 3.35 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.956 0.798 . . . . 0.0 111.802 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 10.0 t -61.77 150.53 36.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.038 0.935 . . . . 0.0 110.938 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.8 t -143.37 -166.66 2.37 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.477 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 mptt -51.35 -28.69 13.07 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.344 0.52 . . . . 0.0 111.995 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -78.52 -23.91 46.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.527 0.731 . . . . 0.0 112.331 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.489 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 7.0 mp0 -92.88 -33.7 14.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.411 HG13 ' SG ' ' A' ' 122' ' ' CYS . 42.5 mt -61.88 -33.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.0 p -83.32 -30.61 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.003 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -73.32 -29.87 62.98 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.907 171.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -68.65 -25.84 65.03 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.205 -0.309 . . . . 0.0 110.671 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -115.8 33.31 5.56 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.666 1.186 . . . . 0.0 109.214 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.1 t -64.35 -13.93 53.35 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.963 0.505 . . . . 0.0 112.252 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.01 13.15 67.68 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.423 ' HB3' HD12 ' A' ' 164' ' ' LEU . 69.4 mt -137.5 -162.22 1.27 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.011 1.724 . . . . 0.0 107.482 -173.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.57 -18.04 0.7 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.629 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER 46.33 -166.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.847 0.859 . . . . 0.0 112.971 -176.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.629 ' H ' HG22 ' A' ' 136' ' ' ILE . 17.0 m -129.21 156.02 78.99 Favored Pre-proline 0 C--N 1.338 0.108 0 C-N-CA 123.852 0.861 . . . . 0.0 109.786 173.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.78 135.59 28.21 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.173 3.249 . . . . 0.0 112.301 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 55.1 t30 40.31 37.36 0.42 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.624 1.17 . . . . 0.0 112.33 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -96.52 28.08 14.81 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 118.934 -0.926 . . . . 0.0 111.75 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.1 mt -132.96 147.01 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 118.968 1.384 . . . . 0.0 109.314 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.8 m -138.11 147.41 43.94 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 123.807 0.843 . . . . 0.0 109.542 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 91.9 mt -139.5 94.38 9.46 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.527 0.731 . . . . 0.0 110.336 -173.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.82 151.62 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.022 2.481 . . . . 0.0 110.695 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.94 166.32 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.331 0.586 . . . . 0.0 111.266 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.423 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 64.4 m-20 -90.82 176.96 2.53 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.684 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 36.9 Cg_exo -58.76 -18.72 42.68 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.981 2.454 . . . . 0.0 111.755 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -81.32 -10.86 59.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.865 0.866 . . . . 0.0 110.683 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.7 14.43 75.72 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -106.54 148.42 28.25 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.5 pt -67.64 149.5 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.421 0.629 . . . . 0.0 111.671 -170.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.5 p -76.42 -7.8 55.82 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.007 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.61 -3.5 32.46 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -139.26 169.89 16.95 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.34 0.57 . . . . 0.0 111.265 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.41 -178.92 7.48 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 111.335 -173.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -144.14 148.11 34.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.468 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 59.9 t -145.76 164.83 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -127.75 99.21 5.46 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 169.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.586 ' CE2' HG11 ' A' ' 113' ' ' VAL . 48.5 m-85 -70.15 172.45 8.02 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.121 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.1 87.56 0.4 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.871 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.5 t 62.6 172.62 0.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.546 1.138 . . . . 0.0 111.383 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -31.11 70.71 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.906 -0.496 . . . . 0.0 111.007 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -59.4 -41.64 89.9 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.331 -0.231 . . . . 0.0 111.06 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -72.78 -38.93 67.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.487 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -62.8 -34.94 78.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.984 -0.448 . . . . 0.0 110.408 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.31 -27.26 66.14 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.53 0.332 . . . . 0.0 110.299 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -77.27 -38.07 51.65 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.339 0.114 . . . . 0.0 111.181 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.409 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -59.53 -24.41 63.65 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.3 mt -68.55 -9.14 47.44 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 122.95 0.5 . . . . 0.0 111.493 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.58 -16.84 78.68 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -76.14 -55.52 5.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.116 0.966 . . . . 0.0 110.678 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.413 ' HA ' HG23 ' A' ' 183' ' ' VAL . 0.6 OUTLIER 23.77 -98.65 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.861 1.264 . . . . 0.0 112.941 -165.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.539 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 55.1 mttp -72.8 20.17 0.08 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -174.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -62.77 -178.22 0.19 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.108 0.963 . . . . 0.0 111.269 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -133.74 168.49 18.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.194 0.598 . . . . 0.0 112.37 -173.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mt -116.47 -13.55 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.521 0.729 . . . . 0.0 112.009 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.44 -31.34 0.53 Allowed Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.52 0.6 . . . . 0.0 114.024 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -152.25 3.06 0.36 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.791 0.796 . . . . 0.0 110.995 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -144.03 156.89 44.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -105.83 148.37 27.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.474 0.654 . . . . 0.0 109.499 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 24.3 mm -111.94 174.92 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -172.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -138.63 154.66 48.67 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.413 HG23 ' HA ' ' A' ' 172' ' ' HIS . 17.0 m -129.92 134.94 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.594 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 19.2 m-85 -142.44 151.72 42.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.459 ' HE3' ' HB3' ' A' ' 108' ' ' ALA . 8.8 mmtm -74.09 154.13 39.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.877 0.37 . . . . 0.0 110.553 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.6 t -157.37 179.41 9.28 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.849 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.9 m -150.76 170.74 18.51 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.137 0.975 . . . . 0.0 108.69 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -54.34 -30.84 52.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.682 0.393 . . . . 0.0 111.328 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.54 0.54 2.18 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.308 0.643 . . . . 0.0 112.701 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -121.25 0.06 10.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.138 0.975 . . . . 0.0 110.932 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.11 14.44 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 121.035 0.445 . . . . 0.0 111.11 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -69.33 10.58 0.31 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 59.1 p -69.23 -0.9 6.73 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.352 0.661 . . . . 0.0 111.201 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 117.185 -1.388 . . . . 0.0 110.896 177.59 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.479 ' C4 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.183 1 O4'-C1'-N19 114.31 6.11 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.515 ' C5 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.935 1 O4'-C1'-N19 112.632 4.432 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.175 1 C3'-C2'-C1' 105.128 4.031 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.815 1 O4'-C1'-N19 115.13 6.93 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.586 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.196 1 C5'-C4'-C3' 108.707 -4.529 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.594 " H1'" ' CZ ' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 P-O3'-C3' 122.989 2.741 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.2 m -62.11 -26.81 68.51 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.13 -33.56 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.695 0.398 . . . . 0.0 110.795 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -161.49 -19.96 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.73 0.412 . . . . 0.0 111.312 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.6 t -153.18 -170.69 3.69 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.977 0.511 . . . . 0.0 110.113 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -148.33 168.02 23.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.939 0.896 . . . . 0.0 109.707 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.453 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 5.4 t-20 -155.85 24.65 0.38 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -172.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -132.88 0.69 3.53 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.03 -9.61 25.08 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.477 -0.392 . . . . 0.0 112.523 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -65.48 147.91 52.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.519 0.676 . . . . 0.0 111.094 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.573 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.6 p -155.49 178.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.207 1.003 . . . . 0.0 108.737 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.4 ' H ' HG21 ' A' ' 113' ' ' VAL . 7.4 mtm180 -134.43 162.81 31.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.938 0.495 . . . . 0.0 111.495 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tp -145.97 142.79 29.01 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.405 ' C ' ' H ' ' A' ' 118' ' ' LEU . 40.7 ttm180 -151.49 -18.54 0.2 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 181' ' ' ILE . . . -78.94 12.9 21.63 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.264 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 116' ' ' ARG . 97.6 mt -59.6 153.7 49.66 Favored Pre-proline 0 N--CA 1.449 -0.516 0 C-N-CA 124.494 1.118 . . . . 0.0 113.267 -172.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.56 147.64 15.77 Favored 'Trans proline' 0 N--CA 1.442 -1.51 0 C-N-CA 123.793 2.995 . . . . 0.0 106.169 162.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.593 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 23.7 m-85 -70.69 10.57 0.48 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -172.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.38 1.18 12.74 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 118.446 0.567 . . . . 0.0 111.88 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.413 ' HG ' ' HB3' ' A' ' 126' ' ' GLU . 48.6 t -65.89 156.44 33.39 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.261 0.625 . . . . 0.0 111.591 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.46 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 2.6 t -152.93 -173.54 4.61 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.577 0.751 . . . . 0.0 109.506 173.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.568 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.2 mptt -50.16 -36.19 29.22 Favored 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.58 -17.66 59.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.413 ' HB3' ' HG ' ' A' ' 122' ' ' CYS . 9.5 tp10 -101.74 -26.68 13.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.9 mt -66.85 -39.91 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.45 -34.77 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.368 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -71.08 -28.75 64.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.498 173.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 21.6 t80 -69.48 -23.16 63.6 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.025 0.375 . . . . 0.0 110.275 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -115.2 32.73 5.86 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.743 1.217 . . . . 0.0 109.244 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 t -68.8 -8.04 39.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.07 0.548 . . . . 0.0 111.994 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.92 15.72 60.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.415 ' HB3' HD12 ' A' ' 164' ' ' LEU . 52.5 mt -138.89 -159.75 0.99 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.002 2.121 . . . . 0.0 105.816 -174.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.52 -28.14 0.54 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 2.5 mt 57.38 162.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.968 0.907 . . . . 0.0 112.352 -175.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 158' ' ' GLN . 2.4 m -74.4 161.34 78.54 Favored Pre-proline 0 C--O 1.231 0.09 0 O-C-N 121.0 -1.063 . . . . 0.0 108.643 169.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -46.07 -30.12 7.06 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.024 3.15 . . . . 0.0 112.738 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -162.33 134.26 5.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 171.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -173.92 17.87 0.05 OUTLIER Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.774 -1.014 . . . . 0.0 113.578 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.1 mt -108.4 147.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 119.517 1.659 . . . . 0.0 109.982 -173.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.5 m -140.66 150.78 43.96 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 123.68 0.792 . . . . 0.0 108.918 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.0 mt -146.76 97.43 4.25 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.062 0.545 . . . . 0.0 110.141 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.34 160.76 10.41 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.611 2.874 . . . . 0.0 111.047 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 151' ' ' ILE . 31.4 m -146.08 165.04 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 CA-C-O 121.295 0.569 . . . . 0.0 111.282 173.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -90.85 175.6 3.52 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 124.167 0.987 . . . . 0.0 108.524 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.07 -20.21 44.62 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.831 2.354 . . . . 0.0 111.352 174.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -79.39 -10.09 59.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.086 0.955 . . . . 0.0 111.253 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.01 0.54 90.37 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -173.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.593 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 87.1 tttt -73.85 134.73 43.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.831 1.253 . . . . 0.0 108.575 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 153' ' ' GLY . 9.3 pt -71.6 10.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -169.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 65.12 -17.2 0.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.859 1.264 . . . . 0.0 112.175 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 105.4 -3.49 40.11 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.04 1.305 . . . . 0.0 112.506 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -132.6 169.59 16.41 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 118.772 1.286 . . . . 0.0 111.505 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.41 -178.37 7.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.12 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -143.39 145.41 32.63 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -175.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.493 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 41.5 t -145.35 160.91 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.404 ' O ' HG22 ' A' ' 137' ' ' VAL . 49.6 tt0 -126.51 119.45 27.19 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 166.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.573 ' CE2' HG11 ' A' ' 113' ' ' VAL . 48.5 m-85 -88.71 174.73 7.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.462 170.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.12 88.42 0.42 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.581 0.753 . . . . 0.0 109.876 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.69 168.06 0.13 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.514 1.126 . . . . 0.0 111.184 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.453 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 1.5 tm0? -64.5 -23.91 67.43 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.846 -0.533 . . . . 0.0 111.214 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.83 -41.13 99.21 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.116 -0.365 . . . . 0.0 110.725 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -70.87 -37.75 73.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.451 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -61.85 -33.86 74.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.066 -0.396 . . . . 0.0 110.803 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -72.43 -27.16 62.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -74.09 -38.12 63.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.544 0.212 . . . . 0.0 110.512 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -61.48 -21.52 64.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.753 0.421 . . . . 0.0 112.086 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.2 mt -68.27 -13.45 62.26 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.965 -0.459 . . . . 0.0 111.161 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.5 -11.99 82.47 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.434 ' HB2' HG12 ' A' ' 183' ' ' VAL . 68.3 mmtt -85.37 -1.67 57.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.478 1.111 . . . . 0.0 112.179 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -51.93 129.08 26.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.748 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 62.72 11.09 4.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.404 1.482 . . . . 0.0 114.335 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -71.39 -171.44 0.62 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.035 0.834 . . . . 0.0 109.361 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -134.36 164.49 27.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -171.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.8 mt -115.53 -11.48 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.764 0.826 . . . . 0.0 111.932 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 151.35 -25.96 0.98 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 121.891 -0.506 . . . . 0.0 113.938 175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -153.59 2.14 0.26 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 117.736 0.768 . . . . 0.0 111.083 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -147.0 160.15 42.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.91 0.884 . . . . 0.0 108.672 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -107.13 145.22 32.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.458 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 21.9 mm -113.17 162.41 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -171.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -130.34 150.91 51.36 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 171' ' ' LYS . 32.6 m -128.11 134.3 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -175.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.706 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 5.2 m-85 -136.61 163.56 30.27 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -82.59 158.59 23.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.879 -0.513 . . . . 0.0 109.959 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.6 t -158.99 -177.33 6.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.469 -0.145 . . . . 0.0 111.325 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.2 t -148.31 178.18 8.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.651 0.78 . . . . 0.0 110.301 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -60.48 -31.95 70.96 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.188 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -65.76 -7.16 14.29 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -112.02 1.38 16.35 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.506 0.723 . . . . 0.0 111.055 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 193' ' ' SER . 9.4 p -144.2 11.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 120.911 0.386 . . . . 0.0 111.555 -176.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -69.18 14.16 0.09 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 191' ' ' VAL . 24.1 m -69.19 -0.4 5.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.574 0.75 . . . . 0.0 111.184 176.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.859 -1.067 . . . . 0.0 111.155 178.254 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.219 2 O4'-C1'-N19 113.94 5.74 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.422 ' C4 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.747 1 C5'-C4'-C3' 107.448 -5.368 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.493 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.407 -3.817 0 C3'-C2'-C1' 104.551 3.39 . 0.01 2a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.493 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.417 -2.983 2 O4'-C1'-N19 115.657 7.457 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.939 1 C5'-C4'-C3' 109.347 -4.102 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.706 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.686 0 C5'-C4'-C3' 111.435 -2.71 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.2 m 53.16 17.51 0.99 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.452 1.101 . . . . 0.0 113.665 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.71 167.06 31.6 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.211 0.604 . . . . 0.0 109.981 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -150.84 -0.69 0.38 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.698 0.399 . . . . 0.0 111.804 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.4 m -149.08 171.54 16.24 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.232 0.613 . . . . 0.0 110.295 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.501 ' HB1' ' HZ2' ' A' ' 185' ' ' LYS . . . 48.44 30.92 2.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.516 1.126 . . . . 0.0 113.961 -178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -149.44 30.7 0.75 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.835 0.35 . . . . 0.0 111.648 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -127.81 3.9 6.03 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 162' ' ' GLN . . . 111.12 -8.83 29.16 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -64.08 142.77 58.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.643 0.735 . . . . 0.0 111.154 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.553 HG13 ' CE2' ' A' ' 159' ' ' PHE . 9.2 p -153.13 175.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.997 1.319 . . . . 0.0 108.037 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -138.97 145.95 40.35 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.09 152.82 35.81 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 123.867 0.867 . . . . 0.0 109.098 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.424 ' HD2' ' CE2' ' A' ' 184' ' ' PHE . 5.8 mtt180 -153.3 166.49 32.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.47 1.56 88.79 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.6 146.95 42.52 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 117.294 0.547 . . . . 0.0 110.78 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 9.7 Cg_exo -63.63 150.17 89.14 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.026 1.818 . . . . 0.0 108.577 167.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.439 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 14.2 m-85 -70.32 5.3 1.79 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -125.94 5.51 7.87 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.448 ' HG ' ' CG ' ' A' ' 126' ' ' GLU . 46.2 t -70.33 157.51 37.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.896 0.479 . . . . 0.0 110.858 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.4 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 4.6 t -154.93 -171.63 3.9 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.262 0.625 . . . . 0.0 109.527 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.4 OUTLIER -51.22 -30.88 18.75 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -80.04 -17.84 51.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.448 ' CG ' ' HG ' ' A' ' 122' ' ' CYS . 28.7 tt0 -107.0 -20.24 13.38 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.8 mt -71.27 -39.92 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 167.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 p -71.17 -38.73 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.217 -177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -74.66 -22.77 58.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.519 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -69.35 -26.6 64.77 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 170.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.487 ' HA ' ' HE3' ' A' ' 171' ' ' LYS . 36.4 m-85 -106.82 32.32 4.65 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.677 0.791 . . . . 0.0 109.629 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.4 t -61.11 146.15 48.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 169.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.58 2.49 76.05 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.412 ' HB3' HD12 ' A' ' 164' ' ' LEU . 23.2 mt -134.58 -172.16 2.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -141.59 -17.73 0.78 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -171.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.616 HG23 ' H ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER 45.84 -165.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.88 0.872 . . . . 0.0 113.272 -176.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.616 ' H ' HG23 ' A' ' 136' ' ' ILE . 17.4 m -129.9 156.08 79.56 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 124.068 0.947 . . . . 0.0 109.769 173.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.14 136.54 30.23 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.045 3.163 . . . . 0.0 112.252 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.5 t30 40.1 38.33 0.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.556 1.142 . . . . 0.0 112.206 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.04 28.66 13.56 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 118.877 -0.957 . . . . 0.0 111.86 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.8 mt -134.31 147.67 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 119.048 1.424 . . . . 0.0 109.538 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.5 m -139.6 149.93 44.4 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.586 0.754 . . . . 0.0 109.788 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.4 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.1 mt -145.52 95.42 4.98 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 123.896 0.878 . . . . 0.0 109.309 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.11 160.96 7.33 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.799 2.999 . . . . 0.0 111.635 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.4 m -141.71 164.71 18.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 121.283 0.564 . . . . 0.0 111.249 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.416 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 67.2 m-20 -86.93 176.12 3.79 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.975 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 34.2 Cg_exo -59.08 -20.23 52.88 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.038 2.492 . . . . 0.0 111.61 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -82.43 -9.85 59.28 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.561 0.744 . . . . 0.0 110.575 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.84 8.48 79.48 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.312 0.482 . . . . 0.0 112.246 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -97.11 147.62 23.86 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 117.616 0.708 . . . . 0.0 109.147 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.0 pt -69.53 152.9 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.719 0.771 . . . . 0.0 112.022 -172.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.7 p -82.74 0.61 42.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.037 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.9 8.3 86.86 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.026 -0.429 . . . . 0.0 112.026 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -138.62 160.38 39.76 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.31 -179.5 7.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.149 0.499 . . . . 0.0 110.909 -172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -145.46 148.58 33.42 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -174.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 60.0 t -145.12 163.9 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -128.28 95.61 4.21 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.553 ' CE2' HG13 ' A' ' 113' ' ' VAL . 52.8 m-85 -67.99 171.71 6.45 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.139 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.56 89.71 0.37 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.644 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.7 167.75 0.13 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.481 1.113 . . . . 0.0 111.007 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 36.8 tp60 -65.96 -20.07 66.08 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.707 -0.62 . . . . 0.0 111.211 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.07 -41.78 94.78 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.998 -0.438 . . . . 0.0 110.593 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -69.72 -36.3 75.76 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.502 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -61.75 -36.23 80.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.036 -0.415 . . . . 0.0 110.845 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.78 -27.26 63.78 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -74.11 -38.0 63.96 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.608 0.242 . . . . 0.0 110.685 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.95 -19.94 64.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.164 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.9 -8.85 52.1 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.041 -0.412 . . . . 0.0 111.419 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.25 -18.21 80.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 131' ' ' PHE . 70.1 mmtt -70.19 -61.21 1.86 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.567 1.147 . . . . 0.0 109.582 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.449 ' HD1' ' HA ' ' A' ' 182' ' ' GLU . 0.9 OUTLIER 25.34 -108.59 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.418 1.087 . . . . 0.0 112.715 -165.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.499 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 56.4 mttp -66.61 10.74 0.11 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -65.57 171.64 3.96 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.554 1.542 . . . . 0.0 109.925 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -123.86 165.25 17.69 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -168.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mt -105.64 -13.28 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.637 0.775 . . . . 0.0 111.963 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.1 -24.28 1.42 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.794 -0.448 . . . . 0.0 113.53 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -152.63 0.98 0.3 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.683 0.741 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -148.27 153.95 39.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.966 0.906 . . . . 0.0 108.73 -172.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -101.02 150.6 22.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.7 mm -117.92 171.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.449 ' HA ' ' HD1' ' A' ' 172' ' ' HIS . 18.2 mt-10 -139.45 160.13 40.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 24.7 m -132.95 127.3 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.655 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 3.1 m-30 -128.07 154.55 45.57 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.501 ' HZ2' ' HB1' ' A' ' 108' ' ' ALA . 11.5 tttm -75.48 163.25 27.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.796 -0.565 . . . . 0.0 110.592 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.7 t -159.06 -175.61 5.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.6 m -149.57 169.02 21.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.292 1.437 . . . . 0.0 109.138 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -57.7 -32.33 67.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.675 0.39 . . . . 0.0 111.38 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -66.94 -1.34 3.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -117.92 1.64 12.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.858 0.863 . . . . 0.0 110.911 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 193' ' ' SER . 7.6 p -143.56 12.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-O 121.036 0.446 . . . . 0.0 110.956 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -68.71 13.45 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 191' ' ' VAL . 30.7 m -67.28 -2.31 5.8 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.346 0.658 . . . . 0.0 111.364 177.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.198 -1.382 . . . . 0.0 111.056 178.479 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.116 3 O4'-C1'-N19 115.236 7.036 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.452 HO2' " C5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.814 0 C5'-C4'-C3' 110.187 -3.542 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.502 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.409 -3.675 0 C3'-C2'-C1' 104.552 3.391 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.502 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.918 2 O4'-C1'-N19 115.897 7.697 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.499 ' C2 ' ' HE3' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.937 0 C5'-C4'-C3' 110.233 -3.512 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.655 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.704 0 C5'-C4'-C3' 110.461 -3.359 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.549 0.214 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.2 p -144.72 4.82 1.16 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.034 0.534 . . . . 0.0 111.307 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.22 168.81 25.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.403 0.681 . . . . 0.0 109.904 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -147.53 175.81 10.55 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.58 0.752 . . . . 0.0 109.932 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 t -151.75 172.77 15.62 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.985 0.514 . . . . 0.0 110.187 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.83 121.82 10.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.45 0.7 . . . . 0.0 110.786 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -161.83 25.27 0.12 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -131.78 6.51 4.34 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.33 -9.68 42.33 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -65.1 144.91 56.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.641 0.734 . . . . 0.0 111.048 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.561 HG12 ' CE2' ' A' ' 159' ' ' PHE . 11.1 p -152.9 174.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.137 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 59.1 ttt180 -136.35 145.33 45.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.043 0.537 . . . . 0.0 109.61 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.3 143.15 48.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -154.35 143.42 21.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.45 -1.11 46.29 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.499 ' HA ' ' CD1' ' A' ' 181' ' ' ILE . 0.0 OUTLIER -67.95 157.45 86.78 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 117.468 0.634 . . . . 0.0 111.055 -176.228 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -54.58 144.85 61.76 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.176 2.584 . . . . 0.0 111.36 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.565 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 29.0 m-85 -71.0 12.27 0.31 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.67 5.82 5.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 51.2 t -69.16 158.44 34.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.387 1.075 . . . . 0.0 110.644 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 125' ' ' GLU . 6.5 t -153.73 -178.98 7.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.442 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 4.0 ptpp? -53.34 -25.36 14.81 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.5 ' H ' HG22 ' A' ' 123' ' ' THR . 41.5 mt-10 -78.34 -22.94 47.27 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.939 0.336 . . . . 0.0 111.611 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -92.69 -30.34 15.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.81 -45.6 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.69 -33.77 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.59 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -72.86 -31.36 64.68 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.494 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -67.34 -16.65 64.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.293 0.497 . . . . 0.0 110.203 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -120.08 30.46 6.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.499 1.119 . . . . 0.0 109.515 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.6 t -63.44 138.15 58.41 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.35 2.43 90.27 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.2 mt -138.07 76.22 1.56 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.198 1.399 . . . . 0.0 107.784 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -49.85 158.11 0.53 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.19 0.996 . . . . 0.0 113.472 -174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.68 147.59 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.1 m -70.66 155.25 93.67 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 118.521 0.601 . . . . 0.0 110.354 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -48.8 138.0 26.69 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.92 3.08 . . . . 0.0 111.739 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.8 t30 41.79 37.22 0.73 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.043 0.937 . . . . 0.0 111.802 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.61 31.85 6.8 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -173.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -139.51 145.97 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.238 1.019 . . . . 0.0 109.077 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.6 m -140.35 151.28 44.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.53 100.0 4.1 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.72 149.55 18.98 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.082 2.521 . . . . 0.0 110.934 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 24.5 m -145.25 160.84 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.434 0.635 . . . . 0.0 110.719 172.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -87.38 176.42 3.47 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -57.67 -18.25 32.38 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.825 2.35 . . . . 0.0 111.944 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.01 -8.54 58.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.425 1.09 . . . . 0.0 111.431 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.04 2.07 88.43 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.533 ' HE3' ' C6 ' ' B' ' 1' ' ' ' A' . 87.9 tttt -68.81 123.91 22.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.715 1.606 . . . . 0.0 109.824 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.439 ' C ' ' H ' ' A' ' 153' ' ' GLY . 8.0 pt -78.28 3.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -165.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p 66.27 -16.76 0.12 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 94.68 9.64 58.54 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.947 0.784 . . . . 0.0 113.794 174.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -143.09 163.51 32.64 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.31 1.055 . . . . 0.0 110.676 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.93 -177.06 6.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.278 0.631 . . . . 0.0 111.089 -173.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -147.17 150.47 34.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.481 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 87.6 t -147.14 165.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -175.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.411 ' O ' HG22 ' A' ' 137' ' ' VAL . 54.5 tt0 -133.44 98.54 4.25 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.004 0.921 . . . . 0.0 108.898 170.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.561 ' CE2' HG12 ' A' ' 113' ' ' VAL . 58.2 m-85 -69.82 170.54 10.86 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -67.82 92.52 0.36 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.15 0.5 . . . . 0.0 110.196 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.2 t 62.42 169.65 0.13 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.717 1.207 . . . . 0.0 111.095 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -12.31 56.3 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.033 -0.417 . . . . 0.0 111.489 -175.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.438 ' CD ' ' HZ1' ' A' ' 167' ' ' LYS . 3.2 tm-20 -74.48 -44.23 52.45 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.492 0.317 . . . . 0.0 110.384 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.07 -36.72 77.93 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.476 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.32 -38.97 78.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.087 -0.383 . . . . 0.0 110.701 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.35 -31.64 71.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.449 0.3 . . . . 0.0 110.623 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.438 ' HZ1' ' CD ' ' A' ' 163' ' ' GLU . 29.6 mttp -69.92 -39.06 76.37 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.434 174.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.73 -13.83 62.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.533 0.333 . . . . 0.0 111.727 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.447 ' HA ' ' CG2' ' A' ' 183' ' ' VAL . 93.9 mt -68.21 -12.26 60.68 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.737 -0.602 . . . . 0.0 111.042 175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.3 13.08 8.23 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.463 ' HB2' HG12 ' A' ' 183' ' ' VAL . 62.5 mmtt -118.87 -0.0 11.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.882 1.673 . . . . 0.0 112.353 -178.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.428 ' CE1' HO2' ' B' ' 6' ' ' ' U' . 6.2 t60 -46.63 -20.95 0.15 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.528 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 98.2 mttt -142.83 15.65 1.94 Allowed 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.536 -0.728 . . . . 0.0 110.85 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -81.82 178.68 8.18 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.819 1.248 . . . . 0.0 109.616 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -129.85 154.26 47.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.02 -16.49 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.143 0.977 . . . . 0.0 111.198 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 153.66 -24.96 0.74 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.746 -0.474 . . . . 0.0 113.399 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -152.54 0.92 0.3 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.794 0.797 . . . . 0.0 111.257 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -148.39 152.78 37.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.938 0.895 . . . . 0.0 108.651 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -103.31 154.83 18.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.39 0.614 . . . . 0.0 110.529 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 26.0 mm -126.22 160.17 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.637 -171.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -129.86 151.97 49.85 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 171' ' ' LYS . 35.8 m -125.77 49.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.028 0.931 . . . . 0.0 113.372 -167.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.585 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 3.5 m-30 -52.1 151.73 3.6 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.789 -0.569 . . . . 0.0 110.226 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -76.28 163.77 26.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.958 -0.464 . . . . 0.0 110.149 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.2 t -159.64 -177.15 6.18 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.2 m -145.24 171.46 14.53 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.753 1.221 . . . . 0.0 109.37 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -57.79 -32.13 67.24 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.764 0.426 . . . . 0.0 111.527 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.33 -4.83 8.79 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -116.63 2.27 12.96 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.751 0.821 . . . . 0.0 110.926 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 193' ' ' SER . 8.4 p -142.83 10.7 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 120.992 0.425 . . . . 0.0 111.172 -177.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -68.99 13.7 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 191' ' ' VAL . 23.2 m -68.22 -1.9 7.06 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.253 176.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.807 -1.092 . . . . 0.0 111.147 178.153 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.533 ' C6 ' ' HE3' ' A' ' 150' ' ' LYS . . . . . . . . 0 O4'--C4' 1.412 -3.383 0 C4'-C3'-C2' 99.74 -2.96 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.565 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.513 1 O4'-C1'-N19 113.332 5.132 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.46 ' OP1' " H1'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.172 1 P-O3'-C3' 125.129 4.524 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.73 2 O4'-C1'-N19 117.485 9.285 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.528 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.891 1 C5'-C4'-C3' 109.016 -4.323 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.585 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.506 1 C5'-C4'-C3' 109.274 -4.151 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.0 t -152.55 172.32 16.76 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.122 0.569 . . . . 0.0 110.019 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 50.74 23.71 1.47 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.086 0.954 . . . . 0.0 112.509 -176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -150.54 155.61 39.79 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.539 0.736 . . . . 0.0 109.502 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 85.6 p -161.4 -175.32 4.73 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.818 0.447 . . . . 0.0 111.043 -176.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 42.6 74.03 0.12 Allowed 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.122 1.369 . . . . 0.0 112.907 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.31 28.96 0.72 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.063 -173.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -134.78 5.81 3.4 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.67 -9.58 32.43 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -63.23 143.11 58.08 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.551 0.691 . . . . 0.0 111.078 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.598 HG13 ' CE2' ' A' ' 159' ' ' PHE . 10.5 p -152.34 174.55 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.372 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 51.3 ttt180 -138.94 147.2 41.95 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.021 0.528 . . . . 0.0 109.976 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -120.98 151.17 40.05 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.457 1.103 . . . . 0.0 109.205 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -157.65 164.83 36.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.14 1.8 88.33 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 120' ' ' PHE . 45.3 mt -53.68 143.53 38.49 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.137 0.575 . . . . 0.0 110.32 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.415 ' CG ' ' SG ' ' A' ' 122' ' ' CYS . 72.8 Cg_endo -72.87 27.96 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 124.785 3.657 . . . . 0.0 113.933 -174.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.426 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 16.9 m-85 52.34 18.82 0.98 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.162 0.985 . . . . 0.0 113.275 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -148.09 -13.97 0.13 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.797 -0.565 . . . . 0.0 113.003 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 119' ' ' PRO . 6.8 m -62.95 158.89 18.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.585 0.692 . . . . 0.0 110.698 174.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.5 t -148.77 -165.03 2.17 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 2.5 mptt -49.91 -34.7 21.21 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.541 0.61 . . . . 0.0 112.049 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.36 -16.58 58.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -101.45 -29.38 12.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.3 mt -65.33 -34.01 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.2 -34.81 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.005 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -71.13 -27.09 63.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.174 -0.611 . . . . 0.0 111.043 172.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 8.8 t80 -70.19 -26.08 63.73 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 174.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -111.82 30.55 6.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.301 1.04 . . . . 0.0 109.545 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -67.57 -14.86 63.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.923 0.489 . . . . 0.0 111.83 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -94.42 16.62 60.69 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 36.6 mt -143.98 -162.05 1.39 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.349 1.859 . . . . 0.0 107.157 -173.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -146.79 165.29 30.13 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.1 mt -142.73 154.49 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.4 m -60.13 156.45 38.55 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.95 -31.06 7.77 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 124.509 3.473 . . . . 0.0 113.813 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -161.41 110.42 1.56 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -149.04 6.51 0.83 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.63 -1.095 . . . . 0.0 113.24 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 78.5 mt -97.68 147.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 119.471 1.636 . . . . 0.0 109.507 -174.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 92.0 m -139.82 147.21 40.41 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.7 mt -143.69 97.24 5.48 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 123.293 0.637 . . . . 0.0 109.408 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.72 159.35 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.404 2.736 . . . . 0.0 110.267 173.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.58 159.68 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-O 121.356 0.598 . . . . 0.0 110.963 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.41 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 54.7 m-20 -84.16 175.75 4.38 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.842 176.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.41 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 36.4 Cg_exo -58.5 -19.11 42.69 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.891 2.394 . . . . 0.0 111.522 175.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -82.64 -10.26 59.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.807 0.843 . . . . 0.0 110.872 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.17 10.81 73.96 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.341 0.496 . . . . 0.0 112.444 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -98.74 150.39 21.86 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 117.436 0.618 . . . . 0.0 109.908 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.476 ' C ' ' H ' ' A' ' 153' ' ' GLY . 6.1 pt -73.77 8.1 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 -160.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 67.06 -21.59 0.11 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.133 0.973 . . . . 0.0 113.533 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 105.21 6.84 38.77 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.862 0.744 . . . . 0.0 113.479 175.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -142.72 168.1 20.52 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.249 1.024 . . . . 0.0 110.787 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -157.74 -179.46 8.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.241 0.543 . . . . 0.0 111.26 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.93 151.74 39.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 40.5 t -147.37 166.06 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -128.99 97.42 4.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 168.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.598 ' CE2' HG13 ' A' ' 113' ' ' VAL . 38.5 m-85 -67.86 172.82 4.98 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.197 0.522 . . . . 0.0 109.916 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.79 90.9 0.61 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t 62.3 167.18 0.11 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.933 1.293 . . . . 0.0 111.738 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -15.69 63.07 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.888 -0.508 . . . . 0.0 111.053 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.421 ' HG2' ' HZ1' ' A' ' 167' ' ' LYS . 35.3 tt0 -67.48 -41.92 83.79 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.876 -0.515 . . . . 0.0 110.443 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 159' ' ' PHE . 1.1 tm? -71.17 -39.26 71.97 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -56.66 -35.78 68.79 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.267 -0.271 . . . . 0.0 111.039 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -71.91 -30.29 65.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.565 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.421 ' HZ1' ' HG2' ' A' ' 163' ' ' GLU . 40.3 mttp -72.34 -37.28 68.9 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.644 0.259 . . . . 0.0 110.487 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.428 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.93 -18.76 64.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.937 0.495 . . . . 0.0 112.09 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.98 -14.64 63.12 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.698 -0.626 . . . . 0.0 111.036 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.58 -12.78 80.44 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 130' ' ' PHE . 71.3 mmtt -83.64 -2.64 56.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.736 1.214 . . . . 0.0 111.692 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -52.55 122.68 9.37 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.562 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 77.7 mttt 60.98 17.04 7.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.326 1.45 . . . . 0.0 113.822 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -79.87 -18.41 50.78 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.36 1.064 . . . . 0.0 113.287 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 79.23 174.41 0.15 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.24 1.416 . . . . 0.0 114.573 170.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.77 -15.2 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.24 0.616 . . . . 0.0 112.611 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.24 -29.3 0.64 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 118.556 0.616 . . . . 0.0 114.191 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -151.51 -1.48 0.33 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.885 0.843 . . . . 0.0 111.066 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -145.78 151.59 38.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -97.19 151.2 20.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.027 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 37.5 mm -123.62 157.5 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -172.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -127.82 158.92 36.4 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 171' ' ' LYS . 35.5 m -133.84 130.5 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.7 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 9.0 m-85 -136.98 150.38 48.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -75.84 158.43 32.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.337 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.9 t -156.71 -175.83 5.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.3 m -145.57 169.48 18.32 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.625 1.17 . . . . 0.0 109.744 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -57.16 -32.24 66.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.847 0.459 . . . . 0.0 111.116 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.24 -2.03 3.92 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -121.0 1.93 10.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.88 0.872 . . . . 0.0 111.051 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.417 ' C ' ' H ' ' A' ' 193' ' ' SER . 7.1 p -143.89 11.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.885 0.374 . . . . 0.0 111.318 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -67.72 12.3 0.11 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 191' ' ' VAL . 30.2 m -69.69 0.38 5.63 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.387 0.675 . . . . 0.0 111.28 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.275 -1.345 . . . . 0.0 111.149 178.091 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.619 0 C5'-C4'-C3' 110.195 -3.537 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.426 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.193 0 C1'-O4'-C4' 106.548 -3.392 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.44 H5'' ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.113 2 C5'-C4'-C3' 108.892 -4.405 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.44 ' C2 ' H5'' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.835 2 O4'-C1'-N19 115.761 7.561 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.562 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.035 0 C5'-C4'-C3' 109.601 -3.933 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.7 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.592 0 C5'-C4'-C3' 111.283 -2.811 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -160.34 172.84 16.59 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.784 0.434 . . . . 0.0 110.574 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 52.94 14.43 0.45 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.854 1.262 . . . . 0.0 114.136 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.1 -6.05 0.27 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.99 0.516 . . . . 0.0 110.909 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 t -160.11 176.04 12.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.887 0.875 . . . . 0.0 108.787 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.22 145.14 48.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.464 0.306 . . . . 0.0 111.109 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.22 17.93 0.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -142.07 4.17 1.63 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.45 -5.9 33.59 Favored Glycine 0 N--CA 1.45 -0.375 0 O-C-N 122.245 -0.284 . . . . 0.0 112.581 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -63.03 148.36 47.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.766 0.793 . . . . 0.0 111.286 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.574 HG13 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -155.11 174.77 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.428 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -137.17 152.21 49.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tp -133.81 150.98 51.43 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -154.07 169.98 22.23 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.83 4.96 88.63 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.556 HD22 ' HG ' ' A' ' 122' ' ' CYS . 2.6 mp -58.5 149.05 62.96 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 117.035 0.418 . . . . 0.0 111.609 -175.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 15.3 Cg_exo -62.04 146.97 95.99 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.255 1.97 . . . . 0.0 108.715 167.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.602 ' CE2' " H1'" ' B' ' 1' ' ' ' A' . 19.8 m-85 -71.35 2.99 4.08 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.24 5.74 12.08 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.556 ' HG ' HD22 ' A' ' 118' ' ' LEU . 49.0 t -66.86 154.43 40.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.249 1.02 . . . . 0.0 111.134 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.2 t -156.05 -166.44 2.19 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.03 -53.14 28.86 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.714 0.688 . . . . 0.0 109.518 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.496 ' HA ' ' CG2' ' A' ' 128' ' ' VAL . 32.6 tt0 -53.36 -21.25 5.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.333 1.453 . . . . 0.0 113.843 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 75.6 mm-40 -97.91 -19.67 17.94 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.004 -1.06 . . . . 0.0 110.635 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.2 mt -86.08 -26.18 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.496 ' CG2' ' HA ' ' A' ' 125' ' ' GLU . 29.0 m -78.88 -33.7 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.04 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -72.66 -32.08 65.56 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.454 0.57 . . . . 0.0 110.698 172.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 16.6 t80 -70.44 -24.39 62.88 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.395 -0.19 . . . . 0.0 111.379 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -120.56 29.25 7.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.855 0.862 . . . . 0.0 109.706 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 t -63.18 -11.54 21.52 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.036 0.534 . . . . 0.0 111.967 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.49 13.95 65.76 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.41 ' HB3' HD12 ' A' ' 164' ' ' LEU . 76.4 mt -137.76 -159.4 0.95 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.641 1.976 . . . . 0.0 106.627 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -141.76 -21.52 0.73 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -175.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.596 HG21 ' H ' ' A' ' 137' ' ' VAL . 1.7 mt 51.6 -176.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.683 0.793 . . . . 0.0 112.606 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.596 ' H ' HG21 ' A' ' 136' ' ' ILE . 20.6 m -120.51 154.83 56.95 Favored Pre-proline 0 C--N 1.339 0.145 0 O-C-N 121.501 -0.749 . . . . 0.0 109.174 167.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.84 134.71 17.67 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.154 3.236 . . . . 0.0 112.746 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.2 t30 41.01 36.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.601 1.161 . . . . 0.0 112.557 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -81.87 -4.61 90.26 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.301 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.91 151.15 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.989 0.894 . . . . 0.0 110.732 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.8 m -143.2 144.33 32.13 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.756 0.822 . . . . 0.0 109.346 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.5 mt -139.54 94.98 9.16 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 124.065 0.946 . . . . 0.0 108.615 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.95 158.6 16.8 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.447 2.765 . . . . 0.0 110.691 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 150' ' ' LYS . 28.5 m -141.5 160.42 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.593 0.711 . . . . 0.0 112.187 174.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -85.55 174.04 6.2 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.467 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.03 -9.67 6.57 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.679 2.92 . . . . 0.0 112.539 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -104.3 -1.48 26.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.599 0.759 . . . . 0.0 111.27 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.66 4.38 90.12 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.433 ' HG2' ' C5 ' ' B' ' 1' ' ' ' A' . 79.0 mttt -66.86 162.56 21.41 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 153' ' ' GLY . 4.4 pt -109.6 11.27 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -166.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 p 63.33 -5.85 0.22 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 69.96 12.22 67.8 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.205 0.907 . . . . 0.0 113.252 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -141.27 164.79 29.3 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.044 0.922 . . . . 0.0 110.574 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.69 -178.04 7.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.55 0.74 . . . . 0.0 110.539 -172.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -145.45 154.66 42.48 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 5.4 t -147.38 169.16 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.407 ' O ' HG23 ' A' ' 137' ' ' VAL . 51.1 tt0 -126.96 115.95 20.03 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.959 -1.496 . . . . 0.0 106.959 164.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.574 ' CE2' HG13 ' A' ' 113' ' ' VAL . 51.7 m-85 -85.26 173.53 10.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.302 172.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.09 88.48 0.6 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.13 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.1 t 64.62 168.33 0.17 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.488 1.115 . . . . 0.0 111.511 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -19.58 63.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.866 0.466 . . . . 0.0 111.752 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.21 -42.57 65.62 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.038 -0.414 . . . . 0.0 111.244 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -68.1 -36.06 79.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.42 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -60.73 -35.06 75.42 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.282 -0.261 . . . . 0.0 110.785 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -71.41 -28.14 63.79 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -74.55 -37.98 62.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.693 0.282 . . . . 0.0 110.602 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.432 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -61.54 -23.49 65.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.932 176.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 99.1 mt -69.26 -12.1 61.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.349 0.522 . . . . 0.0 111.411 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.85 -10.66 83.65 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 130' ' ' PHE . 67.3 mmtt -89.02 2.02 54.65 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.822 1.249 . . . . 0.0 112.231 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -52.53 132.64 35.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.974 176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.482 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 87.7 mttt 59.38 12.04 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.48 1.512 . . . . 0.0 114.345 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -72.89 -169.93 0.65 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.018 0.826 . . . . 0.0 109.53 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.76 168.0 19.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.24 -13.62 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.438 0.695 . . . . 0.0 111.583 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 152.23 -26.05 0.88 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.394 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -154.49 2.78 0.22 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.66 0.73 . . . . 0.0 111.174 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -148.17 157.51 43.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.062 0.945 . . . . 0.0 108.686 -171.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -101.99 146.29 28.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.0 162.12 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -125.59 153.11 44.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.826 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.444 HG13 ' HB2' ' A' ' 171' ' ' LYS . 23.2 m -136.79 132.56 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -177.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.574 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 21.0 m-85 -146.16 154.04 41.34 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -77.53 154.67 32.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.694 0.283 . . . . 0.0 110.724 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.9 t -158.37 -178.64 7.43 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.538 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 66.3 m -148.05 170.3 18.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.695 1.198 . . . . 0.0 108.952 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -56.37 -29.58 61.61 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.761 0.424 . . . . 0.0 111.246 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -66.58 -1.03 3.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.477 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -123.16 2.3 9.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.679 0.792 . . . . 0.0 111.167 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' A' ' 193' ' ' SER . 7.3 p -145.07 9.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -69.19 15.14 0.07 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 191' ' ' VAL . 25.2 m -69.06 -0.07 5.3 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.691 0.797 . . . . 0.0 111.113 176.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.211 -1.376 . . . . 0.0 111.227 178.017 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.602 " H1'" ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.408 -3.743 1 C1'-O4'-C4' 105.747 -4.282 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.522 ' C5 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.95 0 O4'-C1'-N19 111.845 3.645 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.46 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.408 -3.744 0 C3'-C2'-C1' 104.76 3.623 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.46 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.936 1 O4'-C1'-N19 115.96 7.76 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.546 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.041 1 C5'-C4'-C3' 108.71 -4.527 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.574 " H1'" ' CZ ' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.48 0 P-O3'-C3' 122.731 2.526 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.6 m -147.69 12.99 1.03 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.954 0.502 . . . . 0.0 111.213 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.29 14.03 1.43 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.705 0.402 . . . . 0.0 111.718 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -67.71 -5.25 15.14 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.969 0.508 . . . . 0.0 111.895 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 109' ' ' ASN . 51.6 p -148.91 22.02 0.99 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.432 0.693 . . . . 0.0 111.095 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.25 33.35 0.05 OUTLIER 'General case' 0 C--N 1.338 0.067 0 C-N-CA 124.082 0.953 . . . . 0.0 112.498 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 107' ' ' SER . 25.8 p30 -153.43 28.81 0.49 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 122.431 0.293 . . . . 0.0 111.311 -171.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -126.62 4.29 6.79 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.74 -13.49 13.15 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -61.88 139.18 58.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.485 0.659 . . . . 0.0 111.06 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.604 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.9 p -150.91 177.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.725 -177.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 -133.26 161.51 34.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.202 0.601 . . . . 0.0 110.67 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -141.61 148.46 39.27 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.629 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -153.6 161.45 42.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.12 4.72 89.67 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.528 HD22 ' HG ' ' A' ' 122' ' ' CYS . 2.9 mp -59.0 153.22 46.01 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 117.324 0.562 . . . . 0.0 111.487 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -62.26 146.27 95.91 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.387 2.058 . . . . 0.0 108.163 166.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.428 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 20.6 m-85 -73.92 10.63 1.1 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.53 3.47 7.63 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.528 ' HG ' HD22 ' A' ' 118' ' ' LEU . 32.5 t -66.6 151.22 47.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.731 1.212 . . . . 0.0 110.981 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.43 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 3.0 t -146.94 -168.29 3.0 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.568 0.747 . . . . 0.0 109.142 172.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.584 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 mptt -51.69 -29.31 17.7 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -76.02 -24.23 55.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.114 0.566 . . . . 0.0 111.93 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.468 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 5.7 mp0 -90.84 -35.34 14.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.478 -0.764 . . . . 0.0 110.0 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.51 -32.54 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.73 -31.84 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.003 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -71.74 -27.64 63.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.755 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -69.78 -27.03 64.58 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -114.3 32.68 5.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.412 1.085 . . . . 0.0 109.53 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.8 t -64.5 -13.62 53.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.959 0.504 . . . . 0.0 112.164 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.31 13.67 67.05 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.412 ' HB3' HD12 ' A' ' 164' ' ' LEU . 74.5 mt -136.72 -161.47 1.17 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.241 1.817 . . . . 0.0 107.24 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.17 -18.22 0.73 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 117.295 2.331 . . . . 0.0 117.295 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.623 HG21 ' H ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER 46.12 -166.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.819 0.848 . . . . 0.0 112.772 -176.242 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.623 ' H ' HG21 ' A' ' 136' ' ' ILE . 16.4 m -129.98 156.17 79.51 Favored Pre-proline 0 CA--C 1.528 0.106 0 C-N-CA 123.898 0.879 . . . . 0.0 109.852 172.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.96 137.15 22.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.027 3.151 . . . . 0.0 112.178 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 39.52 36.58 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.755 1.222 . . . . 0.0 112.952 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.15 5.33 75.23 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 119.13 -0.817 . . . . 0.0 112.507 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.6 mt -113.28 147.77 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 118.84 1.32 . . . . 0.0 109.476 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.0 m -139.56 150.7 45.37 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.505 0.722 . . . . 0.0 109.249 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 6.1 mt -144.48 97.14 5.13 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.513 0.725 . . . . 0.0 109.52 -175.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 163.81 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 124.11 3.207 . . . . 0.0 112.056 174.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 18.1 m -145.06 160.76 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 110.321 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.406 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 60.9 m-20 -84.64 175.54 4.54 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 32.5 Cg_exo -58.67 -20.22 49.63 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.74 2.294 . . . . 0.0 111.045 174.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.25 -12.88 60.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.108 0.963 . . . . 0.0 110.768 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.77 8.27 76.78 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.459 0.552 . . . . 0.0 112.268 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -95.48 148.96 21.93 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 117.433 0.617 . . . . 0.0 109.785 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.458 ' C ' ' H ' ' A' ' 153' ' ' GLY . 6.1 pt -77.24 7.35 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 -160.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 67.96 -22.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 175.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 94.42 15.59 46.56 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.339 -0.701 . . . . 0.0 113.233 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.77 168.06 20.69 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.286 1.043 . . . . 0.0 110.466 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.99 -179.56 8.33 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.395 0.617 . . . . 0.0 111.154 -173.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -144.06 147.98 34.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.461 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 48.4 t -145.83 165.26 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -127.92 100.71 6.02 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 168.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.604 ' CE2' HG11 ' A' ' 113' ' ' VAL . 47.5 m-85 -70.29 172.05 8.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.971 174.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.41 88.93 0.33 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.564 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.89 168.31 0.13 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.623 1.169 . . . . 0.0 111.026 -174.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -16.95 64.31 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.741 -0.599 . . . . 0.0 111.266 -176.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . 0.435 ' HG2' ' HZ2' ' A' ' 167' ' ' LYS . 35.2 tt0 -69.09 -39.9 78.74 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.86 -0.525 . . . . 0.0 110.685 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 134' ' ' LEU . 0.9 OUTLIER -72.13 -35.21 69.06 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.455 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -60.72 -36.57 79.17 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.076 -0.39 . . . . 0.0 110.625 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.02 -28.54 65.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.435 ' HZ2' ' HG2' ' A' ' 163' ' ' GLU . 40.5 mttp -72.88 -37.1 67.43 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 121.285 -0.166 . . . . 0.0 110.946 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.39 65.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.98 -11.34 60.65 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.613 0.365 . . . . 0.0 111.707 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.78 -16.85 80.15 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -76.27 -56.59 4.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.106 0.962 . . . . 0.0 110.791 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.2 t60 23.76 -99.87 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.881 1.272 . . . . 0.0 112.63 -164.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.472 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 92.4 mttt -70.74 17.39 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -61.28 179.37 0.21 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.616 0.767 . . . . 0.0 111.237 172.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -132.33 164.22 26.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.17 0.588 . . . . 0.0 112.104 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.2 mt -108.79 -12.82 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.32 0.648 . . . . 0.0 112.258 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.82 -24.92 1.31 Allowed Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.866 -0.521 . . . . 0.0 113.962 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -151.56 2.09 0.39 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 117.624 0.712 . . . . 0.0 110.731 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -149.79 157.46 43.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.284 1.034 . . . . 0.0 108.395 -171.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -107.37 153.25 23.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.343 0.592 . . . . 0.0 109.563 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.0 mm -119.01 171.92 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -172.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -139.92 158.31 44.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.07 133.9 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.731 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 3.9 m-85 -134.68 158.29 44.47 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -79.26 163.79 24.66 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.849 0.749 . . . . 0.0 109.701 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.4 t -156.82 -173.26 4.38 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.236 -0.29 . . . . 0.0 111.768 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.2 m -147.04 167.63 23.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.626 1.171 . . . . 0.0 109.713 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -59.91 -30.68 69.19 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.55 -1.42 2.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.971 0.908 . . . . 0.0 112.455 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -122.99 2.23 9.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.12 0.968 . . . . 0.0 111.201 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.428 ' C ' ' H ' ' A' ' 193' ' ' SER . 7.6 p -143.98 11.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-O 120.936 0.398 . . . . 0.0 111.207 -176.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -67.16 11.67 0.1 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 191' ' ' VAL . 20.7 t -69.34 -1.99 9.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.524 0.73 . . . . 0.0 110.818 176.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.246 -1.359 . . . . 0.0 111.257 177.953 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.404 " H4'" " O4'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.411 -3.478 0 O4'-C1'-N19 111.434 3.234 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.428 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.713 2 P-O3'-C3' 126.243 5.453 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.15 1 P-O3'-C3' 124.98 4.4 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.796 1 O4'-C1'-N19 115.319 7.119 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.472 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.415 -3.193 1 C5'-C4'-C3' 109.127 -4.249 OUTLIER-DELTA 0.0 OUTLIER beta 0.0 . . . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.731 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 P-O3'-C3' 124.063 3.636 . 0.011 4d . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.2 t30 . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.5 m 49.51 24.64 1.16 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.35 1.06 . . . . 0.0 113.412 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.86 172.97 15.94 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.062 0.545 . . . . 0.0 110.309 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -152.66 163.51 39.51 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.243 0.617 . . . . 0.0 110.074 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.0 m -143.69 5.62 1.39 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.2 36.35 0.29 Allowed 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.377 0.671 . . . . 0.0 111.113 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.419 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 5.9 t-20 -151.02 28.29 0.68 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.672 -171.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -126.59 9.71 7.13 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.85 -9.7 40.45 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -62.49 138.79 58.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.47 0.653 . . . . 0.0 110.218 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.532 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.9 p -148.6 175.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.862 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -131.56 160.94 33.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.663 0.785 . . . . 0.0 110.045 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.2 tp -144.54 140.83 29.06 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -156.67 172.87 17.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.04 8.01 84.57 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 72.0 mt -56.72 150.58 35.92 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.91 0.884 . . . . 0.0 111.819 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.83 20.34 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 124.844 3.696 . . . . 0.0 113.428 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.546 ' CZ ' ' C8 ' ' B' ' 1' ' ' ' A' . 21.8 m-85 55.21 11.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.631 1.172 . . . . 0.0 114.131 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.22 -7.63 1.94 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 21.8 t -66.33 151.46 47.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.271 1.029 . . . . 0.0 110.342 175.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.453 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 6.4 t -143.27 -173.46 3.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 170.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.452 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.9 ptpp? -54.71 -17.39 3.37 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.447 ' H ' HG22 ' A' ' 123' ' ' THR . 42.1 mt-10 -83.69 -26.12 30.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.949 0.5 . . . . 0.0 111.341 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.461 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 4.8 mp0 -87.59 -32.55 19.27 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.68 -35.62 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 p -82.27 -34.08 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.164 -173.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -79.67 -20.82 45.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.47 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -73.72 -26.08 60.52 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 170.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -111.14 36.85 3.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.175 1.39 . . . . 0.0 109.024 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.3 t -68.11 -11.27 58.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 112.412 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.09 20.96 46.71 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.428 ' HB3' HD13 ' A' ' 164' ' ' LEU . 43.4 mt -141.27 -173.06 3.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.475 2.31 . . . . 0.0 105.043 -172.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -138.64 -18.12 1.09 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -174.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.605 HG23 ' H ' ' A' ' 137' ' ' VAL . 1.3 mt 50.83 -177.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.208 1.003 . . . . 0.0 112.454 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.605 ' H ' HG23 ' A' ' 136' ' ' ILE . 18.9 m -121.45 155.88 58.71 Favored Pre-proline 0 CA--C 1.528 0.119 0 O-C-N 121.361 -0.837 . . . . 0.0 109.869 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.68 138.1 25.84 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.907 3.072 . . . . 0.0 111.881 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 43.26 35.51 0.87 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.849 0.859 . . . . 0.0 111.538 -177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -99.07 28.71 14.01 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 119.256 -0.747 . . . . 0.0 111.737 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.4 mt -138.49 146.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 118.505 1.152 . . . . 0.0 109.513 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 96.8 m -143.9 151.55 39.97 Favored 'General case' 0 C--N 1.335 -0.051 0 C-N-CA 123.623 0.769 . . . . 0.0 109.268 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.453 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 1.4 mt -145.48 101.15 4.36 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -52.18 149.51 21.76 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.384 2.723 . . . . 0.0 111.32 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -145.01 165.74 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.361 0.6 . . . . 0.0 110.75 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.409 ' HB3' ' CD ' ' A' ' 147' ' ' PRO . 65.9 m-20 -86.59 176.27 3.7 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.409 ' CD ' ' HB3' ' A' ' 146' ' ' ASP . 37.8 Cg_exo -57.9 -17.82 32.13 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.982 2.455 . . . . 0.0 112.088 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -86.28 -8.82 57.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.324 1.05 . . . . 0.0 111.458 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.71 1.7 88.96 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.428 ' HE3' ' N1 ' ' B' ' 1' ' ' ' A' . 87.2 tttt -76.66 131.33 38.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.451 1.5 . . . . 0.0 109.092 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.9 pt -70.89 147.34 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.394 0.616 . . . . 0.0 110.319 -174.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.2 p -80.77 -9.7 59.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.165 -174.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 111.72 -6.48 27.81 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.734 -0.481 . . . . 0.0 112.798 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -139.29 166.49 24.41 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 117.78 0.79 . . . . 0.0 110.452 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -150.33 -176.81 5.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.039 0.536 . . . . 0.0 111.058 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -144.67 147.64 33.3 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -174.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 85.7 t -147.7 164.18 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -129.67 104.87 7.68 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.532 ' CE2' HG11 ' A' ' 113' ' ' VAL . 59.0 m-85 -74.31 169.52 17.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.12 91.74 0.37 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.9 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 16.4 t 63.76 171.31 0.17 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.201 1.0 . . . . 0.0 111.135 -175.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 0.6 OUTLIER -61.7 -30.04 70.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.109 -0.369 . . . . 0.0 110.604 -176.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -63.01 -36.69 84.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -76.6 -33.51 58.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.421 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -64.76 -34.7 78.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.682 -0.636 . . . . 0.0 110.839 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -69.97 -29.76 66.95 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -71.81 -37.45 70.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.454 0.169 . . . . 0.0 110.859 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.41 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -60.83 -22.67 64.43 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 122.649 0.38 . . . . 0.0 112.018 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 97.6 mt -68.46 -11.65 60.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 122.213 -0.304 . . . . 0.0 111.397 177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.27 -19.44 79.64 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.15 -63.14 1.14 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.044 0.938 . . . . 0.0 109.458 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.438 ' HD1' ' HA ' ' A' ' 182' ' ' GLU . 1.2 t60 25.11 -107.5 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.45 1.1 . . . . 0.0 112.521 -166.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.475 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 90.9 mttt -68.07 12.77 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.08 171.19 11.36 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.497 1.519 . . . . 0.0 109.635 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 180' ' ' TYR . 96.8 mtt180 -116.92 155.98 28.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -169.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.49 -14.31 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.476 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.32 -27.23 0.61 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.643 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -154.47 -1.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.607 0.703 . . . . 0.0 111.583 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -145.84 150.63 36.52 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.949 0.899 . . . . 0.0 108.727 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 175' ' ' ARG . 25.6 p90 -91.43 159.58 15.89 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.865 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 36.2 mm -125.27 174.38 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 -174.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.526 ' CG ' ' H22' ' B' ' 3' ' ' ' G' . 14.4 mt-10 -138.96 142.17 38.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.2 m -114.61 139.29 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' PHE . . . . . 0.667 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 5.3 m-85 -137.42 159.4 42.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -77.72 163.62 25.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.83 0.741 . . . . 0.0 109.59 175.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t -156.13 -173.18 4.39 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.563 0.22 . . . . 0.0 111.561 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.4 m -147.29 168.99 20.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.351 1.06 . . . . 0.0 109.64 -176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -58.94 -30.35 67.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.638 0.375 . . . . 0.0 110.885 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -67.28 -2.33 5.83 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.368 0.667 . . . . 0.0 112.673 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -116.78 0.49 12.55 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.447 0.699 . . . . 0.0 110.496 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.414 ' C ' ' H ' ' A' ' 193' ' ' SER . 9.9 p -144.59 8.52 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -70.39 16.2 0.08 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 191' ' ' VAL . 35.1 m -68.87 0.02 4.93 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.471 0.708 . . . . 0.0 111.073 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.372 177.896 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ' A' . . . . . 0.546 ' C8 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.413 -3.323 0 C3'-C2'-C1' 104.551 3.39 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.494 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.495 1 C5'-C4'-C3' 108.34 -4.773 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.526 ' H22' ' CG ' ' A' ' 182' ' ' GLU . . . . . . . . 0 O4'--C4' 1.411 -3.479 1 P-O3'-C3' 125.677 4.981 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.524 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.081 1 O4'-C1'-N19 114.661 6.461 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.475 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -2.994 1 C5'-C4'-C3' 109.153 -4.231 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.667 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.64 0 P-O3'-C3' 123.503 3.169 . 0.015 4d . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 121.048 0.452 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -136.27 165.48 25.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.678 1.191 . . . . 0.0 108.451 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.62 1.34 37.7 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.961 -0.355 . . . . 0.0 112.447 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -61.56 144.54 54.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 117.66 0.73 . . . . 0.0 110.808 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.639 HG11 ' CE2' ' A' ' 159' ' ' PHE . 10.7 p -151.77 176.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 124.116 0.966 . . . . 0.0 108.521 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.512 ' H ' HG22 ' A' ' 113' ' ' VAL . 22.4 ttt180 -136.63 147.47 46.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.06 148.28 44.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -152.46 160.27 43.27 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.66 3.65 71.02 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 120' ' ' PHE . 83.5 mt -55.55 140.57 65.83 Favored Pre-proline 0 N--CA 1.453 -0.316 0 C-N-CA 123.321 0.648 . . . . 0.0 110.596 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 24.5 Cg_exo -58.85 16.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 125.172 3.915 . . . . 0.0 116.081 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.42 ' H ' ' C ' ' A' ' 118' ' ' LEU . 22.0 m-85 57.03 9.41 0.63 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.554 1.141 . . . . 0.0 112.847 -171.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.05 -3.16 1.51 Allowed Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.793 -0.567 . . . . 0.0 112.304 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 28.2 t -63.62 153.18 36.74 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.56 HG23 ' H ' ' A' ' 125' ' ' GLU . 5.7 t -150.47 -169.19 3.32 Favored 'General case' 0 CA--C 1.526 0.05 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -51.71 -33.69 35.48 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.139 0.427 . . . . 0.0 111.81 -178.28 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.56 ' H ' HG23 ' A' ' 123' ' ' THR . 40.4 tt0 -76.78 -22.67 53.4 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.447 0.699 . . . . 0.0 112.018 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.506 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 47.2 mm-40 -94.73 -33.87 12.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.431 -0.793 . . . . 0.0 109.33 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.419 HG13 ' SG ' ' A' ' 122' ' ' CYS . 54.0 mt -64.32 -34.57 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.33 -34.02 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.661 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -72.34 -26.6 61.99 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.898 172.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 19.3 t80 -72.09 -23.06 61.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.655 0.264 . . . . 0.0 110.549 175.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -118.14 32.87 5.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.397 1.079 . . . . 0.0 109.042 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.0 t -68.26 -11.67 59.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.122 0.569 . . . . 0.0 112.342 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.56 15.24 63.58 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.621 ' HB3' HD11 ' A' ' 164' ' ' LEU . 28.7 mt -144.14 -162.33 1.45 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.36 1.864 . . . . 0.0 107.196 -173.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -147.94 162.32 39.54 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.981 -0.449 . . . . 0.0 110.069 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.39 148.03 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 158' ' ' GLN . 21.0 m -73.83 153.71 89.12 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 118.588 0.631 . . . . 0.0 110.254 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.89 139.36 25.39 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 124.109 3.206 . . . . 0.0 112.477 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.5 t30 40.59 37.56 0.49 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.369 1.068 . . . . 0.0 111.988 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.86 27.73 13.62 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-O 118.72 -1.045 . . . . 0.0 112.057 -173.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.7 mt -133.37 145.3 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 119.375 1.588 . . . . 0.0 109.36 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.4 m -137.8 144.76 41.7 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.772 0.829 . . . . 0.0 109.158 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 123' ' ' THR . 87.2 mt -136.96 93.72 13.27 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 123.454 0.702 . . . . 0.0 110.029 -173.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.5 150.84 32.91 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.221 2.614 . . . . 0.0 110.764 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -141.57 166.69 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.096 0 CA-C-O 121.437 0.637 . . . . 0.0 111.43 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 64.7 m-20 -92.3 176.99 2.3 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.721 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 35.3 Cg_exo -58.75 -19.18 44.98 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.962 2.441 . . . . 0.0 111.83 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -82.82 -7.56 59.65 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.526 0.73 . . . . 0.0 110.657 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.93 13.44 81.24 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.307 0.48 . . . . 0.0 112.323 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -105.61 149.07 26.64 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.5 pt -68.86 149.76 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.456 0.646 . . . . 0.0 111.493 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 45.4 p -74.91 -7.34 53.26 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.222 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.65 -0.75 36.61 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -140.37 170.72 15.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.066 0.546 . . . . 0.0 110.409 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -157.22 -178.69 7.55 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.269 0.628 . . . . 0.0 111.079 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -143.98 148.85 35.87 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 158' ' ' GLN . 76.2 t -146.84 165.34 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.493 ' N ' HG12 ' A' ' 157' ' ' VAL . 40.8 tt0 -128.52 105.99 8.67 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 167.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.639 ' CE2' HG11 ' A' ' 113' ' ' VAL . 35.1 m-85 -74.69 173.01 11.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.389 170.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.19 90.7 0.9 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.192 0.52 . . . . 0.0 109.796 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.9 t 63.15 170.24 0.15 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.591 1.157 . . . . 0.0 112.415 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -22.06 65.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.5 0.72 . . . . 0.0 111.598 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.71 -43.48 75.92 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.907 -0.495 . . . . 0.0 111.032 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -67.6 -39.15 84.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.509 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.19 -37.23 71.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.129 -0.357 . . . . 0.0 110.867 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -71.78 -28.86 63.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.896 -0.138 . . . . 0.0 110.902 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -72.98 -39.18 66.33 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.656 0.265 . . . . 0.0 110.549 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.53 -17.88 63.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.106 0.562 . . . . 0.0 112.195 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.33 -13.01 61.61 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.462 0.574 . . . . 0.0 111.366 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.05 -11.74 81.47 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.536 ' HB2' HG11 ' A' ' 183' ' ' VAL . 69.9 mmtt -88.54 0.55 56.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.296 1.438 . . . . 0.0 111.705 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -54.54 133.18 46.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.443 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 90.6 mttt 59.51 5.59 0.67 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.617 1.567 . . . . 0.0 114.075 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -76.95 170.41 16.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -112.59 158.31 20.12 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -169.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.1 tt -102.9 -9.52 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.574 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 154.43 -29.08 0.7 Allowed Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.935 -0.37 . . . . 0.0 112.611 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -157.51 0.96 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.411 0.605 . . . . 0.0 111.382 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -145.64 153.46 41.05 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.21 1.004 . . . . 0.0 108.508 -173.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -97.01 152.95 18.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.989 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 38.7 mm -127.47 162.2 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -128.71 160.37 32.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 171' ' ' LYS . 26.5 m -137.0 39.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 123.103 0.561 . . . . 0.0 111.674 -162.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 3.4 m-30 -52.71 152.87 3.5 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.922 0.489 . . . . 0.0 109.816 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -80.06 170.16 16.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.633 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 10.0 t -158.01 179.97 8.69 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.479 0.312 . . . . 0.0 110.821 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -148.18 170.53 17.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.284 1.433 . . . . 0.0 108.291 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -53.92 -31.81 51.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.74 -2.77 2.69 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -122.14 2.16 9.8 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.861 0.864 . . . . 0.0 111.013 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.56 11.55 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-O 120.968 0.413 . . . . 0.0 111.14 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -68.95 13.03 0.11 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 29.3 m -67.24 -1.98 5.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.393 0.677 . . . . 0.0 111.456 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.247 -1.358 . . . . 0.0 110.968 178.272 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.2 p30 . . . . . 0 N--CA 1.444 -0.727 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -128.07 7.13 6.01 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.07 -8.74 25.15 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -64.12 142.18 58.5 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.479 0.657 . . . . 0.0 111.608 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.626 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.4 p -152.92 177.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.435 1.094 . . . . 0.0 108.686 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.524 ' H ' HG22 ' A' ' 113' ' ' VAL . 65.0 ttt180 -135.65 153.66 51.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.951 0.9 . . . . 0.0 109.1 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -126.5 135.62 51.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -150.69 50.68 0.87 Allowed 'General case' 0 C--O 1.226 -0.166 0 CA-C-O 121.282 0.563 . . . . 0.0 112.443 -172.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -160.03 15.94 0.21 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.7 153.46 90.82 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -168.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 24.5 Cg_exo -59.44 143.63 99.65 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.754 2.303 . . . . 0.0 107.951 163.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -69.71 6.73 1.05 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.74 10.66 5.46 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 48.8 t -66.29 157.82 30.64 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.285 1.034 . . . . 0.0 111.404 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 125' ' ' GLU . 3.7 t -152.16 -174.8 5.0 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.248 0.619 . . . . 0.0 109.825 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.603 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -51.77 -34.01 37.7 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 123.378 0.671 . . . . 0.0 112.471 -176.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.53 ' H ' HG23 ' A' ' 123' ' ' THR . 40.2 tt0 -72.39 -25.96 61.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.016 0.527 . . . . 0.0 112.166 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -93.1 -30.7 15.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.76 -40.74 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.35 -34.51 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 O-C-N 122.159 -0.338 . . . . 0.0 111.193 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -74.34 -28.71 61.27 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.162 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 28.9 t80 -67.15 -21.21 65.82 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -115.41 37.15 3.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.341 1.056 . . . . 0.0 108.385 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.2 t -69.48 154.84 41.41 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 167.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.27 5.1 85.11 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.504 ' HB3' HD11 ' A' ' 164' ' ' LEU . 24.0 mt -141.78 -172.2 3.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.668 1.987 . . . . 0.0 106.01 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -147.79 162.6 38.89 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.634 -0.666 . . . . 0.0 110.845 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.7 mt -141.32 147.9 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 158' ' ' GLN . 19.4 m -72.64 154.47 91.42 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 118.459 0.572 . . . . 0.0 110.305 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -48.63 138.61 24.99 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.055 3.17 . . . . 0.0 112.179 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 t30 41.53 36.4 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.471 1.109 . . . . 0.0 112.014 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.25 28.64 10.31 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.793 -1.004 . . . . 0.0 111.739 -173.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.5 mt -136.56 145.75 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 119.061 1.431 . . . . 0.0 109.351 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.0 m -139.5 149.46 43.98 Favored 'General case' 0 N--CA 1.458 -0.048 0 C-N-CA 123.509 0.724 . . . . 0.0 109.827 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.443 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 11.9 mt -144.48 93.26 5.85 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 124.075 0.95 . . . . 0.0 109.649 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -55.72 159.61 11.12 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.813 3.009 . . . . 0.0 111.307 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.2 m -141.21 166.02 18.54 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 CA-C-O 121.216 0.531 . . . . 0.0 111.543 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 66.9 m-20 -90.05 176.48 3.01 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.831 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -58.85 -19.25 46.12 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.089 2.526 . . . . 0.0 111.736 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -82.81 -9.01 59.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.563 0.745 . . . . 0.0 110.745 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.35 11.16 80.98 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 123.384 0.516 . . . . 0.0 112.272 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -102.81 148.75 25.24 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.2 pt -68.17 151.23 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.912 0.863 . . . . 0.0 112.263 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.7 p -79.11 5.87 10.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.481 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.7 15.35 80.73 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -140.83 164.74 29.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.49 178.19 10.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.249 0.547 . . . . 0.0 110.465 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -144.71 145.18 31.59 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 67.9 t -143.79 162.98 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.466 ' N ' HG12 ' A' ' 157' ' ' VAL . 49.3 tt0 -129.17 101.83 6.19 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 169.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.626 ' CE2' HG11 ' A' ' 113' ' ' VAL . 43.6 m-85 -71.55 171.17 11.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.328 171.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.47 93.53 1.19 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 61.8 169.8 0.11 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.688 1.195 . . . . 0.0 111.343 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -61.99 -26.75 68.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.762 -0.586 . . . . 0.0 110.9 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.16 -42.48 90.84 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.243 -0.286 . . . . 0.0 111.119 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 164' ' ' LEU . 0.5 OUTLIER -72.17 -38.79 69.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.526 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.91 -40.54 80.59 Favored 'General case' 0 N--CA 1.457 -0.101 0 O-C-N 122.013 -0.43 . . . . 0.0 110.898 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -67.83 -31.05 70.63 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.719 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -71.56 -39.46 70.63 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.632 0.253 . . . . 0.0 111.011 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.98 -15.39 62.21 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.96 -9.33 51.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.685 0.675 . . . . 0.0 111.524 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.14 -11.96 85.07 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.578 ' HB2' HG11 ' A' ' 183' ' ' VAL . 69.5 mmtt -85.74 2.81 43.97 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.243 1.417 . . . . 0.0 111.588 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -56.28 136.9 53.05 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.972 -0.455 . . . . 0.0 110.314 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 33.0 mttp 50.99 11.39 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.179 1.792 . . . . 0.0 114.242 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.02 179.36 5.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.259 1.024 . . . . 0.0 109.085 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -126.46 163.27 23.7 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -170.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mt -113.0 -13.13 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.277 1.031 . . . . 0.0 111.849 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.41 -27.1 1.37 Allowed Glycine 0 CA--C 1.528 0.901 0 O-C-N 121.922 -0.486 . . . . 0.0 113.975 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -153.05 11.49 0.47 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.843 0.822 . . . . 0.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.11 -173.57 3.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.445 1.098 . . . . 0.0 108.384 -172.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -137.06 144.14 43.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 19.0 mm -116.79 162.62 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -167.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -129.64 154.08 47.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 171' ' ' LYS . 34.5 m -131.24 33.66 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 C-N-CA 123.839 0.855 . . . . 0.0 111.011 -166.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -53.55 154.61 3.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -81.93 170.57 15.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.362 -0.837 . . . . 0.0 111.826 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.8 t -158.88 -173.7 4.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.521 0.328 . . . . 0.0 111.533 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 51.3 m -147.81 168.04 23.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.964 1.306 . . . . 0.0 109.174 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -56.91 -30.75 64.22 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.724 0.409 . . . . 0.0 110.897 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.84 -6.53 6.01 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -117.25 1.91 12.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.589 0.755 . . . . 0.0 111.312 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.61 15.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.269 0.557 . . . . 0.0 110.928 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -69.26 11.53 0.22 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.421 0.688 . . . . 0.0 112.811 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 65.8 p -69.29 -1.52 8.35 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.412 0.685 . . . . 0.0 111.243 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.746 -1.121 . . . . 0.0 110.959 177.949 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.4 p30 . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 120.452 0.168 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -125.15 4.26 7.87 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.5 -9.76 53.17 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -62.5 141.36 58.45 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.568 0.699 . . . . 0.0 110.596 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.63 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.5 p -150.6 172.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 70.4 ttt180 -137.34 152.83 50.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp -136.92 148.2 46.86 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -173.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -158.3 154.93 27.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.689 0.281 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.08 -7.08 60.22 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.706 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -63.82 157.99 64.07 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.881 0.341 . . . . 0.0 111.777 -176.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 21.8 Cg_exo -57.82 152.13 51.88 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.348 2.699 . . . . 0.0 112.522 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -67.89 -5.53 17.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.93 -0.89 31.91 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.437 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 41.8 t -68.2 153.01 44.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.344 0.657 . . . . 0.0 109.407 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.657 HG23 ' H ' ' A' ' 125' ' ' GLU . 8.7 t -154.31 -174.63 5.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 174.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 2.4 ptpp? -56.48 -20.69 21.34 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.657 ' H ' HG23 ' A' ' 123' ' ' THR . 42.2 mt-10 -82.18 -21.86 36.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.911 0.484 . . . . 0.0 111.218 177.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.411 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 60.2 mm-40 -90.74 -33.65 15.67 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.2 mt -61.4 -36.39 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.79 -33.63 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.002 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -75.66 -26.91 58.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.993 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -67.94 -27.57 66.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -108.79 34.71 3.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.3 t -67.15 152.0 46.54 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.94 4.24 90.35 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -172.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.553 ' HB3' HD11 ' A' ' 164' ' ' LEU . 19.2 mt -139.49 -171.56 3.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.165 1.786 . . . . 0.0 106.543 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -146.95 162.54 38.52 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.858 -0.526 . . . . 0.0 110.691 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 mt -141.82 148.74 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.9 m -74.46 154.6 87.81 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 118.476 0.58 . . . . 0.0 110.422 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.15 140.01 26.05 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.073 3.182 . . . . 0.0 112.229 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.6 t30 41.77 34.9 0.45 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.36 1.064 . . . . 0.0 111.929 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.32 30.17 8.04 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-O 118.941 -0.922 . . . . 0.0 111.801 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.8 mt -138.35 146.94 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 118.902 1.351 . . . . 0.0 109.922 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.6 m -140.76 146.88 38.29 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 123.86 0.864 . . . . 0.0 109.643 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.4 mt -142.35 92.84 7.29 Favored Pre-proline 0 CA--C 1.528 0.104 0 C-N-CA 124.268 1.027 . . . . 0.0 109.395 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.99 156.4 15.84 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.584 2.856 . . . . 0.0 111.539 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.4 m -142.43 167.06 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-O 121.367 0.603 . . . . 0.0 110.914 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.455 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 61.7 m-20 -91.03 176.52 2.81 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.707 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.5 Cg_exo -58.07 -20.01 43.7 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.823 2.349 . . . . 0.0 111.712 176.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -80.66 -8.81 59.75 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.165 0.986 . . . . 0.0 111.219 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.53 2.52 90.54 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -174.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -79.14 134.66 36.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.007 1.323 . . . . 0.0 108.886 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.5 pt -68.52 146.52 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.579 0.704 . . . . 0.0 110.163 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.4 p -76.4 0.85 18.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.24 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 85.95 7.44 80.82 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -141.43 168.55 19.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.356 0.578 . . . . 0.0 110.347 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.1 179.43 9.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.308 0.575 . . . . 0.0 111.078 -173.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -143.56 146.21 33.14 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.2 t -146.38 164.72 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.472 ' N ' HG12 ' A' ' 157' ' ' VAL . 53.1 tt0 -129.51 102.58 6.45 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 169.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.63 ' CE2' HG11 ' A' ' 113' ' ' VAL . 37.9 m-85 -73.07 171.57 12.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.379 171.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 92.45 0.91 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.8 t 61.88 167.2 0.11 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.787 1.235 . . . . 0.0 111.488 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -14.2 61.99 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.904 -0.498 . . . . 0.0 111.091 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.61 -41.81 79.03 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 122.05 -0.406 . . . . 0.0 110.546 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 164' ' ' LEU . 0.7 OUTLIER -70.86 -39.67 72.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.497 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.44 -38.76 74.95 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.198 -0.314 . . . . 0.0 110.804 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -68.87 -29.82 68.2 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.764 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -73.24 -38.15 66.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.622 0.248 . . . . 0.0 110.759 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.01 -16.81 63.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.75 -9.68 57.85 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.408 0.549 . . . . 0.0 111.548 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.19 -12.77 81.62 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.49 ' HB2' HG11 ' A' ' 183' ' ' VAL . 68.9 mmtt -82.74 -2.37 54.12 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 125.599 1.56 . . . . 0.0 111.973 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -52.69 133.11 36.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.651 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 56.37 9.69 0.56 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.202 1.801 . . . . 0.0 114.4 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.06 173.04 9.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.068 0.947 . . . . 0.0 108.82 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -125.4 160.27 29.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.796 -0.565 . . . . 0.0 112.169 -172.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.1 tt -113.04 -1.93 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.2 -36.92 0.65 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 121.731 -0.606 . . . . 0.0 113.685 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -155.62 6.87 0.23 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.533 0.666 . . . . 0.0 110.74 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.76 135.36 24.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -86.1 157.9 19.93 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.727 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 27.6 mm -125.05 160.85 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -127.5 156.24 42.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 171' ' ' LYS . 33.1 m -131.71 130.71 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 5.7 m-85 -137.19 153.91 50.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -175.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -76.42 164.09 26.33 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.692 0.678 . . . . 0.0 110.006 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -159.4 -175.35 5.16 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.45 0.167 . . . . 0.0 111.373 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.4 t -148.85 171.84 15.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.947 0.899 . . . . 0.0 110.011 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -60.24 -28.61 68.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.269 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.63 -0.94 2.31 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.8 0.84 . . . . 0.0 112.571 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.59 2.37 7.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.542 0.737 . . . . 0.0 111.601 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.72 10.53 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 122.131 -0.356 . . . . 0.0 111.866 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -69.75 15.6 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.2 m -68.61 -0.48 5.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.593 0.757 . . . . 0.0 111.087 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.237 -1.363 . . . . 0.0 111.244 178.105 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -129.39 5.16 5.19 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.72 -10.16 52.58 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -63.11 141.18 58.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.563 0.696 . . . . 0.0 110.471 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.619 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -150.92 175.94 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.932 -177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.458 ' H ' HG22 ' A' ' 113' ' ' VAL . 33.8 ttt180 -135.4 154.16 51.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 109.28 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.9 tp -139.3 150.28 45.23 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -156.72 157.78 35.73 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.13 -5.13 71.62 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.75 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.93 155.95 90.59 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 116.94 0.37 . . . . 0.0 111.529 -176.437 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 31.3 Cg_exo -54.65 151.25 32.32 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.125 3.217 . . . . 0.0 112.183 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.88 -8.74 16.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.05 0.387 . . . . 0.0 111.688 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.57 -0.1 30.79 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.451 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 44.6 t -64.25 153.77 37.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.292 0.637 . . . . 0.0 109.293 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.646 HG23 ' H ' ' A' ' 125' ' ' GLU . 10.4 t -154.87 -176.17 5.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 0.9 OUTLIER -57.29 -21.75 36.88 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.646 ' H ' HG23 ' A' ' 123' ' ' THR . 39.4 tt0 -78.74 -25.23 44.5 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.19 0.596 . . . . 0.0 110.744 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 56.9 mm-40 -87.9 -37.08 16.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.31 -35.06 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.0 p -79.69 -32.45 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.712 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -75.32 -28.05 59.5 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.961 172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -66.05 -26.42 67.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -111.77 32.58 5.34 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.838 0.855 . . . . 0.0 109.017 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.0 t -64.31 148.89 49.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.59 3.71 86.12 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -172.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.554 ' HB3' HD11 ' A' ' 164' ' ' LEU . 17.9 mt -138.53 -170.55 2.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.744 1.617 . . . . 0.0 106.715 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -146.78 162.2 39.05 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.87 -0.519 . . . . 0.0 110.374 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.3 mt -142.04 148.44 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.6 m -73.29 154.49 90.19 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 118.595 0.634 . . . . 0.0 110.369 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.1 138.74 27.74 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 124.074 3.183 . . . . 0.0 112.155 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.1 t30 41.65 35.81 0.52 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.313 1.045 . . . . 0.0 112.047 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.04 29.96 8.13 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 119.04 -0.867 . . . . 0.0 111.895 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.9 mt -138.24 145.54 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.775 1.288 . . . . 0.0 109.658 -176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 86.3 m -139.59 150.2 44.74 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 123.822 0.849 . . . . 0.0 109.621 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 92.6 mt -139.81 90.77 10.8 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.829 0.852 . . . . 0.0 110.093 -174.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.47 153.87 21.56 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.468 2.779 . . . . 0.0 111.813 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.5 m -142.57 169.09 13.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 121.382 0.61 . . . . 0.0 111.207 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 59.5 m-20 -96.12 177.46 1.73 Allowed Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.105 0.962 . . . . 0.0 108.781 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 40.5 Cg_exo -58.04 -20.55 45.99 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.952 2.435 . . . . 0.0 111.625 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.26 -10.7 59.61 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.184 0.994 . . . . 0.0 110.956 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.22 4.39 86.5 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -83.43 136.31 34.36 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.068 1.347 . . . . 0.0 108.806 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.1 pt -66.98 148.01 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 121.79 0.805 . . . . 0.0 110.754 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.6 p -75.26 -0.69 20.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.16 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 88.28 5.94 75.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -138.53 169.78 17.17 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.279 0.54 . . . . 0.0 110.207 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.81 179.13 9.39 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.212 0.605 . . . . 0.0 110.798 -174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -143.65 145.55 32.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 60.2 t -145.81 164.59 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.472 ' N ' HG12 ' A' ' 157' ' ' VAL . 52.6 tt0 -129.19 102.22 6.36 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.619 ' CE2' HG11 ' A' ' 113' ' ' VAL . 44.6 m-85 -72.74 171.2 13.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.263 172.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.86 92.73 0.71 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t 61.67 168.67 0.11 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.758 1.223 . . . . 0.0 111.505 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -14.66 62.68 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.95 -0.469 . . . . 0.0 111.24 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.07 -42.4 76.27 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 122.052 -0.405 . . . . 0.0 110.679 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -70.84 -38.89 73.24 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.654 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.521 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.48 -39.04 75.55 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.279 -0.263 . . . . 0.0 110.717 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -69.02 -29.05 67.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.892 -0.14 . . . . 0.0 110.956 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -73.52 -38.19 65.38 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.095 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.8 -21.65 66.04 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.553 ' HA ' HG21 ' A' ' 183' ' ' VAL . 97.0 mt -70.35 -7.71 44.88 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 122.847 0.459 . . . . 0.0 111.733 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.04 -15.47 81.37 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -76.07 -55.02 5.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.257 1.023 . . . . 0.0 110.856 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.692 ' HA ' HG22 ' A' ' 183' ' ' VAL . 0.7 OUTLIER 23.86 -101.79 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.863 1.265 . . . . 0.0 113.052 -165.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -71.18 19.55 0.05 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -174.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.28 178.74 0.18 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.003 0.921 . . . . 0.0 111.099 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -128.58 161.18 30.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.343 0.657 . . . . 0.0 110.746 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.0 tt -117.94 -0.08 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.42 -36.17 0.64 Allowed Glycine 0 CA--C 1.529 0.953 0 O-C-N 122.046 -0.409 . . . . 0.0 113.422 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -156.72 5.74 0.16 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.314 0.557 . . . . 0.0 110.489 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -146.51 156.17 43.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.514 1.126 . . . . 0.0 108.485 -170.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -104.07 153.81 20.44 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.373 0.606 . . . . 0.0 110.113 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 182' ' ' GLU . 30.1 mm -120.12 172.14 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -172.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.412 ' N ' HG22 ' A' ' 181' ' ' ILE . 21.8 mt-10 -139.54 155.94 47.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' A' ' 172' ' ' HIS . 22.2 m -130.71 137.5 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -148.18 160.49 42.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -80.18 165.32 22.54 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.677 0.671 . . . . 0.0 110.778 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.7 t -158.74 -174.41 4.76 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.144 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.6 t -147.98 171.85 15.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.162 0.985 . . . . 0.0 109.796 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -59.36 -31.39 69.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.652 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.78 -6.02 7.15 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.678 0.791 . . . . 0.0 112.537 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -118.45 3.01 11.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.598 0.759 . . . . 0.0 111.168 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.26 9.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 122.272 -0.267 . . . . 0.0 111.613 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -69.26 13.5 0.12 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.7 m -67.14 -1.16 3.97 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.509 0.723 . . . . 0.0 111.205 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.287 177.959 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.027 0.442 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -121.7 7.65 9.98 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.64 -9.77 41.26 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -61.27 138.63 58.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.731 0.776 . . . . 0.0 110.823 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.576 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -150.27 174.97 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.235 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 58.4 ttt180 -136.58 155.38 50.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.3 tp -138.28 147.4 43.59 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -173.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -154.72 162.48 41.1 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.83 1.45 58.65 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.6 mt -56.97 150.04 41.3 Favored Pre-proline 0 N--CA 1.453 -0.292 0 C-N-CA 123.23 0.612 . . . . 0.0 111.982 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.27 26.16 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 1 C-N-CA 125.346 4.031 . . . . 0.0 113.522 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.589 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 15.4 m-30 53.47 13.85 0.5 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.903 1.281 . . . . 0.0 114.162 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.02 -13.99 0.58 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.994 0.815 . . . . 0.0 112.724 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.4 m -67.35 153.5 43.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.448 0.624 . . . . 0.0 110.389 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 t -147.23 -160.8 1.21 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.93 0.892 . . . . 0.0 108.733 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.553 ' HE3' HD12 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -50.34 -31.26 14.07 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.198 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -84.07 -19.64 33.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -96.27 -31.54 12.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.756 -0.59 . . . . 0.0 109.816 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.4 mt -62.98 -36.31 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 172.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.7 p -79.32 -32.2 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.921 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -74.15 -30.66 62.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.248 172.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.89 -22.06 65.98 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 118.267 0.485 . . . . 0.0 110.111 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -115.84 31.44 6.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.516 1.126 . . . . 0.0 109.214 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.6 t -63.06 139.58 58.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.87 1.75 90.63 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.8 mt -138.82 78.37 1.67 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.153 1.381 . . . . 0.0 107.673 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -50.07 160.01 0.38 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.858 0.863 . . . . 0.0 113.293 -174.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.1 mt -136.41 153.18 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 158' ' ' GLN . 27.3 m -58.93 155.36 32.61 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 122.597 0.359 . . . . 0.0 110.592 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.99 -31.0 7.8 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.84 3.693 . . . . 0.0 114.084 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -160.12 105.57 1.54 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.04 20.93 1.11 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-O 118.686 -1.063 . . . . 0.0 112.756 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.2 mt -117.48 147.26 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 119.257 1.529 . . . . 0.0 110.271 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.4 m -142.11 144.87 33.72 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.958 0.903 . . . . 0.0 109.49 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.553 HD12 ' HE3' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -139.65 97.81 8.12 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 123.793 0.837 . . . . 0.0 110.047 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.18 154.9 31.68 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.871 3.047 . . . . 0.0 110.998 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.32 168.83 13.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-O 121.408 0.623 . . . . 0.0 111.503 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.46 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 62.9 m-20 -95.13 176.64 2.17 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.549 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -58.08 -19.6 41.81 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.976 2.451 . . . . 0.0 111.913 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.23 -8.14 59.7 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.166 0.986 . . . . 0.0 111.117 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.08 2.76 89.19 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.589 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 80.0 tttt -81.08 134.2 35.62 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.922 1.289 . . . . 0.0 108.304 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.1 148.93 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.505 0.669 . . . . 0.0 109.753 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 53.4 p -72.4 1.46 7.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.989 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 95.75 0.95 62.05 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -140.96 169.71 17.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.913 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.65 -177.89 6.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -144.66 146.46 32.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.521 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 84.4 t -146.16 163.2 10.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.673 ' O ' HG22 ' A' ' 137' ' ' VAL . 58.5 tt0 -130.87 94.6 3.64 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.274 170.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.576 ' CE2' HG11 ' A' ' 113' ' ' VAL . 53.3 m-85 -65.69 170.66 4.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.89 93.37 0.76 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.4 t 62.36 168.28 0.12 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.774 1.23 . . . . 0.0 111.392 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -62.12 -27.55 69.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.713 -0.617 . . . . 0.0 110.901 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.42 -41.28 93.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.198 -0.314 . . . . 0.0 111.016 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.482 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -71.33 -37.88 71.69 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -59.1 -38.48 79.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.83 -0.544 . . . . 0.0 110.648 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -68.87 -31.31 70.16 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.45 0.3 . . . . 0.0 110.572 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -71.0 -40.06 72.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.574 0.226 . . . . 0.0 110.59 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.47 -15.08 62.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.714 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.8 mt -66.62 -11.84 55.4 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.829 0.741 . . . . 0.0 111.934 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.0 -10.65 84.11 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.573 ' HB2' HG11 ' A' ' 183' ' ' VAL . 65.5 mmtt -88.02 -3.38 58.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.214 1.406 . . . . 0.0 112.893 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.559 ' CA ' HG22 ' A' ' 183' ' ' VAL . 6.4 t60 -43.29 -21.47 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -139.58 18.56 2.53 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.522 1.055 . . . . 0.0 111.798 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -76.29 -175.65 3.29 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 122.97 0.508 . . . . 0.0 110.323 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -134.57 163.42 29.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.09 -13.44 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.544 0.738 . . . . 0.0 111.971 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.95 -31.68 0.5 Allowed Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.74 -0.6 . . . . 0.0 113.986 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -152.56 2.96 0.34 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.649 0.725 . . . . 0.0 110.909 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -144.69 155.11 43.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.362 1.065 . . . . 0.0 108.164 -174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -106.78 151.22 25.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.272 0.558 . . . . 0.0 110.037 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.8 mm -121.19 159.93 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -171.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -133.44 145.92 50.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' A' ' 169' ' ' LEU . 18.0 m -115.98 136.84 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 9.1 m-85 -137.24 154.27 50.19 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -76.05 163.0 27.57 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.068 0.849 . . . . 0.0 110.544 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.3 t -158.89 -175.43 5.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.8 m -148.66 170.94 17.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.05 1.34 . . . . 0.0 109.269 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -57.87 -31.77 67.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.877 0.471 . . . . 0.0 111.394 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.37 -5.18 9.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -115.71 2.26 13.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.728 0.811 . . . . 0.0 111.005 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.35 9.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 111.18 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -70.22 16.34 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.374 0.67 . . . . 0.0 112.797 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.0 m -68.45 -0.51 5.06 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.6 0.76 . . . . 0.0 111.23 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.373 178.379 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.8 p30 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -122.47 8.58 9.6 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.14 -8.75 49.63 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -61.77 141.36 57.94 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.553 0.692 . . . . 0.0 110.612 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.622 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.2 p -151.05 175.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.446 ' H ' HG22 ' A' ' 113' ' ' VAL . 55.6 ttt180 -137.01 154.04 50.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.7 tp -133.08 148.32 52.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -152.89 160.66 43.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.82 3.93 70.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.402 HD22 ' SG ' ' A' ' 122' ' ' CYS . 95.8 mt -57.33 150.01 45.32 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 117.118 0.459 . . . . 0.0 111.97 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.11 25.25 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 125.143 3.895 . . . . 0.0 113.66 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 22.6 m-30 52.35 13.48 0.3 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.071 1.348 . . . . 0.0 114.192 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.29 -8.86 1.11 Allowed Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.861 0.755 . . . . 0.0 112.458 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 7.0 t -59.62 149.62 29.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.218 1.007 . . . . 0.0 110.953 174.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.478 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 2.4 t -141.16 -167.86 2.49 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.465 0.706 . . . . 0.0 109.298 172.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.8 mptt -51.18 -29.2 13.22 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.436 0.562 . . . . 0.0 112.356 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.4 ' HA ' HG12 ' A' ' 128' ' ' VAL . 39.9 mt-10 -81.22 -19.91 42.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.457 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 5.7 mp0 -92.98 -33.91 13.95 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.773 -0.58 . . . . 0.0 109.439 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.4 HG13 ' SG ' ' A' ' 122' ' ' CYS . 56.7 mt -62.42 -34.9 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 125' ' ' GLU . 9.4 p -84.1 -32.45 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.007 -173.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -72.91 -27.57 61.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -70.77 -25.94 63.12 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.739 0.304 . . . . 0.0 110.429 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -113.71 32.77 5.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.459 1.104 . . . . 0.0 109.016 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.0 t -67.3 -17.01 64.6 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.965 0.506 . . . . 0.0 111.983 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.36 15.41 60.04 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.631 ' HB3' HD11 ' A' ' 164' ' ' LEU . 33.8 mt -143.73 -163.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.207 1.803 . . . . 0.0 107.403 -173.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -146.94 162.61 38.36 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.3 mt -142.16 150.86 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.6 m -75.2 155.23 86.24 Favored Pre-proline 0 C--O 1.232 0.135 0 O-C-N 122.032 -0.417 . . . . 0.0 110.471 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.09 136.81 29.81 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 124.006 3.137 . . . . 0.0 112.245 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.6 t30 40.05 38.92 0.55 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.448 1.099 . . . . 0.0 112.07 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.67 28.19 13.25 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-O 118.859 -0.967 . . . . 0.0 111.876 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.96 147.15 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 118.99 1.395 . . . . 0.0 109.548 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 88.6 m -138.47 148.38 44.29 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.073 0.949 . . . . 0.0 108.991 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.478 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 6.3 mt -145.74 99.04 4.43 Favored Pre-proline 0 N--CA 1.453 -0.315 0 C-N-CA 123.091 0.557 . . . . 0.0 110.225 -174.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.7 157.59 18.94 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.499 2.8 . . . . 0.0 110.334 171.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 151' ' ' ILE . 31.3 m -145.68 163.73 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-O 121.427 0.632 . . . . 0.0 111.324 173.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.458 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 57.8 m-20 -89.69 175.5 3.82 Favored Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.579 174.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.5 Cg_exo -57.95 -20.46 44.88 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.734 2.289 . . . . 0.0 111.385 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -79.48 -9.96 59.71 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.102 0.961 . . . . 0.0 111.252 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.56 0.7 90.06 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -173.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.626 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 85.3 tttt -72.28 131.79 43.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.914 1.286 . . . . 0.0 108.891 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.469 ' C ' ' H ' ' A' ' 153' ' ' GLY . 8.4 pt -71.88 10.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -169.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p 67.49 -15.71 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.532 1.133 . . . . 0.0 112.197 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 101.33 6.44 50.94 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.338 0.971 . . . . 0.0 112.814 175.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -142.68 168.82 18.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.058 0.929 . . . . 0.0 111.936 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.11 -178.82 7.59 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.671 0.788 . . . . 0.0 110.59 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -143.59 146.24 33.14 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -177.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.3 t -146.42 165.01 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -174.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.633 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.4 tt0 -129.46 96.15 4.2 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.68 0.753 . . . . 0.0 109.009 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.622 ' CE2' HG11 ' A' ' 113' ' ' VAL . 36.3 m-85 -68.6 172.07 6.74 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.23 93.45 1.09 Allowed 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t 61.27 168.73 0.1 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.683 1.193 . . . . 0.0 111.455 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -61.73 -27.3 68.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.76 -0.587 . . . . 0.0 110.65 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.32 -36.21 79.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.05 -0.406 . . . . 0.0 111.515 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.8 OUTLIER -74.76 -40.0 61.47 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.14 -37.89 72.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 122.296 -0.252 . . . . 0.0 110.614 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -68.74 -32.12 71.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.601 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -71.3 -38.56 71.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.581 0.229 . . . . 0.0 110.795 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.52 -18.46 63.84 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.821 0.448 . . . . 0.0 112.033 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.706 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.9 mt -65.95 -14.37 61.45 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.641 0.655 . . . . 0.0 111.836 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.86 -10.26 80.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.574 ' HB2' HG11 ' A' ' 183' ' ' VAL . 63.6 mmtt -90.58 -1.97 57.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.814 1.246 . . . . 0.0 112.606 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.567 ' CA ' HG22 ' A' ' 183' ' ' VAL . 14.5 t60 -43.93 -19.92 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.42 17.02 2.39 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.364 0.984 . . . . 0.0 111.833 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -75.65 -173.78 2.3 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-O 120.997 0.427 . . . . 0.0 110.119 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -134.43 166.21 23.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -170.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.6 -19.83 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 124.633 1.173 . . . . 0.0 109.989 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 137.02 135.48 3.39 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 45.32 2.47 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.791 2.036 . . . . 0.0 115.215 -173.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -151.46 166.8 29.98 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.188 0.595 . . . . 0.0 110.143 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -120.78 155.09 34.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.4 mm -123.44 162.57 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -170.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -134.37 150.6 50.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' A' ' 169' ' ' LEU . 19.7 m -119.77 135.6 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 11.8 m-30 -134.84 153.48 52.02 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -76.49 162.95 27.39 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.674 -0.641 . . . . 0.0 110.629 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.5 t -158.86 -175.93 5.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.3 m -148.18 168.95 21.13 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.249 1.419 . . . . 0.0 109.192 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -57.44 -31.91 66.37 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.734 0.414 . . . . 0.0 111.173 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.87 -16.74 59.89 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -102.35 0.44 34.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.405 0.682 . . . . 0.0 111.47 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.1 p -143.35 14.33 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.002 0.43 . . . . 0.0 111.027 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -69.45 13.45 0.13 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.4 m -68.01 -0.68 4.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.592 0.757 . . . . 0.0 111.199 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.094 178.541 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 110.865 -0.05 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -136.89 2.63 2.63 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.57 -10.23 75.2 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 122.08 -0.388 . . . . 0.0 112.66 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -65.44 150.34 48.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.593 0.711 . . . . 0.0 110.323 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.587 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.0 p -153.11 175.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.676 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.465 ' H ' HG22 ' A' ' 113' ' ' VAL . 32.5 ttt180 -132.32 153.75 50.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.378 1.071 . . . . 0.0 108.673 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.1 tp -137.4 146.52 44.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -152.6 169.41 22.74 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.85 8.59 86.53 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 118' ' ' LEU . 89.5 mt -57.18 142.65 74.72 Favored Pre-proline 0 N--CA 1.451 -0.412 0 C-N-CA 122.858 0.463 . . . . 0.0 111.9 -174.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.99 27.45 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 125.235 3.956 . . . . 0.0 113.609 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 54.79 8.13 0.2 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.03 1.332 . . . . 0.0 114.536 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -136.81 -5.13 1.98 Allowed Glycine 0 CA--C 1.528 0.87 0 CA-C-N 118.786 0.721 . . . . 0.0 112.169 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 44.4 t -61.62 153.04 29.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.69 0.796 . . . . 0.0 111.147 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 t -156.16 -163.35 1.45 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.428 ' HD2' ' HB ' ' A' ' 141' ' ' ILE . 27.3 mmtp -46.17 -39.26 9.39 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.428 0.691 . . . . 0.0 112.679 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.442 ' HA ' HG12 ' A' ' 128' ' ' VAL . 39.3 mt-10 -83.72 -15.3 49.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.515 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 65.5 mm-40 -98.81 -31.47 11.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.413 HG13 ' SG ' ' A' ' 122' ' ' CYS . 32.5 mt -64.37 -37.68 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 172.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 125' ' ' GLU . 11.4 p -79.4 -33.16 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.528 -173.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -74.14 -25.89 60.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.137 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 181' ' ' ILE . 53.8 t80 -71.78 -20.35 61.88 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.872 0.305 . . . . 0.0 110.667 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -120.94 33.59 5.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.481 1.112 . . . . 0.0 108.455 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -64.0 -17.63 63.5 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.16 0.584 . . . . 0.0 112.439 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.27 15.28 58.74 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' A' ' 164' ' ' LEU . 56.4 mt -144.04 -162.53 1.49 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.486 1.514 . . . . 0.0 108.457 -172.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -145.97 163.04 36.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.9 mt -142.25 150.32 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 158' ' ' GLN . 16.3 m -74.55 155.99 87.15 Favored Pre-proline 0 CA--C 1.53 0.177 0 O-C-N 121.995 -0.441 . . . . 0.0 110.527 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.83 133.48 22.43 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 124.196 3.264 . . . . 0.0 112.464 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.2 t30 38.62 39.34 0.32 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.582 1.153 . . . . 0.0 112.16 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.5 35.36 3.97 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-O 119.044 -0.864 . . . . 0.0 111.246 -174.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.428 ' HB ' ' HD2' ' A' ' 124' ' ' LYS . 89.3 mt -137.84 146.68 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 118.74 1.27 . . . . 0.0 109.42 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.3 m -138.23 144.23 40.5 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 123.574 0.749 . . . . 0.0 109.166 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.5 mt -137.78 87.28 17.19 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 123.71 0.804 . . . . 0.0 109.396 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.67 158.85 18.67 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.095 2.53 . . . . 0.0 110.855 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.42 160.34 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 121.552 0.691 . . . . 0.0 112.24 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 22.0 m-20 -83.54 174.12 6.43 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.826 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 33.7 Cg_exo -59.9 -2.65 1.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.274 3.316 . . . . 0.0 113.045 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -117.15 1.38 12.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.799 0.839 . . . . 0.0 110.759 -176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.06 2.83 88.06 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -69.54 161.31 29.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 153' ' ' GLY . 4.8 pt -95.95 13.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -167.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 p 62.71 -3.37 0.31 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.916 0.886 . . . . 0.0 112.358 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 77.27 6.02 85.95 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.779 1.181 . . . . 0.0 113.014 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -142.41 168.41 19.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.238 1.019 . . . . 0.0 111.72 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.27 -177.98 6.99 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.059 0.944 . . . . 0.0 110.453 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -145.56 148.11 32.81 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.477 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 61.7 t -146.11 165.0 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.636 ' O ' HG22 ' A' ' 137' ' ' VAL . 52.4 tt0 -129.74 95.85 4.08 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.74 0.781 . . . . 0.0 108.982 171.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.587 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.1 m-85 -69.03 170.9 9.02 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.763 174.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.29 94.05 0.9 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.7 t 62.66 168.44 0.13 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.538 1.135 . . . . 0.0 111.621 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -61.86 -26.05 67.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.61 -36.55 84.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.035 0.379 . . . . 0.0 111.704 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -73.64 -39.97 64.11 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.541 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.05 -34.76 70.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.293 -0.254 . . . . 0.0 110.631 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -69.16 -32.15 71.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.336 0.255 . . . . 0.0 110.516 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -72.53 -38.05 68.15 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.766 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.01 -19.56 64.47 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.113 0.565 . . . . 0.0 112.341 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.689 ' HA ' HG21 ' A' ' 183' ' ' VAL . 95.2 mt -67.65 -8.46 34.96 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.584 0.629 . . . . 0.0 111.284 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.66 8.09 66.88 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -118.76 3.7 11.62 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 123.852 0.861 . . . . 0.0 111.289 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.583 ' CA ' HG22 ' A' ' 183' ' ' VAL . 5.3 t60 -42.2 -24.48 0.05 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -137.5 18.32 2.91 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.355 0.98 . . . . 0.0 110.897 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -81.57 174.12 11.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.711 1.604 . . . . 0.0 108.792 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -120.35 158.46 27.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.2 tt -98.09 -12.51 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.499 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.87 -26.66 1.77 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.248 0.451 . . . . 0.0 112.209 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -155.4 5.83 0.22 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.148 0.579 . . . . 0.0 110.789 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -145.75 160.57 41.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.556 1.142 . . . . 0.0 108.197 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -107.93 145.27 34.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 130' ' ' PHE . 31.3 mm -122.02 160.62 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -129.98 144.86 51.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.689 HG21 ' HA ' ' A' ' 169' ' ' LEU . 11.0 m -119.3 143.21 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -150.41 156.01 40.67 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -73.71 156.77 37.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.983 0.42 . . . . 0.0 110.696 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.7 t -157.68 -177.06 6.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.118 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.6 t -152.08 174.8 13.25 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.14 0.976 . . . . 0.0 109.558 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.6 tp60 -59.03 -31.7 69.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.726 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.09 -3.8 6.19 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -118.79 2.95 11.65 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.664 0.786 . . . . 0.0 111.308 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.5 10.51 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.913 0.387 . . . . 0.0 111.204 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -68.2 14.12 0.07 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.0 m -68.69 -0.58 5.44 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.433 0.693 . . . . 0.0 111.239 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.079 178.371 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.6 p30 . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -118.15 7.45 12.15 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.03 -8.91 42.68 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.93 139.96 58.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.423 0.63 . . . . 0.0 110.705 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.4 p -149.51 175.81 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.205 1.002 . . . . 0.0 108.764 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.463 ' H ' HG22 ' A' ' 113' ' ' VAL . 33.0 ttt180 -137.49 144.42 42.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.06 0.544 . . . . 0.0 109.743 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.407 ' HB3' HD12 ' A' ' 118' ' ' LEU . 4.0 mm? -119.02 152.25 36.76 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.478 ' HE ' ' HB3' ' A' ' 154' ' ' GLU . 19.3 tpp85 -157.6 152.1 25.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.27 2.45 90.59 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 171.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.752 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -68.25 158.49 84.27 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 37.7 Cg_exo -52.21 153.66 12.44 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.026 2.484 . . . . 0.0 114.311 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -68.25 -1.55 6.42 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.944 0.497 . . . . 0.0 111.802 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.77 2.96 10.97 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.435 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 52.5 t -66.3 153.51 42.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.025 0.93 . . . . 0.0 109.605 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.655 HG23 ' H ' ' A' ' 125' ' ' GLU . 10.0 t -154.97 -175.24 5.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 2.4 ptpp? -56.45 -22.06 29.57 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.655 ' H ' HG23 ' A' ' 123' ' ' THR . 40.8 tt0 -77.72 -25.07 49.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.242 0.617 . . . . 0.0 110.899 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -89.05 -35.52 16.3 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.6 -34.35 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.58 -34.07 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.658 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -73.17 -25.72 60.9 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.921 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -72.04 -25.97 62.01 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.64 0.257 . . . . 0.0 110.336 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -111.29 30.5 6.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.531 1.132 . . . . 0.0 109.022 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.6 t -65.74 -14.68 61.78 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.753 0.421 . . . . 0.0 111.865 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.17 15.26 63.32 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.625 ' HB3' HD11 ' A' ' 164' ' ' LEU . 33.4 mt -143.26 -162.8 1.51 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.249 1.819 . . . . 0.0 107.35 -173.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -147.15 162.29 39.16 Favored 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.2 mt -142.38 152.09 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.9 m -77.65 153.86 81.09 Favored Pre-proline 0 CA--C 1.528 0.105 0 CA-C-N 118.153 0.433 . . . . 0.0 110.683 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.37 140.7 34.11 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.097 3.198 . . . . 0.0 112.094 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 42.02 36.39 0.67 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.201 1.0 . . . . 0.0 111.929 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -99.76 29.28 12.37 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 118.898 -0.945 . . . . 0.0 111.943 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 77.6 mt -137.72 146.07 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.847 1.324 . . . . 0.0 110.2 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.1 m -142.17 147.55 36.8 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.009 0.924 . . . . 0.0 109.728 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.4 mt -140.78 96.48 7.48 Favored Pre-proline 0 CA--C 1.527 0.094 0 C-N-CA 124.243 1.017 . . . . 0.0 109.849 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.74 154.88 8.73 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.713 2.942 . . . . 0.0 112.019 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.77 165.13 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-O 121.244 0.545 . . . . 0.0 110.467 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 67.7 m-20 -86.13 176.4 3.62 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.929 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -59.1 -17.77 40.17 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.102 2.535 . . . . 0.0 111.85 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -86.89 -4.69 59.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.594 0.758 . . . . 0.0 110.789 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.46 11.15 83.58 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 123.477 0.56 . . . . 0.0 112.534 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -102.22 149.81 23.93 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 117.455 0.628 . . . . 0.0 109.55 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.6 pt -69.22 151.87 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.729 0.776 . . . . 0.0 112.606 -170.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.3 p -86.98 -7.14 58.45 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.144 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.74 6.36 57.25 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-O 119.768 -0.462 . . . . 0.0 112.781 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.478 ' HB3' ' HE ' ' A' ' 116' ' ' ARG . 23.0 pt-20 -140.02 168.45 19.79 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.433 0.617 . . . . 0.0 110.546 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.21 178.51 10.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.069 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -141.57 143.95 33.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 69.6 t -144.56 162.61 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -174.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.669 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.4 tt0 -128.51 97.62 4.77 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.863 0.84 . . . . 0.0 109.02 170.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 113' ' ' VAL . 38.5 m-85 -69.07 171.57 8.03 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.433 173.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.29 92.57 0.79 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t 61.33 170.42 0.11 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.757 1.223 . . . . 0.0 111.423 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -62.63 -27.18 69.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.818 -0.551 . . . . 0.0 110.696 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.48 -41.56 85.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.153 -0.342 . . . . 0.0 111.133 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -72.51 -39.55 67.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.66 -38.26 74.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.002 -0.436 . . . . 0.0 110.93 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -69.27 -30.05 68.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.755 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -72.58 -38.93 67.74 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 120.46 0.172 . . . . 0.0 111.082 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.411 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.39 -19.39 64.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.766 0.427 . . . . 0.0 112.127 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.452 ' HA ' HG21 ' A' ' 183' ' ' VAL . 95.4 mt -69.19 -11.65 60.98 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.842 -0.536 . . . . 0.0 111.345 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.87 -13.24 80.84 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.565 ' HB2' HG11 ' A' ' 183' ' ' VAL . 70.3 mmtt -83.41 -1.04 52.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.299 1.439 . . . . 0.0 111.924 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.441 ' CA ' HG22 ' A' ' 183' ' ' VAL . 6.1 t60 -54.81 134.81 48.1 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.248 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.6 mttp 56.85 6.33 0.3 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.993 1.717 . . . . 0.0 114.567 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.13 172.49 11.63 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.051 0.94 . . . . 0.0 109.325 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -123.05 158.85 29.68 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.949 -0.47 . . . . 0.0 112.197 -170.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.6 tt -112.75 -2.24 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.08 -32.43 0.66 Allowed Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.931 -0.481 . . . . 0.0 113.936 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -156.45 4.21 0.16 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.85 0.825 . . . . 0.0 111.163 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -147.74 159.68 43.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.252 1.021 . . . . 0.0 108.477 -170.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -109.02 130.16 55.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.411 0.624 . . . . 0.0 109.968 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 18.0 mm -94.55 166.53 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -130.65 154.14 48.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 171' ' ' LYS . 24.4 m -135.79 125.2 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 8.2 m-30 -133.47 163.69 28.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -88.64 169.11 11.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.456 1.025 . . . . 0.0 111.598 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -158.32 -177.22 6.38 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.084 0.554 . . . . 0.0 111.156 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.1 m -149.35 168.77 22.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.144 1.378 . . . . 0.0 108.69 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -56.43 -32.54 64.98 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.45 0.3 . . . . 0.0 111.641 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.54 -2.43 6.57 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -117.0 3.02 12.77 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.964 0.906 . . . . 0.0 110.8 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.27 11.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 121.221 0.534 . . . . 0.0 110.825 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -68.06 13.77 0.08 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.85 0.86 . . . . 0.0 113.068 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.4 m -68.28 -1.24 5.86 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.57 0.748 . . . . 0.0 111.254 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.125 178.564 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.1 p30 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.359 0.123 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.83 2.54 6.67 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.09 -10.19 51.21 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.395 174.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -64.04 143.61 57.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.428 0.632 . . . . 0.0 110.372 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.646 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.9 p -150.81 178.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.911 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 113' ' ' VAL . 5.8 mtm180 -133.28 165.07 25.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.318 0.647 . . . . 0.0 111.087 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 115' ' ' LEU . 12.8 tp -147.23 145.16 29.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -154.82 171.2 20.0 Favored 'General case' 0 CA--C 1.527 0.084 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.72 10.45 86.23 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 120' ' ' PHE . 95.2 mt -55.15 149.65 24.5 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 123.289 0.636 . . . . 0.0 111.494 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.06 27.38 0.21 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.798 2.332 . . . . 0.0 113.454 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.447 ' H ' ' C ' ' A' ' 118' ' ' LEU . 62.6 m-85 51.04 12.96 0.13 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.926 1.691 . . . . 0.0 113.603 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.19 -8.14 1.21 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 22.5 t -61.84 154.07 27.0 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.779 0.831 . . . . 0.0 109.847 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.622 HG23 ' H ' ' A' ' 125' ' ' GLU . 10.0 t -147.69 -174.86 4.66 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.469 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.8 ptpp? -55.33 -20.12 10.7 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.622 ' H ' HG23 ' A' ' 123' ' ' THR . 42.2 mt-10 -83.6 -22.38 32.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.018 0.527 . . . . 0.0 111.342 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.509 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 64.3 mm-40 -92.43 -30.49 15.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.49 -36.44 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.07 -32.11 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.685 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -73.15 -27.62 61.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.065 172.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 24.1 t80 -71.67 -24.34 61.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 110.504 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -115.49 32.14 6.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.442 1.097 . . . . 0.0 108.727 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 t -67.92 -16.97 64.31 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.936 0.495 . . . . 0.0 112.075 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.66 15.66 59.9 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.661 ' HB3' HD11 ' A' ' 164' ' ' LEU . 30.0 mt -143.47 -164.83 1.95 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.229 1.812 . . . . 0.0 107.307 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -148.06 161.23 41.81 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.839 -0.538 . . . . 0.0 110.038 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.9 mt -140.43 150.83 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.5 m -77.56 154.09 81.36 Favored Pre-proline 0 CA--C 1.528 0.128 0 CA-C-N 118.407 0.549 . . . . 0.0 110.354 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.1 141.31 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.925 3.083 . . . . 0.0 111.949 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 43.13 35.18 0.76 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.906 0.882 . . . . 0.0 111.777 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.99 28.82 13.48 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-O 119.245 -0.753 . . . . 0.0 111.968 -173.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.8 mt -138.24 144.78 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 118.817 1.308 . . . . 0.0 109.731 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.7 m -140.35 145.74 37.54 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.592 0.757 . . . . 0.0 109.234 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 155' ' ' ALA . 13.0 mt -141.76 94.21 7.38 Favored Pre-proline 0 N--CA 1.455 -0.208 0 C-N-CA 124.154 0.982 . . . . 0.0 109.061 -176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.06 152.89 22.65 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.334 2.689 . . . . 0.0 110.624 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.47 166.02 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 CA-C-O 121.328 0.585 . . . . 0.0 111.072 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 58.9 m-20 -91.56 177.07 2.36 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.861 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 32.6 Cg_exo -59.07 -19.43 48.74 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.942 2.428 . . . . 0.0 111.762 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -81.95 -7.46 59.61 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.768 0.827 . . . . 0.0 110.672 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.33 12.31 83.26 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.675 0.655 . . . . 0.0 112.151 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -102.0 149.97 23.7 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.8 pt -68.24 148.28 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.465 0.65 . . . . 0.0 111.577 -171.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.2 p -76.6 -4.03 40.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.705 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.7 4.31 54.68 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 123.048 0.356 . . . . 0.0 112.46 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -145.15 171.16 14.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.247 0.524 . . . . 0.0 110.092 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.43 ' HB2' HD23 ' A' ' 143' ' ' LEU . . . -154.21 179.12 9.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.3 0.572 . . . . 0.0 110.5 -175.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -144.4 143.79 31.09 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 90.4 t -145.99 164.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -174.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.451 ' N ' HG12 ' A' ' 157' ' ' VAL . 52.2 tt0 -129.82 102.77 6.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.646 ' CE2' HG11 ' A' ' 113' ' ' VAL . 34.0 m-85 -73.83 172.2 11.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.322 171.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.17 91.58 0.72 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.084 0.469 . . . . 0.0 109.815 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 61.61 168.53 0.11 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.666 1.186 . . . . 0.0 111.476 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -16.43 63.91 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.885 -0.51 . . . . 0.0 111.055 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -66.01 -42.96 89.0 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.973 -0.454 . . . . 0.0 110.342 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.8 OUTLIER -70.73 -39.69 73.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.1 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.31 -38.32 73.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.244 -0.285 . . . . 0.0 110.856 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -69.26 -29.98 68.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.728 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -72.52 -38.35 68.11 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.513 0.197 . . . . 0.0 110.814 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.412 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.91 -19.58 65.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.731 0.412 . . . . 0.0 111.935 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.462 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.0 mt -67.55 -12.06 59.49 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.464 0.574 . . . . 0.0 111.336 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.98 -11.96 78.96 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.632 ' HB2' HG11 ' A' ' 183' ' ' VAL . 69.5 mmtt -87.39 1.63 52.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.263 1.425 . . . . 0.0 111.614 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.491 ' HA ' HG22 ' A' ' 183' ' ' VAL . 65.3 t60 -54.32 134.26 45.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.438 ' HE3' ' NE2' ' A' ' 172' ' ' HIS . 90.9 mttt 53.5 14.01 0.53 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.545 1.538 . . . . 0.0 113.967 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.02 163.04 20.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.886 0.766 . . . . 0.0 109.607 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -101.31 159.09 15.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.6 tt -114.99 -7.29 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 160.28 -37.79 0.45 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-O 119.916 -0.38 . . . . 0.0 112.971 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -155.57 11.86 0.32 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.35 0.575 . . . . 0.0 110.761 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -136.0 -179.82 5.89 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.283 1.033 . . . . 0.0 109.141 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -126.15 141.54 51.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.7 mm -112.82 160.87 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -129.89 94.46 3.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -170.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' A' ' 171' ' ' LYS . 13.9 m -74.24 140.44 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.149 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -146.26 161.43 40.29 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -79.55 161.72 25.8 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.833 0.742 . . . . 0.0 109.965 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -157.2 -174.2 4.8 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.53 -0.106 . . . . 0.0 111.13 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.7 t -147.4 172.07 14.5 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.808 0.843 . . . . 0.0 110.155 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -59.99 -31.55 70.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.746 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.42 -1.27 7.98 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -114.36 0.34 14.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.792 0.837 . . . . 0.0 110.547 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.92 14.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 120.956 0.408 . . . . 0.0 110.785 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -67.08 9.8 0.18 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 31.3 m -68.7 -0.7 5.6 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.443 0.697 . . . . 0.0 111.292 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.785 -1.103 . . . . 0.0 111.151 178.347 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.0 p30 . . . . . 0 N--CA 1.446 -0.657 0 CA-C-O 120.853 0.359 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.62 7.82 10.04 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.34 -9.28 30.88 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -61.86 138.22 58.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.362 0.601 . . . . 0.0 110.669 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.5 p -150.25 175.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.044 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.444 ' H ' HG22 ' A' ' 113' ' ' VAL . 9.9 mtm180 -132.35 151.16 51.97 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.608 0.763 . . . . 0.0 110.695 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -123.34 148.71 45.73 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 124.281 1.032 . . . . 0.0 108.39 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -153.18 161.08 42.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.81 0.53 85.18 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.8 mt -53.34 134.93 51.84 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 124.07 0.948 . . . . 0.0 111.238 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -60.31 142.98 99.44 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 107.262 -1.861 . . . . 0.0 107.262 170.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.427 ' CD2' ' HE2' ' A' ' 150' ' ' LYS . 17.5 m-85 -66.9 -2.11 4.82 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.92 -174.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.02 -0.9 27.0 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 47.4 t -63.69 142.77 58.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.031 0.932 . . . . 0.0 109.829 176.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.4 t -148.82 -160.9 1.24 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.407 ' HD2' ' HB ' ' A' ' 141' ' ' ILE . 28.9 mmtp -45.21 -41.03 7.91 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.539 0.736 . . . . 0.0 112.953 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.475 ' HA ' HG12 ' A' ' 128' ' ' VAL . 38.8 mt-10 -77.76 -23.06 49.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -173.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.445 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 9.9 mp0 -86.3 -39.56 16.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.0 mt -64.45 -36.32 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 125' ' ' GLU . 14.5 p -80.64 -34.13 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.08 -170.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -81.2 -20.64 40.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.869 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -71.89 -22.75 61.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 171.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -115.48 35.96 4.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.501 1.12 . . . . 0.0 109.139 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.8 t -62.64 142.53 58.01 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.17 5.11 75.39 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 39.0 mt -140.44 72.13 1.39 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.13 1.372 . . . . 0.0 107.97 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -49.55 159.3 0.36 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.036 0.934 . . . . 0.0 113.473 -174.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.4 mt -135.33 146.91 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.6 m -71.41 155.61 92.56 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 118.506 0.594 . . . . 0.0 110.236 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.89 135.23 23.25 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 124.094 3.196 . . . . 0.0 112.301 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.4 t30 40.21 38.16 0.49 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.423 1.089 . . . . 0.0 111.996 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.02 33.83 4.69 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.407 ' HB ' ' HD2' ' A' ' 124' ' ' LYS . 81.7 mt -140.29 143.92 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 118.522 1.161 . . . . 0.0 108.842 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.0 m -136.91 147.95 46.73 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.439 0.695 . . . . 0.0 109.299 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 88.2 mt -139.75 93.42 9.6 Favored Pre-proline 0 C--O 1.234 0.249 0 C-N-CA 123.278 0.631 . . . . 0.0 110.485 -173.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.04 154.81 26.01 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.931 2.421 . . . . 0.0 110.325 171.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' A' ' 151' ' ' ILE . 27.1 m -146.58 164.64 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 CA-C-O 121.429 0.633 . . . . 0.0 111.588 174.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 59.0 m-20 -90.99 176.04 3.17 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.469 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.8 Cg_exo -58.09 -20.67 47.06 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.842 2.361 . . . . 0.0 111.563 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.63 -10.4 59.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.35 1.06 . . . . 0.0 111.214 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.96 1.58 90.65 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.427 ' HE2' ' CD2' ' A' ' 120' ' ' PHE . 52.2 tttm -73.58 130.59 40.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.888 1.275 . . . . 0.0 109.152 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 153' ' ' GLY . 9.0 pt -70.31 9.93 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -168.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 66.63 -15.88 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.97 0.908 . . . . 0.0 112.417 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 100.41 3.19 55.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.547 1.07 . . . . 0.0 113.063 175.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -139.71 170.41 15.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.263 1.032 . . . . 0.0 111.425 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -160.99 -178.05 6.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.943 0.497 . . . . 0.0 110.561 -174.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -142.52 145.06 33.25 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 89.6 t -145.09 164.3 12.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' ' 157' ' ' VAL . 53.2 tt0 -131.16 101.33 5.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.606 ' CE2' HG11 ' A' ' 113' ' ' VAL . 47.5 m-85 -71.61 171.64 11.09 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.341 171.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 93.05 0.95 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.14 0.495 . . . . 0.0 109.98 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t 62.09 169.43 0.12 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.498 1.119 . . . . 0.0 111.02 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.74 -21.03 66.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.771 -0.58 . . . . 0.0 111.174 -175.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.73 -42.94 99.91 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.917 -0.489 . . . . 0.0 110.302 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 164' ' ' LEU . 0.3 OUTLIER -69.77 -38.69 76.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.4 -40.53 82.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.026 -0.421 . . . . 0.0 110.701 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -68.03 -30.91 70.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.566 0.346 . . . . 0.0 110.668 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -71.6 -39.78 70.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 110.511 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.35 -13.33 61.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.688 ' HA ' HG21 ' A' ' 183' ' ' VAL . 92.4 mt -67.23 -14.09 62.58 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 118.97 0.805 . . . . 0.0 111.954 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.61 -11.9 77.41 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.558 ' HB2' HG11 ' A' ' 183' ' ' VAL . 70.1 mmtt -85.43 -4.94 59.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.17 1.388 . . . . 0.0 113.049 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.569 ' CA ' HG22 ' A' ' 183' ' ' VAL . 13.0 t60 -42.51 -23.54 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -140.55 17.57 2.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.205 0.911 . . . . 0.0 112.005 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -74.6 -174.82 2.21 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.086 0.469 . . . . 0.0 110.11 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.14 159.11 37.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.771 -171.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.1 tt -110.59 -6.36 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 150.53 -29.14 1.06 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.985 -0.341 . . . . 0.0 113.164 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -156.43 4.17 0.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.485 0.642 . . . . 0.0 110.834 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -149.84 157.95 43.69 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.406 1.083 . . . . 0.0 108.49 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -104.83 150.88 24.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.8 mm -123.68 161.93 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -172.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -132.25 157.36 44.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 169' ' ' LEU . 17.8 m -129.91 135.62 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -132.82 158.85 41.44 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -75.16 160.94 29.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.947 0.794 . . . . 0.0 109.629 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t -154.05 -174.1 4.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.724 0.297 . . . . 0.0 111.575 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.5 m -146.11 166.89 24.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.176 0.99 . . . . 0.0 109.977 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -60.09 -32.11 70.65 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.407 0.283 . . . . 0.0 110.564 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -63.54 -17.28 62.63 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -100.0 -0.94 38.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.308 0.643 . . . . 0.0 111.4 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.6 12.07 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.941 0.401 . . . . 0.0 111.523 -174.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -68.17 12.56 0.11 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.0 m -68.95 -1.15 6.68 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.357 0.663 . . . . 0.0 111.127 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.236 -1.364 . . . . 0.0 111.147 178.419 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 p30 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -136.25 7.19 3.11 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 107.53 -8.55 37.56 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -62.6 143.73 56.96 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.508 0.67 . . . . 0.0 110.934 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.4 p -152.2 173.79 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 49.1 ttt180 -136.69 152.97 50.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -135.06 150.81 50.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 122.279 0.232 . . . . 0.0 110.566 -172.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.42 ' HE ' ' HB3' ' A' ' 154' ' ' GLU . 20.0 tpp85 -153.63 147.71 25.65 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.895 0.478 . . . . 0.0 109.908 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.74 -0.97 59.59 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.657 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -64.38 156.95 74.47 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-N 117.255 0.528 . . . . 0.0 111.508 -176.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 27.9 Cg_exo -56.06 147.48 64.05 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.678 2.919 . . . . 0.0 111.762 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -70.41 17.54 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 119' ' ' PRO . . . -137.72 5.42 3.42 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 36.5 t -66.78 152.52 45.37 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.599 1.159 . . . . 0.0 110.552 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 125' ' ' GLU . 5.4 t -155.09 -168.39 2.86 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.592 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -51.87 -32.6 32.89 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.544 ' H ' HG23 ' A' ' 123' ' ' THR . 42.6 tt0 -73.13 -25.23 60.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.517 0.727 . . . . 0.0 112.049 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.402 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 67.3 mm-40 -92.51 -33.23 14.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.718 -0.614 . . . . 0.0 109.516 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.15 -34.26 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.02 -38.34 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.877 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -77.06 -21.39 54.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.073 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -71.0 -26.07 62.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 170.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -108.15 39.4 1.97 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.6 t -68.65 157.21 36.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.4 5.87 78.78 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -173.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.513 ' HB3' HD11 ' A' ' 164' ' ' LEU . 30.0 mt -142.52 -172.42 3.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.291 1.837 . . . . 0.0 106.583 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -147.24 164.15 34.11 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.847 -0.533 . . . . 0.0 110.392 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 mt -142.08 148.23 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 158' ' ' GLN . 21.4 m -73.6 154.45 89.58 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 118.598 0.635 . . . . 0.0 110.134 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.62 138.5 25.03 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.016 3.144 . . . . 0.0 112.213 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.9 t30 40.71 37.93 0.56 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.304 1.041 . . . . 0.0 111.917 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.31 29.36 9.64 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.978 -0.901 . . . . 0.0 111.83 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.7 mt -135.36 147.09 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 119.056 1.428 . . . . 0.0 109.368 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.1 m -138.53 151.14 47.08 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.35 0.66 . . . . 0.0 109.712 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.1 mt -144.55 100.7 4.73 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -55.58 155.22 22.11 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.121 2.547 . . . . 0.0 110.13 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 150' ' ' LYS . 27.2 m -140.78 159.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 121.752 0.787 . . . . 0.0 112.429 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.455 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 17.0 m-20 -86.57 175.04 4.76 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.623 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 35.5 Cg_exo -59.74 1.79 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.509 3.473 . . . . 0.0 113.402 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 146' ' ' ASP . 30.0 tt0 -123.36 3.37 9.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.947 0.899 . . . . 0.0 110.832 -175.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.28 5.96 89.65 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 39.5 mtpt -66.99 167.2 12.19 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.85 10.76 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -167.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 p 63.14 -7.14 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.94 12.2 84.65 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.914 0.768 . . . . 0.0 113.354 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.42 ' HB3' ' HE ' ' A' ' 116' ' ' ARG . 20.3 pt-20 -143.06 164.33 30.4 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.229 1.014 . . . . 0.0 110.923 177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -153.93 -178.47 7.09 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.038 0.535 . . . . 0.0 111.33 -172.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -145.43 150.32 36.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 158' ' ' GLN . 64.4 t -148.12 165.65 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.246 0.546 . . . . 0.0 110.003 -174.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.498 ' N ' HG12 ' A' ' 157' ' ' VAL . 47.6 tt0 -130.13 105.97 8.3 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 168.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 113' ' ' VAL . 35.7 m-85 -76.23 173.15 11.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.644 171.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.83 91.84 1.19 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t 62.82 166.99 0.12 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.727 1.211 . . . . 0.0 111.819 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -15.66 62.38 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.995 -0.441 . . . . 0.0 111.247 -175.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.94 -41.91 73.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.925 -0.484 . . . . 0.0 110.676 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.542 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -68.86 -39.28 79.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.21 -36.29 70.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.102 -0.374 . . . . 0.0 111.107 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -73.22 -29.07 62.54 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -73.5 -38.34 65.39 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.76 -16.3 62.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.153 0.581 . . . . 0.0 112.16 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.412 ' HA ' HG21 ' A' ' 183' ' ' VAL . 95.4 mt -68.35 -12.35 60.96 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.626 0.648 . . . . 0.0 111.333 175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.56 -12.3 80.36 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.517 ' HB2' HG11 ' A' ' 183' ' ' VAL . 66.9 mmtt -84.15 -2.98 57.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.252 1.421 . . . . 0.0 111.978 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -52.11 128.96 26.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.945 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.9 mttt 61.61 9.24 2.67 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.632 1.573 . . . . 0.0 114.138 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -74.43 173.66 9.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.433 1.093 . . . . 0.0 109.053 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -125.95 154.47 42.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -170.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.2 mt -86.47 -18.43 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.164 0.986 . . . . 0.0 110.809 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 143.21 -18.23 2.31 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.837 -0.424 . . . . 0.0 113.056 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -151.34 -3.66 0.3 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.59 0.695 . . . . 0.0 111.231 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -148.06 154.85 40.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -105.51 156.91 17.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.342 0.591 . . . . 0.0 110.04 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 33.0 mm -127.11 163.74 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -170.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -128.55 156.34 43.47 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 171' ' ' LYS . 33.5 m -129.93 129.56 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 6.6 m-30 -135.72 146.11 47.37 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -175.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -73.04 160.63 31.76 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.763 0.71 . . . . 0.0 110.333 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -159.28 -177.26 6.32 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.1 m -146.11 169.73 18.12 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.787 1.235 . . . . 0.0 109.332 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -56.64 -31.49 64.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.741 0.416 . . . . 0.0 111.136 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.76 2.95 1.63 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -124.26 1.38 8.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.521 0.729 . . . . 0.0 110.838 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.68 10.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.728 0.299 . . . . 0.0 111.486 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -69.83 15.42 0.08 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 20.6 t -69.54 -1.44 8.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.122 0.569 . . . . 0.0 110.846 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 117.83 -1.081 . . . . 0.0 111.061 177.991 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.219 0.533 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -129.9 167.08 18.73 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.701 1.2 . . . . 0.0 108.394 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.54 -5.44 29.89 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 120.045 -0.308 . . . . 0.0 112.352 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -61.56 140.39 58.12 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.745 0.783 . . . . 0.0 111.196 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.523 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.5 p -149.98 175.97 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.504 1.122 . . . . 0.0 108.157 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 79.3 ttt180 -135.92 146.36 47.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.74 0.416 . . . . 0.0 110.266 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.415 HD11 ' CZ ' ' A' ' 131' ' ' PHE . 4.0 mm? -122.91 150.74 42.52 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 125.06 1.344 . . . . 0.0 108.372 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -158.96 147.57 18.32 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 110.313 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.85 -3.65 57.39 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.645 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -65.07 155.76 82.97 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 117.257 0.529 . . . . 0.0 110.756 -178.227 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 32.4 Cg_exo -53.37 147.65 36.21 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.612 2.875 . . . . 0.0 112.147 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.405 ' CE1' ' HE2' ' A' ' 150' ' ' LYS . 26.4 m-85 -66.32 2.27 1.29 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -125.39 6.9 8.04 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 40.7 t -67.85 155.1 40.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.839 0.855 . . . . 0.0 110.68 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.7 t -154.57 -172.38 4.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.265 0.626 . . . . 0.0 109.523 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.596 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.3 OUTLIER -50.72 -30.98 15.25 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 123.21 0.604 . . . . 0.0 112.626 -176.444 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.483 ' H ' HG23 ' A' ' 123' ' ' THR . 40.9 mt-10 -77.31 -23.46 51.02 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -92.59 -30.37 15.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.4 mt -66.99 -41.02 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.8 p -73.51 -33.88 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.488 -176.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -73.04 -28.38 62.3 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.212 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 12.1 t80 -69.82 -19.56 63.47 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 115' ' ' LEU . 20.7 m-85 -118.95 33.39 5.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.374 1.47 . . . . 0.0 109.438 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.2 t -69.22 -4.07 16.23 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.807 -0.558 . . . . 0.0 112.289 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -106.25 20.08 36.01 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.499 ' HB3' HD11 ' A' ' 164' ' ' LEU . 55.2 mt -141.23 -167.02 2.3 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.842 2.457 . . . . 0.0 104.83 -173.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.28 -21.35 0.69 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 1.5 mt 52.06 178.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.204 1.002 . . . . 0.0 112.681 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.532 ' H ' HG22 ' A' ' 136' ' ' ILE . 25.1 m -116.44 155.63 48.33 Favored Pre-proline 0 CA--C 1.529 0.138 0 O-C-N 121.338 -0.851 . . . . 0.0 109.69 169.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.0 137.77 22.3 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.197 3.265 . . . . 0.0 112.569 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.1 t30 41.45 36.14 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.273 1.029 . . . . 0.0 111.766 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.64 27.75 13.2 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-O 118.792 -1.005 . . . . 0.0 112.021 -172.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.2 mt -135.23 145.58 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.088 1.444 . . . . 0.0 109.502 -177.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.8 m -138.12 149.75 46.21 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.755 0.822 . . . . 0.0 109.79 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.5 mt -145.11 94.19 5.35 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 124.023 0.929 . . . . 0.0 109.404 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -55.88 159.18 12.32 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.76 2.973 . . . . 0.0 111.638 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.5 167.45 16.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 121.409 0.624 . . . . 0.0 111.285 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 63.9 m-20 -91.89 176.53 2.67 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.2 Cg_exo -58.35 -19.79 44.88 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.822 2.348 . . . . 0.0 111.67 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -81.37 -9.03 59.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.129 0.972 . . . . 0.0 111.213 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.54 2.45 90.62 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.405 ' HE2' ' CE1' ' A' ' 120' ' ' PHE . 76.2 tttt -81.57 133.14 35.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.865 1.266 . . . . 0.0 108.416 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.9 pt -66.33 148.29 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 110.122 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.8 p -75.54 2.82 10.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.198 -174.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.39 6.3 89.35 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -139.25 164.06 30.81 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.087 0.555 . . . . 0.0 109.697 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.81 -178.65 7.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.339 0.59 . . . . 0.0 110.925 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -144.92 147.72 33.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.514 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.5 t -144.88 166.6 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.494 ' N ' HG12 ' A' ' 157' ' ' VAL . 41.2 tt0 -129.26 106.42 8.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 167.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 59.6 m-85 -74.87 171.05 14.72 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.465 170.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.34 88.65 0.46 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.1 0.476 . . . . 0.0 110.055 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.7 t 64.35 170.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.651 1.18 . . . . 0.0 111.583 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -17.53 63.47 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.769 0.428 . . . . 0.0 111.59 -174.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.24 -45.41 66.56 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.914 -0.492 . . . . 0.0 110.531 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -70.83 -31.68 68.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.97 92.78 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.674 -0.641 . . . . 0.0 111.069 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -68.78 -29.06 67.36 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.884 -0.143 . . . . 0.0 110.784 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -70.95 -37.63 72.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.417 -0.177 . . . . 0.0 110.578 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.511 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.16 -20.5 65.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.405 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.0 mt -68.38 -12.23 60.8 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.087 -0.383 . . . . 0.0 111.421 177.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.81 -12.56 80.89 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.555 ' HB2' HG11 ' A' ' 183' ' ' VAL . 71.7 mmtt -83.96 -0.08 50.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.102 1.361 . . . . 0.0 111.638 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.41 ' HA ' HG22 ' A' ' 183' ' ' VAL . 12.5 t60 -53.64 127.18 24.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.83 0.348 . . . . 0.0 110.228 176.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.8 mttp 54.2 20.29 2.53 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.785 1.634 . . . . 0.0 114.034 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -82.78 -13.71 55.78 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 73.49 171.32 0.3 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.011 1.324 . . . . 0.0 114.509 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.98 -12.45 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 154.09 -29.96 0.72 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-N 118.476 0.58 . . . . 0.0 113.993 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -151.79 -0.36 0.33 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.956 0.878 . . . . 0.0 111.162 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -147.8 150.37 34.09 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -174.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -93.49 152.32 19.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.165 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 30.1 mm -122.54 159.24 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.46 ' HB3' ' CE1' ' A' ' 184' ' ' PHE . 5.4 mm-40 -125.17 155.28 40.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.497 -175.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 171' ' ' LYS . 34.4 m -138.09 131.58 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.46 ' CE1' ' HB3' ' A' ' 182' ' ' GLU . 7.3 m-85 -142.18 156.06 45.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -75.91 160.78 29.56 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.679 0.672 . . . . 0.0 110.25 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.0 t -155.54 -174.62 5.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.8 t -147.98 173.19 13.14 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.5 1.12 . . . . 0.0 109.88 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -60.36 -31.71 70.58 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.75 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.14 -0.72 2.63 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -121.55 1.95 10.11 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.548 0.739 . . . . 0.0 111.339 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.16 11.13 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 120.899 0.38 . . . . 0.0 111.287 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -69.09 14.89 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.6 m -67.49 -3.17 7.82 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.292 0.637 . . . . 0.0 111.307 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.184 178.244 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 52.3 p30 . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.79 9.42 1.33 Allowed 'General case' 0 C--N 1.34 0.153 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.21 -5.99 50.02 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 112.172 -0.371 . . . . 0.0 112.172 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -63.49 144.47 56.96 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.645 0.736 . . . . 0.0 110.681 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.58 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.5 p -154.0 174.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.642 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.4 ' H ' HG22 ' A' ' 113' ' ' VAL . 70.9 ttt180 -135.62 154.79 51.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.97 0.908 . . . . 0.0 108.66 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -138.65 148.85 44.54 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -156.38 174.6 15.17 Favored 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.05 5.15 83.65 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.438 HD22 ' SG ' ' A' ' 122' ' ' CYS . 95.0 mt -59.92 150.47 68.99 Favored Pre-proline 0 N--CA 1.452 -0.339 0 C-N-CA 123.594 0.757 . . . . 0.0 112.101 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.3 23.99 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 125.142 3.894 . . . . 0.0 113.965 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 54.77 5.68 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.23 1.412 . . . . 0.0 114.43 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.69 -6.28 3.35 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.956 0.798 . . . . 0.0 111.802 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 10.0 t -61.77 150.53 36.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.038 0.935 . . . . 0.0 110.938 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.8 t -143.37 -166.66 2.37 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 171.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 mptt -51.35 -28.69 13.07 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.344 0.52 . . . . 0.0 111.995 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.495 ' H ' HG23 ' A' ' 123' ' ' THR . 37.1 tt0 -78.52 -23.91 46.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.527 0.731 . . . . 0.0 112.331 -177.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.501 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 7.0 mp0 -92.88 -33.7 14.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.426 HG13 ' SG ' ' A' ' 122' ' ' CYS . 42.5 mt -61.88 -33.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.0 p -83.32 -30.61 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.003 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -73.32 -29.87 62.98 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.907 171.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -68.65 -25.84 65.03 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.205 -0.309 . . . . 0.0 110.671 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -115.8 33.31 5.56 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.666 1.186 . . . . 0.0 109.214 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.1 t -64.35 -13.93 53.35 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.963 0.505 . . . . 0.0 112.252 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.01 13.15 67.68 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.821 ' HB3' HD11 ' A' ' 164' ' ' LEU . 69.4 mt -137.5 -162.22 1.27 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.011 1.724 . . . . 0.0 107.482 -173.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.57 -18.04 0.7 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER 46.33 -166.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.847 0.859 . . . . 0.0 112.971 -176.531 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.0 m -129.21 156.02 78.99 Favored Pre-proline 0 C--N 1.338 0.108 0 C-N-CA 123.852 0.861 . . . . 0.0 109.786 173.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.78 135.59 28.21 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.173 3.249 . . . . 0.0 112.301 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 55.1 t30 40.31 37.36 0.42 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.624 1.17 . . . . 0.0 112.33 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -96.52 28.08 14.81 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 118.934 -0.926 . . . . 0.0 111.75 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.1 mt -132.96 147.01 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 118.968 1.384 . . . . 0.0 109.314 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.8 m -138.11 147.41 43.94 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 123.807 0.843 . . . . 0.0 109.542 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 123' ' ' THR . 91.9 mt -139.5 94.38 9.46 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.527 0.731 . . . . 0.0 110.336 -173.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.82 151.62 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.022 2.481 . . . . 0.0 110.695 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.94 166.32 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.331 0.586 . . . . 0.0 111.266 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 64.4 m-20 -90.82 176.96 2.53 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.684 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 36.9 Cg_exo -58.76 -18.72 42.68 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.981 2.454 . . . . 0.0 111.755 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -81.32 -10.86 59.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.865 0.866 . . . . 0.0 110.683 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.7 14.43 75.72 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -106.54 148.42 28.25 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.5 pt -67.64 149.5 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.421 0.629 . . . . 0.0 111.671 -170.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.5 p -76.42 -7.8 55.82 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.007 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.61 -3.5 32.46 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -139.26 169.89 16.95 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.34 0.57 . . . . 0.0 111.265 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.41 -178.92 7.48 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 111.335 -173.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -144.14 148.11 34.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.488 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 59.9 t -145.76 164.83 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.669 ' O ' HG22 ' A' ' 137' ' ' VAL . 51.9 tt0 -127.75 99.21 5.46 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 169.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.651 ' CD1' HD12 ' A' ' 164' ' ' LEU . 48.5 m-85 -70.15 172.45 8.02 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.121 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.1 87.56 0.4 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.871 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.5 t 62.6 172.62 0.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.546 1.138 . . . . 0.0 111.383 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -31.11 70.71 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.906 -0.496 . . . . 0.0 111.007 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -59.4 -41.64 89.9 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.331 -0.231 . . . . 0.0 111.06 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -72.78 -38.93 67.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -62.8 -34.94 78.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.984 -0.448 . . . . 0.0 110.408 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.31 -27.26 66.14 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.53 0.332 . . . . 0.0 110.299 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -77.27 -38.07 51.65 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.339 0.114 . . . . 0.0 111.181 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.409 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -59.53 -24.41 63.65 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.595 ' HA ' HG21 ' A' ' 183' ' ' VAL . 94.3 mt -68.55 -9.14 47.44 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 122.95 0.5 . . . . 0.0 111.493 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.58 -16.84 78.68 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -76.14 -55.52 5.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.116 0.966 . . . . 0.0 110.678 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.708 ' HA ' HG22 ' A' ' 183' ' ' VAL . 0.6 OUTLIER 23.77 -98.65 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.861 1.264 . . . . 0.0 112.941 -165.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -72.8 20.17 0.08 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -174.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -62.77 -178.22 0.19 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.108 0.963 . . . . 0.0 111.269 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -133.74 168.49 18.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.194 0.598 . . . . 0.0 112.37 -173.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mt -116.47 -13.55 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.521 0.729 . . . . 0.0 112.009 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.44 -31.34 0.53 Allowed Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.52 0.6 . . . . 0.0 114.024 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -152.25 3.06 0.36 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.791 0.796 . . . . 0.0 110.995 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -144.03 156.89 44.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -105.83 148.37 27.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.474 0.654 . . . . 0.0 109.499 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 182' ' ' GLU . 24.3 mm -111.94 174.92 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -172.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.491 ' H ' HG22 ' A' ' 181' ' ' ILE . 12.8 mm-40 -138.63 154.66 48.67 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.708 HG22 ' HA ' ' A' ' 172' ' ' HIS . 17.0 m -129.92 134.94 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -142.44 151.72 42.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -74.09 154.13 39.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.877 0.37 . . . . 0.0 110.553 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.6 t -157.37 179.41 9.28 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.849 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.9 m -150.76 170.74 18.51 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.137 0.975 . . . . 0.0 108.69 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -54.34 -30.84 52.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.682 0.393 . . . . 0.0 111.328 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.54 0.54 2.18 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.308 0.643 . . . . 0.0 112.701 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -121.25 0.06 10.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.138 0.975 . . . . 0.0 110.932 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.11 14.44 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 121.035 0.445 . . . . 0.0 111.11 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -69.33 10.58 0.31 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 59.1 p -69.23 -0.9 6.73 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.352 0.661 . . . . 0.0 111.201 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 117.185 -1.388 . . . . 0.0 110.896 177.59 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.488 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 5.4 t-20 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -132.88 0.69 3.53 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.03 -9.61 25.08 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.477 -0.392 . . . . 0.0 112.523 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -65.48 147.91 52.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.519 0.676 . . . . 0.0 111.094 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.561 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.6 p -155.49 178.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.207 1.003 . . . . 0.0 108.737 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.472 ' H ' HG22 ' A' ' 113' ' ' VAL . 7.4 mtm180 -134.43 162.81 31.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.938 0.495 . . . . 0.0 111.495 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.466 HD23 HD21 ' A' ' 118' ' ' LEU . 6.5 tp -145.97 142.79 29.01 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 154' ' ' GLU . 40.7 ttm180 -151.49 -18.54 0.2 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 181' ' ' ILE . . . -78.94 12.9 21.63 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.264 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 115' ' ' LEU . 97.6 mt -59.6 153.7 49.66 Favored Pre-proline 0 N--CA 1.449 -0.516 0 C-N-CA 124.494 1.118 . . . . 0.0 113.267 -172.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.56 147.64 15.77 Favored 'Trans proline' 0 N--CA 1.442 -1.51 0 C-N-CA 123.793 2.995 . . . . 0.0 106.169 162.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.604 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 23.7 m-85 -70.69 10.57 0.48 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -172.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.38 1.18 12.74 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 118.446 0.567 . . . . 0.0 111.88 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.423 ' SG ' HD22 ' A' ' 118' ' ' LEU . 48.6 t -65.89 156.44 33.39 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.261 0.625 . . . . 0.0 111.591 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 125' ' ' GLU . 2.6 t -152.93 -173.54 4.61 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.577 0.751 . . . . 0.0 109.506 173.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.594 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.2 mptt -50.16 -36.19 29.22 Favored 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.477 ' H ' HG23 ' A' ' 123' ' ' THR . 40.6 mt-10 -75.58 -17.66 59.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -101.74 -26.68 13.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.9 mt -66.85 -39.91 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.45 -34.77 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.368 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -71.08 -28.75 64.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.498 173.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 21.6 t80 -69.48 -23.16 63.6 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.025 0.375 . . . . 0.0 110.275 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -115.2 32.73 5.86 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.743 1.217 . . . . 0.0 109.244 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 t -68.8 -8.04 39.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.07 0.548 . . . . 0.0 111.994 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.92 15.72 60.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.725 ' HB3' HD11 ' A' ' 164' ' ' LEU . 52.5 mt -138.89 -159.75 0.99 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.002 2.121 . . . . 0.0 105.816 -174.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.52 -28.14 0.54 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 2.5 mt 57.38 162.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.968 0.907 . . . . 0.0 112.352 -175.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 158' ' ' GLN . 2.4 m -74.4 161.34 78.54 Favored Pre-proline 0 C--O 1.231 0.09 0 O-C-N 121.0 -1.063 . . . . 0.0 108.643 169.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -46.07 -30.12 7.06 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.024 3.15 . . . . 0.0 112.738 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -162.33 134.26 5.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 171.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -173.92 17.87 0.05 OUTLIER Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.774 -1.014 . . . . 0.0 113.578 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.1 mt -108.4 147.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 119.517 1.659 . . . . 0.0 109.982 -173.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.5 m -140.66 150.78 43.96 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 123.68 0.792 . . . . 0.0 108.918 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.0 mt -146.76 97.43 4.25 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.062 0.545 . . . . 0.0 110.141 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.34 160.76 10.41 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.611 2.874 . . . . 0.0 111.047 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 151' ' ' ILE . 31.4 m -146.08 165.04 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 CA-C-O 121.295 0.569 . . . . 0.0 111.282 173.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.444 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 57.1 m-20 -90.85 175.6 3.52 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 124.167 0.987 . . . . 0.0 108.524 175.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.2 Cg_exo -58.07 -20.21 44.62 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.831 2.354 . . . . 0.0 111.352 174.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -79.39 -10.09 59.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.086 0.955 . . . . 0.0 111.253 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.01 0.54 90.37 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -173.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.604 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 87.1 tttt -73.85 134.73 43.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.831 1.253 . . . . 0.0 108.575 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' A' ' 153' ' ' GLY . 9.3 pt -71.6 10.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -169.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 65.12 -17.2 0.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.859 1.264 . . . . 0.0 112.175 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 105.4 -3.49 40.11 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.04 1.305 . . . . 0.0 112.506 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 116' ' ' ARG . 16.6 pt-20 -132.6 169.59 16.41 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 118.772 1.286 . . . . 0.0 111.505 -177.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.41 -178.37 7.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.12 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -143.39 145.41 32.63 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -175.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.506 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 41.5 t -145.35 160.91 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.565 ' O ' HG22 ' A' ' 137' ' ' VAL . 49.6 tt0 -126.51 119.45 27.19 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 166.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.638 ' CD1' HD12 ' A' ' 164' ' ' LEU . 48.5 m-85 -88.71 174.73 7.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.462 170.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.12 88.42 0.42 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.581 0.753 . . . . 0.0 109.876 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.69 168.06 0.13 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.514 1.126 . . . . 0.0 111.184 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.488 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 1.5 tm0? -64.5 -23.91 67.43 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.846 -0.533 . . . . 0.0 111.214 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.83 -41.13 99.21 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.116 -0.365 . . . . 0.0 110.725 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.725 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -70.87 -37.75 73.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.45 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -61.85 -33.86 74.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.066 -0.396 . . . . 0.0 110.803 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -72.43 -27.16 62.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -74.09 -38.12 63.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.544 0.212 . . . . 0.0 110.512 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -61.48 -21.52 64.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.753 0.421 . . . . 0.0 112.086 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.421 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.2 mt -68.27 -13.45 62.26 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.965 -0.459 . . . . 0.0 111.161 176.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.5 -11.99 82.47 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.546 ' HB2' HG11 ' A' ' 183' ' ' VAL . 68.3 mmtt -85.37 -1.67 57.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.478 1.111 . . . . 0.0 112.179 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -51.93 129.08 26.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.748 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 62.72 11.09 4.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.404 1.482 . . . . 0.0 114.335 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -71.39 -171.44 0.62 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.035 0.834 . . . . 0.0 109.361 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -134.36 164.49 27.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -171.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.8 mt -115.53 -11.48 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.764 0.826 . . . . 0.0 111.932 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 151.35 -25.96 0.98 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 121.891 -0.506 . . . . 0.0 113.938 175.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -153.59 2.14 0.26 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 117.736 0.768 . . . . 0.0 111.083 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -147.0 160.15 42.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.91 0.884 . . . . 0.0 108.672 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -107.13 145.22 32.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.483 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 21.9 mm -113.17 162.41 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -171.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -130.34 150.91 51.36 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.546 HG11 ' HB2' ' A' ' 171' ' ' LYS . 32.6 m -128.11 134.3 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -175.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -136.61 163.56 30.27 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -82.59 158.59 23.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.879 -0.513 . . . . 0.0 109.959 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.6 t -158.99 -177.33 6.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.469 -0.145 . . . . 0.0 111.325 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.2 t -148.31 178.18 8.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.651 0.78 . . . . 0.0 110.301 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -60.48 -31.95 70.96 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.188 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -65.76 -7.16 14.29 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -112.02 1.38 16.35 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.506 0.723 . . . . 0.0 111.055 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.2 11.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 120.911 0.386 . . . . 0.0 111.555 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -69.18 14.16 0.09 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.1 m -69.19 -0.4 5.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.574 0.75 . . . . 0.0 111.184 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.859 -1.067 . . . . 0.0 111.155 178.254 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 p30 . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 120.835 0.35 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -127.81 3.9 6.03 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 162' ' ' GLN . . . 111.12 -8.83 29.16 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -64.08 142.77 58.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.643 0.735 . . . . 0.0 111.154 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.546 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.2 p -153.13 175.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.997 1.319 . . . . 0.0 108.037 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.403 ' H ' HG22 ' A' ' 113' ' ' VAL . 75.1 ttt180 -138.97 145.95 40.35 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.09 152.82 35.81 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 123.867 0.867 . . . . 0.0 109.098 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.447 ' HD2' ' CE2' ' A' ' 184' ' ' PHE . 5.8 mtt180 -153.3 166.49 32.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.47 1.56 88.79 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.6 146.95 42.52 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 117.294 0.547 . . . . 0.0 110.78 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 9.7 Cg_exo -63.63 150.17 89.14 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.026 1.818 . . . . 0.0 108.577 167.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -70.32 5.3 1.79 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -125.94 5.51 7.87 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 46.2 t -70.33 157.51 37.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.896 0.479 . . . . 0.0 110.858 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.6 t -154.93 -171.63 3.9 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.262 0.625 . . . . 0.0 109.527 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.604 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.4 OUTLIER -51.22 -30.88 18.75 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.476 ' H ' HG23 ' A' ' 123' ' ' THR . 39.2 mt-10 -80.04 -17.84 51.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -107.0 -20.24 13.38 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.8 mt -71.27 -39.92 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 167.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 125' ' ' GLU . 12.2 p -71.17 -38.73 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.217 -177.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -74.66 -22.77 58.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.519 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -69.35 -26.6 64.77 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 170.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.48 ' HA ' ' HE3' ' A' ' 171' ' ' LYS . 36.4 m-85 -106.82 32.32 4.65 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.677 0.791 . . . . 0.0 109.629 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.4 t -61.11 146.15 48.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 169.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.58 2.49 76.05 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' A' ' 164' ' ' LEU . 23.2 mt -134.58 -172.16 2.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -141.59 -17.73 0.78 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -171.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER 45.84 -165.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.88 0.872 . . . . 0.0 113.272 -176.558 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.4 m -129.9 156.08 79.56 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 124.068 0.947 . . . . 0.0 109.769 173.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.14 136.54 30.23 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.045 3.163 . . . . 0.0 112.252 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.5 t30 40.1 38.33 0.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.556 1.142 . . . . 0.0 112.206 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.04 28.66 13.56 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 118.877 -0.957 . . . . 0.0 111.86 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.8 mt -134.31 147.67 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 119.048 1.424 . . . . 0.0 109.538 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.5 m -139.6 149.93 44.4 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.586 0.754 . . . . 0.0 109.788 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 mt -145.52 95.42 4.98 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 123.896 0.878 . . . . 0.0 109.309 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.11 160.96 7.33 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.799 2.999 . . . . 0.0 111.635 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.4 m -141.71 164.71 18.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 121.283 0.564 . . . . 0.0 111.249 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 67.2 m-20 -86.93 176.12 3.79 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.975 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.2 Cg_exo -59.08 -20.23 52.88 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.038 2.492 . . . . 0.0 111.61 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -82.43 -9.85 59.28 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.561 0.744 . . . . 0.0 110.575 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.84 8.48 79.48 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.312 0.482 . . . . 0.0 112.246 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -97.11 147.62 23.86 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 117.616 0.708 . . . . 0.0 109.147 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.0 pt -69.53 152.9 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.719 0.771 . . . . 0.0 112.022 -172.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.7 p -82.74 0.61 42.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.037 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.9 8.3 86.86 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.026 -0.429 . . . . 0.0 112.026 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -138.62 160.38 39.76 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.31 -179.5 7.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.149 0.499 . . . . 0.0 110.909 -172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -145.46 148.58 33.42 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -174.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 60.0 t -145.12 163.9 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.661 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.9 tt0 -128.28 95.61 4.21 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.615 ' CD1' HD12 ' A' ' 164' ' ' LEU . 52.8 m-85 -67.99 171.71 6.45 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.139 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.56 89.71 0.37 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.644 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.7 167.75 0.13 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.481 1.113 . . . . 0.0 111.007 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.424 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 36.8 tp60 -65.96 -20.07 66.08 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.707 -0.62 . . . . 0.0 111.211 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.07 -41.78 94.78 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.998 -0.438 . . . . 0.0 110.593 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -69.72 -36.3 75.76 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.648 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.494 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -61.75 -36.23 80.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.036 -0.415 . . . . 0.0 110.845 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.78 -27.26 63.78 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -74.11 -38.0 63.96 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.608 0.242 . . . . 0.0 110.685 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.95 -19.94 64.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.164 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.586 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.1 mt -69.9 -8.85 52.1 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.041 -0.412 . . . . 0.0 111.419 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.25 -18.21 80.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 131' ' ' PHE . 70.1 mmtt -70.19 -61.21 1.86 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.567 1.147 . . . . 0.0 109.582 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.633 ' HA ' HG22 ' A' ' 183' ' ' VAL . 0.9 OUTLIER 25.34 -108.59 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.418 1.087 . . . . 0.0 112.715 -165.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -66.61 10.74 0.11 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -65.57 171.64 3.96 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.554 1.542 . . . . 0.0 109.925 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -123.86 165.25 17.69 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -168.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mt -105.64 -13.28 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.637 0.775 . . . . 0.0 111.963 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.1 -24.28 1.42 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.794 -0.448 . . . . 0.0 113.53 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -152.63 0.98 0.3 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.683 0.741 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -148.27 153.95 39.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.966 0.906 . . . . 0.0 108.73 -172.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -101.02 150.6 22.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.7 mm -117.92 171.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -139.45 160.13 40.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 172' ' ' HIS . 24.7 m -132.95 127.3 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.447 ' CE2' ' HD2' ' A' ' 116' ' ' ARG . 3.1 m-30 -128.07 154.55 45.57 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -75.48 163.25 27.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.796 -0.565 . . . . 0.0 110.592 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.7 t -159.06 -175.61 5.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.6 m -149.57 169.02 21.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.292 1.437 . . . . 0.0 109.138 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -57.7 -32.33 67.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.675 0.39 . . . . 0.0 111.38 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -66.94 -1.34 3.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -117.92 1.64 12.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.858 0.863 . . . . 0.0 110.911 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.56 12.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-O 121.036 0.446 . . . . 0.0 110.956 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -68.71 13.45 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.7 m -67.28 -2.31 5.8 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.346 0.658 . . . . 0.0 111.364 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.198 -1.382 . . . . 0.0 111.056 178.479 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 4.8 t-20 . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -131.78 6.51 4.34 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.33 -9.68 42.33 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -65.1 144.91 56.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.641 0.734 . . . . 0.0 111.048 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.547 HG11 ' CE2' ' A' ' 159' ' ' PHE . 11.1 p -152.9 174.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.137 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 59.1 ttt180 -136.35 145.33 45.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.043 0.537 . . . . 0.0 109.61 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.3 143.15 48.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -154.35 143.42 21.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.45 -1.11 46.29 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.95 157.45 86.78 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 117.468 0.634 . . . . 0.0 111.055 -176.228 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -54.58 144.85 61.76 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.176 2.584 . . . . 0.0 111.36 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -71.0 12.27 0.31 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.67 5.82 5.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 51.2 t -69.16 158.44 34.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.387 1.075 . . . . 0.0 110.644 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.583 HG23 ' H ' ' A' ' 125' ' ' GLU . 6.5 t -153.73 -178.98 7.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.492 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 4.0 ptpp? -53.34 -25.36 14.81 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.583 ' H ' HG23 ' A' ' 123' ' ' THR . 41.5 mt-10 -78.34 -22.94 47.27 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.939 0.336 . . . . 0.0 111.611 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -92.69 -30.34 15.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.81 -45.6 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.69 -33.77 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.59 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -72.86 -31.36 64.68 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.494 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -67.34 -16.65 64.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.293 0.497 . . . . 0.0 110.203 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -120.08 30.46 6.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.499 1.119 . . . . 0.0 109.515 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.6 t -63.44 138.15 58.41 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.35 2.43 90.27 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.2 mt -138.07 76.22 1.56 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.198 1.399 . . . . 0.0 107.784 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -49.85 158.11 0.53 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.19 0.996 . . . . 0.0 113.472 -174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.68 147.59 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.1 m -70.66 155.25 93.67 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 118.521 0.601 . . . . 0.0 110.354 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -48.8 138.0 26.69 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.92 3.08 . . . . 0.0 111.739 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.8 t30 41.79 37.22 0.73 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.043 0.937 . . . . 0.0 111.802 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.61 31.85 6.8 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -173.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -139.51 145.97 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.238 1.019 . . . . 0.0 109.077 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.6 m -140.35 151.28 44.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.53 100.0 4.1 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.72 149.55 18.98 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.082 2.521 . . . . 0.0 110.934 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 24.5 m -145.25 160.84 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.434 0.635 . . . . 0.0 110.719 172.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.444 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 60.9 m-20 -87.38 176.42 3.47 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 42.1 Cg_exo -57.67 -18.25 32.38 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.825 2.35 . . . . 0.0 111.944 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.01 -8.54 58.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.425 1.09 . . . . 0.0 111.431 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.04 2.07 88.43 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -68.81 123.91 22.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.715 1.606 . . . . 0.0 109.824 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.0 pt -78.28 3.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -165.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p 66.27 -16.76 0.12 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.68 9.64 58.54 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.947 0.784 . . . . 0.0 113.794 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -143.09 163.51 32.64 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.31 1.055 . . . . 0.0 110.676 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.93 -177.06 6.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.278 0.631 . . . . 0.0 111.089 -173.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -147.17 150.47 34.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 87.6 t -147.14 165.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -175.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.477 ' N ' HG12 ' A' ' 157' ' ' VAL . 54.5 tt0 -133.44 98.54 4.25 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.004 0.921 . . . . 0.0 108.898 170.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.547 ' CE2' HG11 ' A' ' 113' ' ' VAL . 58.2 m-85 -69.82 170.54 10.86 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -67.82 92.52 0.36 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.15 0.5 . . . . 0.0 110.196 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.2 t 62.42 169.65 0.13 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.717 1.207 . . . . 0.0 111.095 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 0.0 OUTLIER -66.4 -12.31 56.3 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.033 -0.417 . . . . 0.0 111.489 -175.531 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -74.48 -44.23 52.45 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.492 0.317 . . . . 0.0 110.384 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.464 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -69.07 -36.72 77.93 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.32 -38.97 78.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.087 -0.383 . . . . 0.0 110.701 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.35 -31.64 71.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.449 0.3 . . . . 0.0 110.623 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -69.92 -39.06 76.37 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.434 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.73 -13.83 62.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.533 0.333 . . . . 0.0 111.727 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.675 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.9 mt -68.21 -12.26 60.68 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.737 -0.602 . . . . 0.0 111.042 175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.3 13.08 8.23 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.636 ' HB2' HG11 ' A' ' 183' ' ' VAL . 62.5 mmtt -118.87 -0.0 11.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.882 1.673 . . . . 0.0 112.353 -178.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.597 ' HA ' HG22 ' A' ' 183' ' ' VAL . 6.2 t60 -46.63 -20.95 0.15 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -142.83 15.65 1.94 Allowed 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.536 -0.728 . . . . 0.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -81.82 178.68 8.18 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.819 1.248 . . . . 0.0 109.616 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -129.85 154.26 47.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.02 -16.49 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.143 0.977 . . . . 0.0 111.198 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 153.66 -24.96 0.74 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.746 -0.474 . . . . 0.0 113.399 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -152.54 0.92 0.3 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.794 0.797 . . . . 0.0 111.257 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -148.39 152.78 37.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.938 0.895 . . . . 0.0 108.651 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -103.31 154.83 18.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.39 0.614 . . . . 0.0 110.529 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 26.0 mm -126.22 160.17 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.637 -171.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -129.86 151.97 49.85 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 169' ' ' LEU . 35.8 m -125.77 49.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.028 0.931 . . . . 0.0 113.372 -167.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 3.5 m-30 -52.1 151.73 3.6 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.789 -0.569 . . . . 0.0 110.226 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -76.28 163.77 26.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.958 -0.464 . . . . 0.0 110.149 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.2 t -159.64 -177.15 6.18 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.2 m -145.24 171.46 14.53 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.753 1.221 . . . . 0.0 109.37 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -57.79 -32.13 67.24 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.764 0.426 . . . . 0.0 111.527 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.33 -4.83 8.79 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -116.63 2.27 12.96 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.751 0.821 . . . . 0.0 110.926 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.83 10.7 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 120.992 0.425 . . . . 0.0 111.172 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -68.99 13.7 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 m -68.22 -1.9 7.06 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.253 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.807 -1.092 . . . . 0.0 111.147 178.153 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.5 p30 . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -134.78 5.81 3.4 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.67 -9.58 32.43 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -63.23 143.11 58.08 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.551 0.691 . . . . 0.0 111.078 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' A' ' 159' ' ' PHE . 10.5 p -152.34 174.55 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.372 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 51.3 ttt180 -138.94 147.2 41.95 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.021 0.528 . . . . 0.0 109.976 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -120.98 151.17 40.05 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.457 1.103 . . . . 0.0 109.205 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -157.65 164.83 36.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.14 1.8 88.33 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.3 mt -53.68 143.53 38.49 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.137 0.575 . . . . 0.0 110.32 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.415 ' CG ' ' SG ' ' A' ' 122' ' ' CYS . 72.8 Cg_endo -72.87 27.96 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 124.785 3.657 . . . . 0.0 113.933 -174.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 52.34 18.82 0.98 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.162 0.985 . . . . 0.0 113.275 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -148.09 -13.97 0.13 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.797 -0.565 . . . . 0.0 113.003 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 119' ' ' PRO . 6.8 m -62.95 158.89 18.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.585 0.692 . . . . 0.0 110.698 174.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.5 t -148.77 -165.03 2.17 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 2.5 mptt -49.91 -34.7 21.21 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.541 0.61 . . . . 0.0 112.049 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.471 ' H ' HG23 ' A' ' 123' ' ' THR . 40.0 mt-10 -77.36 -16.58 58.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -101.45 -29.38 12.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.3 mt -65.33 -34.01 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.2 -34.81 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.005 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -71.13 -27.09 63.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.174 -0.611 . . . . 0.0 111.043 172.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 8.8 t80 -70.19 -26.08 63.73 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 174.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -111.82 30.55 6.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.301 1.04 . . . . 0.0 109.545 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -67.57 -14.86 63.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.923 0.489 . . . . 0.0 111.83 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -94.42 16.62 60.69 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.581 ' HB3' HD11 ' A' ' 164' ' ' LEU . 36.6 mt -143.98 -162.05 1.39 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.349 1.859 . . . . 0.0 107.157 -173.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -146.79 165.29 30.13 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.1 mt -142.73 154.49 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 158' ' ' GLN . 27.4 m -60.13 156.45 38.55 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.95 -31.06 7.77 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 124.509 3.473 . . . . 0.0 113.813 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -161.41 110.42 1.56 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -149.04 6.51 0.83 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.63 -1.095 . . . . 0.0 113.24 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.441 HG12 HG13 ' A' ' 157' ' ' VAL . 78.5 mt -97.68 147.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 119.471 1.636 . . . . 0.0 109.507 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 92.0 m -139.82 147.21 40.41 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.7 mt -143.69 97.24 5.48 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 123.293 0.637 . . . . 0.0 109.408 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.72 159.35 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.404 2.736 . . . . 0.0 110.267 173.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.58 159.68 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-O 121.356 0.598 . . . . 0.0 110.963 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.478 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 54.7 m-20 -84.16 175.75 4.38 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.842 176.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 36.4 Cg_exo -58.5 -19.11 42.69 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.891 2.394 . . . . 0.0 111.522 175.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -82.64 -10.26 59.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.807 0.843 . . . . 0.0 110.872 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.17 10.81 73.96 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.341 0.496 . . . . 0.0 112.444 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -98.74 150.39 21.86 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 117.436 0.618 . . . . 0.0 109.908 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 153' ' ' GLY . 6.1 pt -73.77 8.1 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 -160.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 67.06 -21.59 0.11 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.133 0.973 . . . . 0.0 113.533 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 105.21 6.84 38.77 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.862 0.744 . . . . 0.0 113.479 175.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -142.72 168.1 20.52 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.249 1.024 . . . . 0.0 110.787 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -157.74 -179.46 8.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.241 0.543 . . . . 0.0 111.26 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.93 151.74 39.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 158' ' ' GLN . 40.5 t -147.37 166.06 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.737 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.1 tt0 -128.99 97.42 4.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 168.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' A' ' 113' ' ' VAL . 38.5 m-85 -67.86 172.82 4.98 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.197 0.522 . . . . 0.0 109.916 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.79 90.9 0.61 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t 62.3 167.18 0.11 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.933 1.293 . . . . 0.0 111.738 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -15.69 63.07 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.888 -0.508 . . . . 0.0 111.053 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.48 -41.92 83.79 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.876 -0.515 . . . . 0.0 110.443 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.613 ' O ' HD13 ' A' ' 164' ' ' LEU . 1.1 tm? -71.17 -39.26 71.97 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -56.66 -35.78 68.79 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.267 -0.271 . . . . 0.0 111.039 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -71.91 -30.29 65.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.565 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -72.34 -37.28 68.9 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.644 0.259 . . . . 0.0 110.487 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.428 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.93 -18.76 64.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.937 0.495 . . . . 0.0 112.09 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.417 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.5 mt -67.98 -14.64 63.12 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.698 -0.626 . . . . 0.0 111.036 176.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.58 -12.78 80.44 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.534 ' HB2' HG11 ' A' ' 183' ' ' VAL . 71.3 mmtt -83.64 -2.64 56.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.736 1.214 . . . . 0.0 111.692 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.404 ' NE2' ' HE3' ' A' ' 173' ' ' LYS . 37.3 t60 -52.55 122.68 9.37 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.404 ' HE3' ' NE2' ' A' ' 172' ' ' HIS . 77.7 mttt 60.98 17.04 7.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.326 1.45 . . . . 0.0 113.822 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -79.87 -18.41 50.78 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.36 1.064 . . . . 0.0 113.287 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 79.23 174.41 0.15 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.24 1.416 . . . . 0.0 114.573 170.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.77 -15.2 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.24 0.616 . . . . 0.0 112.611 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.24 -29.3 0.64 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 118.556 0.616 . . . . 0.0 114.191 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -151.51 -1.48 0.33 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.885 0.843 . . . . 0.0 111.066 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -145.78 151.59 38.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -97.19 151.2 20.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.027 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 37.5 mm -123.62 157.5 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -172.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -127.82 158.92 36.4 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 171' ' ' LYS . 35.5 m -133.84 130.5 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 9.0 m-85 -136.98 150.38 48.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -75.84 158.43 32.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.337 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.9 t -156.71 -175.83 5.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.3 m -145.57 169.48 18.32 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.625 1.17 . . . . 0.0 109.744 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -57.16 -32.24 66.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.847 0.459 . . . . 0.0 111.116 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.24 -2.03 3.92 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -121.0 1.93 10.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.88 0.872 . . . . 0.0 111.051 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.89 11.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.885 0.374 . . . . 0.0 111.318 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -67.72 12.3 0.11 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.2 m -69.69 0.38 5.63 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.387 0.675 . . . . 0.0 111.28 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.275 -1.345 . . . . 0.0 111.149 178.091 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p30 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -142.07 4.17 1.63 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.45 -5.9 33.59 Favored Glycine 0 N--CA 1.45 -0.375 0 O-C-N 122.245 -0.284 . . . . 0.0 112.581 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -63.03 148.36 47.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.766 0.793 . . . . 0.0 111.286 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -155.11 174.77 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.428 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.413 ' H ' HG22 ' A' ' 113' ' ' VAL . 47.3 ttt180 -137.17 152.21 49.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tp -133.81 150.98 51.43 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -154.07 169.98 22.23 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.83 4.96 88.63 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.444 HD23 ' SG ' ' A' ' 122' ' ' CYS . 2.6 mp -58.5 149.05 62.96 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 117.035 0.418 . . . . 0.0 111.609 -175.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 15.3 Cg_exo -62.04 146.97 95.99 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.255 1.97 . . . . 0.0 108.715 167.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.455 ' HA ' HD11 ' A' ' 151' ' ' ILE . 19.8 m-85 -71.35 2.99 4.08 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.24 5.74 12.08 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 49.0 t -66.86 154.43 40.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.249 1.02 . . . . 0.0 111.134 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.2 t -156.05 -166.44 2.19 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.411 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -50.03 -53.14 28.86 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.714 0.688 . . . . 0.0 109.518 -179.384 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.551 ' HA ' ' CG2' ' A' ' 128' ' ' VAL . 32.6 tt0 -53.36 -21.25 5.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.333 1.453 . . . . 0.0 113.843 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.488 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 75.6 mm-40 -97.91 -19.67 17.94 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.004 -1.06 . . . . 0.0 110.635 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.2 mt -86.08 -26.18 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 125' ' ' GLU . 29.0 m -78.88 -33.7 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.04 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -72.66 -32.08 65.56 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.454 0.57 . . . . 0.0 110.698 172.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 16.6 t80 -70.44 -24.39 62.88 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.395 -0.19 . . . . 0.0 111.379 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -120.56 29.25 7.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.855 0.862 . . . . 0.0 109.706 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 t -63.18 -11.54 21.52 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.036 0.534 . . . . 0.0 111.967 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.49 13.95 65.76 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.784 ' HB3' HD11 ' A' ' 164' ' ' LEU . 76.4 mt -137.76 -159.4 0.95 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.641 1.976 . . . . 0.0 106.627 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -141.76 -21.52 0.73 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -175.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.7 mt 51.6 -176.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.683 0.793 . . . . 0.0 112.606 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.599 ' H ' HG22 ' A' ' 136' ' ' ILE . 20.6 m -120.51 154.83 56.95 Favored Pre-proline 0 C--N 1.339 0.145 0 O-C-N 121.501 -0.749 . . . . 0.0 109.174 167.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.84 134.71 17.67 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.154 3.236 . . . . 0.0 112.746 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.2 t30 41.01 36.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.601 1.161 . . . . 0.0 112.557 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -81.87 -4.61 90.26 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.301 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.457 HG12 HG13 ' A' ' 157' ' ' VAL . 96.7 mt -98.91 151.15 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.989 0.894 . . . . 0.0 110.732 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.8 m -143.2 144.33 32.13 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.756 0.822 . . . . 0.0 109.346 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.5 mt -139.54 94.98 9.16 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 124.065 0.946 . . . . 0.0 108.615 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.95 158.6 16.8 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.447 2.765 . . . . 0.0 110.691 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 28.5 m -141.5 160.42 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.593 0.711 . . . . 0.0 112.187 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.463 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 18.3 m-20 -85.55 174.04 6.2 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.467 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 44.8 Cg_exo -58.03 -9.67 6.57 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.679 2.92 . . . . 0.0 112.539 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -104.3 -1.48 26.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.599 0.759 . . . . 0.0 111.27 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.66 4.38 90.12 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -66.86 162.56 21.41 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 120' ' ' PHE . 4.4 pt -109.6 11.27 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -166.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 p 63.33 -5.85 0.22 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 69.96 12.22 67.8 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.205 0.907 . . . . 0.0 113.252 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -141.27 164.79 29.3 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.044 0.922 . . . . 0.0 110.574 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.69 -178.04 7.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.55 0.74 . . . . 0.0 110.539 -172.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -145.45 154.66 42.48 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 158' ' ' GLN . 5.4 t -147.38 169.16 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.523 ' N ' HG12 ' A' ' 157' ' ' VAL . 51.1 tt0 -126.96 115.95 20.03 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.959 -1.496 . . . . 0.0 106.959 164.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.66 ' CD1' HD12 ' A' ' 164' ' ' LEU . 51.7 m-85 -85.26 173.53 10.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.302 172.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.09 88.48 0.6 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.13 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.1 t 64.62 168.33 0.17 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.488 1.115 . . . . 0.0 111.511 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -19.58 63.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.866 0.466 . . . . 0.0 111.752 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.21 -42.57 65.62 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.038 -0.414 . . . . 0.0 111.244 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.784 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -68.1 -36.06 79.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.411 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -60.73 -35.06 75.42 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.282 -0.261 . . . . 0.0 110.785 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -71.41 -28.14 63.79 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -74.55 -37.98 62.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.693 0.282 . . . . 0.0 110.602 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.432 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -61.54 -23.49 65.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.932 176.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 99.1 mt -69.26 -12.1 61.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.349 0.522 . . . . 0.0 111.411 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.85 -10.66 83.65 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.559 ' HB2' HG11 ' A' ' 183' ' ' VAL . 67.3 mmtt -89.02 2.02 54.65 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.822 1.249 . . . . 0.0 112.231 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.458 ' HA ' HG22 ' A' ' 183' ' ' VAL . 42.4 t60 -52.53 132.64 35.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.974 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 59.38 12.04 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.48 1.512 . . . . 0.0 114.345 -176.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -72.89 -169.93 0.65 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.018 0.826 . . . . 0.0 109.53 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.76 168.0 19.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.24 -13.62 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.438 0.695 . . . . 0.0 111.583 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 152.23 -26.05 0.88 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.394 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -154.49 2.78 0.22 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.66 0.73 . . . . 0.0 111.174 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -148.17 157.51 43.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.062 0.945 . . . . 0.0 108.686 -171.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -101.99 146.29 28.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.0 162.12 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -125.59 153.11 44.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.826 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.559 HG11 ' HB2' ' A' ' 171' ' ' LYS . 23.2 m -136.79 132.56 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -177.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -146.16 154.04 41.34 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -77.53 154.67 32.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.694 0.283 . . . . 0.0 110.724 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.9 t -158.37 -178.64 7.43 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.538 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 66.3 m -148.05 170.3 18.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.695 1.198 . . . . 0.0 108.952 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -56.37 -29.58 61.61 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.761 0.424 . . . . 0.0 111.246 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -66.58 -1.03 3.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.477 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -123.16 2.3 9.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.679 0.792 . . . . 0.0 111.167 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.07 9.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -69.19 15.14 0.07 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.2 m -69.06 -0.07 5.3 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.691 0.797 . . . . 0.0 111.113 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.211 -1.376 . . . . 0.0 111.227 178.017 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 25.8 p30 . . . . . 0 N--CA 1.445 -0.691 0 CA-C-O 120.506 0.193 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -126.62 4.29 6.79 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.74 -13.49 13.15 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -61.88 139.18 58.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.485 0.659 . . . . 0.0 111.06 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.597 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.9 p -150.91 177.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.725 -177.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.47 ' H ' HG22 ' A' ' 113' ' ' VAL . 9.9 mtm180 -133.26 161.51 34.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.202 0.601 . . . . 0.0 110.67 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -141.61 148.46 39.27 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.629 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -153.6 161.45 42.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.12 4.72 89.67 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.441 HD23 ' SG ' ' A' ' 122' ' ' CYS . 2.9 mp -59.0 153.22 46.01 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 117.324 0.562 . . . . 0.0 111.487 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -62.26 146.27 95.91 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.387 2.058 . . . . 0.0 108.163 166.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.415 ' HA ' HD11 ' A' ' 151' ' ' ILE . 20.6 m-85 -73.92 10.63 1.1 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.53 3.47 7.63 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 32.5 t -66.6 151.22 47.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.731 1.212 . . . . 0.0 110.981 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.5 HG23 ' H ' ' A' ' 125' ' ' GLU . 3.0 t -146.94 -168.29 3.0 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.568 0.747 . . . . 0.0 109.142 172.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.612 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 mptt -51.69 -29.31 17.7 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.5 ' H ' HG23 ' A' ' 123' ' ' THR . 33.0 tt0 -76.02 -24.23 55.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.114 0.566 . . . . 0.0 111.93 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.485 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 5.7 mp0 -90.84 -35.34 14.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.478 -0.764 . . . . 0.0 110.0 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.51 -32.54 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.73 -31.84 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.003 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -71.74 -27.64 63.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.755 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -69.78 -27.03 64.58 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -114.3 32.68 5.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.412 1.085 . . . . 0.0 109.53 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.8 t -64.5 -13.62 53.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.959 0.504 . . . . 0.0 112.164 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.31 13.67 67.05 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.786 ' HB3' HD11 ' A' ' 164' ' ' LEU . 74.5 mt -136.72 -161.47 1.17 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.241 1.817 . . . . 0.0 107.24 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.17 -18.22 0.73 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 117.295 2.331 . . . . 0.0 117.295 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER 46.12 -166.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.819 0.848 . . . . 0.0 112.772 -176.242 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 158' ' ' GLN . 16.4 m -129.98 156.17 79.51 Favored Pre-proline 0 CA--C 1.528 0.106 0 C-N-CA 123.898 0.879 . . . . 0.0 109.852 172.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.96 137.15 22.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.027 3.151 . . . . 0.0 112.178 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 39.52 36.58 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.755 1.222 . . . . 0.0 112.952 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.15 5.33 75.23 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 119.13 -0.817 . . . . 0.0 112.507 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.6 mt -113.28 147.77 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 118.84 1.32 . . . . 0.0 109.476 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.0 m -139.56 150.7 45.37 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.505 0.722 . . . . 0.0 109.249 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 6.1 mt -144.48 97.14 5.13 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.513 0.725 . . . . 0.0 109.52 -175.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 163.81 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 124.11 3.207 . . . . 0.0 112.056 174.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 18.1 m -145.06 160.76 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 110.321 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 60.9 m-20 -84.64 175.54 4.54 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 32.5 Cg_exo -58.67 -20.22 49.63 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.74 2.294 . . . . 0.0 111.045 174.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.25 -12.88 60.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.108 0.963 . . . . 0.0 110.768 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.77 8.27 76.78 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.459 0.552 . . . . 0.0 112.268 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -95.48 148.96 21.93 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 117.433 0.617 . . . . 0.0 109.785 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 120' ' ' PHE . 6.1 pt -77.24 7.35 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 -160.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 67.96 -22.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 175.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 94.42 15.59 46.56 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.339 -0.701 . . . . 0.0 113.233 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.77 168.06 20.69 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.286 1.043 . . . . 0.0 110.466 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.99 -179.56 8.33 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.395 0.617 . . . . 0.0 111.154 -173.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -144.06 147.98 34.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 158' ' ' GLN . 48.4 t -145.83 165.26 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.669 ' O ' HG22 ' A' ' 137' ' ' VAL . 53.1 tt0 -127.92 100.71 6.02 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 168.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.67 ' CD1' HD12 ' A' ' 164' ' ' LEU . 47.5 m-85 -70.29 172.05 8.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.971 174.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.41 88.93 0.33 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.564 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.89 168.31 0.13 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.623 1.169 . . . . 0.0 111.026 -174.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -16.95 64.31 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.741 -0.599 . . . . 0.0 111.266 -176.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.09 -39.9 78.74 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.86 -0.525 . . . . 0.0 110.685 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.786 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.9 OUTLIER -72.13 -35.21 69.06 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.412 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.451 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -60.72 -36.57 79.17 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.076 -0.39 . . . . 0.0 110.625 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.02 -28.54 65.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -72.88 -37.1 67.43 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 121.285 -0.166 . . . . 0.0 110.946 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.39 65.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.611 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.5 mt -68.98 -11.34 60.65 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.613 0.365 . . . . 0.0 111.707 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.78 -16.85 80.15 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -76.27 -56.59 4.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.106 0.962 . . . . 0.0 110.791 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.674 ' HA ' HG22 ' A' ' 183' ' ' VAL . 1.2 t60 23.76 -99.87 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.881 1.272 . . . . 0.0 112.63 -164.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -70.74 17.39 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -61.28 179.37 0.21 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.616 0.767 . . . . 0.0 111.237 172.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -132.33 164.22 26.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.17 0.588 . . . . 0.0 112.104 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.2 mt -108.79 -12.82 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.32 0.648 . . . . 0.0 112.258 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.82 -24.92 1.31 Allowed Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.866 -0.521 . . . . 0.0 113.962 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -151.56 2.09 0.39 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 117.624 0.712 . . . . 0.0 110.731 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -149.79 157.46 43.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.284 1.034 . . . . 0.0 108.395 -171.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -107.37 153.25 23.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.343 0.592 . . . . 0.0 109.563 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.0 mm -119.01 171.92 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -172.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -139.92 158.31 44.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.674 HG22 ' HA ' ' A' ' 172' ' ' HIS . 21.9 m -129.07 133.9 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -134.68 158.29 44.47 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -79.26 163.79 24.66 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.849 0.749 . . . . 0.0 109.701 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.4 t -156.82 -173.26 4.38 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.236 -0.29 . . . . 0.0 111.768 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.2 m -147.04 167.63 23.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.626 1.171 . . . . 0.0 109.713 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -59.91 -30.68 69.19 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.55 -1.42 2.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.971 0.908 . . . . 0.0 112.455 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -122.99 2.23 9.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.12 0.968 . . . . 0.0 111.201 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.98 11.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-O 120.936 0.398 . . . . 0.0 111.207 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -67.16 11.67 0.1 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 20.7 t -69.34 -1.99 9.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.524 0.73 . . . . 0.0 110.818 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.246 -1.359 . . . . 0.0 111.257 177.953 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.509 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 5.9 t-20 . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -126.59 9.71 7.13 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.85 -9.7 40.45 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -62.49 138.79 58.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.47 0.653 . . . . 0.0 110.218 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.9 p -148.6 175.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.862 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.417 ' H ' HG22 ' A' ' 113' ' ' VAL . 3.3 mtt-85 -131.56 160.94 33.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.663 0.785 . . . . 0.0 110.045 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.2 tp -144.54 140.83 29.06 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -156.67 172.87 17.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.04 8.01 84.57 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 72.0 mt -56.72 150.58 35.92 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.91 0.884 . . . . 0.0 111.819 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.83 20.34 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 124.844 3.696 . . . . 0.0 113.428 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 55.21 11.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.631 1.172 . . . . 0.0 114.131 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.22 -7.63 1.94 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 21.8 t -66.33 151.46 47.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.271 1.029 . . . . 0.0 110.342 175.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 125' ' ' GLU . 6.4 t -143.27 -173.46 3.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 170.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.9 ptpp? -54.71 -17.39 3.37 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.525 ' H ' HG23 ' A' ' 123' ' ' THR . 42.1 mt-10 -83.69 -26.12 30.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.949 0.5 . . . . 0.0 111.341 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.466 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 4.8 mp0 -87.59 -32.55 19.27 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.68 -35.62 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 p -82.27 -34.08 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.164 -173.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -79.67 -20.82 45.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.47 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -73.72 -26.08 60.52 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 170.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -111.14 36.85 3.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.175 1.39 . . . . 0.0 109.024 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.3 t -68.11 -11.27 58.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 112.412 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.09 20.96 46.71 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 164' ' ' LEU . 43.4 mt -141.27 -173.06 3.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.475 2.31 . . . . 0.0 105.043 -172.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -138.64 -18.12 1.09 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -174.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.3 mt 50.83 -177.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.208 1.003 . . . . 0.0 112.454 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.588 ' H ' HG22 ' A' ' 136' ' ' ILE . 18.9 m -121.45 155.88 58.71 Favored Pre-proline 0 CA--C 1.528 0.119 0 O-C-N 121.361 -0.837 . . . . 0.0 109.869 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.68 138.1 25.84 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.907 3.072 . . . . 0.0 111.881 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 43.26 35.51 0.87 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.849 0.859 . . . . 0.0 111.538 -177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -99.07 28.71 14.01 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 119.256 -0.747 . . . . 0.0 111.737 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.4 mt -138.49 146.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 118.505 1.152 . . . . 0.0 109.513 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 96.8 m -143.9 151.55 39.97 Favored 'General case' 0 C--N 1.335 -0.051 0 C-N-CA 123.623 0.769 . . . . 0.0 109.268 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 1.4 mt -145.48 101.15 4.36 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -52.18 149.51 21.76 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.384 2.723 . . . . 0.0 111.32 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -145.01 165.74 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.361 0.6 . . . . 0.0 110.75 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.437 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 65.9 m-20 -86.59 176.27 3.7 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.8 Cg_exo -57.9 -17.82 32.13 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.982 2.455 . . . . 0.0 112.088 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -86.28 -8.82 57.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.324 1.05 . . . . 0.0 111.458 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.71 1.7 88.96 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -76.66 131.33 38.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.451 1.5 . . . . 0.0 109.092 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.9 pt -70.89 147.34 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.394 0.616 . . . . 0.0 110.319 -174.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.2 p -80.77 -9.7 59.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.165 -174.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 111.72 -6.48 27.81 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.734 -0.481 . . . . 0.0 112.798 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -139.29 166.49 24.41 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 117.78 0.79 . . . . 0.0 110.452 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -150.33 -176.81 5.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.039 0.536 . . . . 0.0 111.058 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -144.67 147.64 33.3 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -174.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.509 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 85.7 t -147.7 164.18 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.467 ' N ' HG12 ' A' ' 157' ' ' VAL . 52.4 tt0 -129.67 104.87 7.68 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 59.0 m-85 -74.31 169.52 17.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.12 91.74 0.37 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.9 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 16.4 t 63.76 171.31 0.17 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.201 1.0 . . . . 0.0 111.135 -175.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.509 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 0.6 OUTLIER -61.7 -30.04 70.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.109 -0.369 . . . . 0.0 110.604 -176.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -63.01 -36.69 84.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -76.6 -33.51 58.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -64.76 -34.7 78.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.682 -0.636 . . . . 0.0 110.839 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -69.97 -29.76 66.95 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -71.81 -37.45 70.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.454 0.169 . . . . 0.0 110.859 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.41 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -60.83 -22.67 64.43 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 122.649 0.38 . . . . 0.0 112.018 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.639 ' HA ' HG21 ' A' ' 183' ' ' VAL . 97.6 mt -68.46 -11.65 60.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 122.213 -0.304 . . . . 0.0 111.397 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.27 -19.44 79.64 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.15 -63.14 1.14 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.044 0.938 . . . . 0.0 109.458 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.638 ' HA ' HG22 ' A' ' 183' ' ' VAL . 1.2 t60 25.11 -107.5 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.45 1.1 . . . . 0.0 112.521 -166.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -68.07 12.77 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.08 171.19 11.36 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.497 1.519 . . . . 0.0 109.635 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -116.92 155.98 28.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -169.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.49 -14.31 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.476 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.32 -27.23 0.61 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.643 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -154.47 -1.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.607 0.703 . . . . 0.0 111.583 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -145.84 150.63 36.52 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.949 0.899 . . . . 0.0 108.727 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -91.43 159.58 15.89 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.865 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 182' ' ' GLU . 36.2 mm -125.27 174.38 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 -174.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.418 ' N ' HG22 ' A' ' 181' ' ' ILE . 14.4 mt-10 -138.96 142.17 38.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.639 HG21 ' HA ' ' A' ' 169' ' ' LEU . 22.2 m -114.61 139.29 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -137.42 159.4 42.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -77.72 163.62 25.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.83 0.741 . . . . 0.0 109.59 175.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t -156.13 -173.18 4.39 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.563 0.22 . . . . 0.0 111.561 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.4 m -147.29 168.99 20.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.351 1.06 . . . . 0.0 109.64 -176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -58.94 -30.35 67.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.638 0.375 . . . . 0.0 110.885 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -67.28 -2.33 5.83 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.368 0.667 . . . . 0.0 112.673 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -116.78 0.49 12.55 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.447 0.699 . . . . 0.0 110.496 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.59 8.52 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -70.39 16.2 0.08 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 35.1 m -68.87 0.02 4.93 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.471 0.708 . . . . 0.0 111.073 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.372 177.896 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 58.5 t30 . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.6 m -144.81 8.04 1.26 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.845 0.458 . . . . 0.0 112.079 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.08 168.4 25.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.156 0.435 . . . . 0.0 111.006 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -150.9 4.83 0.48 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.614 0.366 . . . . 0.0 111.755 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.6 p -149.88 7.91 0.65 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.785 0.434 . . . . 0.0 111.845 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.9 157.1 40.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.036 0.446 . . . . 0.0 110.759 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -161.43 29.84 0.13 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.826 0.85 . . . . 0.0 109.856 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -136.27 165.48 25.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.678 1.191 . . . . 0.0 108.451 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.62 1.34 37.7 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.961 -0.355 . . . . 0.0 112.447 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -61.56 144.54 54.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 117.66 0.73 . . . . 0.0 110.808 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.639 HG11 ' CE2' ' A' ' 159' ' ' PHE . 10.7 p -151.77 176.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 124.116 0.966 . . . . 0.0 108.521 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.512 ' H ' HG22 ' A' ' 113' ' ' VAL . 22.4 ttt180 -136.63 147.47 46.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.06 148.28 44.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -152.46 160.27 43.27 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.66 3.65 71.02 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 120' ' ' PHE . 83.5 mt -55.55 140.57 65.83 Favored Pre-proline 0 N--CA 1.453 -0.316 0 C-N-CA 123.321 0.648 . . . . 0.0 110.596 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 24.5 Cg_exo -58.85 16.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 125.172 3.915 . . . . 0.0 116.081 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.439 ' CZ ' ' C4 ' ' B' ' 2' ' ' ' G' . 22.0 m-85 57.03 9.41 0.63 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.554 1.141 . . . . 0.0 112.847 -171.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.05 -3.16 1.51 Allowed Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.793 -0.567 . . . . 0.0 112.304 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 28.2 t -63.62 153.18 36.74 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.56 HG23 ' H ' ' A' ' 125' ' ' GLU . 5.7 t -150.47 -169.19 3.32 Favored 'General case' 0 CA--C 1.526 0.05 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -51.71 -33.69 35.48 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.139 0.427 . . . . 0.0 111.81 -178.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.56 ' H ' HG23 ' A' ' 123' ' ' THR . 40.4 tt0 -76.78 -22.67 53.4 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.447 0.699 . . . . 0.0 112.018 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.506 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 47.2 mm-40 -94.73 -33.87 12.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.431 -0.793 . . . . 0.0 109.33 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.419 HG13 ' SG ' ' A' ' 122' ' ' CYS . 54.0 mt -64.32 -34.57 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.33 -34.02 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.661 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -72.34 -26.6 61.99 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.898 172.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 19.3 t80 -72.09 -23.06 61.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.655 0.264 . . . . 0.0 110.549 175.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -118.14 32.87 5.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.397 1.079 . . . . 0.0 109.042 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.0 t -68.26 -11.67 59.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.122 0.569 . . . . 0.0 112.342 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.56 15.24 63.58 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.621 ' HB3' HD11 ' A' ' 164' ' ' LEU . 28.7 mt -144.14 -162.33 1.45 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.36 1.864 . . . . 0.0 107.196 -173.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -147.94 162.32 39.54 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.981 -0.449 . . . . 0.0 110.069 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.39 148.03 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 158' ' ' GLN . 21.0 m -73.83 153.71 89.12 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 118.588 0.631 . . . . 0.0 110.254 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.89 139.36 25.39 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 124.109 3.206 . . . . 0.0 112.477 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.5 t30 40.59 37.56 0.49 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.369 1.068 . . . . 0.0 111.988 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.86 27.73 13.62 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-O 118.72 -1.045 . . . . 0.0 112.057 -173.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.7 mt -133.37 145.3 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 119.375 1.588 . . . . 0.0 109.36 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.4 m -137.8 144.76 41.7 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.772 0.829 . . . . 0.0 109.158 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 123' ' ' THR . 87.2 mt -136.96 93.72 13.27 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 123.454 0.702 . . . . 0.0 110.029 -173.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.5 150.84 32.91 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.221 2.614 . . . . 0.0 110.764 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -141.57 166.69 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.096 0 CA-C-O 121.437 0.637 . . . . 0.0 111.43 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 64.7 m-20 -92.3 176.99 2.3 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.721 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 35.3 Cg_exo -58.75 -19.18 44.98 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.962 2.441 . . . . 0.0 111.83 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -82.82 -7.56 59.65 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.526 0.73 . . . . 0.0 110.657 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.93 13.44 81.24 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.307 0.48 . . . . 0.0 112.323 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -105.61 149.07 26.64 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.5 pt -68.86 149.76 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.456 0.646 . . . . 0.0 111.493 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 45.4 p -74.91 -7.34 53.26 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.222 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.65 -0.75 36.61 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -140.37 170.72 15.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.066 0.546 . . . . 0.0 110.409 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -157.22 -178.69 7.55 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.269 0.628 . . . . 0.0 111.079 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -143.98 148.85 35.87 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 158' ' ' GLN . 76.2 t -146.84 165.34 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.493 ' N ' HG12 ' A' ' 157' ' ' VAL . 40.8 tt0 -128.52 105.99 8.67 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 167.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.639 ' CE2' HG11 ' A' ' 113' ' ' VAL . 35.1 m-85 -74.69 173.01 11.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.389 170.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.19 90.7 0.9 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.192 0.52 . . . . 0.0 109.796 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.9 t 63.15 170.24 0.15 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.591 1.157 . . . . 0.0 112.415 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -22.06 65.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.5 0.72 . . . . 0.0 111.598 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.71 -43.48 75.92 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.907 -0.495 . . . . 0.0 111.032 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -67.6 -39.15 84.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.509 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.19 -37.23 71.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.129 -0.357 . . . . 0.0 110.867 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -71.78 -28.86 63.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.896 -0.138 . . . . 0.0 110.902 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -72.98 -39.18 66.33 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.656 0.265 . . . . 0.0 110.549 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.53 -17.88 63.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.106 0.562 . . . . 0.0 112.195 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.33 -13.01 61.61 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.462 0.574 . . . . 0.0 111.366 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.05 -11.74 81.47 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.536 ' HB2' HG11 ' A' ' 183' ' ' VAL . 69.9 mmtt -88.54 0.55 56.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.296 1.438 . . . . 0.0 111.705 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -54.54 133.18 46.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.443 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.452 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 90.6 mttt 59.51 5.59 0.67 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.617 1.567 . . . . 0.0 114.075 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -76.95 170.41 16.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -112.59 158.31 20.12 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -169.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.1 tt -102.9 -9.52 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.574 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 154.43 -29.08 0.7 Allowed Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.935 -0.37 . . . . 0.0 112.611 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -157.51 0.96 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.411 0.605 . . . . 0.0 111.382 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -145.64 153.46 41.05 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.21 1.004 . . . . 0.0 108.508 -173.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -97.01 152.95 18.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.989 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 38.7 mm -127.47 162.2 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -128.71 160.37 32.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 171' ' ' LYS . 26.5 m -137.0 39.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 123.103 0.561 . . . . 0.0 111.674 -162.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.677 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 3.4 m-30 -52.71 152.87 3.5 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.922 0.489 . . . . 0.0 109.816 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -80.06 170.16 16.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.633 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 10.0 t -158.01 179.97 8.69 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.479 0.312 . . . . 0.0 110.821 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -148.18 170.53 17.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.284 1.433 . . . . 0.0 108.291 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -53.92 -31.81 51.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.74 -2.77 2.69 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -122.14 2.16 9.8 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.861 0.864 . . . . 0.0 111.013 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.56 11.55 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-O 120.968 0.413 . . . . 0.0 111.14 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -68.95 13.03 0.11 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 29.3 m -67.24 -1.98 5.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.393 0.677 . . . . 0.0 111.456 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.247 -1.358 . . . . 0.0 110.968 178.272 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.412 1 O4'-C1'-N19 114.164 5.964 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.439 ' C4 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.954 0 O4'-C1'-N19 111.759 3.559 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.476 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.407 -3.792 0 C3'-C2'-C1' 104.759 3.621 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.476 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.829 1 O4'-C1'-N19 115.594 7.394 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.452 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.952 1 C5'-C4'-C3' 109.362 -4.092 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.677 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.634 0 O4'-C1'-C2' 102.677 -2.659 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -146.42 14.08 1.24 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.017 0.527 . . . . 0.0 111.463 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.45 179.29 7.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.726 0.81 . . . . 0.0 109.62 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -149.01 157.11 43.17 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.697 0.284 . . . . 0.0 110.723 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.6 m -145.87 19.87 1.45 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.788 0.835 . . . . 0.0 110.629 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.36 33.98 0.09 Allowed 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.033 0.933 . . . . 0.0 112.136 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -146.85 28.8 1.02 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -170.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -128.07 7.13 6.01 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.07 -8.74 25.15 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -64.12 142.18 58.5 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.479 0.657 . . . . 0.0 111.608 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.626 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.4 p -152.92 177.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.435 1.094 . . . . 0.0 108.686 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.524 ' H ' HG22 ' A' ' 113' ' ' VAL . 65.0 ttt180 -135.65 153.66 51.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.951 0.9 . . . . 0.0 109.1 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -126.5 135.62 51.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -150.69 50.68 0.87 Allowed 'General case' 0 C--O 1.226 -0.166 0 CA-C-O 121.282 0.563 . . . . 0.0 112.443 -172.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -160.03 15.94 0.21 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.7 153.46 90.82 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -168.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 24.5 Cg_exo -59.44 143.63 99.65 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.754 2.303 . . . . 0.0 107.951 163.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -69.71 6.73 1.05 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.74 10.66 5.46 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 48.8 t -66.29 157.82 30.64 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.285 1.034 . . . . 0.0 111.404 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 125' ' ' GLU . 3.7 t -152.16 -174.8 5.0 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.248 0.619 . . . . 0.0 109.825 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.603 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -51.77 -34.01 37.7 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 123.378 0.671 . . . . 0.0 112.471 -176.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.53 ' H ' HG23 ' A' ' 123' ' ' THR . 40.2 tt0 -72.39 -25.96 61.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.016 0.527 . . . . 0.0 112.166 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -93.1 -30.7 15.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.76 -40.74 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.35 -34.51 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 O-C-N 122.159 -0.338 . . . . 0.0 111.193 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -74.34 -28.71 61.27 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.162 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 28.9 t80 -67.15 -21.21 65.82 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -115.41 37.15 3.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.341 1.056 . . . . 0.0 108.385 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.2 t -69.48 154.84 41.41 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 167.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.27 5.1 85.11 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.504 ' HB3' HD11 ' A' ' 164' ' ' LEU . 24.0 mt -141.78 -172.2 3.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.668 1.987 . . . . 0.0 106.01 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -147.79 162.6 38.89 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.634 -0.666 . . . . 0.0 110.845 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.7 mt -141.32 147.9 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 158' ' ' GLN . 19.4 m -72.64 154.47 91.42 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 118.459 0.572 . . . . 0.0 110.305 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -48.63 138.61 24.99 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.055 3.17 . . . . 0.0 112.179 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 t30 41.53 36.4 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.471 1.109 . . . . 0.0 112.014 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.25 28.64 10.31 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.793 -1.004 . . . . 0.0 111.739 -173.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.5 mt -136.56 145.75 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 119.061 1.431 . . . . 0.0 109.351 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.0 m -139.5 149.46 43.98 Favored 'General case' 0 N--CA 1.458 -0.048 0 C-N-CA 123.509 0.724 . . . . 0.0 109.827 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.443 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 11.9 mt -144.48 93.26 5.85 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 124.075 0.95 . . . . 0.0 109.649 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -55.72 159.61 11.12 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.813 3.009 . . . . 0.0 111.307 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.2 m -141.21 166.02 18.54 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 CA-C-O 121.216 0.531 . . . . 0.0 111.543 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 66.9 m-20 -90.05 176.48 3.01 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.831 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -58.85 -19.25 46.12 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.089 2.526 . . . . 0.0 111.736 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -82.81 -9.01 59.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.563 0.745 . . . . 0.0 110.745 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.35 11.16 80.98 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 123.384 0.516 . . . . 0.0 112.272 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -102.81 148.75 25.24 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.2 pt -68.17 151.23 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.912 0.863 . . . . 0.0 112.263 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.7 p -79.11 5.87 10.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.481 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.7 15.35 80.73 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -140.83 164.74 29.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.49 178.19 10.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.249 0.547 . . . . 0.0 110.465 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -144.71 145.18 31.59 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 67.9 t -143.79 162.98 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.466 ' N ' HG12 ' A' ' 157' ' ' VAL . 49.3 tt0 -129.17 101.83 6.19 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 169.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.626 ' CE2' HG11 ' A' ' 113' ' ' VAL . 43.6 m-85 -71.55 171.17 11.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.328 171.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.47 93.53 1.19 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 61.8 169.8 0.11 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.688 1.195 . . . . 0.0 111.343 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -61.99 -26.75 68.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.762 -0.586 . . . . 0.0 110.9 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.16 -42.48 90.84 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.243 -0.286 . . . . 0.0 111.119 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -72.17 -38.79 69.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.526 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.91 -40.54 80.59 Favored 'General case' 0 N--CA 1.457 -0.101 0 O-C-N 122.013 -0.43 . . . . 0.0 110.898 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -67.83 -31.05 70.63 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.719 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -71.56 -39.46 70.63 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.632 0.253 . . . . 0.0 111.011 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.98 -15.39 62.21 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.96 -9.33 51.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.685 0.675 . . . . 0.0 111.524 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.14 -11.96 85.07 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.578 ' HB2' HG11 ' A' ' 183' ' ' VAL . 69.5 mmtt -85.74 2.81 43.97 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.243 1.417 . . . . 0.0 111.588 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -56.28 136.9 53.05 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.972 -0.455 . . . . 0.0 110.314 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.444 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 33.0 mttp 50.99 11.39 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.179 1.792 . . . . 0.0 114.242 -175.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.02 179.36 5.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.259 1.024 . . . . 0.0 109.085 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -126.46 163.27 23.7 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -170.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mt -113.0 -13.13 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.277 1.031 . . . . 0.0 111.849 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.41 -27.1 1.37 Allowed Glycine 0 CA--C 1.528 0.901 0 O-C-N 121.922 -0.486 . . . . 0.0 113.975 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -153.05 11.49 0.47 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.843 0.822 . . . . 0.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.11 -173.57 3.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.445 1.098 . . . . 0.0 108.384 -172.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -137.06 144.14 43.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 19.0 mm -116.79 162.62 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -167.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -129.64 154.08 47.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 171' ' ' LYS . 34.5 m -131.24 33.66 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 C-N-CA 123.839 0.855 . . . . 0.0 111.011 -166.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.696 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 10.6 m-30 -53.55 154.61 3.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -81.93 170.57 15.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.362 -0.837 . . . . 0.0 111.826 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.8 t -158.88 -173.7 4.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.521 0.328 . . . . 0.0 111.533 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 51.3 m -147.81 168.04 23.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.964 1.306 . . . . 0.0 109.174 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -56.91 -30.75 64.22 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.724 0.409 . . . . 0.0 110.897 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.84 -6.53 6.01 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -117.25 1.91 12.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.589 0.755 . . . . 0.0 111.312 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.61 15.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.269 0.557 . . . . 0.0 110.928 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -69.26 11.53 0.22 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.421 0.688 . . . . 0.0 112.811 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 65.8 p -69.29 -1.52 8.35 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.412 0.685 . . . . 0.0 111.243 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.746 -1.121 . . . . 0.0 110.959 177.949 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.434 ' C4 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.949 0 C5'-C4'-C3' 110.18 -3.547 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.471 1 C1'-O4'-C4' 105.045 -5.062 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.464 " H4'" " C5'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.149 0 O4'-C1'-N19 111.487 3.287 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.464 " C5'" " H4'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.556 1 O4'-C1'-N19 113.975 5.775 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.623 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.412 -3.457 2 C1'-O4'-C4' 105.672 -4.365 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.696 " H1'" ' CZ ' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 O4'-C1'-N19 111.358 3.158 . 0.0 OUTLIER '7D dist 6g' 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.8 p30 . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 110.646 -0.131 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.4 p -144.4 19.5 1.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.971 0.508 . . . . 0.0 111.441 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -142.11 4.73 1.65 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -147.5 3.61 0.76 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.074 0.55 . . . . 0.0 110.694 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 t -156.25 -173.45 4.51 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.107 0.963 . . . . 0.0 108.92 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.61 161.55 37.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.01 0.524 . . . . 0.0 110.678 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -155.29 31.22 0.39 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.677 0.391 . . . . 0.0 111.046 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -125.15 4.26 7.87 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.5 -9.76 53.17 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -62.5 141.36 58.45 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.568 0.699 . . . . 0.0 110.596 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.63 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.5 p -150.6 172.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 70.4 ttt180 -137.34 152.83 50.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp -136.92 148.2 46.86 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -173.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -158.3 154.93 27.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.689 0.281 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.08 -7.08 60.22 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.706 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -63.82 157.99 64.07 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.881 0.341 . . . . 0.0 111.777 -176.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 21.8 Cg_exo -57.82 152.13 51.88 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.348 2.699 . . . . 0.0 112.522 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.406 ' CD2' ' C8 ' ' B' ' 1' ' ' ' A' . 82.7 m-85 -67.89 -5.53 17.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.93 -0.89 31.91 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.437 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 41.8 t -68.2 153.01 44.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.344 0.657 . . . . 0.0 109.407 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.657 HG23 ' H ' ' A' ' 125' ' ' GLU . 8.7 t -154.31 -174.63 5.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 174.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 2.4 ptpp? -56.48 -20.69 21.34 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.657 ' H ' HG23 ' A' ' 123' ' ' THR . 42.2 mt-10 -82.18 -21.86 36.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.911 0.484 . . . . 0.0 111.218 177.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.411 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 60.2 mm-40 -90.74 -33.65 15.67 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.2 mt -61.4 -36.39 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.79 -33.63 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.002 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -75.66 -26.91 58.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.993 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -67.94 -27.57 66.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -108.79 34.71 3.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.3 t -67.15 152.0 46.54 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.94 4.24 90.35 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -172.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.553 ' HB3' HD11 ' A' ' 164' ' ' LEU . 19.2 mt -139.49 -171.56 3.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.165 1.786 . . . . 0.0 106.543 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -146.95 162.54 38.52 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.858 -0.526 . . . . 0.0 110.691 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 mt -141.82 148.74 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.9 m -74.46 154.6 87.81 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 118.476 0.58 . . . . 0.0 110.422 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.15 140.01 26.05 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.073 3.182 . . . . 0.0 112.229 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.6 t30 41.77 34.9 0.45 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.36 1.064 . . . . 0.0 111.929 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.32 30.17 8.04 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-O 118.941 -0.922 . . . . 0.0 111.801 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.8 mt -138.35 146.94 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 118.902 1.351 . . . . 0.0 109.922 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.6 m -140.76 146.88 38.29 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 123.86 0.864 . . . . 0.0 109.643 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.4 mt -142.35 92.84 7.29 Favored Pre-proline 0 CA--C 1.528 0.104 0 C-N-CA 124.268 1.027 . . . . 0.0 109.395 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.99 156.4 15.84 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.584 2.856 . . . . 0.0 111.539 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.4 m -142.43 167.06 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-O 121.367 0.603 . . . . 0.0 110.914 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.455 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 61.7 m-20 -91.03 176.52 2.81 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.707 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.5 Cg_exo -58.07 -20.01 43.7 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.823 2.349 . . . . 0.0 111.712 176.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -80.66 -8.81 59.75 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.165 0.986 . . . . 0.0 111.219 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.53 2.52 90.54 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -174.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.433 ' HE3' ' N3 ' ' B' ' 1' ' ' ' A' . 82.5 tttt -79.14 134.66 36.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.007 1.323 . . . . 0.0 108.886 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.5 pt -68.52 146.52 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.579 0.704 . . . . 0.0 110.163 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.4 p -76.4 0.85 18.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.24 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 85.95 7.44 80.82 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -141.43 168.55 19.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.356 0.578 . . . . 0.0 110.347 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.1 179.43 9.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.308 0.575 . . . . 0.0 111.078 -173.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -143.56 146.21 33.14 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.2 t -146.38 164.72 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.472 ' N ' HG12 ' A' ' 157' ' ' VAL . 53.1 tt0 -129.51 102.58 6.45 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 169.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.63 ' CE2' HG11 ' A' ' 113' ' ' VAL . 37.9 m-85 -73.07 171.57 12.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.379 171.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 92.45 0.91 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.8 t 61.88 167.2 0.11 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.787 1.235 . . . . 0.0 111.488 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -14.2 61.99 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.904 -0.498 . . . . 0.0 111.091 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.61 -41.81 79.03 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 122.05 -0.406 . . . . 0.0 110.546 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.56 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.7 OUTLIER -70.86 -39.67 72.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.44 -38.76 74.95 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.198 -0.314 . . . . 0.0 110.804 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -68.87 -29.82 68.2 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.764 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -73.24 -38.15 66.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.622 0.248 . . . . 0.0 110.759 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.01 -16.81 63.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.75 -9.68 57.85 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.408 0.549 . . . . 0.0 111.548 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.19 -12.77 81.62 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.49 ' HB2' HG11 ' A' ' 183' ' ' VAL . 68.9 mmtt -82.74 -2.37 54.12 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 125.599 1.56 . . . . 0.0 111.973 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -52.69 133.11 36.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.651 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.495 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 44.5 mttp 56.37 9.69 0.56 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.202 1.801 . . . . 0.0 114.4 -176.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.06 173.04 9.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.068 0.947 . . . . 0.0 108.82 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -125.4 160.27 29.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.796 -0.565 . . . . 0.0 112.169 -172.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.1 tt -113.04 -1.93 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.2 -36.92 0.65 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 121.731 -0.606 . . . . 0.0 113.685 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -155.62 6.87 0.23 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.533 0.666 . . . . 0.0 110.74 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.76 135.36 24.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -86.1 157.9 19.93 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.727 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 27.6 mm -125.05 160.85 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -127.5 156.24 42.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 171' ' ' LYS . 33.1 m -131.71 130.71 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.578 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 5.7 m-85 -137.19 153.91 50.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -175.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -76.42 164.09 26.33 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.692 0.678 . . . . 0.0 110.006 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -159.4 -175.35 5.16 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.45 0.167 . . . . 0.0 111.373 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.4 t -148.85 171.84 15.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.947 0.899 . . . . 0.0 110.011 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -60.24 -28.61 68.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.269 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.63 -0.94 2.31 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.8 0.84 . . . . 0.0 112.571 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.59 2.37 7.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.542 0.737 . . . . 0.0 111.601 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.72 10.53 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 122.131 -0.356 . . . . 0.0 111.866 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -69.75 15.6 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.2 m -68.61 -0.48 5.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.593 0.757 . . . . 0.0 111.087 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.237 -1.363 . . . . 0.0 111.244 178.105 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.438 " H4'" " O5'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.407 -3.838 2 C1'-O4'-C4' 100.322 -10.309 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.438 " O5'" " H4'" ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.718 1 C5'-C4'-C3' 109.005 -4.33 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.504 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.408 -3.74 1 P-O3'-C3' 125.381 4.734 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.504 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.869 2 O4'-C1'-N19 117.68 9.48 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.614 " H1'" ' C6 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.828 0 C4'-C3'-C2' 99.217 -3.483 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.614 ' C6 ' " H1'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.45 0 P-O3'-C3' 122.998 2.748 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 120.548 0.213 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -152.73 -0.5 0.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.734 0.413 . . . . 0.0 111.807 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.01 14.65 0.72 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.266 0.626 . . . . 0.0 110.282 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -139.67 6.61 2.27 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.948 0.899 . . . . 0.0 111.117 -174.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.9 m -71.12 -2.48 15.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.577 0.751 . . . . 0.0 112.372 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -154.61 163.63 39.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.886 0.374 . . . . 0.0 111.316 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -159.56 35.13 0.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.51 0.724 . . . . 0.0 110.399 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -129.39 5.16 5.19 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.72 -10.16 52.58 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -63.11 141.18 58.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.563 0.696 . . . . 0.0 110.471 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.619 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -150.92 175.94 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.932 -177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.458 ' H ' HG22 ' A' ' 113' ' ' VAL . 33.8 ttt180 -135.4 154.16 51.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 109.28 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.9 tp -139.3 150.28 45.23 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -156.72 157.78 35.73 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.13 -5.13 71.62 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.75 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.93 155.95 90.59 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 116.94 0.37 . . . . 0.0 111.529 -176.437 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 31.3 Cg_exo -54.65 151.25 32.32 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.125 3.217 . . . . 0.0 112.183 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.454 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 22.9 m-85 -64.88 -8.74 16.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.05 0.387 . . . . 0.0 111.688 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.57 -0.1 30.79 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.451 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 44.6 t -64.25 153.77 37.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.292 0.637 . . . . 0.0 109.293 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.646 HG23 ' H ' ' A' ' 125' ' ' GLU . 10.4 t -154.87 -176.17 5.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 0.9 OUTLIER -57.29 -21.75 36.88 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.646 ' H ' HG23 ' A' ' 123' ' ' THR . 39.4 tt0 -78.74 -25.23 44.5 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.19 0.596 . . . . 0.0 110.744 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 56.9 mm-40 -87.9 -37.08 16.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.31 -35.06 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.0 p -79.69 -32.45 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.712 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -75.32 -28.05 59.5 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.961 172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -66.05 -26.42 67.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -111.77 32.58 5.34 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.838 0.855 . . . . 0.0 109.017 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.0 t -64.31 148.89 49.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.59 3.71 86.12 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -172.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.554 ' HB3' HD11 ' A' ' 164' ' ' LEU . 17.9 mt -138.53 -170.55 2.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.744 1.617 . . . . 0.0 106.715 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -146.78 162.2 39.05 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.87 -0.519 . . . . 0.0 110.374 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.3 mt -142.04 148.44 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.6 m -73.29 154.49 90.19 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 118.595 0.634 . . . . 0.0 110.369 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.1 138.74 27.74 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 124.074 3.183 . . . . 0.0 112.155 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.1 t30 41.65 35.81 0.52 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.313 1.045 . . . . 0.0 112.047 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.04 29.96 8.13 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 119.04 -0.867 . . . . 0.0 111.895 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.9 mt -138.24 145.54 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.775 1.288 . . . . 0.0 109.658 -176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 86.3 m -139.59 150.2 44.74 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 123.822 0.849 . . . . 0.0 109.621 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 92.6 mt -139.81 90.77 10.8 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.829 0.852 . . . . 0.0 110.093 -174.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.47 153.87 21.56 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.468 2.779 . . . . 0.0 111.813 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.5 m -142.57 169.09 13.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 121.382 0.61 . . . . 0.0 111.207 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 59.5 m-20 -96.12 177.46 1.73 Allowed Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.105 0.962 . . . . 0.0 108.781 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 40.5 Cg_exo -58.04 -20.55 45.99 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.952 2.435 . . . . 0.0 111.625 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.26 -10.7 59.61 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.184 0.994 . . . . 0.0 110.956 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.22 4.39 86.5 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.469 ' HE3' ' N3 ' ' B' ' 1' ' ' ' A' . 55.0 tttm -83.43 136.31 34.36 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.068 1.347 . . . . 0.0 108.806 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.1 pt -66.98 148.01 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 121.79 0.805 . . . . 0.0 110.754 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.6 p -75.26 -0.69 20.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.16 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 88.28 5.94 75.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -138.53 169.78 17.17 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.279 0.54 . . . . 0.0 110.207 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.81 179.13 9.39 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.212 0.605 . . . . 0.0 110.798 -174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -143.65 145.55 32.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 60.2 t -145.81 164.59 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.472 ' N ' HG12 ' A' ' 157' ' ' VAL . 52.6 tt0 -129.19 102.22 6.36 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.619 ' CE2' HG11 ' A' ' 113' ' ' VAL . 44.6 m-85 -72.74 171.2 13.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.263 172.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.86 92.73 0.71 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t 61.67 168.67 0.11 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.758 1.223 . . . . 0.0 111.505 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -14.66 62.68 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.95 -0.469 . . . . 0.0 111.24 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.07 -42.4 76.27 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 122.052 -0.405 . . . . 0.0 110.679 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -70.84 -38.89 73.24 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.521 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.48 -39.04 75.55 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.279 -0.263 . . . . 0.0 110.717 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -69.02 -29.05 67.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.892 -0.14 . . . . 0.0 110.956 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -73.52 -38.19 65.38 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.095 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.8 -21.65 66.04 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.553 ' HA ' HG21 ' A' ' 183' ' ' VAL . 97.0 mt -70.35 -7.71 44.88 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 122.847 0.459 . . . . 0.0 111.733 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.04 -15.47 81.37 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -76.07 -55.02 5.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.257 1.023 . . . . 0.0 110.856 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.692 ' HA ' HG22 ' A' ' 183' ' ' VAL . 0.7 OUTLIER 23.86 -101.79 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.863 1.265 . . . . 0.0 113.052 -165.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.457 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 56.0 mttp -71.18 19.55 0.05 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -174.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.28 178.74 0.18 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.003 0.921 . . . . 0.0 111.099 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -128.58 161.18 30.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.343 0.657 . . . . 0.0 110.746 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.0 tt -117.94 -0.08 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.42 -36.17 0.64 Allowed Glycine 0 CA--C 1.529 0.953 0 O-C-N 122.046 -0.409 . . . . 0.0 113.422 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -156.72 5.74 0.16 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.314 0.557 . . . . 0.0 110.489 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -146.51 156.17 43.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.514 1.126 . . . . 0.0 108.485 -170.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -104.07 153.81 20.44 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.373 0.606 . . . . 0.0 110.113 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 182' ' ' GLU . 30.1 mm -120.12 172.14 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -172.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.412 ' N ' HG22 ' A' ' 181' ' ' ILE . 21.8 mt-10 -139.54 155.94 47.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' A' ' 172' ' ' HIS . 22.2 m -130.71 137.5 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.468 ' CE1' ' C2 ' ' B' ' 6' ' ' ' U' . 33.0 m-85 -148.18 160.49 42.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -80.18 165.32 22.54 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.677 0.671 . . . . 0.0 110.778 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.7 t -158.74 -174.41 4.76 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.144 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.6 t -147.98 171.85 15.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.162 0.985 . . . . 0.0 109.796 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -59.36 -31.39 69.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.652 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.78 -6.02 7.15 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.678 0.791 . . . . 0.0 112.537 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -118.45 3.01 11.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.598 0.759 . . . . 0.0 111.168 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.26 9.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 122.272 -0.267 . . . . 0.0 111.613 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -69.26 13.5 0.12 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.7 m -67.14 -1.16 3.97 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.509 0.723 . . . . 0.0 111.205 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.287 177.959 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.538 ' C8 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.052 0 C3'-C2'-C1' 104.638 3.486 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.454 ' C5 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 P--O5' 1.617 2.387 1 C5'-C4'-C3' 108.691 -4.539 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.123 1 P-O3'-C3' 124.925 4.354 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.012 1 O4'-C1'-N19 114.712 6.512 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.647 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.02 1 C5'-C4'-C3' 107.946 -5.036 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.647 ' C5 ' " H1'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.658 0 C3'-C2'-C1' 98.779 -3.024 . 0.0 OUTLIER '7D dist 4a' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.8 t30 . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -152.52 169.31 22.95 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.04 0.536 . . . . 0.0 110.136 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.39 175.77 13.16 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.012 0.525 . . . . 0.0 110.737 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 55.21 16.39 1.63 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.48 1.112 . . . . 0.0 113.401 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.3 p -153.67 166.89 31.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 122.04 -0.412 . . . . 0.0 110.68 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 47.0 25.65 0.51 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.188 1.395 . . . . 0.0 114.754 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -150.27 29.89 0.7 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.027 0.442 . . . . 0.0 111.758 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -121.7 7.65 9.98 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.64 -9.77 41.26 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -61.27 138.63 58.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.731 0.776 . . . . 0.0 110.823 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.576 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -150.27 174.97 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.235 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 58.4 ttt180 -136.58 155.38 50.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.3 tp -138.28 147.4 43.59 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -173.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -154.72 162.48 41.1 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.83 1.45 58.65 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.6 mt -56.97 150.04 41.3 Favored Pre-proline 0 N--CA 1.453 -0.292 0 C-N-CA 123.23 0.612 . . . . 0.0 111.982 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.27 26.16 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 1 C-N-CA 125.346 4.031 . . . . 0.0 113.522 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.589 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 15.4 m-30 53.47 13.85 0.5 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.903 1.281 . . . . 0.0 114.162 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.02 -13.99 0.58 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.994 0.815 . . . . 0.0 112.724 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.4 m -67.35 153.5 43.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.448 0.624 . . . . 0.0 110.389 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 t -147.23 -160.8 1.21 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.93 0.892 . . . . 0.0 108.733 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.553 ' HE3' HD12 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -50.34 -31.26 14.07 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -84.07 -19.64 33.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -96.27 -31.54 12.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.756 -0.59 . . . . 0.0 109.816 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.4 mt -62.98 -36.31 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 172.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.7 p -79.32 -32.2 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.921 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -74.15 -30.66 62.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.248 172.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.89 -22.06 65.98 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 118.267 0.485 . . . . 0.0 110.111 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -115.84 31.44 6.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.516 1.126 . . . . 0.0 109.214 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.6 t -63.06 139.58 58.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.87 1.75 90.63 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.8 mt -138.82 78.37 1.67 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.153 1.381 . . . . 0.0 107.673 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -50.07 160.01 0.38 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.858 0.863 . . . . 0.0 113.293 -174.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.1 mt -136.41 153.18 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 158' ' ' GLN . 27.3 m -58.93 155.36 32.61 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 122.597 0.359 . . . . 0.0 110.592 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.99 -31.0 7.8 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.84 3.693 . . . . 0.0 114.084 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -160.12 105.57 1.54 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.04 20.93 1.11 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-O 118.686 -1.063 . . . . 0.0 112.756 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.2 mt -117.48 147.26 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 119.257 1.529 . . . . 0.0 110.271 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.4 m -142.11 144.87 33.72 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.958 0.903 . . . . 0.0 109.49 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.553 HD12 ' HE3' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -139.65 97.81 8.12 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 123.793 0.837 . . . . 0.0 110.047 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.18 154.9 31.68 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.871 3.047 . . . . 0.0 110.998 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.32 168.83 13.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-O 121.408 0.623 . . . . 0.0 111.503 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.46 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 62.9 m-20 -95.13 176.64 2.17 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.549 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -58.08 -19.6 41.81 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.976 2.451 . . . . 0.0 111.913 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.23 -8.14 59.7 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.166 0.986 . . . . 0.0 111.117 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.08 2.76 89.19 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.589 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 80.0 tttt -81.08 134.2 35.62 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.922 1.289 . . . . 0.0 108.304 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.1 148.93 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.505 0.669 . . . . 0.0 109.753 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 53.4 p -72.4 1.46 7.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.989 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 95.75 0.95 62.05 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -140.96 169.71 17.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.913 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.65 -177.89 6.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -144.66 146.46 32.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.521 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 84.4 t -146.16 163.2 10.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.673 ' O ' HG22 ' A' ' 137' ' ' VAL . 58.5 tt0 -130.87 94.6 3.64 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.274 170.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.576 ' CE2' HG11 ' A' ' 113' ' ' VAL . 53.3 m-85 -65.69 170.66 4.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.89 93.37 0.76 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.4 t 62.36 168.28 0.12 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.774 1.23 . . . . 0.0 111.392 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -62.12 -27.55 69.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.713 -0.617 . . . . 0.0 110.901 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.42 -41.28 93.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.198 -0.314 . . . . 0.0 111.016 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.482 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -71.33 -37.88 71.69 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -59.1 -38.48 79.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.83 -0.544 . . . . 0.0 110.648 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -68.87 -31.31 70.16 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.45 0.3 . . . . 0.0 110.572 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -71.0 -40.06 72.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.574 0.226 . . . . 0.0 110.59 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.47 -15.08 62.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.714 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.8 mt -66.62 -11.84 55.4 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.829 0.741 . . . . 0.0 111.934 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.0 -10.65 84.11 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.573 ' HB2' HG11 ' A' ' 183' ' ' VAL . 65.5 mmtt -88.02 -3.38 58.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.214 1.406 . . . . 0.0 112.893 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.559 ' CA ' HG22 ' A' ' 183' ' ' VAL . 6.4 t60 -43.29 -21.47 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.401 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 60.0 mttp -139.58 18.56 2.53 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.522 1.055 . . . . 0.0 111.798 176.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -76.29 -175.65 3.29 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 122.97 0.508 . . . . 0.0 110.323 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -134.57 163.42 29.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.09 -13.44 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.544 0.738 . . . . 0.0 111.971 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.95 -31.68 0.5 Allowed Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.74 -0.6 . . . . 0.0 113.986 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -152.56 2.96 0.34 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.649 0.725 . . . . 0.0 110.909 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -144.69 155.11 43.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.362 1.065 . . . . 0.0 108.164 -174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -106.78 151.22 25.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.272 0.558 . . . . 0.0 110.037 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.8 mm -121.19 159.93 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -171.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -133.44 145.92 50.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' A' ' 169' ' ' LEU . 18.0 m -115.98 136.84 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.707 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 9.1 m-85 -137.24 154.27 50.19 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -76.05 163.0 27.57 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.068 0.849 . . . . 0.0 110.544 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.3 t -158.89 -175.43 5.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.8 m -148.66 170.94 17.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.05 1.34 . . . . 0.0 109.269 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -57.87 -31.77 67.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.877 0.471 . . . . 0.0 111.394 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.37 -5.18 9.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -115.71 2.26 13.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.728 0.811 . . . . 0.0 111.005 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.35 9.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 111.18 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -70.22 16.34 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.374 0.67 . . . . 0.0 112.797 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.0 m -68.45 -0.51 5.06 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.6 0.76 . . . . 0.0 111.23 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.373 178.379 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.189 2 O4'-C1'-N19 113.809 5.609 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.443 " H1'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.6 2 C5'-C4'-C3' 106.478 -6.014 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.443 ' OP1' " H1'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.071 2 P-O3'-C3' 125.389 4.741 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.447 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.414 -3.214 1 O4'-C1'-N19 114.94 6.74 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.464 " O3'" " H3'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.763 1 C5'-C4'-C3' 109.324 -4.118 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.707 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.492 0 C5'-C4'-C3' 111.241 -2.839 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 m -143.38 8.55 1.59 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.879 0.472 . . . . 0.0 111.45 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.12 172.43 17.56 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.315 0.646 . . . . 0.0 109.96 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -146.49 -3.02 0.64 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.733 0.413 . . . . 0.0 111.536 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.7 p -155.98 169.8 23.62 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.017 0.527 . . . . 0.0 110.383 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 41.55 46.1 2.99 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.74 1.216 . . . . 0.0 114.047 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -145.28 26.76 1.3 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -122.47 8.58 9.6 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.14 -8.75 49.63 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -61.77 141.36 57.94 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.553 0.692 . . . . 0.0 110.612 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.622 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.2 p -151.05 175.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.446 ' H ' HG22 ' A' ' 113' ' ' VAL . 55.6 ttt180 -137.01 154.04 50.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.7 tp -133.08 148.32 52.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.419 ' HD2' ' C6 ' ' B' ' 4' ' ' ' G' . 20.3 tpp85 -152.89 160.66 43.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.82 3.93 70.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.402 HD22 ' SG ' ' A' ' 122' ' ' CYS . 95.8 mt -57.33 150.01 45.32 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 117.118 0.459 . . . . 0.0 111.97 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.11 25.25 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 125.143 3.895 . . . . 0.0 113.66 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 22.6 m-30 52.35 13.48 0.3 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.071 1.348 . . . . 0.0 114.192 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.29 -8.86 1.11 Allowed Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.861 0.755 . . . . 0.0 112.458 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 7.0 t -59.62 149.62 29.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.218 1.007 . . . . 0.0 110.953 174.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.478 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 2.4 t -141.16 -167.86 2.49 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.465 0.706 . . . . 0.0 109.298 172.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.8 mptt -51.18 -29.2 13.22 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.436 0.562 . . . . 0.0 112.356 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.4 ' HA ' HG12 ' A' ' 128' ' ' VAL . 39.9 mt-10 -81.22 -19.91 42.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.457 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 5.7 mp0 -92.98 -33.91 13.95 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.773 -0.58 . . . . 0.0 109.439 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.4 HG13 ' SG ' ' A' ' 122' ' ' CYS . 56.7 mt -62.42 -34.9 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 125' ' ' GLU . 9.4 p -84.1 -32.45 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.007 -173.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -72.91 -27.57 61.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -70.77 -25.94 63.12 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.739 0.304 . . . . 0.0 110.429 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -113.71 32.77 5.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.459 1.104 . . . . 0.0 109.016 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.0 t -67.3 -17.01 64.6 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.965 0.506 . . . . 0.0 111.983 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.36 15.41 60.04 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.631 ' HB3' HD11 ' A' ' 164' ' ' LEU . 33.8 mt -143.73 -163.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.207 1.803 . . . . 0.0 107.403 -173.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -146.94 162.61 38.36 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.3 mt -142.16 150.86 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.6 m -75.2 155.23 86.24 Favored Pre-proline 0 C--O 1.232 0.135 0 O-C-N 122.032 -0.417 . . . . 0.0 110.471 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.09 136.81 29.81 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 124.006 3.137 . . . . 0.0 112.245 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.6 t30 40.05 38.92 0.55 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.448 1.099 . . . . 0.0 112.07 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.67 28.19 13.25 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-O 118.859 -0.967 . . . . 0.0 111.876 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.96 147.15 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 118.99 1.395 . . . . 0.0 109.548 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 88.6 m -138.47 148.38 44.29 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.073 0.949 . . . . 0.0 108.991 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.478 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 6.3 mt -145.74 99.04 4.43 Favored Pre-proline 0 N--CA 1.453 -0.315 0 C-N-CA 123.091 0.557 . . . . 0.0 110.225 -174.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.7 157.59 18.94 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.499 2.8 . . . . 0.0 110.334 171.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 151' ' ' ILE . 31.3 m -145.68 163.73 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-O 121.427 0.632 . . . . 0.0 111.324 173.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.458 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 57.8 m-20 -89.69 175.5 3.82 Favored Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.579 174.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.5 Cg_exo -57.95 -20.46 44.88 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.734 2.289 . . . . 0.0 111.385 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -79.48 -9.96 59.71 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.102 0.961 . . . . 0.0 111.252 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.56 0.7 90.06 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -173.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.626 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 85.3 tttt -72.28 131.79 43.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.914 1.286 . . . . 0.0 108.891 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.469 ' C ' ' H ' ' A' ' 153' ' ' GLY . 8.4 pt -71.88 10.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -169.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p 67.49 -15.71 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.532 1.133 . . . . 0.0 112.197 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 101.33 6.44 50.94 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.338 0.971 . . . . 0.0 112.814 175.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -142.68 168.82 18.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.058 0.929 . . . . 0.0 111.936 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.11 -178.82 7.59 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.671 0.788 . . . . 0.0 110.59 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -143.59 146.24 33.14 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -177.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.3 t -146.42 165.01 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -174.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.633 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.4 tt0 -129.46 96.15 4.2 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.68 0.753 . . . . 0.0 109.009 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.622 ' CE2' HG11 ' A' ' 113' ' ' VAL . 36.3 m-85 -68.6 172.07 6.74 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.23 93.45 1.09 Allowed 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t 61.27 168.73 0.1 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.683 1.193 . . . . 0.0 111.455 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -61.73 -27.3 68.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.76 -0.587 . . . . 0.0 110.65 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.32 -36.21 79.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.05 -0.406 . . . . 0.0 111.515 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.8 OUTLIER -74.76 -40.0 61.47 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.14 -37.89 72.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 122.296 -0.252 . . . . 0.0 110.614 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -68.74 -32.12 71.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.601 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -71.3 -38.56 71.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.581 0.229 . . . . 0.0 110.795 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.52 -18.46 63.84 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.821 0.448 . . . . 0.0 112.033 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.706 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.9 mt -65.95 -14.37 61.45 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.641 0.655 . . . . 0.0 111.836 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.86 -10.26 80.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.574 ' HB2' HG11 ' A' ' 183' ' ' VAL . 63.6 mmtt -90.58 -1.97 57.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.814 1.246 . . . . 0.0 112.606 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.567 ' CA ' HG22 ' A' ' 183' ' ' VAL . 11.6 t-160 -43.93 -19.92 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.42 17.02 2.39 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.364 0.984 . . . . 0.0 111.833 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -75.65 -173.78 2.3 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-O 120.997 0.427 . . . . 0.0 110.119 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -134.43 166.21 23.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -170.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.6 -19.83 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 124.633 1.173 . . . . 0.0 109.989 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 137.02 135.48 3.39 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 45.32 2.47 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.791 2.036 . . . . 0.0 115.215 -173.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -151.46 166.8 29.98 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.188 0.595 . . . . 0.0 110.143 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -120.78 155.09 34.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.4 mm -123.44 162.57 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -170.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -134.37 150.6 50.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' A' ' 169' ' ' LEU . 19.7 m -119.77 135.6 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.703 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 11.8 m-30 -134.84 153.48 52.02 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -76.49 162.95 27.39 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.674 -0.641 . . . . 0.0 110.629 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.5 t -158.86 -175.93 5.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.3 m -148.18 168.95 21.13 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.249 1.419 . . . . 0.0 109.192 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -57.44 -31.91 66.37 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.734 0.414 . . . . 0.0 111.173 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.87 -16.74 59.89 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -102.35 0.44 34.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.405 0.682 . . . . 0.0 111.47 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.1 p -143.35 14.33 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.002 0.43 . . . . 0.0 111.027 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -69.45 13.45 0.13 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.4 m -68.01 -0.68 4.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.592 0.757 . . . . 0.0 111.199 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.094 178.541 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.291 2 O4'-C1'-N19 114.166 5.966 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.453 ' C4 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.655 1 C5'-C4'-C3' 107.301 -5.466 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.49 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.405 -3.998 0 C3'-C2'-C1' 104.471 3.301 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.49 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.831 2 O4'-C1'-N19 116.235 8.035 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.433 " O3'" " H3'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.418 -2.926 1 C5'-C4'-C3' 109.477 -4.015 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.703 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.523 0 C5'-C4'-C3' 110.885 -3.077 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.6 t -146.82 15.95 1.23 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.927 0.491 . . . . 0.0 111.035 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.2 4.45 1.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -145.32 -6.89 0.63 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.899 0.318 . . . . 0.0 111.467 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.7 t -156.03 157.14 35.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.868 0.467 . . . . 0.0 109.835 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -163.65 -179.41 6.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.658 0.783 . . . . 0.0 109.902 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.05 26.5 0.26 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.982 0.513 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -136.89 2.63 2.63 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.57 -10.23 75.2 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 122.08 -0.388 . . . . 0.0 112.66 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -65.44 150.34 48.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.593 0.711 . . . . 0.0 110.323 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.587 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.0 p -153.11 175.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.676 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.465 ' H ' HG22 ' A' ' 113' ' ' VAL . 32.5 ttt180 -132.32 153.75 50.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.378 1.071 . . . . 0.0 108.673 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.1 tp -137.4 146.52 44.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -152.6 169.41 22.74 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.407 ' HA3' ' N2 ' ' B' ' 3' ' ' ' G' . . . 81.85 8.59 86.53 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 118' ' ' LEU . 89.5 mt -57.18 142.65 74.72 Favored Pre-proline 0 N--CA 1.451 -0.412 0 C-N-CA 122.858 0.463 . . . . 0.0 111.9 -174.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.99 27.45 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 125.235 3.956 . . . . 0.0 113.609 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.455 ' CE2' H5'' ' B' ' 1' ' ' ' A' . 83.3 m-85 54.79 8.13 0.2 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.03 1.332 . . . . 0.0 114.536 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -136.81 -5.13 1.98 Allowed Glycine 0 CA--C 1.528 0.87 0 CA-C-N 118.786 0.721 . . . . 0.0 112.169 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 44.4 t -61.62 153.04 29.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.69 0.796 . . . . 0.0 111.147 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 t -156.16 -163.35 1.45 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.428 ' HD2' ' HB ' ' A' ' 141' ' ' ILE . 27.3 mmtp -46.17 -39.26 9.39 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.428 0.691 . . . . 0.0 112.679 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.442 ' HA ' HG12 ' A' ' 128' ' ' VAL . 39.3 mt-10 -83.72 -15.3 49.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.515 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 65.5 mm-40 -98.81 -31.47 11.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.413 HG13 ' SG ' ' A' ' 122' ' ' CYS . 32.5 mt -64.37 -37.68 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 172.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 125' ' ' GLU . 11.4 p -79.4 -33.16 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.528 -173.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -74.14 -25.89 60.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.137 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 181' ' ' ILE . 53.8 t80 -71.78 -20.35 61.88 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.872 0.305 . . . . 0.0 110.667 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -120.94 33.59 5.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.481 1.112 . . . . 0.0 108.455 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -64.0 -17.63 63.5 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.16 0.584 . . . . 0.0 112.439 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.27 15.28 58.74 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' A' ' 164' ' ' LEU . 56.4 mt -144.04 -162.53 1.49 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.486 1.514 . . . . 0.0 108.457 -172.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -145.97 163.04 36.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.9 mt -142.25 150.32 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 158' ' ' GLN . 16.3 m -74.55 155.99 87.15 Favored Pre-proline 0 CA--C 1.53 0.177 0 O-C-N 121.995 -0.441 . . . . 0.0 110.527 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.83 133.48 22.43 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 124.196 3.264 . . . . 0.0 112.464 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.2 t30 38.62 39.34 0.32 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.582 1.153 . . . . 0.0 112.16 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.5 35.36 3.97 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-O 119.044 -0.864 . . . . 0.0 111.246 -174.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.428 ' HB ' ' HD2' ' A' ' 124' ' ' LYS . 89.3 mt -137.84 146.68 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 118.74 1.27 . . . . 0.0 109.42 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.3 m -138.23 144.23 40.5 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 123.574 0.749 . . . . 0.0 109.166 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.5 mt -137.78 87.28 17.19 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 123.71 0.804 . . . . 0.0 109.396 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.67 158.85 18.67 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.095 2.53 . . . . 0.0 110.855 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.42 160.34 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 121.552 0.691 . . . . 0.0 112.24 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 22.0 m-20 -83.54 174.12 6.43 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.826 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 33.7 Cg_exo -59.9 -2.65 1.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.274 3.316 . . . . 0.0 113.045 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -117.15 1.38 12.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.799 0.839 . . . . 0.0 110.759 -176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.06 2.83 88.06 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -69.54 161.31 29.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 153' ' ' GLY . 4.8 pt -95.95 13.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -167.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 p 62.71 -3.37 0.31 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.916 0.886 . . . . 0.0 112.358 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 77.27 6.02 85.95 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.779 1.181 . . . . 0.0 113.014 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -142.41 168.41 19.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.238 1.019 . . . . 0.0 111.72 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.27 -177.98 6.99 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.059 0.944 . . . . 0.0 110.453 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -145.56 148.11 32.81 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.477 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 61.7 t -146.11 165.0 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.636 ' O ' HG22 ' A' ' 137' ' ' VAL . 52.4 tt0 -129.74 95.85 4.08 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.74 0.781 . . . . 0.0 108.982 171.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.587 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.1 m-85 -69.03 170.9 9.02 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.763 174.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.29 94.05 0.9 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.7 t 62.66 168.44 0.13 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.538 1.135 . . . . 0.0 111.621 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -61.86 -26.05 67.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.61 -36.55 84.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.035 0.379 . . . . 0.0 111.704 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -73.64 -39.97 64.11 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.05 -34.76 70.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.293 -0.254 . . . . 0.0 110.631 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -69.16 -32.15 71.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.336 0.255 . . . . 0.0 110.516 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -72.53 -38.05 68.15 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.766 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.01 -19.56 64.47 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.113 0.565 . . . . 0.0 112.341 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.689 ' HA ' HG21 ' A' ' 183' ' ' VAL . 95.2 mt -67.65 -8.46 34.96 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.584 0.629 . . . . 0.0 111.284 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.66 8.09 66.88 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -118.76 3.7 11.62 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 123.852 0.861 . . . . 0.0 111.289 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.583 ' CA ' HG22 ' A' ' 183' ' ' VAL . 5.3 t60 -42.2 -24.48 0.05 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.41 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 61.1 mttp -137.5 18.32 2.91 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.355 0.98 . . . . 0.0 110.897 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -81.57 174.12 11.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.711 1.604 . . . . 0.0 108.792 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -120.35 158.46 27.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.2 tt -98.09 -12.51 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.499 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.87 -26.66 1.77 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.248 0.451 . . . . 0.0 112.209 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -155.4 5.83 0.22 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.148 0.579 . . . . 0.0 110.789 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -145.75 160.57 41.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.556 1.142 . . . . 0.0 108.197 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.409 ' CZ ' ' C2 ' ' B' ' 3' ' ' ' G' . 19.7 p90 -107.93 145.27 34.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 130' ' ' PHE . 31.3 mm -122.02 160.62 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -129.98 144.86 51.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.689 HG21 ' HA ' ' A' ' 169' ' ' LEU . 11.0 m -119.3 143.21 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.464 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 47.5 m-85 -150.41 156.01 40.67 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -73.71 156.77 37.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.983 0.42 . . . . 0.0 110.696 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.7 t -157.68 -177.06 6.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.118 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.6 t -152.08 174.8 13.25 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.14 0.976 . . . . 0.0 109.558 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.6 tp60 -59.03 -31.7 69.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.726 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.09 -3.8 6.19 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -118.79 2.95 11.65 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.664 0.786 . . . . 0.0 111.308 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.5 10.51 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.913 0.387 . . . . 0.0 111.204 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -68.2 14.12 0.07 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.0 m -68.69 -0.58 5.44 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.433 0.693 . . . . 0.0 111.239 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.079 178.371 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.455 H5'' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.413 -3.309 0 C5'-C4'-C3' 110.353 -3.432 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 C5'-C4'-C3' 110.179 -3.548 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.526 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.411 -3.534 1 P-O3'-C3' 125.3 4.667 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.526 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.9 1 O4'-C1'-N19 115.041 6.841 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.566 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.84 1 C5'-C4'-C3' 108.304 -4.798 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.566 ' C5 ' " H1'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.541 0 O4'-C1'-C2' 103.075 -2.375 . 0.0 OUTLIER '7D dist 4a' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.5 t30 . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.4 p -150.54 12.84 0.72 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.225 0.61 . . . . 0.0 111.517 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.42 -179.3 6.85 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.87 0.468 . . . . 0.0 110.734 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 52.48 26.99 4.59 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.709 0.804 . . . . 0.0 112.409 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.1 p -140.93 18.83 2.3 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.693 0.797 . . . . 0.0 110.98 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.2 52.98 1.82 Allowed 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.888 0.875 . . . . 0.0 110.041 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -147.73 34.78 0.85 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.447 -171.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -118.15 7.45 12.15 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.03 -8.91 42.68 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.93 139.96 58.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.423 0.63 . . . . 0.0 110.705 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.4 p -149.51 175.81 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.205 1.002 . . . . 0.0 108.764 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.463 ' H ' HG22 ' A' ' 113' ' ' VAL . 33.0 ttt180 -137.49 144.42 42.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.06 0.544 . . . . 0.0 109.743 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.407 ' HB3' HD12 ' A' ' 118' ' ' LEU . 4.0 mm? -119.02 152.25 36.76 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.478 ' HE ' ' HB3' ' A' ' 154' ' ' GLU . 19.3 tpp85 -157.6 152.1 25.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.27 2.45 90.59 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 171.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.752 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -68.25 158.49 84.27 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 37.7 Cg_exo -52.21 153.66 12.44 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.026 2.484 . . . . 0.0 114.311 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.59 ' CE1' ' C5 ' ' B' ' 2' ' ' ' G' . 55.0 m-85 -68.25 -1.55 6.42 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.944 0.497 . . . . 0.0 111.802 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.77 2.96 10.97 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.435 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 52.5 t -66.3 153.51 42.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.025 0.93 . . . . 0.0 109.605 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.655 HG23 ' H ' ' A' ' 125' ' ' GLU . 10.0 t -154.97 -175.24 5.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 2.4 ptpp? -56.45 -22.06 29.57 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.655 ' H ' HG23 ' A' ' 123' ' ' THR . 40.8 tt0 -77.72 -25.07 49.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.242 0.617 . . . . 0.0 110.899 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -89.05 -35.52 16.3 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.6 -34.35 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.58 -34.07 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.658 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -73.17 -25.72 60.9 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.921 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -72.04 -25.97 62.01 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.64 0.257 . . . . 0.0 110.336 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -111.29 30.5 6.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.531 1.132 . . . . 0.0 109.022 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.6 t -65.74 -14.68 61.78 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.753 0.421 . . . . 0.0 111.865 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.17 15.26 63.32 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.625 ' HB3' HD11 ' A' ' 164' ' ' LEU . 33.4 mt -143.26 -162.8 1.51 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.249 1.819 . . . . 0.0 107.35 -173.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -147.15 162.29 39.16 Favored 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.2 mt -142.38 152.09 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.9 m -77.65 153.86 81.09 Favored Pre-proline 0 CA--C 1.528 0.105 0 CA-C-N 118.153 0.433 . . . . 0.0 110.683 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.37 140.7 34.11 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.097 3.198 . . . . 0.0 112.094 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 42.02 36.39 0.67 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.201 1.0 . . . . 0.0 111.929 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -99.76 29.28 12.37 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 118.898 -0.945 . . . . 0.0 111.943 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 77.6 mt -137.72 146.07 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.847 1.324 . . . . 0.0 110.2 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.1 m -142.17 147.55 36.8 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.009 0.924 . . . . 0.0 109.728 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.4 mt -140.78 96.48 7.48 Favored Pre-proline 0 CA--C 1.527 0.094 0 C-N-CA 124.243 1.017 . . . . 0.0 109.849 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.74 154.88 8.73 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.713 2.942 . . . . 0.0 112.019 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.77 165.13 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-O 121.244 0.545 . . . . 0.0 110.467 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 67.7 m-20 -86.13 176.4 3.62 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.929 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -59.1 -17.77 40.17 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.102 2.535 . . . . 0.0 111.85 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -86.89 -4.69 59.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.594 0.758 . . . . 0.0 110.789 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.46 11.15 83.58 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 123.477 0.56 . . . . 0.0 112.534 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -102.22 149.81 23.93 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 117.455 0.628 . . . . 0.0 109.55 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.6 pt -69.22 151.87 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.729 0.776 . . . . 0.0 112.606 -170.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.3 p -86.98 -7.14 58.45 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.144 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.408 ' HA2' ' O6 ' ' B' ' 2' ' ' ' G' . . . 97.74 6.36 57.25 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-O 119.768 -0.462 . . . . 0.0 112.781 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.478 ' HB3' ' HE ' ' A' ' 116' ' ' ARG . 23.0 pt-20 -140.02 168.45 19.79 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.433 0.617 . . . . 0.0 110.546 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.21 178.51 10.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.069 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -141.57 143.95 33.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 69.6 t -144.56 162.61 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -174.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.669 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.4 tt0 -128.51 97.62 4.77 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.863 0.84 . . . . 0.0 109.02 170.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 113' ' ' VAL . 38.5 m-85 -69.07 171.57 8.03 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.433 173.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.29 92.57 0.79 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t 61.33 170.42 0.11 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.757 1.223 . . . . 0.0 111.423 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -62.63 -27.18 69.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.818 -0.551 . . . . 0.0 110.696 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.48 -41.56 85.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.153 -0.342 . . . . 0.0 111.133 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -72.51 -39.55 67.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.66 -38.26 74.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.002 -0.436 . . . . 0.0 110.93 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -69.27 -30.05 68.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.755 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -72.58 -38.93 67.74 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 120.46 0.172 . . . . 0.0 111.082 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.411 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.39 -19.39 64.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.766 0.427 . . . . 0.0 112.127 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.452 ' HA ' HG21 ' A' ' 183' ' ' VAL . 95.4 mt -69.19 -11.65 60.98 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.842 -0.536 . . . . 0.0 111.345 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.87 -13.24 80.84 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.565 ' HB2' HG11 ' A' ' 183' ' ' VAL . 70.3 mmtt -83.41 -1.04 52.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.299 1.439 . . . . 0.0 111.924 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.441 ' CA ' HG22 ' A' ' 183' ' ' VAL . 6.1 t60 -54.81 134.81 48.1 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.248 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.55 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 47.6 mttp 56.85 6.33 0.3 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.993 1.717 . . . . 0.0 114.567 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.13 172.49 11.63 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.051 0.94 . . . . 0.0 109.325 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -123.05 158.85 29.68 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.949 -0.47 . . . . 0.0 112.197 -170.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.6 tt -112.75 -2.24 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.08 -32.43 0.66 Allowed Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.931 -0.481 . . . . 0.0 113.936 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -156.45 4.21 0.16 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.85 0.825 . . . . 0.0 111.163 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -147.74 159.68 43.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.252 1.021 . . . . 0.0 108.477 -170.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -109.02 130.16 55.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.411 0.624 . . . . 0.0 109.968 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 18.0 mm -94.55 166.53 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -130.65 154.14 48.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 171' ' ' LYS . 24.4 m -135.79 125.2 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.665 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 8.2 m-30 -133.47 163.69 28.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -88.64 169.11 11.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.456 1.025 . . . . 0.0 111.598 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -158.32 -177.22 6.38 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.084 0.554 . . . . 0.0 111.156 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.1 m -149.35 168.77 22.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.144 1.378 . . . . 0.0 108.69 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -56.43 -32.54 64.98 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.45 0.3 . . . . 0.0 111.641 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.54 -2.43 6.57 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -117.0 3.02 12.77 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.964 0.906 . . . . 0.0 110.8 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.27 11.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 121.221 0.534 . . . . 0.0 110.825 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -68.06 13.77 0.08 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.85 0.86 . . . . 0.0 113.068 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.4 m -68.28 -1.24 5.86 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.57 0.748 . . . . 0.0 111.254 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.125 178.564 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.942 2 O4'-C1'-N19 114.567 6.367 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.59 ' C5 ' ' CE1' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.748 1 C5'-C4'-C3' 106.12 -6.254 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.425 " H5'" " H1'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 P--O5' 1.623 2.972 2 P-O3'-C3' 124.651 4.126 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.435 ' C6 ' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 O4'--C4' 1.418 -2.885 2 O4'-C1'-N19 117.131 8.931 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.55 ' C2 ' ' HE3' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.075 1 C5'-C4'-C3' 109.407 -4.062 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.665 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.502 0 P-O3'-C3' 123.604 3.253 . 0.013 4d . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.921 -0.029 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.5 m 48.44 28.55 1.73 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.147 0.979 . . . . 0.0 112.933 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.33 17.7 1.53 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.453 0.701 . . . . 0.0 110.417 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -148.97 179.31 7.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.951 0.9 . . . . 0.0 109.125 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.5 m -135.52 172.85 12.42 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.771 0.428 . . . . 0.0 110.893 -177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -150.23 169.37 21.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.749 0.419 . . . . 0.0 111.082 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -152.78 30.55 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.203 0.601 . . . . 0.0 110.963 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.83 2.54 6.67 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.09 -10.19 51.21 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.395 174.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -64.04 143.61 57.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.428 0.632 . . . . 0.0 110.372 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.646 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.9 p -150.81 178.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.911 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 113' ' ' VAL . 5.8 mtm180 -133.28 165.07 25.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.318 0.647 . . . . 0.0 111.087 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 115' ' ' LEU . 12.8 tp -147.23 145.16 29.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -154.82 171.2 20.0 Favored 'General case' 0 CA--C 1.527 0.084 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.72 10.45 86.23 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 120' ' ' PHE . 95.2 mt -55.15 149.65 24.5 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 123.289 0.636 . . . . 0.0 111.494 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.06 27.38 0.21 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.798 2.332 . . . . 0.0 113.454 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.549 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 62.6 m-85 51.04 12.96 0.13 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.926 1.691 . . . . 0.0 113.603 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.19 -8.14 1.21 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 22.5 t -61.84 154.07 27.0 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.779 0.831 . . . . 0.0 109.847 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.622 HG23 ' H ' ' A' ' 125' ' ' GLU . 10.0 t -147.69 -174.86 4.66 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.469 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.8 ptpp? -55.33 -20.12 10.7 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.622 ' H ' HG23 ' A' ' 123' ' ' THR . 42.2 mt-10 -83.6 -22.38 32.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.018 0.527 . . . . 0.0 111.342 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.509 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 64.3 mm-40 -92.43 -30.49 15.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.49 -36.44 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.07 -32.11 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.685 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -73.15 -27.62 61.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.065 172.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 24.1 t80 -71.67 -24.34 61.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 110.504 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -115.49 32.14 6.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.442 1.097 . . . . 0.0 108.727 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 t -67.92 -16.97 64.31 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.936 0.495 . . . . 0.0 112.075 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.66 15.66 59.9 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.661 ' HB3' HD11 ' A' ' 164' ' ' LEU . 30.0 mt -143.47 -164.83 1.95 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.229 1.812 . . . . 0.0 107.307 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -148.06 161.23 41.81 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.839 -0.538 . . . . 0.0 110.038 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.9 mt -140.43 150.83 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.5 m -77.56 154.09 81.36 Favored Pre-proline 0 CA--C 1.528 0.128 0 CA-C-N 118.407 0.549 . . . . 0.0 110.354 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.1 141.31 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.925 3.083 . . . . 0.0 111.949 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 43.13 35.18 0.76 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.906 0.882 . . . . 0.0 111.777 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.99 28.82 13.48 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-O 119.245 -0.753 . . . . 0.0 111.968 -173.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.8 mt -138.24 144.78 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 118.817 1.308 . . . . 0.0 109.731 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.7 m -140.35 145.74 37.54 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.592 0.757 . . . . 0.0 109.234 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 155' ' ' ALA . 13.0 mt -141.76 94.21 7.38 Favored Pre-proline 0 N--CA 1.455 -0.208 0 C-N-CA 124.154 0.982 . . . . 0.0 109.061 -176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.06 152.89 22.65 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.334 2.689 . . . . 0.0 110.624 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.47 166.02 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 CA-C-O 121.328 0.585 . . . . 0.0 111.072 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 58.9 m-20 -91.56 177.07 2.36 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.861 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 32.6 Cg_exo -59.07 -19.43 48.74 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.942 2.428 . . . . 0.0 111.762 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -81.95 -7.46 59.61 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.768 0.827 . . . . 0.0 110.672 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.33 12.31 83.26 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.675 0.655 . . . . 0.0 112.151 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -102.0 149.97 23.7 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.8 pt -68.24 148.28 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.465 0.65 . . . . 0.0 111.577 -171.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.2 p -76.6 -4.03 40.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.705 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.7 4.31 54.68 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 123.048 0.356 . . . . 0.0 112.46 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -145.15 171.16 14.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.247 0.524 . . . . 0.0 110.092 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.43 ' HB2' HD23 ' A' ' 143' ' ' LEU . . . -154.21 179.12 9.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.3 0.572 . . . . 0.0 110.5 -175.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -144.4 143.79 31.09 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 90.4 t -145.99 164.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -174.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.451 ' N ' HG12 ' A' ' 157' ' ' VAL . 52.2 tt0 -129.82 102.77 6.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.646 ' CE2' HG11 ' A' ' 113' ' ' VAL . 34.0 m-85 -73.83 172.2 11.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.322 171.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.17 91.58 0.72 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.084 0.469 . . . . 0.0 109.815 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 61.61 168.53 0.11 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.666 1.186 . . . . 0.0 111.476 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -16.43 63.91 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.885 -0.51 . . . . 0.0 111.055 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -66.01 -42.96 89.0 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.973 -0.454 . . . . 0.0 110.342 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.8 OUTLIER -70.73 -39.69 73.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.31 -38.32 73.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.244 -0.285 . . . . 0.0 110.856 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -69.26 -29.98 68.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.728 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -72.52 -38.35 68.11 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.513 0.197 . . . . 0.0 110.814 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.412 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.91 -19.58 65.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.731 0.412 . . . . 0.0 111.935 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.462 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.0 mt -67.55 -12.06 59.49 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.464 0.574 . . . . 0.0 111.336 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.98 -11.96 78.96 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.632 ' HB2' HG11 ' A' ' 183' ' ' VAL . 69.5 mmtt -87.39 1.63 52.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.263 1.425 . . . . 0.0 111.614 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.491 ' HA ' HG22 ' A' ' 183' ' ' VAL . 65.3 t60 -54.32 134.26 45.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.51 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 90.9 mttt 53.5 14.01 0.53 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.545 1.538 . . . . 0.0 113.967 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.02 163.04 20.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.886 0.766 . . . . 0.0 109.607 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -101.31 159.09 15.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.6 tt -114.99 -7.29 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 160.28 -37.79 0.45 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-O 119.916 -0.38 . . . . 0.0 112.971 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -155.57 11.86 0.32 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.35 0.575 . . . . 0.0 110.761 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -136.0 -179.82 5.89 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.283 1.033 . . . . 0.0 109.141 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -126.15 141.54 51.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.7 mm -112.82 160.87 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.472 ' CG ' ' H21' ' B' ' 3' ' ' ' G' . 22.7 mm-40 -129.89 94.46 3.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -170.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' A' ' 171' ' ' LYS . 13.9 m -74.24 140.44 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.149 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.648 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 18.3 m-85 -146.26 161.43 40.29 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -79.55 161.72 25.8 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.833 0.742 . . . . 0.0 109.965 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -157.2 -174.2 4.8 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.53 -0.106 . . . . 0.0 111.13 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.7 t -147.4 172.07 14.5 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.808 0.843 . . . . 0.0 110.155 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -59.99 -31.55 70.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.746 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.42 -1.27 7.98 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -114.36 0.34 14.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.792 0.837 . . . . 0.0 110.547 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.92 14.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 120.956 0.408 . . . . 0.0 110.785 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -67.08 9.8 0.18 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 31.3 m -68.7 -0.7 5.6 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.443 0.697 . . . . 0.0 111.292 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.785 -1.103 . . . . 0.0 111.151 178.347 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.142 2 O4'-C1'-N19 114.381 6.181 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.553 H5'' ' C8 ' ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.92 1 C5'-C4'-C3' 107.031 -5.646 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.472 ' H21' ' CG ' ' A' ' 182' ' ' GLU . . . . . . . . 0 O4'--C4' 1.411 -3.532 2 P-O3'-C3' 124.863 4.302 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.948 1 O4'-C1'-N19 115.167 6.967 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.578 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.176 1 C5'-C4'-C3' 108.606 -4.596 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.648 " H1'" ' CZ ' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.522 0 P-O3'-C3' 122.814 2.595 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.5 p -147.62 9.23 0.91 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.777 0.431 . . . . 0.0 111.568 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -147.14 8.51 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.144 0.577 . . . . 0.0 111.204 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -146.09 162.88 36.94 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.686 0.794 . . . . 0.0 109.41 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.5 p 49.31 18.03 0.24 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.801 1.241 . . . . 0.0 113.441 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.18 40.95 2.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.149 0.98 . . . . 0.0 110.179 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -146.98 35.08 0.91 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.47 -172.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.62 7.82 10.04 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.34 -9.28 30.88 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -61.86 138.22 58.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.362 0.601 . . . . 0.0 110.669 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.5 p -150.25 175.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.044 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.444 ' H ' HG22 ' A' ' 113' ' ' VAL . 9.9 mtm180 -132.35 151.16 51.97 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.608 0.763 . . . . 0.0 110.695 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -123.34 148.71 45.73 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 124.281 1.032 . . . . 0.0 108.39 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.402 ' HD2' ' C6 ' ' B' ' 4' ' ' ' G' . 20.3 tpp85 -153.18 161.08 42.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.81 0.53 85.18 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.8 mt -53.34 134.93 51.84 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 124.07 0.948 . . . . 0.0 111.238 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -60.31 142.98 99.44 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 107.262 -1.861 . . . . 0.0 107.262 170.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.454 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 17.5 m-85 -66.9 -2.11 4.82 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.92 -174.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.02 -0.9 27.0 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 47.4 t -63.69 142.77 58.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.031 0.932 . . . . 0.0 109.829 176.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.4 t -148.82 -160.9 1.24 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.407 ' HD2' ' HB ' ' A' ' 141' ' ' ILE . 28.9 mmtp -45.21 -41.03 7.91 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.539 0.736 . . . . 0.0 112.953 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.475 ' HA ' HG12 ' A' ' 128' ' ' VAL . 38.8 mt-10 -77.76 -23.06 49.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -173.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.445 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 9.9 mp0 -86.3 -39.56 16.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.0 mt -64.45 -36.32 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 125' ' ' GLU . 14.5 p -80.64 -34.13 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.08 -170.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -81.2 -20.64 40.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.869 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -71.89 -22.75 61.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 171.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -115.48 35.96 4.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.501 1.12 . . . . 0.0 109.139 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.8 t -62.64 142.53 58.01 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.17 5.11 75.39 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 39.0 mt -140.44 72.13 1.39 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.13 1.372 . . . . 0.0 107.97 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -49.55 159.3 0.36 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.036 0.934 . . . . 0.0 113.473 -174.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.4 mt -135.33 146.91 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.6 m -71.41 155.61 92.56 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 118.506 0.594 . . . . 0.0 110.236 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.89 135.23 23.25 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 124.094 3.196 . . . . 0.0 112.301 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.4 t30 40.21 38.16 0.49 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.423 1.089 . . . . 0.0 111.996 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.02 33.83 4.69 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.407 ' HB ' ' HD2' ' A' ' 124' ' ' LYS . 81.7 mt -140.29 143.92 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 118.522 1.161 . . . . 0.0 108.842 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.0 m -136.91 147.95 46.73 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.439 0.695 . . . . 0.0 109.299 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 88.2 mt -139.75 93.42 9.6 Favored Pre-proline 0 C--O 1.234 0.249 0 C-N-CA 123.278 0.631 . . . . 0.0 110.485 -173.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.04 154.81 26.01 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.931 2.421 . . . . 0.0 110.325 171.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' A' ' 151' ' ' ILE . 27.1 m -146.58 164.64 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 CA-C-O 121.429 0.633 . . . . 0.0 111.588 174.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 59.0 m-20 -90.99 176.04 3.17 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.469 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.8 Cg_exo -58.09 -20.67 47.06 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.842 2.361 . . . . 0.0 111.563 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.63 -10.4 59.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.35 1.06 . . . . 0.0 111.214 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.96 1.58 90.65 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.427 ' HE2' ' CD2' ' A' ' 120' ' ' PHE . 52.2 tttm -73.58 130.59 40.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.888 1.275 . . . . 0.0 109.152 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 153' ' ' GLY . 9.0 pt -70.31 9.93 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -168.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 66.63 -15.88 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.97 0.908 . . . . 0.0 112.417 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 100.41 3.19 55.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.547 1.07 . . . . 0.0 113.063 175.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -139.71 170.41 15.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.263 1.032 . . . . 0.0 111.425 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -160.99 -178.05 6.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.943 0.497 . . . . 0.0 110.561 -174.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -142.52 145.06 33.25 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 89.6 t -145.09 164.3 12.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' ' 157' ' ' VAL . 53.2 tt0 -131.16 101.33 5.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.606 ' CE2' HG11 ' A' ' 113' ' ' VAL . 47.5 m-85 -71.61 171.64 11.09 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.341 171.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 93.05 0.95 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.14 0.495 . . . . 0.0 109.98 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t 62.09 169.43 0.12 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.498 1.119 . . . . 0.0 111.02 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.74 -21.03 66.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.771 -0.58 . . . . 0.0 111.174 -175.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.73 -42.94 99.91 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.917 -0.489 . . . . 0.0 110.302 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.471 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -69.77 -38.69 76.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.4 -40.53 82.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.026 -0.421 . . . . 0.0 110.701 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -68.03 -30.91 70.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.566 0.346 . . . . 0.0 110.668 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -71.6 -39.78 70.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 110.511 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.35 -13.33 61.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.688 ' HA ' HG21 ' A' ' 183' ' ' VAL . 92.4 mt -67.23 -14.09 62.58 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 118.97 0.805 . . . . 0.0 111.954 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.61 -11.9 77.41 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.558 ' HB2' HG11 ' A' ' 183' ' ' VAL . 70.1 mmtt -85.43 -4.94 59.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.17 1.388 . . . . 0.0 113.049 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.569 ' CA ' HG22 ' A' ' 183' ' ' VAL . 13.0 t60 -42.51 -23.54 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.42 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 98.5 mttt -140.55 17.57 2.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.205 0.911 . . . . 0.0 112.005 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -74.6 -174.82 2.21 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.086 0.469 . . . . 0.0 110.11 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.14 159.11 37.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.771 -171.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.1 tt -110.59 -6.36 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 150.53 -29.14 1.06 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.985 -0.341 . . . . 0.0 113.164 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -156.43 4.17 0.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.485 0.642 . . . . 0.0 110.834 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -149.84 157.95 43.69 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.406 1.083 . . . . 0.0 108.49 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -104.83 150.88 24.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.8 mm -123.68 161.93 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -172.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -132.25 157.36 44.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 169' ' ' LEU . 17.8 m -129.91 135.62 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.562 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 5.4 m-85 -132.82 158.85 41.44 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -75.16 160.94 29.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.947 0.794 . . . . 0.0 109.629 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t -154.05 -174.1 4.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.724 0.297 . . . . 0.0 111.575 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.5 m -146.11 166.89 24.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.176 0.99 . . . . 0.0 109.977 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -60.09 -32.11 70.65 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.407 0.283 . . . . 0.0 110.564 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -63.54 -17.28 62.63 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -100.0 -0.94 38.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.308 0.643 . . . . 0.0 111.4 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.6 12.07 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.941 0.401 . . . . 0.0 111.523 -174.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -68.17 12.56 0.11 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.0 m -68.95 -1.15 6.68 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.357 0.663 . . . . 0.0 111.127 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.236 -1.364 . . . . 0.0 111.147 178.419 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.577 ' C8 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.413 -3.338 0 C5'-C4'-C3' 111.872 -2.418 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.461 H5'' " C5'" ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.769 1 O4'-C1'-N19 113.022 4.822 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.531 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.408 -3.739 0 C3'-C2'-C1' 104.807 3.675 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.531 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.777 2 O4'-C1'-N19 116.747 8.547 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.435 ' H2 ' ' CE1' ' A' ' 172' ' ' HIS . . . . . . . . 0 O4'--C4' 1.419 -2.861 0 C5'-C4'-C3' 109.811 -3.793 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.562 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.424 -2.454 0 C5'-C4'-C3' 109.624 -3.917 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 120.412 0.148 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.3 p -150.66 2.97 0.47 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.558 0.343 . . . . 0.0 111.922 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.17 9.84 0.67 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.776 0.43 . . . . 0.0 111.312 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -154.45 160.34 41.56 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.025 0.53 . . . . 0.0 110.539 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.0 m -152.9 159.49 42.99 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.449 0.7 . . . . 0.0 109.953 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.84 122.71 22.04 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.716 0.406 . . . . 0.0 109.96 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -164.12 23.91 0.07 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -136.25 7.19 3.11 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 107.53 -8.55 37.56 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -62.6 143.73 56.96 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.508 0.67 . . . . 0.0 110.934 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.4 p -152.2 173.79 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 49.1 ttt180 -136.69 152.97 50.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -135.06 150.81 50.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 122.279 0.232 . . . . 0.0 110.566 -172.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.42 ' HE ' ' HB3' ' A' ' 154' ' ' GLU . 20.0 tpp85 -153.63 147.71 25.65 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.895 0.478 . . . . 0.0 109.908 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.74 -0.97 59.59 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.657 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -64.38 156.95 74.47 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-N 117.255 0.528 . . . . 0.0 111.508 -176.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 27.9 Cg_exo -56.06 147.48 64.05 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.678 2.919 . . . . 0.0 111.762 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.578 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 23.9 m-85 -70.41 17.54 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 119' ' ' PRO . . . -137.72 5.42 3.42 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 36.5 t -66.78 152.52 45.37 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.599 1.159 . . . . 0.0 110.552 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 125' ' ' GLU . 5.4 t -155.09 -168.39 2.86 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.592 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -51.87 -32.6 32.89 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.544 ' H ' HG23 ' A' ' 123' ' ' THR . 42.6 tt0 -73.13 -25.23 60.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.517 0.727 . . . . 0.0 112.049 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.402 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 67.3 mm-40 -92.51 -33.23 14.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.718 -0.614 . . . . 0.0 109.516 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.15 -34.26 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.02 -38.34 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.877 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -77.06 -21.39 54.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.073 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -71.0 -26.07 62.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 170.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -108.15 39.4 1.97 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.6 t -68.65 157.21 36.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.4 5.87 78.78 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -173.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.513 ' HB3' HD11 ' A' ' 164' ' ' LEU . 30.0 mt -142.52 -172.42 3.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.291 1.837 . . . . 0.0 106.583 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -147.24 164.15 34.11 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.847 -0.533 . . . . 0.0 110.392 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 mt -142.08 148.23 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 158' ' ' GLN . 21.4 m -73.6 154.45 89.58 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 118.598 0.635 . . . . 0.0 110.134 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.62 138.5 25.03 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.016 3.144 . . . . 0.0 112.213 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.9 t30 40.71 37.93 0.56 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.304 1.041 . . . . 0.0 111.917 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.31 29.36 9.64 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.978 -0.901 . . . . 0.0 111.83 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.7 mt -135.36 147.09 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 119.056 1.428 . . . . 0.0 109.368 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.1 m -138.53 151.14 47.08 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.35 0.66 . . . . 0.0 109.712 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.1 mt -144.55 100.7 4.73 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -55.58 155.22 22.11 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.121 2.547 . . . . 0.0 110.13 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 150' ' ' LYS . 27.2 m -140.78 159.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 121.752 0.787 . . . . 0.0 112.429 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.455 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 17.0 m-20 -86.57 175.04 4.76 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.623 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 35.5 Cg_exo -59.74 1.79 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.509 3.473 . . . . 0.0 113.402 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 146' ' ' ASP . 30.0 tt0 -123.36 3.37 9.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.947 0.899 . . . . 0.0 110.832 -175.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.28 5.96 89.65 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 39.5 mtpt -66.99 167.2 12.19 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.85 10.76 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -167.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 p 63.14 -7.14 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.94 12.2 84.65 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.914 0.768 . . . . 0.0 113.354 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.42 ' HB3' ' HE ' ' A' ' 116' ' ' ARG . 20.3 pt-20 -143.06 164.33 30.4 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.229 1.014 . . . . 0.0 110.923 177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -153.93 -178.47 7.09 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.038 0.535 . . . . 0.0 111.33 -172.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -145.43 150.32 36.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 158' ' ' GLN . 64.4 t -148.12 165.65 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.246 0.546 . . . . 0.0 110.003 -174.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.498 ' N ' HG12 ' A' ' 157' ' ' VAL . 47.6 tt0 -130.13 105.97 8.3 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 168.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 113' ' ' VAL . 35.7 m-85 -76.23 173.15 11.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.644 171.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.83 91.84 1.19 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t 62.82 166.99 0.12 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.727 1.211 . . . . 0.0 111.819 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -15.66 62.38 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.995 -0.441 . . . . 0.0 111.247 -175.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.94 -41.91 73.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.925 -0.484 . . . . 0.0 110.676 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.542 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -68.86 -39.28 79.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.21 -36.29 70.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.102 -0.374 . . . . 0.0 111.107 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -73.22 -29.07 62.54 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -73.5 -38.34 65.39 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.76 -16.3 62.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.153 0.581 . . . . 0.0 112.16 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.412 ' HA ' HG21 ' A' ' 183' ' ' VAL . 95.4 mt -68.35 -12.35 60.96 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.626 0.648 . . . . 0.0 111.333 175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.56 -12.3 80.36 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.517 ' HB2' HG11 ' A' ' 183' ' ' VAL . 66.9 mmtt -84.15 -2.98 57.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.252 1.421 . . . . 0.0 111.978 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -52.11 128.96 26.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.945 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.9 mttt 61.61 9.24 2.67 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.632 1.573 . . . . 0.0 114.138 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -74.43 173.66 9.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.433 1.093 . . . . 0.0 109.053 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -125.95 154.47 42.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -170.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.2 mt -86.47 -18.43 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.164 0.986 . . . . 0.0 110.809 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 143.21 -18.23 2.31 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.837 -0.424 . . . . 0.0 113.056 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -151.34 -3.66 0.3 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.59 0.695 . . . . 0.0 111.231 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -148.06 154.85 40.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -105.51 156.91 17.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.342 0.591 . . . . 0.0 110.04 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 33.0 mm -127.11 163.74 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -170.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -128.55 156.34 43.47 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 171' ' ' LYS . 33.5 m -129.93 129.56 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.687 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 6.6 m-30 -135.72 146.11 47.37 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -175.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -73.04 160.63 31.76 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.763 0.71 . . . . 0.0 110.333 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -159.28 -177.26 6.32 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.1 m -146.11 169.73 18.12 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.787 1.235 . . . . 0.0 109.332 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -56.64 -31.49 64.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.741 0.416 . . . . 0.0 111.136 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.76 2.95 1.63 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -124.26 1.38 8.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.521 0.729 . . . . 0.0 110.838 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.68 10.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.728 0.299 . . . . 0.0 111.486 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -69.83 15.42 0.08 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 20.6 t -69.54 -1.44 8.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.122 0.569 . . . . 0.0 110.846 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 117.83 -1.081 . . . . 0.0 111.061 177.991 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.309 0 C4'-C3'-C2' 99.584 -3.116 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.578 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.601 0 O4'-C1'-N19 112.199 3.999 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.928 0 C3'-C2'-C1' 104.935 3.816 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.4 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.845 2 O4'-C1'-N19 117.562 9.362 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.439 " O3'" " H3'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.06 1 C5'-C4'-C3' 109.108 -4.261 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.687 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-C2' 102.523 -2.769 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 110.659 -0.126 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.1 m -145.68 164.17 32.59 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 122.917 0.487 . . . . 0.0 110.319 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.39 21.33 0.84 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.135 0.574 . . . . 0.0 110.891 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -134.38 16.22 3.73 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.053 0.541 . . . . 0.0 111.346 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t -144.71 -11.1 0.59 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.524 0.33 . . . . 0.0 111.539 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.31 155.3 24.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.859 0.463 . . . . 0.0 110.555 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -157.23 35.79 0.28 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.936 0.895 . . . . 0.0 109.709 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -129.9 167.08 18.73 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.701 1.2 . . . . 0.0 108.394 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.54 -5.44 29.89 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 120.045 -0.308 . . . . 0.0 112.352 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -61.56 140.39 58.12 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.745 0.783 . . . . 0.0 111.196 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.523 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.5 p -149.98 175.97 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.504 1.122 . . . . 0.0 108.157 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 79.3 ttt180 -135.92 146.36 47.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.74 0.416 . . . . 0.0 110.266 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.415 HD11 ' CZ ' ' A' ' 131' ' ' PHE . 4.0 mm? -122.91 150.74 42.52 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 125.06 1.344 . . . . 0.0 108.372 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -158.96 147.57 18.32 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 110.313 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.85 -3.65 57.39 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.645 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -65.07 155.76 82.97 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 117.257 0.529 . . . . 0.0 110.756 -178.227 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 32.4 Cg_exo -53.37 147.65 36.21 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.612 2.875 . . . . 0.0 112.147 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.734 ' CE2' " H1'" ' B' ' 1' ' ' ' A' . 26.4 m-85 -66.32 2.27 1.29 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -125.39 6.9 8.04 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 40.7 t -67.85 155.1 40.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.839 0.855 . . . . 0.0 110.68 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.7 t -154.57 -172.38 4.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.265 0.626 . . . . 0.0 109.523 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.596 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.3 OUTLIER -50.72 -30.98 15.25 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 123.21 0.604 . . . . 0.0 112.626 -176.444 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.483 ' H ' HG23 ' A' ' 123' ' ' THR . 40.9 mt-10 -77.31 -23.46 51.02 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -92.59 -30.37 15.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.4 mt -66.99 -41.02 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.8 p -73.51 -33.88 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.488 -176.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -73.04 -28.38 62.3 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.212 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 12.1 t80 -69.82 -19.56 63.47 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 115' ' ' LEU . 20.7 m-85 -118.95 33.39 5.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.374 1.47 . . . . 0.0 109.438 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.2 t -69.22 -4.07 16.23 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.807 -0.558 . . . . 0.0 112.289 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -106.25 20.08 36.01 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.499 ' HB3' HD11 ' A' ' 164' ' ' LEU . 55.2 mt -141.23 -167.02 2.3 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.842 2.457 . . . . 0.0 104.83 -173.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.28 -21.35 0.69 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 1.5 mt 52.06 178.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.204 1.002 . . . . 0.0 112.681 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.532 ' H ' HG22 ' A' ' 136' ' ' ILE . 25.1 m -116.44 155.63 48.33 Favored Pre-proline 0 CA--C 1.529 0.138 0 O-C-N 121.338 -0.851 . . . . 0.0 109.69 169.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.0 137.77 22.3 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.197 3.265 . . . . 0.0 112.569 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.1 t30 41.45 36.14 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.273 1.029 . . . . 0.0 111.766 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.64 27.75 13.2 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-O 118.792 -1.005 . . . . 0.0 112.021 -172.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.2 mt -135.23 145.58 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.088 1.444 . . . . 0.0 109.502 -177.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.8 m -138.12 149.75 46.21 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.755 0.822 . . . . 0.0 109.79 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.5 mt -145.11 94.19 5.35 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 124.023 0.929 . . . . 0.0 109.404 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -55.88 159.18 12.32 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.76 2.973 . . . . 0.0 111.638 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.5 167.45 16.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 121.409 0.624 . . . . 0.0 111.285 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 63.9 m-20 -91.89 176.53 2.67 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.2 Cg_exo -58.35 -19.79 44.88 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.822 2.348 . . . . 0.0 111.67 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -81.37 -9.03 59.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.129 0.972 . . . . 0.0 111.213 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.54 2.45 90.62 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.459 ' HE3' ' N3 ' ' B' ' 1' ' ' ' A' . 76.2 tttt -81.57 133.14 35.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.865 1.266 . . . . 0.0 108.416 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.9 pt -66.33 148.29 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 110.122 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.8 p -75.54 2.82 10.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.198 -174.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.39 6.3 89.35 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -139.25 164.06 30.81 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.087 0.555 . . . . 0.0 109.697 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.81 -178.65 7.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.339 0.59 . . . . 0.0 110.925 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -144.92 147.72 33.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.514 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.5 t -144.88 166.6 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.494 ' N ' HG12 ' A' ' 157' ' ' VAL . 41.2 tt0 -129.26 106.42 8.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 167.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 59.6 m-85 -74.87 171.05 14.72 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.465 170.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.34 88.65 0.46 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.1 0.476 . . . . 0.0 110.055 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.7 t 64.35 170.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.651 1.18 . . . . 0.0 111.583 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -17.53 63.47 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.769 0.428 . . . . 0.0 111.59 -174.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.24 -45.41 66.56 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.914 -0.492 . . . . 0.0 110.531 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -70.83 -31.68 68.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.97 92.78 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.674 -0.641 . . . . 0.0 111.069 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -68.78 -29.06 67.36 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.884 -0.143 . . . . 0.0 110.784 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -70.95 -37.63 72.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.417 -0.177 . . . . 0.0 110.578 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.511 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.16 -20.5 65.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.405 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.0 mt -68.38 -12.23 60.8 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.087 -0.383 . . . . 0.0 111.421 177.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.81 -12.56 80.89 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.555 ' HB2' HG11 ' A' ' 183' ' ' VAL . 71.7 mmtt -83.96 -0.08 50.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.102 1.361 . . . . 0.0 111.638 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.41 ' HA ' HG22 ' A' ' 183' ' ' VAL . 12.5 t60 -53.64 127.18 24.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.83 0.348 . . . . 0.0 110.228 176.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.627 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 26.8 mttp 54.2 20.29 2.53 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.785 1.634 . . . . 0.0 114.034 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -82.78 -13.71 55.78 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 73.49 171.32 0.3 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.011 1.324 . . . . 0.0 114.509 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.98 -12.45 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 154.09 -29.96 0.72 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-N 118.476 0.58 . . . . 0.0 113.993 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -151.79 -0.36 0.33 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.956 0.878 . . . . 0.0 111.162 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -147.8 150.37 34.09 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -174.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -93.49 152.32 19.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.165 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 30.1 mm -122.54 159.24 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.46 ' HB3' ' CE1' ' A' ' 184' ' ' PHE . 5.4 mm-40 -125.17 155.28 40.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.497 -175.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 171' ' ' LYS . 34.4 m -138.09 131.58 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.611 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 7.3 m-85 -142.18 156.06 45.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -75.91 160.78 29.56 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.679 0.672 . . . . 0.0 110.25 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.0 t -155.54 -174.62 5.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.8 t -147.98 173.19 13.14 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.5 1.12 . . . . 0.0 109.88 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -60.36 -31.71 70.58 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.75 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.14 -0.72 2.63 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -121.55 1.95 10.11 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.548 0.739 . . . . 0.0 111.339 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.16 11.13 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 120.899 0.38 . . . . 0.0 111.287 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -69.09 14.89 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.6 m -67.49 -3.17 7.82 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.292 0.637 . . . . 0.0 111.307 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.184 178.244 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.734 " H1'" ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.146 1 C5'-C4'-C3' 108.548 -4.635 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.692 2 O4'-C1'-N19 113.906 5.706 OUTLIER-EPSILON 0.107 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.454 ' C8 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.102 1 P-O3'-C3' 124.631 4.109 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.734 1 O4'-C1'-N19 115.875 7.675 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.627 ' C2 ' ' HE3' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.897 0 C5'-C4'-C3' 109.831 -3.779 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.611 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.636 0 C5'-C4'-C3' 110.077 -3.616 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 106' ' ' ASP . 89.2 p -162.0 -172.35 3.22 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.733 0.413 . . . . 0.0 110.753 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.08 15.36 0.05 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.854 0.861 . . . . 0.0 111.939 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.457 ' H ' ' C ' ' A' ' 104' ' ' SER . 33.4 t70 -128.56 13.58 6.49 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.889 0.876 . . . . 0.0 110.187 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.3 p -132.66 3.25 3.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.526 0.73 . . . . 0.0 110.709 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.476 ' HB3' ' HE3' ' A' ' 185' ' ' LYS . . . -159.25 164.6 34.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.077 1.351 . . . . 0.0 108.187 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -156.91 13.29 0.26 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.79 9.42 1.33 Allowed 'General case' 0 C--N 1.34 0.153 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.21 -5.99 50.02 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 112.172 -0.371 . . . . 0.0 112.172 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -63.49 144.47 56.96 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.645 0.736 . . . . 0.0 110.681 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.58 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.5 p -154.0 174.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.642 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.4 ' H ' HG22 ' A' ' 113' ' ' VAL . 70.9 ttt180 -135.62 154.79 51.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.97 0.908 . . . . 0.0 108.66 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -138.65 148.85 44.54 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -156.38 174.6 15.17 Favored 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.05 5.15 83.65 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.438 HD22 ' SG ' ' A' ' 122' ' ' CYS . 95.0 mt -59.92 150.47 68.99 Favored Pre-proline 0 N--CA 1.452 -0.339 0 C-N-CA 123.594 0.757 . . . . 0.0 112.101 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.3 23.99 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 125.142 3.894 . . . . 0.0 113.965 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.515 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 22.0 m-30 54.77 5.68 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.23 1.412 . . . . 0.0 114.43 -177.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.69 -6.28 3.35 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.956 0.798 . . . . 0.0 111.802 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 10.0 t -61.77 150.53 36.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.038 0.935 . . . . 0.0 110.938 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.8 t -143.37 -166.66 2.37 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 171.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 mptt -51.35 -28.69 13.07 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.344 0.52 . . . . 0.0 111.995 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.495 ' H ' HG23 ' A' ' 123' ' ' THR . 37.1 tt0 -78.52 -23.91 46.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.527 0.731 . . . . 0.0 112.331 -177.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.501 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 7.0 mp0 -92.88 -33.7 14.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.426 HG13 ' SG ' ' A' ' 122' ' ' CYS . 42.5 mt -61.88 -33.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.0 p -83.32 -30.61 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.003 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -73.32 -29.87 62.98 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.907 171.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -68.65 -25.84 65.03 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.205 -0.309 . . . . 0.0 110.671 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -115.8 33.31 5.56 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.666 1.186 . . . . 0.0 109.214 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.1 t -64.35 -13.93 53.35 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.963 0.505 . . . . 0.0 112.252 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.01 13.15 67.68 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.821 ' HB3' HD11 ' A' ' 164' ' ' LEU . 69.4 mt -137.5 -162.22 1.27 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.011 1.724 . . . . 0.0 107.482 -173.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.57 -18.04 0.7 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER 46.33 -166.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.847 0.859 . . . . 0.0 112.971 -176.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.0 m -129.21 156.02 78.99 Favored Pre-proline 0 C--N 1.338 0.108 0 C-N-CA 123.852 0.861 . . . . 0.0 109.786 173.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.78 135.59 28.21 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.173 3.249 . . . . 0.0 112.301 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 55.1 t30 40.31 37.36 0.42 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.624 1.17 . . . . 0.0 112.33 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -96.52 28.08 14.81 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 118.934 -0.926 . . . . 0.0 111.75 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.1 mt -132.96 147.01 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 118.968 1.384 . . . . 0.0 109.314 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.8 m -138.11 147.41 43.94 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 123.807 0.843 . . . . 0.0 109.542 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 123' ' ' THR . 91.9 mt -139.5 94.38 9.46 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.527 0.731 . . . . 0.0 110.336 -173.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.82 151.62 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.022 2.481 . . . . 0.0 110.695 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.94 166.32 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.331 0.586 . . . . 0.0 111.266 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 64.4 m-20 -90.82 176.96 2.53 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.684 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 36.9 Cg_exo -58.76 -18.72 42.68 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.981 2.454 . . . . 0.0 111.755 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -81.32 -10.86 59.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.865 0.866 . . . . 0.0 110.683 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.7 14.43 75.72 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -106.54 148.42 28.25 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.5 pt -67.64 149.5 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.421 0.629 . . . . 0.0 111.671 -170.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.5 p -76.42 -7.8 55.82 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.007 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.61 -3.5 32.46 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -139.26 169.89 16.95 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.34 0.57 . . . . 0.0 111.265 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.41 -178.92 7.48 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 111.335 -173.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -144.14 148.11 34.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.488 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 59.9 t -145.76 164.83 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.669 ' O ' HG22 ' A' ' 137' ' ' VAL . 51.9 tt0 -127.75 99.21 5.46 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 169.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.651 ' CD1' HD12 ' A' ' 164' ' ' LEU . 48.5 m-85 -70.15 172.45 8.02 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.121 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.1 87.56 0.4 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.871 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.5 t 62.6 172.62 0.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.546 1.138 . . . . 0.0 111.383 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -31.11 70.71 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.906 -0.496 . . . . 0.0 111.007 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -59.4 -41.64 89.9 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.331 -0.231 . . . . 0.0 111.06 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -72.78 -38.93 67.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -62.8 -34.94 78.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.984 -0.448 . . . . 0.0 110.408 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.31 -27.26 66.14 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.53 0.332 . . . . 0.0 110.299 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -77.27 -38.07 51.65 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.339 0.114 . . . . 0.0 111.181 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.409 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -59.53 -24.41 63.65 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.595 ' HA ' HG21 ' A' ' 183' ' ' VAL . 94.3 mt -68.55 -9.14 47.44 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 122.95 0.5 . . . . 0.0 111.493 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.58 -16.84 78.68 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -76.14 -55.52 5.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.116 0.966 . . . . 0.0 110.678 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.708 ' HA ' HG22 ' A' ' 183' ' ' VAL . 0.6 OUTLIER 23.77 -98.65 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.861 1.264 . . . . 0.0 112.941 -165.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.538 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 55.1 mttp -72.8 20.17 0.08 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -174.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -62.77 -178.22 0.19 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.108 0.963 . . . . 0.0 111.269 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -133.74 168.49 18.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.194 0.598 . . . . 0.0 112.37 -173.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mt -116.47 -13.55 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.521 0.729 . . . . 0.0 112.009 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.44 -31.34 0.53 Allowed Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.52 0.6 . . . . 0.0 114.024 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -152.25 3.06 0.36 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.791 0.796 . . . . 0.0 110.995 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -144.03 156.89 44.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -105.83 148.37 27.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.474 0.654 . . . . 0.0 109.499 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 182' ' ' GLU . 24.3 mm -111.94 174.92 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -172.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.491 ' H ' HG22 ' A' ' 181' ' ' ILE . 12.8 mm-40 -138.63 154.66 48.67 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.708 HG22 ' HA ' ' A' ' 172' ' ' HIS . 17.0 m -129.92 134.94 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.63 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 19.2 m-85 -142.44 151.72 42.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 108' ' ' ALA . 8.8 mmtm -74.09 154.13 39.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.877 0.37 . . . . 0.0 110.553 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.6 t -157.37 179.41 9.28 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.849 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.9 m -150.76 170.74 18.51 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.137 0.975 . . . . 0.0 108.69 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -54.34 -30.84 52.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.682 0.393 . . . . 0.0 111.328 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.54 0.54 2.18 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.308 0.643 . . . . 0.0 112.701 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -121.25 0.06 10.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.138 0.975 . . . . 0.0 110.932 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.11 14.44 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 121.035 0.445 . . . . 0.0 111.11 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -69.33 10.58 0.31 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 59.1 p -69.23 -0.9 6.73 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.352 0.661 . . . . 0.0 111.201 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 117.185 -1.388 . . . . 0.0 110.896 177.59 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.479 ' C4 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.183 1 O4'-C1'-N19 114.31 6.11 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.515 ' C5 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.935 1 O4'-C1'-N19 112.632 4.432 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.175 1 C3'-C2'-C1' 105.128 4.031 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.815 1 O4'-C1'-N19 115.13 6.93 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.609 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.196 1 C5'-C4'-C3' 108.707 -4.529 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.63 " H1'" ' CZ ' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 P-O3'-C3' 122.989 2.741 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.2 m -62.11 -26.81 68.51 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.13 -33.56 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.695 0.398 . . . . 0.0 110.795 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -161.49 -19.96 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.73 0.412 . . . . 0.0 111.312 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.6 t -153.18 -170.69 3.69 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.977 0.511 . . . . 0.0 110.113 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -148.33 168.02 23.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.939 0.896 . . . . 0.0 109.707 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.488 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 5.4 t-20 -155.85 24.65 0.38 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -172.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -132.88 0.69 3.53 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.03 -9.61 25.08 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.477 -0.392 . . . . 0.0 112.523 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -65.48 147.91 52.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.519 0.676 . . . . 0.0 111.094 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.561 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.6 p -155.49 178.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.207 1.003 . . . . 0.0 108.737 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.472 ' H ' HG22 ' A' ' 113' ' ' VAL . 7.4 mtm180 -134.43 162.81 31.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.938 0.495 . . . . 0.0 111.495 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.466 HD23 HD21 ' A' ' 118' ' ' LEU . 6.5 tp -145.97 142.79 29.01 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 154' ' ' GLU . 40.7 ttm180 -151.49 -18.54 0.2 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 181' ' ' ILE . . . -78.94 12.9 21.63 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.264 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 115' ' ' LEU . 97.6 mt -59.6 153.7 49.66 Favored Pre-proline 0 N--CA 1.449 -0.516 0 C-N-CA 124.494 1.118 . . . . 0.0 113.267 -172.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.56 147.64 15.77 Favored 'Trans proline' 0 N--CA 1.442 -1.51 0 C-N-CA 123.793 2.995 . . . . 0.0 106.169 162.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.604 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 23.7 m-85 -70.69 10.57 0.48 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -172.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.38 1.18 12.74 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 118.446 0.567 . . . . 0.0 111.88 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.423 ' SG ' HD22 ' A' ' 118' ' ' LEU . 48.6 t -65.89 156.44 33.39 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.261 0.625 . . . . 0.0 111.591 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 125' ' ' GLU . 2.6 t -152.93 -173.54 4.61 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.577 0.751 . . . . 0.0 109.506 173.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.594 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.2 mptt -50.16 -36.19 29.22 Favored 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.477 ' H ' HG23 ' A' ' 123' ' ' THR . 40.6 mt-10 -75.58 -17.66 59.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -101.74 -26.68 13.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.9 mt -66.85 -39.91 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.45 -34.77 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.368 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -71.08 -28.75 64.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.498 173.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 21.6 t80 -69.48 -23.16 63.6 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.025 0.375 . . . . 0.0 110.275 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -115.2 32.73 5.86 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.743 1.217 . . . . 0.0 109.244 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 t -68.8 -8.04 39.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.07 0.548 . . . . 0.0 111.994 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.92 15.72 60.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.725 ' HB3' HD11 ' A' ' 164' ' ' LEU . 52.5 mt -138.89 -159.75 0.99 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.002 2.121 . . . . 0.0 105.816 -174.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.52 -28.14 0.54 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 2.5 mt 57.38 162.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.968 0.907 . . . . 0.0 112.352 -175.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 158' ' ' GLN . 2.4 m -74.4 161.34 78.54 Favored Pre-proline 0 C--O 1.231 0.09 0 O-C-N 121.0 -1.063 . . . . 0.0 108.643 169.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -46.07 -30.12 7.06 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.024 3.15 . . . . 0.0 112.738 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -162.33 134.26 5.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 171.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -173.92 17.87 0.05 OUTLIER Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.774 -1.014 . . . . 0.0 113.578 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.1 mt -108.4 147.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 119.517 1.659 . . . . 0.0 109.982 -173.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.5 m -140.66 150.78 43.96 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 123.68 0.792 . . . . 0.0 108.918 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.0 mt -146.76 97.43 4.25 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.062 0.545 . . . . 0.0 110.141 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.34 160.76 10.41 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.611 2.874 . . . . 0.0 111.047 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 151' ' ' ILE . 31.4 m -146.08 165.04 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 CA-C-O 121.295 0.569 . . . . 0.0 111.282 173.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.444 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 57.1 m-20 -90.85 175.6 3.52 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 124.167 0.987 . . . . 0.0 108.524 175.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.2 Cg_exo -58.07 -20.21 44.62 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.831 2.354 . . . . 0.0 111.352 174.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -79.39 -10.09 59.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.086 0.955 . . . . 0.0 111.253 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.01 0.54 90.37 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -173.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.604 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 87.1 tttt -73.85 134.73 43.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.831 1.253 . . . . 0.0 108.575 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' A' ' 153' ' ' GLY . 9.3 pt -71.6 10.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -169.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 65.12 -17.2 0.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.859 1.264 . . . . 0.0 112.175 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 105.4 -3.49 40.11 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.04 1.305 . . . . 0.0 112.506 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 116' ' ' ARG . 16.6 pt-20 -132.6 169.59 16.41 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 118.772 1.286 . . . . 0.0 111.505 -177.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.41 -178.37 7.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.12 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -143.39 145.41 32.63 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -175.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.506 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 41.5 t -145.35 160.91 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.565 ' O ' HG22 ' A' ' 137' ' ' VAL . 49.6 tt0 -126.51 119.45 27.19 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 166.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.638 ' CD1' HD12 ' A' ' 164' ' ' LEU . 48.5 m-85 -88.71 174.73 7.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.462 170.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.12 88.42 0.42 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.581 0.753 . . . . 0.0 109.876 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.69 168.06 0.13 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.514 1.126 . . . . 0.0 111.184 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.488 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 1.5 tm0? -64.5 -23.91 67.43 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.846 -0.533 . . . . 0.0 111.214 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.83 -41.13 99.21 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.116 -0.365 . . . . 0.0 110.725 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.725 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -70.87 -37.75 73.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.45 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -61.85 -33.86 74.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.066 -0.396 . . . . 0.0 110.803 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -72.43 -27.16 62.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -74.09 -38.12 63.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.544 0.212 . . . . 0.0 110.512 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -61.48 -21.52 64.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.753 0.421 . . . . 0.0 112.086 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.421 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.2 mt -68.27 -13.45 62.26 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.965 -0.459 . . . . 0.0 111.161 176.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.5 -11.99 82.47 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.546 ' HB2' HG11 ' A' ' 183' ' ' VAL . 68.3 mmtt -85.37 -1.67 57.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.478 1.111 . . . . 0.0 112.179 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -51.93 129.08 26.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.748 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 62.72 11.09 4.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.404 1.482 . . . . 0.0 114.335 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -71.39 -171.44 0.62 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.035 0.834 . . . . 0.0 109.361 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -134.36 164.49 27.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -171.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.8 mt -115.53 -11.48 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.764 0.826 . . . . 0.0 111.932 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 151.35 -25.96 0.98 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 121.891 -0.506 . . . . 0.0 113.938 175.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -153.59 2.14 0.26 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 117.736 0.768 . . . . 0.0 111.083 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -147.0 160.15 42.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.91 0.884 . . . . 0.0 108.672 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -107.13 145.22 32.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.483 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 21.9 mm -113.17 162.41 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -171.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.424 ' HG3' ' H21' ' B' ' 3' ' ' ' G' . 24.4 mt-10 -130.34 150.91 51.36 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.546 HG11 ' HB2' ' A' ' 171' ' ' LYS . 32.6 m -128.11 134.3 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -175.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.72 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 5.2 m-85 -136.61 163.56 30.27 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -82.59 158.59 23.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.879 -0.513 . . . . 0.0 109.959 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.6 t -158.99 -177.33 6.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.469 -0.145 . . . . 0.0 111.325 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.2 t -148.31 178.18 8.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.651 0.78 . . . . 0.0 110.301 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -60.48 -31.95 70.96 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.188 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -65.76 -7.16 14.29 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -112.02 1.38 16.35 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.506 0.723 . . . . 0.0 111.055 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.2 11.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 120.911 0.386 . . . . 0.0 111.555 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -69.18 14.16 0.09 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.1 m -69.19 -0.4 5.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.574 0.75 . . . . 0.0 111.184 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.859 -1.067 . . . . 0.0 111.155 178.254 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.219 2 O4'-C1'-N19 113.94 5.74 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.422 ' C4 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.747 1 C5'-C4'-C3' 107.448 -5.368 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.494 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.407 -3.817 0 C3'-C2'-C1' 104.551 3.39 . 0.01 2a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.494 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.417 -2.983 2 O4'-C1'-N19 115.657 7.457 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.939 1 C5'-C4'-C3' 109.347 -4.102 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.72 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.686 0 C5'-C4'-C3' 111.435 -2.71 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.2 m 53.16 17.51 0.99 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.452 1.101 . . . . 0.0 113.665 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.71 167.06 31.6 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.211 0.604 . . . . 0.0 109.981 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -150.84 -0.69 0.38 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.698 0.399 . . . . 0.0 111.804 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.4 m -149.08 171.54 16.24 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.232 0.613 . . . . 0.0 110.295 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 48.44 30.92 2.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.516 1.126 . . . . 0.0 113.961 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -149.44 30.7 0.75 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.835 0.35 . . . . 0.0 111.648 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -127.81 3.9 6.03 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 162' ' ' GLN . . . 111.12 -8.83 29.16 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -64.08 142.77 58.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.643 0.735 . . . . 0.0 111.154 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.546 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.2 p -153.13 175.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.997 1.319 . . . . 0.0 108.037 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.403 ' H ' HG22 ' A' ' 113' ' ' VAL . 75.1 ttt180 -138.97 145.95 40.35 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.09 152.82 35.81 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 123.867 0.867 . . . . 0.0 109.098 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.447 ' HD2' ' CE2' ' A' ' 184' ' ' PHE . 5.8 mtt180 -153.3 166.49 32.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.47 1.56 88.79 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.6 146.95 42.52 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 117.294 0.547 . . . . 0.0 110.78 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 9.7 Cg_exo -63.63 150.17 89.14 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.026 1.818 . . . . 0.0 108.577 167.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.439 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 14.2 m-85 -70.32 5.3 1.79 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -125.94 5.51 7.87 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 46.2 t -70.33 157.51 37.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.896 0.479 . . . . 0.0 110.858 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.6 t -154.93 -171.63 3.9 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.262 0.625 . . . . 0.0 109.527 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.604 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.4 OUTLIER -51.22 -30.88 18.75 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.476 ' H ' HG23 ' A' ' 123' ' ' THR . 39.2 mt-10 -80.04 -17.84 51.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -107.0 -20.24 13.38 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.8 mt -71.27 -39.92 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 167.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 125' ' ' GLU . 12.2 p -71.17 -38.73 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.217 -177.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -74.66 -22.77 58.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.519 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -69.35 -26.6 64.77 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 170.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.48 ' HA ' ' HE3' ' A' ' 171' ' ' LYS . 36.4 m-85 -106.82 32.32 4.65 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.677 0.791 . . . . 0.0 109.629 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.4 t -61.11 146.15 48.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 169.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.58 2.49 76.05 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' A' ' 164' ' ' LEU . 23.2 mt -134.58 -172.16 2.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -141.59 -17.73 0.78 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -171.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER 45.84 -165.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.88 0.872 . . . . 0.0 113.272 -176.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.4 m -129.9 156.08 79.56 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 124.068 0.947 . . . . 0.0 109.769 173.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.14 136.54 30.23 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.045 3.163 . . . . 0.0 112.252 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.5 t30 40.1 38.33 0.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.556 1.142 . . . . 0.0 112.206 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.04 28.66 13.56 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 118.877 -0.957 . . . . 0.0 111.86 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.8 mt -134.31 147.67 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 119.048 1.424 . . . . 0.0 109.538 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.5 m -139.6 149.93 44.4 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.586 0.754 . . . . 0.0 109.788 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 mt -145.52 95.42 4.98 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 123.896 0.878 . . . . 0.0 109.309 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.11 160.96 7.33 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.799 2.999 . . . . 0.0 111.635 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.4 m -141.71 164.71 18.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 121.283 0.564 . . . . 0.0 111.249 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 67.2 m-20 -86.93 176.12 3.79 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.975 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.2 Cg_exo -59.08 -20.23 52.88 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.038 2.492 . . . . 0.0 111.61 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -82.43 -9.85 59.28 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.561 0.744 . . . . 0.0 110.575 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.84 8.48 79.48 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.312 0.482 . . . . 0.0 112.246 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -97.11 147.62 23.86 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 117.616 0.708 . . . . 0.0 109.147 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.0 pt -69.53 152.9 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.719 0.771 . . . . 0.0 112.022 -172.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.7 p -82.74 0.61 42.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.037 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.9 8.3 86.86 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.026 -0.429 . . . . 0.0 112.026 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -138.62 160.38 39.76 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.31 -179.5 7.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.149 0.499 . . . . 0.0 110.909 -172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -145.46 148.58 33.42 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -174.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 60.0 t -145.12 163.9 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.661 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.9 tt0 -128.28 95.61 4.21 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.615 ' CD1' HD12 ' A' ' 164' ' ' LEU . 52.8 m-85 -67.99 171.71 6.45 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.139 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.56 89.71 0.37 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.644 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.7 167.75 0.13 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.481 1.113 . . . . 0.0 111.007 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.424 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 36.8 tp60 -65.96 -20.07 66.08 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.707 -0.62 . . . . 0.0 111.211 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.07 -41.78 94.78 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.998 -0.438 . . . . 0.0 110.593 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -69.72 -36.3 75.76 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.648 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.494 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -61.75 -36.23 80.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.036 -0.415 . . . . 0.0 110.845 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.78 -27.26 63.78 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -74.11 -38.0 63.96 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.608 0.242 . . . . 0.0 110.685 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.95 -19.94 64.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.164 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.586 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.1 mt -69.9 -8.85 52.1 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.041 -0.412 . . . . 0.0 111.419 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.25 -18.21 80.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 131' ' ' PHE . 70.1 mmtt -70.19 -61.21 1.86 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.567 1.147 . . . . 0.0 109.582 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.633 ' HA ' HG22 ' A' ' 183' ' ' VAL . 0.9 OUTLIER 25.34 -108.59 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.418 1.087 . . . . 0.0 112.715 -165.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.497 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 56.4 mttp -66.61 10.74 0.11 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -65.57 171.64 3.96 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.554 1.542 . . . . 0.0 109.925 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -123.86 165.25 17.69 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -168.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mt -105.64 -13.28 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.637 0.775 . . . . 0.0 111.963 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.1 -24.28 1.42 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.794 -0.448 . . . . 0.0 113.53 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -152.63 0.98 0.3 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.683 0.741 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -148.27 153.95 39.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.966 0.906 . . . . 0.0 108.73 -172.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -101.02 150.6 22.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.7 mm -117.92 171.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' CG ' ' H21' ' B' ' 3' ' ' ' G' . 18.2 mt-10 -139.45 160.13 40.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 172' ' ' HIS . 24.7 m -132.95 127.3 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.68 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 3.1 m-30 -128.07 154.55 45.57 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -75.48 163.25 27.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.796 -0.565 . . . . 0.0 110.592 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.7 t -159.06 -175.61 5.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.6 m -149.57 169.02 21.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.292 1.437 . . . . 0.0 109.138 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -57.7 -32.33 67.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.675 0.39 . . . . 0.0 111.38 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -66.94 -1.34 3.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -117.92 1.64 12.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.858 0.863 . . . . 0.0 110.911 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.56 12.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-O 121.036 0.446 . . . . 0.0 110.956 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -68.71 13.45 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.7 m -67.28 -2.31 5.8 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.346 0.658 . . . . 0.0 111.364 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.198 -1.382 . . . . 0.0 111.056 178.479 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.404 " H4'" " C5'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.116 3 O4'-C1'-N19 115.236 7.036 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.439 ' C5 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.814 0 C5'-C4'-C3' 110.187 -3.542 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.508 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.409 -3.675 0 C3'-C2'-C1' 104.552 3.391 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.508 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.918 2 O4'-C1'-N19 115.897 7.697 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.497 ' C2 ' ' HE3' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.937 0 C5'-C4'-C3' 110.233 -3.512 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.68 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.704 0 C5'-C4'-C3' 110.461 -3.359 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.549 0.214 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.2 p -144.72 4.82 1.16 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.034 0.534 . . . . 0.0 111.307 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.22 168.81 25.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.403 0.681 . . . . 0.0 109.904 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -147.53 175.81 10.55 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.58 0.752 . . . . 0.0 109.932 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 t -151.75 172.77 15.62 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.985 0.514 . . . . 0.0 110.187 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.83 121.82 10.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.45 0.7 . . . . 0.0 110.786 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 4.8 t-20 -161.83 25.27 0.12 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -131.78 6.51 4.34 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.33 -9.68 42.33 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -65.1 144.91 56.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.641 0.734 . . . . 0.0 111.048 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.547 HG11 ' CE2' ' A' ' 159' ' ' PHE . 11.1 p -152.9 174.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.137 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 59.1 ttt180 -136.35 145.33 45.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.043 0.537 . . . . 0.0 109.61 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.3 143.15 48.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -154.35 143.42 21.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.45 -1.11 46.29 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.95 157.45 86.78 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 117.468 0.634 . . . . 0.0 111.055 -176.228 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -54.58 144.85 61.76 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.176 2.584 . . . . 0.0 111.36 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.565 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 29.0 m-85 -71.0 12.27 0.31 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.67 5.82 5.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 51.2 t -69.16 158.44 34.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.387 1.075 . . . . 0.0 110.644 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.583 HG23 ' H ' ' A' ' 125' ' ' GLU . 6.5 t -153.73 -178.98 7.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.492 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 4.0 ptpp? -53.34 -25.36 14.81 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.583 ' H ' HG23 ' A' ' 123' ' ' THR . 41.5 mt-10 -78.34 -22.94 47.27 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.939 0.336 . . . . 0.0 111.611 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -92.69 -30.34 15.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.81 -45.6 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.69 -33.77 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.59 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -72.86 -31.36 64.68 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.494 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -67.34 -16.65 64.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.293 0.497 . . . . 0.0 110.203 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -120.08 30.46 6.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.499 1.119 . . . . 0.0 109.515 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.6 t -63.44 138.15 58.41 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.35 2.43 90.27 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.2 mt -138.07 76.22 1.56 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.198 1.399 . . . . 0.0 107.784 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -49.85 158.11 0.53 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.19 0.996 . . . . 0.0 113.472 -174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.68 147.59 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.1 m -70.66 155.25 93.67 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 118.521 0.601 . . . . 0.0 110.354 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -48.8 138.0 26.69 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.92 3.08 . . . . 0.0 111.739 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.8 t30 41.79 37.22 0.73 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.043 0.937 . . . . 0.0 111.802 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.61 31.85 6.8 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -173.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -139.51 145.97 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.238 1.019 . . . . 0.0 109.077 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.6 m -140.35 151.28 44.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.53 100.0 4.1 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.72 149.55 18.98 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.082 2.521 . . . . 0.0 110.934 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 24.5 m -145.25 160.84 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.434 0.635 . . . . 0.0 110.719 172.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.444 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 60.9 m-20 -87.38 176.42 3.47 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 42.1 Cg_exo -57.67 -18.25 32.38 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.825 2.35 . . . . 0.0 111.944 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.01 -8.54 58.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.425 1.09 . . . . 0.0 111.431 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.04 2.07 88.43 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.545 ' HE3' ' C6 ' ' B' ' 1' ' ' ' A' . 87.9 tttt -68.81 123.91 22.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.715 1.606 . . . . 0.0 109.824 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.0 pt -78.28 3.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -165.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p 66.27 -16.76 0.12 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.68 9.64 58.54 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.947 0.784 . . . . 0.0 113.794 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -143.09 163.51 32.64 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.31 1.055 . . . . 0.0 110.676 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.93 -177.06 6.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.278 0.631 . . . . 0.0 111.089 -173.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -147.17 150.47 34.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 87.6 t -147.14 165.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -175.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.477 ' N ' HG12 ' A' ' 157' ' ' VAL . 54.5 tt0 -133.44 98.54 4.25 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.004 0.921 . . . . 0.0 108.898 170.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.547 ' CE2' HG11 ' A' ' 113' ' ' VAL . 58.2 m-85 -69.82 170.54 10.86 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -67.82 92.52 0.36 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.15 0.5 . . . . 0.0 110.196 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.2 t 62.42 169.65 0.13 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.717 1.207 . . . . 0.0 111.095 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 0.0 OUTLIER -66.4 -12.31 56.3 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.033 -0.417 . . . . 0.0 111.489 -175.531 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -74.48 -44.23 52.45 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.492 0.317 . . . . 0.0 110.384 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.464 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -69.07 -36.72 77.93 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.32 -38.97 78.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.087 -0.383 . . . . 0.0 110.701 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.35 -31.64 71.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.449 0.3 . . . . 0.0 110.623 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -69.92 -39.06 76.37 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.434 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.73 -13.83 62.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.533 0.333 . . . . 0.0 111.727 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.675 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.9 mt -68.21 -12.26 60.68 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.737 -0.602 . . . . 0.0 111.042 175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.3 13.08 8.23 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.636 ' HB2' HG11 ' A' ' 183' ' ' VAL . 62.5 mmtt -118.87 -0.0 11.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.882 1.673 . . . . 0.0 112.353 -178.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.597 ' HA ' HG22 ' A' ' 183' ' ' VAL . 6.2 t60 -46.63 -20.95 0.15 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.527 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 98.2 mttt -142.83 15.65 1.94 Allowed 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.536 -0.728 . . . . 0.0 110.85 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -81.82 178.68 8.18 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.819 1.248 . . . . 0.0 109.616 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -129.85 154.26 47.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.02 -16.49 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.143 0.977 . . . . 0.0 111.198 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 153.66 -24.96 0.74 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.746 -0.474 . . . . 0.0 113.399 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -152.54 0.92 0.3 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.794 0.797 . . . . 0.0 111.257 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -148.39 152.78 37.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.938 0.895 . . . . 0.0 108.651 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -103.31 154.83 18.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.39 0.614 . . . . 0.0 110.529 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 26.0 mm -126.22 160.17 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.637 -171.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -129.86 151.97 49.85 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 169' ' ' LEU . 35.8 m -125.77 49.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.028 0.931 . . . . 0.0 113.372 -167.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.599 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 3.5 m-30 -52.1 151.73 3.6 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.789 -0.569 . . . . 0.0 110.226 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -76.28 163.77 26.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.958 -0.464 . . . . 0.0 110.149 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.2 t -159.64 -177.15 6.18 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.2 m -145.24 171.46 14.53 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.753 1.221 . . . . 0.0 109.37 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -57.79 -32.13 67.24 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.764 0.426 . . . . 0.0 111.527 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.33 -4.83 8.79 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -116.63 2.27 12.96 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.751 0.821 . . . . 0.0 110.926 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.83 10.7 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 120.992 0.425 . . . . 0.0 111.172 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -68.99 13.7 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 m -68.22 -1.9 7.06 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.253 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.807 -1.092 . . . . 0.0 111.147 178.153 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.545 ' C6 ' ' HE3' ' A' ' 150' ' ' LYS . . . . . . . . 0 O4'--C4' 1.412 -3.383 0 C4'-C3'-C2' 99.74 -2.96 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.565 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.513 1 O4'-C1'-N19 113.332 5.132 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.43 ' OP1' " H1'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.172 1 P-O3'-C3' 125.129 4.524 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.73 2 O4'-C1'-N19 117.485 9.285 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.527 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.891 1 C5'-C4'-C3' 109.016 -4.323 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.599 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.506 1 C5'-C4'-C3' 109.274 -4.151 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.0 t -152.55 172.32 16.76 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.122 0.569 . . . . 0.0 110.019 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 50.74 23.71 1.47 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.086 0.954 . . . . 0.0 112.509 -176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -150.54 155.61 39.79 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.539 0.736 . . . . 0.0 109.502 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 85.6 p -161.4 -175.32 4.73 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.818 0.447 . . . . 0.0 111.043 -176.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 42.6 74.03 0.12 Allowed 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.122 1.369 . . . . 0.0 112.907 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -150.31 28.96 0.72 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.063 -173.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -134.78 5.81 3.4 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.67 -9.58 32.43 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -63.23 143.11 58.08 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.551 0.691 . . . . 0.0 111.078 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' A' ' 159' ' ' PHE . 10.5 p -152.34 174.55 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.372 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 51.3 ttt180 -138.94 147.2 41.95 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.021 0.528 . . . . 0.0 109.976 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -120.98 151.17 40.05 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.457 1.103 . . . . 0.0 109.205 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -157.65 164.83 36.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.14 1.8 88.33 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.3 mt -53.68 143.53 38.49 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.137 0.575 . . . . 0.0 110.32 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.415 ' CG ' ' SG ' ' A' ' 122' ' ' CYS . 72.8 Cg_endo -72.87 27.96 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 124.785 3.657 . . . . 0.0 113.933 -174.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.426 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 16.9 m-85 52.34 18.82 0.98 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.162 0.985 . . . . 0.0 113.275 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -148.09 -13.97 0.13 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.797 -0.565 . . . . 0.0 113.003 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 119' ' ' PRO . 6.8 m -62.95 158.89 18.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.585 0.692 . . . . 0.0 110.698 174.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.5 t -148.77 -165.03 2.17 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 2.5 mptt -49.91 -34.7 21.21 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.541 0.61 . . . . 0.0 112.049 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.471 ' H ' HG23 ' A' ' 123' ' ' THR . 40.0 mt-10 -77.36 -16.58 58.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -101.45 -29.38 12.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.3 mt -65.33 -34.01 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.2 -34.81 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.005 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -71.13 -27.09 63.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.174 -0.611 . . . . 0.0 111.043 172.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 8.8 t80 -70.19 -26.08 63.73 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 174.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -111.82 30.55 6.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.301 1.04 . . . . 0.0 109.545 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -67.57 -14.86 63.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.923 0.489 . . . . 0.0 111.83 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -94.42 16.62 60.69 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.581 ' HB3' HD11 ' A' ' 164' ' ' LEU . 36.6 mt -143.98 -162.05 1.39 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.349 1.859 . . . . 0.0 107.157 -173.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -146.79 165.29 30.13 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.1 mt -142.73 154.49 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 158' ' ' GLN . 27.4 m -60.13 156.45 38.55 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.95 -31.06 7.77 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 124.509 3.473 . . . . 0.0 113.813 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -161.41 110.42 1.56 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -149.04 6.51 0.83 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.63 -1.095 . . . . 0.0 113.24 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.441 HG12 HG13 ' A' ' 157' ' ' VAL . 78.5 mt -97.68 147.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 119.471 1.636 . . . . 0.0 109.507 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 92.0 m -139.82 147.21 40.41 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.7 mt -143.69 97.24 5.48 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 123.293 0.637 . . . . 0.0 109.408 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.72 159.35 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.404 2.736 . . . . 0.0 110.267 173.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.58 159.68 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-O 121.356 0.598 . . . . 0.0 110.963 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.478 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 54.7 m-20 -84.16 175.75 4.38 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.842 176.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 36.4 Cg_exo -58.5 -19.11 42.69 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.891 2.394 . . . . 0.0 111.522 175.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -82.64 -10.26 59.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.807 0.843 . . . . 0.0 110.872 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.17 10.81 73.96 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.341 0.496 . . . . 0.0 112.444 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -98.74 150.39 21.86 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 117.436 0.618 . . . . 0.0 109.908 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 153' ' ' GLY . 6.1 pt -73.77 8.1 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 -160.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 67.06 -21.59 0.11 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.133 0.973 . . . . 0.0 113.533 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 105.21 6.84 38.77 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.862 0.744 . . . . 0.0 113.479 175.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -142.72 168.1 20.52 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.249 1.024 . . . . 0.0 110.787 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -157.74 -179.46 8.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.241 0.543 . . . . 0.0 111.26 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.93 151.74 39.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 158' ' ' GLN . 40.5 t -147.37 166.06 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.737 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.1 tt0 -128.99 97.42 4.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 168.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' A' ' 113' ' ' VAL . 38.5 m-85 -67.86 172.82 4.98 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.197 0.522 . . . . 0.0 109.916 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.79 90.9 0.61 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t 62.3 167.18 0.11 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.933 1.293 . . . . 0.0 111.738 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -15.69 63.07 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.888 -0.508 . . . . 0.0 111.053 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.48 -41.92 83.79 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.876 -0.515 . . . . 0.0 110.443 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.613 ' O ' HD13 ' A' ' 164' ' ' LEU . 1.1 tm? -71.17 -39.26 71.97 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -56.66 -35.78 68.79 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.267 -0.271 . . . . 0.0 111.039 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -71.91 -30.29 65.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.565 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -72.34 -37.28 68.9 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.644 0.259 . . . . 0.0 110.487 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.428 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.93 -18.76 64.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.937 0.495 . . . . 0.0 112.09 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.417 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.5 mt -67.98 -14.64 63.12 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.698 -0.626 . . . . 0.0 111.036 176.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.58 -12.78 80.44 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.534 ' HB2' HG11 ' A' ' 183' ' ' VAL . 71.3 mmtt -83.64 -2.64 56.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.736 1.214 . . . . 0.0 111.692 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.404 ' NE2' ' HE3' ' A' ' 173' ' ' LYS . 37.3 t60 -52.55 122.68 9.37 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.566 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 77.7 mttt 60.98 17.04 7.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.326 1.45 . . . . 0.0 113.822 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -79.87 -18.41 50.78 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.36 1.064 . . . . 0.0 113.287 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 79.23 174.41 0.15 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.24 1.416 . . . . 0.0 114.573 170.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.77 -15.2 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.24 0.616 . . . . 0.0 112.611 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.24 -29.3 0.64 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 118.556 0.616 . . . . 0.0 114.191 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -151.51 -1.48 0.33 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.885 0.843 . . . . 0.0 111.066 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -145.78 151.59 38.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -97.19 151.2 20.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.027 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 37.5 mm -123.62 157.5 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -172.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -127.82 158.92 36.4 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 171' ' ' LYS . 35.5 m -133.84 130.5 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.716 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 9.0 m-85 -136.98 150.38 48.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -75.84 158.43 32.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.337 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.9 t -156.71 -175.83 5.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.3 m -145.57 169.48 18.32 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.625 1.17 . . . . 0.0 109.744 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -57.16 -32.24 66.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.847 0.459 . . . . 0.0 111.116 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.24 -2.03 3.92 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -121.0 1.93 10.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.88 0.872 . . . . 0.0 111.051 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.89 11.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.885 0.374 . . . . 0.0 111.318 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -67.72 12.3 0.11 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.2 m -69.69 0.38 5.63 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.387 0.675 . . . . 0.0 111.28 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.275 -1.345 . . . . 0.0 111.149 178.091 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.619 0 C5'-C4'-C3' 110.195 -3.537 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.426 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.193 0 C1'-O4'-C4' 106.548 -3.392 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.433 H5'' ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.113 2 C5'-C4'-C3' 108.892 -4.405 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.433 ' C2 ' H5'' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.835 2 O4'-C1'-N19 115.761 7.561 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.566 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.035 0 C5'-C4'-C3' 109.601 -3.933 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.716 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.592 0 C5'-C4'-C3' 111.283 -2.811 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -160.34 172.84 16.59 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.784 0.434 . . . . 0.0 110.574 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 52.94 14.43 0.45 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.854 1.262 . . . . 0.0 114.136 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.1 -6.05 0.27 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.99 0.516 . . . . 0.0 110.909 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 t -160.11 176.04 12.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.887 0.875 . . . . 0.0 108.787 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.22 145.14 48.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.464 0.306 . . . . 0.0 111.109 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.22 17.93 0.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -142.07 4.17 1.63 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.45 -5.9 33.59 Favored Glycine 0 N--CA 1.45 -0.375 0 O-C-N 122.245 -0.284 . . . . 0.0 112.581 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -63.03 148.36 47.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.766 0.793 . . . . 0.0 111.286 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -155.11 174.77 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.428 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.413 ' H ' HG22 ' A' ' 113' ' ' VAL . 47.3 ttt180 -137.17 152.21 49.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tp -133.81 150.98 51.43 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -154.07 169.98 22.23 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.83 4.96 88.63 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.444 HD23 ' SG ' ' A' ' 122' ' ' CYS . 2.6 mp -58.5 149.05 62.96 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 117.035 0.418 . . . . 0.0 111.609 -175.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 15.3 Cg_exo -62.04 146.97 95.99 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.255 1.97 . . . . 0.0 108.715 167.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.649 ' CE2' " H1'" ' B' ' 1' ' ' ' A' . 19.8 m-85 -71.35 2.99 4.08 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.24 5.74 12.08 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 49.0 t -66.86 154.43 40.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.249 1.02 . . . . 0.0 111.134 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.2 t -156.05 -166.44 2.19 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.411 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -50.03 -53.14 28.86 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.714 0.688 . . . . 0.0 109.518 -179.384 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.551 ' HA ' ' CG2' ' A' ' 128' ' ' VAL . 32.6 tt0 -53.36 -21.25 5.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.333 1.453 . . . . 0.0 113.843 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.488 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 75.6 mm-40 -97.91 -19.67 17.94 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.004 -1.06 . . . . 0.0 110.635 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.2 mt -86.08 -26.18 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 125' ' ' GLU . 29.0 m -78.88 -33.7 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.04 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -72.66 -32.08 65.56 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.454 0.57 . . . . 0.0 110.698 172.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 16.6 t80 -70.44 -24.39 62.88 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.395 -0.19 . . . . 0.0 111.379 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -120.56 29.25 7.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.855 0.862 . . . . 0.0 109.706 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 t -63.18 -11.54 21.52 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.036 0.534 . . . . 0.0 111.967 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.49 13.95 65.76 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.784 ' HB3' HD11 ' A' ' 164' ' ' LEU . 76.4 mt -137.76 -159.4 0.95 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.641 1.976 . . . . 0.0 106.627 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -141.76 -21.52 0.73 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -175.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.7 mt 51.6 -176.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.683 0.793 . . . . 0.0 112.606 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.599 ' H ' HG22 ' A' ' 136' ' ' ILE . 20.6 m -120.51 154.83 56.95 Favored Pre-proline 0 C--N 1.339 0.145 0 O-C-N 121.501 -0.749 . . . . 0.0 109.174 167.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.84 134.71 17.67 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.154 3.236 . . . . 0.0 112.746 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.2 t30 41.01 36.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.601 1.161 . . . . 0.0 112.557 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -81.87 -4.61 90.26 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.301 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.457 HG12 HG13 ' A' ' 157' ' ' VAL . 96.7 mt -98.91 151.15 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.989 0.894 . . . . 0.0 110.732 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.8 m -143.2 144.33 32.13 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.756 0.822 . . . . 0.0 109.346 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.5 mt -139.54 94.98 9.16 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 124.065 0.946 . . . . 0.0 108.615 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.95 158.6 16.8 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.447 2.765 . . . . 0.0 110.691 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 28.5 m -141.5 160.42 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.593 0.711 . . . . 0.0 112.187 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.463 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 18.3 m-20 -85.55 174.04 6.2 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.467 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 44.8 Cg_exo -58.03 -9.67 6.57 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.679 2.92 . . . . 0.0 112.539 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -104.3 -1.48 26.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.599 0.759 . . . . 0.0 111.27 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.66 4.38 90.12 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.436 ' HG2' ' C5 ' ' B' ' 1' ' ' ' A' . 79.0 mttt -66.86 162.56 21.41 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 120' ' ' PHE . 4.4 pt -109.6 11.27 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -166.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 p 63.33 -5.85 0.22 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 69.96 12.22 67.8 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.205 0.907 . . . . 0.0 113.252 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -141.27 164.79 29.3 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.044 0.922 . . . . 0.0 110.574 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.69 -178.04 7.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.55 0.74 . . . . 0.0 110.539 -172.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -145.45 154.66 42.48 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 158' ' ' GLN . 5.4 t -147.38 169.16 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.523 ' N ' HG12 ' A' ' 157' ' ' VAL . 51.1 tt0 -126.96 115.95 20.03 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.959 -1.496 . . . . 0.0 106.959 164.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.66 ' CD1' HD12 ' A' ' 164' ' ' LEU . 51.7 m-85 -85.26 173.53 10.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.302 172.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.09 88.48 0.6 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.13 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.1 t 64.62 168.33 0.17 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.488 1.115 . . . . 0.0 111.511 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -19.58 63.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.866 0.466 . . . . 0.0 111.752 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.21 -42.57 65.62 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.038 -0.414 . . . . 0.0 111.244 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.784 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -68.1 -36.06 79.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.411 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -60.73 -35.06 75.42 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.282 -0.261 . . . . 0.0 110.785 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -71.41 -28.14 63.79 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -74.55 -37.98 62.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.693 0.282 . . . . 0.0 110.602 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.432 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -61.54 -23.49 65.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.932 176.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 99.1 mt -69.26 -12.1 61.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.349 0.522 . . . . 0.0 111.411 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.85 -10.66 83.65 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.559 ' HB2' HG11 ' A' ' 183' ' ' VAL . 67.3 mmtt -89.02 2.02 54.65 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.822 1.249 . . . . 0.0 112.231 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.458 ' HA ' HG22 ' A' ' 183' ' ' VAL . 42.4 t60 -52.53 132.64 35.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.974 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.487 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 87.7 mttt 59.38 12.04 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.48 1.512 . . . . 0.0 114.345 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -72.89 -169.93 0.65 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.018 0.826 . . . . 0.0 109.53 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.76 168.0 19.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.24 -13.62 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.438 0.695 . . . . 0.0 111.583 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 152.23 -26.05 0.88 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.394 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -154.49 2.78 0.22 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.66 0.73 . . . . 0.0 111.174 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -148.17 157.51 43.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.062 0.945 . . . . 0.0 108.686 -171.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -101.99 146.29 28.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.0 162.12 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -125.59 153.11 44.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.826 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.559 HG11 ' HB2' ' A' ' 171' ' ' LYS . 23.2 m -136.79 132.56 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -177.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.613 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 21.0 m-85 -146.16 154.04 41.34 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -77.53 154.67 32.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.694 0.283 . . . . 0.0 110.724 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.9 t -158.37 -178.64 7.43 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.538 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 66.3 m -148.05 170.3 18.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.695 1.198 . . . . 0.0 108.952 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -56.37 -29.58 61.61 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.761 0.424 . . . . 0.0 111.246 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -66.58 -1.03 3.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.477 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -123.16 2.3 9.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.679 0.792 . . . . 0.0 111.167 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.07 9.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -69.19 15.14 0.07 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.2 m -69.06 -0.07 5.3 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.691 0.797 . . . . 0.0 111.113 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.211 -1.376 . . . . 0.0 111.227 178.017 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.649 " H1'" ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.408 -3.743 1 C1'-O4'-C4' 105.747 -4.282 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.522 ' C5 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.95 0 O4'-C1'-N19 111.845 3.645 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.462 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.408 -3.744 0 C3'-C2'-C1' 104.76 3.623 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.462 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.936 1 O4'-C1'-N19 115.96 7.76 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.559 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.041 1 C5'-C4'-C3' 108.71 -4.527 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.613 " H1'" ' CZ ' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.48 0 P-O3'-C3' 122.731 2.526 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.6 m -147.69 12.99 1.03 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.954 0.502 . . . . 0.0 111.213 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.29 14.03 1.43 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.705 0.402 . . . . 0.0 111.718 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -67.71 -5.25 15.14 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.969 0.508 . . . . 0.0 111.895 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.6 p -148.91 22.02 0.99 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.432 0.693 . . . . 0.0 111.095 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.25 33.35 0.05 OUTLIER 'General case' 0 C--N 1.338 0.067 0 C-N-CA 124.082 0.953 . . . . 0.0 112.498 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -153.43 28.81 0.49 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 122.431 0.293 . . . . 0.0 111.311 -171.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -126.62 4.29 6.79 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.74 -13.49 13.15 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -61.88 139.18 58.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.485 0.659 . . . . 0.0 111.06 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.597 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.9 p -150.91 177.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.725 -177.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.47 ' H ' HG22 ' A' ' 113' ' ' VAL . 9.9 mtm180 -133.26 161.51 34.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.202 0.601 . . . . 0.0 110.67 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -141.61 148.46 39.27 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.629 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -153.6 161.45 42.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.12 4.72 89.67 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.441 HD23 ' SG ' ' A' ' 122' ' ' CYS . 2.9 mp -59.0 153.22 46.01 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 117.324 0.562 . . . . 0.0 111.487 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -62.26 146.27 95.91 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.387 2.058 . . . . 0.0 108.163 166.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.428 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 20.6 m-85 -73.92 10.63 1.1 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.53 3.47 7.63 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 32.5 t -66.6 151.22 47.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.731 1.212 . . . . 0.0 110.981 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.5 HG23 ' H ' ' A' ' 125' ' ' GLU . 3.0 t -146.94 -168.29 3.0 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.568 0.747 . . . . 0.0 109.142 172.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.612 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 mptt -51.69 -29.31 17.7 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.5 ' H ' HG23 ' A' ' 123' ' ' THR . 33.0 tt0 -76.02 -24.23 55.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.114 0.566 . . . . 0.0 111.93 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.485 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 5.7 mp0 -90.84 -35.34 14.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.478 -0.764 . . . . 0.0 110.0 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.51 -32.54 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.73 -31.84 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.003 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -71.74 -27.64 63.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.755 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -69.78 -27.03 64.58 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -114.3 32.68 5.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.412 1.085 . . . . 0.0 109.53 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.8 t -64.5 -13.62 53.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.959 0.504 . . . . 0.0 112.164 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.31 13.67 67.05 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.786 ' HB3' HD11 ' A' ' 164' ' ' LEU . 74.5 mt -136.72 -161.47 1.17 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.241 1.817 . . . . 0.0 107.24 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.17 -18.22 0.73 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 117.295 2.331 . . . . 0.0 117.295 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER 46.12 -166.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.819 0.848 . . . . 0.0 112.772 -176.242 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 158' ' ' GLN . 16.4 m -129.98 156.17 79.51 Favored Pre-proline 0 CA--C 1.528 0.106 0 C-N-CA 123.898 0.879 . . . . 0.0 109.852 172.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.96 137.15 22.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.027 3.151 . . . . 0.0 112.178 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 39.52 36.58 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.755 1.222 . . . . 0.0 112.952 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.15 5.33 75.23 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 119.13 -0.817 . . . . 0.0 112.507 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.6 mt -113.28 147.77 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 118.84 1.32 . . . . 0.0 109.476 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.0 m -139.56 150.7 45.37 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.505 0.722 . . . . 0.0 109.249 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 6.1 mt -144.48 97.14 5.13 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.513 0.725 . . . . 0.0 109.52 -175.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 163.81 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 124.11 3.207 . . . . 0.0 112.056 174.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 18.1 m -145.06 160.76 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 110.321 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 60.9 m-20 -84.64 175.54 4.54 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 32.5 Cg_exo -58.67 -20.22 49.63 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.74 2.294 . . . . 0.0 111.045 174.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.25 -12.88 60.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.108 0.963 . . . . 0.0 110.768 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.77 8.27 76.78 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.459 0.552 . . . . 0.0 112.268 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -95.48 148.96 21.93 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 117.433 0.617 . . . . 0.0 109.785 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 120' ' ' PHE . 6.1 pt -77.24 7.35 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 -160.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 67.96 -22.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 175.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 94.42 15.59 46.56 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.339 -0.701 . . . . 0.0 113.233 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.77 168.06 20.69 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.286 1.043 . . . . 0.0 110.466 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.99 -179.56 8.33 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.395 0.617 . . . . 0.0 111.154 -173.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -144.06 147.98 34.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 158' ' ' GLN . 48.4 t -145.83 165.26 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.669 ' O ' HG22 ' A' ' 137' ' ' VAL . 53.1 tt0 -127.92 100.71 6.02 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 168.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.67 ' CD1' HD12 ' A' ' 164' ' ' LEU . 47.5 m-85 -70.29 172.05 8.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.971 174.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.41 88.93 0.33 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.564 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.89 168.31 0.13 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.623 1.169 . . . . 0.0 111.026 -174.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -16.95 64.31 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.741 -0.599 . . . . 0.0 111.266 -176.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.09 -39.9 78.74 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.86 -0.525 . . . . 0.0 110.685 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.786 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.9 OUTLIER -72.13 -35.21 69.06 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.412 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.451 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -60.72 -36.57 79.17 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.076 -0.39 . . . . 0.0 110.625 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.02 -28.54 65.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -72.88 -37.1 67.43 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 121.285 -0.166 . . . . 0.0 110.946 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.39 65.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.611 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.5 mt -68.98 -11.34 60.65 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.613 0.365 . . . . 0.0 111.707 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.78 -16.85 80.15 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -76.27 -56.59 4.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.106 0.962 . . . . 0.0 110.791 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.674 ' HA ' HG22 ' A' ' 183' ' ' VAL . 1.2 t60 23.76 -99.87 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.881 1.272 . . . . 0.0 112.63 -164.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.471 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 92.4 mttt -70.74 17.39 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -61.28 179.37 0.21 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.616 0.767 . . . . 0.0 111.237 172.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -132.33 164.22 26.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.17 0.588 . . . . 0.0 112.104 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.2 mt -108.79 -12.82 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.32 0.648 . . . . 0.0 112.258 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.82 -24.92 1.31 Allowed Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.866 -0.521 . . . . 0.0 113.962 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -151.56 2.09 0.39 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 117.624 0.712 . . . . 0.0 110.731 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -149.79 157.46 43.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.284 1.034 . . . . 0.0 108.395 -171.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -107.37 153.25 23.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.343 0.592 . . . . 0.0 109.563 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.0 mm -119.01 171.92 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -172.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -139.92 158.31 44.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.674 HG22 ' HA ' ' A' ' 172' ' ' HIS . 21.9 m -129.07 133.9 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.749 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 3.9 m-85 -134.68 158.29 44.47 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -79.26 163.79 24.66 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.849 0.749 . . . . 0.0 109.701 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.4 t -156.82 -173.26 4.38 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.236 -0.29 . . . . 0.0 111.768 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.2 m -147.04 167.63 23.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.626 1.171 . . . . 0.0 109.713 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -59.91 -30.68 69.19 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.55 -1.42 2.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.971 0.908 . . . . 0.0 112.455 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -122.99 2.23 9.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.12 0.968 . . . . 0.0 111.201 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.98 11.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-O 120.936 0.398 . . . . 0.0 111.207 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -67.16 11.67 0.1 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 20.7 t -69.34 -1.99 9.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.524 0.73 . . . . 0.0 110.818 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.246 -1.359 . . . . 0.0 111.257 177.953 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.478 0 O4'-C1'-N19 111.434 3.234 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.428 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.713 2 P-O3'-C3' 126.243 5.453 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.4 " H5'" ' C8 ' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.15 1 P-O3'-C3' 124.98 4.4 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.796 1 O4'-C1'-N19 115.319 7.119 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.471 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.415 -3.193 1 C5'-C4'-C3' 109.127 -4.249 OUTLIER-DELTA 0.0 OUTLIER beta 0.0 . . . . . . . . . . 4 4 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.749 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 P-O3'-C3' 124.063 3.636 . 0.011 4d . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.2 t30 . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.5 m 49.51 24.64 1.16 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.35 1.06 . . . . 0.0 113.412 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.86 172.97 15.94 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.062 0.545 . . . . 0.0 110.309 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -152.66 163.51 39.51 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.243 0.617 . . . . 0.0 110.074 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.0 m -143.69 5.62 1.39 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.2 36.35 0.29 Allowed 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.377 0.671 . . . . 0.0 111.113 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.509 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 5.9 t-20 -151.02 28.29 0.68 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.672 -171.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -126.59 9.71 7.13 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.85 -9.7 40.45 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -62.49 138.79 58.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.47 0.653 . . . . 0.0 110.218 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.9 p -148.6 175.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.862 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.417 ' H ' HG22 ' A' ' 113' ' ' VAL . 3.3 mtt-85 -131.56 160.94 33.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.663 0.785 . . . . 0.0 110.045 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.2 tp -144.54 140.83 29.06 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -156.67 172.87 17.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.415 ' HA3' ' N2 ' ' B' ' 3' ' ' ' G' . . . 84.04 8.01 84.57 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -176.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 72.0 mt -56.72 150.58 35.92 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.91 0.884 . . . . 0.0 111.819 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.83 20.34 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 124.844 3.696 . . . . 0.0 113.428 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.546 ' CZ ' ' C8 ' ' B' ' 1' ' ' ' A' . 21.8 m-85 55.21 11.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.631 1.172 . . . . 0.0 114.131 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.22 -7.63 1.94 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 21.8 t -66.33 151.46 47.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.271 1.029 . . . . 0.0 110.342 175.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 125' ' ' GLU . 6.4 t -143.27 -173.46 3.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 170.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.9 ptpp? -54.71 -17.39 3.37 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.525 ' H ' HG23 ' A' ' 123' ' ' THR . 42.1 mt-10 -83.69 -26.12 30.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.949 0.5 . . . . 0.0 111.341 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.466 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 4.8 mp0 -87.59 -32.55 19.27 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.68 -35.62 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 p -82.27 -34.08 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.164 -173.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -79.67 -20.82 45.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.47 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -73.72 -26.08 60.52 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 170.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -111.14 36.85 3.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.175 1.39 . . . . 0.0 109.024 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.3 t -68.11 -11.27 58.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 112.412 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.09 20.96 46.71 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 164' ' ' LEU . 43.4 mt -141.27 -173.06 3.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.475 2.31 . . . . 0.0 105.043 -172.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -138.64 -18.12 1.09 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -174.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.3 mt 50.83 -177.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.208 1.003 . . . . 0.0 112.454 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.588 ' H ' HG22 ' A' ' 136' ' ' ILE . 18.9 m -121.45 155.88 58.71 Favored Pre-proline 0 CA--C 1.528 0.119 0 O-C-N 121.361 -0.837 . . . . 0.0 109.869 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.68 138.1 25.84 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.907 3.072 . . . . 0.0 111.881 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 43.26 35.51 0.87 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.849 0.859 . . . . 0.0 111.538 -177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -99.07 28.71 14.01 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 119.256 -0.747 . . . . 0.0 111.737 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.4 mt -138.49 146.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 118.505 1.152 . . . . 0.0 109.513 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 96.8 m -143.9 151.55 39.97 Favored 'General case' 0 C--N 1.335 -0.051 0 C-N-CA 123.623 0.769 . . . . 0.0 109.268 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 1.4 mt -145.48 101.15 4.36 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -52.18 149.51 21.76 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.384 2.723 . . . . 0.0 111.32 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -145.01 165.74 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.361 0.6 . . . . 0.0 110.75 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.437 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 65.9 m-20 -86.59 176.27 3.7 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.8 Cg_exo -57.9 -17.82 32.13 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.982 2.455 . . . . 0.0 112.088 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -86.28 -8.82 57.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.324 1.05 . . . . 0.0 111.458 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.71 1.7 88.96 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.444 ' HE3' ' N1 ' ' B' ' 1' ' ' ' A' . 87.2 tttt -76.66 131.33 38.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.451 1.5 . . . . 0.0 109.092 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.9 pt -70.89 147.34 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.394 0.616 . . . . 0.0 110.319 -174.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.2 p -80.77 -9.7 59.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.165 -174.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 111.72 -6.48 27.81 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.734 -0.481 . . . . 0.0 112.798 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -139.29 166.49 24.41 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 117.78 0.79 . . . . 0.0 110.452 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -150.33 -176.81 5.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.039 0.536 . . . . 0.0 111.058 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -144.67 147.64 33.3 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -174.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.509 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 85.7 t -147.7 164.18 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.467 ' N ' HG12 ' A' ' 157' ' ' VAL . 52.4 tt0 -129.67 104.87 7.68 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 59.0 m-85 -74.31 169.52 17.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.12 91.74 0.37 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.9 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 16.4 t 63.76 171.31 0.17 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.201 1.0 . . . . 0.0 111.135 -175.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.509 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 0.6 OUTLIER -61.7 -30.04 70.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.109 -0.369 . . . . 0.0 110.604 -176.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -63.01 -36.69 84.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -76.6 -33.51 58.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -64.76 -34.7 78.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.682 -0.636 . . . . 0.0 110.839 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -69.97 -29.76 66.95 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -71.81 -37.45 70.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.454 0.169 . . . . 0.0 110.859 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.41 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -60.83 -22.67 64.43 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 122.649 0.38 . . . . 0.0 112.018 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.639 ' HA ' HG21 ' A' ' 183' ' ' VAL . 97.6 mt -68.46 -11.65 60.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 122.213 -0.304 . . . . 0.0 111.397 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.27 -19.44 79.64 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.15 -63.14 1.14 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.044 0.938 . . . . 0.0 109.458 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.638 ' HA ' HG22 ' A' ' 183' ' ' VAL . 1.2 t60 25.11 -107.5 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.45 1.1 . . . . 0.0 112.521 -166.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.475 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 90.9 mttt -68.07 12.77 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.08 171.19 11.36 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.497 1.519 . . . . 0.0 109.635 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -116.92 155.98 28.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -169.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.49 -14.31 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.476 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.32 -27.23 0.61 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.643 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -154.47 -1.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.607 0.703 . . . . 0.0 111.583 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -145.84 150.63 36.52 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.949 0.899 . . . . 0.0 108.727 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -91.43 159.58 15.89 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.865 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 182' ' ' GLU . 36.2 mm -125.27 174.38 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 -174.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.542 ' CG ' ' H21' ' B' ' 3' ' ' ' G' . 14.4 mt-10 -138.96 142.17 38.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.639 HG21 ' HA ' ' A' ' 169' ' ' LEU . 22.2 m -114.61 139.29 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' PHE . . . . . 0.692 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 5.3 m-85 -137.42 159.4 42.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -77.72 163.62 25.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.83 0.741 . . . . 0.0 109.59 175.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t -156.13 -173.18 4.39 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.563 0.22 . . . . 0.0 111.561 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.4 m -147.29 168.99 20.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.351 1.06 . . . . 0.0 109.64 -176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -58.94 -30.35 67.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.638 0.375 . . . . 0.0 110.885 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -67.28 -2.33 5.83 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.368 0.667 . . . . 0.0 112.673 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -116.78 0.49 12.55 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.447 0.699 . . . . 0.0 110.496 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.59 8.52 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -70.39 16.2 0.08 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 35.1 m -68.87 0.02 4.93 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.471 0.708 . . . . 0.0 111.073 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.372 177.896 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ' A' . . . . . 0.546 ' C8 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.413 -3.323 0 C3'-C2'-C1' 104.551 3.39 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.494 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.495 1 C5'-C4'-C3' 108.34 -4.773 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.542 ' H21' ' CG ' ' A' ' 182' ' ' GLU . . . . . . . . 0 O4'--C4' 1.411 -3.479 1 P-O3'-C3' 125.677 4.981 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.535 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.081 1 O4'-C1'-N19 114.661 6.461 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.475 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -2.994 1 C5'-C4'-C3' 109.153 -4.231 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.692 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.64 0 P-O3'-C3' 123.503 3.169 . 0.015 4d . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 121.048 0.452 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -136.27 165.48 25.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.678 1.191 . . . . 0.0 108.451 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.62 1.34 37.7 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.961 -0.355 . . . . 0.0 112.447 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -61.56 144.54 54.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 117.66 0.73 . . . . 0.0 110.808 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.639 HG11 ' CE2' ' A' ' 159' ' ' PHE . 10.7 p -151.77 176.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 124.116 0.966 . . . . 0.0 108.521 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.512 ' H ' HG22 ' A' ' 113' ' ' VAL . 22.4 ttt180 -136.63 147.47 46.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.06 148.28 44.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -152.46 160.27 43.27 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.66 3.65 71.02 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 120' ' ' PHE . 83.5 mt -55.55 140.57 65.83 Favored Pre-proline 0 N--CA 1.453 -0.316 0 C-N-CA 123.321 0.648 . . . . 0.0 110.596 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 24.5 Cg_exo -58.85 16.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 125.172 3.915 . . . . 0.0 116.081 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.42 ' H ' ' C ' ' A' ' 118' ' ' LEU . 22.0 m-85 57.03 9.41 0.63 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.554 1.141 . . . . 0.0 112.847 -171.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.05 -3.16 1.51 Allowed Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.793 -0.567 . . . . 0.0 112.304 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 28.2 t -63.62 153.18 36.74 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.56 HG23 ' H ' ' A' ' 125' ' ' GLU . 5.7 t -150.47 -169.19 3.32 Favored 'General case' 0 CA--C 1.526 0.05 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -51.71 -33.69 35.48 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.139 0.427 . . . . 0.0 111.81 -178.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.56 ' H ' HG23 ' A' ' 123' ' ' THR . 40.4 tt0 -76.78 -22.67 53.4 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.447 0.699 . . . . 0.0 112.018 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.506 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 47.2 mm-40 -94.73 -33.87 12.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.431 -0.793 . . . . 0.0 109.33 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.419 HG13 ' SG ' ' A' ' 122' ' ' CYS . 54.0 mt -64.32 -34.57 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.33 -34.02 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.661 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -72.34 -26.6 61.99 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.898 172.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 19.3 t80 -72.09 -23.06 61.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.655 0.264 . . . . 0.0 110.549 175.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -118.14 32.87 5.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.397 1.079 . . . . 0.0 109.042 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.0 t -68.26 -11.67 59.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.122 0.569 . . . . 0.0 112.342 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.56 15.24 63.58 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.621 ' HB3' HD11 ' A' ' 164' ' ' LEU . 28.7 mt -144.14 -162.33 1.45 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.36 1.864 . . . . 0.0 107.196 -173.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -147.94 162.32 39.54 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.981 -0.449 . . . . 0.0 110.069 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.39 148.03 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 158' ' ' GLN . 21.0 m -73.83 153.71 89.12 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 118.588 0.631 . . . . 0.0 110.254 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.89 139.36 25.39 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 124.109 3.206 . . . . 0.0 112.477 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.5 t30 40.59 37.56 0.49 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.369 1.068 . . . . 0.0 111.988 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.86 27.73 13.62 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-O 118.72 -1.045 . . . . 0.0 112.057 -173.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.7 mt -133.37 145.3 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 119.375 1.588 . . . . 0.0 109.36 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.4 m -137.8 144.76 41.7 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.772 0.829 . . . . 0.0 109.158 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 123' ' ' THR . 87.2 mt -136.96 93.72 13.27 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 123.454 0.702 . . . . 0.0 110.029 -173.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.5 150.84 32.91 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.221 2.614 . . . . 0.0 110.764 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -141.57 166.69 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.096 0 CA-C-O 121.437 0.637 . . . . 0.0 111.43 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 64.7 m-20 -92.3 176.99 2.3 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.721 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 35.3 Cg_exo -58.75 -19.18 44.98 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.962 2.441 . . . . 0.0 111.83 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -82.82 -7.56 59.65 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.526 0.73 . . . . 0.0 110.657 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.93 13.44 81.24 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.307 0.48 . . . . 0.0 112.323 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -105.61 149.07 26.64 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.5 pt -68.86 149.76 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.456 0.646 . . . . 0.0 111.493 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 45.4 p -74.91 -7.34 53.26 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.222 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.65 -0.75 36.61 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -140.37 170.72 15.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.066 0.546 . . . . 0.0 110.409 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -157.22 -178.69 7.55 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.269 0.628 . . . . 0.0 111.079 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -143.98 148.85 35.87 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 158' ' ' GLN . 76.2 t -146.84 165.34 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.493 ' N ' HG12 ' A' ' 157' ' ' VAL . 40.8 tt0 -128.52 105.99 8.67 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 167.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.639 ' CE2' HG11 ' A' ' 113' ' ' VAL . 35.1 m-85 -74.69 173.01 11.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.389 170.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.19 90.7 0.9 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.192 0.52 . . . . 0.0 109.796 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.9 t 63.15 170.24 0.15 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.591 1.157 . . . . 0.0 112.415 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -22.06 65.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.5 0.72 . . . . 0.0 111.598 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.71 -43.48 75.92 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.907 -0.495 . . . . 0.0 111.032 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -67.6 -39.15 84.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.509 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.19 -37.23 71.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.129 -0.357 . . . . 0.0 110.867 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -71.78 -28.86 63.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.896 -0.138 . . . . 0.0 110.902 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -72.98 -39.18 66.33 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.656 0.265 . . . . 0.0 110.549 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.53 -17.88 63.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.106 0.562 . . . . 0.0 112.195 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.33 -13.01 61.61 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.462 0.574 . . . . 0.0 111.366 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.05 -11.74 81.47 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.536 ' HB2' HG11 ' A' ' 183' ' ' VAL . 69.9 mmtt -88.54 0.55 56.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.296 1.438 . . . . 0.0 111.705 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -54.54 133.18 46.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.443 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 90.6 mttt 59.51 5.59 0.67 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.617 1.567 . . . . 0.0 114.075 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -76.95 170.41 16.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -112.59 158.31 20.12 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -169.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.1 tt -102.9 -9.52 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.574 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 154.43 -29.08 0.7 Allowed Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.935 -0.37 . . . . 0.0 112.611 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -157.51 0.96 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.411 0.605 . . . . 0.0 111.382 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -145.64 153.46 41.05 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.21 1.004 . . . . 0.0 108.508 -173.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -97.01 152.95 18.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.989 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 38.7 mm -127.47 162.2 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -128.71 160.37 32.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 171' ' ' LYS . 26.5 m -137.0 39.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 123.103 0.561 . . . . 0.0 111.674 -162.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 3.4 m-30 -52.71 152.87 3.5 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.922 0.489 . . . . 0.0 109.816 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -80.06 170.16 16.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.633 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 10.0 t -158.01 179.97 8.69 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.479 0.312 . . . . 0.0 110.821 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -148.18 170.53 17.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.284 1.433 . . . . 0.0 108.291 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -53.92 -31.81 51.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.74 -2.77 2.69 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -122.14 2.16 9.8 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.861 0.864 . . . . 0.0 111.013 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.56 11.55 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-O 120.968 0.413 . . . . 0.0 111.14 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -68.95 13.03 0.11 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 29.3 m -67.24 -1.98 5.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.393 0.677 . . . . 0.0 111.456 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.247 -1.358 . . . . 0.0 110.968 178.272 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.2 p30 . . . . . 0 N--CA 1.444 -0.727 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -128.07 7.13 6.01 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.07 -8.74 25.15 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -64.12 142.18 58.5 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.479 0.657 . . . . 0.0 111.608 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.626 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.4 p -152.92 177.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.435 1.094 . . . . 0.0 108.686 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.524 ' H ' HG22 ' A' ' 113' ' ' VAL . 65.0 ttt180 -135.65 153.66 51.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.951 0.9 . . . . 0.0 109.1 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -126.5 135.62 51.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -150.69 50.68 0.87 Allowed 'General case' 0 C--O 1.226 -0.166 0 CA-C-O 121.282 0.563 . . . . 0.0 112.443 -172.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -160.03 15.94 0.21 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.7 153.46 90.82 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -168.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 24.5 Cg_exo -59.44 143.63 99.65 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.754 2.303 . . . . 0.0 107.951 163.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -69.71 6.73 1.05 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.74 10.66 5.46 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 48.8 t -66.29 157.82 30.64 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.285 1.034 . . . . 0.0 111.404 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 125' ' ' GLU . 3.7 t -152.16 -174.8 5.0 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.248 0.619 . . . . 0.0 109.825 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.603 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -51.77 -34.01 37.7 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 123.378 0.671 . . . . 0.0 112.471 -176.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.53 ' H ' HG23 ' A' ' 123' ' ' THR . 40.2 tt0 -72.39 -25.96 61.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.016 0.527 . . . . 0.0 112.166 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -93.1 -30.7 15.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.76 -40.74 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.35 -34.51 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 O-C-N 122.159 -0.338 . . . . 0.0 111.193 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -74.34 -28.71 61.27 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.162 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 28.9 t80 -67.15 -21.21 65.82 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -115.41 37.15 3.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.341 1.056 . . . . 0.0 108.385 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.2 t -69.48 154.84 41.41 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 167.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.27 5.1 85.11 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.504 ' HB3' HD11 ' A' ' 164' ' ' LEU . 24.0 mt -141.78 -172.2 3.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.668 1.987 . . . . 0.0 106.01 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -147.79 162.6 38.89 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.634 -0.666 . . . . 0.0 110.845 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.7 mt -141.32 147.9 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 158' ' ' GLN . 19.4 m -72.64 154.47 91.42 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 118.459 0.572 . . . . 0.0 110.305 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -48.63 138.61 24.99 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.055 3.17 . . . . 0.0 112.179 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 t30 41.53 36.4 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.471 1.109 . . . . 0.0 112.014 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.25 28.64 10.31 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.793 -1.004 . . . . 0.0 111.739 -173.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.5 mt -136.56 145.75 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 119.061 1.431 . . . . 0.0 109.351 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.0 m -139.5 149.46 43.98 Favored 'General case' 0 N--CA 1.458 -0.048 0 C-N-CA 123.509 0.724 . . . . 0.0 109.827 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.443 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 11.9 mt -144.48 93.26 5.85 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 124.075 0.95 . . . . 0.0 109.649 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -55.72 159.61 11.12 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.813 3.009 . . . . 0.0 111.307 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.2 m -141.21 166.02 18.54 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 CA-C-O 121.216 0.531 . . . . 0.0 111.543 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 66.9 m-20 -90.05 176.48 3.01 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.831 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -58.85 -19.25 46.12 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.089 2.526 . . . . 0.0 111.736 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -82.81 -9.01 59.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.563 0.745 . . . . 0.0 110.745 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.35 11.16 80.98 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 123.384 0.516 . . . . 0.0 112.272 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -102.81 148.75 25.24 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.2 pt -68.17 151.23 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.912 0.863 . . . . 0.0 112.263 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.7 p -79.11 5.87 10.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.481 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.7 15.35 80.73 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -140.83 164.74 29.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.49 178.19 10.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.249 0.547 . . . . 0.0 110.465 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -144.71 145.18 31.59 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 67.9 t -143.79 162.98 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.466 ' N ' HG12 ' A' ' 157' ' ' VAL . 49.3 tt0 -129.17 101.83 6.19 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 169.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.626 ' CE2' HG11 ' A' ' 113' ' ' VAL . 43.6 m-85 -71.55 171.17 11.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.328 171.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.47 93.53 1.19 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 61.8 169.8 0.11 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.688 1.195 . . . . 0.0 111.343 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -61.99 -26.75 68.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.762 -0.586 . . . . 0.0 110.9 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.16 -42.48 90.84 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.243 -0.286 . . . . 0.0 111.119 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 164' ' ' LEU . 0.5 OUTLIER -72.17 -38.79 69.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.526 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.91 -40.54 80.59 Favored 'General case' 0 N--CA 1.457 -0.101 0 O-C-N 122.013 -0.43 . . . . 0.0 110.898 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -67.83 -31.05 70.63 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.719 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -71.56 -39.46 70.63 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.632 0.253 . . . . 0.0 111.011 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.98 -15.39 62.21 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.96 -9.33 51.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.685 0.675 . . . . 0.0 111.524 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.14 -11.96 85.07 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.578 ' HB2' HG11 ' A' ' 183' ' ' VAL . 69.5 mmtt -85.74 2.81 43.97 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.243 1.417 . . . . 0.0 111.588 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -56.28 136.9 53.05 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.972 -0.455 . . . . 0.0 110.314 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 33.0 mttp 50.99 11.39 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.179 1.792 . . . . 0.0 114.242 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.02 179.36 5.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.259 1.024 . . . . 0.0 109.085 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -126.46 163.27 23.7 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -170.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mt -113.0 -13.13 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.277 1.031 . . . . 0.0 111.849 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.41 -27.1 1.37 Allowed Glycine 0 CA--C 1.528 0.901 0 O-C-N 121.922 -0.486 . . . . 0.0 113.975 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -153.05 11.49 0.47 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.843 0.822 . . . . 0.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.11 -173.57 3.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.445 1.098 . . . . 0.0 108.384 -172.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -137.06 144.14 43.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 19.0 mm -116.79 162.62 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -167.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -129.64 154.08 47.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 171' ' ' LYS . 34.5 m -131.24 33.66 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 C-N-CA 123.839 0.855 . . . . 0.0 111.011 -166.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -53.55 154.61 3.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -81.93 170.57 15.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.362 -0.837 . . . . 0.0 111.826 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.8 t -158.88 -173.7 4.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.521 0.328 . . . . 0.0 111.533 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 51.3 m -147.81 168.04 23.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.964 1.306 . . . . 0.0 109.174 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -56.91 -30.75 64.22 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.724 0.409 . . . . 0.0 110.897 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.84 -6.53 6.01 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -117.25 1.91 12.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.589 0.755 . . . . 0.0 111.312 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.61 15.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.269 0.557 . . . . 0.0 110.928 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -69.26 11.53 0.22 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.421 0.688 . . . . 0.0 112.811 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 65.8 p -69.29 -1.52 8.35 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.412 0.685 . . . . 0.0 111.243 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.746 -1.121 . . . . 0.0 110.959 177.949 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.4 p30 . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 120.452 0.168 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -125.15 4.26 7.87 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.5 -9.76 53.17 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -62.5 141.36 58.45 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.568 0.699 . . . . 0.0 110.596 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.63 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.5 p -150.6 172.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 70.4 ttt180 -137.34 152.83 50.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp -136.92 148.2 46.86 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -173.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -158.3 154.93 27.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.689 0.281 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.08 -7.08 60.22 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.706 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -63.82 157.99 64.07 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.881 0.341 . . . . 0.0 111.777 -176.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 21.8 Cg_exo -57.82 152.13 51.88 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.348 2.699 . . . . 0.0 112.522 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -67.89 -5.53 17.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.93 -0.89 31.91 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.437 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 41.8 t -68.2 153.01 44.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.344 0.657 . . . . 0.0 109.407 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.657 HG23 ' H ' ' A' ' 125' ' ' GLU . 8.7 t -154.31 -174.63 5.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 174.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 2.4 ptpp? -56.48 -20.69 21.34 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.657 ' H ' HG23 ' A' ' 123' ' ' THR . 42.2 mt-10 -82.18 -21.86 36.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.911 0.484 . . . . 0.0 111.218 177.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.411 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 60.2 mm-40 -90.74 -33.65 15.67 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.2 mt -61.4 -36.39 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.79 -33.63 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.002 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -75.66 -26.91 58.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.993 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -67.94 -27.57 66.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -108.79 34.71 3.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.3 t -67.15 152.0 46.54 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.94 4.24 90.35 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -172.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.553 ' HB3' HD11 ' A' ' 164' ' ' LEU . 19.2 mt -139.49 -171.56 3.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.165 1.786 . . . . 0.0 106.543 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -146.95 162.54 38.52 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.858 -0.526 . . . . 0.0 110.691 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 mt -141.82 148.74 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.9 m -74.46 154.6 87.81 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 118.476 0.58 . . . . 0.0 110.422 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.15 140.01 26.05 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.073 3.182 . . . . 0.0 112.229 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.6 t30 41.77 34.9 0.45 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.36 1.064 . . . . 0.0 111.929 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.32 30.17 8.04 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-O 118.941 -0.922 . . . . 0.0 111.801 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.8 mt -138.35 146.94 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 118.902 1.351 . . . . 0.0 109.922 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.6 m -140.76 146.88 38.29 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 123.86 0.864 . . . . 0.0 109.643 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.4 mt -142.35 92.84 7.29 Favored Pre-proline 0 CA--C 1.528 0.104 0 C-N-CA 124.268 1.027 . . . . 0.0 109.395 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.99 156.4 15.84 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.584 2.856 . . . . 0.0 111.539 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.4 m -142.43 167.06 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-O 121.367 0.603 . . . . 0.0 110.914 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.455 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 61.7 m-20 -91.03 176.52 2.81 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.707 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.5 Cg_exo -58.07 -20.01 43.7 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.823 2.349 . . . . 0.0 111.712 176.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -80.66 -8.81 59.75 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.165 0.986 . . . . 0.0 111.219 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.53 2.52 90.54 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -174.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -79.14 134.66 36.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.007 1.323 . . . . 0.0 108.886 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.5 pt -68.52 146.52 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.579 0.704 . . . . 0.0 110.163 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.4 p -76.4 0.85 18.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.24 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 85.95 7.44 80.82 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -141.43 168.55 19.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.356 0.578 . . . . 0.0 110.347 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.1 179.43 9.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.308 0.575 . . . . 0.0 111.078 -173.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -143.56 146.21 33.14 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.2 t -146.38 164.72 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.472 ' N ' HG12 ' A' ' 157' ' ' VAL . 53.1 tt0 -129.51 102.58 6.45 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 169.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.63 ' CE2' HG11 ' A' ' 113' ' ' VAL . 37.9 m-85 -73.07 171.57 12.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.379 171.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 92.45 0.91 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.8 t 61.88 167.2 0.11 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.787 1.235 . . . . 0.0 111.488 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -14.2 61.99 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.904 -0.498 . . . . 0.0 111.091 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.61 -41.81 79.03 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 122.05 -0.406 . . . . 0.0 110.546 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 164' ' ' LEU . 0.7 OUTLIER -70.86 -39.67 72.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.44 -38.76 74.95 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.198 -0.314 . . . . 0.0 110.804 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -68.87 -29.82 68.2 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.764 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -73.24 -38.15 66.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.622 0.248 . . . . 0.0 110.759 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.01 -16.81 63.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.75 -9.68 57.85 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.408 0.549 . . . . 0.0 111.548 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.19 -12.77 81.62 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.49 ' HB2' HG11 ' A' ' 183' ' ' VAL . 68.9 mmtt -82.74 -2.37 54.12 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 125.599 1.56 . . . . 0.0 111.973 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -52.69 133.11 36.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.651 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 44.5 mttp 56.37 9.69 0.56 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.202 1.801 . . . . 0.0 114.4 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.06 173.04 9.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.068 0.947 . . . . 0.0 108.82 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -125.4 160.27 29.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.796 -0.565 . . . . 0.0 112.169 -172.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.1 tt -113.04 -1.93 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.2 -36.92 0.65 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 121.731 -0.606 . . . . 0.0 113.685 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -155.62 6.87 0.23 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.533 0.666 . . . . 0.0 110.74 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.76 135.36 24.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -86.1 157.9 19.93 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.727 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 27.6 mm -125.05 160.85 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -127.5 156.24 42.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 171' ' ' LYS . 33.1 m -131.71 130.71 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 5.7 m-85 -137.19 153.91 50.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -175.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -76.42 164.09 26.33 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.692 0.678 . . . . 0.0 110.006 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -159.4 -175.35 5.16 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.45 0.167 . . . . 0.0 111.373 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.4 t -148.85 171.84 15.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.947 0.899 . . . . 0.0 110.011 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -60.24 -28.61 68.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.269 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.63 -0.94 2.31 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.8 0.84 . . . . 0.0 112.571 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.59 2.37 7.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.542 0.737 . . . . 0.0 111.601 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.72 10.53 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 122.131 -0.356 . . . . 0.0 111.866 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -69.75 15.6 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.2 m -68.61 -0.48 5.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.593 0.757 . . . . 0.0 111.087 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.237 -1.363 . . . . 0.0 111.244 178.105 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -129.39 5.16 5.19 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.72 -10.16 52.58 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -63.11 141.18 58.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.563 0.696 . . . . 0.0 110.471 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.619 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -150.92 175.94 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.932 -177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.458 ' H ' HG22 ' A' ' 113' ' ' VAL . 33.8 ttt180 -135.4 154.16 51.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 109.28 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.9 tp -139.3 150.28 45.23 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -156.72 157.78 35.73 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.13 -5.13 71.62 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.75 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.93 155.95 90.59 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 116.94 0.37 . . . . 0.0 111.529 -176.437 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 31.3 Cg_exo -54.65 151.25 32.32 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.125 3.217 . . . . 0.0 112.183 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -64.88 -8.74 16.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.05 0.387 . . . . 0.0 111.688 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.57 -0.1 30.79 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.451 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 44.6 t -64.25 153.77 37.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.292 0.637 . . . . 0.0 109.293 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.646 HG23 ' H ' ' A' ' 125' ' ' GLU . 10.4 t -154.87 -176.17 5.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 0.9 OUTLIER -57.29 -21.75 36.88 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.646 ' H ' HG23 ' A' ' 123' ' ' THR . 39.4 tt0 -78.74 -25.23 44.5 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.19 0.596 . . . . 0.0 110.744 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 56.9 mm-40 -87.9 -37.08 16.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.31 -35.06 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.0 p -79.69 -32.45 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.712 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -75.32 -28.05 59.5 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.961 172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -66.05 -26.42 67.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -111.77 32.58 5.34 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.838 0.855 . . . . 0.0 109.017 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.0 t -64.31 148.89 49.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.59 3.71 86.12 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -172.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.554 ' HB3' HD11 ' A' ' 164' ' ' LEU . 17.9 mt -138.53 -170.55 2.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.744 1.617 . . . . 0.0 106.715 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -146.78 162.2 39.05 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.87 -0.519 . . . . 0.0 110.374 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.3 mt -142.04 148.44 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.6 m -73.29 154.49 90.19 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 118.595 0.634 . . . . 0.0 110.369 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.1 138.74 27.74 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 124.074 3.183 . . . . 0.0 112.155 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.1 t30 41.65 35.81 0.52 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.313 1.045 . . . . 0.0 112.047 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.04 29.96 8.13 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 119.04 -0.867 . . . . 0.0 111.895 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.9 mt -138.24 145.54 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.775 1.288 . . . . 0.0 109.658 -176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 86.3 m -139.59 150.2 44.74 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 123.822 0.849 . . . . 0.0 109.621 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 92.6 mt -139.81 90.77 10.8 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.829 0.852 . . . . 0.0 110.093 -174.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.47 153.87 21.56 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.468 2.779 . . . . 0.0 111.813 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.5 m -142.57 169.09 13.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 121.382 0.61 . . . . 0.0 111.207 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 59.5 m-20 -96.12 177.46 1.73 Allowed Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.105 0.962 . . . . 0.0 108.781 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 40.5 Cg_exo -58.04 -20.55 45.99 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.952 2.435 . . . . 0.0 111.625 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.26 -10.7 59.61 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.184 0.994 . . . . 0.0 110.956 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.22 4.39 86.5 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -83.43 136.31 34.36 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.068 1.347 . . . . 0.0 108.806 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.1 pt -66.98 148.01 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 121.79 0.805 . . . . 0.0 110.754 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.6 p -75.26 -0.69 20.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.16 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 88.28 5.94 75.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -138.53 169.78 17.17 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.279 0.54 . . . . 0.0 110.207 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.81 179.13 9.39 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.212 0.605 . . . . 0.0 110.798 -174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -143.65 145.55 32.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 60.2 t -145.81 164.59 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.472 ' N ' HG12 ' A' ' 157' ' ' VAL . 52.6 tt0 -129.19 102.22 6.36 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.619 ' CE2' HG11 ' A' ' 113' ' ' VAL . 44.6 m-85 -72.74 171.2 13.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.263 172.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.86 92.73 0.71 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t 61.67 168.67 0.11 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.758 1.223 . . . . 0.0 111.505 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -14.66 62.68 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.95 -0.469 . . . . 0.0 111.24 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.07 -42.4 76.27 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 122.052 -0.405 . . . . 0.0 110.679 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -70.84 -38.89 73.24 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.521 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.48 -39.04 75.55 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.279 -0.263 . . . . 0.0 110.717 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -69.02 -29.05 67.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.892 -0.14 . . . . 0.0 110.956 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -73.52 -38.19 65.38 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.095 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.8 -21.65 66.04 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.553 ' HA ' HG21 ' A' ' 183' ' ' VAL . 97.0 mt -70.35 -7.71 44.88 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 122.847 0.459 . . . . 0.0 111.733 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.04 -15.47 81.37 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -76.07 -55.02 5.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.257 1.023 . . . . 0.0 110.856 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.692 ' HA ' HG22 ' A' ' 183' ' ' VAL . 0.7 OUTLIER 23.86 -101.79 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.863 1.265 . . . . 0.0 113.052 -165.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -71.18 19.55 0.05 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -174.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.28 178.74 0.18 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.003 0.921 . . . . 0.0 111.099 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -128.58 161.18 30.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.343 0.657 . . . . 0.0 110.746 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.0 tt -117.94 -0.08 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.42 -36.17 0.64 Allowed Glycine 0 CA--C 1.529 0.953 0 O-C-N 122.046 -0.409 . . . . 0.0 113.422 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -156.72 5.74 0.16 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.314 0.557 . . . . 0.0 110.489 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -146.51 156.17 43.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.514 1.126 . . . . 0.0 108.485 -170.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -104.07 153.81 20.44 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.373 0.606 . . . . 0.0 110.113 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 182' ' ' GLU . 30.1 mm -120.12 172.14 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -172.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.412 ' N ' HG22 ' A' ' 181' ' ' ILE . 21.8 mt-10 -139.54 155.94 47.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' A' ' 172' ' ' HIS . 22.2 m -130.71 137.5 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -148.18 160.49 42.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -80.18 165.32 22.54 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.677 0.671 . . . . 0.0 110.778 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.7 t -158.74 -174.41 4.76 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.144 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.6 t -147.98 171.85 15.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.162 0.985 . . . . 0.0 109.796 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -59.36 -31.39 69.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.652 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.78 -6.02 7.15 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.678 0.791 . . . . 0.0 112.537 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -118.45 3.01 11.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.598 0.759 . . . . 0.0 111.168 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.26 9.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 122.272 -0.267 . . . . 0.0 111.613 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -69.26 13.5 0.12 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.7 m -67.14 -1.16 3.97 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.509 0.723 . . . . 0.0 111.205 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.287 177.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.027 0.442 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -121.7 7.65 9.98 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.64 -9.77 41.26 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -61.27 138.63 58.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.731 0.776 . . . . 0.0 110.823 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.576 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -150.27 174.97 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.235 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 58.4 ttt180 -136.58 155.38 50.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.3 tp -138.28 147.4 43.59 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -173.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -154.72 162.48 41.1 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.83 1.45 58.65 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.6 mt -56.97 150.04 41.3 Favored Pre-proline 0 N--CA 1.453 -0.292 0 C-N-CA 123.23 0.612 . . . . 0.0 111.982 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.27 26.16 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 1 C-N-CA 125.346 4.031 . . . . 0.0 113.522 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.589 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 15.4 m-30 53.47 13.85 0.5 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.903 1.281 . . . . 0.0 114.162 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.02 -13.99 0.58 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.994 0.815 . . . . 0.0 112.724 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.4 m -67.35 153.5 43.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.448 0.624 . . . . 0.0 110.389 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 t -147.23 -160.8 1.21 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.93 0.892 . . . . 0.0 108.733 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.553 ' HE3' HD12 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -50.34 -31.26 14.07 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -84.07 -19.64 33.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -96.27 -31.54 12.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.756 -0.59 . . . . 0.0 109.816 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.4 mt -62.98 -36.31 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 172.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.7 p -79.32 -32.2 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.921 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -74.15 -30.66 62.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.248 172.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.89 -22.06 65.98 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 118.267 0.485 . . . . 0.0 110.111 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -115.84 31.44 6.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.516 1.126 . . . . 0.0 109.214 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.6 t -63.06 139.58 58.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.87 1.75 90.63 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.8 mt -138.82 78.37 1.67 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.153 1.381 . . . . 0.0 107.673 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -50.07 160.01 0.38 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.858 0.863 . . . . 0.0 113.293 -174.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.1 mt -136.41 153.18 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 158' ' ' GLN . 27.3 m -58.93 155.36 32.61 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 122.597 0.359 . . . . 0.0 110.592 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.99 -31.0 7.8 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.84 3.693 . . . . 0.0 114.084 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -160.12 105.57 1.54 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.04 20.93 1.11 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-O 118.686 -1.063 . . . . 0.0 112.756 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.2 mt -117.48 147.26 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 119.257 1.529 . . . . 0.0 110.271 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.4 m -142.11 144.87 33.72 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.958 0.903 . . . . 0.0 109.49 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.553 HD12 ' HE3' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -139.65 97.81 8.12 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 123.793 0.837 . . . . 0.0 110.047 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.18 154.9 31.68 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.871 3.047 . . . . 0.0 110.998 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.32 168.83 13.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-O 121.408 0.623 . . . . 0.0 111.503 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.46 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 62.9 m-20 -95.13 176.64 2.17 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.549 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -58.08 -19.6 41.81 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.976 2.451 . . . . 0.0 111.913 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.23 -8.14 59.7 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.166 0.986 . . . . 0.0 111.117 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.08 2.76 89.19 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.589 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 80.0 tttt -81.08 134.2 35.62 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.922 1.289 . . . . 0.0 108.304 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.1 148.93 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.505 0.669 . . . . 0.0 109.753 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 53.4 p -72.4 1.46 7.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.989 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 95.75 0.95 62.05 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -140.96 169.71 17.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.913 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.65 -177.89 6.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -144.66 146.46 32.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.521 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 84.4 t -146.16 163.2 10.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.673 ' O ' HG22 ' A' ' 137' ' ' VAL . 58.5 tt0 -130.87 94.6 3.64 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.274 170.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.576 ' CE2' HG11 ' A' ' 113' ' ' VAL . 53.3 m-85 -65.69 170.66 4.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.89 93.37 0.76 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.4 t 62.36 168.28 0.12 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.774 1.23 . . . . 0.0 111.392 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -62.12 -27.55 69.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.713 -0.617 . . . . 0.0 110.901 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.42 -41.28 93.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.198 -0.314 . . . . 0.0 111.016 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.482 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -71.33 -37.88 71.69 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -59.1 -38.48 79.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.83 -0.544 . . . . 0.0 110.648 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -68.87 -31.31 70.16 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.45 0.3 . . . . 0.0 110.572 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -71.0 -40.06 72.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.574 0.226 . . . . 0.0 110.59 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.47 -15.08 62.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.714 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.8 mt -66.62 -11.84 55.4 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.829 0.741 . . . . 0.0 111.934 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.0 -10.65 84.11 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.573 ' HB2' HG11 ' A' ' 183' ' ' VAL . 65.5 mmtt -88.02 -3.38 58.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.214 1.406 . . . . 0.0 112.893 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.559 ' CA ' HG22 ' A' ' 183' ' ' VAL . 6.4 t60 -43.29 -21.47 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -139.58 18.56 2.53 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.522 1.055 . . . . 0.0 111.798 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -76.29 -175.65 3.29 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 122.97 0.508 . . . . 0.0 110.323 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -134.57 163.42 29.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.09 -13.44 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.544 0.738 . . . . 0.0 111.971 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.95 -31.68 0.5 Allowed Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.74 -0.6 . . . . 0.0 113.986 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -152.56 2.96 0.34 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.649 0.725 . . . . 0.0 110.909 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -144.69 155.11 43.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.362 1.065 . . . . 0.0 108.164 -174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -106.78 151.22 25.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.272 0.558 . . . . 0.0 110.037 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.8 mm -121.19 159.93 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -171.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -133.44 145.92 50.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' A' ' 169' ' ' LEU . 18.0 m -115.98 136.84 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 9.1 m-85 -137.24 154.27 50.19 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -76.05 163.0 27.57 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.068 0.849 . . . . 0.0 110.544 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.3 t -158.89 -175.43 5.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.8 m -148.66 170.94 17.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.05 1.34 . . . . 0.0 109.269 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -57.87 -31.77 67.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.877 0.471 . . . . 0.0 111.394 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.37 -5.18 9.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -115.71 2.26 13.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.728 0.811 . . . . 0.0 111.005 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.35 9.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 111.18 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -70.22 16.34 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.374 0.67 . . . . 0.0 112.797 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.0 m -68.45 -0.51 5.06 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.6 0.76 . . . . 0.0 111.23 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.373 178.379 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.8 p30 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -122.47 8.58 9.6 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.14 -8.75 49.63 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -61.77 141.36 57.94 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.553 0.692 . . . . 0.0 110.612 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.622 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.2 p -151.05 175.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.446 ' H ' HG22 ' A' ' 113' ' ' VAL . 55.6 ttt180 -137.01 154.04 50.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.7 tp -133.08 148.32 52.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -152.89 160.66 43.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.82 3.93 70.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.402 HD22 ' SG ' ' A' ' 122' ' ' CYS . 95.8 mt -57.33 150.01 45.32 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 117.118 0.459 . . . . 0.0 111.97 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.11 25.25 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 125.143 3.895 . . . . 0.0 113.66 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 22.6 m-30 52.35 13.48 0.3 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.071 1.348 . . . . 0.0 114.192 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.29 -8.86 1.11 Allowed Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.861 0.755 . . . . 0.0 112.458 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 7.0 t -59.62 149.62 29.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.218 1.007 . . . . 0.0 110.953 174.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.478 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 2.4 t -141.16 -167.86 2.49 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.465 0.706 . . . . 0.0 109.298 172.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.8 mptt -51.18 -29.2 13.22 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.436 0.562 . . . . 0.0 112.356 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.4 ' HA ' HG12 ' A' ' 128' ' ' VAL . 39.9 mt-10 -81.22 -19.91 42.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.457 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 5.7 mp0 -92.98 -33.91 13.95 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.773 -0.58 . . . . 0.0 109.439 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.4 HG13 ' SG ' ' A' ' 122' ' ' CYS . 56.7 mt -62.42 -34.9 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 125' ' ' GLU . 9.4 p -84.1 -32.45 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.007 -173.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -72.91 -27.57 61.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -70.77 -25.94 63.12 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.739 0.304 . . . . 0.0 110.429 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -113.71 32.77 5.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.459 1.104 . . . . 0.0 109.016 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.0 t -67.3 -17.01 64.6 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.965 0.506 . . . . 0.0 111.983 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.36 15.41 60.04 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.631 ' HB3' HD11 ' A' ' 164' ' ' LEU . 33.8 mt -143.73 -163.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.207 1.803 . . . . 0.0 107.403 -173.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -146.94 162.61 38.36 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.3 mt -142.16 150.86 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.6 m -75.2 155.23 86.24 Favored Pre-proline 0 C--O 1.232 0.135 0 O-C-N 122.032 -0.417 . . . . 0.0 110.471 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.09 136.81 29.81 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 124.006 3.137 . . . . 0.0 112.245 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.6 t30 40.05 38.92 0.55 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.448 1.099 . . . . 0.0 112.07 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.67 28.19 13.25 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-O 118.859 -0.967 . . . . 0.0 111.876 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.96 147.15 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 118.99 1.395 . . . . 0.0 109.548 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 88.6 m -138.47 148.38 44.29 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.073 0.949 . . . . 0.0 108.991 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.478 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 6.3 mt -145.74 99.04 4.43 Favored Pre-proline 0 N--CA 1.453 -0.315 0 C-N-CA 123.091 0.557 . . . . 0.0 110.225 -174.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.7 157.59 18.94 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.499 2.8 . . . . 0.0 110.334 171.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 151' ' ' ILE . 31.3 m -145.68 163.73 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-O 121.427 0.632 . . . . 0.0 111.324 173.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.458 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 57.8 m-20 -89.69 175.5 3.82 Favored Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.579 174.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.5 Cg_exo -57.95 -20.46 44.88 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.734 2.289 . . . . 0.0 111.385 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -79.48 -9.96 59.71 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.102 0.961 . . . . 0.0 111.252 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.56 0.7 90.06 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -173.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.626 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 85.3 tttt -72.28 131.79 43.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.914 1.286 . . . . 0.0 108.891 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.469 ' C ' ' H ' ' A' ' 153' ' ' GLY . 8.4 pt -71.88 10.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -169.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p 67.49 -15.71 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.532 1.133 . . . . 0.0 112.197 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 101.33 6.44 50.94 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.338 0.971 . . . . 0.0 112.814 175.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -142.68 168.82 18.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.058 0.929 . . . . 0.0 111.936 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.11 -178.82 7.59 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.671 0.788 . . . . 0.0 110.59 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -143.59 146.24 33.14 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -177.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.3 t -146.42 165.01 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -174.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.633 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.4 tt0 -129.46 96.15 4.2 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.68 0.753 . . . . 0.0 109.009 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.622 ' CE2' HG11 ' A' ' 113' ' ' VAL . 36.3 m-85 -68.6 172.07 6.74 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.23 93.45 1.09 Allowed 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t 61.27 168.73 0.1 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.683 1.193 . . . . 0.0 111.455 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -61.73 -27.3 68.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.76 -0.587 . . . . 0.0 110.65 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.32 -36.21 79.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.05 -0.406 . . . . 0.0 111.515 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.8 OUTLIER -74.76 -40.0 61.47 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.14 -37.89 72.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 122.296 -0.252 . . . . 0.0 110.614 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -68.74 -32.12 71.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.601 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -71.3 -38.56 71.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.581 0.229 . . . . 0.0 110.795 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.52 -18.46 63.84 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.821 0.448 . . . . 0.0 112.033 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.706 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.9 mt -65.95 -14.37 61.45 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.641 0.655 . . . . 0.0 111.836 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.86 -10.26 80.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.574 ' HB2' HG11 ' A' ' 183' ' ' VAL . 63.6 mmtt -90.58 -1.97 57.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.814 1.246 . . . . 0.0 112.606 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.567 ' CA ' HG22 ' A' ' 183' ' ' VAL . 14.5 t60 -43.93 -19.92 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.42 17.02 2.39 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.364 0.984 . . . . 0.0 111.833 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -75.65 -173.78 2.3 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-O 120.997 0.427 . . . . 0.0 110.119 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -134.43 166.21 23.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -170.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.6 -19.83 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 124.633 1.173 . . . . 0.0 109.989 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 137.02 135.48 3.39 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 45.32 2.47 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.791 2.036 . . . . 0.0 115.215 -173.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -151.46 166.8 29.98 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.188 0.595 . . . . 0.0 110.143 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -120.78 155.09 34.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.4 mm -123.44 162.57 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -170.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -134.37 150.6 50.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' A' ' 169' ' ' LEU . 19.7 m -119.77 135.6 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 11.8 m-30 -134.84 153.48 52.02 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -76.49 162.95 27.39 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.674 -0.641 . . . . 0.0 110.629 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.5 t -158.86 -175.93 5.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.3 m -148.18 168.95 21.13 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.249 1.419 . . . . 0.0 109.192 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -57.44 -31.91 66.37 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.734 0.414 . . . . 0.0 111.173 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.87 -16.74 59.89 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -102.35 0.44 34.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.405 0.682 . . . . 0.0 111.47 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.1 p -143.35 14.33 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.002 0.43 . . . . 0.0 111.027 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -69.45 13.45 0.13 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.4 m -68.01 -0.68 4.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.592 0.757 . . . . 0.0 111.199 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.094 178.541 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 110.865 -0.05 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -136.89 2.63 2.63 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.57 -10.23 75.2 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 122.08 -0.388 . . . . 0.0 112.66 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -65.44 150.34 48.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.593 0.711 . . . . 0.0 110.323 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.587 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.0 p -153.11 175.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.676 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.465 ' H ' HG22 ' A' ' 113' ' ' VAL . 32.5 ttt180 -132.32 153.75 50.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.378 1.071 . . . . 0.0 108.673 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.1 tp -137.4 146.52 44.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -152.6 169.41 22.74 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.85 8.59 86.53 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 118' ' ' LEU . 89.5 mt -57.18 142.65 74.72 Favored Pre-proline 0 N--CA 1.451 -0.412 0 C-N-CA 122.858 0.463 . . . . 0.0 111.9 -174.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.99 27.45 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 125.235 3.956 . . . . 0.0 113.609 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 54.79 8.13 0.2 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.03 1.332 . . . . 0.0 114.536 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -136.81 -5.13 1.98 Allowed Glycine 0 CA--C 1.528 0.87 0 CA-C-N 118.786 0.721 . . . . 0.0 112.169 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 44.4 t -61.62 153.04 29.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.69 0.796 . . . . 0.0 111.147 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 t -156.16 -163.35 1.45 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.428 ' HD2' ' HB ' ' A' ' 141' ' ' ILE . 27.3 mmtp -46.17 -39.26 9.39 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.428 0.691 . . . . 0.0 112.679 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.442 ' HA ' HG12 ' A' ' 128' ' ' VAL . 39.3 mt-10 -83.72 -15.3 49.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.515 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 65.5 mm-40 -98.81 -31.47 11.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.413 HG13 ' SG ' ' A' ' 122' ' ' CYS . 32.5 mt -64.37 -37.68 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 172.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 125' ' ' GLU . 11.4 p -79.4 -33.16 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.528 -173.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -74.14 -25.89 60.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.137 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 181' ' ' ILE . 53.8 t80 -71.78 -20.35 61.88 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.872 0.305 . . . . 0.0 110.667 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -120.94 33.59 5.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.481 1.112 . . . . 0.0 108.455 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -64.0 -17.63 63.5 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.16 0.584 . . . . 0.0 112.439 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.27 15.28 58.74 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' A' ' 164' ' ' LEU . 56.4 mt -144.04 -162.53 1.49 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.486 1.514 . . . . 0.0 108.457 -172.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -145.97 163.04 36.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.9 mt -142.25 150.32 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 158' ' ' GLN . 16.3 m -74.55 155.99 87.15 Favored Pre-proline 0 CA--C 1.53 0.177 0 O-C-N 121.995 -0.441 . . . . 0.0 110.527 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.83 133.48 22.43 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 124.196 3.264 . . . . 0.0 112.464 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.2 t30 38.62 39.34 0.32 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.582 1.153 . . . . 0.0 112.16 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.5 35.36 3.97 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-O 119.044 -0.864 . . . . 0.0 111.246 -174.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.428 ' HB ' ' HD2' ' A' ' 124' ' ' LYS . 89.3 mt -137.84 146.68 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 118.74 1.27 . . . . 0.0 109.42 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.3 m -138.23 144.23 40.5 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 123.574 0.749 . . . . 0.0 109.166 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.5 mt -137.78 87.28 17.19 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 123.71 0.804 . . . . 0.0 109.396 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.67 158.85 18.67 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.095 2.53 . . . . 0.0 110.855 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.42 160.34 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 121.552 0.691 . . . . 0.0 112.24 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 22.0 m-20 -83.54 174.12 6.43 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.826 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 33.7 Cg_exo -59.9 -2.65 1.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.274 3.316 . . . . 0.0 113.045 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -117.15 1.38 12.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.799 0.839 . . . . 0.0 110.759 -176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.06 2.83 88.06 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -69.54 161.31 29.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 153' ' ' GLY . 4.8 pt -95.95 13.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -167.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 p 62.71 -3.37 0.31 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.916 0.886 . . . . 0.0 112.358 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 77.27 6.02 85.95 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.779 1.181 . . . . 0.0 113.014 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -142.41 168.41 19.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.238 1.019 . . . . 0.0 111.72 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.27 -177.98 6.99 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.059 0.944 . . . . 0.0 110.453 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -145.56 148.11 32.81 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.477 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 61.7 t -146.11 165.0 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.636 ' O ' HG22 ' A' ' 137' ' ' VAL . 52.4 tt0 -129.74 95.85 4.08 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.74 0.781 . . . . 0.0 108.982 171.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.587 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.1 m-85 -69.03 170.9 9.02 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.763 174.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.29 94.05 0.9 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.7 t 62.66 168.44 0.13 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.538 1.135 . . . . 0.0 111.621 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -61.86 -26.05 67.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.61 -36.55 84.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.035 0.379 . . . . 0.0 111.704 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -73.64 -39.97 64.11 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.05 -34.76 70.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.293 -0.254 . . . . 0.0 110.631 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -69.16 -32.15 71.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.336 0.255 . . . . 0.0 110.516 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -72.53 -38.05 68.15 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.766 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.01 -19.56 64.47 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.113 0.565 . . . . 0.0 112.341 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.689 ' HA ' HG21 ' A' ' 183' ' ' VAL . 95.2 mt -67.65 -8.46 34.96 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.584 0.629 . . . . 0.0 111.284 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.66 8.09 66.88 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -118.76 3.7 11.62 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 123.852 0.861 . . . . 0.0 111.289 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.583 ' CA ' HG22 ' A' ' 183' ' ' VAL . 5.3 t60 -42.2 -24.48 0.05 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -137.5 18.32 2.91 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.355 0.98 . . . . 0.0 110.897 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -81.57 174.12 11.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.711 1.604 . . . . 0.0 108.792 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -120.35 158.46 27.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.2 tt -98.09 -12.51 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.499 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.87 -26.66 1.77 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.248 0.451 . . . . 0.0 112.209 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -155.4 5.83 0.22 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.148 0.579 . . . . 0.0 110.789 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -145.75 160.57 41.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.556 1.142 . . . . 0.0 108.197 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -107.93 145.27 34.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 130' ' ' PHE . 31.3 mm -122.02 160.62 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -129.98 144.86 51.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.689 HG21 ' HA ' ' A' ' 169' ' ' LEU . 11.0 m -119.3 143.21 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -150.41 156.01 40.67 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -73.71 156.77 37.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.983 0.42 . . . . 0.0 110.696 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.7 t -157.68 -177.06 6.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.118 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.6 t -152.08 174.8 13.25 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.14 0.976 . . . . 0.0 109.558 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.6 tp60 -59.03 -31.7 69.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.726 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.09 -3.8 6.19 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -118.79 2.95 11.65 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.664 0.786 . . . . 0.0 111.308 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.5 10.51 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.913 0.387 . . . . 0.0 111.204 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -68.2 14.12 0.07 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.0 m -68.69 -0.58 5.44 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.433 0.693 . . . . 0.0 111.239 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.079 178.371 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.6 p30 . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -118.15 7.45 12.15 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.03 -8.91 42.68 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.93 139.96 58.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.423 0.63 . . . . 0.0 110.705 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.4 p -149.51 175.81 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.205 1.002 . . . . 0.0 108.764 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.463 ' H ' HG22 ' A' ' 113' ' ' VAL . 33.0 ttt180 -137.49 144.42 42.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.06 0.544 . . . . 0.0 109.743 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.407 ' HB3' HD12 ' A' ' 118' ' ' LEU . 4.0 mm? -119.02 152.25 36.76 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.478 ' HE ' ' HB3' ' A' ' 154' ' ' GLU . 19.3 tpp85 -157.6 152.1 25.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.27 2.45 90.59 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 171.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.752 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -68.25 158.49 84.27 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 37.7 Cg_exo -52.21 153.66 12.44 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.026 2.484 . . . . 0.0 114.311 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -68.25 -1.55 6.42 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.944 0.497 . . . . 0.0 111.802 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.77 2.96 10.97 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.435 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 52.5 t -66.3 153.51 42.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.025 0.93 . . . . 0.0 109.605 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.655 HG23 ' H ' ' A' ' 125' ' ' GLU . 10.0 t -154.97 -175.24 5.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 2.4 ptpp? -56.45 -22.06 29.57 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.655 ' H ' HG23 ' A' ' 123' ' ' THR . 40.8 tt0 -77.72 -25.07 49.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.242 0.617 . . . . 0.0 110.899 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -89.05 -35.52 16.3 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.6 -34.35 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.58 -34.07 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.658 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -73.17 -25.72 60.9 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.921 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -72.04 -25.97 62.01 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.64 0.257 . . . . 0.0 110.336 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -111.29 30.5 6.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.531 1.132 . . . . 0.0 109.022 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.6 t -65.74 -14.68 61.78 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.753 0.421 . . . . 0.0 111.865 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.17 15.26 63.32 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.625 ' HB3' HD11 ' A' ' 164' ' ' LEU . 33.4 mt -143.26 -162.8 1.51 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.249 1.819 . . . . 0.0 107.35 -173.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -147.15 162.29 39.16 Favored 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.2 mt -142.38 152.09 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.9 m -77.65 153.86 81.09 Favored Pre-proline 0 CA--C 1.528 0.105 0 CA-C-N 118.153 0.433 . . . . 0.0 110.683 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.37 140.7 34.11 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.097 3.198 . . . . 0.0 112.094 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 42.02 36.39 0.67 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.201 1.0 . . . . 0.0 111.929 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -99.76 29.28 12.37 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 118.898 -0.945 . . . . 0.0 111.943 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 77.6 mt -137.72 146.07 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.847 1.324 . . . . 0.0 110.2 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.1 m -142.17 147.55 36.8 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.009 0.924 . . . . 0.0 109.728 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.4 mt -140.78 96.48 7.48 Favored Pre-proline 0 CA--C 1.527 0.094 0 C-N-CA 124.243 1.017 . . . . 0.0 109.849 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.74 154.88 8.73 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.713 2.942 . . . . 0.0 112.019 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.77 165.13 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-O 121.244 0.545 . . . . 0.0 110.467 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 67.7 m-20 -86.13 176.4 3.62 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.929 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -59.1 -17.77 40.17 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.102 2.535 . . . . 0.0 111.85 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -86.89 -4.69 59.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.594 0.758 . . . . 0.0 110.789 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.46 11.15 83.58 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 123.477 0.56 . . . . 0.0 112.534 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -102.22 149.81 23.93 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 117.455 0.628 . . . . 0.0 109.55 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.6 pt -69.22 151.87 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.729 0.776 . . . . 0.0 112.606 -170.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.3 p -86.98 -7.14 58.45 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.144 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 97.74 6.36 57.25 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-O 119.768 -0.462 . . . . 0.0 112.781 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.478 ' HB3' ' HE ' ' A' ' 116' ' ' ARG . 23.0 pt-20 -140.02 168.45 19.79 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.433 0.617 . . . . 0.0 110.546 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.21 178.51 10.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.069 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -141.57 143.95 33.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 69.6 t -144.56 162.61 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -174.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.669 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.4 tt0 -128.51 97.62 4.77 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.863 0.84 . . . . 0.0 109.02 170.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 113' ' ' VAL . 38.5 m-85 -69.07 171.57 8.03 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.433 173.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.29 92.57 0.79 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t 61.33 170.42 0.11 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.757 1.223 . . . . 0.0 111.423 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -62.63 -27.18 69.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.818 -0.551 . . . . 0.0 110.696 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.48 -41.56 85.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.153 -0.342 . . . . 0.0 111.133 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -72.51 -39.55 67.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.66 -38.26 74.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.002 -0.436 . . . . 0.0 110.93 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -69.27 -30.05 68.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.755 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -72.58 -38.93 67.74 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 120.46 0.172 . . . . 0.0 111.082 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.411 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.39 -19.39 64.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.766 0.427 . . . . 0.0 112.127 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.452 ' HA ' HG21 ' A' ' 183' ' ' VAL . 95.4 mt -69.19 -11.65 60.98 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.842 -0.536 . . . . 0.0 111.345 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.87 -13.24 80.84 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.565 ' HB2' HG11 ' A' ' 183' ' ' VAL . 70.3 mmtt -83.41 -1.04 52.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.299 1.439 . . . . 0.0 111.924 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.441 ' CA ' HG22 ' A' ' 183' ' ' VAL . 6.1 t60 -54.81 134.81 48.1 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.248 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.6 mttp 56.85 6.33 0.3 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.993 1.717 . . . . 0.0 114.567 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.13 172.49 11.63 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.051 0.94 . . . . 0.0 109.325 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -123.05 158.85 29.68 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.949 -0.47 . . . . 0.0 112.197 -170.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.6 tt -112.75 -2.24 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.08 -32.43 0.66 Allowed Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.931 -0.481 . . . . 0.0 113.936 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -156.45 4.21 0.16 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.85 0.825 . . . . 0.0 111.163 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -147.74 159.68 43.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.252 1.021 . . . . 0.0 108.477 -170.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -109.02 130.16 55.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.411 0.624 . . . . 0.0 109.968 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 18.0 mm -94.55 166.53 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -130.65 154.14 48.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 171' ' ' LYS . 24.4 m -135.79 125.2 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 8.2 m-30 -133.47 163.69 28.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -88.64 169.11 11.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.456 1.025 . . . . 0.0 111.598 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -158.32 -177.22 6.38 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.084 0.554 . . . . 0.0 111.156 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.1 m -149.35 168.77 22.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.144 1.378 . . . . 0.0 108.69 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -56.43 -32.54 64.98 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.45 0.3 . . . . 0.0 111.641 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.54 -2.43 6.57 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -117.0 3.02 12.77 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.964 0.906 . . . . 0.0 110.8 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.27 11.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 121.221 0.534 . . . . 0.0 110.825 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -68.06 13.77 0.08 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.85 0.86 . . . . 0.0 113.068 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.4 m -68.28 -1.24 5.86 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.57 0.748 . . . . 0.0 111.254 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.125 178.564 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.1 p30 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.359 0.123 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.83 2.54 6.67 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.09 -10.19 51.21 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.395 174.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -64.04 143.61 57.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.428 0.632 . . . . 0.0 110.372 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.646 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.9 p -150.81 178.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.911 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 113' ' ' VAL . 5.8 mtm180 -133.28 165.07 25.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.318 0.647 . . . . 0.0 111.087 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 115' ' ' LEU . 12.8 tp -147.23 145.16 29.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -154.82 171.2 20.0 Favored 'General case' 0 CA--C 1.527 0.084 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.72 10.45 86.23 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 120' ' ' PHE . 95.2 mt -55.15 149.65 24.5 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 123.289 0.636 . . . . 0.0 111.494 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.06 27.38 0.21 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.798 2.332 . . . . 0.0 113.454 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.447 ' H ' ' C ' ' A' ' 118' ' ' LEU . 62.6 m-85 51.04 12.96 0.13 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.926 1.691 . . . . 0.0 113.603 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.19 -8.14 1.21 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 22.5 t -61.84 154.07 27.0 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.779 0.831 . . . . 0.0 109.847 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.622 HG23 ' H ' ' A' ' 125' ' ' GLU . 10.0 t -147.69 -174.86 4.66 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.469 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.8 ptpp? -55.33 -20.12 10.7 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.622 ' H ' HG23 ' A' ' 123' ' ' THR . 42.2 mt-10 -83.6 -22.38 32.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.018 0.527 . . . . 0.0 111.342 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.509 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 64.3 mm-40 -92.43 -30.49 15.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.49 -36.44 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.07 -32.11 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.685 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -73.15 -27.62 61.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.065 172.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 24.1 t80 -71.67 -24.34 61.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 110.504 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -115.49 32.14 6.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.442 1.097 . . . . 0.0 108.727 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 t -67.92 -16.97 64.31 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.936 0.495 . . . . 0.0 112.075 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.66 15.66 59.9 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.661 ' HB3' HD11 ' A' ' 164' ' ' LEU . 30.0 mt -143.47 -164.83 1.95 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.229 1.812 . . . . 0.0 107.307 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -148.06 161.23 41.81 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.839 -0.538 . . . . 0.0 110.038 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.9 mt -140.43 150.83 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.5 m -77.56 154.09 81.36 Favored Pre-proline 0 CA--C 1.528 0.128 0 CA-C-N 118.407 0.549 . . . . 0.0 110.354 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.1 141.31 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.925 3.083 . . . . 0.0 111.949 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 43.13 35.18 0.76 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.906 0.882 . . . . 0.0 111.777 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.99 28.82 13.48 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-O 119.245 -0.753 . . . . 0.0 111.968 -173.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.8 mt -138.24 144.78 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 118.817 1.308 . . . . 0.0 109.731 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.7 m -140.35 145.74 37.54 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.592 0.757 . . . . 0.0 109.234 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 155' ' ' ALA . 13.0 mt -141.76 94.21 7.38 Favored Pre-proline 0 N--CA 1.455 -0.208 0 C-N-CA 124.154 0.982 . . . . 0.0 109.061 -176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.06 152.89 22.65 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.334 2.689 . . . . 0.0 110.624 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.47 166.02 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 CA-C-O 121.328 0.585 . . . . 0.0 111.072 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 58.9 m-20 -91.56 177.07 2.36 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.861 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 32.6 Cg_exo -59.07 -19.43 48.74 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.942 2.428 . . . . 0.0 111.762 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -81.95 -7.46 59.61 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.768 0.827 . . . . 0.0 110.672 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.33 12.31 83.26 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.675 0.655 . . . . 0.0 112.151 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -102.0 149.97 23.7 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.8 pt -68.24 148.28 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.465 0.65 . . . . 0.0 111.577 -171.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.2 p -76.6 -4.03 40.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.705 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.7 4.31 54.68 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 123.048 0.356 . . . . 0.0 112.46 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -145.15 171.16 14.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.247 0.524 . . . . 0.0 110.092 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.43 ' HB2' HD23 ' A' ' 143' ' ' LEU . . . -154.21 179.12 9.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.3 0.572 . . . . 0.0 110.5 -175.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -144.4 143.79 31.09 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 90.4 t -145.99 164.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -174.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.451 ' N ' HG12 ' A' ' 157' ' ' VAL . 52.2 tt0 -129.82 102.77 6.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.646 ' CE2' HG11 ' A' ' 113' ' ' VAL . 34.0 m-85 -73.83 172.2 11.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.322 171.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.17 91.58 0.72 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.084 0.469 . . . . 0.0 109.815 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 61.61 168.53 0.11 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.666 1.186 . . . . 0.0 111.476 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -16.43 63.91 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.885 -0.51 . . . . 0.0 111.055 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -66.01 -42.96 89.0 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.973 -0.454 . . . . 0.0 110.342 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.8 OUTLIER -70.73 -39.69 73.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.31 -38.32 73.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.244 -0.285 . . . . 0.0 110.856 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -69.26 -29.98 68.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.728 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -72.52 -38.35 68.11 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.513 0.197 . . . . 0.0 110.814 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.412 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.91 -19.58 65.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.731 0.412 . . . . 0.0 111.935 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.462 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.0 mt -67.55 -12.06 59.49 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.464 0.574 . . . . 0.0 111.336 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.98 -11.96 78.96 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.632 ' HB2' HG11 ' A' ' 183' ' ' VAL . 69.5 mmtt -87.39 1.63 52.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.263 1.425 . . . . 0.0 111.614 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.491 ' HA ' HG22 ' A' ' 183' ' ' VAL . 65.3 t60 -54.32 134.26 45.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.438 ' HE3' ' NE2' ' A' ' 172' ' ' HIS . 90.9 mttt 53.5 14.01 0.53 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.545 1.538 . . . . 0.0 113.967 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.02 163.04 20.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.886 0.766 . . . . 0.0 109.607 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -101.31 159.09 15.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.6 tt -114.99 -7.29 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 160.28 -37.79 0.45 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-O 119.916 -0.38 . . . . 0.0 112.971 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -155.57 11.86 0.32 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.35 0.575 . . . . 0.0 110.761 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -136.0 -179.82 5.89 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.283 1.033 . . . . 0.0 109.141 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -126.15 141.54 51.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.7 mm -112.82 160.87 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -129.89 94.46 3.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -170.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' A' ' 171' ' ' LYS . 13.9 m -74.24 140.44 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.149 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -146.26 161.43 40.29 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -79.55 161.72 25.8 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.833 0.742 . . . . 0.0 109.965 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -157.2 -174.2 4.8 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.53 -0.106 . . . . 0.0 111.13 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.7 t -147.4 172.07 14.5 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.808 0.843 . . . . 0.0 110.155 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -59.99 -31.55 70.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.746 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.42 -1.27 7.98 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -114.36 0.34 14.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.792 0.837 . . . . 0.0 110.547 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.92 14.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 120.956 0.408 . . . . 0.0 110.785 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -67.08 9.8 0.18 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 31.3 m -68.7 -0.7 5.6 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.443 0.697 . . . . 0.0 111.292 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.785 -1.103 . . . . 0.0 111.151 178.347 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.0 p30 . . . . . 0 N--CA 1.446 -0.657 0 CA-C-O 120.853 0.359 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.62 7.82 10.04 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.34 -9.28 30.88 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -61.86 138.22 58.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.362 0.601 . . . . 0.0 110.669 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.5 p -150.25 175.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.044 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.444 ' H ' HG22 ' A' ' 113' ' ' VAL . 9.9 mtm180 -132.35 151.16 51.97 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.608 0.763 . . . . 0.0 110.695 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -123.34 148.71 45.73 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 124.281 1.032 . . . . 0.0 108.39 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -153.18 161.08 42.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.81 0.53 85.18 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.8 mt -53.34 134.93 51.84 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 124.07 0.948 . . . . 0.0 111.238 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -60.31 142.98 99.44 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 107.262 -1.861 . . . . 0.0 107.262 170.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.427 ' CD2' ' HE2' ' A' ' 150' ' ' LYS . 17.5 m-85 -66.9 -2.11 4.82 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.92 -174.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.02 -0.9 27.0 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 47.4 t -63.69 142.77 58.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.031 0.932 . . . . 0.0 109.829 176.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.4 t -148.82 -160.9 1.24 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.407 ' HD2' ' HB ' ' A' ' 141' ' ' ILE . 28.9 mmtp -45.21 -41.03 7.91 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.539 0.736 . . . . 0.0 112.953 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.475 ' HA ' HG12 ' A' ' 128' ' ' VAL . 38.8 mt-10 -77.76 -23.06 49.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -173.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.445 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 9.9 mp0 -86.3 -39.56 16.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.0 mt -64.45 -36.32 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 125' ' ' GLU . 14.5 p -80.64 -34.13 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.08 -170.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -81.2 -20.64 40.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.869 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -71.89 -22.75 61.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 171.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -115.48 35.96 4.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.501 1.12 . . . . 0.0 109.139 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.8 t -62.64 142.53 58.01 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.17 5.11 75.39 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 39.0 mt -140.44 72.13 1.39 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.13 1.372 . . . . 0.0 107.97 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -49.55 159.3 0.36 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.036 0.934 . . . . 0.0 113.473 -174.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.4 mt -135.33 146.91 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.6 m -71.41 155.61 92.56 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 118.506 0.594 . . . . 0.0 110.236 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.89 135.23 23.25 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 124.094 3.196 . . . . 0.0 112.301 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.4 t30 40.21 38.16 0.49 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.423 1.089 . . . . 0.0 111.996 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.02 33.83 4.69 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.407 ' HB ' ' HD2' ' A' ' 124' ' ' LYS . 81.7 mt -140.29 143.92 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 118.522 1.161 . . . . 0.0 108.842 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.0 m -136.91 147.95 46.73 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.439 0.695 . . . . 0.0 109.299 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 88.2 mt -139.75 93.42 9.6 Favored Pre-proline 0 C--O 1.234 0.249 0 C-N-CA 123.278 0.631 . . . . 0.0 110.485 -173.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.04 154.81 26.01 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.931 2.421 . . . . 0.0 110.325 171.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' A' ' 151' ' ' ILE . 27.1 m -146.58 164.64 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 CA-C-O 121.429 0.633 . . . . 0.0 111.588 174.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 59.0 m-20 -90.99 176.04 3.17 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.469 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.8 Cg_exo -58.09 -20.67 47.06 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.842 2.361 . . . . 0.0 111.563 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.63 -10.4 59.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.35 1.06 . . . . 0.0 111.214 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.96 1.58 90.65 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.427 ' HE2' ' CD2' ' A' ' 120' ' ' PHE . 52.2 tttm -73.58 130.59 40.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.888 1.275 . . . . 0.0 109.152 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 153' ' ' GLY . 9.0 pt -70.31 9.93 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -168.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 66.63 -15.88 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.97 0.908 . . . . 0.0 112.417 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 100.41 3.19 55.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.547 1.07 . . . . 0.0 113.063 175.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -139.71 170.41 15.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.263 1.032 . . . . 0.0 111.425 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -160.99 -178.05 6.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.943 0.497 . . . . 0.0 110.561 -174.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -142.52 145.06 33.25 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 89.6 t -145.09 164.3 12.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' ' 157' ' ' VAL . 53.2 tt0 -131.16 101.33 5.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.606 ' CE2' HG11 ' A' ' 113' ' ' VAL . 47.5 m-85 -71.61 171.64 11.09 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.341 171.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 93.05 0.95 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.14 0.495 . . . . 0.0 109.98 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t 62.09 169.43 0.12 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.498 1.119 . . . . 0.0 111.02 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.74 -21.03 66.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.771 -0.58 . . . . 0.0 111.174 -175.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.73 -42.94 99.91 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.917 -0.489 . . . . 0.0 110.302 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 164' ' ' LEU . 0.3 OUTLIER -69.77 -38.69 76.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.4 -40.53 82.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.026 -0.421 . . . . 0.0 110.701 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -68.03 -30.91 70.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.566 0.346 . . . . 0.0 110.668 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -71.6 -39.78 70.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 110.511 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.35 -13.33 61.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.688 ' HA ' HG21 ' A' ' 183' ' ' VAL . 92.4 mt -67.23 -14.09 62.58 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 118.97 0.805 . . . . 0.0 111.954 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.61 -11.9 77.41 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.558 ' HB2' HG11 ' A' ' 183' ' ' VAL . 70.1 mmtt -85.43 -4.94 59.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.17 1.388 . . . . 0.0 113.049 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.569 ' CA ' HG22 ' A' ' 183' ' ' VAL . 13.0 t60 -42.51 -23.54 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -140.55 17.57 2.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.205 0.911 . . . . 0.0 112.005 177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -74.6 -174.82 2.21 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.086 0.469 . . . . 0.0 110.11 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.14 159.11 37.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.771 -171.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.1 tt -110.59 -6.36 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 150.53 -29.14 1.06 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.985 -0.341 . . . . 0.0 113.164 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -156.43 4.17 0.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.485 0.642 . . . . 0.0 110.834 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -149.84 157.95 43.69 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.406 1.083 . . . . 0.0 108.49 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -104.83 150.88 24.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.8 mm -123.68 161.93 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -172.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -132.25 157.36 44.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 169' ' ' LEU . 17.8 m -129.91 135.62 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -132.82 158.85 41.44 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -75.16 160.94 29.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.947 0.794 . . . . 0.0 109.629 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t -154.05 -174.1 4.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.724 0.297 . . . . 0.0 111.575 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.5 m -146.11 166.89 24.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.176 0.99 . . . . 0.0 109.977 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -60.09 -32.11 70.65 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.407 0.283 . . . . 0.0 110.564 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -63.54 -17.28 62.63 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -100.0 -0.94 38.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.308 0.643 . . . . 0.0 111.4 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.6 12.07 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.941 0.401 . . . . 0.0 111.523 -174.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -68.17 12.56 0.11 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.0 m -68.95 -1.15 6.68 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.357 0.663 . . . . 0.0 111.127 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.236 -1.364 . . . . 0.0 111.147 178.419 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 p30 . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -136.25 7.19 3.11 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 107.53 -8.55 37.56 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -62.6 143.73 56.96 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.508 0.67 . . . . 0.0 110.934 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.4 p -152.2 173.79 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 49.1 ttt180 -136.69 152.97 50.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -135.06 150.81 50.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 122.279 0.232 . . . . 0.0 110.566 -172.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.42 ' HE ' ' HB3' ' A' ' 154' ' ' GLU . 20.0 tpp85 -153.63 147.71 25.65 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.895 0.478 . . . . 0.0 109.908 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.74 -0.97 59.59 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.657 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -64.38 156.95 74.47 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-N 117.255 0.528 . . . . 0.0 111.508 -176.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 27.9 Cg_exo -56.06 147.48 64.05 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.678 2.919 . . . . 0.0 111.762 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -70.41 17.54 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 119' ' ' PRO . . . -137.72 5.42 3.42 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 36.5 t -66.78 152.52 45.37 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.599 1.159 . . . . 0.0 110.552 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 125' ' ' GLU . 5.4 t -155.09 -168.39 2.86 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.592 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -51.87 -32.6 32.89 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.544 ' H ' HG23 ' A' ' 123' ' ' THR . 42.6 tt0 -73.13 -25.23 60.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.517 0.727 . . . . 0.0 112.049 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.402 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 67.3 mm-40 -92.51 -33.23 14.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.718 -0.614 . . . . 0.0 109.516 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.15 -34.26 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.02 -38.34 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.877 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -77.06 -21.39 54.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.073 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -71.0 -26.07 62.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 170.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -108.15 39.4 1.97 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.6 t -68.65 157.21 36.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.4 5.87 78.78 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -173.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.513 ' HB3' HD11 ' A' ' 164' ' ' LEU . 30.0 mt -142.52 -172.42 3.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.291 1.837 . . . . 0.0 106.583 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -147.24 164.15 34.11 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.847 -0.533 . . . . 0.0 110.392 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 mt -142.08 148.23 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 158' ' ' GLN . 21.4 m -73.6 154.45 89.58 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 118.598 0.635 . . . . 0.0 110.134 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.62 138.5 25.03 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.016 3.144 . . . . 0.0 112.213 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.9 t30 40.71 37.93 0.56 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.304 1.041 . . . . 0.0 111.917 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.31 29.36 9.64 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.978 -0.901 . . . . 0.0 111.83 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.7 mt -135.36 147.09 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 119.056 1.428 . . . . 0.0 109.368 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.1 m -138.53 151.14 47.08 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.35 0.66 . . . . 0.0 109.712 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.1 mt -144.55 100.7 4.73 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -55.58 155.22 22.11 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.121 2.547 . . . . 0.0 110.13 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 150' ' ' LYS . 27.2 m -140.78 159.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 121.752 0.787 . . . . 0.0 112.429 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.455 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 17.0 m-20 -86.57 175.04 4.76 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.623 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 35.5 Cg_exo -59.74 1.79 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.509 3.473 . . . . 0.0 113.402 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 146' ' ' ASP . 30.0 tt0 -123.36 3.37 9.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.947 0.899 . . . . 0.0 110.832 -175.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.28 5.96 89.65 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 39.5 mtpt -66.99 167.2 12.19 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.85 10.76 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -167.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 p 63.14 -7.14 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.94 12.2 84.65 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.914 0.768 . . . . 0.0 113.354 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.42 ' HB3' ' HE ' ' A' ' 116' ' ' ARG . 20.3 pt-20 -143.06 164.33 30.4 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.229 1.014 . . . . 0.0 110.923 177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -153.93 -178.47 7.09 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.038 0.535 . . . . 0.0 111.33 -172.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -145.43 150.32 36.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 158' ' ' GLN . 64.4 t -148.12 165.65 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.246 0.546 . . . . 0.0 110.003 -174.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.498 ' N ' HG12 ' A' ' 157' ' ' VAL . 47.6 tt0 -130.13 105.97 8.3 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 168.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 113' ' ' VAL . 35.7 m-85 -76.23 173.15 11.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.644 171.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.83 91.84 1.19 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t 62.82 166.99 0.12 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.727 1.211 . . . . 0.0 111.819 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -15.66 62.38 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.995 -0.441 . . . . 0.0 111.247 -175.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.94 -41.91 73.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.925 -0.484 . . . . 0.0 110.676 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.542 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -68.86 -39.28 79.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.21 -36.29 70.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.102 -0.374 . . . . 0.0 111.107 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -73.22 -29.07 62.54 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -73.5 -38.34 65.39 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.76 -16.3 62.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.153 0.581 . . . . 0.0 112.16 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.412 ' HA ' HG21 ' A' ' 183' ' ' VAL . 95.4 mt -68.35 -12.35 60.96 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.626 0.648 . . . . 0.0 111.333 175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.56 -12.3 80.36 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.517 ' HB2' HG11 ' A' ' 183' ' ' VAL . 66.9 mmtt -84.15 -2.98 57.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.252 1.421 . . . . 0.0 111.978 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -52.11 128.96 26.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.945 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.9 mttt 61.61 9.24 2.67 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.632 1.573 . . . . 0.0 114.138 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -74.43 173.66 9.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.433 1.093 . . . . 0.0 109.053 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -125.95 154.47 42.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -170.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.2 mt -86.47 -18.43 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.164 0.986 . . . . 0.0 110.809 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 143.21 -18.23 2.31 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.837 -0.424 . . . . 0.0 113.056 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -151.34 -3.66 0.3 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.59 0.695 . . . . 0.0 111.231 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -148.06 154.85 40.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -105.51 156.91 17.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.342 0.591 . . . . 0.0 110.04 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 33.0 mm -127.11 163.74 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -170.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -128.55 156.34 43.47 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 171' ' ' LYS . 33.5 m -129.93 129.56 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 6.6 m-30 -135.72 146.11 47.37 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -175.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -73.04 160.63 31.76 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.763 0.71 . . . . 0.0 110.333 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -159.28 -177.26 6.32 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.1 m -146.11 169.73 18.12 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.787 1.235 . . . . 0.0 109.332 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -56.64 -31.49 64.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.741 0.416 . . . . 0.0 111.136 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.76 2.95 1.63 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -124.26 1.38 8.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.521 0.729 . . . . 0.0 110.838 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.68 10.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.728 0.299 . . . . 0.0 111.486 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -69.83 15.42 0.08 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 20.6 t -69.54 -1.44 8.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.122 0.569 . . . . 0.0 110.846 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 117.83 -1.081 . . . . 0.0 111.061 177.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.219 0.533 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -129.9 167.08 18.73 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.701 1.2 . . . . 0.0 108.394 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.54 -5.44 29.89 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 120.045 -0.308 . . . . 0.0 112.352 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -61.56 140.39 58.12 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.745 0.783 . . . . 0.0 111.196 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.523 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.5 p -149.98 175.97 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.504 1.122 . . . . 0.0 108.157 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 79.3 ttt180 -135.92 146.36 47.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.74 0.416 . . . . 0.0 110.266 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.415 HD11 ' CZ ' ' A' ' 131' ' ' PHE . 4.0 mm? -122.91 150.74 42.52 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 125.06 1.344 . . . . 0.0 108.372 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -158.96 147.57 18.32 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 110.313 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.85 -3.65 57.39 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.645 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -65.07 155.76 82.97 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 117.257 0.529 . . . . 0.0 110.756 -178.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 32.4 Cg_exo -53.37 147.65 36.21 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.612 2.875 . . . . 0.0 112.147 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.405 ' CE1' ' HE2' ' A' ' 150' ' ' LYS . 26.4 m-85 -66.32 2.27 1.29 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -125.39 6.9 8.04 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 40.7 t -67.85 155.1 40.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.839 0.855 . . . . 0.0 110.68 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.7 t -154.57 -172.38 4.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.265 0.626 . . . . 0.0 109.523 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.596 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.3 OUTLIER -50.72 -30.98 15.25 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 123.21 0.604 . . . . 0.0 112.626 -176.444 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.483 ' H ' HG23 ' A' ' 123' ' ' THR . 40.9 mt-10 -77.31 -23.46 51.02 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -92.59 -30.37 15.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.4 mt -66.99 -41.02 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.8 p -73.51 -33.88 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.488 -176.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -73.04 -28.38 62.3 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.212 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 12.1 t80 -69.82 -19.56 63.47 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 115' ' ' LEU . 20.7 m-85 -118.95 33.39 5.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.374 1.47 . . . . 0.0 109.438 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.2 t -69.22 -4.07 16.23 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.807 -0.558 . . . . 0.0 112.289 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -106.25 20.08 36.01 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.499 ' HB3' HD11 ' A' ' 164' ' ' LEU . 55.2 mt -141.23 -167.02 2.3 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.842 2.457 . . . . 0.0 104.83 -173.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.28 -21.35 0.69 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 1.5 mt 52.06 178.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.204 1.002 . . . . 0.0 112.681 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.532 ' H ' HG22 ' A' ' 136' ' ' ILE . 25.1 m -116.44 155.63 48.33 Favored Pre-proline 0 CA--C 1.529 0.138 0 O-C-N 121.338 -0.851 . . . . 0.0 109.69 169.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.0 137.77 22.3 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.197 3.265 . . . . 0.0 112.569 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.1 t30 41.45 36.14 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.273 1.029 . . . . 0.0 111.766 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.64 27.75 13.2 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-O 118.792 -1.005 . . . . 0.0 112.021 -172.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.2 mt -135.23 145.58 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.088 1.444 . . . . 0.0 109.502 -177.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.8 m -138.12 149.75 46.21 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.755 0.822 . . . . 0.0 109.79 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.5 mt -145.11 94.19 5.35 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 124.023 0.929 . . . . 0.0 109.404 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -55.88 159.18 12.32 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.76 2.973 . . . . 0.0 111.638 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.5 167.45 16.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 121.409 0.624 . . . . 0.0 111.285 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 63.9 m-20 -91.89 176.53 2.67 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.2 Cg_exo -58.35 -19.79 44.88 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.822 2.348 . . . . 0.0 111.67 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -81.37 -9.03 59.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.129 0.972 . . . . 0.0 111.213 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.54 2.45 90.62 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.405 ' HE2' ' CE1' ' A' ' 120' ' ' PHE . 76.2 tttt -81.57 133.14 35.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.865 1.266 . . . . 0.0 108.416 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.9 pt -66.33 148.29 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 110.122 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.8 p -75.54 2.82 10.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.198 -174.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.39 6.3 89.35 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -139.25 164.06 30.81 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.087 0.555 . . . . 0.0 109.697 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.81 -178.65 7.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.339 0.59 . . . . 0.0 110.925 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -144.92 147.72 33.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.514 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.5 t -144.88 166.6 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.494 ' N ' HG12 ' A' ' 157' ' ' VAL . 41.2 tt0 -129.26 106.42 8.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 167.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 59.6 m-85 -74.87 171.05 14.72 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.465 170.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.34 88.65 0.46 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.1 0.476 . . . . 0.0 110.055 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.7 t 64.35 170.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.651 1.18 . . . . 0.0 111.583 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -17.53 63.47 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.769 0.428 . . . . 0.0 111.59 -174.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.24 -45.41 66.56 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.914 -0.492 . . . . 0.0 110.531 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -70.83 -31.68 68.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.97 92.78 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.674 -0.641 . . . . 0.0 111.069 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -68.78 -29.06 67.36 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.884 -0.143 . . . . 0.0 110.784 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -70.95 -37.63 72.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.417 -0.177 . . . . 0.0 110.578 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.511 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.16 -20.5 65.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.405 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.0 mt -68.38 -12.23 60.8 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.087 -0.383 . . . . 0.0 111.421 177.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.81 -12.56 80.89 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.555 ' HB2' HG11 ' A' ' 183' ' ' VAL . 71.7 mmtt -83.96 -0.08 50.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.102 1.361 . . . . 0.0 111.638 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.41 ' HA ' HG22 ' A' ' 183' ' ' VAL . 12.5 t60 -53.64 127.18 24.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.83 0.348 . . . . 0.0 110.228 176.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 26.8 mttp 54.2 20.29 2.53 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.785 1.634 . . . . 0.0 114.034 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -82.78 -13.71 55.78 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 73.49 171.32 0.3 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.011 1.324 . . . . 0.0 114.509 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.98 -12.45 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 154.09 -29.96 0.72 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-N 118.476 0.58 . . . . 0.0 113.993 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -151.79 -0.36 0.33 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.956 0.878 . . . . 0.0 111.162 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -147.8 150.37 34.09 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -174.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -93.49 152.32 19.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.165 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 30.1 mm -122.54 159.24 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.46 ' HB3' ' CE1' ' A' ' 184' ' ' PHE . 5.4 mm-40 -125.17 155.28 40.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.497 -175.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 171' ' ' LYS . 34.4 m -138.09 131.58 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.46 ' CE1' ' HB3' ' A' ' 182' ' ' GLU . 7.3 m-85 -142.18 156.06 45.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -75.91 160.78 29.56 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.679 0.672 . . . . 0.0 110.25 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.0 t -155.54 -174.62 5.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.8 t -147.98 173.19 13.14 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.5 1.12 . . . . 0.0 109.88 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -60.36 -31.71 70.58 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.75 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.14 -0.72 2.63 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -121.55 1.95 10.11 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.548 0.739 . . . . 0.0 111.339 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.16 11.13 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 120.899 0.38 . . . . 0.0 111.287 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -69.09 14.89 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.6 m -67.49 -3.17 7.82 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.292 0.637 . . . . 0.0 111.307 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.184 178.244 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 52.3 p30 . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.79 9.42 1.33 Allowed 'General case' 0 C--N 1.34 0.153 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.21 -5.99 50.02 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 112.172 -0.371 . . . . 0.0 112.172 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -63.49 144.47 56.96 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.645 0.736 . . . . 0.0 110.681 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.58 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.5 p -154.0 174.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.642 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.4 ' H ' HG22 ' A' ' 113' ' ' VAL . 70.9 ttt180 -135.62 154.79 51.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.97 0.908 . . . . 0.0 108.66 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -138.65 148.85 44.54 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -156.38 174.6 15.17 Favored 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.05 5.15 83.65 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.438 HD22 ' SG ' ' A' ' 122' ' ' CYS . 95.0 mt -59.92 150.47 68.99 Favored Pre-proline 0 N--CA 1.452 -0.339 0 C-N-CA 123.594 0.757 . . . . 0.0 112.101 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.3 23.99 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 125.142 3.894 . . . . 0.0 113.965 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 54.77 5.68 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.23 1.412 . . . . 0.0 114.43 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.69 -6.28 3.35 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.956 0.798 . . . . 0.0 111.802 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 10.0 t -61.77 150.53 36.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.038 0.935 . . . . 0.0 110.938 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.8 t -143.37 -166.66 2.37 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 171.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 mptt -51.35 -28.69 13.07 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.344 0.52 . . . . 0.0 111.995 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.495 ' H ' HG23 ' A' ' 123' ' ' THR . 37.1 tt0 -78.52 -23.91 46.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.527 0.731 . . . . 0.0 112.331 -177.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.501 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 7.0 mp0 -92.88 -33.7 14.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.426 HG13 ' SG ' ' A' ' 122' ' ' CYS . 42.5 mt -61.88 -33.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.0 p -83.32 -30.61 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.003 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -73.32 -29.87 62.98 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.907 171.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -68.65 -25.84 65.03 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.205 -0.309 . . . . 0.0 110.671 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -115.8 33.31 5.56 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.666 1.186 . . . . 0.0 109.214 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.1 t -64.35 -13.93 53.35 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.963 0.505 . . . . 0.0 112.252 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.01 13.15 67.68 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.821 ' HB3' HD11 ' A' ' 164' ' ' LEU . 69.4 mt -137.5 -162.22 1.27 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.011 1.724 . . . . 0.0 107.482 -173.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.57 -18.04 0.7 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER 46.33 -166.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.847 0.859 . . . . 0.0 112.971 -176.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.0 m -129.21 156.02 78.99 Favored Pre-proline 0 C--N 1.338 0.108 0 C-N-CA 123.852 0.861 . . . . 0.0 109.786 173.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.78 135.59 28.21 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.173 3.249 . . . . 0.0 112.301 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 55.1 t30 40.31 37.36 0.42 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.624 1.17 . . . . 0.0 112.33 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -96.52 28.08 14.81 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 118.934 -0.926 . . . . 0.0 111.75 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.1 mt -132.96 147.01 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 118.968 1.384 . . . . 0.0 109.314 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.8 m -138.11 147.41 43.94 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 123.807 0.843 . . . . 0.0 109.542 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 123' ' ' THR . 91.9 mt -139.5 94.38 9.46 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.527 0.731 . . . . 0.0 110.336 -173.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.82 151.62 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.022 2.481 . . . . 0.0 110.695 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.94 166.32 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.331 0.586 . . . . 0.0 111.266 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 64.4 m-20 -90.82 176.96 2.53 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.684 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 36.9 Cg_exo -58.76 -18.72 42.68 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.981 2.454 . . . . 0.0 111.755 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -81.32 -10.86 59.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.865 0.866 . . . . 0.0 110.683 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.7 14.43 75.72 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -106.54 148.42 28.25 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.5 pt -67.64 149.5 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.421 0.629 . . . . 0.0 111.671 -170.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.5 p -76.42 -7.8 55.82 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.007 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.61 -3.5 32.46 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -139.26 169.89 16.95 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.34 0.57 . . . . 0.0 111.265 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.41 -178.92 7.48 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 111.335 -173.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -144.14 148.11 34.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.488 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 59.9 t -145.76 164.83 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.669 ' O ' HG22 ' A' ' 137' ' ' VAL . 51.9 tt0 -127.75 99.21 5.46 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 169.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.651 ' CD1' HD12 ' A' ' 164' ' ' LEU . 48.5 m-85 -70.15 172.45 8.02 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.121 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.1 87.56 0.4 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.871 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.5 t 62.6 172.62 0.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.546 1.138 . . . . 0.0 111.383 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -31.11 70.71 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.906 -0.496 . . . . 0.0 111.007 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -59.4 -41.64 89.9 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.331 -0.231 . . . . 0.0 111.06 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -72.78 -38.93 67.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -62.8 -34.94 78.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.984 -0.448 . . . . 0.0 110.408 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.31 -27.26 66.14 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.53 0.332 . . . . 0.0 110.299 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -77.27 -38.07 51.65 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.339 0.114 . . . . 0.0 111.181 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.409 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -59.53 -24.41 63.65 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.595 ' HA ' HG21 ' A' ' 183' ' ' VAL . 94.3 mt -68.55 -9.14 47.44 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 122.95 0.5 . . . . 0.0 111.493 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.58 -16.84 78.68 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -76.14 -55.52 5.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.116 0.966 . . . . 0.0 110.678 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.708 ' HA ' HG22 ' A' ' 183' ' ' VAL . 0.6 OUTLIER 23.77 -98.65 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.861 1.264 . . . . 0.0 112.941 -165.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -72.8 20.17 0.08 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -174.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -62.77 -178.22 0.19 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.108 0.963 . . . . 0.0 111.269 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -133.74 168.49 18.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.194 0.598 . . . . 0.0 112.37 -173.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mt -116.47 -13.55 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.521 0.729 . . . . 0.0 112.009 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.44 -31.34 0.53 Allowed Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.52 0.6 . . . . 0.0 114.024 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -152.25 3.06 0.36 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.791 0.796 . . . . 0.0 110.995 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -144.03 156.89 44.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -105.83 148.37 27.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.474 0.654 . . . . 0.0 109.499 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 182' ' ' GLU . 24.3 mm -111.94 174.92 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -172.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.491 ' H ' HG22 ' A' ' 181' ' ' ILE . 12.8 mm-40 -138.63 154.66 48.67 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.708 HG22 ' HA ' ' A' ' 172' ' ' HIS . 17.0 m -129.92 134.94 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -142.44 151.72 42.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -74.09 154.13 39.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.877 0.37 . . . . 0.0 110.553 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.6 t -157.37 179.41 9.28 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.849 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.9 m -150.76 170.74 18.51 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.137 0.975 . . . . 0.0 108.69 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -54.34 -30.84 52.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.682 0.393 . . . . 0.0 111.328 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.54 0.54 2.18 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.308 0.643 . . . . 0.0 112.701 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -121.25 0.06 10.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.138 0.975 . . . . 0.0 110.932 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.11 14.44 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 121.035 0.445 . . . . 0.0 111.11 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -69.33 10.58 0.31 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 59.1 p -69.23 -0.9 6.73 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.352 0.661 . . . . 0.0 111.201 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 117.185 -1.388 . . . . 0.0 110.896 177.59 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.488 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 5.4 t-20 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -132.88 0.69 3.53 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.03 -9.61 25.08 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.477 -0.392 . . . . 0.0 112.523 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -65.48 147.91 52.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.519 0.676 . . . . 0.0 111.094 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.561 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.6 p -155.49 178.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.207 1.003 . . . . 0.0 108.737 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.472 ' H ' HG22 ' A' ' 113' ' ' VAL . 7.4 mtm180 -134.43 162.81 31.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.938 0.495 . . . . 0.0 111.495 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.466 HD23 HD21 ' A' ' 118' ' ' LEU . 6.5 tp -145.97 142.79 29.01 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 154' ' ' GLU . 40.7 ttm180 -151.49 -18.54 0.2 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 181' ' ' ILE . . . -78.94 12.9 21.63 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.264 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 115' ' ' LEU . 97.6 mt -59.6 153.7 49.66 Favored Pre-proline 0 N--CA 1.449 -0.516 0 C-N-CA 124.494 1.118 . . . . 0.0 113.267 -172.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.56 147.64 15.77 Favored 'Trans proline' 0 N--CA 1.442 -1.51 0 C-N-CA 123.793 2.995 . . . . 0.0 106.169 162.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.604 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 23.7 m-85 -70.69 10.57 0.48 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -172.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.38 1.18 12.74 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 118.446 0.567 . . . . 0.0 111.88 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.423 ' SG ' HD22 ' A' ' 118' ' ' LEU . 48.6 t -65.89 156.44 33.39 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.261 0.625 . . . . 0.0 111.591 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 125' ' ' GLU . 2.6 t -152.93 -173.54 4.61 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.577 0.751 . . . . 0.0 109.506 173.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.594 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.2 mptt -50.16 -36.19 29.22 Favored 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.477 ' H ' HG23 ' A' ' 123' ' ' THR . 40.6 mt-10 -75.58 -17.66 59.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -101.74 -26.68 13.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.9 mt -66.85 -39.91 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.45 -34.77 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.368 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -71.08 -28.75 64.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.498 173.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 21.6 t80 -69.48 -23.16 63.6 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.025 0.375 . . . . 0.0 110.275 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -115.2 32.73 5.86 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.743 1.217 . . . . 0.0 109.244 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 t -68.8 -8.04 39.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.07 0.548 . . . . 0.0 111.994 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.92 15.72 60.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.725 ' HB3' HD11 ' A' ' 164' ' ' LEU . 52.5 mt -138.89 -159.75 0.99 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.002 2.121 . . . . 0.0 105.816 -174.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.52 -28.14 0.54 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 2.5 mt 57.38 162.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.968 0.907 . . . . 0.0 112.352 -175.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 158' ' ' GLN . 2.4 m -74.4 161.34 78.54 Favored Pre-proline 0 C--O 1.231 0.09 0 O-C-N 121.0 -1.063 . . . . 0.0 108.643 169.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -46.07 -30.12 7.06 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.024 3.15 . . . . 0.0 112.738 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -162.33 134.26 5.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 171.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -173.92 17.87 0.05 OUTLIER Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.774 -1.014 . . . . 0.0 113.578 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.1 mt -108.4 147.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 119.517 1.659 . . . . 0.0 109.982 -173.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.5 m -140.66 150.78 43.96 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 123.68 0.792 . . . . 0.0 108.918 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.0 mt -146.76 97.43 4.25 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.062 0.545 . . . . 0.0 110.141 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.34 160.76 10.41 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.611 2.874 . . . . 0.0 111.047 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 151' ' ' ILE . 31.4 m -146.08 165.04 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 CA-C-O 121.295 0.569 . . . . 0.0 111.282 173.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.444 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 57.1 m-20 -90.85 175.6 3.52 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 124.167 0.987 . . . . 0.0 108.524 175.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.2 Cg_exo -58.07 -20.21 44.62 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.831 2.354 . . . . 0.0 111.352 174.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -79.39 -10.09 59.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.086 0.955 . . . . 0.0 111.253 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.01 0.54 90.37 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -173.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.604 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 87.1 tttt -73.85 134.73 43.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.831 1.253 . . . . 0.0 108.575 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' A' ' 153' ' ' GLY . 9.3 pt -71.6 10.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -169.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 65.12 -17.2 0.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.859 1.264 . . . . 0.0 112.175 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 105.4 -3.49 40.11 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.04 1.305 . . . . 0.0 112.506 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 116' ' ' ARG . 16.6 pt-20 -132.6 169.59 16.41 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 118.772 1.286 . . . . 0.0 111.505 -177.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.41 -178.37 7.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.12 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -143.39 145.41 32.63 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -175.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.506 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 41.5 t -145.35 160.91 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.565 ' O ' HG22 ' A' ' 137' ' ' VAL . 49.6 tt0 -126.51 119.45 27.19 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 166.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.638 ' CD1' HD12 ' A' ' 164' ' ' LEU . 48.5 m-85 -88.71 174.73 7.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.462 170.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.12 88.42 0.42 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.581 0.753 . . . . 0.0 109.876 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.69 168.06 0.13 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.514 1.126 . . . . 0.0 111.184 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.488 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 1.5 tm0? -64.5 -23.91 67.43 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.846 -0.533 . . . . 0.0 111.214 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.83 -41.13 99.21 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.116 -0.365 . . . . 0.0 110.725 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.725 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -70.87 -37.75 73.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -61.85 -33.86 74.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.066 -0.396 . . . . 0.0 110.803 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -72.43 -27.16 62.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -74.09 -38.12 63.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.544 0.212 . . . . 0.0 110.512 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -61.48 -21.52 64.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.753 0.421 . . . . 0.0 112.086 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.421 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.2 mt -68.27 -13.45 62.26 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.965 -0.459 . . . . 0.0 111.161 176.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.5 -11.99 82.47 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.546 ' HB2' HG11 ' A' ' 183' ' ' VAL . 68.3 mmtt -85.37 -1.67 57.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.478 1.111 . . . . 0.0 112.179 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -51.93 129.08 26.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.748 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 62.72 11.09 4.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.404 1.482 . . . . 0.0 114.335 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -71.39 -171.44 0.62 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.035 0.834 . . . . 0.0 109.361 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -134.36 164.49 27.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -171.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.8 mt -115.53 -11.48 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.764 0.826 . . . . 0.0 111.932 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 151.35 -25.96 0.98 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 121.891 -0.506 . . . . 0.0 113.938 175.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -153.59 2.14 0.26 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 117.736 0.768 . . . . 0.0 111.083 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -147.0 160.15 42.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.91 0.884 . . . . 0.0 108.672 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -107.13 145.22 32.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.483 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 21.9 mm -113.17 162.41 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -171.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -130.34 150.91 51.36 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.546 HG11 ' HB2' ' A' ' 171' ' ' LYS . 32.6 m -128.11 134.3 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -175.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -136.61 163.56 30.27 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -82.59 158.59 23.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.879 -0.513 . . . . 0.0 109.959 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.6 t -158.99 -177.33 6.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.469 -0.145 . . . . 0.0 111.325 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.2 t -148.31 178.18 8.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.651 0.78 . . . . 0.0 110.301 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -60.48 -31.95 70.96 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.188 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -65.76 -7.16 14.29 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -112.02 1.38 16.35 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.506 0.723 . . . . 0.0 111.055 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.2 11.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 120.911 0.386 . . . . 0.0 111.555 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -69.18 14.16 0.09 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.1 m -69.19 -0.4 5.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.574 0.75 . . . . 0.0 111.184 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.859 -1.067 . . . . 0.0 111.155 178.254 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 p30 . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 120.835 0.35 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -127.81 3.9 6.03 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 162' ' ' GLN . . . 111.12 -8.83 29.16 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -64.08 142.77 58.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.643 0.735 . . . . 0.0 111.154 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.546 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.2 p -153.13 175.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.997 1.319 . . . . 0.0 108.037 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.403 ' H ' HG22 ' A' ' 113' ' ' VAL . 75.1 ttt180 -138.97 145.95 40.35 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.09 152.82 35.81 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 123.867 0.867 . . . . 0.0 109.098 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.447 ' HD2' ' CE2' ' A' ' 184' ' ' PHE . 5.8 mtt180 -153.3 166.49 32.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.47 1.56 88.79 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.6 146.95 42.52 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 117.294 0.547 . . . . 0.0 110.78 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 9.7 Cg_exo -63.63 150.17 89.14 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.026 1.818 . . . . 0.0 108.577 167.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -70.32 5.3 1.79 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -125.94 5.51 7.87 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 46.2 t -70.33 157.51 37.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.896 0.479 . . . . 0.0 110.858 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.6 t -154.93 -171.63 3.9 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.262 0.625 . . . . 0.0 109.527 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.604 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.4 OUTLIER -51.22 -30.88 18.75 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.476 ' H ' HG23 ' A' ' 123' ' ' THR . 39.2 mt-10 -80.04 -17.84 51.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -107.0 -20.24 13.38 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.8 mt -71.27 -39.92 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 167.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 125' ' ' GLU . 12.2 p -71.17 -38.73 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.217 -177.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -74.66 -22.77 58.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.519 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -69.35 -26.6 64.77 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 170.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.48 ' HA ' ' HE3' ' A' ' 171' ' ' LYS . 36.4 m-85 -106.82 32.32 4.65 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.677 0.791 . . . . 0.0 109.629 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.4 t -61.11 146.15 48.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 169.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.58 2.49 76.05 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' A' ' 164' ' ' LEU . 23.2 mt -134.58 -172.16 2.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -141.59 -17.73 0.78 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -171.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER 45.84 -165.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.88 0.872 . . . . 0.0 113.272 -176.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.4 m -129.9 156.08 79.56 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 124.068 0.947 . . . . 0.0 109.769 173.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.14 136.54 30.23 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.045 3.163 . . . . 0.0 112.252 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.5 t30 40.1 38.33 0.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.556 1.142 . . . . 0.0 112.206 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.04 28.66 13.56 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 118.877 -0.957 . . . . 0.0 111.86 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.8 mt -134.31 147.67 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 119.048 1.424 . . . . 0.0 109.538 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.5 m -139.6 149.93 44.4 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.586 0.754 . . . . 0.0 109.788 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 mt -145.52 95.42 4.98 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 123.896 0.878 . . . . 0.0 109.309 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.11 160.96 7.33 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.799 2.999 . . . . 0.0 111.635 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.4 m -141.71 164.71 18.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 121.283 0.564 . . . . 0.0 111.249 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 67.2 m-20 -86.93 176.12 3.79 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.975 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.2 Cg_exo -59.08 -20.23 52.88 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.038 2.492 . . . . 0.0 111.61 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -82.43 -9.85 59.28 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.561 0.744 . . . . 0.0 110.575 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.84 8.48 79.48 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.312 0.482 . . . . 0.0 112.246 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -97.11 147.62 23.86 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 117.616 0.708 . . . . 0.0 109.147 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.0 pt -69.53 152.9 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.719 0.771 . . . . 0.0 112.022 -172.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.7 p -82.74 0.61 42.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.037 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.9 8.3 86.86 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.026 -0.429 . . . . 0.0 112.026 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -138.62 160.38 39.76 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.31 -179.5 7.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.149 0.499 . . . . 0.0 110.909 -172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -145.46 148.58 33.42 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -174.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 60.0 t -145.12 163.9 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.661 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.9 tt0 -128.28 95.61 4.21 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.615 ' CD1' HD12 ' A' ' 164' ' ' LEU . 52.8 m-85 -67.99 171.71 6.45 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.139 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.56 89.71 0.37 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.644 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.7 167.75 0.13 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.481 1.113 . . . . 0.0 111.007 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.424 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 36.8 tp60 -65.96 -20.07 66.08 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.707 -0.62 . . . . 0.0 111.211 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.07 -41.78 94.78 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.998 -0.438 . . . . 0.0 110.593 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -69.72 -36.3 75.76 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.494 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -61.75 -36.23 80.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.036 -0.415 . . . . 0.0 110.845 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.78 -27.26 63.78 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -74.11 -38.0 63.96 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.608 0.242 . . . . 0.0 110.685 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.95 -19.94 64.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.164 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.586 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.1 mt -69.9 -8.85 52.1 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.041 -0.412 . . . . 0.0 111.419 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.25 -18.21 80.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 131' ' ' PHE . 70.1 mmtt -70.19 -61.21 1.86 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.567 1.147 . . . . 0.0 109.582 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.633 ' HA ' HG22 ' A' ' 183' ' ' VAL . 0.9 OUTLIER 25.34 -108.59 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.418 1.087 . . . . 0.0 112.715 -165.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -66.61 10.74 0.11 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -65.57 171.64 3.96 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.554 1.542 . . . . 0.0 109.925 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -123.86 165.25 17.69 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -168.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mt -105.64 -13.28 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.637 0.775 . . . . 0.0 111.963 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.1 -24.28 1.42 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.794 -0.448 . . . . 0.0 113.53 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -152.63 0.98 0.3 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.683 0.741 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -148.27 153.95 39.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.966 0.906 . . . . 0.0 108.73 -172.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -101.02 150.6 22.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.7 mm -117.92 171.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -139.45 160.13 40.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 172' ' ' HIS . 24.7 m -132.95 127.3 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.447 ' CE2' ' HD2' ' A' ' 116' ' ' ARG . 3.1 m-30 -128.07 154.55 45.57 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -75.48 163.25 27.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.796 -0.565 . . . . 0.0 110.592 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.7 t -159.06 -175.61 5.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.6 m -149.57 169.02 21.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.292 1.437 . . . . 0.0 109.138 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -57.7 -32.33 67.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.675 0.39 . . . . 0.0 111.38 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -66.94 -1.34 3.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -117.92 1.64 12.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.858 0.863 . . . . 0.0 110.911 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.56 12.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-O 121.036 0.446 . . . . 0.0 110.956 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -68.71 13.45 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.7 m -67.28 -2.31 5.8 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.346 0.658 . . . . 0.0 111.364 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.198 -1.382 . . . . 0.0 111.056 178.479 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 4.8 t-20 . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -131.78 6.51 4.34 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.33 -9.68 42.33 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -65.1 144.91 56.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.641 0.734 . . . . 0.0 111.048 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.547 HG11 ' CE2' ' A' ' 159' ' ' PHE . 11.1 p -152.9 174.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.137 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 59.1 ttt180 -136.35 145.33 45.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.043 0.537 . . . . 0.0 109.61 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.3 143.15 48.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -154.35 143.42 21.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.45 -1.11 46.29 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.95 157.45 86.78 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 117.468 0.634 . . . . 0.0 111.055 -176.228 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -54.58 144.85 61.76 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.176 2.584 . . . . 0.0 111.36 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -71.0 12.27 0.31 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.67 5.82 5.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 51.2 t -69.16 158.44 34.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.387 1.075 . . . . 0.0 110.644 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.583 HG23 ' H ' ' A' ' 125' ' ' GLU . 6.5 t -153.73 -178.98 7.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.492 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 4.0 ptpp? -53.34 -25.36 14.81 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.583 ' H ' HG23 ' A' ' 123' ' ' THR . 41.5 mt-10 -78.34 -22.94 47.27 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.939 0.336 . . . . 0.0 111.611 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -92.69 -30.34 15.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.81 -45.6 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.69 -33.77 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.59 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -72.86 -31.36 64.68 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.494 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -67.34 -16.65 64.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.293 0.497 . . . . 0.0 110.203 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -120.08 30.46 6.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.499 1.119 . . . . 0.0 109.515 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.6 t -63.44 138.15 58.41 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.35 2.43 90.27 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.2 mt -138.07 76.22 1.56 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.198 1.399 . . . . 0.0 107.784 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -49.85 158.11 0.53 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.19 0.996 . . . . 0.0 113.472 -174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.68 147.59 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.1 m -70.66 155.25 93.67 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 118.521 0.601 . . . . 0.0 110.354 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -48.8 138.0 26.69 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.92 3.08 . . . . 0.0 111.739 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.8 t30 41.79 37.22 0.73 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.043 0.937 . . . . 0.0 111.802 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.61 31.85 6.8 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -173.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -139.51 145.97 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.238 1.019 . . . . 0.0 109.077 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.6 m -140.35 151.28 44.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.53 100.0 4.1 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.72 149.55 18.98 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.082 2.521 . . . . 0.0 110.934 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 24.5 m -145.25 160.84 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.434 0.635 . . . . 0.0 110.719 172.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.444 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 60.9 m-20 -87.38 176.42 3.47 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 42.1 Cg_exo -57.67 -18.25 32.38 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.825 2.35 . . . . 0.0 111.944 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.01 -8.54 58.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.425 1.09 . . . . 0.0 111.431 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.04 2.07 88.43 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -68.81 123.91 22.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.715 1.606 . . . . 0.0 109.824 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.0 pt -78.28 3.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -165.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p 66.27 -16.76 0.12 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.68 9.64 58.54 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.947 0.784 . . . . 0.0 113.794 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -143.09 163.51 32.64 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.31 1.055 . . . . 0.0 110.676 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.93 -177.06 6.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.278 0.631 . . . . 0.0 111.089 -173.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -147.17 150.47 34.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 87.6 t -147.14 165.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -175.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.477 ' N ' HG12 ' A' ' 157' ' ' VAL . 54.5 tt0 -133.44 98.54 4.25 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.004 0.921 . . . . 0.0 108.898 170.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.547 ' CE2' HG11 ' A' ' 113' ' ' VAL . 58.2 m-85 -69.82 170.54 10.86 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -67.82 92.52 0.36 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.15 0.5 . . . . 0.0 110.196 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.2 t 62.42 169.65 0.13 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.717 1.207 . . . . 0.0 111.095 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 0.0 OUTLIER -66.4 -12.31 56.3 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.033 -0.417 . . . . 0.0 111.489 -175.531 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -74.48 -44.23 52.45 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.492 0.317 . . . . 0.0 110.384 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.464 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -69.07 -36.72 77.93 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.32 -38.97 78.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.087 -0.383 . . . . 0.0 110.701 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.35 -31.64 71.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.449 0.3 . . . . 0.0 110.623 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -69.92 -39.06 76.37 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.434 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.73 -13.83 62.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.533 0.333 . . . . 0.0 111.727 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.675 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.9 mt -68.21 -12.26 60.68 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.737 -0.602 . . . . 0.0 111.042 175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.3 13.08 8.23 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.636 ' HB2' HG11 ' A' ' 183' ' ' VAL . 62.5 mmtt -118.87 -0.0 11.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.882 1.673 . . . . 0.0 112.353 -178.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.597 ' HA ' HG22 ' A' ' 183' ' ' VAL . 6.2 t60 -46.63 -20.95 0.15 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -142.83 15.65 1.94 Allowed 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.536 -0.728 . . . . 0.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -81.82 178.68 8.18 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.819 1.248 . . . . 0.0 109.616 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -129.85 154.26 47.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.02 -16.49 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.143 0.977 . . . . 0.0 111.198 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 153.66 -24.96 0.74 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.746 -0.474 . . . . 0.0 113.399 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -152.54 0.92 0.3 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.794 0.797 . . . . 0.0 111.257 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -148.39 152.78 37.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.938 0.895 . . . . 0.0 108.651 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -103.31 154.83 18.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.39 0.614 . . . . 0.0 110.529 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 26.0 mm -126.22 160.17 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.637 -171.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -129.86 151.97 49.85 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 169' ' ' LEU . 35.8 m -125.77 49.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.028 0.931 . . . . 0.0 113.372 -167.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 3.5 m-30 -52.1 151.73 3.6 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.789 -0.569 . . . . 0.0 110.226 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -76.28 163.77 26.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.958 -0.464 . . . . 0.0 110.149 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.2 t -159.64 -177.15 6.18 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.2 m -145.24 171.46 14.53 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.753 1.221 . . . . 0.0 109.37 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -57.79 -32.13 67.24 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.764 0.426 . . . . 0.0 111.527 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.33 -4.83 8.79 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -116.63 2.27 12.96 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.751 0.821 . . . . 0.0 110.926 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.83 10.7 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 120.992 0.425 . . . . 0.0 111.172 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -68.99 13.7 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 m -68.22 -1.9 7.06 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.253 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.807 -1.092 . . . . 0.0 111.147 178.153 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -134.78 5.81 3.4 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.67 -9.58 32.43 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -63.23 143.11 58.08 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.551 0.691 . . . . 0.0 111.078 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' A' ' 159' ' ' PHE . 10.5 p -152.34 174.55 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.372 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 51.3 ttt180 -138.94 147.2 41.95 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.021 0.528 . . . . 0.0 109.976 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -120.98 151.17 40.05 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.457 1.103 . . . . 0.0 109.205 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -157.65 164.83 36.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.14 1.8 88.33 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.3 mt -53.68 143.53 38.49 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.137 0.575 . . . . 0.0 110.32 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.415 ' CG ' ' SG ' ' A' ' 122' ' ' CYS . 72.8 Cg_endo -72.87 27.96 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 124.785 3.657 . . . . 0.0 113.933 -174.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 52.34 18.82 0.98 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.162 0.985 . . . . 0.0 113.275 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -148.09 -13.97 0.13 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.797 -0.565 . . . . 0.0 113.003 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 119' ' ' PRO . 6.8 m -62.95 158.89 18.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.585 0.692 . . . . 0.0 110.698 174.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.5 t -148.77 -165.03 2.17 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 2.5 mptt -49.91 -34.7 21.21 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.541 0.61 . . . . 0.0 112.049 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.471 ' H ' HG23 ' A' ' 123' ' ' THR . 40.0 mt-10 -77.36 -16.58 58.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -101.45 -29.38 12.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.3 mt -65.33 -34.01 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.2 -34.81 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.005 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -71.13 -27.09 63.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.174 -0.611 . . . . 0.0 111.043 172.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 8.8 t80 -70.19 -26.08 63.73 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 174.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -111.82 30.55 6.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.301 1.04 . . . . 0.0 109.545 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -67.57 -14.86 63.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.923 0.489 . . . . 0.0 111.83 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -94.42 16.62 60.69 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.581 ' HB3' HD11 ' A' ' 164' ' ' LEU . 36.6 mt -143.98 -162.05 1.39 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.349 1.859 . . . . 0.0 107.157 -173.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -146.79 165.29 30.13 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.1 mt -142.73 154.49 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 158' ' ' GLN . 27.4 m -60.13 156.45 38.55 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.95 -31.06 7.77 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 124.509 3.473 . . . . 0.0 113.813 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -161.41 110.42 1.56 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -149.04 6.51 0.83 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.63 -1.095 . . . . 0.0 113.24 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.441 HG12 HG13 ' A' ' 157' ' ' VAL . 78.5 mt -97.68 147.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 119.471 1.636 . . . . 0.0 109.507 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 92.0 m -139.82 147.21 40.41 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.7 mt -143.69 97.24 5.48 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 123.293 0.637 . . . . 0.0 109.408 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.72 159.35 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.404 2.736 . . . . 0.0 110.267 173.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.58 159.68 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-O 121.356 0.598 . . . . 0.0 110.963 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.478 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 54.7 m-20 -84.16 175.75 4.38 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.842 176.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 36.4 Cg_exo -58.5 -19.11 42.69 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.891 2.394 . . . . 0.0 111.522 175.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -82.64 -10.26 59.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.807 0.843 . . . . 0.0 110.872 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.17 10.81 73.96 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.341 0.496 . . . . 0.0 112.444 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -98.74 150.39 21.86 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 117.436 0.618 . . . . 0.0 109.908 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 153' ' ' GLY . 6.1 pt -73.77 8.1 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 -160.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 67.06 -21.59 0.11 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.133 0.973 . . . . 0.0 113.533 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 105.21 6.84 38.77 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.862 0.744 . . . . 0.0 113.479 175.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -142.72 168.1 20.52 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.249 1.024 . . . . 0.0 110.787 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -157.74 -179.46 8.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.241 0.543 . . . . 0.0 111.26 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.93 151.74 39.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 158' ' ' GLN . 40.5 t -147.37 166.06 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.737 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.1 tt0 -128.99 97.42 4.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 168.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' A' ' 113' ' ' VAL . 38.5 m-85 -67.86 172.82 4.98 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.197 0.522 . . . . 0.0 109.916 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.79 90.9 0.61 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t 62.3 167.18 0.11 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.933 1.293 . . . . 0.0 111.738 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -15.69 63.07 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.888 -0.508 . . . . 0.0 111.053 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.48 -41.92 83.79 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.876 -0.515 . . . . 0.0 110.443 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.613 ' O ' HD13 ' A' ' 164' ' ' LEU . 1.1 tm? -71.17 -39.26 71.97 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -56.66 -35.78 68.79 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.267 -0.271 . . . . 0.0 111.039 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -71.91 -30.29 65.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.565 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -72.34 -37.28 68.9 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.644 0.259 . . . . 0.0 110.487 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.428 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.93 -18.76 64.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.937 0.495 . . . . 0.0 112.09 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.417 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.5 mt -67.98 -14.64 63.12 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.698 -0.626 . . . . 0.0 111.036 176.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.58 -12.78 80.44 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.534 ' HB2' HG11 ' A' ' 183' ' ' VAL . 71.3 mmtt -83.64 -2.64 56.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.736 1.214 . . . . 0.0 111.692 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.404 ' NE2' ' HE3' ' A' ' 173' ' ' LYS . 37.3 t60 -52.55 122.68 9.37 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.404 ' HE3' ' NE2' ' A' ' 172' ' ' HIS . 77.7 mttt 60.98 17.04 7.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.326 1.45 . . . . 0.0 113.822 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -79.87 -18.41 50.78 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.36 1.064 . . . . 0.0 113.287 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 79.23 174.41 0.15 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.24 1.416 . . . . 0.0 114.573 170.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.77 -15.2 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.24 0.616 . . . . 0.0 112.611 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.24 -29.3 0.64 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 118.556 0.616 . . . . 0.0 114.191 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -151.51 -1.48 0.33 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.885 0.843 . . . . 0.0 111.066 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -145.78 151.59 38.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -97.19 151.2 20.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.027 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 37.5 mm -123.62 157.5 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -172.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -127.82 158.92 36.4 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 171' ' ' LYS . 35.5 m -133.84 130.5 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 114' ' ' ARG . 9.0 m-85 -136.98 150.38 48.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -75.84 158.43 32.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.337 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.9 t -156.71 -175.83 5.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.3 m -145.57 169.48 18.32 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.625 1.17 . . . . 0.0 109.744 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -57.16 -32.24 66.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.847 0.459 . . . . 0.0 111.116 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.24 -2.03 3.92 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -121.0 1.93 10.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.88 0.872 . . . . 0.0 111.051 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.89 11.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.885 0.374 . . . . 0.0 111.318 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -67.72 12.3 0.11 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.2 m -69.69 0.38 5.63 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.387 0.675 . . . . 0.0 111.28 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.275 -1.345 . . . . 0.0 111.149 178.091 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -142.07 4.17 1.63 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.45 -5.9 33.59 Favored Glycine 0 N--CA 1.45 -0.375 0 O-C-N 122.245 -0.284 . . . . 0.0 112.581 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -63.03 148.36 47.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.766 0.793 . . . . 0.0 111.286 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -155.11 174.77 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.428 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.413 ' H ' HG22 ' A' ' 113' ' ' VAL . 47.3 ttt180 -137.17 152.21 49.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tp -133.81 150.98 51.43 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -154.07 169.98 22.23 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.83 4.96 88.63 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.444 HD23 ' SG ' ' A' ' 122' ' ' CYS . 2.6 mp -58.5 149.05 62.96 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 117.035 0.418 . . . . 0.0 111.609 -175.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 15.3 Cg_exo -62.04 146.97 95.99 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.255 1.97 . . . . 0.0 108.715 167.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.455 ' HA ' HD11 ' A' ' 151' ' ' ILE . 19.8 m-85 -71.35 2.99 4.08 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.24 5.74 12.08 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 49.0 t -66.86 154.43 40.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.249 1.02 . . . . 0.0 111.134 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.2 t -156.05 -166.44 2.19 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.411 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -50.03 -53.14 28.86 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.714 0.688 . . . . 0.0 109.518 -179.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.551 ' HA ' ' CG2' ' A' ' 128' ' ' VAL . 32.6 tt0 -53.36 -21.25 5.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.333 1.453 . . . . 0.0 113.843 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.488 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 75.6 mm-40 -97.91 -19.67 17.94 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.004 -1.06 . . . . 0.0 110.635 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.2 mt -86.08 -26.18 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 125' ' ' GLU . 29.0 m -78.88 -33.7 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.04 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -72.66 -32.08 65.56 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.454 0.57 . . . . 0.0 110.698 172.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 16.6 t80 -70.44 -24.39 62.88 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.395 -0.19 . . . . 0.0 111.379 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -120.56 29.25 7.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.855 0.862 . . . . 0.0 109.706 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 t -63.18 -11.54 21.52 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.036 0.534 . . . . 0.0 111.967 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.49 13.95 65.76 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.784 ' HB3' HD11 ' A' ' 164' ' ' LEU . 76.4 mt -137.76 -159.4 0.95 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.641 1.976 . . . . 0.0 106.627 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -141.76 -21.52 0.73 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -175.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.7 mt 51.6 -176.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.683 0.793 . . . . 0.0 112.606 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.599 ' H ' HG22 ' A' ' 136' ' ' ILE . 20.6 m -120.51 154.83 56.95 Favored Pre-proline 0 C--N 1.339 0.145 0 O-C-N 121.501 -0.749 . . . . 0.0 109.174 167.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.84 134.71 17.67 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.154 3.236 . . . . 0.0 112.746 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.2 t30 41.01 36.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.601 1.161 . . . . 0.0 112.557 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -81.87 -4.61 90.26 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.301 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.457 HG12 HG13 ' A' ' 157' ' ' VAL . 96.7 mt -98.91 151.15 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.989 0.894 . . . . 0.0 110.732 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.8 m -143.2 144.33 32.13 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.756 0.822 . . . . 0.0 109.346 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.5 mt -139.54 94.98 9.16 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 124.065 0.946 . . . . 0.0 108.615 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.95 158.6 16.8 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.447 2.765 . . . . 0.0 110.691 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 28.5 m -141.5 160.42 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.593 0.711 . . . . 0.0 112.187 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.463 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 18.3 m-20 -85.55 174.04 6.2 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.467 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 44.8 Cg_exo -58.03 -9.67 6.57 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.679 2.92 . . . . 0.0 112.539 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -104.3 -1.48 26.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.599 0.759 . . . . 0.0 111.27 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.66 4.38 90.12 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -66.86 162.56 21.41 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 120' ' ' PHE . 4.4 pt -109.6 11.27 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -166.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 p 63.33 -5.85 0.22 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 69.96 12.22 67.8 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.205 0.907 . . . . 0.0 113.252 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -141.27 164.79 29.3 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.044 0.922 . . . . 0.0 110.574 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.69 -178.04 7.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.55 0.74 . . . . 0.0 110.539 -172.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -145.45 154.66 42.48 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 158' ' ' GLN . 5.4 t -147.38 169.16 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.523 ' N ' HG12 ' A' ' 157' ' ' VAL . 51.1 tt0 -126.96 115.95 20.03 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.959 -1.496 . . . . 0.0 106.959 164.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.66 ' CD1' HD12 ' A' ' 164' ' ' LEU . 51.7 m-85 -85.26 173.53 10.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.302 172.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.09 88.48 0.6 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.13 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.1 t 64.62 168.33 0.17 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.488 1.115 . . . . 0.0 111.511 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -19.58 63.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.866 0.466 . . . . 0.0 111.752 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.21 -42.57 65.62 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.038 -0.414 . . . . 0.0 111.244 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.784 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -68.1 -36.06 79.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.411 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -60.73 -35.06 75.42 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.282 -0.261 . . . . 0.0 110.785 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -71.41 -28.14 63.79 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -74.55 -37.98 62.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.693 0.282 . . . . 0.0 110.602 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.432 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -61.54 -23.49 65.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.932 176.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 99.1 mt -69.26 -12.1 61.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.349 0.522 . . . . 0.0 111.411 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.85 -10.66 83.65 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.559 ' HB2' HG11 ' A' ' 183' ' ' VAL . 67.3 mmtt -89.02 2.02 54.65 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.822 1.249 . . . . 0.0 112.231 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.458 ' HA ' HG22 ' A' ' 183' ' ' VAL . 42.4 t60 -52.53 132.64 35.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.974 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 59.38 12.04 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.48 1.512 . . . . 0.0 114.345 -176.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -72.89 -169.93 0.65 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.018 0.826 . . . . 0.0 109.53 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.76 168.0 19.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.24 -13.62 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.438 0.695 . . . . 0.0 111.583 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 152.23 -26.05 0.88 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.394 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -154.49 2.78 0.22 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.66 0.73 . . . . 0.0 111.174 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -148.17 157.51 43.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.062 0.945 . . . . 0.0 108.686 -171.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -101.99 146.29 28.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.0 162.12 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -125.59 153.11 44.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.826 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.559 HG11 ' HB2' ' A' ' 171' ' ' LYS . 23.2 m -136.79 132.56 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -177.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -146.16 154.04 41.34 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -77.53 154.67 32.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.694 0.283 . . . . 0.0 110.724 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.9 t -158.37 -178.64 7.43 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.538 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 66.3 m -148.05 170.3 18.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.695 1.198 . . . . 0.0 108.952 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -56.37 -29.58 61.61 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.761 0.424 . . . . 0.0 111.246 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -66.58 -1.03 3.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.477 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -123.16 2.3 9.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.679 0.792 . . . . 0.0 111.167 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.07 9.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -69.19 15.14 0.07 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.2 m -69.06 -0.07 5.3 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.691 0.797 . . . . 0.0 111.113 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.211 -1.376 . . . . 0.0 111.227 178.017 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 25.8 p30 . . . . . 0 N--CA 1.445 -0.691 0 CA-C-O 120.506 0.193 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -126.62 4.29 6.79 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.74 -13.49 13.15 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -61.88 139.18 58.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.485 0.659 . . . . 0.0 111.06 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.597 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.9 p -150.91 177.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.725 -177.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.47 ' H ' HG22 ' A' ' 113' ' ' VAL . 9.9 mtm180 -133.26 161.51 34.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.202 0.601 . . . . 0.0 110.67 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -141.61 148.46 39.27 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.629 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -153.6 161.45 42.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.12 4.72 89.67 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.441 HD23 ' SG ' ' A' ' 122' ' ' CYS . 2.9 mp -59.0 153.22 46.01 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 117.324 0.562 . . . . 0.0 111.487 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -62.26 146.27 95.91 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.387 2.058 . . . . 0.0 108.163 166.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.415 ' HA ' HD11 ' A' ' 151' ' ' ILE . 20.6 m-85 -73.92 10.63 1.1 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.53 3.47 7.63 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 32.5 t -66.6 151.22 47.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.731 1.212 . . . . 0.0 110.981 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.5 HG23 ' H ' ' A' ' 125' ' ' GLU . 3.0 t -146.94 -168.29 3.0 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.568 0.747 . . . . 0.0 109.142 172.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.612 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 mptt -51.69 -29.31 17.7 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.5 ' H ' HG23 ' A' ' 123' ' ' THR . 33.0 tt0 -76.02 -24.23 55.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.114 0.566 . . . . 0.0 111.93 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.485 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 5.7 mp0 -90.84 -35.34 14.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.478 -0.764 . . . . 0.0 110.0 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.51 -32.54 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.73 -31.84 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.003 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -71.74 -27.64 63.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.755 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -69.78 -27.03 64.58 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -114.3 32.68 5.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.412 1.085 . . . . 0.0 109.53 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.8 t -64.5 -13.62 53.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.959 0.504 . . . . 0.0 112.164 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.31 13.67 67.05 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.786 ' HB3' HD11 ' A' ' 164' ' ' LEU . 74.5 mt -136.72 -161.47 1.17 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.241 1.817 . . . . 0.0 107.24 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.17 -18.22 0.73 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 117.295 2.331 . . . . 0.0 117.295 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER 46.12 -166.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.819 0.848 . . . . 0.0 112.772 -176.242 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 158' ' ' GLN . 16.4 m -129.98 156.17 79.51 Favored Pre-proline 0 CA--C 1.528 0.106 0 C-N-CA 123.898 0.879 . . . . 0.0 109.852 172.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.96 137.15 22.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.027 3.151 . . . . 0.0 112.178 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 39.52 36.58 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.755 1.222 . . . . 0.0 112.952 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.15 5.33 75.23 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 119.13 -0.817 . . . . 0.0 112.507 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.6 mt -113.28 147.77 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 118.84 1.32 . . . . 0.0 109.476 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.0 m -139.56 150.7 45.37 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.505 0.722 . . . . 0.0 109.249 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 6.1 mt -144.48 97.14 5.13 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.513 0.725 . . . . 0.0 109.52 -175.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 163.81 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 124.11 3.207 . . . . 0.0 112.056 174.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 18.1 m -145.06 160.76 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 110.321 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 60.9 m-20 -84.64 175.54 4.54 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 32.5 Cg_exo -58.67 -20.22 49.63 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.74 2.294 . . . . 0.0 111.045 174.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.25 -12.88 60.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.108 0.963 . . . . 0.0 110.768 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.77 8.27 76.78 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.459 0.552 . . . . 0.0 112.268 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -95.48 148.96 21.93 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 117.433 0.617 . . . . 0.0 109.785 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 120' ' ' PHE . 6.1 pt -77.24 7.35 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 -160.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 67.96 -22.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 175.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 94.42 15.59 46.56 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.339 -0.701 . . . . 0.0 113.233 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.77 168.06 20.69 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.286 1.043 . . . . 0.0 110.466 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.99 -179.56 8.33 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.395 0.617 . . . . 0.0 111.154 -173.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -144.06 147.98 34.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 158' ' ' GLN . 48.4 t -145.83 165.26 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.669 ' O ' HG22 ' A' ' 137' ' ' VAL . 53.1 tt0 -127.92 100.71 6.02 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 168.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.67 ' CD1' HD12 ' A' ' 164' ' ' LEU . 47.5 m-85 -70.29 172.05 8.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.971 174.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.41 88.93 0.33 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.564 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.89 168.31 0.13 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.623 1.169 . . . . 0.0 111.026 -174.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -16.95 64.31 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.741 -0.599 . . . . 0.0 111.266 -176.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.09 -39.9 78.74 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.86 -0.525 . . . . 0.0 110.685 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.786 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.9 OUTLIER -72.13 -35.21 69.06 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.451 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -60.72 -36.57 79.17 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.076 -0.39 . . . . 0.0 110.625 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.02 -28.54 65.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -72.88 -37.1 67.43 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 121.285 -0.166 . . . . 0.0 110.946 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.39 65.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.611 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.5 mt -68.98 -11.34 60.65 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.613 0.365 . . . . 0.0 111.707 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.78 -16.85 80.15 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -76.27 -56.59 4.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.106 0.962 . . . . 0.0 110.791 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.674 ' HA ' HG22 ' A' ' 183' ' ' VAL . 1.2 t60 23.76 -99.87 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.881 1.272 . . . . 0.0 112.63 -164.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -70.74 17.39 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -61.28 179.37 0.21 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.616 0.767 . . . . 0.0 111.237 172.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -132.33 164.22 26.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.17 0.588 . . . . 0.0 112.104 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.2 mt -108.79 -12.82 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.32 0.648 . . . . 0.0 112.258 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.82 -24.92 1.31 Allowed Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.866 -0.521 . . . . 0.0 113.962 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -151.56 2.09 0.39 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 117.624 0.712 . . . . 0.0 110.731 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -149.79 157.46 43.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.284 1.034 . . . . 0.0 108.395 -171.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -107.37 153.25 23.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.343 0.592 . . . . 0.0 109.563 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.0 mm -119.01 171.92 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -172.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -139.92 158.31 44.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.674 HG22 ' HA ' ' A' ' 172' ' ' HIS . 21.9 m -129.07 133.9 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -134.68 158.29 44.47 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -79.26 163.79 24.66 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.849 0.749 . . . . 0.0 109.701 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.4 t -156.82 -173.26 4.38 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.236 -0.29 . . . . 0.0 111.768 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.2 m -147.04 167.63 23.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.626 1.171 . . . . 0.0 109.713 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -59.91 -30.68 69.19 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.55 -1.42 2.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.971 0.908 . . . . 0.0 112.455 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -122.99 2.23 9.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.12 0.968 . . . . 0.0 111.201 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.98 11.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-O 120.936 0.398 . . . . 0.0 111.207 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -67.16 11.67 0.1 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 20.7 t -69.34 -1.99 9.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.524 0.73 . . . . 0.0 110.818 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.246 -1.359 . . . . 0.0 111.257 177.953 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.509 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 5.9 t-20 . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -126.59 9.71 7.13 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.85 -9.7 40.45 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -62.49 138.79 58.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.47 0.653 . . . . 0.0 110.218 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.9 p -148.6 175.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.862 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.417 ' H ' HG22 ' A' ' 113' ' ' VAL . 3.3 mtt-85 -131.56 160.94 33.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.663 0.785 . . . . 0.0 110.045 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.2 tp -144.54 140.83 29.06 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -156.67 172.87 17.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.04 8.01 84.57 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -176.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 72.0 mt -56.72 150.58 35.92 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.91 0.884 . . . . 0.0 111.819 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.83 20.34 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 124.844 3.696 . . . . 0.0 113.428 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 55.21 11.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.631 1.172 . . . . 0.0 114.131 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.22 -7.63 1.94 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 21.8 t -66.33 151.46 47.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.271 1.029 . . . . 0.0 110.342 175.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 125' ' ' GLU . 6.4 t -143.27 -173.46 3.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 170.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.9 ptpp? -54.71 -17.39 3.37 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.525 ' H ' HG23 ' A' ' 123' ' ' THR . 42.1 mt-10 -83.69 -26.12 30.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.949 0.5 . . . . 0.0 111.341 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.466 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 4.8 mp0 -87.59 -32.55 19.27 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.68 -35.62 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 p -82.27 -34.08 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.164 -173.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -79.67 -20.82 45.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.47 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -73.72 -26.08 60.52 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 170.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -111.14 36.85 3.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.175 1.39 . . . . 0.0 109.024 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.3 t -68.11 -11.27 58.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 112.412 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.09 20.96 46.71 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 164' ' ' LEU . 43.4 mt -141.27 -173.06 3.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.475 2.31 . . . . 0.0 105.043 -172.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -138.64 -18.12 1.09 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -174.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.3 mt 50.83 -177.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.208 1.003 . . . . 0.0 112.454 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.588 ' H ' HG22 ' A' ' 136' ' ' ILE . 18.9 m -121.45 155.88 58.71 Favored Pre-proline 0 CA--C 1.528 0.119 0 O-C-N 121.361 -0.837 . . . . 0.0 109.869 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.68 138.1 25.84 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.907 3.072 . . . . 0.0 111.881 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 43.26 35.51 0.87 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.849 0.859 . . . . 0.0 111.538 -177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -99.07 28.71 14.01 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 119.256 -0.747 . . . . 0.0 111.737 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.4 mt -138.49 146.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 118.505 1.152 . . . . 0.0 109.513 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 96.8 m -143.9 151.55 39.97 Favored 'General case' 0 C--N 1.335 -0.051 0 C-N-CA 123.623 0.769 . . . . 0.0 109.268 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 1.4 mt -145.48 101.15 4.36 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -52.18 149.51 21.76 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.384 2.723 . . . . 0.0 111.32 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -145.01 165.74 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.361 0.6 . . . . 0.0 110.75 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.437 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 65.9 m-20 -86.59 176.27 3.7 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.8 Cg_exo -57.9 -17.82 32.13 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.982 2.455 . . . . 0.0 112.088 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -86.28 -8.82 57.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.324 1.05 . . . . 0.0 111.458 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.71 1.7 88.96 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -76.66 131.33 38.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.451 1.5 . . . . 0.0 109.092 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.9 pt -70.89 147.34 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.394 0.616 . . . . 0.0 110.319 -174.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.2 p -80.77 -9.7 59.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.165 -174.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 111.72 -6.48 27.81 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.734 -0.481 . . . . 0.0 112.798 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -139.29 166.49 24.41 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 117.78 0.79 . . . . 0.0 110.452 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -150.33 -176.81 5.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.039 0.536 . . . . 0.0 111.058 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -144.67 147.64 33.3 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -174.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.509 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 85.7 t -147.7 164.18 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.467 ' N ' HG12 ' A' ' 157' ' ' VAL . 52.4 tt0 -129.67 104.87 7.68 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 59.0 m-85 -74.31 169.52 17.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.12 91.74 0.37 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.9 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 16.4 t 63.76 171.31 0.17 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.201 1.0 . . . . 0.0 111.135 -175.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.509 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 0.6 OUTLIER -61.7 -30.04 70.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.109 -0.369 . . . . 0.0 110.604 -176.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -63.01 -36.69 84.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -76.6 -33.51 58.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -64.76 -34.7 78.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.682 -0.636 . . . . 0.0 110.839 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -69.97 -29.76 66.95 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -71.81 -37.45 70.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.454 0.169 . . . . 0.0 110.859 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.41 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -60.83 -22.67 64.43 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 122.649 0.38 . . . . 0.0 112.018 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.639 ' HA ' HG21 ' A' ' 183' ' ' VAL . 97.6 mt -68.46 -11.65 60.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 122.213 -0.304 . . . . 0.0 111.397 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.27 -19.44 79.64 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.15 -63.14 1.14 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.044 0.938 . . . . 0.0 109.458 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.638 ' HA ' HG22 ' A' ' 183' ' ' VAL . 1.2 t60 25.11 -107.5 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.45 1.1 . . . . 0.0 112.521 -166.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -68.07 12.77 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.08 171.19 11.36 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.497 1.519 . . . . 0.0 109.635 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -116.92 155.98 28.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -169.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.49 -14.31 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.476 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.32 -27.23 0.61 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.643 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -154.47 -1.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.607 0.703 . . . . 0.0 111.583 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -145.84 150.63 36.52 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.949 0.899 . . . . 0.0 108.727 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -91.43 159.58 15.89 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.865 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 182' ' ' GLU . 36.2 mm -125.27 174.38 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 -174.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.418 ' N ' HG22 ' A' ' 181' ' ' ILE . 14.4 mt-10 -138.96 142.17 38.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.639 HG21 ' HA ' ' A' ' 169' ' ' LEU . 22.2 m -114.61 139.29 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -137.42 159.4 42.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -77.72 163.62 25.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.83 0.741 . . . . 0.0 109.59 175.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t -156.13 -173.18 4.39 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.563 0.22 . . . . 0.0 111.561 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.4 m -147.29 168.99 20.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.351 1.06 . . . . 0.0 109.64 -176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -58.94 -30.35 67.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.638 0.375 . . . . 0.0 110.885 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -67.28 -2.33 5.83 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.368 0.667 . . . . 0.0 112.673 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -116.78 0.49 12.55 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.447 0.699 . . . . 0.0 110.496 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.59 8.52 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -70.39 16.2 0.08 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 35.1 m -68.87 0.02 4.93 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.471 0.708 . . . . 0.0 111.073 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.372 177.896 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 58.5 t30 . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.6 m -144.81 8.04 1.26 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.845 0.458 . . . . 0.0 112.079 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.08 168.4 25.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.156 0.435 . . . . 0.0 111.006 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -150.9 4.83 0.48 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.614 0.366 . . . . 0.0 111.755 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.6 p -149.88 7.91 0.65 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.785 0.434 . . . . 0.0 111.845 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.9 157.1 40.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.036 0.446 . . . . 0.0 110.759 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -161.43 29.84 0.13 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.826 0.85 . . . . 0.0 109.856 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -136.27 165.48 25.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.678 1.191 . . . . 0.0 108.451 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.62 1.34 37.7 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 119.961 -0.355 . . . . 0.0 112.447 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -61.56 144.54 54.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 117.66 0.73 . . . . 0.0 110.808 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.639 HG11 ' CE2' ' A' ' 159' ' ' PHE . 10.7 p -151.77 176.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 124.116 0.966 . . . . 0.0 108.521 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.512 ' H ' HG22 ' A' ' 113' ' ' VAL . 22.4 ttt180 -136.63 147.47 46.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -121.06 148.28 44.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -152.46 160.27 43.27 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.66 3.65 71.02 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 120' ' ' PHE . 83.5 mt -55.55 140.57 65.83 Favored Pre-proline 0 N--CA 1.453 -0.316 0 C-N-CA 123.321 0.648 . . . . 0.0 110.596 -176.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 24.5 Cg_exo -58.85 16.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 125.172 3.915 . . . . 0.0 116.081 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.439 ' CZ ' ' C4 ' ' B' ' 2' ' ' ' G' . 22.0 m-85 57.03 9.41 0.63 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.554 1.141 . . . . 0.0 112.847 -171.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.05 -3.16 1.51 Allowed Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.793 -0.567 . . . . 0.0 112.304 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 28.2 t -63.62 153.18 36.74 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.56 HG23 ' H ' ' A' ' 125' ' ' GLU . 5.7 t -150.47 -169.19 3.32 Favored 'General case' 0 CA--C 1.526 0.05 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.7 OUTLIER -51.71 -33.69 35.48 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.139 0.427 . . . . 0.0 111.81 -178.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.56 ' H ' HG23 ' A' ' 123' ' ' THR . 40.4 tt0 -76.78 -22.67 53.4 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.447 0.699 . . . . 0.0 112.018 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.506 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 47.2 mm-40 -94.73 -33.87 12.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.431 -0.793 . . . . 0.0 109.33 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.419 HG13 ' SG ' ' A' ' 122' ' ' CYS . 54.0 mt -64.32 -34.57 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.33 -34.02 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.661 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -72.34 -26.6 61.99 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.898 172.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 19.3 t80 -72.09 -23.06 61.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.655 0.264 . . . . 0.0 110.549 175.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -118.14 32.87 5.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.397 1.079 . . . . 0.0 109.042 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.0 t -68.26 -11.67 59.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.122 0.569 . . . . 0.0 112.342 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.56 15.24 63.58 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.621 ' HB3' HD11 ' A' ' 164' ' ' LEU . 28.7 mt -144.14 -162.33 1.45 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.36 1.864 . . . . 0.0 107.196 -173.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -147.94 162.32 39.54 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.981 -0.449 . . . . 0.0 110.069 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.2 mt -141.39 148.03 21.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 158' ' ' GLN . 21.0 m -73.83 153.71 89.12 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 118.588 0.631 . . . . 0.0 110.254 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -48.89 139.36 25.39 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 124.109 3.206 . . . . 0.0 112.477 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.5 t30 40.59 37.56 0.49 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.369 1.068 . . . . 0.0 111.988 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.86 27.73 13.62 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-O 118.72 -1.045 . . . . 0.0 112.057 -173.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.7 mt -133.37 145.3 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 119.375 1.588 . . . . 0.0 109.36 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.4 m -137.8 144.76 41.7 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.772 0.829 . . . . 0.0 109.158 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 123' ' ' THR . 87.2 mt -136.96 93.72 13.27 Favored Pre-proline 0 CA--C 1.53 0.211 0 C-N-CA 123.454 0.702 . . . . 0.0 110.029 -173.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.5 150.84 32.91 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.221 2.614 . . . . 0.0 110.764 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -141.57 166.69 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.096 0 CA-C-O 121.437 0.637 . . . . 0.0 111.43 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 64.7 m-20 -92.3 176.99 2.3 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.721 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 35.3 Cg_exo -58.75 -19.18 44.98 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.962 2.441 . . . . 0.0 111.83 177.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -82.82 -7.56 59.65 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.526 0.73 . . . . 0.0 110.657 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.93 13.44 81.24 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.307 0.48 . . . . 0.0 112.323 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -105.61 149.07 26.64 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.5 pt -68.86 149.76 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 121.456 0.646 . . . . 0.0 111.493 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 45.4 p -74.91 -7.34 53.26 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.222 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 106.65 -0.75 36.61 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -140.37 170.72 15.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.066 0.546 . . . . 0.0 110.409 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -157.22 -178.69 7.55 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.269 0.628 . . . . 0.0 111.079 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -143.98 148.85 35.87 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 158' ' ' GLN . 76.2 t -146.84 165.34 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.493 ' N ' HG12 ' A' ' 157' ' ' VAL . 40.8 tt0 -128.52 105.99 8.67 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 167.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.639 ' CE2' HG11 ' A' ' 113' ' ' VAL . 35.1 m-85 -74.69 173.01 11.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.389 170.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.19 90.7 0.9 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.192 0.52 . . . . 0.0 109.796 177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 17.9 t 63.15 170.24 0.15 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.591 1.157 . . . . 0.0 112.415 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -22.06 65.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.5 0.72 . . . . 0.0 111.598 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.71 -43.48 75.92 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.907 -0.495 . . . . 0.0 111.032 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -67.6 -39.15 84.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.509 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.19 -37.23 71.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.129 -0.357 . . . . 0.0 110.867 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -71.78 -28.86 63.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.896 -0.138 . . . . 0.0 110.902 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -72.98 -39.18 66.33 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.656 0.265 . . . . 0.0 110.549 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.53 -17.88 63.25 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.106 0.562 . . . . 0.0 112.195 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.33 -13.01 61.61 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.462 0.574 . . . . 0.0 111.366 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.05 -11.74 81.47 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.536 ' HB2' HG11 ' A' ' 183' ' ' VAL . 69.9 mmtt -88.54 0.55 56.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.296 1.438 . . . . 0.0 111.705 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -54.54 133.18 46.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.443 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.452 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 90.6 mttt 59.51 5.59 0.67 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.617 1.567 . . . . 0.0 114.075 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -76.95 170.41 16.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 173.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -112.59 158.31 20.12 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -169.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.1 tt -102.9 -9.52 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.574 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 154.43 -29.08 0.7 Allowed Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.935 -0.37 . . . . 0.0 112.611 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -157.51 0.96 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.411 0.605 . . . . 0.0 111.382 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -145.64 153.46 41.05 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.21 1.004 . . . . 0.0 108.508 -173.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -97.01 152.95 18.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.989 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 38.7 mm -127.47 162.2 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -128.71 160.37 32.71 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 171' ' ' LYS . 26.5 m -137.0 39.98 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 123.103 0.561 . . . . 0.0 111.674 -162.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.677 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 3.4 m-30 -52.71 152.87 3.5 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.922 0.489 . . . . 0.0 109.816 -177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -80.06 170.16 16.85 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.633 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 10.0 t -158.01 179.97 8.69 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.479 0.312 . . . . 0.0 110.821 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.4 m -148.18 170.53 17.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.284 1.433 . . . . 0.0 108.291 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -53.92 -31.81 51.49 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.74 -2.77 2.69 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -122.14 2.16 9.8 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.861 0.864 . . . . 0.0 111.013 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.56 11.55 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-O 120.968 0.413 . . . . 0.0 111.14 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -68.95 13.03 0.11 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 29.3 m -67.24 -1.98 5.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.393 0.677 . . . . 0.0 111.456 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.247 -1.358 . . . . 0.0 110.968 178.272 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.412 1 O4'-C1'-N19 114.164 5.964 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.439 ' C4 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.954 0 O4'-C1'-N19 111.759 3.559 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.476 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.407 -3.792 0 C3'-C2'-C1' 104.759 3.621 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.476 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.829 1 O4'-C1'-N19 115.594 7.394 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.452 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.952 1 C5'-C4'-C3' 109.362 -4.092 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.677 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.634 0 O4'-C1'-C2' 102.677 -2.659 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -146.42 14.08 1.24 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.017 0.527 . . . . 0.0 111.463 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.45 179.29 7.91 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.726 0.81 . . . . 0.0 109.62 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -149.01 157.11 43.17 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.697 0.284 . . . . 0.0 110.723 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.6 m -145.87 19.87 1.45 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.788 0.835 . . . . 0.0 110.629 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.36 33.98 0.09 Allowed 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 124.033 0.933 . . . . 0.0 112.136 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -146.85 28.8 1.02 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -170.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -128.07 7.13 6.01 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.07 -8.74 25.15 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -64.12 142.18 58.5 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.479 0.657 . . . . 0.0 111.608 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.626 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.4 p -152.92 177.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.435 1.094 . . . . 0.0 108.686 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.524 ' H ' HG22 ' A' ' 113' ' ' VAL . 65.0 ttt180 -135.65 153.66 51.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.951 0.9 . . . . 0.0 109.1 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -126.5 135.62 51.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -150.69 50.68 0.87 Allowed 'General case' 0 C--O 1.226 -0.166 0 CA-C-O 121.282 0.563 . . . . 0.0 112.443 -172.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -160.03 15.94 0.21 Allowed Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.7 153.46 90.82 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -168.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 24.5 Cg_exo -59.44 143.63 99.65 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.754 2.303 . . . . 0.0 107.951 163.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -69.71 6.73 1.05 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.74 10.66 5.46 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 48.8 t -66.29 157.82 30.64 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.285 1.034 . . . . 0.0 111.404 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 125' ' ' GLU . 3.7 t -152.16 -174.8 5.0 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.248 0.619 . . . . 0.0 109.825 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.603 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -51.77 -34.01 37.7 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 123.378 0.671 . . . . 0.0 112.471 -176.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.53 ' H ' HG23 ' A' ' 123' ' ' THR . 40.2 tt0 -72.39 -25.96 61.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.016 0.527 . . . . 0.0 112.166 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -93.1 -30.7 15.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.8 mt -66.76 -40.74 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.5 p -72.35 -34.51 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 O-C-N 122.159 -0.338 . . . . 0.0 111.193 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -74.34 -28.71 61.27 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.162 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 28.9 t80 -67.15 -21.21 65.82 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -115.41 37.15 3.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.341 1.056 . . . . 0.0 108.385 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.2 t -69.48 154.84 41.41 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 167.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.27 5.1 85.11 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.504 ' HB3' HD11 ' A' ' 164' ' ' LEU . 24.0 mt -141.78 -172.2 3.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.668 1.987 . . . . 0.0 106.01 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -147.79 162.6 38.89 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.634 -0.666 . . . . 0.0 110.845 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.7 mt -141.32 147.9 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 158' ' ' GLN . 19.4 m -72.64 154.47 91.42 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 118.459 0.572 . . . . 0.0 110.305 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -48.63 138.61 24.99 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.055 3.17 . . . . 0.0 112.179 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 t30 41.53 36.4 0.55 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.471 1.109 . . . . 0.0 112.014 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.25 28.64 10.31 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.793 -1.004 . . . . 0.0 111.739 -173.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.5 mt -136.56 145.75 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 119.061 1.431 . . . . 0.0 109.351 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 90.0 m -139.5 149.46 43.98 Favored 'General case' 0 N--CA 1.458 -0.048 0 C-N-CA 123.509 0.724 . . . . 0.0 109.827 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.443 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 11.9 mt -144.48 93.26 5.85 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 124.075 0.95 . . . . 0.0 109.649 -176.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -55.72 159.61 11.12 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.813 3.009 . . . . 0.0 111.307 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 17.2 m -141.21 166.02 18.54 Favored 'Isoleucine or valine' 0 C--N 1.338 0.088 0 CA-C-O 121.216 0.531 . . . . 0.0 111.543 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 66.9 m-20 -90.05 176.48 3.01 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.831 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -58.85 -19.25 46.12 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.089 2.526 . . . . 0.0 111.736 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -82.81 -9.01 59.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.563 0.745 . . . . 0.0 110.745 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.35 11.16 80.98 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 123.384 0.516 . . . . 0.0 112.272 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -102.81 148.75 25.24 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.2 pt -68.17 151.23 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.912 0.863 . . . . 0.0 112.263 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 82.7 p -79.11 5.87 10.95 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.481 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 74.7 15.35 80.73 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -140.83 164.74 29.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.49 178.19 10.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.249 0.547 . . . . 0.0 110.465 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -144.71 145.18 31.59 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 67.9 t -143.79 162.98 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.466 ' N ' HG12 ' A' ' 157' ' ' VAL . 49.3 tt0 -129.17 101.83 6.19 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 169.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.626 ' CE2' HG11 ' A' ' 113' ' ' VAL . 43.6 m-85 -71.55 171.17 11.88 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.328 171.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.47 93.53 1.19 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 61.8 169.8 0.11 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.688 1.195 . . . . 0.0 111.343 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -61.99 -26.75 68.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.762 -0.586 . . . . 0.0 110.9 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.16 -42.48 90.84 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 122.243 -0.286 . . . . 0.0 111.119 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.5 OUTLIER -72.17 -38.79 69.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.526 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.91 -40.54 80.59 Favored 'General case' 0 N--CA 1.457 -0.101 0 O-C-N 122.013 -0.43 . . . . 0.0 110.898 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -67.83 -31.05 70.63 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.719 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -71.56 -39.46 70.63 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.632 0.253 . . . . 0.0 111.011 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.98 -15.39 62.21 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 93.8 mt -68.96 -9.33 51.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.685 0.675 . . . . 0.0 111.524 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.14 -11.96 85.07 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.578 ' HB2' HG11 ' A' ' 183' ' ' VAL . 69.5 mmtt -85.74 2.81 43.97 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.243 1.417 . . . . 0.0 111.588 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -56.28 136.9 53.05 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.972 -0.455 . . . . 0.0 110.314 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.444 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 33.0 mttp 50.99 11.39 0.09 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.179 1.792 . . . . 0.0 114.242 -175.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -75.02 179.36 5.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.259 1.024 . . . . 0.0 109.085 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -126.46 163.27 23.7 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -170.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.3 mt -113.0 -13.13 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.277 1.031 . . . . 0.0 111.849 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.41 -27.1 1.37 Allowed Glycine 0 CA--C 1.528 0.901 0 O-C-N 121.922 -0.486 . . . . 0.0 113.975 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -153.05 11.49 0.47 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 117.843 0.822 . . . . 0.0 110.65 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.11 -173.57 3.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.445 1.098 . . . . 0.0 108.384 -172.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -137.06 144.14 43.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 19.0 mm -116.79 162.62 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -167.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -129.64 154.08 47.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 171' ' ' LYS . 34.5 m -131.24 33.66 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.228 -0.068 0 C-N-CA 123.839 0.855 . . . . 0.0 111.011 -166.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.696 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 10.6 m-30 -53.55 154.61 3.48 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -81.93 170.57 15.46 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.362 -0.837 . . . . 0.0 111.826 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.8 t -158.88 -173.7 4.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.521 0.328 . . . . 0.0 111.533 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 51.3 m -147.81 168.04 23.2 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.964 1.306 . . . . 0.0 109.174 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -56.91 -30.75 64.22 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.724 0.409 . . . . 0.0 110.897 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.84 -6.53 6.01 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -117.25 1.91 12.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.589 0.755 . . . . 0.0 111.312 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.61 15.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.269 0.557 . . . . 0.0 110.928 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -69.26 11.53 0.22 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.421 0.688 . . . . 0.0 112.811 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 65.8 p -69.29 -1.52 8.35 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.412 0.685 . . . . 0.0 111.243 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.746 -1.121 . . . . 0.0 110.959 177.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.434 ' C4 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.949 0 C5'-C4'-C3' 110.18 -3.547 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.471 1 C1'-O4'-C4' 105.045 -5.062 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.464 " H4'" " C5'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.149 0 O4'-C1'-N19 111.487 3.287 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.464 " C5'" " H4'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.556 1 O4'-C1'-N19 113.975 5.775 . 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.623 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.412 -3.457 2 C1'-O4'-C4' 105.672 -4.365 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.696 " H1'" ' CZ ' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.531 0 O4'-C1'-N19 111.358 3.158 . 0.0 OUTLIER '7D dist 6g' 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.8 p30 . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 110.646 -0.131 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.4 p -144.4 19.5 1.71 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.971 0.508 . . . . 0.0 111.441 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -142.11 4.73 1.65 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -147.5 3.61 0.76 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.074 0.55 . . . . 0.0 110.694 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 t -156.25 -173.45 4.51 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.107 0.963 . . . . 0.0 108.92 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.61 161.55 37.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.01 0.524 . . . . 0.0 110.678 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -155.29 31.22 0.39 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.677 0.391 . . . . 0.0 111.046 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -125.15 4.26 7.87 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.5 -9.76 53.17 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -62.5 141.36 58.45 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.568 0.699 . . . . 0.0 110.596 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.63 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.5 p -150.6 172.95 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 70.4 ttt180 -137.34 152.83 50.15 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp -136.92 148.2 46.86 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -173.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -158.3 154.93 27.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.689 0.281 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.08 -7.08 60.22 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.706 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -63.82 157.99 64.07 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.881 0.341 . . . . 0.0 111.777 -176.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 21.8 Cg_exo -57.82 152.13 51.88 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.348 2.699 . . . . 0.0 112.522 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.406 ' CD2' ' C8 ' ' B' ' 1' ' ' ' A' . 82.7 m-85 -67.89 -5.53 17.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.93 -0.89 31.91 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.437 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 41.8 t -68.2 153.01 44.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.344 0.657 . . . . 0.0 109.407 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.657 HG23 ' H ' ' A' ' 125' ' ' GLU . 8.7 t -154.31 -174.63 5.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 174.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 2.4 ptpp? -56.48 -20.69 21.34 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.657 ' H ' HG23 ' A' ' 123' ' ' THR . 42.2 mt-10 -82.18 -21.86 36.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.911 0.484 . . . . 0.0 111.218 177.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.411 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 60.2 mm-40 -90.74 -33.65 15.67 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.2 mt -61.4 -36.39 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.79 -33.63 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.002 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -75.66 -26.91 58.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.993 172.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -67.94 -27.57 66.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -108.79 34.71 3.54 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.3 t -67.15 152.0 46.54 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 168.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.94 4.24 90.35 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -172.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.553 ' HB3' HD11 ' A' ' 164' ' ' LEU . 19.2 mt -139.49 -171.56 3.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.165 1.786 . . . . 0.0 106.543 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -146.95 162.54 38.52 Favored 'General case' 0 C--N 1.333 -0.131 0 O-C-N 121.858 -0.526 . . . . 0.0 110.691 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 mt -141.82 148.74 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.9 m -74.46 154.6 87.81 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 118.476 0.58 . . . . 0.0 110.422 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.15 140.01 26.05 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 124.073 3.182 . . . . 0.0 112.229 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.6 t30 41.77 34.9 0.45 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.36 1.064 . . . . 0.0 111.929 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.32 30.17 8.04 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-O 118.941 -0.922 . . . . 0.0 111.801 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.8 mt -138.35 146.94 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 118.902 1.351 . . . . 0.0 109.922 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.6 m -140.76 146.88 38.29 Favored 'General case' 0 C--N 1.337 0.041 0 C-N-CA 123.86 0.864 . . . . 0.0 109.643 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.4 mt -142.35 92.84 7.29 Favored Pre-proline 0 CA--C 1.528 0.104 0 C-N-CA 124.268 1.027 . . . . 0.0 109.395 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -54.99 156.4 15.84 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.584 2.856 . . . . 0.0 111.539 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.4 m -142.43 167.06 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-O 121.367 0.603 . . . . 0.0 110.914 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.455 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 61.7 m-20 -91.03 176.52 2.81 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.707 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.5 Cg_exo -58.07 -20.01 43.7 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.823 2.349 . . . . 0.0 111.712 176.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -80.66 -8.81 59.75 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.165 0.986 . . . . 0.0 111.219 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.53 2.52 90.54 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -174.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.433 ' HE3' ' N3 ' ' B' ' 1' ' ' ' A' . 82.5 tttt -79.14 134.66 36.71 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.007 1.323 . . . . 0.0 108.886 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.5 pt -68.52 146.52 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.579 0.704 . . . . 0.0 110.163 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.4 p -76.4 0.85 18.12 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.24 -174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 85.95 7.44 80.82 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -141.43 168.55 19.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 117.356 0.578 . . . . 0.0 110.347 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.1 179.43 9.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.308 0.575 . . . . 0.0 111.078 -173.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -143.56 146.21 33.14 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.2 t -146.38 164.72 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.472 ' N ' HG12 ' A' ' 157' ' ' VAL . 53.1 tt0 -129.51 102.58 6.45 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 169.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.63 ' CE2' HG11 ' A' ' 113' ' ' VAL . 37.9 m-85 -73.07 171.57 12.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.379 171.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 92.45 0.91 Allowed 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.8 t 61.88 167.2 0.11 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.787 1.235 . . . . 0.0 111.488 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -14.2 61.99 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.904 -0.498 . . . . 0.0 111.091 -176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.61 -41.81 79.03 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 122.05 -0.406 . . . . 0.0 110.546 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.56 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.7 OUTLIER -70.86 -39.67 72.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.44 -38.76 74.95 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.198 -0.314 . . . . 0.0 110.804 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -68.87 -29.82 68.2 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.78 -0.191 . . . . 0.0 110.764 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -73.24 -38.15 66.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.622 0.248 . . . . 0.0 110.759 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.01 -16.81 63.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.75 -9.68 57.85 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.408 0.549 . . . . 0.0 111.548 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.19 -12.77 81.62 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.49 ' HB2' HG11 ' A' ' 183' ' ' VAL . 68.9 mmtt -82.74 -2.37 54.12 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 125.599 1.56 . . . . 0.0 111.973 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -52.69 133.11 36.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.651 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.495 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 44.5 mttp 56.37 9.69 0.56 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.202 1.801 . . . . 0.0 114.4 -176.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.06 173.04 9.93 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.068 0.947 . . . . 0.0 108.82 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -125.4 160.27 29.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.796 -0.565 . . . . 0.0 112.169 -172.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.1 tt -113.04 -1.93 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.2 -36.92 0.65 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 121.731 -0.606 . . . . 0.0 113.685 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -155.62 6.87 0.23 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.533 0.666 . . . . 0.0 110.74 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.76 135.36 24.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -86.1 157.9 19.93 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.727 176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 27.6 mm -125.05 160.85 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -127.5 156.24 42.48 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 171' ' ' LYS . 33.1 m -131.71 130.71 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.578 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 5.7 m-85 -137.19 153.91 50.32 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -175.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -76.42 164.09 26.33 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.692 0.678 . . . . 0.0 110.006 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -159.4 -175.35 5.16 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.45 0.167 . . . . 0.0 111.373 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.4 t -148.85 171.84 15.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.947 0.899 . . . . 0.0 110.011 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -60.24 -28.61 68.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.269 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.63 -0.94 2.31 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.8 0.84 . . . . 0.0 112.571 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.59 2.37 7.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.542 0.737 . . . . 0.0 111.601 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.72 10.53 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 122.131 -0.356 . . . . 0.0 111.866 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -69.75 15.6 0.08 Allowed 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.2 m -68.61 -0.48 5.23 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.593 0.757 . . . . 0.0 111.087 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.237 -1.363 . . . . 0.0 111.244 178.105 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.438 " H4'" " O5'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.407 -3.838 2 C1'-O4'-C4' 100.322 -10.309 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.438 " O5'" " H4'" ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.718 1 C5'-C4'-C3' 109.005 -4.33 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.504 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.408 -3.74 1 P-O3'-C3' 125.381 4.734 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.504 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.869 2 O4'-C1'-N19 117.68 9.48 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.614 " H1'" ' C6 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.828 0 C4'-C3'-C2' 99.217 -3.483 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.614 ' C6 ' " H1'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.424 -2.45 0 P-O3'-C3' 122.998 2.748 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 120.548 0.213 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -152.73 -0.5 0.27 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.734 0.413 . . . . 0.0 111.807 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -151.01 14.65 0.72 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.266 0.626 . . . . 0.0 110.282 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -139.67 6.61 2.27 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.948 0.899 . . . . 0.0 111.117 -174.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.9 m -71.12 -2.48 15.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.577 0.751 . . . . 0.0 112.372 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -154.61 163.63 39.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.886 0.374 . . . . 0.0 111.316 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -159.56 35.13 0.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.51 0.724 . . . . 0.0 110.399 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -129.39 5.16 5.19 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.72 -10.16 52.58 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -63.11 141.18 58.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.563 0.696 . . . . 0.0 110.471 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.619 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -150.92 175.94 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.932 -177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.458 ' H ' HG22 ' A' ' 113' ' ' VAL . 33.8 ttt180 -135.4 154.16 51.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.993 0.917 . . . . 0.0 109.28 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.9 tp -139.3 150.28 45.23 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -156.72 157.78 35.73 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.13 -5.13 71.62 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 174.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.75 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.93 155.95 90.59 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-N 116.94 0.37 . . . . 0.0 111.529 -176.437 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 31.3 Cg_exo -54.65 151.25 32.32 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 124.125 3.217 . . . . 0.0 112.183 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.454 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 22.9 m-85 -64.88 -8.74 16.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.05 0.387 . . . . 0.0 111.688 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.57 -0.1 30.79 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.451 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 44.6 t -64.25 153.77 37.1 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.292 0.637 . . . . 0.0 109.293 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.646 HG23 ' H ' ' A' ' 125' ' ' GLU . 10.4 t -154.87 -176.17 5.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 0.9 OUTLIER -57.29 -21.75 36.88 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.646 ' H ' HG23 ' A' ' 123' ' ' THR . 39.4 tt0 -78.74 -25.23 44.5 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.19 0.596 . . . . 0.0 110.744 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 56.9 mm-40 -87.9 -37.08 16.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.31 -35.06 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.0 p -79.69 -32.45 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.712 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -75.32 -28.05 59.5 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.961 172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -66.05 -26.42 67.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -111.77 32.58 5.34 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.838 0.855 . . . . 0.0 109.017 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.0 t -64.31 148.89 49.29 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.59 3.71 86.12 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -172.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.554 ' HB3' HD11 ' A' ' 164' ' ' LEU . 17.9 mt -138.53 -170.55 2.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.744 1.617 . . . . 0.0 106.715 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -146.78 162.2 39.05 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.87 -0.519 . . . . 0.0 110.374 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.3 mt -142.04 148.44 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.6 m -73.29 154.49 90.19 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 118.595 0.634 . . . . 0.0 110.369 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -49.1 138.74 27.74 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 124.074 3.183 . . . . 0.0 112.155 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.1 t30 41.65 35.81 0.52 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.313 1.045 . . . . 0.0 112.047 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.04 29.96 8.13 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 119.04 -0.867 . . . . 0.0 111.895 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.9 mt -138.24 145.54 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 118.775 1.288 . . . . 0.0 109.658 -176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 86.3 m -139.59 150.2 44.74 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 123.822 0.849 . . . . 0.0 109.621 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 92.6 mt -139.81 90.77 10.8 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.829 0.852 . . . . 0.0 110.093 -174.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.47 153.87 21.56 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.468 2.779 . . . . 0.0 111.813 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.5 m -142.57 169.09 13.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 121.382 0.61 . . . . 0.0 111.207 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 59.5 m-20 -96.12 177.46 1.73 Allowed Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.105 0.962 . . . . 0.0 108.781 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 40.5 Cg_exo -58.04 -20.55 45.99 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.952 2.435 . . . . 0.0 111.625 176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.26 -10.7 59.61 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.184 0.994 . . . . 0.0 110.956 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.22 4.39 86.5 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.469 ' HE3' ' N3 ' ' B' ' 1' ' ' ' A' . 55.0 tttm -83.43 136.31 34.36 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.068 1.347 . . . . 0.0 108.806 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.1 pt -66.98 148.01 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 121.79 0.805 . . . . 0.0 110.754 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 69.6 p -75.26 -0.69 20.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.71 -1.132 . . . . 0.0 112.16 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 88.28 5.94 75.29 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -138.53 169.78 17.17 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.279 0.54 . . . . 0.0 110.207 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.81 179.13 9.39 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.212 0.605 . . . . 0.0 110.798 -174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -143.65 145.55 32.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 60.2 t -145.81 164.59 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.472 ' N ' HG12 ' A' ' 157' ' ' VAL . 52.6 tt0 -129.19 102.22 6.36 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 169.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.619 ' CE2' HG11 ' A' ' 113' ' ' VAL . 44.6 m-85 -72.74 171.2 13.03 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.263 172.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.86 92.73 0.71 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t 61.67 168.67 0.11 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.758 1.223 . . . . 0.0 111.505 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -14.66 62.68 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.95 -0.469 . . . . 0.0 111.24 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -69.07 -42.4 76.27 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 122.052 -0.405 . . . . 0.0 110.679 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -70.84 -38.89 73.24 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.521 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.48 -39.04 75.55 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.279 -0.263 . . . . 0.0 110.717 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -69.02 -29.05 67.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 116.892 -0.14 . . . . 0.0 110.956 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -73.52 -38.19 65.38 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 121.227 -0.189 . . . . 0.0 111.095 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.8 -21.65 66.04 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.553 ' HA ' HG21 ' A' ' 183' ' ' VAL . 97.0 mt -70.35 -7.71 44.88 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 122.847 0.459 . . . . 0.0 111.733 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.04 -15.47 81.37 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -76.07 -55.02 5.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.257 1.023 . . . . 0.0 110.856 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.692 ' HA ' HG22 ' A' ' 183' ' ' VAL . 0.7 OUTLIER 23.86 -101.79 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.863 1.265 . . . . 0.0 113.052 -165.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.457 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 56.0 mttp -71.18 19.55 0.05 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -174.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -60.28 178.74 0.18 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.003 0.921 . . . . 0.0 111.099 172.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -128.58 161.18 30.21 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.343 0.657 . . . . 0.0 110.746 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.0 tt -117.94 -0.08 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.42 -36.17 0.64 Allowed Glycine 0 CA--C 1.529 0.953 0 O-C-N 122.046 -0.409 . . . . 0.0 113.422 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -156.72 5.74 0.16 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.314 0.557 . . . . 0.0 110.489 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -146.51 156.17 43.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.514 1.126 . . . . 0.0 108.485 -170.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -104.07 153.81 20.44 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.373 0.606 . . . . 0.0 110.113 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 182' ' ' GLU . 30.1 mm -120.12 172.14 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -172.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.412 ' N ' HG22 ' A' ' 181' ' ' ILE . 21.8 mt-10 -139.54 155.94 47.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' A' ' 172' ' ' HIS . 22.2 m -130.71 137.5 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.468 ' CE1' ' C2 ' ' B' ' 6' ' ' ' U' . 33.0 m-85 -148.18 160.49 42.87 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -80.18 165.32 22.54 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.677 0.671 . . . . 0.0 110.778 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.7 t -158.74 -174.41 4.76 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.144 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.6 t -147.98 171.85 15.15 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.162 0.985 . . . . 0.0 109.796 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -59.36 -31.39 69.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.652 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.78 -6.02 7.15 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.678 0.791 . . . . 0.0 112.537 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -118.45 3.01 11.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.598 0.759 . . . . 0.0 111.168 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.26 9.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 122.272 -0.267 . . . . 0.0 111.613 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -69.26 13.5 0.12 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.7 m -67.14 -1.16 3.97 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.509 0.723 . . . . 0.0 111.205 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.777 -1.106 . . . . 0.0 111.287 177.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.538 ' C8 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.052 0 C3'-C2'-C1' 104.638 3.486 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.454 ' C5 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 P--O5' 1.617 2.387 1 C5'-C4'-C3' 108.691 -4.539 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.123 1 P-O3'-C3' 124.925 4.354 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.012 1 O4'-C1'-N19 114.712 6.512 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.647 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.02 1 C5'-C4'-C3' 107.946 -5.036 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.647 ' C5 ' " H1'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.658 0 C3'-C2'-C1' 98.779 -3.024 . 0.0 OUTLIER '7D dist 4a' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.8 t30 . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 t -152.52 169.31 22.95 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.04 0.536 . . . . 0.0 110.136 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.39 175.77 13.16 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.012 0.525 . . . . 0.0 110.737 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 55.21 16.39 1.63 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.48 1.112 . . . . 0.0 113.401 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.3 p -153.67 166.89 31.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 122.04 -0.412 . . . . 0.0 110.68 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 47.0 25.65 0.51 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 125.188 1.395 . . . . 0.0 114.754 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -150.27 29.89 0.7 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.027 0.442 . . . . 0.0 111.758 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -121.7 7.65 9.98 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.64 -9.77 41.26 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -61.27 138.63 58.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.731 0.776 . . . . 0.0 110.823 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.576 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -150.27 174.97 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.235 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 58.4 ttt180 -136.58 155.38 50.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.3 tp -138.28 147.4 43.59 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -173.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -154.72 162.48 41.1 Favored 'General case' 0 C--O 1.227 -0.086 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.83 1.45 58.65 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.6 mt -56.97 150.04 41.3 Favored Pre-proline 0 N--CA 1.453 -0.292 0 C-N-CA 123.23 0.612 . . . . 0.0 111.982 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.27 26.16 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 1 C-N-CA 125.346 4.031 . . . . 0.0 113.522 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.589 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 15.4 m-30 53.47 13.85 0.5 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.903 1.281 . . . . 0.0 114.162 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -140.02 -13.99 0.58 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.994 0.815 . . . . 0.0 112.724 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 13.4 m -67.35 153.5 43.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.448 0.624 . . . . 0.0 110.389 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.5 t -147.23 -160.8 1.21 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.93 0.892 . . . . 0.0 108.733 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.553 ' HE3' HD12 ' A' ' 143' ' ' LEU . 0.6 OUTLIER -50.34 -31.26 14.07 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -84.07 -19.64 33.99 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -175.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -96.27 -31.54 12.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.756 -0.59 . . . . 0.0 109.816 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 29.4 mt -62.98 -36.31 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 172.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.7 p -79.32 -32.2 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.921 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -74.15 -30.66 62.38 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.248 172.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.89 -22.06 65.98 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 118.267 0.485 . . . . 0.0 110.111 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -115.84 31.44 6.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.516 1.126 . . . . 0.0 109.214 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 42.6 t -63.06 139.58 58.79 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.87 1.75 90.63 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -172.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 28.8 mt -138.82 78.37 1.67 Allowed 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.153 1.381 . . . . 0.0 107.673 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -50.07 160.01 0.38 Allowed 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.858 0.863 . . . . 0.0 113.293 -174.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.1 mt -136.41 153.18 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 158' ' ' GLN . 27.3 m -58.93 155.36 32.61 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 122.597 0.359 . . . . 0.0 110.592 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.99 -31.0 7.8 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.84 3.693 . . . . 0.0 114.084 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -160.12 105.57 1.54 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -150.04 20.93 1.11 Allowed Glycine 0 CA--C 1.522 0.511 0 CA-C-O 118.686 -1.063 . . . . 0.0 112.756 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.2 mt -117.48 147.26 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 CA-C-N 119.257 1.529 . . . . 0.0 110.271 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.4 m -142.11 144.87 33.72 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.958 0.903 . . . . 0.0 109.49 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.553 HD12 ' HE3' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -139.65 97.81 8.12 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 123.793 0.837 . . . . 0.0 110.047 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.18 154.9 31.68 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.871 3.047 . . . . 0.0 110.998 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.32 168.83 13.89 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-O 121.408 0.623 . . . . 0.0 111.503 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.46 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 62.9 m-20 -95.13 176.64 2.17 Favored Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.549 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -58.08 -19.6 41.81 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.976 2.451 . . . . 0.0 111.913 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.23 -8.14 59.7 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.166 0.986 . . . . 0.0 111.117 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.08 2.76 89.19 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.589 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 80.0 tttt -81.08 134.2 35.62 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.922 1.289 . . . . 0.0 108.304 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.1 pt -68.1 148.93 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.505 0.669 . . . . 0.0 109.753 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 53.4 p -72.4 1.46 7.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.989 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 95.75 0.95 62.05 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -140.96 169.71 17.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.913 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.65 -177.89 6.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.788 0.835 . . . . 0.0 110.345 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -144.66 146.46 32.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.521 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 84.4 t -146.16 163.2 10.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.673 ' O ' HG22 ' A' ' 137' ' ' VAL . 58.5 tt0 -130.87 94.6 3.64 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.274 170.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.576 ' CE2' HG11 ' A' ' 113' ' ' VAL . 53.3 m-85 -65.69 170.66 4.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.89 93.37 0.76 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.4 t 62.36 168.28 0.12 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.774 1.23 . . . . 0.0 111.392 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -62.12 -27.55 69.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 121.713 -0.617 . . . . 0.0 110.901 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -60.42 -41.28 93.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.198 -0.314 . . . . 0.0 111.016 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.482 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -71.33 -37.88 71.69 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -59.1 -38.48 79.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.83 -0.544 . . . . 0.0 110.648 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -68.87 -31.31 70.16 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 122.45 0.3 . . . . 0.0 110.572 -176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -71.0 -40.06 72.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.574 0.226 . . . . 0.0 110.59 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.47 -15.08 62.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.714 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.8 mt -66.62 -11.84 55.4 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.829 0.741 . . . . 0.0 111.934 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.0 -10.65 84.11 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.573 ' HB2' HG11 ' A' ' 183' ' ' VAL . 65.5 mmtt -88.02 -3.38 58.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.214 1.406 . . . . 0.0 112.893 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.559 ' CA ' HG22 ' A' ' 183' ' ' VAL . 6.4 t60 -43.29 -21.47 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.401 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 60.0 mttp -139.58 18.56 2.53 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.522 1.055 . . . . 0.0 111.798 176.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -76.29 -175.65 3.29 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 122.97 0.508 . . . . 0.0 110.323 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -134.57 163.42 29.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 mt -108.09 -13.44 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.544 0.738 . . . . 0.0 111.971 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.95 -31.68 0.5 Allowed Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.74 -0.6 . . . . 0.0 113.986 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -152.56 2.96 0.34 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.649 0.725 . . . . 0.0 110.909 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -144.69 155.11 43.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.362 1.065 . . . . 0.0 108.164 -174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -106.78 151.22 25.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.272 0.558 . . . . 0.0 110.037 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.8 mm -121.19 159.93 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -171.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -133.44 145.92 50.71 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' A' ' 169' ' ' LEU . 18.0 m -115.98 136.84 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.707 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 9.1 m-85 -137.24 154.27 50.19 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -76.05 163.0 27.57 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.068 0.849 . . . . 0.0 110.544 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.3 t -158.89 -175.43 5.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 68.8 m -148.66 170.94 17.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.05 1.34 . . . . 0.0 109.269 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -57.87 -31.77 67.02 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.877 0.471 . . . . 0.0 111.394 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.37 -5.18 9.87 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -115.71 2.26 13.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.728 0.811 . . . . 0.0 111.005 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.35 9.56 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 111.18 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -70.22 16.34 0.07 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.374 0.67 . . . . 0.0 112.797 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.0 m -68.45 -0.51 5.06 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.6 0.76 . . . . 0.0 111.23 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.373 178.379 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.189 2 O4'-C1'-N19 113.809 5.609 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.443 " H1'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.6 2 C5'-C4'-C3' 106.478 -6.014 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.443 ' OP1' " H1'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.071 2 P-O3'-C3' 125.389 4.741 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.447 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.414 -3.214 1 O4'-C1'-N19 114.94 6.74 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.464 " O3'" " H3'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.763 1 C5'-C4'-C3' 109.324 -4.118 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.707 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.492 0 C5'-C4'-C3' 111.241 -2.839 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 43.4 m -143.38 8.55 1.59 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.879 0.472 . . . . 0.0 111.45 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.12 172.43 17.56 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.315 0.646 . . . . 0.0 109.96 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -146.49 -3.02 0.64 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.733 0.413 . . . . 0.0 111.536 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.7 p -155.98 169.8 23.62 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.017 0.527 . . . . 0.0 110.383 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 41.55 46.1 2.99 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.74 1.216 . . . . 0.0 114.047 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -145.28 26.76 1.3 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -122.47 8.58 9.6 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.14 -8.75 49.63 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -61.77 141.36 57.94 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.553 0.692 . . . . 0.0 110.612 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.622 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.2 p -151.05 175.89 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.446 ' H ' HG22 ' A' ' 113' ' ' VAL . 55.6 ttt180 -137.01 154.04 50.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.7 tp -133.08 148.32 52.17 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.419 ' HD2' ' C6 ' ' B' ' 4' ' ' ' G' . 20.3 tpp85 -152.89 160.66 43.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.82 3.93 70.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.402 HD22 ' SG ' ' A' ' 122' ' ' CYS . 95.8 mt -57.33 150.01 45.32 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 117.118 0.459 . . . . 0.0 111.97 -175.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.11 25.25 0.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 125.143 3.895 . . . . 0.0 113.66 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.626 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 22.6 m-30 52.35 13.48 0.3 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.071 1.348 . . . . 0.0 114.192 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.29 -8.86 1.11 Allowed Glycine 0 CA--C 1.529 0.958 0 CA-C-N 118.861 0.755 . . . . 0.0 112.458 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 7.0 t -59.62 149.62 29.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.218 1.007 . . . . 0.0 110.953 174.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.478 ' HA ' ' CD1' ' A' ' 143' ' ' LEU . 2.4 t -141.16 -167.86 2.49 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.465 0.706 . . . . 0.0 109.298 172.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.8 mptt -51.18 -29.2 13.22 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.436 0.562 . . . . 0.0 112.356 -178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.4 ' HA ' HG12 ' A' ' 128' ' ' VAL . 39.9 mt-10 -81.22 -19.91 42.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.457 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 5.7 mp0 -92.98 -33.91 13.95 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.773 -0.58 . . . . 0.0 109.439 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.4 HG13 ' SG ' ' A' ' 122' ' ' CYS . 56.7 mt -62.42 -34.9 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 125' ' ' GLU . 9.4 p -84.1 -32.45 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.007 -173.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -72.91 -27.57 61.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -70.77 -25.94 63.12 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 120.739 0.304 . . . . 0.0 110.429 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -113.71 32.77 5.59 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.459 1.104 . . . . 0.0 109.016 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.0 t -67.3 -17.01 64.6 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.965 0.506 . . . . 0.0 111.983 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.36 15.41 60.04 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.631 ' HB3' HD11 ' A' ' 164' ' ' LEU . 33.8 mt -143.73 -163.53 1.68 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.207 1.803 . . . . 0.0 107.403 -173.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -146.94 162.61 38.36 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 8.3 mt -142.16 150.86 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.6 m -75.2 155.23 86.24 Favored Pre-proline 0 C--O 1.232 0.135 0 O-C-N 122.032 -0.417 . . . . 0.0 110.471 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.09 136.81 29.81 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 124.006 3.137 . . . . 0.0 112.245 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.6 t30 40.05 38.92 0.55 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.448 1.099 . . . . 0.0 112.07 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.67 28.19 13.25 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-O 118.859 -0.967 . . . . 0.0 111.876 -173.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.96 147.15 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 118.99 1.395 . . . . 0.0 109.548 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 88.6 m -138.47 148.38 44.29 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.073 0.949 . . . . 0.0 108.991 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.478 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 6.3 mt -145.74 99.04 4.43 Favored Pre-proline 0 N--CA 1.453 -0.315 0 C-N-CA 123.091 0.557 . . . . 0.0 110.225 -174.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.7 157.59 18.94 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.499 2.8 . . . . 0.0 110.334 171.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 151' ' ' ILE . 31.3 m -145.68 163.73 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-O 121.427 0.632 . . . . 0.0 111.324 173.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.458 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 57.8 m-20 -89.69 175.5 3.82 Favored Pre-proline 0 N--CA 1.454 -0.251 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.579 174.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.5 Cg_exo -57.95 -20.46 44.88 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.734 2.289 . . . . 0.0 111.385 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -79.48 -9.96 59.71 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.102 0.961 . . . . 0.0 111.252 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.56 0.7 90.06 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -173.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.626 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 85.3 tttt -72.28 131.79 43.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.914 1.286 . . . . 0.0 108.891 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.469 ' C ' ' H ' ' A' ' 153' ' ' GLY . 8.4 pt -71.88 10.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -169.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p 67.49 -15.71 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.532 1.133 . . . . 0.0 112.197 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 101.33 6.44 50.94 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.338 0.971 . . . . 0.0 112.814 175.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -142.68 168.82 18.82 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.058 0.929 . . . . 0.0 111.936 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.11 -178.82 7.59 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.671 0.788 . . . . 0.0 110.59 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -143.59 146.24 33.14 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -177.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.3 t -146.42 165.01 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -174.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.633 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.4 tt0 -129.46 96.15 4.2 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.68 0.753 . . . . 0.0 109.009 170.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.622 ' CE2' HG11 ' A' ' 113' ' ' VAL . 36.3 m-85 -68.6 172.07 6.74 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.23 93.45 1.09 Allowed 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t 61.27 168.73 0.1 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.683 1.193 . . . . 0.0 111.455 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -61.73 -27.3 68.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.76 -0.587 . . . . 0.0 110.65 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.32 -36.21 79.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.05 -0.406 . . . . 0.0 111.515 -176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.8 OUTLIER -74.76 -40.0 61.47 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.14 -37.89 72.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 122.296 -0.252 . . . . 0.0 110.614 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -68.74 -32.12 71.66 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.601 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -71.3 -38.56 71.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.581 0.229 . . . . 0.0 110.795 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.52 -18.46 63.84 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.821 0.448 . . . . 0.0 112.033 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.706 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.9 mt -65.95 -14.37 61.45 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.641 0.655 . . . . 0.0 111.836 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.86 -10.26 80.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.574 ' HB2' HG11 ' A' ' 183' ' ' VAL . 63.6 mmtt -90.58 -1.97 57.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.814 1.246 . . . . 0.0 112.606 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.567 ' CA ' HG22 ' A' ' 183' ' ' VAL . 14.5 t60 -43.93 -19.92 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -140.42 17.02 2.39 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.364 0.984 . . . . 0.0 111.833 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -75.65 -173.78 2.3 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-O 120.997 0.427 . . . . 0.0 110.119 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -134.43 166.21 23.37 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -170.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 7.5 mt -121.6 -19.83 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 124.633 1.173 . . . . 0.0 109.989 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 137.02 135.48 3.39 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 45.32 2.47 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.791 2.036 . . . . 0.0 115.215 -173.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -151.46 166.8 29.98 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.188 0.595 . . . . 0.0 110.143 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -120.78 155.09 34.74 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.4 mm -123.44 162.57 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -170.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -134.37 150.6 50.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' A' ' 169' ' ' LEU . 19.7 m -119.77 135.6 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.703 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 11.8 m-30 -134.84 153.48 52.02 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -76.49 162.95 27.39 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.674 -0.641 . . . . 0.0 110.629 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.5 t -158.86 -175.93 5.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 67.3 m -148.18 168.95 21.13 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.249 1.419 . . . . 0.0 109.192 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -57.44 -31.91 66.37 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.734 0.414 . . . . 0.0 111.173 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -62.87 -16.74 59.89 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -102.35 0.44 34.09 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.405 0.682 . . . . 0.0 111.47 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.1 p -143.35 14.33 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.002 0.43 . . . . 0.0 111.027 -175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.8 ptm180 -69.45 13.45 0.13 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.4 m -68.01 -0.68 4.67 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.592 0.757 . . . . 0.0 111.199 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.094 178.541 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.291 2 O4'-C1'-N19 114.166 5.966 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.453 ' C4 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.655 1 C5'-C4'-C3' 107.301 -5.466 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.49 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.405 -3.998 0 C3'-C2'-C1' 104.471 3.301 OUTLIER-DELTA 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.49 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.831 2 O4'-C1'-N19 116.235 8.035 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.433 " O3'" " H3'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.418 -2.926 1 C5'-C4'-C3' 109.477 -4.015 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.703 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.523 0 C5'-C4'-C3' 110.885 -3.077 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.6 t -146.82 15.95 1.23 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.927 0.491 . . . . 0.0 111.035 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.2 4.45 1.07 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -145.32 -6.89 0.63 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.899 0.318 . . . . 0.0 111.467 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.7 t -156.03 157.14 35.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.868 0.467 . . . . 0.0 109.835 177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -163.65 -179.41 6.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.658 0.783 . . . . 0.0 109.902 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.05 26.5 0.26 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.982 0.513 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -136.89 2.63 2.63 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.57 -10.23 75.2 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 122.08 -0.388 . . . . 0.0 112.66 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -65.44 150.34 48.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.593 0.711 . . . . 0.0 110.323 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.587 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.0 p -153.11 175.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.676 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.465 ' H ' HG22 ' A' ' 113' ' ' VAL . 32.5 ttt180 -132.32 153.75 50.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.378 1.071 . . . . 0.0 108.673 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.1 tp -137.4 146.52 44.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -152.6 169.41 22.74 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.407 ' HA3' ' N2 ' ' B' ' 3' ' ' ' G' . . . 81.85 8.59 86.53 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 118' ' ' LEU . 89.5 mt -57.18 142.65 74.72 Favored Pre-proline 0 N--CA 1.451 -0.412 0 C-N-CA 122.858 0.463 . . . . 0.0 111.9 -174.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.99 27.45 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 125.235 3.956 . . . . 0.0 113.609 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.455 ' CE2' H5'' ' B' ' 1' ' ' ' A' . 83.3 m-85 54.79 8.13 0.2 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.03 1.332 . . . . 0.0 114.536 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -136.81 -5.13 1.98 Allowed Glycine 0 CA--C 1.528 0.87 0 CA-C-N 118.786 0.721 . . . . 0.0 112.169 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 44.4 t -61.62 153.04 29.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.69 0.796 . . . . 0.0 111.147 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 t -156.16 -163.35 1.45 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.428 ' HD2' ' HB ' ' A' ' 141' ' ' ILE . 27.3 mmtp -46.17 -39.26 9.39 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 123.428 0.691 . . . . 0.0 112.679 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.442 ' HA ' HG12 ' A' ' 128' ' ' VAL . 39.3 mt-10 -83.72 -15.3 49.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.515 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 65.5 mm-40 -98.81 -31.47 11.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.413 HG13 ' SG ' ' A' ' 122' ' ' CYS . 32.5 mt -64.37 -37.68 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 172.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 125' ' ' GLU . 11.4 p -79.4 -33.16 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.528 -173.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -74.14 -25.89 60.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.137 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 181' ' ' ILE . 53.8 t80 -71.78 -20.35 61.88 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.872 0.305 . . . . 0.0 110.667 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -120.94 33.59 5.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.481 1.112 . . . . 0.0 108.455 177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -64.0 -17.63 63.5 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.16 0.584 . . . . 0.0 112.439 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.27 15.28 58.74 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' A' ' 164' ' ' LEU . 56.4 mt -144.04 -162.53 1.49 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.486 1.514 . . . . 0.0 108.457 -172.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -145.97 163.04 36.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.9 mt -142.25 150.32 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 158' ' ' GLN . 16.3 m -74.55 155.99 87.15 Favored Pre-proline 0 CA--C 1.53 0.177 0 O-C-N 121.995 -0.441 . . . . 0.0 110.527 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -47.83 133.48 22.43 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 124.196 3.264 . . . . 0.0 112.464 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.2 t30 38.62 39.34 0.32 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.582 1.153 . . . . 0.0 112.16 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -91.5 35.36 3.97 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-O 119.044 -0.864 . . . . 0.0 111.246 -174.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.428 ' HB ' ' HD2' ' A' ' 124' ' ' LYS . 89.3 mt -137.84 146.68 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 118.74 1.27 . . . . 0.0 109.42 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 91.3 m -138.23 144.23 40.5 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 123.574 0.749 . . . . 0.0 109.166 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 51.5 mt -137.78 87.28 17.19 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 123.71 0.804 . . . . 0.0 109.396 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.67 158.85 18.67 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.095 2.53 . . . . 0.0 110.855 177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.42 160.34 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-O 121.552 0.691 . . . . 0.0 112.24 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 22.0 m-20 -83.54 174.12 6.43 Favored Pre-proline 0 N--CA 1.454 -0.253 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.826 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 33.7 Cg_exo -59.9 -2.65 1.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.274 3.316 . . . . 0.0 113.045 176.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -117.15 1.38 12.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.799 0.839 . . . . 0.0 110.759 -176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.06 2.83 88.06 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.956 -0.457 . . . . 0.0 111.956 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.3 mtpt -69.54 161.31 29.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 153' ' ' GLY . 4.8 pt -95.95 13.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -167.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 p 62.71 -3.37 0.31 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.916 0.886 . . . . 0.0 112.358 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 77.27 6.02 85.95 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.779 1.181 . . . . 0.0 113.014 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -142.41 168.41 19.8 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.238 1.019 . . . . 0.0 111.72 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.27 -177.98 6.99 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.059 0.944 . . . . 0.0 110.453 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -145.56 148.11 32.81 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.477 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 61.7 t -146.11 165.0 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.636 ' O ' HG22 ' A' ' 137' ' ' VAL . 52.4 tt0 -129.74 95.85 4.08 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.74 0.781 . . . . 0.0 108.982 171.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.587 ' CE2' HG11 ' A' ' 113' ' ' VAL . 46.1 m-85 -69.03 170.9 9.02 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.763 174.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.29 94.05 0.9 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.7 t 62.66 168.44 0.13 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.538 1.135 . . . . 0.0 111.621 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -61.86 -26.05 67.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.61 -36.55 84.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.035 0.379 . . . . 0.0 111.704 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -73.64 -39.97 64.11 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.05 -34.76 70.45 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.293 -0.254 . . . . 0.0 110.631 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -69.16 -32.15 71.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.336 0.255 . . . . 0.0 110.516 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -72.53 -38.05 68.15 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.766 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.01 -19.56 64.47 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.113 0.565 . . . . 0.0 112.341 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.689 ' HA ' HG21 ' A' ' 183' ' ' VAL . 95.2 mt -67.65 -8.46 34.96 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.584 0.629 . . . . 0.0 111.284 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -83.66 8.09 66.88 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -118.76 3.7 11.62 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 123.852 0.861 . . . . 0.0 111.289 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.583 ' CA ' HG22 ' A' ' 183' ' ' VAL . 5.3 t60 -42.2 -24.48 0.05 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.41 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 61.1 mttp -137.5 18.32 2.91 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 119.355 0.98 . . . . 0.0 110.897 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -81.57 174.12 11.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.711 1.604 . . . . 0.0 108.792 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -120.35 158.46 27.06 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.2 tt -98.09 -12.51 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.499 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 145.87 -26.66 1.77 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.248 0.451 . . . . 0.0 112.209 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -155.4 5.83 0.22 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.148 0.579 . . . . 0.0 110.789 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -145.75 160.57 41.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.556 1.142 . . . . 0.0 108.197 -175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.409 ' CZ ' ' C2 ' ' B' ' 3' ' ' ' G' . 19.7 p90 -107.93 145.27 34.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 130' ' ' PHE . 31.3 mm -122.02 160.62 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -129.98 144.86 51.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.689 HG21 ' HA ' ' A' ' 169' ' ' LEU . 11.0 m -119.3 143.21 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.464 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 47.5 m-85 -150.41 156.01 40.67 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -73.71 156.77 37.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.983 0.42 . . . . 0.0 110.696 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.7 t -157.68 -177.06 6.3 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.118 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.6 t -152.08 174.8 13.25 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.14 0.976 . . . . 0.0 109.558 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.6 tp60 -59.03 -31.7 69.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.726 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.09 -3.8 6.19 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -118.79 2.95 11.65 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.664 0.786 . . . . 0.0 111.308 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.5 10.51 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.913 0.387 . . . . 0.0 111.204 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -68.2 14.12 0.07 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.0 m -68.69 -0.58 5.44 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.433 0.693 . . . . 0.0 111.239 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.252 1.205 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.079 178.371 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.455 H5'' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.413 -3.309 0 C5'-C4'-C3' 110.353 -3.432 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.427 0 C5'-C4'-C3' 110.179 -3.548 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.526 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.411 -3.534 1 P-O3'-C3' 125.3 4.667 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.526 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.9 1 O4'-C1'-N19 115.041 6.841 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.566 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.84 1 C5'-C4'-C3' 108.304 -4.798 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.566 ' C5 ' " H1'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.541 0 O4'-C1'-C2' 103.075 -2.375 . 0.0 OUTLIER '7D dist 4a' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.5 t30 . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.4 p -150.54 12.84 0.72 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.225 0.61 . . . . 0.0 111.517 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.42 -179.3 6.85 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.87 0.468 . . . . 0.0 110.734 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 52.48 26.99 4.59 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.709 0.804 . . . . 0.0 112.409 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 83.1 p -140.93 18.83 2.3 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.693 0.797 . . . . 0.0 110.98 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -138.2 52.98 1.82 Allowed 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.888 0.875 . . . . 0.0 110.041 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -147.73 34.78 0.85 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.447 -171.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -118.15 7.45 12.15 Favored 'General case' 0 N--CA 1.458 -0.067 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.03 -8.91 42.68 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.93 139.96 58.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.423 0.63 . . . . 0.0 110.705 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.4 p -149.51 175.81 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 124.205 1.002 . . . . 0.0 108.764 -178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.463 ' H ' HG22 ' A' ' 113' ' ' VAL . 33.0 ttt180 -137.49 144.42 42.21 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.06 0.544 . . . . 0.0 109.743 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.407 ' HB3' HD12 ' A' ' 118' ' ' LEU . 4.0 mm? -119.02 152.25 36.76 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.478 ' HE ' ' HB3' ' A' ' 154' ' ' GLU . 19.3 tpp85 -157.6 152.1 25.02 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.27 2.45 90.59 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 171.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.752 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -68.25 158.49 84.27 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 37.7 Cg_exo -52.21 153.66 12.44 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.026 2.484 . . . . 0.0 114.311 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.59 ' CE1' ' C5 ' ' B' ' 2' ' ' ' G' . 55.0 m-85 -68.25 -1.55 6.42 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.944 0.497 . . . . 0.0 111.802 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.77 2.96 10.97 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.435 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 52.5 t -66.3 153.51 42.42 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.025 0.93 . . . . 0.0 109.605 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.655 HG23 ' H ' ' A' ' 125' ' ' GLU . 10.0 t -154.97 -175.24 5.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 124' ' ' LYS . 2.4 ptpp? -56.45 -22.06 29.57 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.655 ' H ' HG23 ' A' ' 123' ' ' THR . 40.8 tt0 -77.72 -25.07 49.05 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.242 0.617 . . . . 0.0 110.899 176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -89.05 -35.52 16.3 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.6 -34.35 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.58 -34.07 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.658 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -73.17 -25.72 60.9 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.921 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -72.04 -25.97 62.01 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.64 0.257 . . . . 0.0 110.336 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -111.29 30.5 6.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.531 1.132 . . . . 0.0 109.022 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.6 t -65.74 -14.68 61.78 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.753 0.421 . . . . 0.0 111.865 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.17 15.26 63.32 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.625 ' HB3' HD11 ' A' ' 164' ' ' LEU . 33.4 mt -143.26 -162.8 1.51 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.249 1.819 . . . . 0.0 107.35 -173.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -147.15 162.29 39.16 Favored 'General case' 0 C--N 1.335 -0.06 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.2 mt -142.38 152.09 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.9 m -77.65 153.86 81.09 Favored Pre-proline 0 CA--C 1.528 0.105 0 CA-C-N 118.153 0.433 . . . . 0.0 110.683 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.37 140.7 34.11 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 124.097 3.198 . . . . 0.0 112.094 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 42.02 36.39 0.67 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.201 1.0 . . . . 0.0 111.929 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -99.76 29.28 12.37 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 118.898 -0.945 . . . . 0.0 111.943 -173.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 77.6 mt -137.72 146.07 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.847 1.324 . . . . 0.0 110.2 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.1 m -142.17 147.55 36.8 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.009 0.924 . . . . 0.0 109.728 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.4 mt -140.78 96.48 7.48 Favored Pre-proline 0 CA--C 1.527 0.094 0 C-N-CA 124.243 1.017 . . . . 0.0 109.849 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.74 154.88 8.73 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.713 2.942 . . . . 0.0 112.019 173.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.77 165.13 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-O 121.244 0.545 . . . . 0.0 110.467 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 67.7 m-20 -86.13 176.4 3.62 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.929 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.7 Cg_exo -59.1 -17.77 40.17 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.102 2.535 . . . . 0.0 111.85 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -86.89 -4.69 59.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.594 0.758 . . . . 0.0 110.789 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.46 11.15 83.58 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 123.477 0.56 . . . . 0.0 112.534 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -102.22 149.81 23.93 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 117.455 0.628 . . . . 0.0 109.55 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.6 pt -69.22 151.87 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.729 0.776 . . . . 0.0 112.606 -170.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.3 p -86.98 -7.14 58.45 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.144 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.408 ' HA2' ' O6 ' ' B' ' 2' ' ' ' G' . . . 97.74 6.36 57.25 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-O 119.768 -0.462 . . . . 0.0 112.781 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.478 ' HB3' ' HE ' ' A' ' 116' ' ' ARG . 23.0 pt-20 -140.02 168.45 19.79 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.433 0.617 . . . . 0.0 110.546 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.21 178.51 10.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.069 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -141.57 143.95 33.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 69.6 t -144.56 162.61 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -174.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.669 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.4 tt0 -128.51 97.62 4.77 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.863 0.84 . . . . 0.0 109.02 170.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 113' ' ' VAL . 38.5 m-85 -69.07 171.57 8.03 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.433 173.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.29 92.57 0.79 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t 61.33 170.42 0.11 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.757 1.223 . . . . 0.0 111.423 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -62.63 -27.18 69.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.818 -0.551 . . . . 0.0 110.696 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -58.48 -41.56 85.53 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.153 -0.342 . . . . 0.0 111.133 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -72.51 -39.55 67.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.498 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.66 -38.26 74.79 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.002 -0.436 . . . . 0.0 110.93 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -69.27 -30.05 68.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.755 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -72.58 -38.93 67.74 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 120.46 0.172 . . . . 0.0 111.082 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.411 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.39 -19.39 64.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.766 0.427 . . . . 0.0 112.127 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.452 ' HA ' HG21 ' A' ' 183' ' ' VAL . 95.4 mt -69.19 -11.65 60.98 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.842 -0.536 . . . . 0.0 111.345 177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.87 -13.24 80.84 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.565 ' HB2' HG11 ' A' ' 183' ' ' VAL . 70.3 mmtt -83.41 -1.04 52.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.299 1.439 . . . . 0.0 111.924 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.441 ' CA ' HG22 ' A' ' 183' ' ' VAL . 6.1 t60 -54.81 134.81 48.1 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.248 176.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.55 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 47.6 mttp 56.85 6.33 0.3 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.993 1.717 . . . . 0.0 114.567 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.13 172.49 11.63 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.051 0.94 . . . . 0.0 109.325 175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -123.05 158.85 29.68 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.949 -0.47 . . . . 0.0 112.197 -170.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.6 tt -112.75 -2.24 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.08 -32.43 0.66 Allowed Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.931 -0.481 . . . . 0.0 113.936 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -156.45 4.21 0.16 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.85 0.825 . . . . 0.0 111.163 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -147.74 159.68 43.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.252 1.021 . . . . 0.0 108.477 -170.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -109.02 130.16 55.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.411 0.624 . . . . 0.0 109.968 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 18.0 mm -94.55 166.53 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -130.65 154.14 48.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.565 HG11 ' HB2' ' A' ' 171' ' ' LYS . 24.4 m -135.79 125.2 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.665 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 8.2 m-30 -133.47 163.69 28.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -88.64 169.11 11.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.456 1.025 . . . . 0.0 111.598 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -158.32 -177.22 6.38 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.084 0.554 . . . . 0.0 111.156 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 52.1 m -149.35 168.77 22.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.144 1.378 . . . . 0.0 108.69 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -56.43 -32.54 64.98 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.45 0.3 . . . . 0.0 111.641 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.54 -2.43 6.57 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -117.0 3.02 12.77 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.964 0.906 . . . . 0.0 110.8 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.27 11.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 121.221 0.534 . . . . 0.0 110.825 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 50.5 ptt85 -68.06 13.77 0.08 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.85 0.86 . . . . 0.0 113.068 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.4 m -68.28 -1.24 5.86 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.57 0.748 . . . . 0.0 111.254 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.706 -1.14 . . . . 0.0 111.125 178.564 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.942 2 O4'-C1'-N19 114.567 6.367 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.59 ' C5 ' ' CE1' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.748 1 C5'-C4'-C3' 106.12 -6.254 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.425 " H5'" " H1'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 P--O5' 1.623 2.972 2 P-O3'-C3' 124.651 4.126 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.435 ' C6 ' ' HD2' ' A' ' 116' ' ' ARG . . . . . . . . 0 O4'--C4' 1.418 -2.885 2 O4'-C1'-N19 117.131 8.931 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.55 ' C2 ' ' HE3' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.416 -3.075 1 C5'-C4'-C3' 109.407 -4.062 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.665 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.502 0 P-O3'-C3' 123.604 3.253 . 0.013 4d . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.921 -0.029 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.5 m 48.44 28.55 1.73 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.147 0.979 . . . . 0.0 112.933 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.33 17.7 1.53 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.453 0.701 . . . . 0.0 110.417 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -148.97 179.31 7.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.951 0.9 . . . . 0.0 109.125 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.5 m -135.52 172.85 12.42 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.771 0.428 . . . . 0.0 110.893 -177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -150.23 169.37 21.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.749 0.419 . . . . 0.0 111.082 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -152.78 30.55 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.203 0.601 . . . . 0.0 110.963 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.83 2.54 6.67 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.09 -10.19 51.21 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.5 -0.381 . . . . 0.0 112.395 174.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -64.04 143.61 57.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.428 0.632 . . . . 0.0 110.372 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.646 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.9 p -150.81 178.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.911 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 113' ' ' VAL . 5.8 mtm180 -133.28 165.07 25.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.318 0.647 . . . . 0.0 111.087 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 115' ' ' LEU . 12.8 tp -147.23 145.16 29.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -154.82 171.2 20.0 Favored 'General case' 0 CA--C 1.527 0.084 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.72 10.45 86.23 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 120' ' ' PHE . 95.2 mt -55.15 149.65 24.5 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 123.289 0.636 . . . . 0.0 111.494 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -71.06 27.38 0.21 Allowed 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.798 2.332 . . . . 0.0 113.454 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.549 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 62.6 m-85 51.04 12.96 0.13 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.926 1.691 . . . . 0.0 113.603 -178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -138.19 -8.14 1.21 Allowed Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 22.5 t -61.84 154.07 27.0 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.779 0.831 . . . . 0.0 109.847 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.622 HG23 ' H ' ' A' ' 125' ' ' GLU . 10.0 t -147.69 -174.86 4.66 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.469 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.8 ptpp? -55.33 -20.12 10.7 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.622 ' H ' HG23 ' A' ' 123' ' ' THR . 42.2 mt-10 -83.6 -22.38 32.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.018 0.527 . . . . 0.0 111.342 177.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.509 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 64.3 mm-40 -92.43 -30.49 15.72 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.49 -36.44 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.07 -32.11 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.685 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -73.15 -27.62 61.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.065 172.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 24.1 t80 -71.67 -24.34 61.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.776 0.322 . . . . 0.0 110.504 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -115.49 32.14 6.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.442 1.097 . . . . 0.0 108.727 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.1 t -67.92 -16.97 64.31 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.936 0.495 . . . . 0.0 112.075 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.66 15.66 59.9 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.661 ' HB3' HD11 ' A' ' 164' ' ' LEU . 30.0 mt -143.47 -164.83 1.95 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.229 1.812 . . . . 0.0 107.307 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -148.06 161.23 41.81 Favored 'General case' 0 C--O 1.226 -0.144 0 O-C-N 121.839 -0.538 . . . . 0.0 110.038 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.9 mt -140.43 150.83 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.5 m -77.56 154.09 81.36 Favored Pre-proline 0 CA--C 1.528 0.128 0 CA-C-N 118.407 0.549 . . . . 0.0 110.354 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.1 141.31 30.64 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.925 3.083 . . . . 0.0 111.949 175.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 43.13 35.18 0.76 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.906 0.882 . . . . 0.0 111.777 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.99 28.82 13.48 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-O 119.245 -0.753 . . . . 0.0 111.968 -173.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.8 mt -138.24 144.78 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 118.817 1.308 . . . . 0.0 109.731 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 97.7 m -140.35 145.74 37.54 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.592 0.757 . . . . 0.0 109.234 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 155' ' ' ALA . 13.0 mt -141.76 94.21 7.38 Favored Pre-proline 0 N--CA 1.455 -0.208 0 C-N-CA 124.154 0.982 . . . . 0.0 109.061 -176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.06 152.89 22.65 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.334 2.689 . . . . 0.0 110.624 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.47 166.02 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.086 0 CA-C-O 121.328 0.585 . . . . 0.0 111.072 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 58.9 m-20 -91.56 177.07 2.36 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.861 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 32.6 Cg_exo -59.07 -19.43 48.74 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.942 2.428 . . . . 0.0 111.762 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -81.95 -7.46 59.61 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.768 0.827 . . . . 0.0 110.672 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.33 12.31 83.26 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 123.675 0.655 . . . . 0.0 112.151 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -102.0 149.97 23.7 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.8 pt -68.24 148.28 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.465 0.65 . . . . 0.0 111.577 -171.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.2 p -76.6 -4.03 40.78 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.705 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.7 4.31 54.68 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 123.048 0.356 . . . . 0.0 112.46 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -145.15 171.16 14.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.247 0.524 . . . . 0.0 110.092 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.43 ' HB2' HD23 ' A' ' 143' ' ' LEU . . . -154.21 179.12 9.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.3 0.572 . . . . 0.0 110.5 -175.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -144.4 143.79 31.09 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 90.4 t -145.99 164.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -174.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.451 ' N ' HG12 ' A' ' 157' ' ' VAL . 52.2 tt0 -129.82 102.77 6.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 169.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.646 ' CE2' HG11 ' A' ' 113' ' ' VAL . 34.0 m-85 -73.83 172.2 11.98 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.322 171.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.17 91.58 0.72 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.084 0.469 . . . . 0.0 109.815 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 61.61 168.53 0.11 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.666 1.186 . . . . 0.0 111.476 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -16.43 63.91 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.885 -0.51 . . . . 0.0 111.055 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -66.01 -42.96 89.0 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.973 -0.454 . . . . 0.0 110.342 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.8 OUTLIER -70.73 -39.69 73.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.31 -38.32 73.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.244 -0.285 . . . . 0.0 110.856 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -69.26 -29.98 68.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.728 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -72.52 -38.35 68.11 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 120.513 0.197 . . . . 0.0 110.814 175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.412 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.91 -19.58 65.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.731 0.412 . . . . 0.0 111.935 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.462 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.0 mt -67.55 -12.06 59.49 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.464 0.574 . . . . 0.0 111.336 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.98 -11.96 78.96 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.632 ' HB2' HG11 ' A' ' 183' ' ' VAL . 69.5 mmtt -87.39 1.63 52.79 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.263 1.425 . . . . 0.0 111.614 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.491 ' HA ' HG22 ' A' ' 183' ' ' VAL . 65.3 t60 -54.32 134.26 45.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 173.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.51 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 90.9 mttt 53.5 14.01 0.53 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.545 1.538 . . . . 0.0 113.967 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.02 163.04 20.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.886 0.766 . . . . 0.0 109.607 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -101.31 159.09 15.55 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.6 tt -114.99 -7.29 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 160.28 -37.79 0.45 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-O 119.916 -0.38 . . . . 0.0 112.971 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -155.57 11.86 0.32 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.35 0.575 . . . . 0.0 110.761 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -136.0 -179.82 5.89 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.283 1.033 . . . . 0.0 109.141 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -126.15 141.54 51.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.7 mm -112.82 160.87 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.472 ' CG ' ' H21' ' B' ' 3' ' ' ' G' . 22.7 mm-40 -129.89 94.46 3.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -170.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.632 HG11 ' HB2' ' A' ' 171' ' ' LYS . 13.9 m -74.24 140.44 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.149 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.648 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 18.3 m-85 -146.26 161.43 40.29 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -79.55 161.72 25.8 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.833 0.742 . . . . 0.0 109.965 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.0 t -157.2 -174.2 4.8 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.53 -0.106 . . . . 0.0 111.13 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.7 t -147.4 172.07 14.5 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.808 0.843 . . . . 0.0 110.155 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -59.99 -31.55 70.02 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.746 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.42 -1.27 7.98 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -114.36 0.34 14.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.792 0.837 . . . . 0.0 110.547 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.92 14.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-O 120.956 0.408 . . . . 0.0 110.785 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -67.08 9.8 0.18 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 31.3 m -68.7 -0.7 5.6 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.443 0.697 . . . . 0.0 111.292 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.785 -1.103 . . . . 0.0 111.151 178.347 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.142 2 O4'-C1'-N19 114.381 6.181 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.553 H5'' ' C8 ' ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.92 1 C5'-C4'-C3' 107.031 -5.646 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.472 ' H21' ' CG ' ' A' ' 182' ' ' GLU . . . . . . . . 0 O4'--C4' 1.411 -3.532 2 P-O3'-C3' 124.863 4.302 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.948 1 O4'-C1'-N19 115.167 6.967 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.578 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.176 1 C5'-C4'-C3' 108.606 -4.596 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.648 " H1'" ' CZ ' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.522 0 P-O3'-C3' 122.814 2.595 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.5 p -147.62 9.23 0.91 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.777 0.431 . . . . 0.0 111.568 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -147.14 8.51 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.144 0.577 . . . . 0.0 111.204 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -146.09 162.88 36.94 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.686 0.794 . . . . 0.0 109.41 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.5 p 49.31 18.03 0.24 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.801 1.241 . . . . 0.0 113.441 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.18 40.95 2.84 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 124.149 0.98 . . . . 0.0 110.179 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -146.98 35.08 0.91 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.47 -172.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -121.62 7.82 10.04 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 110.34 -9.28 30.88 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -61.86 138.22 58.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.362 0.601 . . . . 0.0 110.669 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.5 p -150.25 175.94 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.044 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.444 ' H ' HG22 ' A' ' 113' ' ' VAL . 9.9 mtm180 -132.35 151.16 51.97 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.608 0.763 . . . . 0.0 110.695 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -123.34 148.71 45.73 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 124.281 1.032 . . . . 0.0 108.39 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.402 ' HD2' ' C6 ' ' B' ' 4' ' ' ' G' . 20.3 tpp85 -153.18 161.08 42.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.81 0.53 85.18 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.8 mt -53.34 134.93 51.84 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 124.07 0.948 . . . . 0.0 111.238 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -60.31 142.98 99.44 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 N-CA-C 107.262 -1.861 . . . . 0.0 107.262 170.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.454 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 17.5 m-85 -66.9 -2.11 4.82 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.92 -174.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.02 -0.9 27.0 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 47.4 t -63.69 142.77 58.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.031 0.932 . . . . 0.0 109.829 176.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.4 t -148.82 -160.9 1.24 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.407 ' HD2' ' HB ' ' A' ' 141' ' ' ILE . 28.9 mmtp -45.21 -41.03 7.91 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.539 0.736 . . . . 0.0 112.953 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.475 ' HA ' HG12 ' A' ' 128' ' ' VAL . 38.8 mt-10 -77.76 -23.06 49.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -173.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.445 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 9.9 mp0 -86.3 -39.56 16.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.0 mt -64.45 -36.32 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.475 HG12 ' HA ' ' A' ' 125' ' ' GLU . 14.5 p -80.64 -34.13 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.08 -170.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -81.2 -20.64 40.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.869 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -71.89 -22.75 61.46 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 171.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -115.48 35.96 4.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.501 1.12 . . . . 0.0 109.139 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.8 t -62.64 142.53 58.01 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.17 5.11 75.39 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 39.0 mt -140.44 72.13 1.39 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.13 1.372 . . . . 0.0 107.97 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -49.55 159.3 0.36 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.036 0.934 . . . . 0.0 113.473 -174.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.4 mt -135.33 146.91 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.6 m -71.41 155.61 92.56 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 118.506 0.594 . . . . 0.0 110.236 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -47.89 135.23 23.25 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 124.094 3.196 . . . . 0.0 112.301 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.4 t30 40.21 38.16 0.49 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.423 1.089 . . . . 0.0 111.996 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -92.02 33.83 4.69 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -174.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.407 ' HB ' ' HD2' ' A' ' 124' ' ' LYS . 81.7 mt -140.29 143.92 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 118.522 1.161 . . . . 0.0 108.842 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.0 m -136.91 147.95 46.73 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.439 0.695 . . . . 0.0 109.299 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 88.2 mt -139.75 93.42 9.6 Favored Pre-proline 0 C--O 1.234 0.249 0 C-N-CA 123.278 0.631 . . . . 0.0 110.485 -173.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.04 154.81 26.01 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.931 2.421 . . . . 0.0 110.325 171.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' A' ' 151' ' ' ILE . 27.1 m -146.58 164.64 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 CA-C-O 121.429 0.633 . . . . 0.0 111.588 174.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.468 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 59.0 m-20 -90.99 176.04 3.17 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.469 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.8 Cg_exo -58.09 -20.67 47.06 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.842 2.361 . . . . 0.0 111.563 175.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -78.63 -10.4 59.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.35 1.06 . . . . 0.0 111.214 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.96 1.58 90.65 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.427 ' HE2' ' CD2' ' A' ' 120' ' ' PHE . 52.2 tttm -73.58 130.59 40.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.888 1.275 . . . . 0.0 109.152 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 153' ' ' GLY . 9.0 pt -70.31 9.93 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 -168.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 66.63 -15.88 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.97 0.908 . . . . 0.0 112.417 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 100.41 3.19 55.5 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.547 1.07 . . . . 0.0 113.063 175.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -139.71 170.41 15.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.263 1.032 . . . . 0.0 111.425 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -160.99 -178.05 6.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 122.943 0.497 . . . . 0.0 110.561 -174.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -142.52 145.06 33.25 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 89.6 t -145.09 164.3 12.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' ' 157' ' ' VAL . 53.2 tt0 -131.16 101.33 5.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.606 ' CE2' HG11 ' A' ' 113' ' ' VAL . 47.5 m-85 -71.61 171.64 11.09 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.341 171.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.91 93.05 0.95 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.14 0.495 . . . . 0.0 109.98 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t 62.09 169.43 0.12 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.498 1.119 . . . . 0.0 111.02 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.74 -21.03 66.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.771 -0.58 . . . . 0.0 111.174 -175.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.73 -42.94 99.91 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 121.917 -0.489 . . . . 0.0 110.302 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.471 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -69.77 -38.69 76.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.4 -40.53 82.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.026 -0.421 . . . . 0.0 110.701 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -68.03 -30.91 70.25 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.566 0.346 . . . . 0.0 110.668 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -71.6 -39.78 70.29 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.768 0.318 . . . . 0.0 110.511 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.35 -13.33 61.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.688 ' HA ' HG21 ' A' ' 183' ' ' VAL . 92.4 mt -67.23 -14.09 62.58 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 118.97 0.805 . . . . 0.0 111.954 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -72.61 -11.9 77.41 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.558 ' HB2' HG11 ' A' ' 183' ' ' VAL . 70.1 mmtt -85.43 -4.94 59.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.17 1.388 . . . . 0.0 113.049 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.569 ' CA ' HG22 ' A' ' 183' ' ' VAL . 13.0 t60 -42.51 -23.54 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.42 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 98.5 mttt -140.55 17.57 2.37 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.205 0.911 . . . . 0.0 112.005 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -74.6 -174.82 2.21 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-O 121.086 0.469 . . . . 0.0 110.11 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.14 159.11 37.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.771 -171.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.1 tt -110.59 -6.36 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 150.53 -29.14 1.06 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.985 -0.341 . . . . 0.0 113.164 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -156.43 4.17 0.16 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.485 0.642 . . . . 0.0 110.834 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -149.84 157.95 43.69 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.406 1.083 . . . . 0.0 108.49 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -104.83 150.88 24.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 26.8 mm -123.68 161.93 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -172.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -132.25 157.36 44.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 169' ' ' LEU . 17.8 m -129.91 135.62 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.562 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 5.4 m-85 -132.82 158.85 41.44 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -75.16 160.94 29.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.947 0.794 . . . . 0.0 109.629 176.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t -154.05 -174.1 4.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.724 0.297 . . . . 0.0 111.575 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.5 m -146.11 166.89 24.8 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.176 0.99 . . . . 0.0 109.977 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -60.09 -32.11 70.65 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.407 0.283 . . . . 0.0 110.564 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -63.54 -17.28 62.63 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -100.0 -0.94 38.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.308 0.643 . . . . 0.0 111.4 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.6 12.07 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.941 0.401 . . . . 0.0 111.523 -174.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -68.17 12.56 0.11 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.0 m -68.95 -1.15 6.68 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.357 0.663 . . . . 0.0 111.127 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.236 -1.364 . . . . 0.0 111.147 178.419 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.577 ' C8 ' H5'' ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.413 -3.338 0 C5'-C4'-C3' 111.872 -2.418 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.461 H5'' " C5'" ' B' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.769 1 O4'-C1'-N19 113.022 4.822 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.531 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.408 -3.739 0 C3'-C2'-C1' 104.807 3.675 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.531 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.42 -2.777 2 O4'-C1'-N19 116.747 8.547 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.435 ' H2 ' ' CE1' ' A' ' 172' ' ' HIS . . . . . . . . 0 O4'--C4' 1.419 -2.861 0 C5'-C4'-C3' 109.811 -3.793 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.562 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.424 -2.454 0 C5'-C4'-C3' 109.624 -3.917 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 120.412 0.148 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.3 p -150.66 2.97 0.47 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.558 0.343 . . . . 0.0 111.922 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.17 9.84 0.67 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.776 0.43 . . . . 0.0 111.312 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -154.45 160.34 41.56 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.025 0.53 . . . . 0.0 110.539 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.0 m -152.9 159.49 42.99 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.449 0.7 . . . . 0.0 109.953 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.84 122.71 22.04 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.716 0.406 . . . . 0.0 109.96 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -164.12 23.91 0.07 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -136.25 7.19 3.11 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 107.53 -8.55 37.56 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -62.6 143.73 56.96 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.508 0.67 . . . . 0.0 110.934 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.4 p -152.2 173.79 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 49.1 ttt180 -136.69 152.97 50.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -135.06 150.81 50.33 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 122.279 0.232 . . . . 0.0 110.566 -172.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.42 ' HE ' ' HB3' ' A' ' 154' ' ' GLU . 20.0 tpp85 -153.63 147.71 25.65 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 122.895 0.478 . . . . 0.0 109.908 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.74 -0.97 59.59 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 173.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.657 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -64.38 156.95 74.47 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-N 117.255 0.528 . . . . 0.0 111.508 -176.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 27.9 Cg_exo -56.06 147.48 64.05 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.678 2.919 . . . . 0.0 111.762 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.578 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 23.9 m-85 -70.41 17.54 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 119' ' ' PRO . . . -137.72 5.42 3.42 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 176.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 36.5 t -66.78 152.52 45.37 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.599 1.159 . . . . 0.0 110.552 178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 125' ' ' GLU . 5.4 t -155.09 -168.39 2.86 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.592 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -51.87 -32.6 32.89 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.544 ' H ' HG23 ' A' ' 123' ' ' THR . 42.6 tt0 -73.13 -25.23 60.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.517 0.727 . . . . 0.0 112.049 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.402 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 67.3 mm-40 -92.51 -33.23 14.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.718 -0.614 . . . . 0.0 109.516 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.6 mt -67.15 -34.26 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.02 -38.34 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.877 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -77.06 -21.39 54.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.073 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -71.0 -26.07 62.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 170.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -108.15 39.4 1.97 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.6 t -68.65 157.21 36.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.4 5.87 78.78 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -173.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.513 ' HB3' HD11 ' A' ' 164' ' ' LEU . 30.0 mt -142.52 -172.42 3.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.291 1.837 . . . . 0.0 106.583 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -147.24 164.15 34.11 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.847 -0.533 . . . . 0.0 110.392 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 mt -142.08 148.23 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 158' ' ' GLN . 21.4 m -73.6 154.45 89.58 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 118.598 0.635 . . . . 0.0 110.134 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.62 138.5 25.03 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.016 3.144 . . . . 0.0 112.213 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.9 t30 40.71 37.93 0.56 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.304 1.041 . . . . 0.0 111.917 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.31 29.36 9.64 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.978 -0.901 . . . . 0.0 111.83 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.7 mt -135.36 147.09 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 119.056 1.428 . . . . 0.0 109.368 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.1 m -138.53 151.14 47.08 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.35 0.66 . . . . 0.0 109.712 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.1 mt -144.55 100.7 4.73 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -55.58 155.22 22.11 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.121 2.547 . . . . 0.0 110.13 174.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 150' ' ' LYS . 27.2 m -140.78 159.81 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 121.752 0.787 . . . . 0.0 112.429 174.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.455 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 17.0 m-20 -86.57 175.04 4.76 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.623 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 35.5 Cg_exo -59.74 1.79 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 124.509 3.473 . . . . 0.0 113.402 176.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 146' ' ' ASP . 30.0 tt0 -123.36 3.37 9.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.947 0.899 . . . . 0.0 110.832 -175.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.28 5.96 89.65 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 39.5 mtpt -66.99 167.2 12.19 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.85 10.76 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -167.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.8 p 63.14 -7.14 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 77.94 12.2 84.65 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.914 0.768 . . . . 0.0 113.354 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.42 ' HB3' ' HE ' ' A' ' 116' ' ' ARG . 20.3 pt-20 -143.06 164.33 30.4 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.229 1.014 . . . . 0.0 110.923 177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -153.93 -178.47 7.09 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.038 0.535 . . . . 0.0 111.33 -172.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -145.43 150.32 36.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 158' ' ' GLN . 64.4 t -148.12 165.65 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 121.246 0.546 . . . . 0.0 110.003 -174.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.498 ' N ' HG12 ' A' ' 157' ' ' VAL . 47.6 tt0 -130.13 105.97 8.3 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 168.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.627 ' CE2' HG11 ' A' ' 113' ' ' VAL . 35.7 m-85 -76.23 173.15 11.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.644 171.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -71.83 91.84 1.19 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t 62.82 166.99 0.12 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.727 1.211 . . . . 0.0 111.819 -178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -15.66 62.38 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.995 -0.441 . . . . 0.0 111.247 -175.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.94 -41.91 73.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.925 -0.484 . . . . 0.0 110.676 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.542 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.6 OUTLIER -68.86 -39.28 79.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -57.21 -36.29 70.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 O-C-N 122.102 -0.374 . . . . 0.0 111.107 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -73.22 -29.07 62.54 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 -176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -73.5 -38.34 65.39 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.76 -16.3 62.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.153 0.581 . . . . 0.0 112.16 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.412 ' HA ' HG21 ' A' ' 183' ' ' VAL . 95.4 mt -68.35 -12.35 60.96 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.626 0.648 . . . . 0.0 111.333 175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.56 -12.3 80.36 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.517 ' HB2' HG11 ' A' ' 183' ' ' VAL . 66.9 mmtt -84.15 -2.98 57.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.252 1.421 . . . . 0.0 111.978 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -52.11 128.96 26.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.945 175.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.9 mttt 61.61 9.24 2.67 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.632 1.573 . . . . 0.0 114.138 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -74.43 173.66 9.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.433 1.093 . . . . 0.0 109.053 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -125.95 154.47 42.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -170.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.2 mt -86.47 -18.43 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.164 0.986 . . . . 0.0 110.809 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 143.21 -18.23 2.31 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.837 -0.424 . . . . 0.0 113.056 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -151.34 -3.66 0.3 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.59 0.695 . . . . 0.0 111.231 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -148.06 154.85 40.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -105.51 156.91 17.76 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.342 0.591 . . . . 0.0 110.04 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 33.0 mm -127.11 163.74 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -170.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -128.55 156.34 43.47 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.517 HG11 ' HB2' ' A' ' 171' ' ' LYS . 33.5 m -129.93 129.56 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -173.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.687 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 6.6 m-30 -135.72 146.11 47.37 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -175.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -73.04 160.63 31.76 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.763 0.71 . . . . 0.0 110.333 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.6 t -159.28 -177.26 6.32 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.1 m -146.11 169.73 18.12 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.787 1.235 . . . . 0.0 109.332 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -56.64 -31.49 64.41 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.741 0.416 . . . . 0.0 111.136 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -67.76 2.95 1.63 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -124.26 1.38 8.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.521 0.729 . . . . 0.0 110.838 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.2 p -142.68 10.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.728 0.299 . . . . 0.0 111.486 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -69.83 15.42 0.08 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 20.6 t -69.54 -1.44 8.72 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.122 0.569 . . . . 0.0 110.846 176.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 117.83 -1.081 . . . . 0.0 111.061 177.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.309 0 C4'-C3'-C2' 99.584 -3.116 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.578 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.601 0 O4'-C1'-N19 112.199 3.999 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.928 0 C3'-C2'-C1' 104.935 3.816 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.4 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.845 2 O4'-C1'-N19 117.562 9.362 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.439 " O3'" " H3'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.416 -3.06 1 C5'-C4'-C3' 109.108 -4.261 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.687 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.574 0 O4'-C1'-C2' 102.523 -2.769 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 110.659 -0.126 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 49.1 m -145.68 164.17 32.59 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 122.917 0.487 . . . . 0.0 110.319 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.39 21.33 0.84 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.135 0.574 . . . . 0.0 110.891 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -134.38 16.22 3.73 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.053 0.541 . . . . 0.0 111.346 -175.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t -144.71 -11.1 0.59 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.524 0.33 . . . . 0.0 111.539 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.31 155.3 24.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.859 0.463 . . . . 0.0 110.555 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -157.23 35.79 0.28 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.936 0.895 . . . . 0.0 109.709 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -129.9 167.08 18.73 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.701 1.2 . . . . 0.0 108.394 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.54 -5.44 29.89 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 120.045 -0.308 . . . . 0.0 112.352 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -61.56 140.39 58.12 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.745 0.783 . . . . 0.0 111.196 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.523 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.5 p -149.98 175.97 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.504 1.122 . . . . 0.0 108.157 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 79.3 ttt180 -135.92 146.36 47.24 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.74 0.416 . . . . 0.0 110.266 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.415 HD11 ' CZ ' ' A' ' 131' ' ' PHE . 4.0 mm? -122.91 150.74 42.52 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 125.06 1.344 . . . . 0.0 108.372 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -158.96 147.57 18.32 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.685 0.279 . . . . 0.0 110.313 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.85 -3.65 57.39 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.645 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -65.07 155.76 82.97 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 117.257 0.529 . . . . 0.0 110.756 -178.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 32.4 Cg_exo -53.37 147.65 36.21 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.612 2.875 . . . . 0.0 112.147 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.734 ' CE2' " H1'" ' B' ' 1' ' ' ' A' . 26.4 m-85 -66.32 2.27 1.29 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -125.39 6.9 8.04 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 40.7 t -67.85 155.1 40.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.839 0.855 . . . . 0.0 110.68 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.7 t -154.57 -172.38 4.18 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.265 0.626 . . . . 0.0 109.523 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.596 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.3 OUTLIER -50.72 -30.98 15.25 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 123.21 0.604 . . . . 0.0 112.626 -176.444 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.483 ' H ' HG23 ' A' ' 123' ' ' THR . 40.9 mt-10 -77.31 -23.46 51.02 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -175.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -92.59 -30.37 15.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.4 mt -66.99 -41.02 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.8 p -73.51 -33.88 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.488 -176.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -73.04 -28.38 62.3 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.212 174.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 12.1 t80 -69.82 -19.56 63.47 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 115' ' ' LEU . 20.7 m-85 -118.95 33.39 5.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.374 1.47 . . . . 0.0 109.438 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.2 t -69.22 -4.07 16.23 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.807 -0.558 . . . . 0.0 112.289 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -106.25 20.08 36.01 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 175.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.499 ' HB3' HD11 ' A' ' 164' ' ' LEU . 55.2 mt -141.23 -167.02 2.3 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.842 2.457 . . . . 0.0 104.83 -173.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.28 -21.35 0.69 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 1.5 mt 52.06 178.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.204 1.002 . . . . 0.0 112.681 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.532 ' H ' HG22 ' A' ' 136' ' ' ILE . 25.1 m -116.44 155.63 48.33 Favored Pre-proline 0 CA--C 1.529 0.138 0 O-C-N 121.338 -0.851 . . . . 0.0 109.69 169.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.0 137.77 22.3 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.197 3.265 . . . . 0.0 112.569 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.1 t30 41.45 36.14 0.51 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.273 1.029 . . . . 0.0 111.766 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -94.64 27.75 13.2 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-O 118.792 -1.005 . . . . 0.0 112.021 -172.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.2 mt -135.23 145.58 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.088 1.444 . . . . 0.0 109.502 -177.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.8 m -138.12 149.75 46.21 Favored 'General case' 0 C--O 1.228 -0.063 0 C-N-CA 123.755 0.822 . . . . 0.0 109.79 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.5 mt -145.11 94.19 5.35 Favored Pre-proline 0 CA--C 1.53 0.21 0 C-N-CA 124.023 0.929 . . . . 0.0 109.404 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -55.88 159.18 12.32 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.76 2.973 . . . . 0.0 111.638 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.5 167.45 16.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 121.409 0.624 . . . . 0.0 111.285 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 63.9 m-20 -91.89 176.53 2.67 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.2 Cg_exo -58.35 -19.79 44.88 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.822 2.348 . . . . 0.0 111.67 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -81.37 -9.03 59.82 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.129 0.972 . . . . 0.0 111.213 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.54 2.45 90.62 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.459 ' HE3' ' N3 ' ' B' ' 1' ' ' ' A' . 76.2 tttt -81.57 133.14 35.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.865 1.266 . . . . 0.0 108.416 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.9 pt -66.33 148.29 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.484 0.659 . . . . 0.0 110.122 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.8 p -75.54 2.82 10.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.198 -174.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.39 6.3 89.35 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.797 -0.521 . . . . 0.0 111.797 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -139.25 164.06 30.81 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.087 0.555 . . . . 0.0 109.697 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.81 -178.65 7.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.339 0.59 . . . . 0.0 110.925 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -144.92 147.72 33.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -175.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.514 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 63.5 t -144.88 166.6 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.494 ' N ' HG12 ' A' ' 157' ' ' VAL . 41.2 tt0 -129.26 106.42 8.8 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 167.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 59.6 m-85 -74.87 171.05 14.72 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.465 170.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.34 88.65 0.46 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.1 0.476 . . . . 0.0 110.055 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.7 t 64.35 170.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.651 1.18 . . . . 0.0 111.583 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -17.53 63.47 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.769 0.428 . . . . 0.0 111.59 -174.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.24 -45.41 66.56 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.914 -0.492 . . . . 0.0 110.531 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -70.83 -31.68 68.48 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.97 92.78 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.674 -0.641 . . . . 0.0 111.069 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -68.78 -29.06 67.36 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.884 -0.143 . . . . 0.0 110.784 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -70.95 -37.63 72.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.417 -0.177 . . . . 0.0 110.578 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.511 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.16 -20.5 65.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.405 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.0 mt -68.38 -12.23 60.8 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.087 -0.383 . . . . 0.0 111.421 177.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.81 -12.56 80.89 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.555 ' HB2' HG11 ' A' ' 183' ' ' VAL . 71.7 mmtt -83.96 -0.08 50.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.102 1.361 . . . . 0.0 111.638 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.41 ' HA ' HG22 ' A' ' 183' ' ' VAL . 12.5 t60 -53.64 127.18 24.53 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.83 0.348 . . . . 0.0 110.228 176.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.627 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 26.8 mttp 54.2 20.29 2.53 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.785 1.634 . . . . 0.0 114.034 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -82.78 -13.71 55.78 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 73.49 171.32 0.3 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.011 1.324 . . . . 0.0 114.509 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.98 -12.45 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 154.09 -29.96 0.72 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-N 118.476 0.58 . . . . 0.0 113.993 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -151.79 -0.36 0.33 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.956 0.878 . . . . 0.0 111.162 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -147.8 150.37 34.09 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -174.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -93.49 152.32 19.14 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.165 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 30.1 mm -122.54 159.24 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -172.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.46 ' HB3' ' CE1' ' A' ' 184' ' ' PHE . 5.4 mm-40 -125.17 155.28 40.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.497 -175.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 171' ' ' LYS . 34.4 m -138.09 131.58 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.611 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 7.3 m-85 -142.18 156.06 45.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -75.91 160.78 29.56 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.679 0.672 . . . . 0.0 110.25 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 9.0 t -155.54 -174.62 5.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.8 t -147.98 173.19 13.14 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.5 1.12 . . . . 0.0 109.88 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -60.36 -31.71 70.58 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.75 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.14 -0.72 2.63 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -121.55 1.95 10.11 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.548 0.739 . . . . 0.0 111.339 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.16 11.13 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 120.899 0.38 . . . . 0.0 111.287 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -69.09 14.89 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.6 m -67.49 -3.17 7.82 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.292 0.637 . . . . 0.0 111.307 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.184 178.244 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.734 " H1'" ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.146 1 C5'-C4'-C3' 108.548 -4.635 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.692 2 O4'-C1'-N19 113.906 5.706 OUTLIER-EPSILON 0.107 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.454 ' C8 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.102 1 P-O3'-C3' 124.631 4.109 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.734 1 O4'-C1'-N19 115.875 7.675 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.627 ' C2 ' ' HE3' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.897 0 C5'-C4'-C3' 109.831 -3.779 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.611 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.636 0 C5'-C4'-C3' 110.077 -3.616 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 106' ' ' ASP . 89.2 p -162.0 -172.35 3.22 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.733 0.413 . . . . 0.0 110.753 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.08 15.36 0.05 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.854 0.861 . . . . 0.0 111.939 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.457 ' H ' ' C ' ' A' ' 104' ' ' SER . 33.4 t70 -128.56 13.58 6.49 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.889 0.876 . . . . 0.0 110.187 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.3 p -132.66 3.25 3.82 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.526 0.73 . . . . 0.0 110.709 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.476 ' HB3' ' HE3' ' A' ' 185' ' ' LYS . . . -159.25 164.6 34.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.077 1.351 . . . . 0.0 108.187 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -156.91 13.29 0.26 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -144.79 9.42 1.33 Allowed 'General case' 0 C--N 1.34 0.153 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.21 -5.99 50.02 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 112.172 -0.371 . . . . 0.0 112.172 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -63.49 144.47 56.96 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.645 0.736 . . . . 0.0 110.681 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.58 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.5 p -154.0 174.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.642 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.4 ' H ' HG22 ' A' ' 113' ' ' VAL . 70.9 ttt180 -135.62 154.79 51.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.97 0.908 . . . . 0.0 108.66 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -138.65 148.85 44.54 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -156.38 174.6 15.17 Favored 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.05 5.15 83.65 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.438 HD22 ' SG ' ' A' ' 122' ' ' CYS . 95.0 mt -59.92 150.47 68.99 Favored Pre-proline 0 N--CA 1.452 -0.339 0 C-N-CA 123.594 0.757 . . . . 0.0 112.101 -175.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.3 23.99 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 125.142 3.894 . . . . 0.0 113.965 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.515 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 22.0 m-30 54.77 5.68 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.23 1.412 . . . . 0.0 114.43 -177.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.69 -6.28 3.35 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.956 0.798 . . . . 0.0 111.802 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 10.0 t -61.77 150.53 36.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.038 0.935 . . . . 0.0 110.938 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.8 t -143.37 -166.66 2.37 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 171.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 mptt -51.35 -28.69 13.07 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.344 0.52 . . . . 0.0 111.995 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.495 ' H ' HG23 ' A' ' 123' ' ' THR . 37.1 tt0 -78.52 -23.91 46.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.527 0.731 . . . . 0.0 112.331 -177.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.501 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 7.0 mp0 -92.88 -33.7 14.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.342 -0.849 . . . . 0.0 110.093 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.426 HG13 ' SG ' ' A' ' 122' ' ' CYS . 42.5 mt -61.88 -33.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.0 p -83.32 -30.61 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.003 -174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -73.32 -29.87 62.98 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.907 171.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -68.65 -25.84 65.03 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.205 -0.309 . . . . 0.0 110.671 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -115.8 33.31 5.56 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.666 1.186 . . . . 0.0 109.214 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.1 t -64.35 -13.93 53.35 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.963 0.505 . . . . 0.0 112.252 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.01 13.15 67.68 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.821 ' HB3' HD11 ' A' ' 164' ' ' LEU . 69.4 mt -137.5 -162.22 1.27 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.011 1.724 . . . . 0.0 107.482 -173.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -142.57 -18.04 0.7 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -173.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER 46.33 -166.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.847 0.859 . . . . 0.0 112.971 -176.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.0 m -129.21 156.02 78.99 Favored Pre-proline 0 C--N 1.338 0.108 0 C-N-CA 123.852 0.861 . . . . 0.0 109.786 173.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.78 135.59 28.21 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.173 3.249 . . . . 0.0 112.301 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 55.1 t30 40.31 37.36 0.42 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.624 1.17 . . . . 0.0 112.33 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -96.52 28.08 14.81 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 118.934 -0.926 . . . . 0.0 111.75 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.1 mt -132.96 147.01 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 118.968 1.384 . . . . 0.0 109.314 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 98.8 m -138.11 147.41 43.94 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 123.807 0.843 . . . . 0.0 109.542 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 123' ' ' THR . 91.9 mt -139.5 94.38 9.46 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.527 0.731 . . . . 0.0 110.336 -173.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.82 151.62 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.022 2.481 . . . . 0.0 110.695 172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.94 166.32 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 CA-C-O 121.331 0.586 . . . . 0.0 111.266 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 64.4 m-20 -90.82 176.96 2.53 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.298 -0.865 . . . . 0.0 108.684 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 36.9 Cg_exo -58.76 -18.72 42.68 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.981 2.454 . . . . 0.0 111.755 177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -81.32 -10.86 59.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.865 0.866 . . . . 0.0 110.683 178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.7 14.43 75.72 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 112.078 -0.409 . . . . 0.0 112.078 -178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -106.54 148.42 28.25 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.5 pt -67.64 149.5 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.421 0.629 . . . . 0.0 111.671 -170.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 44.5 p -76.42 -7.8 55.82 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.007 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 108.61 -3.5 32.46 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -139.26 169.89 16.95 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.34 0.57 . . . . 0.0 111.265 -178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.41 -178.92 7.48 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 111.335 -173.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -144.14 148.11 34.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.488 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 59.9 t -145.76 164.83 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.669 ' O ' HG22 ' A' ' 137' ' ' VAL . 51.9 tt0 -127.75 99.21 5.46 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 169.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.651 ' CD1' HD12 ' A' ' 164' ' ' LEU . 48.5 m-85 -70.15 172.45 8.02 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.121 175.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.1 87.56 0.4 Allowed 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.871 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.5 t 62.6 172.62 0.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.546 1.138 . . . . 0.0 111.383 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -31.11 70.71 Favored 'General case' 0 N--CA 1.456 -0.147 0 O-C-N 121.906 -0.496 . . . . 0.0 111.007 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -59.4 -41.64 89.9 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.331 -0.231 . . . . 0.0 111.06 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.821 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.7 OUTLIER -72.78 -38.93 67.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -62.8 -34.94 78.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.984 -0.448 . . . . 0.0 110.408 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.31 -27.26 66.14 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.53 0.332 . . . . 0.0 110.299 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -77.27 -38.07 51.65 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.339 0.114 . . . . 0.0 111.181 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.409 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -59.53 -24.41 63.65 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.595 ' HA ' HG21 ' A' ' 183' ' ' VAL . 94.3 mt -68.55 -9.14 47.44 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 122.95 0.5 . . . . 0.0 111.493 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -78.58 -16.84 78.68 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -76.14 -55.52 5.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.116 0.966 . . . . 0.0 110.678 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.708 ' HA ' HG22 ' A' ' 183' ' ' VAL . 0.6 OUTLIER 23.77 -98.65 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.861 1.264 . . . . 0.0 112.941 -165.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.538 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 55.1 mttp -72.8 20.17 0.08 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -174.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -62.77 -178.22 0.19 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.108 0.963 . . . . 0.0 111.269 173.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -133.74 168.49 18.62 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.194 0.598 . . . . 0.0 112.37 -173.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.2 mt -116.47 -13.55 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.521 0.729 . . . . 0.0 112.009 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.44 -31.34 0.53 Allowed Glycine 0 CA--C 1.529 0.957 0 CA-C-N 118.52 0.6 . . . . 0.0 114.024 175.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -152.25 3.06 0.36 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.791 0.796 . . . . 0.0 110.995 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -144.03 156.89 44.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -105.83 148.37 27.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.474 0.654 . . . . 0.0 109.499 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 182' ' ' GLU . 24.3 mm -111.94 174.92 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -172.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.491 ' H ' HG22 ' A' ' 181' ' ' ILE . 12.8 mm-40 -138.63 154.66 48.67 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.708 HG22 ' HA ' ' A' ' 172' ' ' HIS . 17.0 m -129.92 134.94 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.63 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 19.2 m-85 -142.44 151.72 42.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 108' ' ' ALA . 8.8 mmtm -74.09 154.13 39.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.877 0.37 . . . . 0.0 110.553 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.6 t -157.37 179.41 9.28 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.849 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.9 m -150.76 170.74 18.51 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.137 0.975 . . . . 0.0 108.69 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -54.34 -30.84 52.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.682 0.393 . . . . 0.0 111.328 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.54 0.54 2.18 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.308 0.643 . . . . 0.0 112.701 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -121.25 0.06 10.01 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.138 0.975 . . . . 0.0 110.932 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.11 14.44 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-O 121.035 0.445 . . . . 0.0 111.11 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -69.33 10.58 0.31 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 59.1 p -69.23 -0.9 6.73 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.352 0.661 . . . . 0.0 111.201 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 117.185 -1.388 . . . . 0.0 110.896 177.59 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.479 ' C4 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.183 1 O4'-C1'-N19 114.31 6.11 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.515 ' C5 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.935 1 O4'-C1'-N19 112.632 4.432 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.175 1 C3'-C2'-C1' 105.128 4.031 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.815 1 O4'-C1'-N19 115.13 6.93 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.609 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.415 -3.196 1 C5'-C4'-C3' 108.707 -4.529 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.63 " H1'" ' CZ ' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.533 0 P-O3'-C3' 122.989 2.741 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 30.2 m -62.11 -26.81 68.51 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.13 -33.56 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.695 0.398 . . . . 0.0 110.795 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -161.49 -19.96 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.73 0.412 . . . . 0.0 111.312 177.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.6 t -153.18 -170.69 3.69 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.977 0.511 . . . . 0.0 110.113 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -148.33 168.02 23.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.939 0.896 . . . . 0.0 109.707 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.488 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 5.4 t-20 -155.85 24.65 0.38 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -172.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -132.88 0.69 3.53 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -173.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 113.03 -9.61 25.08 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.477 -0.392 . . . . 0.0 112.523 173.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -65.48 147.91 52.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.519 0.676 . . . . 0.0 111.094 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.561 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.6 p -155.49 178.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.207 1.003 . . . . 0.0 108.737 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.472 ' H ' HG22 ' A' ' 113' ' ' VAL . 7.4 mtm180 -134.43 162.81 31.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.938 0.495 . . . . 0.0 111.495 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.466 HD23 HD21 ' A' ' 118' ' ' LEU . 6.5 tp -145.97 142.79 29.01 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 154' ' ' GLU . 40.7 ttm180 -151.49 -18.54 0.2 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 181' ' ' ILE . . . -78.94 12.9 21.63 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.264 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 115' ' ' LEU . 97.6 mt -59.6 153.7 49.66 Favored Pre-proline 0 N--CA 1.449 -0.516 0 C-N-CA 124.494 1.118 . . . . 0.0 113.267 -172.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.56 147.64 15.77 Favored 'Trans proline' 0 N--CA 1.442 -1.51 0 C-N-CA 123.793 2.995 . . . . 0.0 106.169 162.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.604 ' CD2' ' HE3' ' A' ' 150' ' ' LYS . 23.7 m-85 -70.69 10.57 0.48 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -172.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.38 1.18 12.74 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 118.446 0.567 . . . . 0.0 111.88 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.423 ' SG ' HD22 ' A' ' 118' ' ' LEU . 48.6 t -65.89 156.44 33.39 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.261 0.625 . . . . 0.0 111.591 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 125' ' ' GLU . 2.6 t -152.93 -173.54 4.61 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.577 0.751 . . . . 0.0 109.506 173.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.594 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.2 mptt -50.16 -36.19 29.22 Favored 'General case' 0 N--CA 1.461 0.083 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.477 ' H ' HG23 ' A' ' 123' ' ' THR . 40.6 mt-10 -75.58 -17.66 59.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -101.74 -26.68 13.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.9 mt -66.85 -39.91 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.45 -34.77 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.368 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -71.08 -28.75 64.56 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.498 173.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 21.6 t80 -69.48 -23.16 63.6 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.025 0.375 . . . . 0.0 110.275 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -115.2 32.73 5.86 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.743 1.217 . . . . 0.0 109.244 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 t -68.8 -8.04 39.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.07 0.548 . . . . 0.0 111.994 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.92 15.72 60.35 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.725 ' HB3' HD11 ' A' ' 164' ' ' LEU . 52.5 mt -138.89 -159.75 0.99 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.002 2.121 . . . . 0.0 105.816 -174.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -143.52 -28.14 0.54 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -176.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 159' ' ' PHE . 2.5 mt 57.38 162.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.968 0.907 . . . . 0.0 112.352 -175.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 158' ' ' GLN . 2.4 m -74.4 161.34 78.54 Favored Pre-proline 0 C--O 1.231 0.09 0 O-C-N 121.0 -1.063 . . . . 0.0 108.643 169.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -46.07 -30.12 7.06 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.024 3.15 . . . . 0.0 112.738 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -162.33 134.26 5.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 171.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -173.92 17.87 0.05 OUTLIER Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.774 -1.014 . . . . 0.0 113.578 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.1 mt -108.4 147.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 119.517 1.659 . . . . 0.0 109.982 -173.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.5 m -140.66 150.78 43.96 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 123.68 0.792 . . . . 0.0 108.918 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 4.0 mt -146.76 97.43 4.25 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 123.062 0.545 . . . . 0.0 110.141 -174.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.34 160.76 10.41 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.611 2.874 . . . . 0.0 111.047 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 151' ' ' ILE . 31.4 m -146.08 165.04 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 CA-C-O 121.295 0.569 . . . . 0.0 111.282 173.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.444 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 57.1 m-20 -90.85 175.6 3.52 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 124.167 0.987 . . . . 0.0 108.524 175.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 38.2 Cg_exo -58.07 -20.21 44.62 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.831 2.354 . . . . 0.0 111.352 174.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -79.39 -10.09 59.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.086 0.955 . . . . 0.0 111.253 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.01 0.54 90.37 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -173.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.604 ' HE3' ' CD2' ' A' ' 120' ' ' PHE . 87.1 tttt -73.85 134.73 43.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.831 1.253 . . . . 0.0 108.575 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' A' ' 153' ' ' GLY . 9.3 pt -71.6 10.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -169.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 65.12 -17.2 0.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.859 1.264 . . . . 0.0 112.175 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 105.4 -3.49 40.11 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.04 1.305 . . . . 0.0 112.506 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 116' ' ' ARG . 16.6 pt-20 -132.6 169.59 16.41 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 118.772 1.286 . . . . 0.0 111.505 -177.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.41 -178.37 7.29 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.12 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -143.39 145.41 32.63 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -175.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.506 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 41.5 t -145.35 160.91 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.565 ' O ' HG22 ' A' ' 137' ' ' VAL . 49.6 tt0 -126.51 119.45 27.19 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 166.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.638 ' CD1' HD12 ' A' ' 164' ' ' LEU . 48.5 m-85 -88.71 174.73 7.85 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.462 170.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.12 88.42 0.42 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.581 0.753 . . . . 0.0 109.876 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.69 168.06 0.13 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.514 1.126 . . . . 0.0 111.184 -176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.488 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 1.5 tm0? -64.5 -23.91 67.43 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.846 -0.533 . . . . 0.0 111.214 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -62.83 -41.13 99.21 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.116 -0.365 . . . . 0.0 110.725 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.725 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -70.87 -37.75 73.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -61.85 -33.86 74.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.066 -0.396 . . . . 0.0 110.803 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -72.43 -27.16 62.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -74.09 -38.12 63.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.544 0.212 . . . . 0.0 110.512 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -61.48 -21.52 64.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.753 0.421 . . . . 0.0 112.086 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.421 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.2 mt -68.27 -13.45 62.26 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.965 -0.459 . . . . 0.0 111.161 176.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.5 -11.99 82.47 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.546 ' HB2' HG11 ' A' ' 183' ' ' VAL . 68.3 mmtt -85.37 -1.67 57.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.478 1.111 . . . . 0.0 112.179 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -51.93 129.08 26.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.748 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 62.72 11.09 4.62 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.404 1.482 . . . . 0.0 114.335 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -71.39 -171.44 0.62 Allowed 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.035 0.834 . . . . 0.0 109.361 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -134.36 164.49 27.3 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -171.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.8 mt -115.53 -11.48 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.764 0.826 . . . . 0.0 111.932 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 151.35 -25.96 0.98 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 121.891 -0.506 . . . . 0.0 113.938 175.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -153.59 2.14 0.26 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 117.736 0.768 . . . . 0.0 111.083 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -147.0 160.15 42.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.91 0.884 . . . . 0.0 108.672 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -107.13 145.22 32.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.483 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 21.9 mm -113.17 162.41 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -171.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.424 ' HG3' ' H21' ' B' ' 3' ' ' ' G' . 24.4 mt-10 -130.34 150.91 51.36 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.546 HG11 ' HB2' ' A' ' 171' ' ' LYS . 32.6 m -128.11 134.3 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -175.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.72 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 5.2 m-85 -136.61 163.56 30.27 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -82.59 158.59 23.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.879 -0.513 . . . . 0.0 109.959 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.6 t -158.99 -177.33 6.43 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.469 -0.145 . . . . 0.0 111.325 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.2 t -148.31 178.18 8.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.651 0.78 . . . . 0.0 110.301 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -60.48 -31.95 70.96 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.188 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -65.76 -7.16 14.29 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -112.02 1.38 16.35 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.506 0.723 . . . . 0.0 111.055 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.4 p -144.2 11.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 120.911 0.386 . . . . 0.0 111.555 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -69.18 14.16 0.09 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 24.1 m -69.19 -0.4 5.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.574 0.75 . . . . 0.0 111.184 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.859 -1.067 . . . . 0.0 111.155 178.254 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.219 2 O4'-C1'-N19 113.94 5.74 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.422 ' C4 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.747 1 C5'-C4'-C3' 107.448 -5.368 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.494 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.407 -3.817 0 C3'-C2'-C1' 104.551 3.39 . 0.01 2a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.494 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.417 -2.983 2 O4'-C1'-N19 115.657 7.457 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.939 1 C5'-C4'-C3' 109.347 -4.102 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.72 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.686 0 C5'-C4'-C3' 111.435 -2.71 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 27.2 m 53.16 17.51 0.99 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.452 1.101 . . . . 0.0 113.665 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.71 167.06 31.6 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.211 0.604 . . . . 0.0 109.981 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -150.84 -0.69 0.38 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.698 0.399 . . . . 0.0 111.804 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 69.4 m -149.08 171.54 16.24 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.232 0.613 . . . . 0.0 110.295 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 48.44 30.92 2.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.516 1.126 . . . . 0.0 113.961 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -149.44 30.7 0.75 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 120.835 0.35 . . . . 0.0 111.648 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -127.81 3.9 6.03 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 162' ' ' GLN . . . 111.12 -8.83 29.16 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 175.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -64.08 142.77 58.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.643 0.735 . . . . 0.0 111.154 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.546 HG11 ' CE2' ' A' ' 159' ' ' PHE . 9.2 p -153.13 175.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.997 1.319 . . . . 0.0 108.037 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.403 ' H ' HG22 ' A' ' 113' ' ' VAL . 75.1 ttt180 -138.97 145.95 40.35 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -119.09 152.82 35.81 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 123.867 0.867 . . . . 0.0 109.098 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.447 ' HD2' ' CE2' ' A' ' 184' ' ' PHE . 5.8 mtt180 -153.3 166.49 32.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 176.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.47 1.56 88.79 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.6 146.95 42.52 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 117.294 0.547 . . . . 0.0 110.78 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 9.7 Cg_exo -63.63 150.17 89.14 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.026 1.818 . . . . 0.0 108.577 167.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.439 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 14.2 m-85 -70.32 5.3 1.79 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -125.94 5.51 7.87 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 119' ' ' PRO . 46.2 t -70.33 157.51 37.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.896 0.479 . . . . 0.0 110.858 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.6 t -154.93 -171.63 3.9 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.262 0.625 . . . . 0.0 109.527 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.604 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 0.4 OUTLIER -51.22 -30.88 18.75 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -176.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.476 ' H ' HG23 ' A' ' 123' ' ' THR . 39.2 mt-10 -80.04 -17.84 51.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -107.0 -20.24 13.38 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 14.8 mt -71.27 -39.92 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 167.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 125' ' ' GLU . 12.2 p -71.17 -38.73 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.217 -177.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -74.66 -22.77 58.71 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.519 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -69.35 -26.6 64.77 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 170.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.48 ' HA ' ' HE3' ' A' ' 171' ' ' LYS . 36.4 m-85 -106.82 32.32 4.65 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.677 0.791 . . . . 0.0 109.629 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.4 t -61.11 146.15 48.42 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 169.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 89.58 2.49 76.05 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -172.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' A' ' 164' ' ' LEU . 23.2 mt -134.58 -172.16 2.95 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -141.59 -17.73 0.78 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -171.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.63 HG22 ' H ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER 45.84 -165.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.88 0.872 . . . . 0.0 113.272 -176.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 158' ' ' GLN . 17.4 m -129.9 156.08 79.56 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 124.068 0.947 . . . . 0.0 109.769 173.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.14 136.54 30.23 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.045 3.163 . . . . 0.0 112.252 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 53.5 t30 40.1 38.33 0.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.556 1.142 . . . . 0.0 112.206 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.04 28.66 13.56 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-O 118.877 -0.957 . . . . 0.0 111.86 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.8 mt -134.31 147.67 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 119.048 1.424 . . . . 0.0 109.538 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.5 m -139.6 149.93 44.4 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.586 0.754 . . . . 0.0 109.788 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 mt -145.52 95.42 4.98 Favored Pre-proline 0 N--CA 1.454 -0.225 0 C-N-CA 123.896 0.878 . . . . 0.0 109.309 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -55.11 160.96 7.33 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.799 2.999 . . . . 0.0 111.635 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.4 m -141.71 164.71 18.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-O 121.283 0.564 . . . . 0.0 111.249 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 67.2 m-20 -86.93 176.12 3.79 Favored Pre-proline 0 N--CA 1.453 -0.283 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.975 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 34.2 Cg_exo -59.08 -20.23 52.88 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.038 2.492 . . . . 0.0 111.61 177.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -82.43 -9.85 59.28 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.561 0.744 . . . . 0.0 110.575 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.84 8.48 79.48 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.312 0.482 . . . . 0.0 112.246 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -97.11 147.62 23.86 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 117.616 0.708 . . . . 0.0 109.147 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.0 pt -69.53 152.9 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.719 0.771 . . . . 0.0 112.022 -172.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.7 p -82.74 0.61 42.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.037 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.9 8.3 86.86 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.026 -0.429 . . . . 0.0 112.026 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -138.62 160.38 39.76 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.31 -179.5 7.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.149 0.499 . . . . 0.0 110.909 -172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -145.46 148.58 33.42 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -174.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 60.0 t -145.12 163.9 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -177.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.661 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.9 tt0 -128.28 95.61 4.21 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 170.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.615 ' CD1' HD12 ' A' ' 164' ' ' LEU . 52.8 m-85 -67.99 171.71 6.45 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.139 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.56 89.71 0.37 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.644 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.7 167.75 0.13 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.481 1.113 . . . . 0.0 111.007 -174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.424 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 36.8 tp60 -65.96 -20.07 66.08 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.707 -0.62 . . . . 0.0 111.211 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.07 -41.78 94.78 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.998 -0.438 . . . . 0.0 110.593 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -69.72 -36.3 75.76 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.494 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -61.75 -36.23 80.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 122.036 -0.415 . . . . 0.0 110.845 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -70.78 -27.26 63.78 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -74.11 -38.0 63.96 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.608 0.242 . . . . 0.0 110.685 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.95 -19.94 64.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.164 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.586 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.1 mt -69.9 -8.85 52.1 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.041 -0.412 . . . . 0.0 111.419 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -75.25 -18.21 80.07 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 131' ' ' PHE . 70.1 mmtt -70.19 -61.21 1.86 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.567 1.147 . . . . 0.0 109.582 175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.633 ' HA ' HG22 ' A' ' 183' ' ' VAL . 0.9 OUTLIER 25.34 -108.59 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.418 1.087 . . . . 0.0 112.715 -165.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.497 ' HE3' ' C2 ' ' B' ' 5' ' ' ' A' . 56.4 mttp -66.61 10.74 0.11 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -65.57 171.64 3.96 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.554 1.542 . . . . 0.0 109.925 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -123.86 165.25 17.69 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -168.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mt -105.64 -13.28 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 123.637 0.775 . . . . 0.0 111.963 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.1 -24.28 1.42 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.794 -0.448 . . . . 0.0 113.53 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -152.63 0.98 0.3 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 117.683 0.741 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -148.27 153.95 39.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.966 0.906 . . . . 0.0 108.73 -172.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -101.02 150.6 22.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.7 mm -117.92 171.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' CG ' ' H21' ' B' ' 3' ' ' ' G' . 18.2 mt-10 -139.45 160.13 40.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 172' ' ' HIS . 24.7 m -132.95 127.3 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.68 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 3.1 m-30 -128.07 154.55 45.57 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -75.48 163.25 27.59 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.796 -0.565 . . . . 0.0 110.592 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.7 t -159.06 -175.61 5.37 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.6 m -149.57 169.02 21.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.292 1.437 . . . . 0.0 109.138 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -57.7 -32.33 67.28 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.675 0.39 . . . . 0.0 111.38 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -66.94 -1.34 3.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -117.92 1.64 12.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.858 0.863 . . . . 0.0 110.911 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.56 12.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-O 121.036 0.446 . . . . 0.0 110.956 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -68.71 13.45 0.1 Allowed 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.7 m -67.28 -2.31 5.8 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.346 0.658 . . . . 0.0 111.364 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 117.198 -1.382 . . . . 0.0 111.056 178.479 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.404 " H4'" " C5'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.116 3 O4'-C1'-N19 115.236 7.036 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.439 ' C5 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.419 -2.814 0 C5'-C4'-C3' 110.187 -3.542 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.508 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.409 -3.675 0 C3'-C2'-C1' 104.552 3.391 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.508 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.918 2 O4'-C1'-N19 115.897 7.697 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.497 ' C2 ' ' HE3' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.937 0 C5'-C4'-C3' 110.233 -3.512 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.68 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.704 0 C5'-C4'-C3' 110.461 -3.359 . 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.549 0.214 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 80.2 p -144.72 4.82 1.16 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.034 0.534 . . . . 0.0 111.307 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.22 168.81 25.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.403 0.681 . . . . 0.0 109.904 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -147.53 175.81 10.55 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.58 0.752 . . . . 0.0 109.932 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 t -151.75 172.77 15.62 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.985 0.514 . . . . 0.0 110.187 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.83 121.82 10.11 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.45 0.7 . . . . 0.0 110.786 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 4.8 t-20 -161.83 25.27 0.12 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -131.78 6.51 4.34 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.33 -9.68 42.33 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.856 -0.498 . . . . 0.0 111.856 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -65.1 144.91 56.93 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.641 0.734 . . . . 0.0 111.048 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.547 HG11 ' CE2' ' A' ' 159' ' ' PHE . 11.1 p -152.9 174.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.137 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 59.1 ttt180 -136.35 145.33 45.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.043 0.537 . . . . 0.0 109.61 -177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.3 143.15 48.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -154.35 143.42 21.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 103.45 -1.11 46.29 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -67.95 157.45 86.78 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 117.468 0.634 . . . . 0.0 111.055 -176.228 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -54.58 144.85 61.76 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.176 2.584 . . . . 0.0 111.36 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.565 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 29.0 m-85 -71.0 12.27 0.31 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -131.67 5.82 5.51 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 51.2 t -69.16 158.44 34.89 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.387 1.075 . . . . 0.0 110.644 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.583 HG23 ' H ' ' A' ' 125' ' ' GLU . 6.5 t -153.73 -178.98 7.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.492 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 4.0 ptpp? -53.34 -25.36 14.81 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.583 ' H ' HG23 ' A' ' 123' ' ' THR . 41.5 mt-10 -78.34 -22.94 47.27 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.939 0.336 . . . . 0.0 111.611 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -92.69 -30.34 15.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.81 -45.6 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.69 -33.77 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.59 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -72.86 -31.36 64.68 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.494 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -67.34 -16.65 64.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.293 0.497 . . . . 0.0 110.203 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -120.08 30.46 6.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.499 1.119 . . . . 0.0 109.515 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.6 t -63.44 138.15 58.41 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 171.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.35 2.43 90.27 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -172.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 30.2 mt -138.07 76.22 1.56 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.198 1.399 . . . . 0.0 107.784 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -49.85 158.11 0.53 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.19 0.996 . . . . 0.0 113.472 -174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.6 mt -136.68 147.59 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 158' ' ' GLN . 18.1 m -70.66 155.25 93.67 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 118.521 0.601 . . . . 0.0 110.354 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -48.8 138.0 26.69 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.92 3.08 . . . . 0.0 111.739 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.8 t30 41.79 37.22 0.73 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.043 0.937 . . . . 0.0 111.802 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -95.61 31.85 6.8 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -173.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -139.51 145.97 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 118.238 1.019 . . . . 0.0 109.077 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 94.6 m -140.35 151.28 44.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.53 100.0 4.1 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -51.72 149.55 18.98 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.082 2.521 . . . . 0.0 110.934 173.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 24.5 m -145.25 160.84 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.434 0.635 . . . . 0.0 110.719 172.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.444 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 60.9 m-20 -87.38 176.42 3.47 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 42.1 Cg_exo -57.67 -18.25 32.38 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.825 2.35 . . . . 0.0 111.944 177.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.01 -8.54 58.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.425 1.09 . . . . 0.0 111.431 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.04 2.07 88.43 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.545 ' HE3' ' C6 ' ' B' ' 1' ' ' ' A' . 87.9 tttt -68.81 123.91 22.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.715 1.606 . . . . 0.0 109.824 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.0 pt -78.28 3.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -165.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p 66.27 -16.76 0.12 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 94.68 9.64 58.54 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.947 0.784 . . . . 0.0 113.794 174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -143.09 163.51 32.64 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.31 1.055 . . . . 0.0 110.676 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -154.93 -177.06 6.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.278 0.631 . . . . 0.0 111.089 -173.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -147.17 150.47 34.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 87.6 t -147.14 165.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -175.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.477 ' N ' HG12 ' A' ' 157' ' ' VAL . 54.5 tt0 -133.44 98.54 4.25 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.004 0.921 . . . . 0.0 108.898 170.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.547 ' CE2' HG11 ' A' ' 113' ' ' VAL . 58.2 m-85 -69.82 170.54 10.86 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -67.82 92.52 0.36 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.15 0.5 . . . . 0.0 110.196 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.2 t 62.42 169.65 0.13 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.717 1.207 . . . . 0.0 111.095 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 0.0 OUTLIER -66.4 -12.31 56.3 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.033 -0.417 . . . . 0.0 111.489 -175.531 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -74.48 -44.23 52.45 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.492 0.317 . . . . 0.0 110.384 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.464 ' O ' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -69.07 -36.72 77.93 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -58.32 -38.97 78.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.087 -0.383 . . . . 0.0 110.701 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -68.35 -31.64 71.18 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.449 0.3 . . . . 0.0 110.623 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -69.92 -39.06 76.37 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.434 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.73 -13.83 62.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.533 0.333 . . . . 0.0 111.727 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.675 ' HA ' HG21 ' A' ' 183' ' ' VAL . 93.9 mt -68.21 -12.26 60.68 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.737 -0.602 . . . . 0.0 111.042 175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -76.3 13.08 8.23 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.636 ' HB2' HG11 ' A' ' 183' ' ' VAL . 62.5 mmtt -118.87 -0.0 11.3 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.882 1.673 . . . . 0.0 112.353 -178.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.597 ' HA ' HG22 ' A' ' 183' ' ' VAL . 6.2 t60 -46.63 -20.95 0.15 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.527 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 98.2 mttt -142.83 15.65 1.94 Allowed 'General case' 0 C--N 1.33 -0.241 0 O-C-N 121.536 -0.728 . . . . 0.0 110.85 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -81.82 178.68 8.18 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.819 1.248 . . . . 0.0 109.616 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -129.85 154.26 47.46 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.02 -16.49 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 124.143 0.977 . . . . 0.0 111.198 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 153.66 -24.96 0.74 Allowed Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.746 -0.474 . . . . 0.0 113.399 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -152.54 0.92 0.3 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.794 0.797 . . . . 0.0 111.257 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -148.39 152.78 37.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.938 0.895 . . . . 0.0 108.651 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -103.31 154.83 18.96 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.39 0.614 . . . . 0.0 110.529 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 118' ' ' LEU . 26.0 mm -126.22 160.17 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.637 -171.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -129.86 151.97 49.85 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.675 HG21 ' HA ' ' A' ' 169' ' ' LEU . 35.8 m -125.77 49.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.028 0.931 . . . . 0.0 113.372 -167.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.599 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 3.5 m-30 -52.1 151.73 3.6 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.789 -0.569 . . . . 0.0 110.226 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -76.28 163.77 26.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.958 -0.464 . . . . 0.0 110.149 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 5.2 t -159.64 -177.15 6.18 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 69.2 m -145.24 171.46 14.53 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.753 1.221 . . . . 0.0 109.37 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -57.79 -32.13 67.24 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.764 0.426 . . . . 0.0 111.527 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.33 -4.83 8.79 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -116.63 2.27 12.96 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.751 0.821 . . . . 0.0 110.926 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.83 10.7 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-O 120.992 0.425 . . . . 0.0 111.172 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -68.99 13.7 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 m -68.22 -1.9 7.06 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.253 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.807 -1.092 . . . . 0.0 111.147 178.153 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.545 ' C6 ' ' HE3' ' A' ' 150' ' ' LYS . . . . . . . . 0 O4'--C4' 1.412 -3.383 0 C4'-C3'-C2' 99.74 -2.96 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.565 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.513 1 O4'-C1'-N19 113.332 5.132 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.43 ' OP1' " H1'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.172 1 P-O3'-C3' 125.129 4.524 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.73 2 O4'-C1'-N19 117.485 9.285 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.527 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.891 1 C5'-C4'-C3' 109.016 -4.323 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.599 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.506 1 C5'-C4'-C3' 109.274 -4.151 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.0 t -152.55 172.32 16.76 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.122 0.569 . . . . 0.0 110.019 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 50.74 23.71 1.47 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.086 0.954 . . . . 0.0 112.509 -176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -150.54 155.61 39.79 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.539 0.736 . . . . 0.0 109.502 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 85.6 p -161.4 -175.32 4.73 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.818 0.447 . . . . 0.0 111.043 -176.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 42.6 74.03 0.12 Allowed 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.122 1.369 . . . . 0.0 112.907 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.31 28.96 0.72 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.063 -173.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -134.78 5.81 3.4 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 109.67 -9.58 32.43 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -63.23 143.11 58.08 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.551 0.691 . . . . 0.0 111.078 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' A' ' 159' ' ' PHE . 10.5 p -152.34 174.55 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.372 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 184' ' ' PHE . 51.3 ttt180 -138.94 147.2 41.95 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.021 0.528 . . . . 0.0 109.976 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -120.98 151.17 40.05 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.457 1.103 . . . . 0.0 109.205 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -157.65 164.83 36.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.14 1.8 88.33 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.3 mt -53.68 143.53 38.49 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 123.137 0.575 . . . . 0.0 110.32 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.415 ' CG ' ' SG ' ' A' ' 122' ' ' CYS . 72.8 Cg_endo -72.87 27.96 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 124.785 3.657 . . . . 0.0 113.933 -174.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.426 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 16.9 m-85 52.34 18.82 0.98 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.162 0.985 . . . . 0.0 113.275 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -148.09 -13.97 0.13 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.797 -0.565 . . . . 0.0 113.003 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 119' ' ' PRO . 6.8 m -62.95 158.89 18.11 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.585 0.692 . . . . 0.0 110.698 174.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 125' ' ' GLU . 4.5 t -148.77 -165.03 2.17 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 2.5 mptt -49.91 -34.7 21.21 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.541 0.61 . . . . 0.0 112.049 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.471 ' H ' HG23 ' A' ' 123' ' ' THR . 40.0 mt-10 -77.36 -16.58 58.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -176.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -101.45 -29.38 12.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.3 mt -65.33 -34.01 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.2 -34.81 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.005 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -71.13 -27.09 63.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.174 -0.611 . . . . 0.0 111.043 172.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 8.8 t80 -70.19 -26.08 63.73 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 174.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -111.82 30.55 6.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.301 1.04 . . . . 0.0 109.545 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -67.57 -14.86 63.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 122.923 0.489 . . . . 0.0 111.83 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -94.42 16.62 60.69 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.581 ' HB3' HD11 ' A' ' 164' ' ' LEU . 36.6 mt -143.98 -162.05 1.39 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.349 1.859 . . . . 0.0 107.157 -173.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -146.79 165.29 30.13 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.1 mt -142.73 154.49 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 158' ' ' GLN . 27.4 m -60.13 156.45 38.55 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -45.95 -31.06 7.77 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 124.509 3.473 . . . . 0.0 113.813 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -161.41 110.42 1.56 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -149.04 6.51 0.83 Allowed Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.63 -1.095 . . . . 0.0 113.24 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.441 HG12 HG13 ' A' ' 157' ' ' VAL . 78.5 mt -97.68 147.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 119.471 1.636 . . . . 0.0 109.507 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 92.0 m -139.82 147.21 40.41 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.7 mt -143.69 97.24 5.48 Favored Pre-proline 0 N--CA 1.451 -0.41 0 C-N-CA 123.293 0.637 . . . . 0.0 109.408 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.72 159.35 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.404 2.736 . . . . 0.0 110.267 173.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.58 159.68 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-O 121.356 0.598 . . . . 0.0 110.963 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.478 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 54.7 m-20 -84.16 175.75 4.38 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.842 176.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 36.4 Cg_exo -58.5 -19.11 42.69 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.891 2.394 . . . . 0.0 111.522 175.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -82.64 -10.26 59.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.807 0.843 . . . . 0.0 110.872 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.17 10.81 73.96 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.341 0.496 . . . . 0.0 112.444 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -98.74 150.39 21.86 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 117.436 0.618 . . . . 0.0 109.908 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 153' ' ' GLY . 6.1 pt -73.77 8.1 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 -160.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 67.06 -21.59 0.11 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.133 0.973 . . . . 0.0 113.533 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 105.21 6.84 38.77 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.862 0.744 . . . . 0.0 113.479 175.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -142.72 168.1 20.52 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.249 1.024 . . . . 0.0 110.787 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -157.74 -179.46 8.18 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.241 0.543 . . . . 0.0 111.26 -174.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.93 151.74 39.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 158' ' ' GLN . 40.5 t -147.37 166.06 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -177.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.737 ' O ' HG22 ' A' ' 137' ' ' VAL . 55.1 tt0 -128.99 97.42 4.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 168.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' A' ' 113' ' ' VAL . 38.5 m-85 -67.86 172.82 4.98 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.197 0.522 . . . . 0.0 109.916 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.79 90.9 0.61 Allowed 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t 62.3 167.18 0.11 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.933 1.293 . . . . 0.0 111.738 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -15.69 63.07 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.888 -0.508 . . . . 0.0 111.053 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.48 -41.92 83.79 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.876 -0.515 . . . . 0.0 110.443 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.613 ' O ' HD13 ' A' ' 164' ' ' LEU . 1.1 tm? -71.17 -39.26 71.97 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -56.66 -35.78 68.79 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.267 -0.271 . . . . 0.0 111.039 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -71.91 -30.29 65.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.565 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -72.34 -37.28 68.9 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 120.644 0.259 . . . . 0.0 110.487 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.428 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -63.93 -18.76 64.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.937 0.495 . . . . 0.0 112.09 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.417 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.5 mt -67.98 -14.64 63.12 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.698 -0.626 . . . . 0.0 111.036 176.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.58 -12.78 80.44 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.534 ' HB2' HG11 ' A' ' 183' ' ' VAL . 71.3 mmtt -83.64 -2.64 56.57 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.736 1.214 . . . . 0.0 111.692 178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.404 ' NE2' ' HE3' ' A' ' 173' ' ' LYS . 37.3 t60 -52.55 122.68 9.37 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.566 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 77.7 mttt 60.98 17.04 7.53 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.326 1.45 . . . . 0.0 113.822 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -79.87 -18.41 50.78 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.36 1.064 . . . . 0.0 113.287 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 79.23 174.41 0.15 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.24 1.416 . . . . 0.0 114.573 170.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.77 -15.2 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.24 0.616 . . . . 0.0 112.611 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.24 -29.3 0.64 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 118.556 0.616 . . . . 0.0 114.191 175.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -151.51 -1.48 0.33 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.885 0.843 . . . . 0.0 111.066 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -145.78 151.59 38.19 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -97.19 151.2 20.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.027 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 37.5 mm -123.62 157.5 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -172.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -127.82 158.92 36.4 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.534 HG11 ' HB2' ' A' ' 171' ' ' LYS . 35.5 m -133.84 130.5 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.716 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 9.0 m-85 -136.98 150.38 48.1 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -75.84 158.43 32.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.337 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.9 t -156.71 -175.83 5.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.3 m -145.57 169.48 18.32 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.625 1.17 . . . . 0.0 109.744 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -57.16 -32.24 66.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.847 0.459 . . . . 0.0 111.116 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.24 -2.03 3.92 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -121.0 1.93 10.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.88 0.872 . . . . 0.0 111.051 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.89 11.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.885 0.374 . . . . 0.0 111.318 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -67.72 12.3 0.11 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 30.2 m -69.69 0.38 5.63 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.387 0.675 . . . . 0.0 111.28 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.275 -1.345 . . . . 0.0 111.149 178.091 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.41 -3.619 0 C5'-C4'-C3' 110.195 -3.537 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.426 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.193 0 C1'-O4'-C4' 106.548 -3.392 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.433 H5'' ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.113 2 C5'-C4'-C3' 108.892 -4.405 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.433 ' C2 ' H5'' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.419 -2.835 2 O4'-C1'-N19 115.761 7.561 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.566 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -3.035 0 C5'-C4'-C3' 109.601 -3.933 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.716 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.422 -2.592 0 C5'-C4'-C3' 111.283 -2.811 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 79.1 p -160.34 172.84 16.59 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.784 0.434 . . . . 0.0 110.574 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 52.94 14.43 0.45 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.854 1.262 . . . . 0.0 114.136 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.1 -6.05 0.27 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.99 0.516 . . . . 0.0 110.909 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 t -160.11 176.04 12.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.887 0.875 . . . . 0.0 108.787 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.22 145.14 48.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.464 0.306 . . . . 0.0 111.109 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.22 17.93 0.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -142.07 4.17 1.63 Allowed 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 108.45 -5.9 33.59 Favored Glycine 0 N--CA 1.45 -0.375 0 O-C-N 122.245 -0.284 . . . . 0.0 112.581 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -63.03 148.36 47.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.766 0.793 . . . . 0.0 111.286 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 159' ' ' PHE . 8.2 p -155.11 174.77 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.428 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.413 ' H ' HG22 ' A' ' 113' ' ' VAL . 47.3 ttt180 -137.17 152.21 49.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 tp -133.81 150.98 51.43 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -154.07 169.98 22.23 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.83 4.96 88.63 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.444 HD23 ' SG ' ' A' ' 122' ' ' CYS . 2.6 mp -58.5 149.05 62.96 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-N 117.035 0.418 . . . . 0.0 111.609 -175.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 122' ' ' CYS . 15.3 Cg_exo -62.04 146.97 95.99 Favored 'Trans proline' 0 N--CA 1.444 -1.431 0 C-N-CA 122.255 1.97 . . . . 0.0 108.715 167.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.649 ' CE2' " H1'" ' B' ' 1' ' ' ' A' . 19.8 m-85 -71.35 2.99 4.08 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.24 5.74 12.08 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 49.0 t -66.86 154.43 40.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.249 1.02 . . . . 0.0 111.134 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.2 t -156.05 -166.44 2.19 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.411 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -50.03 -53.14 28.86 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.714 0.688 . . . . 0.0 109.518 -179.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.551 ' HA ' ' CG2' ' A' ' 128' ' ' VAL . 32.6 tt0 -53.36 -21.25 5.49 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.333 1.453 . . . . 0.0 113.843 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.488 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 75.6 mm-40 -97.91 -19.67 17.94 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 121.004 -1.06 . . . . 0.0 110.635 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.2 mt -86.08 -26.18 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 125' ' ' GLU . 29.0 m -78.88 -33.7 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.04 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -72.66 -32.08 65.56 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.454 0.57 . . . . 0.0 110.698 172.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 171' ' ' LYS . 16.6 t80 -70.44 -24.39 62.88 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.395 -0.19 . . . . 0.0 111.379 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -120.56 29.25 7.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 123.855 0.862 . . . . 0.0 109.706 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 t -63.18 -11.54 21.52 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.036 0.534 . . . . 0.0 111.967 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.49 13.95 65.76 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.784 ' HB3' HD11 ' A' ' 164' ' ' LEU . 76.4 mt -137.76 -159.4 0.95 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.641 1.976 . . . . 0.0 106.627 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -141.76 -21.52 0.73 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -175.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.7 mt 51.6 -176.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.683 0.793 . . . . 0.0 112.606 -178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.599 ' H ' HG22 ' A' ' 136' ' ' ILE . 20.6 m -120.51 154.83 56.95 Favored Pre-proline 0 C--N 1.339 0.145 0 O-C-N 121.501 -0.749 . . . . 0.0 109.174 167.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.84 134.71 17.67 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.154 3.236 . . . . 0.0 112.746 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.2 t30 41.01 36.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.601 1.161 . . . . 0.0 112.557 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -81.87 -4.61 90.26 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 119.612 -0.549 . . . . 0.0 112.301 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.457 HG12 HG13 ' A' ' 157' ' ' VAL . 96.7 mt -98.91 151.15 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.989 0.894 . . . . 0.0 110.732 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.8 m -143.2 144.33 32.13 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.756 0.822 . . . . 0.0 109.346 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.5 mt -139.54 94.98 9.16 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 124.065 0.946 . . . . 0.0 108.615 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.95 158.6 16.8 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.447 2.765 . . . . 0.0 110.691 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 28.5 m -141.5 160.42 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-O 121.593 0.711 . . . . 0.0 112.187 174.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.463 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 18.3 m-20 -85.55 174.04 6.2 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.467 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 44.8 Cg_exo -58.03 -9.67 6.57 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.679 2.92 . . . . 0.0 112.539 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -104.3 -1.48 26.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.599 0.759 . . . . 0.0 111.27 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 82.66 4.38 90.12 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.436 ' HG2' ' C5 ' ' B' ' 1' ' ' ' A' . 79.0 mttt -66.86 162.56 21.41 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' A' ' 120' ' ' PHE . 4.4 pt -109.6 11.27 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 -166.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.6 p 63.33 -5.85 0.22 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 69.96 12.22 67.8 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.205 0.907 . . . . 0.0 113.252 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -141.27 164.79 29.3 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 118.044 0.922 . . . . 0.0 110.574 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -155.69 -178.04 7.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.55 0.74 . . . . 0.0 110.539 -172.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -145.45 154.66 42.48 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 158' ' ' GLN . 5.4 t -147.38 169.16 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.523 ' N ' HG12 ' A' ' 157' ' ' VAL . 51.1 tt0 -126.96 115.95 20.03 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.959 -1.496 . . . . 0.0 106.959 164.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.66 ' CD1' HD12 ' A' ' 164' ' ' LEU . 51.7 m-85 -85.26 173.53 10.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.302 172.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -70.09 88.48 0.6 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.13 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.1 t 64.62 168.33 0.17 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.488 1.115 . . . . 0.0 111.511 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -19.58 63.26 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.866 0.466 . . . . 0.0 111.752 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.21 -42.57 65.62 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.038 -0.414 . . . . 0.0 111.244 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.784 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -68.1 -36.06 79.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.411 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -60.73 -35.06 75.42 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.282 -0.261 . . . . 0.0 110.785 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -71.41 -28.14 63.79 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -74.55 -37.98 62.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.693 0.282 . . . . 0.0 110.602 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.432 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -61.54 -23.49 65.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.932 176.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 99.1 mt -69.26 -12.1 61.38 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 118.349 0.522 . . . . 0.0 111.411 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.85 -10.66 83.65 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.559 ' HB2' HG11 ' A' ' 183' ' ' VAL . 67.3 mmtt -89.02 2.02 54.65 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.822 1.249 . . . . 0.0 112.231 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.458 ' HA ' HG22 ' A' ' 183' ' ' VAL . 42.4 t60 -52.53 132.64 35.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.974 176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.487 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 87.7 mttt 59.38 12.04 2.49 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.48 1.512 . . . . 0.0 114.345 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -72.89 -169.93 0.65 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.018 0.826 . . . . 0.0 109.53 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.76 168.0 19.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -172.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.24 -13.62 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.438 0.695 . . . . 0.0 111.583 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 152.23 -26.05 0.88 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.394 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -154.49 2.78 0.22 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.66 0.73 . . . . 0.0 111.174 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -148.17 157.51 43.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.062 0.945 . . . . 0.0 108.686 -171.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -101.99 146.29 28.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 30.4 mm -119.0 162.12 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -125.59 153.11 44.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.826 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.559 HG11 ' HB2' ' A' ' 171' ' ' LYS . 23.2 m -136.79 132.56 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -177.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.613 ' CZ ' " H1'" ' B' ' 6' ' ' ' U' . 21.0 m-85 -146.16 154.04 41.34 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -77.53 154.67 32.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.694 0.283 . . . . 0.0 110.724 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.9 t -158.37 -178.64 7.43 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.538 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 66.3 m -148.05 170.3 18.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.695 1.198 . . . . 0.0 108.952 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -56.37 -29.58 61.61 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.761 0.424 . . . . 0.0 111.246 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -66.58 -1.03 3.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.664 0.786 . . . . 0.0 112.477 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -123.16 2.3 9.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.679 0.792 . . . . 0.0 111.167 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.07 9.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -69.19 15.14 0.07 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 25.2 m -69.06 -0.07 5.3 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.691 0.797 . . . . 0.0 111.113 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.211 -1.376 . . . . 0.0 111.227 178.017 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.649 " H1'" ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.408 -3.743 1 C1'-O4'-C4' 105.747 -4.282 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.522 ' C5 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.95 0 O4'-C1'-N19 111.845 3.645 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.462 " H5'" ' C2 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.408 -3.744 0 C3'-C2'-C1' 104.76 3.623 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.462 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.418 -2.936 1 O4'-C1'-N19 115.96 7.76 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.559 " H1'" ' C5 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.417 -3.041 1 C5'-C4'-C3' 108.71 -4.527 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.613 " H1'" ' CZ ' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.48 0 P-O3'-C3' 122.731 2.526 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.6 m -147.69 12.99 1.03 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.954 0.502 . . . . 0.0 111.213 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.29 14.03 1.43 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.705 0.402 . . . . 0.0 111.718 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -67.71 -5.25 15.14 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.969 0.508 . . . . 0.0 111.895 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.6 p -148.91 22.02 0.99 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.432 0.693 . . . . 0.0 111.095 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.25 33.35 0.05 OUTLIER 'General case' 0 C--N 1.338 0.067 0 C-N-CA 124.082 0.953 . . . . 0.0 112.498 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -153.43 28.81 0.49 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 122.431 0.293 . . . . 0.0 111.311 -171.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -126.62 4.29 6.79 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.74 -13.49 13.15 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -61.88 139.18 58.39 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.485 0.659 . . . . 0.0 111.06 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.597 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.9 p -150.91 177.43 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.725 -177.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.47 ' H ' HG22 ' A' ' 113' ' ' VAL . 9.9 mtm180 -133.26 161.51 34.29 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.202 0.601 . . . . 0.0 110.67 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -141.61 148.46 39.27 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.629 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -153.6 161.45 42.18 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.12 4.72 89.67 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.441 HD23 ' SG ' ' A' ' 122' ' ' CYS . 2.9 mp -59.0 153.22 46.01 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 117.324 0.562 . . . . 0.0 111.487 -177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -62.26 146.27 95.91 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.387 2.058 . . . . 0.0 108.163 166.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.428 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 20.6 m-85 -73.92 10.63 1.1 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.53 3.47 7.63 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 177.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 32.5 t -66.6 151.22 47.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.731 1.212 . . . . 0.0 110.981 178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.5 HG23 ' H ' ' A' ' 125' ' ' GLU . 3.0 t -146.94 -168.29 3.0 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.568 0.747 . . . . 0.0 109.142 172.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.612 ' H ' ' HD2' ' A' ' 124' ' ' LYS . 1.1 mptt -51.69 -29.31 17.7 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.5 ' H ' HG23 ' A' ' 123' ' ' THR . 33.0 tt0 -76.02 -24.23 55.22 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.114 0.566 . . . . 0.0 111.93 -178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.485 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 5.7 mp0 -90.84 -35.34 14.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.478 -0.764 . . . . 0.0 110.0 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.51 -32.54 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.73 -31.84 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.003 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -71.74 -27.64 63.13 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.755 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -69.78 -27.03 64.58 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 174.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -114.3 32.68 5.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.412 1.085 . . . . 0.0 109.53 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.8 t -64.5 -13.62 53.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.959 0.504 . . . . 0.0 112.164 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.31 13.67 67.05 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.786 ' HB3' HD11 ' A' ' 164' ' ' LEU . 74.5 mt -136.72 -161.47 1.17 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.241 1.817 . . . . 0.0 107.24 -173.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -142.17 -18.22 0.73 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 117.295 2.331 . . . . 0.0 117.295 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER 46.12 -166.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.819 0.848 . . . . 0.0 112.772 -176.242 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 158' ' ' GLN . 16.4 m -129.98 156.17 79.51 Favored Pre-proline 0 CA--C 1.528 0.106 0 C-N-CA 123.898 0.879 . . . . 0.0 109.852 172.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.96 137.15 22.75 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.027 3.151 . . . . 0.0 112.178 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 39.52 36.58 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.755 1.222 . . . . 0.0 112.952 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -93.15 5.33 75.23 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-O 119.13 -0.817 . . . . 0.0 112.507 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 84.6 mt -113.28 147.77 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 118.84 1.32 . . . . 0.0 109.476 -174.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 95.0 m -139.56 150.7 45.37 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.505 0.722 . . . . 0.0 109.249 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 6.1 mt -144.48 97.14 5.13 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.513 0.725 . . . . 0.0 109.52 -175.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 163.81 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 124.11 3.207 . . . . 0.0 112.056 174.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 18.1 m -145.06 160.76 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 110.321 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 60.9 m-20 -84.64 175.54 4.54 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 32.5 Cg_exo -58.67 -20.22 49.63 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.74 2.294 . . . . 0.0 111.045 174.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.25 -12.88 60.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.108 0.963 . . . . 0.0 110.768 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.77 8.27 76.78 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.459 0.552 . . . . 0.0 112.268 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -95.48 148.96 21.93 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-N 117.433 0.617 . . . . 0.0 109.785 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 120' ' ' PHE . 6.1 pt -77.24 7.35 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 -160.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.2 p 67.96 -22.9 0.12 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 175.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 151' ' ' ILE . . . 94.42 15.59 46.56 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.339 -0.701 . . . . 0.0 113.233 177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.77 168.06 20.69 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.286 1.043 . . . . 0.0 110.466 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -156.99 -179.56 8.33 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.395 0.617 . . . . 0.0 111.154 -173.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -144.06 147.98 34.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 158' ' ' GLN . 48.4 t -145.83 165.26 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.669 ' O ' HG22 ' A' ' 137' ' ' VAL . 53.1 tt0 -127.92 100.71 6.02 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 168.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.67 ' CD1' HD12 ' A' ' 164' ' ' LEU . 47.5 m-85 -70.29 172.05 8.86 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.971 174.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.41 88.93 0.33 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.564 178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t 62.89 168.31 0.13 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.623 1.169 . . . . 0.0 111.026 -174.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -16.95 64.31 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.741 -0.599 . . . . 0.0 111.266 -176.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.09 -39.9 78.74 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.86 -0.525 . . . . 0.0 110.685 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.786 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.9 OUTLIER -72.13 -35.21 69.06 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.451 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -60.72 -36.57 79.17 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.076 -0.39 . . . . 0.0 110.625 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.02 -28.54 65.56 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -72.88 -37.1 67.43 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 121.285 -0.166 . . . . 0.0 110.946 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.27 -23.39 65.63 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 111.936 0.346 . . . . 0.0 111.936 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.611 ' HA ' HG21 ' A' ' 183' ' ' VAL . 96.5 mt -68.98 -11.34 60.65 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.613 0.365 . . . . 0.0 111.707 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.78 -16.85 80.15 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -76.27 -56.59 4.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.106 0.962 . . . . 0.0 110.791 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.674 ' HA ' HG22 ' A' ' 183' ' ' VAL . 1.2 t60 23.76 -99.87 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.881 1.272 . . . . 0.0 112.63 -164.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.471 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 92.4 mttt -70.74 17.39 0.07 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -175.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -61.28 179.37 0.21 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.616 0.767 . . . . 0.0 111.237 172.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -132.33 164.22 26.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.17 0.588 . . . . 0.0 112.104 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.2 mt -108.79 -12.82 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.32 0.648 . . . . 0.0 112.258 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 148.82 -24.92 1.31 Allowed Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.866 -0.521 . . . . 0.0 113.962 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -151.56 2.09 0.39 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 117.624 0.712 . . . . 0.0 110.731 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -149.79 157.46 43.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.284 1.034 . . . . 0.0 108.395 -171.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -107.37 153.25 23.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.343 0.592 . . . . 0.0 109.563 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 28.0 mm -119.01 171.92 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -172.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -139.92 158.31 44.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.674 HG22 ' HA ' ' A' ' 172' ' ' HIS . 21.9 m -129.07 133.9 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.749 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 3.9 m-85 -134.68 158.29 44.47 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -79.26 163.79 24.66 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.849 0.749 . . . . 0.0 109.701 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.4 t -156.82 -173.26 4.38 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.236 -0.29 . . . . 0.0 111.768 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.2 m -147.04 167.63 23.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.626 1.171 . . . . 0.0 109.713 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -59.91 -30.68 69.19 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.55 -1.42 2.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.971 0.908 . . . . 0.0 112.455 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -122.99 2.23 9.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.12 0.968 . . . . 0.0 111.201 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.98 11.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-O 120.936 0.398 . . . . 0.0 111.207 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -67.16 11.67 0.1 Allowed 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 20.7 t -69.34 -1.99 9.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.524 0.73 . . . . 0.0 110.818 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.246 -1.359 . . . . 0.0 111.257 177.953 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.411 -3.478 0 O4'-C1'-N19 111.434 3.234 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.428 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.713 2 P-O3'-C3' 126.243 5.453 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.4 " H5'" ' C8 ' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.15 1 P-O3'-C3' 124.98 4.4 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.796 1 O4'-C1'-N19 115.319 7.119 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.471 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.415 -3.193 1 C5'-C4'-C3' 109.127 -4.249 OUTLIER-DELTA 0.0 OUTLIER beta 0.0 . . . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.749 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.629 0 P-O3'-C3' 124.063 3.636 . 0.011 4d . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.2 t30 . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 39.5 m 49.51 24.64 1.16 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.35 1.06 . . . . 0.0 113.412 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.86 172.97 15.94 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.062 0.545 . . . . 0.0 110.309 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -152.66 163.51 39.51 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.243 0.617 . . . . 0.0 110.074 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.0 m -143.69 5.62 1.39 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.2 36.35 0.29 Allowed 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.377 0.671 . . . . 0.0 111.113 177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.509 ' HA ' ' HG3' ' A' ' 162' ' ' GLN . 5.9 t-20 -151.02 28.29 0.68 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.672 -171.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -126.59 9.71 7.13 Favored 'General case' 0 CA--C 1.523 -0.083 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.85 -9.7 40.45 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -62.49 138.79 58.54 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.47 0.653 . . . . 0.0 110.218 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.53 HG11 ' CE2' ' A' ' 159' ' ' PHE . 7.9 p -148.6 175.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.862 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.417 ' H ' HG22 ' A' ' 113' ' ' VAL . 3.3 mtt-85 -131.56 160.94 33.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.663 0.785 . . . . 0.0 110.045 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.2 tp -144.54 140.83 29.06 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -156.67 172.87 17.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.415 ' HA3' ' N2 ' ' B' ' 3' ' ' ' G' . . . 84.04 8.01 84.57 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -176.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 72.0 mt -56.72 150.58 35.92 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.91 0.884 . . . . 0.0 111.819 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.83 20.34 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 124.844 3.696 . . . . 0.0 113.428 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.546 ' CZ ' ' C8 ' ' B' ' 1' ' ' ' A' . 21.8 m-85 55.21 11.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.631 1.172 . . . . 0.0 114.131 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.22 -7.63 1.94 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 126' ' ' GLU . 21.8 t -66.33 151.46 47.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.271 1.029 . . . . 0.0 110.342 175.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 125' ' ' GLU . 6.4 t -143.27 -173.46 3.94 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 170.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 2.9 ptpp? -54.71 -17.39 3.37 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.525 ' H ' HG23 ' A' ' 123' ' ' THR . 42.1 mt-10 -83.69 -26.12 30.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.949 0.5 . . . . 0.0 111.341 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.466 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 4.8 mp0 -87.59 -32.55 19.27 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.68 -35.62 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.5 p -82.27 -34.08 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.164 -173.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -79.67 -20.82 45.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.47 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -73.72 -26.08 60.52 Favored 'General case' 0 N--CA 1.457 -0.075 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 170.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -111.14 36.85 3.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.175 1.39 . . . . 0.0 109.024 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.3 t -68.11 -11.27 58.8 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 112.412 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -100.09 20.96 46.71 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 164' ' ' LEU . 43.4 mt -141.27 -173.06 3.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.475 2.31 . . . . 0.0 105.043 -172.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -138.64 -18.12 1.09 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -174.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 137' ' ' VAL . 1.3 mt 50.83 -177.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.208 1.003 . . . . 0.0 112.454 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.588 ' H ' HG22 ' A' ' 136' ' ' ILE . 18.9 m -121.45 155.88 58.71 Favored Pre-proline 0 CA--C 1.528 0.119 0 O-C-N 121.361 -0.837 . . . . 0.0 109.869 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -48.68 138.1 25.84 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 123.907 3.072 . . . . 0.0 111.881 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 43.26 35.51 0.87 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.849 0.859 . . . . 0.0 111.538 -177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -99.07 28.71 14.01 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-O 119.256 -0.747 . . . . 0.0 111.737 -173.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.4 mt -138.49 146.53 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 118.505 1.152 . . . . 0.0 109.513 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 96.8 m -143.9 151.55 39.97 Favored 'General case' 0 C--N 1.335 -0.051 0 C-N-CA 123.623 0.769 . . . . 0.0 109.268 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 123' ' ' THR . 1.4 mt -145.48 101.15 4.36 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -52.18 149.51 21.76 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.384 2.723 . . . . 0.0 111.32 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.5 m -145.01 165.74 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.361 0.6 . . . . 0.0 110.75 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.437 ' HB3' ' HD2' ' A' ' 147' ' ' PRO . 65.9 m-20 -86.59 176.27 3.7 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 146' ' ' ASP . 37.8 Cg_exo -57.9 -17.82 32.13 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.982 2.455 . . . . 0.0 112.088 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -86.28 -8.82 57.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.324 1.05 . . . . 0.0 111.458 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.71 1.7 88.96 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.444 ' HE3' ' N1 ' ' B' ' 1' ' ' ' A' . 87.2 tttt -76.66 131.33 38.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.451 1.5 . . . . 0.0 109.092 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.9 pt -70.89 147.34 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.394 0.616 . . . . 0.0 110.319 -174.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 30.2 p -80.77 -9.7 59.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.165 -174.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 111.72 -6.48 27.81 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.734 -0.481 . . . . 0.0 112.798 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -139.29 166.49 24.41 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 117.78 0.79 . . . . 0.0 110.452 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -150.33 -176.81 5.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.039 0.536 . . . . 0.0 111.058 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -144.67 147.64 33.3 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -174.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.509 ' HB ' ' CG1' ' A' ' 113' ' ' VAL . 85.7 t -147.7 164.18 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -178.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.467 ' N ' HG12 ' A' ' 157' ' ' VAL . 52.4 tt0 -129.67 104.87 7.68 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 168.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 136' ' ' ILE . 59.0 m-85 -74.31 169.52 17.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.12 91.74 0.37 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.9 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 16.4 t 63.76 171.31 0.17 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.201 1.0 . . . . 0.0 111.135 -175.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.509 ' HG3' ' HA ' ' A' ' 109' ' ' ASN . 0.6 OUTLIER -61.7 -30.04 70.49 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.109 -0.369 . . . . 0.0 110.604 -176.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -63.01 -36.69 84.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 134' ' ' LEU . 0.2 OUTLIER -76.6 -33.51 58.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 159' ' ' PHE . . . -64.76 -34.7 78.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.682 -0.636 . . . . 0.0 110.839 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -69.97 -29.76 66.95 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -71.81 -37.45 70.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.454 0.169 . . . . 0.0 110.859 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.41 ' CB ' ' CE2' ' A' ' 159' ' ' PHE . . . -60.83 -22.67 64.43 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 122.649 0.38 . . . . 0.0 112.018 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.639 ' HA ' HG21 ' A' ' 183' ' ' VAL . 97.6 mt -68.46 -11.65 60.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 122.213 -0.304 . . . . 0.0 111.397 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -73.27 -19.44 79.64 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.15 -63.14 1.14 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.044 0.938 . . . . 0.0 109.458 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.638 ' HA ' HG22 ' A' ' 183' ' ' VAL . 1.2 t60 25.11 -107.5 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.45 1.1 . . . . 0.0 112.521 -166.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.475 ' HE2' ' C2 ' ' B' ' 5' ' ' ' A' . 90.9 mttt -68.07 12.77 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -174.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.08 171.19 11.36 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.497 1.519 . . . . 0.0 109.635 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -116.92 155.98 28.17 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -169.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.49 -14.31 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.476 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 155.32 -27.23 0.61 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.643 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -154.47 -1.21 0.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.607 0.703 . . . . 0.0 111.583 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -145.84 150.63 36.52 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.949 0.899 . . . . 0.0 108.727 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -91.43 159.58 15.89 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.865 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 182' ' ' GLU . 36.2 mm -125.27 174.38 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 -174.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.542 ' CG ' ' H21' ' B' ' 3' ' ' ' G' . 14.4 mt-10 -138.96 142.17 38.39 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 172.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.639 HG21 ' HA ' ' A' ' 169' ' ' LEU . 22.2 m -114.61 139.29 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' PHE . . . . . 0.692 ' CE1' " H1'" ' B' ' 6' ' ' ' U' . 5.3 m-85 -137.42 159.4 42.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -77.72 163.62 25.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.83 0.741 . . . . 0.0 109.59 175.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t -156.13 -173.18 4.39 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.563 0.22 . . . . 0.0 111.561 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.4 m -147.29 168.99 20.37 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.351 1.06 . . . . 0.0 109.64 -176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -58.94 -30.35 67.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.638 0.375 . . . . 0.0 110.885 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -67.28 -2.33 5.83 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.368 0.667 . . . . 0.0 112.673 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -116.78 0.49 12.55 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.447 0.699 . . . . 0.0 110.496 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.59 8.52 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -70.39 16.2 0.08 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 35.1 m -68.87 0.02 4.93 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.471 0.708 . . . . 0.0 111.073 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.372 177.896 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ' A' . . . . . 0.546 ' C8 ' ' CZ ' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.413 -3.323 0 C3'-C2'-C1' 104.551 3.39 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.494 ' C5 ' ' CE2' ' A' ' 120' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.495 1 C5'-C4'-C3' 108.34 -4.773 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.542 ' H21' ' CG ' ' A' ' 182' ' ' GLU . . . . . . . . 0 O4'--C4' 1.411 -3.479 1 P-O3'-C3' 125.677 4.981 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.535 ' C2 ' " H5'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.081 1 O4'-C1'-N19 114.661 6.461 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.475 ' C2 ' ' HE2' ' A' ' 173' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -2.994 1 C5'-C4'-C3' 109.153 -4.231 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.692 " H1'" ' CE1' ' A' ' 184' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.64 0 P-O3'-C3' 123.503 3.169 . 0.015 4d . 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_